<SEC-DOCUMENT>0000927653-20-000093.txt : 20201103
<SEC-HEADER>0000927653-20-000093.hdr.sgml : 20201103
<ACCEPTANCE-DATETIME>20201103090759
ACCESSION NUMBER:		0000927653-20-000093
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201103
DATE AS OF CHANGE:		20201103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		201282061

	BUSINESS ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039
		BUSINESS PHONE:		972-446-4800

	MAIL ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mck-20200930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:f15aa9b5-be6e-4b9d-af45-f9d5f89227d0,g:ffd6c493-ffba-42d6-bea4-20131f0e9c42,d:ecfa0e5b7669406c886f8e2dcd87b845--><html xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:mck="http://mckesson123.com/20200930" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mck-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80L2ZyYWc6ZTU5NTg2ODlmMGYwNDdjMjlhNGU3NjlkODBlODk2MzIvdGFibGU6Nzc0Y2M2NGFhZWJmNDVlZTk5MDU1MmY1OGMwNGIzZTUvdGFibGVyYW5nZTo3NzRjYzY0YWFlYmY0NWVlOTkwNTUyZjU4YzA0YjNlNV8zLTItMS0xLTA_7e32a88c-6a1f-4b61-aca5-37b5d5312087">0000927653</ix:nonNumeric><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80L2ZyYWc6ZTU5NTg2ODlmMGYwNDdjMjlhNGU3NjlkODBlODk2MzIvdGFibGU6Nzc0Y2M2NGFhZWJmNDVlZTk5MDU1MmY1OGMwNGIzZTUvdGFibGVyYW5nZTo3NzRjYzY0YWFlYmY0NWVlOTkwNTUyZjU4YzA0YjNlNV80LTQtMS0xLTA_92fe6136-e7e8-476a-b1af-aa19ea5ea2d0">03/31</ix:nonNumeric><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80L2ZyYWc6ZTU5NTg2ODlmMGYwNDdjMjlhNGU3NjlkODBlODk2MzIvdGFibGU6Nzc0Y2M2NGFhZWJmNDVlZTk5MDU1MmY1OGMwNGIzZTUvdGFibGVyYW5nZTo3NzRjYzY0YWFlYmY0NWVlOTkwNTUyZjU4YzA0YjNlNV8xMS0yLTEtMS0w_71d010e3-4c62-4b27-acb1-82eb9f2ff533">2021</ix:nonNumeric><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80L2ZyYWc6ZTU5NTg2ODlmMGYwNDdjMjlhNGU3NjlkODBlODk2MzIvdGFibGU6Nzc0Y2M2NGFhZWJmNDVlZTk5MDU1MmY1OGMwNGIzZTUvdGFibGVyYW5nZTo3NzRjYzY0YWFlYmY0NWVlOTkwNTUyZjU4YzA0YjNlNV8xMi0yLTEtMS0w_c0036654-e436-4d6b-bfe7-c8e6d3ff12b9">Q2</ix:nonNumeric><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80L2ZyYWc6ZTU5NTg2ODlmMGYwNDdjMjlhNGU3NjlkODBlODk2MzIvdGFibGU6Nzc0Y2M2NGFhZWJmNDVlZTk5MDU1MmY1OGMwNGIzZTUvdGFibGVyYW5nZTo3NzRjYzY0YWFlYmY0NWVlOTkwNTUyZjU4YzA0YjNlNV8xMy0yLTEtMS0w_6252257b-6ed9-478e-aba8-c254c5e5f955">false</ix:nonNumeric><ix:nonNumeric contextRef="i4cf42a143b384f7684c59e0d55a8c9b9_D20200401-20200630" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1OTA_ef5deb27-a7a7-4410-a2df-e6fb8d4e63c9">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mck-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ef51821948842009566650c1ce108b0_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8b77cedb5a047039f862615e00010a3_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A0625NotesDue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3322bd7072c84251b61b81da05e4e706_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1500NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5cc1815dee34619a8e2ef3a22a42bf7_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1625NotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied6bc4345b4a4bd99bae269ad7084d51_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3125NotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i0ab19df7575e4779a1875a5d7ee85303_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i66de38bda2a744608a06a9b06ebf6645_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabc3b5f8046b48bdbf4349b5c0383f8a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dff60c859bc426a838f894b4001b9d9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56da4268cdee4c4a9b797e2a40feb4ae_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85c629cca8f64e44b872aac957b63d76_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib14ebdd9a67d42c6bff9fab1cd0291e3_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81a912f5f9a04d1ca5e7cb90f142a641_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86b3fd731c6a451da95296357c34854c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i624020a8d4c24a6faaadd5ffc919e8d5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86e7603b06d743728a36650859d04420_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff67f3d353954a34b18bf9eacb22eb74_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3307f8c1c01d4ecd976da193c588305c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dd3918b313740288772fde625402248_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3419ea2dc9594c8db2d6ab1f18fb857a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6d260abae684b3ea39deb99f2accdd9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9648da59dbf240cc901798b3fb380aac_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a499ada4b6a4143af9f09f3d2d3773d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b83385881344e4aaa0f55d53948d509_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id56ecd8e059f4e6696b7b1cc7c7988e4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife081627cfce4fe3accedd30e135266f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idadfecb50b694b9bad1fd34884a1ae60_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i750ef09c38ef490d90ed96590f8d7966_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b44c64ad2334280876102b25c03fa42_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie29e4f7dbe464f82b90c57337a3111f3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a50be3402444652b3cf2b02bc8f0cc8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c61eeba8b38459f985453da0e8c781d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8e660e321e04b6ea0ec390e4691fed2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebba672c55ee4c2a87f45e310c89afba_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if984c282fc6a4300aa9745b9ad1fd08a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cda9b3c50e4403fa7bbac61edca84dd_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07103e6d5410451f92642b65d23b443c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if90923f0cdf346f99356c5f1b103aa11_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaac2ef7159664221a50c14397114988b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib75098dd74134d5a900a9f389f1d593c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8628eafe53c44bb99de6a01f4fe1ec09_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ef50364db694bba8732ee06158ca2c4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie29be4b914d54b66b7225683b6f4fcab_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f826e5b14454ea8a2ada91a6bda9f6f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d91f70852e349d78d41746fc9b3a841_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3845b80d46e4483e96a588f5092ba0ba_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i151045664f014db396ec4d1388abafec_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic98282253ac24d17bb300a34d9842800_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i837e1a2cf1964b3c874339affc1c8eac_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ab0556aa9f340e3ac3f07efb1786652_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd49ad70765946169fa5a2c37504d223_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id27e19e091c34eb9b9768fcff47f09e6_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f0ea496105b47b2be2796a2ab03ad9b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i527d69e72eba46ae8d65ce3a0001cecc_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i055c7fe4fa114e6fa2ee03924ec916e5_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0e512234a3947858289f71240af0e24_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56a82c257d8b45a3beba6b2dfcf0cceb_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c459fbda98f4d89b895296afc039b3e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e227831a81048e1a8c4e713692e6037_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d9f213396824bbc864a45e30a5b1379_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14715badbe50426696183870464fb77d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ccc82d868704bdeabe6b0ed81650efa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebfb081bd626464390ff45f5fef68f5e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida674b76527d474486ce8b22743056d8_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i066d88a46b864f71bd116fd264f47155_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b95a05a13af42d5b440fef8def022b9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ef9e0529026452082cff03d5ad3ef31_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1d225eb50904ac7afd16a3e52e96014_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id047fe71417d4ba0a432ed05ef05fedc_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2ca1a2d209b4ea4a677b11a4d562bff_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0bd0811c0224eb6a8188a2281171287_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1038eaf9e8794cbcbded983f8ccfcb9a_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74dbf3756e304d92aeaccdcd0a323a87_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i519675db2894462f940aec3609198a9f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8a280e4073e4978b428ac6b0c0dd2be_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0532330a51214e249b3b9e2fbc5ebee3_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a26b872a65c49fbab22d3dd61751d4c_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7004546d044b4049a10a34e53e7b21d2_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i793953b750ac4456be2099940de03f04_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie193bb9fa6704fa3acc5751bc7472c22_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9726c90f483c47acb129d2e23e982038_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i153fe9ad0eb8417e837f3785055c6ed3_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ba7615df4f54c9394bdceec616f160b_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f906acdf8544001a98097ca5fefee5f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7f4bc7c87de41ec95337b9a9c2a5980_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffa749c811f44f839ea4c4218238ca96_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1414642232a64093b59196114d7bbe81_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8097b9305824e04b33569a91abcc550_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb9ee476d3394ecc80affa02786a5506_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27e2aad7746c41ebb5c5c95a5334fdd4_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee4f408f0d454849b9073de0b78b77a9_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95551ce68b8e47f0bba655aea0ee5f0c_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3093e8b5aa4420189b9a3f12efb6235_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6278551f7fc3480497a143f010615c9c_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8770d32fa2448e1a5a96bbcbabee231_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="numberofsegments"><xbrli:measure>mck:numberOfSegments</xbrli:measure></xbrli:unit><xbrli:context id="i72068016134b43bfacb6383f8d1e74f7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cf42a143b384f7684c59e0d55a8c9b9_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4506d920ace04fa991e79fe64d985216_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic83c30e7937b464a894f08434c22f5e9_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f8e385f66604149983dba6c977a6283_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifafa59fc61fa4be8b5cec6e15a260447_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i0ceed8f44d4e4223932f42e65df7847c_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0a54c8ec69a4c91a3f3e8c1893a07aa_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf37a667c0ec40628d54cc1c80d639b0_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ed1ecc0893943d88156c671256bec07_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cbe8bd08e2043a691eb83cc4d84f2ec_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bceb76fc90f4fc4a14733d6ed803565_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5abddbabf5c94c0fa20a7d1605f5465f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id816b0893be348beafb61bf8e5f30f0b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2bab316f14f4a24b71fb9d74d18cdf3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia19a8a6ef0bd48e1be49afd2d6d8a75d_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b52e33cd5364b31ad0004abbc59b28d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a597186da7942b78a164787ea1dea53_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf5d0799400b4399a996c8da70230763_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49c0062ceda84079a8aac41c1f01e410_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i805f21e7f7e04fbeb97134f767b3e1a8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c678c2a6d6247e8b531105d084453a3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c9ccbb6fda842ceb43fb552e0daf01e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6656f9779e14248b3ab954ea86b6abd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdd739be481242018906607a0e292bcd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0412307b393b4b31809303ea6964eadd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4809ccdb789473eb416b9fdf1aea69a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dcc43c72e854787a25695f0ff26f3e3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31f383b4585b4d15840458661a81ecf3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46a8b56ffa35493ba482183ab526d9bd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d1520f234a14153a52538db1d0fbc55_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia003613bb8bc483286b8644efc98f668_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27e5cc6dcf7146199a2f75c2b2ffa8af_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib875ce3800a84805974094ef7390c47b_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ee29e972613498aa1e93fe830d2eb8e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7c1d98305344009a39b536f04f12c9e_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedb569793bdf49caa63b344631feb0d0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iceed4414407b4b86847ad2d2815f97dd_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8f59e8d12d84c3893cbe9b46385b3ed_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e76a24704794920bda6de2102ffebac_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib73487326569472394f59d7b9300567d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0838a6f327724e01a3d66fd6fc84b706_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd88456c2f48402184d07594c1ba6eeb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68ff9ffbf98d4a1781d19ab625704e99_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11292865b78d4742933b20217600c04b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i017eaec1fb0f4fcaa8bf8c05655a17ab_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4343021266684e09aac01da8724fc70e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1671d32a17be409fba3f84f83e2794f7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia54b0b6c830541ae8639a2eaa798e845_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c961f18f05e48699a6932152d3b4bf5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="idb66d47f37f94937b69269c1af59b8b9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47b5375d9880408783a5c35d0bf9a5a6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9749be689974b10b3717c1f4f66b1b7_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id809ea9c3d4348ba9c6347b08f2823f8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13b7d11348f2478dbc84c872d3eeacea_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f53e387d5a04f1fb44fa3972fa2143a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f1078720e5143e4b52c84e6e385b68b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa11ecf1c6d5459db583272a482d2382_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbdd4b3c559743d6869a9f70f2186ede_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d27cf1f90fc45b3ae73b669b099480f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ca04e14279740e28d9b9ddcb4dba385_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17d9381377c24a9ab35373e9e45ff3c0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52c6f40d2729407c94ff1c3df7df4ff2_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i818f8654b0e24954be9c97bd24ef37ab_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i389a8e5295ce4baf8bf99cd380e382ca_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bc860b936064f418b265dc92fb1e420_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d9fefc80324149bd26fbe32cfb7e78_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib35aa222c90b4f96af5dce4124e6fa37_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefc14ef243d44219b893fb6a33e8dec3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic21c3596993443348892ffc6b8dca3b1_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i453234fb946045ff8438628a7160ef19_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a29c719f1364338a8ee516a3a09bc49_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i660c5557487b4523bf470784c38e3aac_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54063222c8ab42b3ae44fd8854c2bf05_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ba538365d5e441a82217d66cdb7223c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f3890eafd704e1a9986d7f4b86e0128_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief750a41c974485c93c0149cb17947dc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ecbc2cba03648fcb37d779597f1e7e6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ef7bc345256444fb9b45e1218e9f993_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf45d6fc4e38421a8db5b7f7cafe2475_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f8c08fbc7af4c1a9f49870c08e48b80_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic320828dd03442ee9aaea62c9ff4f7ec_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff6a7243fae845218e8fb56aa25e2fab_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cc04539515847199daba415d910a6b7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7567972184114435b6959d8ccf29fe0a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4db1b4b02324493a0d2914c618224a4_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a9512d260804f718da6e350b1800535_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i784afe00169946859b02a103c522f100_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2978b39e5aad4aa98f0c28c043489c2a_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ff32fde532b4686b339b43a1460c33e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie295c63a512442a9a5a5f6037b32648e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13d8fa5857224b039c9983f670be125b_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb2673c258d340f29617801db8c6fb15_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i910303b53ca54b109dae4facc910bf03_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i643229e9e25c45bea23409a01f621fd7_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i819bef3ae9cf456ab4d6f597308e2091_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1f31df78005498ca5d7cdfcef7b62ff_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ac1d82117e34d24b3c7ace14a5f0a9c_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i923fbba79f824ad3b6ee7bbdbb9b6d22_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1112ba0650748618ecb2605c5c0d6e4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a05e5e085724cafb5736c6c660887d5_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib26d4d498b2241b28165e3a6aa3585cc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87e3ce919cec41759ba7b04549cc3dd9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8153b95460de463caaddc69ee4d76393_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A365NotesDueNovember302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7ff3def80794627a2f81c1fa3fa88b7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A365NotesDueNovember302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12cf340a696a46ccbc81980bb0ca828e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaee8abcfafb84ff798eb09d3d083a04f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e6d0550b478436495bc0fe4be6cba3d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15cc3c8cf89346e69d4e74ca74186f27_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3c56f40d6044473b6be9ef97877702e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30b436690be1400f81e8c682814e47b5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a7a25e2db1543149b28b05daeacffbe_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia52812d9b87043cbb33eb38e018afe29_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21479c35ac7947908fe229498bfad314_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i804e09f7332d4333b3d930fc39208c0b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i367acbb5aa6f41a89563cba34fc5e16a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied4ba394ed964ed29284c6a42d50859e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1db34deedcb444fcafd3824ea72a77fa_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i986b499c7ecf4099ac52aa32adaf7eef_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i840a57d92c2e46fca0b999599fd6e33b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i512dab20822e47d0a0cc52e0e34781dc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf662601f4324e058290f105eaa0b95f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie46a2a101c1946dfad26f454b2205e3a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i767d2070f41b43f08cadfcfde4ee0193_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0094db52755c430db5bb53ecf3675114_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3f4f9c5449c42758be9a4044c781b77_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70c5081e1fcc46fbbaab261e039a3f10_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cd299e885c34f10b74ee273e0f81d20_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3028d3a5bee645aaa6efb97a0e849ab2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7950cda1af7346a88986fcba915ab374_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3948c23924c4bb09533ac72ede98ae9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39366f5479b542dfafca236d0d404772_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i154e895b81404074985fd505c76d4a57_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82f9efd5a22a44eba025d8456a2a8394_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fc86cfb0d1743db9420435fcbe782c0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie51ec41d88fc4fcbbb4e98a2489344d4_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i747404c509964f31988b62072dd13f33_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfac515039344132aade2b5793055812_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bd3593ba0404917bb09d01792baf9d6_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44874b5446184867b047a21535e841fb_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic59633479ac94c10987acde294155741_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id887e8ba801a4f9f9555dc352f23f1de_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5dfa0efbd542b0bd5acb63dc7fb114_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5752cf5996be43f88c48f5343cf12504_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i629e2b60a9a340a78d36af765192f461_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc317023efda478c82c32736a1b73ada_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0473786d65074893b89caa770decaf2f_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie58a935d3b8640fcb9895478c6828da4_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifafe5ac3b39e4334b35a9018a18479ae_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49ee6f642eb4455483bb1c23124fdf11_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="participant"><xbrli:measure>mck:participant</xbrli:measure></xbrli:unit><xbrli:context id="ic18da827aa754e04a2fad2bf8a72cc18_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27674bc44ccc4dcc843eb0366732e666_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8259a0225045474dace4f33866146c8b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5be699bdd1a4617bcd28de6f863eaab_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="idf0d0beda4f94c1c95f3735c727aaa99_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefe68917b64346948a4da9e249ab34f7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28545f9d3bda45efaa5277b002e22e7a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11351bf2991743d7af90b551540fc919_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib49781b522ea4f76b1513c0e998abcab_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8234a3e5eda4043b4d3fa3510856378_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="i4ddc0b315b6f44b0ae7eb4080f845509_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if390d59ed27b4bc8a9ae736d392c53fb_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="iecdece7bccac464e91de8f41f5c11988_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8acb42c198243e4a41c9b1198ebd29b_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i845cf95a4c8a421fafec2976a240ff82_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8df2eff3ed674556a1b6d76ac1e2fc2b_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib993ed38bcaa44e992d425b235b667ba_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdb08454a4384d82896df1a6d61f11f9_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88ca01400a5e4f17a31f7e6a13628bec_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31bf530a67154f4089f298f4daebb618_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccbce5482ad640f5b90191abd057ac63_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ad1ff26ff3e4d089de290e9695a1cb1_I20200427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c1475ccb75f4635a9bf4d405fc5d8f5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i123bf8d69a8548fda1b8942d92d2fc33_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85cd2589de304d938cfd483404ca1653_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia124b703fd9c4666841454b448394b00_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9356380a99d4079b931630ff762728b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i258110de1c154e9480bae6db28d0f729_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a7c1b74f86c479b816159c6d3ae04b0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b5ddc35c76e45c7a9c189c497c848b8_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bc3ab577dc7480fae3d98e14277684f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21e4948d75de4a3baf98851aa5242f47_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9949b55995c54523b05daddb017a3ac4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i206a9aeb7e4a4008803c87c65282730e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic03b5f5fc26d47c3be37eff2f0e07604_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba46bb814a6e4d07bedaae798f4c086c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2e52268a81f4aa28240eea26becc2ba_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f31411e76594912ad9c4c6fdc037070_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69864efaf345415db2c3cc9adba8a027_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a67d47d26e744bea5b1a64745a103ef_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie09c8165d0db4a47be02c5ba356b27a9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15eb6e4eb94b4f57885a65039289f579_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb450020edcc4eafb4f6204bd56f1294_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48d17d2683c04f8e978bbfeeda49522e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c01ee54c64b4e738869a1a426b32be8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b838d45789a4813a7f70a4900210195_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eaf2c336e1d400ba5e9a2c97cfb4467_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e77147ea2824ec685fc498f61706e2b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i851951555ad24db390460dd6eda13a71_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbba6884ea2d430c82bef1bffa38851e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54c29ac67c524830b5346ac601e7912c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1469f9d2f2f144f6ac3ea35586bb7cf0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b890927812447aa911816632e628829_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5badf059a14f4d8ab6f9ce6affac29bc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fa8c90408ea4e3dae6e394bf3fa943b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b844b3b721f4a0d922cde7ae32b2875_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="company"><xbrli:measure>mck:company</xbrli:measure></xbrli:unit><xbrli:context id="i0f5ac3d5d5f4479592e96e5bf4ee0a01_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cb4731f3b53414bac5ded8a850e5f3b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mck:case</xbrli:measure></xbrli:unit><xbrli:context id="i7ed3f74dc0ae44f8baf2c9b085580e45_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib06af04e28ba4e4ea6652465ca257cfe_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="county"><xbrli:measure>mck:county</xbrli:measure></xbrli:unit><xbrli:context id="ibd6d24f4b8e64a778fb5af40d017aedc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaaee7621692492e90da6fe2f00a5923_I20200114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e08cb2f184f4ac491a30c4f2f86b5cd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>mck:state</xbrli:measure></xbrli:unit><xbrli:context id="ia89ab571675d4fe1be458deb9d1756b6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state_attorney"><xbrli:measure>mck:state_attorney</xbrli:measure></xbrli:unit><xbrli:context id="ifef9ed0f951845c09b3a887cc0f7469f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b88d5a3d4ab496188c56155a2880f90_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56fa48494eef42e2a81d8b80e6683829_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4a0fa8d9f0a41d0a8385cb9c0f43e82_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="relator"><xbrli:measure>mck:relator</xbrli:measure></xbrli:unit><xbrli:context id="ife3f7c8428454d1a83b2d27fbb7084b5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelKelley19Cv2233Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic933332211124a748e5866fc45b2d46c_D20130517-20130517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-17</xbrli:startDate><xbrli:endDate>2013-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c69b4d259c846329b91b3b6969f1004_D20130517-20130517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-17</xbrli:startDate><xbrli:endDate>2013-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="fax_number"><xbrli:measure>mck:fax_number</xbrli:measure></xbrli:unit><xbrli:context id="iace4f3d9ad444347aa132bbc7bb400f2_I20190813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="fax"><xbrli:measure>mck:fax</xbrli:measure></xbrli:unit><xbrli:context id="ia241be660d814c9dbfbab339569e8b37_I20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>mck:vote</xbrli:measure></xbrli:unit><xbrli:context id="ib24b30ad412f4321bcaff6b945c5ab8a_D20200728-20200728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-28</xbrli:startDate><xbrli:endDate>2020-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc731429591343fb9685ce4e3d37b71c_D20200729-20200729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-29</xbrli:startDate><xbrli:endDate>2020-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i094f2986d473404cb6ffd79049564a6b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i360a0a25e36a496585c2f2d80ef31321_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e72211ec5474ca28d33b7a18d5879c3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1009c601f4d148e38fd22bf9694cd964_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3801a94ee254dec8814967fb501debd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iade843f75deb448186e6e38895fb48b7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15202989514f4acf8e987ae99a0216ba_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3646d4cbd2ad43c3b6da83e852552ca4_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cfff32ee6a14e168c5922d492015d9b_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dfcb285fb6b4a5c8cbbe9bd79f0a497_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93126ac576fd4ee59dbe2a22e4b7078f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24e52575e1654c46a8f81e254c90ab96_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94c06ecc9cc7491180bd8fb5bd26438d_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i081813b992464ea9ad8920cab184e999_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2801f5e86df94d55bd75e10e15bf4d5b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d3a810191074649bfd35939eee1cfc4_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b41db262baa42ac85b207a7a3c6851b_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7ed596faccb4197854f21d92b8137b6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i364845bbc169420e8195d9305f9f4c1a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bd48cde79e84ac4a46f6744e674f4ab_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8de456c9de55433dac6af26e743f73cd_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71ac51620ddf48c0a43eb177d2b8787c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8566f25837414d39ba7f2dfa91ef0a42_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08d04048582a441a9829e7d02b02b64f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafe0cb7d5ecb4f14bdcf107625ab76a4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3642cd678a64ba1b231726d09a37604_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4cc9f5f8d11498da1ed9306dc8d7f7f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2530e99848e4b36ba92e924f579d9df_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i785fd2b4e9024f8ea22b4baf93fe610a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c6aa5965ffb4e8b8ddd05a70b872808_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6a19d8b0fe745be9ff1c9a795dfd0bb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64d90c4a197c4d62b7688640c6c181c2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i584b4e2274074d37aba8cd24589cb580_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i666e4b283dc645e7900ef3d3a1d91aac_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i560a87a2893946699ede55eeca7bfd22_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ea0dc529a904ec9a931482f59d28dd8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0604a8575de4a9396ed7d28ed0294c7_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i152a0a34c50a4f5b95780eafe02e0ea9_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3de1a24b580146c49c37a4942dd6c16c_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id36e3e6db92b4ddd84ae2a9af1d43fd3_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bdc606394464f49b8531ade9f76854b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a725751bc8343cdbc4cd04f87ce1ad6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14767a5727ac4417a8c16be22209e0bf_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0aa1d9903934d4bb44c6053ee11ca01_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f028c579ca84ba1a3fdffbd5ad2731a_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4471500f1af84287bc5e2719e750de11_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64bc67d401ba41cd98cdc8120660d0ca_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f4759dae41f41e98b79f41976fa69ca_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e7e3d6a2fc24aba8fe36b60b9a70d8e_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10878ad786c14616809f16456682cb91_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47b46bdea51b4a518badab77507f0e56_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>mck:country</xbrli:measure></xbrli:unit><xbrli:context id="ifd8554d6b3ce4907859a8adc5bfd5199_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="numberofproducts"><xbrli:measure>mck:numberOfProducts</xbrli:measure></xbrli:unit><xbrli:context id="id3e327dccb0243cd8c395cc18f592326_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5842c602b5a9464db55d6b8a5ea2fef9_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02e816dd3ea9489cb878840d51f8df47_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fed2bcc3c3b42febd8b01ce2735ad1d_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida57532d2ac84b80a31ba148be33330e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ea2351304814e458dca8d34103c7273_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76b51bde9d3d4cb0addfd0460eab9c05_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i647a92415ea7432f9ea523b7b0536a18_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e287f0b27c448b49c58667e8198eae1_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if891f7281b7d419086880575baba6e9d_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf4e3d6784d447beb68308a48fff9d3c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie18fac8f12304381ba36b0b283d93b84_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;           &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTU1_7f344c05-565e-41fc-af8f-f9311bd33fa2">10-Q</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6OTA0MDhkNGJkMTlkNDNlOGJkODZlZjUzMWJiZmY2YjcvdGFibGVyYW5nZTo5MDQwOGQ0YmQxOWQ0M2U4YmQ4NmVmNTMxYmJmZjZiN18wLTAtMS0xLTA_d336c2fd-6559-4cbf-af89-1b3ca1176f93">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8xMjQ_dddfae91-c4be-4a4b-b50a-3e81645a1e11">September 30, 2020</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6ZmVlYTkwOTZjMDllNGUxZThjZGJhZDE3MjNmZjY1NTcvdGFibGVyYW5nZTpmZWVhOTA5NmMwOWU0ZTFlOGNkYmFkMTcyM2ZmNjU1N18wLTAtMS0xLTA_c55b7159-39fc-4835-bcc4-97e8ebed65b2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTQ3_8fa1c23c-5cb2-4f61-ae1d-58d76a3f021f">1-13252</ix:nonNumeric> </span></div><div style="text-align:center"><img src="mck-20200930_g1.jpg" alt="mck-20200930_g1.jpg" style="height:29px;width:196px;"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTQ4_204cb848-7938-456f-991d-b2771fac0dd0">McKESSON CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6ZWNmZjhjNTE4Yzk4NDA3NTg4ZmFlYTZlNDQ4NTUzNzkvdGFibGVyYW5nZTplY2ZmOGM1MThjOTg0MDc1ODhmYWVhNmU0NDg1NTM3OV8wLTAtMS0xLTA_35d9fd66-7868-47d8-82f5-5b0e1179e541">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6ZWNmZjhjNTE4Yzk4NDA3NTg4ZmFlYTZlNDQ4NTUzNzkvdGFibGVyYW5nZTplY2ZmOGM1MThjOTg0MDc1ODhmYWVhNmU0NDg1NTM3OV8wLTItMS0xLTA_0593c3f2-a926-4756-b502-7f2cb02a613a">94-3207296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTQ5_b351bf4c-7c12-4445-9766-2e3366ccfbed">6555 State Hwy 161</ix:nonNumeric>, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTU2_24a9ef06-b182-4bff-98e6-5fa03370c9f4">Irving</ix:nonNumeric>, <ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTUw_0e07738c-8569-4d31-88bd-d7ab314ab538">TX</ix:nonNumeric> <ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTUx_78630802-2f80-41a5-9218-9bcc30acb433">75039</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTU3_44bb97df-8f48-41b5-ba23-8a77eb99a940">972</ix:nonNumeric>) <ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTUy_02f1673c-79b7-4809-817f-cb8256e08ed5">446-4800</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Title of each class)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Trading Symbol)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Name of each exchange on which registered)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0ef51821948842009566650c1ce108b0_D20200401-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18xLTAtMS0xLTA_044808d1-6826-44ef-ac2e-74ed905bda01">Common stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0ef51821948842009566650c1ce108b0_D20200401-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18xLTEtMS0xLTA_ce7744dd-c145-4531-9499-46f7be883e7f">MCK</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0ef51821948842009566650c1ce108b0_D20200401-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18xLTItMS0xLTA_c46e87d6-2908-4119-b080-10f77c03566a">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if8b77cedb5a047039f862615e00010a3_D20200401-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18yLTAtMS0xLTA_615d984c-fd24-41bb-923a-2f07ca49fb1b">0.625% Notes due 2021</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if8b77cedb5a047039f862615e00010a3_D20200401-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18yLTEtMS0xLTA_7a3c3150-4bcd-4b89-a838-a56224882b32">MCK21A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if8b77cedb5a047039f862615e00010a3_D20200401-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18yLTItMS0xLTA_12145c4a-6433-4b29-af47-f34d6932e44c">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3322bd7072c84251b61b81da05e4e706_D20200401-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18zLTAtMS0xLTA_dba528be-37f7-4f68-a108-4c8009249861">1.500% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3322bd7072c84251b61b81da05e4e706_D20200401-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18zLTEtMS0xLTA_b3110639-d78a-4447-a871-d67062ffb68d">MCK25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3322bd7072c84251b61b81da05e4e706_D20200401-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18zLTItMS0xLTA_e7e97a92-82b1-4c3a-a391-13dd85368d8c">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia5cc1815dee34619a8e2ef3a22a42bf7_D20200401-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N180LTAtMS0xLTA_98a27405-396e-40ab-aa37-018725f07762">1.625% Notes due 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia5cc1815dee34619a8e2ef3a22a42bf7_D20200401-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N180LTEtMS0xLTA_71e957b5-2c7c-4b94-a1ac-71019114a35d">MCK26</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia5cc1815dee34619a8e2ef3a22a42bf7_D20200401-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N180LTItMS0xLTA_df0faaa5-22f8-48aa-a666-f9bdee92dc7c">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ied6bc4345b4a4bd99bae269ad7084d51_D20200401-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N181LTAtMS0xLTA_6d2864a1-041b-4983-84d6-3fe5519d662c">3.125% Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ied6bc4345b4a4bd99bae269ad7084d51_D20200401-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N181LTEtMS0xLTA_93d77702-e1f4-4fce-89dd-4b8be1e1a23d">MCK29</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ied6bc4345b4a4bd99bae269ad7084d51_D20200401-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N181LTItMS0xLTA_78bee83f-6ac5-4625-b3f3-d6d89757a122">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTUz_b070e9c2-c9d3-40d4-99af-f79ab814f26d">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTQ2_ec0153d1-ff9a-4c67-b266-51ad99ba70fa">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:28.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.727%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.745%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6M2YxODUxMzMzMmViNDBjZmI0MTJkYmI4ZDRjMmQ1YjAvdGFibGVyYW5nZTozZjE4NTEzMzMyZWI0MGNmYjQxMmRiYjhkNGMyZDViMF8wLTAtMS0xLTA_2e4e438b-3b4c-4002-b2ce-5be052f2eff7">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6M2YxODUxMzMzMmViNDBjZmI0MTJkYmI4ZDRjMmQ1YjAvdGFibGVyYW5nZTozZjE4NTEzMzMyZWI0MGNmYjQxMmRiYjhkNGMyZDViMF8xLTYtMS0xLTA_19f3f165-732f-4731-94a3-06bc9200253e">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6M2YxODUxMzMzMmViNDBjZmI0MTJkYmI4ZDRjMmQ1YjAvdGFibGVyYW5nZTozZjE4NTEzMzMyZWI0MGNmYjQxMmRiYjhkNGMyZDViMF8yLTYtMS0xLTA_55de63ef-f71b-465f-a2eb-bbe821f3fd29">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTU0_ea6b644b-eac1-4f50-9dfd-8743b28aa1ec">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date. <ix:nonFraction unitRef="shares" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMDc5_300239a9-c9aa-4683-81df-9b4ac842b777">160,564,425</ix:nonFraction> shares of the issuer&#8217;s common stock were outstanding as of September&#160;30, 2020.</span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_7"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_10">PART I&#8212;FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_10">Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_13">Condensed Consolidated Statements of Operations for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_13">and six </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_13">months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2020</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_13"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_13">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_16">Condensed Consolidated Statements of Comprehensive Income for the three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_16"> and six </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_16">months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2020</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_16"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_19">Condensed Consolidated Balance Sheets as of </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2020</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_19"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 31, 2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_22">Condensed Consolidated Statements of Stockholders&#8217; Equity for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_22">and six </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_22">months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2020</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_22"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_22">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_25">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_25">six</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_25"> months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2020</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_25"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_25">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_28">Financial Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_28">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_31">Note 1 - Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_31">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_34">Note 2 - Investment in Change Healthcare Joint Venture</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_34">11</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_43">Note 3 - Held for Sale</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_43">12</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_49">Note 4 - Restructuring, Impairment</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_49">,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_49"> and Related Charges</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_49">14</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_52">Note 5 - Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_52">17</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_58">Note 6 - Redeemable Noncontrolling Interests and Noncontrolling Interests</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_58">18</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_64">Note 7 - Earnings per Common Share</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_64">20</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_67">Note 8 - Goodwill and Intangible Assets, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_67">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_70">Note 9 - Debt and Financing Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_70">22</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_76">Note 10 - Pension Benefits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_76">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_79">Note 11 - Hedging Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_79">24</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_85">Note 12 - Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_85">26</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_88">Note 13 - Commitments and Contingent Liabilities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_88">28</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_94">Note 14 - Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_94">32</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_97">Note 15 - Segments of Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_97">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_106">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_106">38</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_130">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_130">55</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_133">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_133">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_136">PART II&#8212;OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_139">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_139">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_142">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_142">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_145">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_145">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_151">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_151">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_154">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_154">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_157">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_157">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_160">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_160">58</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_163">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_163">59</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Financial Statements.</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_13"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMi0xLTEtMS0w_41ae867b-eb1f-4dd1-8286-55910d610dc9">60,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMi0zLTEtMS0w_c8825bc7-341e-463b-8219-7053aa4564e8">57,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMi01LTEtMS0w_303aaa0d-3a3f-48be-9b56-3bf242ea6e23">116,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMi03LTEtMS0w_d5047290-3921-48f9-85c0-b4b167d8a4c6">113,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMy0xLTEtMS0w_a04754ca-b21e-4a8e-830c-7b75f85bc1ea">57,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMy0zLTEtMS0w_b7d18708-567e-4ba0-b035-2f20943e5510">54,749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMy01LTEtMS0w_1e73971f-9bfb-42ae-8cda-993b7056fa30">110,787</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMy03LTEtMS0w_617f1125-9097-4de2-b83a-5fb0f5c2122a">107,690</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNC0xLTEtMS0w_0099352e-224f-49c6-8f83-dfbebc3b64c4">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNC0zLTEtMS0w_17d32651-e08d-47ba-9c99-f5d02dd02040">2,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNC01LTEtMS0w_71d03c36-f90a-4bfa-8d27-f588a94c72d5">5,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNC03LTEtMS0w_8322990d-ff42-49b9-aabf-c71cb5254a65">5,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNS0xLTEtMS0w_c99babe2-1e8a-4d35-973b-b65a5a2b6fdd">2,237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNS0zLTEtMS0w_8722ab5e-dec7-4008-af68-21bb93ed56bc">2,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNS01LTEtMS0w_ca39750b-029b-4600-ba71-32cb659b9eb8">4,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNS03LTEtMS0w_86ef6198-75e4-453d-aa58-42868b6d3dc8">4,326</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNi0xLTEtMS0w_368afc1d-aa3b-4c0a-a4c0-8e6adaa09e22">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNi0zLTEtMS0w_3ce0b150-3d14-442a-a64e-e0e39ce1d862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNi01LTEtMS0w_29334946-38c3-4d65-a662-06a9d583ddc9">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNi03LTEtMS0w_a710cc48-a0db-4079-8b46-e1d6dfb16e18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNy0xLTEtMS0w_f81affba-ef54-481d-a00e-e41eb1230f5a">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNy0zLTEtMS0w_4831df33-a490-4390-9318-0d7afaa018d6">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNy01LTEtMS0w_df831478-91a8-4b5d-b405-621cdeacd2b6">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNy03LTEtMS0w_d7462138-9158-4fc4-93a3-28d4a540ab57">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfOS0xLTEtMS0w_fdf1c8c3-45b7-42cf-8754-a9cac4c8029a">2,366</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfOS0zLTEtMS0w_6adf24c2-daf5-423f-a259-d24d848b857c">2,241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfOS01LTEtMS0w_f7f243ed-224e-48bf-9a82-ad24b5b54e11">4,388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfOS03LTEtMS0w_d195d81d-5408-448d-8652-b6604720f51a">4,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTAtMS0xLTEtMA_8acaceea-724b-491d-9e53-08bae9a85640">634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTAtMy0xLTEtMA_aa49a6c8-f221-424c-b9df-bbd744c468bf">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTAtNS0xLTEtMA_3e390ad6-1f44-4cd8-a559-44aa6eb95e34">1,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTAtNy0xLTEtMA_d8d1d695-b54b-411d-a221-ea165faeb774">1,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTEtMS0xLTEtMA_ad39ba36-5d86-42da-bb2c-16d0233a1466">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTEtMy0xLTEtMA_fc6a8f88-9c77-4c48-be2b-bd3b057ad536">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTEtNS0xLTEtMA_1abb6bdd-7431-42fc-b4f0-6c0fadb6253d">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTEtNy0xLTEtMA_f8c664b4-e2f0-4054-9d8a-bfe6d66a3114">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity earnings and charges from investment in Change Healthcare Joint Venture</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTItMS0xLTEtMA_0377fdc8-8359-4543-b185-350ba8cc2025">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTItMy0xLTEtMA_e5deaaf8-ebd0-449d-9ffc-da2d6e33dff9">1,454</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTItNS0xLTEtMA_42650225-fe20-4564-9dcc-821bca3948f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTItNy0xLTEtMA_0d2e73be-8ecb-4190-9454-3a962c046b0d">1,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTMtMS0xLTEtMA_377b459b-adc6-4e04-8da7-363e533871bf">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTMtMy0xLTEtMA_b0eb8e54-534c-4ccd-9421-5ee06cfc3b71">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTMtNS0xLTEtMA_c19bf850-f6ae-4c3d-93f0-3e744b8c6a7f">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTMtNy0xLTEtMA_8b81855d-abfd-46dd-a184-089ff6ea5961">120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTQtMS0xLTEtMA_bf8fb90f-f916-4747-bd63-61a5e382d7d5">655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTQtMy0xLTEtMA_9cdcc040-2613-444d-9238-9614232a3f40">970</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTQtNS0xLTEtMA_8ad0e3a7-d630-4886-9bc5-9e08adbe1fd3">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTQtNy0xLTEtMA_87195ee3-5c53-4ec7-bc79-4d0a95019c08">351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTUtMS0xLTEtMA_50806244-12f5-426e-96a6-2682a76d33b5">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTUtMy0xLTEtMA_45027bf9-30b6-45b7-b490-606b4f1c7375">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTUtNS0xLTEtMA_f1f99336-39de-4717-b0bc-f9a8077dc2b7">178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTUtNy0xLTEtMA_cd055d23-563d-4541-b1a5-f96dea206dfe">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTYtMS0xLTEtMA_5d3e1ae2-4c56-432a-9888-f5d15873262c">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTYtMy0xLTEtMA_a3db7ac6-d468-4e7d-8749-9c132897f530">676</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTYtNS0xLTEtMA_5f6f9193-cd8d-494e-b168-5152e3e18996">1,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTYtNy0xLTEtMA_78e1f0d3-8c1c-4006-9fcb-b49a8af1f21b">193</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTctMS0xLTEtMA_88a43354-20f2-41ce-9956-c40b256a5271">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTctMy0xLTEtMA_1a07d8bf-7e79-4955-adca-6ff91ac8bd23">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTctNS0xLTEtMA_8b64fd77-eaab-4ade-82ae-d8d1b6a528ce">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTctNy0xLTEtMA_1d7cf47d-7194-4cc8-a1b7-1bfd1df945e1">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTgtMS0xLTEtMA_79bd6b40-9013-4eee-b32c-e78989510210">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTgtMy0xLTEtMA_1286c29d-3daf-4dc3-9b79-926ba3764d8b">677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTgtNS0xLTEtMA_41c64d66-ab20-4687-8202-d3b961e19831">1,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTgtNy0xLTEtMA_67cd62a1-90a9-4489-ba6f-930b74b402f9">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTktMS0xLTEtMA_c867085e-0ca0-48c5-bf9c-23de805e299b">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTktMy0xLTEtMA_b6a4d599-b277-4732-b4ed-f3a83a2d608a">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTktNS0xLTEtMA_2fa899b8-2f70-4288-9295-f7fcd2532b55">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTktNy0xLTEtMA_5b66d056-4d37-4994-9b99-f535d944a9de">107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjAtMS0xLTEtMA_8aada90a-0403-4c1d-908e-9285b9a6ebe1">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjAtMy0xLTEtMA_655af68e-abec-4001-94a8-39e838d51974">730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjAtNS0xLTEtMA_efe5e655-bf53-4a47-88b7-0f5c48c91952">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjAtNy0xLTEtMA_6a8597f4-662a-469b-8eef-48c7c4b28eb0">307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjQtMS0xLTEtMA_1b42c000-c593-4b7c-81c0-9e4f99983ce2">3.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjQtMy0xLTEtMA_02bce3d3-2d27-412f-b63e-cbca4357fbc4">3.99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjQtNS0xLTEtMA_fd918d79-c677-4f63-aadb-0cd8b07536fe">6.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjQtNy0xLTEtMA_9c8da92e-39d9-41a5-abc9-bce74b896ae8">1.62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjUtMS0xLTEtMA_87684a09-4f90-4379-ae59-5b51440b392d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjUtMy0xLTEtMA_55df852f-9e87-475e-b6c9-8429ee9cec79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjUtNS0xLTEtMA_0a719ae8-dac4-41a8-887d-08fd48760b65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjUtNy0xLTEtMA_bf108e3f-a247-4780-a624-66539b16ffd4">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjYtMS0xLTEtMA_f944bf8d-4b43-4723-be69-40b2b1e08ae0">3.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjYtMy0xLTEtMA_0abeb36c-bf94-4c28-bdc3-d5e61d94c376">3.99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjYtNS0xLTEtMA_dc3dfd56-fbea-4994-b048-1f3c9f4c62e9">6.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjYtNy0xLTEtMA_8707952e-7505-4795-a798-9ab1f799d3a2">1.65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjgtMS0xLTEtMA_78f4e3c9-7fed-4406-ba24-bd3e54f7906e">3.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjgtMy0xLTEtMA_eef86ded-cf18-459c-a8a4-125bb9c31b7c">3.99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjgtNS0xLTEtMA_111b0250-535a-4562-bf72-249c718f3980">6.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjgtNy0xLTEtMA_6b824e0e-db84-474d-b221-3094d195ecbd">1.62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjktMS0xLTEtMA_b75c1d8e-5ac6-4bb4-b5b5-21e5e96f7502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjktMy0xLTEtMA_fe10e8fb-2448-42c4-834c-3f9d729c5c36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjktNS0xLTEtMA_897f0275-2434-45ee-a2d0-0a22e7133034">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjktNy0xLTEtMA_463a67b6-7df4-4d91-b77d-99ac980e7f50">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzAtMS0xLTEtMA_8ea48245-225b-44c6-a30d-bc070bb71038">3.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzAtMy0xLTEtMA_a2eb293c-b8e4-4429-af16-b8951c0dfaa1">3.99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzAtNS0xLTEtMA_142504c6-fdcc-402a-bf74-7623742e3514">6.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzAtNy0xLTEtMA_e41e576b-7145-4e4e-9d41-db59dc7a5ef2">1.65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzMtMS0xLTEtMA_74e5bc0b-fc1e-40c7-8c66-651e8efd1d99">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzMtMy0xLTEtMA_e6639797-8229-481a-a2bf-239747334293">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzMtNS0xLTEtMA_86ba8bce-a256-4192-8a50-e4c1c6a8e06a">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzMtNy0xLTEtMA_19d353cf-765b-4471-a640-2110c603feeb">185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzQtMS0xLTEtMA_7ddc15ec-1709-471a-95c3-6923eb75d586">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzQtMy0xLTEtMA_1e795560-ff49-475e-a809-58ccf70ac28e">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzQtNS0xLTEtMA_f0c620ee-6b4f-4939-bc07-a57fed89f91e">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzQtNy0xLTEtMA_17363c6b-da6d-4685-91e6-c3fa6885828b">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMi0xLTEtMS0w_14513f4c-0441-4e23-8b9b-661a754ff4c5">627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMi0zLTEtMS0w_e61e9e54-3e6d-42b1-b720-656dc878de8f">677</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMi01LTEtMS0w_d0e80d98-e0ce-4b54-afea-e9a9a3d56bff">1,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMi03LTEtMS0w_a9007bae-1e7f-4643-a398-b90bc0a8719e">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNS0xLTEtMS0w_b899c9a6-4a6e-4521-8866-2d8a595f20bc">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNS0zLTEtMS0w_fe7aada3-5292-4f06-a567-0192d0c83c12">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNS01LTEtMS0w_31548b78-1fb3-4e02-afae-1bb20fa3e5ef">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNS03LTEtMS0w_34d25982-bec5-4147-a6bf-fead6621ba22">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNi0xLTEtMS0w_342d34ec-2960-41f1-973d-455a901a7d9a">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNi0zLTEtMS0w_eb5315d7-669e-4d17-a9af-70c2ea983be6">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNi01LTEtMS0w_e0480c1b-abe1-4292-bdb2-cc770f503cc0">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNi03LTEtMS0w_210539dd-eb86-4d0f-a142-048913a99ef2">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNy0xLTEtMS0w_52233141-fa58-4061-9150-464ca17c053c">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNy0zLTEtMS0w_58aa9c71-1fdb-45fc-84f1-57280a0d8ac4">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNy01LTEtMS0w_4425c353-681e-4b73-a1d2-7732fa7549e7">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNy03LTEtMS0w_2ca82175-78c8-44e5-864f-62875a49f04c">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfOC0xLTEtMS0w_eb953ad6-de9f-40eb-8fc6-c59ec2bb6715">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfOC0zLTEtMS0w_c0762406-817f-4882-9d4c-aec89dd4e10d">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfOC01LTEtMS0w_f92e75e9-552f-45a5-85e5-388ffae7f12d">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfOC03LTEtMS0w_bec23aa3-3b1e-4391-ae54-0fc15bc793f5">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTAtMS0xLTEtMA_2b0c1636-6e09-4ccf-9aa7-534e3f40a2d5">640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTAtMy0xLTEtMA_b676f501-06c6-4a76-9624-55298aa690ed">621</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTAtNS0xLTEtMA_e4e67dac-bdda-4ee5-a63f-7f56fd8a3307">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTAtNy0xLTEtMA_51da9010-74a1-45d8-af13-b3d55177c2a7">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTEtMS0xLTEtMA_635e0ad8-202d-4250-9273-8c078af4ef24">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTEtMy0xLTEtMA_b6a645b6-d96a-49a1-af8a-417d0b639f85">35</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTEtNS0xLTEtMA_b3b7c46b-9741-4955-a71c-4132c3c9dc7b">36</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTEtNy0xLTEtMA_d8850f7a-4d06-4d6f-bdc3-972c8c3cdc43">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTItMS0xLTEtMA_273405d5-64fd-43c8-9e57-4f81fe1a86f1">715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTItMy0xLTEtMA_32a056ec-d7db-475c-93d9-7f4a27ad38d7">656</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTItNS0xLTEtMA_36e27215-30c6-4af5-9bd4-149c6bef0ffe">1,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTItNy0xLTEtMA_cf30678e-a44f-4b79-bfeb-353a7c24dbed">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMy0xLTEtMS0w_9bfa4f06-1e15-4b60-903a-ddea6e17ddf7">3,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMy0zLTEtMS0w_8ac6dcf0-f266-4389-bdac-88aed8033751">4,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNC0xLTEtMS0w_f1c15020-1194-427b-acf9-d97b65fa8890">19,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNC0zLTEtMS0w_aa1282b2-f484-4ec9-b4cc-333f8e4b9ea5">19,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNS0xLTEtMS0w_64852765-888b-48ca-8420-9cd77cdcb6aa">18,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNS0zLTEtMS0w_724c3c5a-9a68-4723-b933-63304829133c">16,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNi0xLTEtMS0w_a3852de1-c7fa-48f0-a858-540d6364046a">833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNi0zLTEtMS0w_4e3f9c04-80aa-4e11-a57e-25e46dae740c">906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNy0xLTEtMS0w_625c2ace-3d18-40f5-9df2-e89c05b56f92">701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNy0zLTEtMS0w_ded48bfc-eb0d-435c-b73f-e35e4004a18e">617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfOC0xLTEtMS0w_f4804016-7733-4f11-a70a-2e3533635056">42,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfOC0zLTEtMS0w_593c33ee-9ddc-4bc8-a76a-0b1f6f9a045a">42,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfOS0xLTEtMS0w_dbbc369b-f887-481e-a623-0ff977a1aeec">2,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfOS0zLTEtMS0w_147f18e6-fa7a-4e24-8a0b-07143f858fb7">2,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTAtMS0xLTEtMA_930d087f-d35f-4669-9480-96dd7cac8ed0">1,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTAtMy0xLTEtMA_400eddd5-5af5-49bf-b468-9d8729bdce16">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTEtMS0xLTEtMA_15345445-b257-4cfd-8d95-8adba0ae8d76">9,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTEtMy0xLTEtMA_afce8ae9-87ab-4dea-a029-b7c486873f2e">9,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTItMS0xLTEtMA_97010a8f-9b36-453c-8df8-69547681f59b">3,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTItMy0xLTEtMA_d728c73e-5105-40dd-a3f0-cb4ee91a9954">3,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTQtMS0xLTEtMA_7a368309-8c42-4dec-8f42-25f40db24a37">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTQtMy0xLTEtMA_a2701b85-dbdd-4b5f-987a-0e16b5e174f3">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTUtMS0xLTEtMA_ddba9fde-c409-4c9a-8972-1bf32e532420">61,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTUtMy0xLTEtMA_b51fd6fe-cf2d-4436-bc28-c63ebd53d691">61,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTktMS0xLTEtMA_d59ac918-4cb6-4b5f-83ee-a22d53fc336d">36,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTktMy0xLTEtMA_bbdcc4f0-f0ee-4633-a041-15bdf5258e25">37,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjEtMS0xLTEtMA_46115275-1a8c-4b17-afdf-811b1ea9512c">1,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjEtMy0xLTEtMA_4752fd8e-7c14-4be6-b13f-e8c2b553e754">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjItMS0xLTEtMA_fae474c1-a9fd-4c2f-871e-14f025e79224">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjItMy0xLTEtMA_f66b18d8-52fb-45f8-a5eb-3122d1e22752">354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjMtMS0xLTEtMA_451305ba-ccee-464a-93da-e1d93caeb64a">537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjMtMy0xLTEtMA_1d6ab8d8-b161-4669-87aa-08738b2a5a91">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjQtMS0xLTEtMA_11cbc3e9-2916-4d0f-9bc1-d85c8f2b3f38">3,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjQtMy0xLTEtMA_2fe464bf-7ddb-42a6-a57e-4cc1084f8e04">3,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjUtMS0xLTEtMA_a4a6b34d-1113-49ce-9a76-03570d37e6db">42,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjUtMy0xLTEtMA_e23338e4-5740-43a5-b587-6cdc7864a16f">42,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjYtMS0xLTEtMA_ea97f76e-093b-4574-ba56-336b5968776f">5,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjYtMy0xLTEtMA_678d3f51-f32b-4e4f-9fb8-eef91b17bc04">6,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjctMS0xLTEtMA_eedc6502-7023-4dc8-b694-4491f197661f">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjctMy0xLTEtMA_272d9a3b-c245-4ea7-a2c6-31ba3c4cb48f">2,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjgtMS0xLTEtMA_bbd4149d-5e77-4793-b601-a06246f7ff1f">1,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjgtMy0xLTEtMA_20b2b9e7-e790-4b06-aee4-332c042a7562">1,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjktMS0xLTEtMA_c6bc4cf6-6a2b-4adf-9546-45ea887768df">1,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjktMy0xLTEtMA_a1743f14-0186-472b-bb63-bead5c2924bf">1,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzAtMS0xLTEtMA_fbf21d65-6d0e-4acf-915e-92e68590a052">1,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzAtMy0xLTEtMA_e58258d0-17c4-46ed-907f-ab1a444aa9ce">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzIx_453e728b-f497-424b-9db3-8b447362141a"><ix:nonFraction unitRef="usdPerShare" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzIx_9c42c2b9-986f-40bc-b2a8-8c93c3a686e5">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzM1_98360614-0648-495c-8021-279688de8a7a"><ix:nonFraction unitRef="shares" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzM1_bd849231-789f-447c-bb70-6ea20047a7df">100</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzU3_267f70e1-1675-419e-a2b1-c077e58688ae"><ix:nonFraction unitRef="shares" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzU3_8c61678c-2ef9-41fc-b647-99e17ec3bb71"><ix:nonFraction unitRef="shares" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzU3_bf7859a9-2014-4450-9822-90133dbf5bb4"><ix:nonFraction unitRef="shares" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzU3_d8534ab2-28bb-4ecc-9b53-4456ef499038">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMS0xLTEtMA_8f4a93f3-0209-4045-a073-f5ae2a339e03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMy0xLTEtMA_1a2ccc3b-ebaf-4971-88b9-9d18a9360d99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlODlhOTIyNTM4YTQ3N2JiMTQxMWUyOThhOTNhNjM1XzE4_9905d288-f028-412f-bb2a-b9e58ad5d748"><ix:nonFraction unitRef="usdPerShare" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlODlhOTIyNTM4YTQ3N2JiMTQxMWUyOThhOTNhNjM1XzE4_b2f402fc-aa14-4369-bf9b-21708809f0fa">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlODlhOTIyNTM4YTQ3N2JiMTQxMWUyOThhOTNhNjM1XzMy_7c3f0147-8bd8-4941-81af-b14d9c8c7a20"><ix:nonFraction unitRef="shares" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlODlhOTIyNTM4YTQ3N2JiMTQxMWUyOThhOTNhNjM1XzMy_da510c24-f2e2-4425-b35b-698ff2518edf">800</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlODlhOTIyNTM4YTQ3N2JiMTQxMWUyOThhOTNhNjM1Xzcx_e6990d54-dc19-46da-afd6-0447313eeb89">273</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlODlhOTIyNTM4YTQ3N2JiMTQxMWUyOThhOTNhNjM1XzEwNDQ1MzYwNDYzOTc4_9b1f1861-0745-4b4f-b33b-613889601e19">272</ix:nonFraction> shares issued at September 30, 2020 and March 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMS0xLTEtMA_c9a717ab-4569-4577-a728-ebae96338823">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMy0xLTEtMA_442f599b-e865-4163-9ccc-388baf8786cf">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzQtMS0xLTEtMA_63e21425-99df-4504-bddd-2bce7b462d87">6,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzQtMy0xLTEtMA_3af32827-bbbc-4698-8aac-550c762da02f">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzUtMS0xLTEtMA_14811877-db17-4c4a-b736-c07c135b0d73">13,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzUtMy0xLTEtMA_3d2194d7-0b7d-4e63-a647-283d1972025d">13,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzYtMS0xLTEtMA_0287b86c-1903-4882-88f1-8fd5267ba7d0">1,597</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzYtMy0xLTEtMA_d58fdbca-9992-410c-913b-6087e1a8428b">1,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury shares, at cost, <ix:nonFraction unitRef="shares" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjZhMjE0ODNlYTRlZTQ1ODI4NjRmMzc2OGUyNjZlZjZkXzMw_2a3e96a1-179d-4db8-8a3a-1a3d77d2ca6f">112</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjZhMjE0ODNlYTRlZTQ1ODI4NjRmMzc2OGUyNjZlZjZkXzY1OTcwNjk3NjY3NDE_72d0b150-290a-45d1-a4f3-94d25e386f0f">110</ix:nonFraction> shares at September 30, 2020 and March 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzgtMS0xLTEtMA_2b813fd4-e7b8-41f9-bc45-8c87df651074">13,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzgtMy0xLTEtMA_41c7dc33-45d1-4a78-b382-bd3cb60bdb10">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total McKesson Corporation stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzktMS0xLTEtMA_ac8fd171-b01b-4723-be68-67ee5b9bcf87">5,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzktMy0xLTEtMA_f6290b75-140f-4154-a3fe-05eab8e098f3">5,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNDAtMS0xLTEtMA_3304b4d2-30fb-4036-8a6b-c840a744dab3">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNDAtMy0xLTEtMA_cf4c7d8c-daca-492b-bdc7-e3b70edab3e1">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNDEtMS0xLTEtMA_202dc0ab-0d82-4f47-9b8d-6a9d67170d60">6,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNDEtMy0xLTEtMA_923d6915-b92c-48b8-b938-308d05417b1e">5,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests, and equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNDItMS0xLTEtMA_30358e24-7e11-48fc-a932-6882564a9688">61,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNDItMy0xLTEtMA_2f9aa81c-c411-47c1-b350-84eabf5ee682">61,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:21.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.210%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iabc3b5f8046b48bdbf4349b5c0383f8a_I20200630" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0xLTEtMS0w_d84692d5-f151-4dd3-8a86-3f3a3c710f30">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabc3b5f8046b48bdbf4349b5c0383f8a_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0zLTEtMS0w_9179c910-2dfb-4689-bb9f-e90d192ee4c0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dff60c859bc426a838f894b4001b9d9_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy01LTEtMS0w_910e76f5-2911-4e86-819d-40c835524d2a">6,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56da4268cdee4c4a9b797e2a40feb4ae_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy03LTEtMS0w_945d757e-d28a-46c9-a066-a0fa10c34ef0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85c629cca8f64e44b872aac957b63d76_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy05LTEtMS0w_64503273-cf2b-4817-ba9f-0c7442d6cf26">13,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib14ebdd9a67d42c6bff9fab1cd0291e3_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0xMS0xLTEtMA_42fc5e50-5cad-42e7-9399-6dccf45cfcf2">1,735</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i81a912f5f9a04d1ca5e7cb90f142a641_I20200630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0xMy0xLTEtMA_b78e2c33-20d7-42fa-8908-0c5a87e53309">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a912f5f9a04d1ca5e7cb90f142a641_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0xNS0xLTEtMA_1f9a473c-6a0a-4ff1-87b3-cecfcd043707">12,916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86b3fd731c6a451da95296357c34854c_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0xNy0xLTEtMA_a3439cd6-d0ae-47b0-8994-fac5ba756c0c">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i624020a8d4c24a6faaadd5ffc919e8d5_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0xOS0xLTEtMA_2d651e1d-0e49-4d3a-832c-9100df1f4e1e">5,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86e7603b06d743728a36650859d04420_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfNi0xLTEtMS0w_6427ee6c-c58e-412c-bdf1-c8dd61793a35">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff67f3d353954a34b18bf9eacb22eb74_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfNi01LTEtMS0w_dd465cf5-b64e-4a4f-a31b-17d4e6822dca">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3307f8c1c01d4ecd976da193c588305c_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfNi0xNS0xLTEtMA_ea37b13a-b435-435b-90f4-17bab0b6295e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfNi0xOS0xLTEtMA_33a35287-0b49-49d4-8d1e-45cd8b0b82f6">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff67f3d353954a34b18bf9eacb22eb74_D20200701-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfNy01LTEtMS0w_0d7de6fa-dde0-4f28-805e-4e08574360cb">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfNy0xOS0xLTEtMA_e789a960-1d99-4068-8098-526b20ef7b88">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfOC0xNy0xLTEtMA_c6b1f56b-7654-4535-966f-ac9133752c45">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfOC0xOS0xLTEtMA_3593d8ce-9f16-453f-9c01-1762e0f612e4">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd3918b313740288772fde625402248_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfOS0xMS0xLTEtMA_107683de-a3aa-4609-8f6a-ed2f6ee77c29">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfOS0xOS0xLTEtMA_f9cf8eb4-3f00-4c9d-9dc2-27737e8c188b">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3419ea2dc9594c8db2d6ab1f18fb857a_D20200701-20200930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTAtOS0xLTEtMA_13d2641b-e543-47d5-a726-f6e188fecffa">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTAtMTctMS0xLTA_64c88783-7c2a-4616-81e5-d68f6e834957">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTAtMTktMS0xLTA_a8f6caf2-3f43-48a4-81fe-86ff78569994">617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3307f8c1c01d4ecd976da193c588305c_D20200701-20200930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTEtMTMtMS0xLTA_ed9cdaa3-edf7-4735-8960-4b9f54b8a9cc">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3307f8c1c01d4ecd976da193c588305c_D20200701-20200930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTEtMTUtMS0xLTA_0004b995-a53d-4cca-98fc-c799dd341d03">269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTEtMTktMS0xLTA_1aca15a1-c722-4fa0-8426-c3397b1898b8">269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ2NDAyYzhkNDMyMzQ0Y2I4Y2ZkNTE3NjI2MDUzYTFhXzE2NDkyNjc0NDE3MjE_1fdabf4e-ced7-4825-afab-1ad5690fa35b">0.42</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3419ea2dc9594c8db2d6ab1f18fb857a_D20200701-20200930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTMtOS0xLTEtMA_01331206-1dc0-4d1c-ada7-2af80539c2fc">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTMtMTktMS0xLTA_d519012d-ddd7-4898-a6b8-41fddc61d353">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff67f3d353954a34b18bf9eacb22eb74_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTQtNS0xLTEtMA_d9573e55-639d-4ce1-afec-6246e84cb0ba">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3419ea2dc9594c8db2d6ab1f18fb857a_D20200701-20200930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTQtOS0xLTEtMA_b365dbca-9d65-48b2-84bf-e4cfd930b4c7">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTQtMTctMS0xLTA_d279a15c-bb1b-42d6-97f7-f94abf254083">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTQtMTktMS0xLTA_2708e8d0-bdd9-4828-913a-cdec86241e9f">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6d260abae684b3ea39deb99f2accdd9_I20200930" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMS0xLTEtMA_369a5285-61e7-438b-b28d-68382e865946">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d260abae684b3ea39deb99f2accdd9_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMy0xLTEtMA_a3d59343-af17-46aa-a9c4-99fd4a42cc53">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9648da59dbf240cc901798b3fb380aac_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtNS0xLTEtMA_c00df390-6a95-4579-ac8a-8a8a1a91132f">6,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a499ada4b6a4143af9f09f3d2d3773d_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtNy0xLTEtMA_355764f9-c2e5-494a-82cf-5bb92b34a9ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b83385881344e4aaa0f55d53948d509_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtOS0xLTEtMA_15b351b3-1fb0-471e-8418-664017c745dc">13,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id56ecd8e059f4e6696b7b1cc7c7988e4_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMTEtMS0xLTA_30a449c8-218e-4ed5-82d6-a9ecbbd11acd">1,597</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ife081627cfce4fe3accedd30e135266f_I20200930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMTMtMS0xLTA_385b7d4f-3fde-42a2-a1c9-3a0874541d62">112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife081627cfce4fe3accedd30e135266f_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMTUtMS0xLTA_15a076b1-f814-446f-be6e-8c0b5fab185f">13,185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadfecb50b694b9bad1fd34884a1ae60_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMTctMS0xLTA_edf15039-2de1-4954-9949-161291b27497">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMTktMS0xLTA_7495f418-24a4-4e4e-8e7b-1ababf27fd37">6,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:21.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.210%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2020</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive<br/>Loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i750ef09c38ef490d90ed96590f8d7966_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0xLTEtMS0zMjQ_10140fea-3a46-4553-9d1e-8b6b63b10b54">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750ef09c38ef490d90ed96590f8d7966_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0zLTEtMS0zMjQ_191f155b-e8a9-4b3a-b9bd-1824709b03ea">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b44c64ad2334280876102b25c03fa42_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy01LTEtMS0zMjQ_247a346c-089d-41f3-9b5a-b33af370001f">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie29e4f7dbe464f82b90c57337a3111f3_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy03LTEtMS0zMjQ_ff4adedf-4392-404e-8e86-3e88fbe44b71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a50be3402444652b3cf2b02bc8f0cc8_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy05LTEtMS0zMjQ_1a597fb3-b45c-48a0-ad37-5b44e6940941">13,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c61eeba8b38459f985453da0e8c781d_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0xMS0xLTEtMzI0_0333b6ab-542d-40cd-bff5-f6a1994272c1">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie8e660e321e04b6ea0ec390e4691fed2_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0xMy0xLTEtMzI0_67112051-ace1-42cb-8aa1-30385eff2586">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8e660e321e04b6ea0ec390e4691fed2_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0xNS0xLTEtMzI0_02e26c6a-66ee-434e-958c-e6e8ce2f31ff">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebba672c55ee4c2a87f45e310c89afba_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0xNy0xLTEtMzI0_be84fe67-1e66-4a43-9449-b135b81c5fec">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0xOS0xLTEtMzI0_bc5a1703-449c-4d3b-ae21-fc983f80e267">5,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opening retained earnings adjustment: adoption of new accounting standard</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if984c282fc6a4300aa9745b9ad1fd08a_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNC05LTEtMS00NTc_a91b4461-15b1-44d3-85f4-3312d9604cda">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cda9b3c50e4403fa7bbac61edca84dd_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNC0xOS0xLTEtNDU3_acb6b60e-b15e-4651-89a8-9dd3e3529207">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, April 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07103e6d5410451f92642b65d23b443c_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0xLTEtMS00NTc_55ed693d-7f3d-412e-aa5e-f1329098e78d">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07103e6d5410451f92642b65d23b443c_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0zLTEtMS00NTc_ab29c988-bf08-4374-96c8-7990d57306fd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90923f0cdf346f99356c5f1b103aa11_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS01LTEtMS00NTc_0bb41c72-a40e-4828-9919-31c7f9592088">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaac2ef7159664221a50c14397114988b_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS03LTEtMS00NTc_f9dc5bd1-c79e-4210-b9ec-07be7c5dfde9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib75098dd74134d5a900a9f389f1d593c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS05LTEtMS00NTc_efe371ce-25d3-47ee-a148-5fa153eb77d9">13,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8628eafe53c44bb99de6a01f4fe1ec09_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0xMS0xLTEtNDU3_b8972016-4b7b-42d2-8e02-a4943b92d627">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3ef50364db694bba8732ee06158ca2c4_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0xMy0xLTEtNDU3_de91dcb1-2bb5-4e9c-b222-6ccd70fb0cde">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ef50364db694bba8732ee06158ca2c4_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0xNS0xLTEtNDU3_e8d34857-5cd7-4dac-8708-5e63643fc69c">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie29be4b914d54b66b7225683b6f4fcab_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0xNy0xLTEtNDU3_e5eb6852-16d0-426b-af4d-cb77f912bdda">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f826e5b14454ea8a2ada91a6bda9f6f_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0xOS0xLTEtNDU3_5a6e0c9f-4430-46b2-9ea8-a0b0c9064065">5,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d91f70852e349d78d41746fc9b3a841_D20200401-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNi0xLTEtMS00NTc_7ade01c3-e343-4894-b4c7-0000bc091ede">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3845b80d46e4483e96a588f5092ba0ba_D20200401-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNi01LTEtMS00NTc_12a6e9db-49a4-480f-b200-c8b1846cb8d9">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i151045664f014db396ec4d1388abafec_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNi0xNS0xLTEtNDU3_90e947e0-6eec-48b7-8301-e57ef173f728">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNi0xOS0xLTEtNDU3_c1652b50-6ce8-44be-98ce-153d39eaf9b4">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3845b80d46e4483e96a588f5092ba0ba_D20200401-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNy01LTEtMS00NTc_50f6a913-f845-42a1-95b2-ea93607fdbfc">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNy0xOS0xLTEtNDU3_8ab3e39a-1fe3-4e68-bc87-9125bf48145b">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfOC0xNy0xLTEtNDU3_f9514aef-1e22-410a-a7ec-97f436be49e3">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfOC0xOS0xLTEtNDU3_dd3d200f-1aba-4f74-9b89-6554323f8258">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic98282253ac24d17bb300a34d9842800_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfOS0xMS0xLTEtNDU3_5ad389a3-9282-4a33-88cc-201e0e27f103">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfOS0xOS0xLTEtNDU3_a537872e-7aa8-4420-b45d-98b135da737e">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i837e1a2cf1964b3c874339affc1c8eac_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTAtOS0xLTEtNDU3_fac7698a-19a6-4023-b4b3-9727817e2c78">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTAtMTctMS0xLTQ1Nw_1d5a870e-d057-4927-a5fd-eb725a1289e2">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTAtMTktMS0xLTQ1Nw_7f67026b-3f3e-463c-be47-4a0456e8937b">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3845b80d46e4483e96a588f5092ba0ba_D20200401-20200930" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTEtNS0xLTEtNDU3_d633ab39-2d71-47ad-a16d-a2d52a81d541">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTEtMTktMS0xLTQ1Nw_d6f557ba-afb4-4348-9f22-6f686909a255">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i151045664f014db396ec4d1388abafec_D20200401-20200930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTItMTMtMS0xLTQ1Nw_6dc1d7cd-d1d8-4601-900e-b747c3269a73">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i151045664f014db396ec4d1388abafec_D20200401-20200930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTItMTUtMS0xLTQ1Nw_acb52f94-2b59-4f1a-852e-1e20fe88ce7d">269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTItMTktMS0xLTQ1Nw_72576826-6d69-4e8f-8834-8d56e4b8b214">269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTMtMC0xLTEtNDc4L3RleHRyZWdpb246OGNkOTMzZjhmOTUwNGYwNmI0YzJmYmM4YjUwNThiZjVfMTY0OTI2NzQ0MTcyMQ_dc2cd7b1-c7d3-4f54-a94e-cf11bb8c9d76">0.83</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i837e1a2cf1964b3c874339affc1c8eac_D20200401-20200930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTMtOS0xLTEtNDU3_c12a9f37-3469-4fa5-aed5-5c760d57ea38">136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTMtMTktMS0xLTQ1Nw_636faa14-c344-44aa-81e2-5aa776fecd9a">136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3845b80d46e4483e96a588f5092ba0ba_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTQtNS0xLTEtNDU3_b5f3f0e8-f664-43ba-9b57-ed6d3e21161a">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i837e1a2cf1964b3c874339affc1c8eac_D20200401-20200930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTQtOS0xLTEtNDU3_ef66b330-950d-4ff0-bfe5-5fad800f4d69">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTQtMTctMS0xLTQ1Nw_e0488d42-a322-40f9-a5b0-3656fa74668d">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTQtMTktMS0xLTQ1Nw_26af89f5-ab28-43c8-8639-26f34de89938">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6d260abae684b3ea39deb99f2accdd9_I20200930" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMS0xLTEtMzM0_2599a2ef-e287-4a8b-92d8-ac42dd18bf81">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d260abae684b3ea39deb99f2accdd9_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMy0xLTEtMzM0_13760973-3968-47a4-a21d-f593ef1ef38c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9648da59dbf240cc901798b3fb380aac_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtNS0xLTEtMzM0_21c32d6a-0121-48c9-94ff-5a6957063f7e">6,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a499ada4b6a4143af9f09f3d2d3773d_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtNy0xLTEtMzM0_2a76cd48-dd1d-4069-b5cc-e265f5a78872">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b83385881344e4aaa0f55d53948d509_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtOS0xLTEtMzM0_7e3b974d-7e1d-4a43-976f-1ec87804450d">13,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id56ecd8e059f4e6696b7b1cc7c7988e4_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMTEtMS0xLTMzNA_9750229d-18d9-449f-882f-d51cdabaf0c0">1,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ife081627cfce4fe3accedd30e135266f_I20200930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMTMtMS0xLTMzNA_897df49b-b1e6-48ae-87d9-6eb43b9f696a">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife081627cfce4fe3accedd30e135266f_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMTUtMS0xLTMzNA_c61f3c2b-a6e7-40aa-baa1-3b1c4d1e085f">13,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadfecb50b694b9bad1fd34884a1ae60_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMTctMS0xLTMzNA_ca61d33f-6f2f-40eb-8c29-320e76a84449">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMTktMS0xLTMzNA_e37e1d93-2cc5-4f93-8a49-8a13f6307252">6,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:21.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.365%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.660%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.387%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.546%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.956%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.227%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, June 30, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ab0556aa9f340e3ac3f07efb1786652_I20190630" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0xLTEtMS0xMjUw_27070284-25b3-4125-ab4d-e0210ef9adc4">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ab0556aa9f340e3ac3f07efb1786652_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0zLTEtMS0xMjUw_4807c4fb-9955-45c4-8566-14d231ee811b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd49ad70765946169fa5a2c37504d223_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy01LTEtMS0xMjUw_8eb10c3f-8ba2-4dfb-91ec-7fc0bc9af0dc">6,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id27e19e091c34eb9b9768fcff47f09e6_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy03LTEtMS0xMjUw_bbc76e52-cecc-4f20-ae7e-b0ac274036fb">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f0ea496105b47b2be2796a2ab03ad9b_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy05LTEtMS0xMjUw_98d32d9e-a747-4216-9cb6-b6bebdf40bbc">12,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i527d69e72eba46ae8d65ce3a0001cecc_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0xMS0xLTEtMTI1MA_547da7f6-c93e-4320-8d11-2a976a7a96f0">1,778</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i055c7fe4fa114e6fa2ee03924ec916e5_I20190630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0xMy0xLTEtMTI1MA_030cf7df-db76-418a-8656-73b38c9992b4">86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i055c7fe4fa114e6fa2ee03924ec916e5_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0xNS0xLTEtMTI1MA_845f1be9-6562-42a0-8ad7-6db66301e721">9,603</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0e512234a3947858289f71240af0e24_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0xNy0xLTEtMTI1MA_c33985db-83a3-4c01-81fb-ae175db288fc">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a82c257d8b45a3beba6b2dfcf0cceb_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0xOS0xLTEtMTI1MA_e31c0865-7180-4fe1-97ee-eca4d3921796">8,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c459fbda98f4d89b895296afc039b3e_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfNi0xLTEtMS0xMjk5_ec0f942c-0034-4c48-9d0e-26ce669ec465">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e227831a81048e1a8c4e713692e6037_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfNi01LTEtMS0xMjk5_c6f30264-97d5-414e-bc98-1d8e630b1f41">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d9f213396824bbc864a45e30a5b1379_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfNi0xNS0xLTEtMTI5OQ_31816b3a-a674-40fb-8a4a-e154405c4d7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfNi0xOS0xLTEtMTI5OQ_733e072f-2ec8-4439-9b72-b845ee3b01d5">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e227831a81048e1a8c4e713692e6037_D20190701-20190930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfNy01LTEtMS0xMjk5_dc2a4494-86b1-4aaa-bf4e-2a90ad3c919f">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfNy0xOS0xLTEtMTI5OQ_6e650043-22af-4b77-9773-5a6a5f9ed306">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfOC0xNy0xLTEtMTI5OQ_20b3860e-9d53-4d82-91e7-c874338fa998">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfOC0xOS0xLTEtMTI5OQ_e644d2a0-6aa2-4d28-a8e2-6fd8bcc28b4b">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14715badbe50426696183870464fb77d_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfOS0xMS0xLTEtMTI5OQ_a1ffddad-f531-4a98-8fa4-6a159fe824af">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfOS0xOS0xLTEtMTI5OQ_79a8ad9d-1983-4431-8a58-f44f732de650">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ccc82d868704bdeabe6b0ed81650efa_D20190701-20190930" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTAtOS0xLTEtMTI5OQ_545402d4-6c89-4897-a8cb-8d88a97ec2fb">730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTAtMTctMS0xLTEyOTk_b2fb7e4b-3225-4a64-9f56-dcbae434def1">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTAtMTktMS0xLTEyOTk_af570123-1921-4ba0-88af-d61f5baf88ba">688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5d9f213396824bbc864a45e30a5b1379_D20190701-20190930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTEtMTMtMS0xLTEyOTk_a40bbebe-6f5e-4123-876f-a0213acb86de">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d9f213396824bbc864a45e30a5b1379_D20190701-20190930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTEtMTUtMS0xLTEyOTk_f5e7028e-784e-4e7d-8fa3-2bdb4a5566c3">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTEtMTktMS0xLTEyOTk_0bd2b340-20a8-41f4-907b-25eb650b23de">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTMtMC0xLTEtMTIzNy90ZXh0cmVnaW9uOjNhNDJlYzAxNTVjYzQ1ZDY5ZmY5OGJlOTdiZGU2Y2VhXzI3NDg3NzkwNjk0OTY_85e29b41-fab7-4a45-bd99-b61a9bfc7877">0.41</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ccc82d868704bdeabe6b0ed81650efa_D20190701-20190930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTMtOS0xLTEtMTI5OQ_513ac044-7a2d-4727-86a6-431ea76c4d4d">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTMtMTktMS0xLTEyOTk_934d16bc-fd89-416a-8d60-1cb858c5edbe">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e227831a81048e1a8c4e713692e6037_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTQtNS0xLTEtMTI5OQ_54fb6d2b-5be4-44d5-9cfe-5cab0f29781c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebfb081bd626464390ff45f5fef68f5e_D20190701-20190930" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTQtNy0xLTEtMTI5OQ_840d4132-99a7-4d39-90eb-f0080f2301a5">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTQtMTctMS0xLTEyOTk_27d45959-8d54-4423-bb8c-cf935719cedf">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTQtMTktMS0xLTEyOTk_5a30e36c-efa4-4de9-9a0d-5c16830dc7e6">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, September 30, 2019</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida674b76527d474486ce8b22743056d8_I20190930" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMS0xLTEtMTI5OQ_92353648-0058-42dd-ac3d-a1dd59fd389a">272</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida674b76527d474486ce8b22743056d8_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMy0xLTEtMTI5OQ_7cb67c23-53ee-4b09-8806-cfdced128208">3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i066d88a46b864f71bd116fd264f47155_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtNS0xLTEtMTI5OQ_8599978c-7a58-4e7e-94b0-42562ce2841f">6,573</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b95a05a13af42d5b440fef8def022b9_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtNy0xLTEtMTI5OQ_785f9acb-5db1-4b11-b151-654c0e59be2b">2</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ef9e0529026452082cff03d5ad3ef31_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtOS0xLTEtMTI5OQ_a9a60a9e-e6ab-47e2-8faf-0bfdd3149f8a">11,965</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1d225eb50904ac7afd16a3e52e96014_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMTEtMS0xLTEyOTk_445e9681-fba2-434e-a0ba-2ec0469fa931">1,704</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id047fe71417d4ba0a432ed05ef05fedc_I20190930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMTMtMS0xLTEyOTk_29d46a33-0367-4b99-9d9a-6dbf242cb495">92</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id047fe71417d4ba0a432ed05ef05fedc_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMTUtMS0xLTEyOTk_2cfccead-c6f5-4964-8b81-8f0ffa630dd6">10,353</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2ca1a2d209b4ea4a677b11a4d562bff_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMTctMS0xLTEyOTk_3263dccc-0d83-4611-a358-3d64b898a07e">210</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0bd0811c0224eb6a8188a2281171287_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMTktMS0xLTEyOTk_dc9aa1c0-e5e1-40fb-ba9c-adbdd60e4f64">6,692</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:21.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.365%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.660%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.387%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.546%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.956%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.227%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, March 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1038eaf9e8794cbcbded983f8ccfcb9a_I20190331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0xLTEtMS0w_b84be021-ea69-48b2-b471-d63546b0e436">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1038eaf9e8794cbcbded983f8ccfcb9a_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0zLTEtMS0w_ff954600-994c-481d-9dfa-bec848ffa750">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74dbf3756e304d92aeaccdcd0a323a87_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy01LTEtMS0w_2908c1cf-47e5-4388-b266-ff9b63c91d71">6,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i519675db2894462f940aec3609198a9f_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy03LTEtMS0w_fb5df18f-dd14-4d8e-aed9-9d2c6840ff92">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8a280e4073e4978b428ac6b0c0dd2be_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy05LTEtMS0w_1bb65311-512f-46d3-a6b1-f7cc31b16252">12,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0532330a51214e249b3b9e2fbc5ebee3_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0xMS0xLTEtMA_87a43d2b-86c4-4ee8-aaec-7d1285304156">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0a26b872a65c49fbab22d3dd61751d4c_I20190331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0xMy0xLTEtMA_571925f6-ab9c-420a-bbb9-ebdb492d5124">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a26b872a65c49fbab22d3dd61751d4c_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0xNS0xLTEtMA_705ee5e8-58eb-491f-ba00-7061428ec7ea">8,902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7004546d044b4049a10a34e53e7b21d2_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0xNy0xLTEtMA_cb63204c-a7b3-47e8-9a5b-fe901d0506ba">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i793953b750ac4456be2099940de03f04_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0xOS0xLTEtMA_de1cc1c4-2500-43cc-8dbb-f4735d31420c">8,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opening retained earnings adjustments: adoption of new accounting standards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie193bb9fa6704fa3acc5751bc7472c22_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNC05LTEtMS0w_5521c3a1-a6df-4c7f-9bf8-49adac7f47fa">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9726c90f483c47acb129d2e23e982038_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNC0xOS0xLTEtMA_4dfc03b1-b669-4765-8026-d54031ed6291">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, April 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i153fe9ad0eb8417e837f3785055c6ed3_I20190331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0xLTEtMS0w_4a623797-3284-4a9a-9941-8ada1e23ba4b">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153fe9ad0eb8417e837f3785055c6ed3_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0zLTEtMS0w_d1c5af13-7011-4e05-a4f0-32d55f976a83">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ba7615df4f54c9394bdceec616f160b_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS01LTEtMS0w_1ed89ba3-9bae-434a-b999-c1226972053d">6,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f906acdf8544001a98097ca5fefee5f_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS03LTEtMS0w_d4352301-374d-4460-8673-fbdbeb39bee1">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f4bc7c87de41ec95337b9a9c2a5980_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS05LTEtMS0w_b535de27-e882-40c6-8fe9-43100aa43ec9">12,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffa749c811f44f839ea4c4218238ca96_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0xMS0xLTEtMA_512aac95-be40-4101-979f-47a2ad6b1f6f">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1414642232a64093b59196114d7bbe81_I20190331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0xMy0xLTEtMA_8cea5553-cb75-4f08-a9f8-f9e5a9f215e1">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1414642232a64093b59196114d7bbe81_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0xNS0xLTEtMA_801fb3e9-1a26-46f8-b9a0-73c7c1d4aaa7">8,902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8097b9305824e04b33569a91abcc550_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0xNy0xLTEtMA_fbc174f6-3be7-435a-a122-193670b76380">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb9ee476d3394ecc80affa02786a5506_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0xOS0xLTEtMA_728e3e36-1c69-44cf-a994-38b117bae5d4">8,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27e2aad7746c41ebb5c5c95a5334fdd4_D20190401-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNi0xLTEtMS0w_63ab6845-be59-4713-8db3-19e9b3cc89d3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4f408f0d454849b9073de0b78b77a9_D20190401-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNi01LTEtMS0w_f3a9761f-36bc-438e-99da-ed5991b44d1a">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95551ce68b8e47f0bba655aea0ee5f0c_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNi0xNS0xLTEtMA_10fbf620-d722-4d3e-8118-63391716f459">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNi0xOS0xLTEtMA_ac7212a8-6c8c-4d6d-b582-1f2e8927611e">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4f408f0d454849b9073de0b78b77a9_D20190401-20190930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNy01LTEtMS0w_a597d0d0-55ee-4414-bb24-3f998c887872">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNy0xOS0xLTEtMA_de0b4cb0-3e29-4b62-962a-51e0db7d6729">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfOC0xNy0xLTEtMA_8d5f2fe4-c1a9-49b4-ac70-06f9ba44ece6">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfOC0xOS0xLTEtMA_e467b240-8c58-4aa3-9920-a397caf20eb4">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3093e8b5aa4420189b9a3f12efb6235_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfOS0xMS0xLTEtMA_d643ebb9-fcbd-40fc-bd5a-10d77b7fb5c0">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfOS0xOS0xLTEtMA_e61ca33d-d34e-4bf8-a706-fdebaf70d14f">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6278551f7fc3480497a143f010615c9c_D20190401-20190930" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTAtOS0xLTEtMA_1ac04e6f-73eb-4f06-9cdf-4b6a3f1649df">307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTAtMTctMS0xLTA_3fbd7dbd-e82b-4daf-9df0-3975be117326">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTAtMTktMS0xLTA_24d2f928-0c8e-4270-a299-86c1fee1224b">222</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i95551ce68b8e47f0bba655aea0ee5f0c_D20190401-20190930" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTEtMTMtMS0xLTA_5f2306f9-fa22-45da-8d3f-3f7c22a9db38">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95551ce68b8e47f0bba655aea0ee5f0c_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTEtMTUtMS0xLTA_8970d5a4-1600-4d86-8df7-8d8953e07e03">1,434</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTEtMTktMS0xLTA_513330bf-1b0a-43ca-ae05-2ceadcbd2203">1,434</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjJkODJkODg5YzE1NzRmYWM4MWY5NTVkNjVjYTU3Y2QyXzI3NDg3NzkwNjk0OTY_0a9a1c82-3386-4f25-b4a3-21ab33263e0d">0.80</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6278551f7fc3480497a143f010615c9c_D20190401-20190930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTMtOS0xLTEtMA_6495d8c9-b46c-4a98-be9d-a9f05c0a34d2">148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTMtMTktMS0xLTA_33e33768-9abd-4fcd-9ba7-e6daca9be3ab">148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4f408f0d454849b9073de0b78b77a9_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTQtNS0xLTEtMA_2320c9e3-17af-4c4d-8511-5308d7c29a3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8770d32fa2448e1a5a96bbcbabee231_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTQtNy0xLTEtMA_12ff929f-50d7-47ad-bb7f-ac886516a207">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTQtMTctMS0xLTA_f3ff36eb-c7f6-4015-966f-8f3becde9781">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTQtMTktMS0xLTA_688df46f-ab35-492a-8976-3f12d86bd9e6">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, September 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida674b76527d474486ce8b22743056d8_I20190930" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMS0xLTEtMA_9d4a8a94-2d4e-4054-86b1-683498467e16">272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida674b76527d474486ce8b22743056d8_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMy0xLTEtMA_3e69bae7-a36d-42b0-bb6b-5fb113abdd8d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i066d88a46b864f71bd116fd264f47155_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtNS0xLTEtMA_89f37d5f-2e9a-40de-98fe-67552cb0d142">6,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b95a05a13af42d5b440fef8def022b9_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtNy0xLTEtMA_723e0ab3-96f2-4910-aa98-4ccad5019786">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ef9e0529026452082cff03d5ad3ef31_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtOS0xLTEtMA_c3a720a2-e015-484a-a667-bfd6499bd6d5">11,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1d225eb50904ac7afd16a3e52e96014_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMTEtMS0xLTA_10b1c847-e48f-4252-af55-0047fd2c8ade">1,704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id047fe71417d4ba0a432ed05ef05fedc_I20190930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMTMtMS0xLTA_877fe59b-fa44-41c3-b2cc-f99e499ff77c">92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id047fe71417d4ba0a432ed05ef05fedc_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMTUtMS0xLTA_2553509a-ddab-432e-9e5a-bf92c8889b50">10,353</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2ca1a2d209b4ea4a677b11a4d562bff_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMTctMS0xLTA_41dffe8d-ce56-452b-8167-bce688149e30">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0bd0811c0224eb6a8188a2281171287_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMTktMS0xLTA_37786e50-dd89-4aa2-9a51-690055b672a3">6,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMy0xLTEtMS0w_83302c50-db8f-4bd9-ad7f-81ce716fea1c">1,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMy0zLTEtMS0w_e4a6b3af-7469-4e26-8dbb-05995138fe84">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNS0xLTEtMS0w_b15ae3fd-cb81-4d48-be1f-8f73e7824564">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNS0zLTEtMS0w_b4655c6d-f466-4ced-b1ac-0ba55492f37c">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNi0xLTEtMS0w_5ad89680-2833-4d06-a252-0ce15b07a6a3">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNi0zLTEtMS0w_7a2f50ab-c26e-403a-ade2-abcaa291407d">303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and other asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNy0xLTEtMS0w_6e2e1cc9-83f1-44e3-84bc-133a5c565172">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNy0zLTEtMS0w_b07df4a1-90a3-4f78-a7e2-d06a95ecb23d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity earnings and charges from investment in Change Healthcare Joint Venture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfOC0xLTEtMS0w_35457731-0fe0-49c9-83ee-40412b812be0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfOC0zLTEtMS0w_9c9306be-e3da-4035-9f9d-07aaf7c103cd">1,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfOS0xLTEtMS0w_e298db0e-a13b-4196-b803-1734ad00c4f5">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfOS0zLTEtMS0w_b07d2245-0f1e-4841-939f-15633f7fd63a">380</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credits associated with last-in, first-out inventory method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTAtMS0xLTEtMA_3f3c62bc-eebe-4a41-9843-732d95dd3f47">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTAtMy0xLTEtMA_677aeb6f-8104-4eb4-bbfc-c06c349ad1a2">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTEtMS0xLTEtMA_03126d1d-c0fb-48cc-958a-6c876ef7f01a">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTEtMy0xLTEtMA_65b7cd27-fa4d-47b6-8d53-28b4b8386a25">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) from sales of businesses and investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTItMS0xLTEtMA_a3207a33-e91c-409d-83b6-4c086b277fd2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTItMy0xLTEtMA_cfc8718c-67bc-4f01-8647-938f68452532">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTMtMS0xLTEtMA_9339c9a6-18a9-466f-bb00-964a94470704">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTMtMy0xLTEtMA_b8a3d9a6-09f1-4450-9690-583497119038">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTUtMS0xLTEtMA_b95947d9-8a4a-4de9-90c7-820c4d250c08">981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTUtMy0xLTEtMA_bcc54610-60bb-4320-b10f-d9c15da870cd">866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTYtMS0xLTEtMA_5c59d58b-61f1-4371-90a3-e0c509e55af7">1,396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTYtMy0xLTEtMA_11e174da-e723-4409-be59-7d7e68d06eea">331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTctMS0xLTEtMA_024c1335-be7e-4975-b185-99fc775c6478">1,305</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTctMy0xLTEtMA_e5496676-2b03-4ff1-9dcf-d25fb1f6029f">1,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="mck:IncreaseDecreaseinOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTgtMS0xLTEtMA_470ecd24-5fdc-41ab-890f-24b433044f56">185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="mck:IncreaseDecreaseinOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTgtMy0xLTEtMA_2cf5bbed-01f6-47e8-b4ee-f300f57bceb5">189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTktMS0xLTEtMA_78e734cf-40b2-4d3b-a31f-bccd6d5b948f">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTktMy0xLTEtMA_30e5340c-a15b-4c63-8802-b0e70b820294">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjAtMS0xLTEtMA_a1bc3d6f-96c4-447a-9ef3-d5b7eda75145">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjAtMy0xLTEtMA_c976c273-9072-4186-9f93-5ed5cea9f012">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjEtMS0xLTEtMA_08536a1d-8cc1-4da2-bb8e-86b431d4ccb1">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjEtMy0xLTEtMA_610955e1-899f-4c2b-b4a7-737c2353264c">159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjQtMS0xLTEtMA_4c4931f9-9b6b-4bea-86fb-6406bb4d4c24">174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjQtMy0xLTEtMA_58195e62-1aa4-4688-8671-7e591498ba23">126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized software expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjUtMS0xLTEtMA_620180a8-d6af-414e-b0a6-1d5e58568b1f">91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjUtMy0xLTEtMA_2d05afa5-af43-4725-b9cc-45955e0cd6e4">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjYtMS0xLTEtMA_717336c6-4f6c-4393-bd2f-14265da07224">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjYtMy0xLTEtMA_686570d8-9a6e-4e5e-9845-2af3dd000167">95</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of businesses and investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjctMS0xLTEtMA_a1f572db-845c-4218-82ad-929f000acaf3">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjctMy0xLTEtMA_9bdc5c09-d85f-4cc3-b25c-48c1b326dad8">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjgtMS0xLTEtMA_86feaa7c-7004-41df-a016-51bd1f8d774e">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjgtMy0xLTEtMA_f48590e3-347f-43d5-a85e-25afd1f5f33e">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjktMS0xLTEtMA_c25c9b14-c274-4588-b79b-accf8ccaff8a">278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjktMy0xLTEtMA_91037395-6153-4000-85b4-16edd0cb5e7c">285</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzItMS0xLTEtMA_d7461c1e-4e71-4454-861d-7b524e6f5d21">5,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzItMy0xLTEtMA_07fd7a53-1fe3-4cb2-bf5c-6ecd17ff20b3">8,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzMtMS0xLTEtMA_90a7c3ef-960d-4b55-9595-d234e83562ed">5,303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzMtMy0xLTEtMA_bbd53135-5c6e-4f61-81ff-d6daf61fcbb0">8,122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzUtMS0xLTEtMA_b8ae7c25-1d65-4dca-b63b-0de86fe2b376">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzUtMy0xLTEtMA_54017a61-a8af-4ade-b1a8-9f49a97fbf91">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzctMS0xLTEtMA_7f8b416a-49d3-46b3-aaf6-8b9147dbc2d2">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzctMy0xLTEtMA_d1218993-705b-4e70-b329-2b9f837190bc">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchases, including shares surrendered for tax withholding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzgtMS0xLTEtMA_6f3336bc-8c14-44e2-a483-69a00bc34f9b">272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzgtMy0xLTEtMA_365dd549-fc6b-4e3b-9b93-01be05c34095">1,452</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzktMS0xLTEtMA_04b44549-d284-4690-87fd-c45612162dfa">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzktMy0xLTEtMA_a4e607be-ed48-49a0-a121-311c5caac3c9">148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDAtMS0xLTEtMA_3fa72840-121d-4390-bc59-90bdf4686e71">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDAtMy0xLTEtMA_45b31d6d-db07-4fdb-8a9c-0282607b196b">224</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDEtMS0xLTEtMA_6f379bbc-b052-4143-9a9b-8e0eeb84325d">401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDEtMy0xLTEtMA_f919bb0f-5886-42c2-9625-11e3cd94d260">1,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDItMS0xLTEtMA_f9071808-ca66-4675-8f9c-5daef418e446">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDItMy0xLTEtMA_8ec3a2ca-0c11-4847-8b4f-6daa71c9b59a">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDMtMS0xLTEtMA_5937cdf8-22ad-44e6-b601-88a17290fbaa">783</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDMtMy0xLTEtMA_c272b4f4-6eb9-4215-a541-5fe685806643">1,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDQtMS0xLTEtMA_6f674f02-8654-4209-8a3c-737137612403">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i793953b750ac4456be2099940de03f04_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDQtMy0xLTEtMA_12d897d0-d894-4724-91b7-ae59a373f4f8">2,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDUtMS0xLTEtMA_29a54411-1fbd-4acb-a5be-7b84f80e57e4">3,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0bd0811c0224eb6a8188a2281171287_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDUtMy0xLTEtMA_803b75cb-cfb3-43ab-b484-e18c06587a90">1,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Restricted cash at end of period included in Prepaid expenses and other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDYtMS0xLTEtMA_eaac7f0e-76da-4c26-91c5-b344e6a70301">149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0bd0811c0224eb6a8188a2281171287_I20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDYtMy0xLTEtMA_cf7c4edf-ab1b-4770-adce-904a84834e01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDgtMS0xLTEtMA_93df0196-a7d7-4d4d-acd6-0616b23df3a1">3,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0bd0811c0224eb6a8188a2281171287_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDgtMy0xLTEtMA_3a03346f-6171-496d-a793-71137f4cac58">1,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_31"></div><div style="margin-bottom:12pt;margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1NzM_fac7ff9e-1398-43b7-8985-974231d361fd" continuedAt="i65e02df2b868464284a56bf281dd99dc" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i65e02df2b868464284a56bf281dd99dc" continuedAt="iad73c0e7516647eeb8bad2909f881fad"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. Commencing in the second quarter of 2021, the Company reports its financial results in <ix:nonFraction unitRef="numberofsegments" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTY0OTI2NzQ1MjM3NQ_177ff9d1-723a-4311-9b63-1ec03f851e22">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#8220;RxTS&#8221;). The Company&#8217;s equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented. All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation.  Refer to Financial Note 15, &#8220;Segments of Business,&#8221; for more information.</span></div><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1OTg_3abbee8e-8b69-4fb5-a158-b12fa94a91bc" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The severity, magnitude, and duration, as well as the economic consequences of the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, the Company&#8217;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. The Company continues to evaluate the legislation for future impacts to its consolidated financial statements, however it did not cause a material impact to the Company&#8217;s financial results for the three and six months ended September 30, 2020.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1ODY_744f9ec9-e94f-4e2e-94c5-7389c443cc21" escape="true">The results of operations for the three and six months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 previously filed with the SEC on May 22, 2020 (&#8220;2020 Annual Report&#8221;).</ix:nonNumeric> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1NzY_cfe264b5-daaa-4c67-a614-2e02a48075f1" escape="true">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</ix:nonNumeric> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="iad73c0e7516647eeb8bad2909f881fad" continuedAt="i18ae7ed30ebd4dd4a9c938467988ed0d"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1ODc_5a972ec5-6ee4-4d74-9564-ffa808d97cf3" escape="true">Certain prior year amounts have been reclassified to conform to the current year presentation.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1OTM_7214732a-00c8-4dd1-85a8-16db52224ba4" continuedAt="i820bcb537d4f45a7bdb1c7516e9d2211" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company prospectively adopted Accounting Standards Update (&#8220;ASU&#8221;) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Retirement Benefits - Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to remove, modify and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2016-13&#8221;), which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $<ix:nonFraction unitRef="usd" contextRef="i72068016134b43bfacb6383f8d1e74f7_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTY0OTI2NzQ1MzExNA_4e5a634a-d555-40c2-8332-247ad7156182">13</ix:nonFraction> million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1OTA_ef5deb27-a7a7-4410-a2df-e6fb8d4e63c9">ASU 2016-13</span> in the first quarter of 2021, the Company began using the Current Expected Credit Losses ("CECL") methodology to determine an allowance for credit losses related to financial assets measured at amortized cost. The Company considers historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfOTU3OA_f49773cf-89b1-4e1e-9f0f-c8b9fd6ecdea">219</ix:nonFraction> million was included in Receivables, net on the Condensed Consolidated Balance Sheet as of September 30, 2020. Changes in the allowance were not material for the three and six months ended September 30, 2020.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i18ae7ed30ebd4dd4a9c938467988ed0d"><ix:continuation id="i820bcb537d4f45a7bdb1c7516e9d2211"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2019, ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The Company is currently evaluating the impact of this amended guidance on its condensed consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="iecfa0e5b7669406c886f8e2dcd87b845_34"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMzk3Nw_a874b39a-f276-40d8-bdb1-4112cb666a33" continuedAt="i1e45624220a4437eb58feb25eb92d321" escape="true">Investment in Change Healthcare Joint Venture</ix:nonNumeric></span></div><ix:continuation id="i1e45624220a4437eb58feb25eb92d321" continuedAt="i4c5cb6bcef2c4d9dbc39ea9a5379066b"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the separation of its interest in the Change Healthcare JV on March 10, 2020, the Company accounted for its interest in the joint venture using the equity method of accounting with a one-month reporting lag, with disclosure made for any intervening events of the joint venture in the lag period that could materially affect its condensed consolidated financial statements. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective April 1, 2019, the Change Healthcare JV adopted the amended revenue recognition guidance. In the first quarter of 2020, the Company recorded its proportionate share of the joint venture&#8217;s adoption impact of the amended revenue recognition guidance of approximately $<ix:nonFraction unitRef="usd" contextRef="i4506d920ace04fa991e79fe64d985216_I20190401" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfNzA1_6f2e308f-e569-40a5-baa9-b99633c55d96">80</ix:nonFraction> million, net of tax, to the Company&#8217;s opening retained earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2019, common stock and certain other securities of Change Healthcare Inc. (&#8220;Change&#8221;) began trading on the NASDAQ (&#8220;IPO&#8221;). Change was a holding company and did not own any material assets or have any operations other than its interest in the Change Healthcare JV.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2019, upon the completion of its IPO, Change received net cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="ic83c30e7937b464a894f08434c22f5e9_D20190701-20190701" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0NjI3Nw_6be0b42d-ac05-40e4-b30c-75a05b13d69f">888</ix:nonFraction> million. Change contributed the proceeds of $<ix:nonFraction unitRef="usd" contextRef="i8f8e385f66604149983dba6c977a6283_D20190701-20190701" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInterestInJointVenture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTA0NDUzNjA0ODMyOTc_302df439-38eb-4b7c-9cf3-77c16d8148ed">609</ix:nonFraction> million from its offering of common stock to the Change Healthcare&#160;JV in exchange for additional membership interests of the Change Healthcare JV (&#8220;LLC Units&#8221;) at the equivalent of its offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ifafa59fc61fa4be8b5cec6e15a260447_I20190701" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMjc0ODc3OTA4MjU2Nw_869f390e-80e2-4b93-b824-6f0e61011a96">13</ix:nonFraction> per share. The proceeds of $<ix:nonFraction unitRef="usd" contextRef="ic83c30e7937b464a894f08434c22f5e9_D20190701-20190701" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromOtherEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTA0NDUzNjA0ODMzMjA_96e91657-90fc-457e-b806-a3cedb13eccc">279</ix:nonFraction> million from the concurrent offering of other securities were used by Change to acquire certain securities of the Change Healthcare JV that substantially mirrored the terms of other securities included in the offering by Change. As a result, McKesson&#8217;s equity interest in the Change Healthcare JV was diluted from approximately <ix:nonFraction unitRef="number" contextRef="i0ceed8f44d4e4223932f42e65df7847c_I20190630" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0NzA0Nw_b66e3677-f4f3-45a4-b9b6-abdc2776171d">70</ix:nonFraction>% to approximately <ix:nonFraction unitRef="number" contextRef="id0a54c8ec69a4c91a3f3e8c1893a07aa_I20190701" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0NzA2Nw_42f839d9-b97b-4eec-ba19-f4c45aab4311">58.5</ix:nonFraction>% while Change owned approximately <ix:nonFraction unitRef="number" contextRef="idf37a667c0ec40628d54cc1c80d639b0_I20190701" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMjc0ODc3OTA4Mjc5Mw_b4c4030e-756a-4d1b-8ab1-d97c2db3a270">41.5</ix:nonFraction>% of the outstanding LLC Units. Accordingly, in the second quarter of 2020, the Company recognized a pre-tax dilution loss of $<ix:nonFraction unitRef="usd" contextRef="i4ed1ecc0893943d88156c671256bec07_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0NzI1OA_e6673afd-782e-44c9-a0e2-6b5db38176f5"><ix:nonFraction unitRef="usd" contextRef="i9cbe8bd08e2043a691eb83cc4d84f2ec_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0NzI1OA_fa2e65bd-67b8-49c9-9df1-c6a43b6f647a">246</ix:nonFraction></ix:nonFraction> million primarily representing the difference between its proportionate share of the IPO proceeds and the dilution effect on the investment&#8217;s carrying value. These items were included in Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#8217;s Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2019. The Company&#8217;s proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company recorded a pre-tax other-than-temporary&#160;impairment (&#8220;OTTI&#8221;) charge of $<ix:nonFraction unitRef="usd" contextRef="i3bceb76fc90f4fc4a14733d6ed803565_D20190401-20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTA0NDUzNjA0NzQwNDc_c8edc0fe-f588-48ad-ac0d-bce58ac3d90e"><ix:nonFraction unitRef="usd" contextRef="i5abddbabf5c94c0fa20a7d1605f5465f_D20190701-20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTA0NDUzNjA0NzQwNDc_dcd1812b-6158-496f-bdfc-8f1e323a3137">1.2</ix:nonFraction></ix:nonFraction> billion to its investment in the Change Healthcare JV, representing the difference between the carrying value of the Company&#8217;s investment and the fair value derived from the corresponding closing price of Change&#8217;s common stock at September 30, 2019. This charge was included in Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#8217;s Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded its proportionate share of loss from its investment in Change Healthcare JV of $<ix:nonFraction unitRef="usd" contextRef="i5abddbabf5c94c0fa20a7d1605f5465f_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0ODU4MA_477e685e-53b8-4c0e-b514-bed4765ae71c">51</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3bceb76fc90f4fc4a14733d6ed803565_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0ODU4Nw_b30254c2-e9ea-4d26-acf3-d374ac9cb870">47</ix:nonFraction> million, respectively, for the three and six months ended September 30, 2019. The Company&#8217;s proportionate share of income or loss from this investment included integration expenses incurred by Change Healthcare JV and basis differences between the joint venture and McKesson, including amortization of fair value adjustments primarily representing incremental intangible assets. These amounts were included within Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#8217;s Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV which eliminated the Company&#8217;s investment in the joint venture. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i4c5cb6bcef2c4d9dbc39ea9a5379066b"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While a party to the joint venture, the Company had various ancillary agreements related to the Change Healthcare JV, including transition services agreements (&#8220;TSA&#8221;), a transaction and advisory fee agreement (&#8220;Advisory Agreement&#8221;), a tax receivable agreement (&#8220;TRA&#8221;), and certain other agreements. Revenues recognized and expenses incurred under these agreements with the Change Healthcare JV were not material during the three and six months ended September 30, 2020 and 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement executed in 2019 between the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson. McKesson exercised its right under the agreement and allocated certain depreciation and amortization deductions to Change for the tax year ended March 31, 2019, and estimated certain depreciation and amortization deductions for the tax year ended March 31, 2020. These allocated depreciation and amortization deductions may change as certain events occur, including the filing of the Change Healthcare JV tax return for the tax year ended March 31, 2020.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After McKesson&#8217;s separation of its interest in the Change Healthcare JV, the aforementioned TRA agreement requires the Change Healthcare JV to pay McKesson <ix:nonFraction unitRef="number" contextRef="id816b0893be348beafb61bf8e5f30f0b_I20200930" decimals="INF" name="mck:TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMjk3MA_c77a7e78-8de3-430b-93a8-b8c6492422e0">85</ix:nonFraction>% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the depreciation or amortization allocated to Change by McKesson. The receipt of any payments from the Change Healthcare JV under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings. This creates uncertainty over the amount, timing, and probability of the gain recognized. As such, the Company accounts for the TRA as a gain contingency, with no receivable recognized as of September 30, 2020.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020 in conjunction with the separation transaction, the Company recorded a reversal of the deferred tax liability related to its investment. Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed. Any such change is not expected to have a material impact on the Company&#8217;s condensed consolidated financial statements.</span></div></ix:continuation><div id="iecfa0e5b7669406c886f8e2dcd87b845_43"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTUzOTMxNjI3OTQ1OTI_9daa5144-d60e-4acd-838a-0ce62fbac761" continuedAt="i5bf2de45560e4e13abe210280991ec91" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5bf2de45560e4e13abe210280991ec91" continuedAt="i1e18b007d33547fa927d32ae1cbf42de">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less cost to sell is reported as an adjustment to the carrying value of the disposal group. Assets and liabilities that have met the classification of held for sale were $<ix:nonFraction unitRef="usd" contextRef="ia2bab316f14f4a24b71fb9d74d18cdf3_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTAxMQ_ecb84a67-af7e-457e-ab39-1eb608ae5a5b">833</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia2bab316f14f4a24b71fb9d74d18cdf3_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTAxOA_21d8bd61-330a-4ff7-917f-ac8efbf2eb8f">537</ix:nonFraction> million, respectively, at September 30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTA0Ng_4e3f9c04-80aa-4e11-a57e-25e46dae740c">906</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTA1Mw_1d6ab8d8-b161-4669-87aa-08738b2a5a91">683</ix:nonFraction> million, respectively, at March 31, 2020. These amounts primarily consist of the majority of the Company&#8217;s German pharmaceutical wholesale business described below.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i1e18b007d33547fa927d32ae1cbf42de"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">German Pharmaceutical Wholesale Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2019, the Company announced that it had entered into an agreement (the &#8220;Contribution Agreement&#8221;) with Walgreens Boots Alliance intending to contribute the majority of its German pharmaceutical wholesale business to create a joint venture in which McKesson will have a noncontrolling interest. This business is within the Company&#8217;s International segment. The agreement was subject to regulatory approvals, which were received in the second quarter of 2021, and the contribution was completed on November 1, 2020, as noted below. The transaction does not meet the criteria to be reported as a discontinued operation as it does not constitute a significant strategic business shift. For the three and six months ended September 30, 2020, the Company recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="ia19a8a6ef0bd48e1be49afd2d6d8a75d_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTA5OTUxMTYzMjk3NQ_013402e1-6e3b-4eb4-bd8c-e8727996bb42"><ix:nonFraction unitRef="usd" contextRef="i5b52e33cd5364b31ad0004abbc59b28d_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTA5OTUxMTYzMjk3NQ_81d8ec25-5112-4832-9fc8-24468254300f">10</ix:nonFraction></ix:nonFraction>&#160;million to remeasure the held for sale assets and liabilities to fair value less costs to sell. The Company&#8217;s measurement of the fair value of the disposal group was based on the total consideration received by the Company as outlined in the Contribution Agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMjczMg_ed169262-9677-4b2b-8329-3e1c3ce3a9cf" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The total assets and liabilities of the German pharmaceutical wholesale joint venture that have met the classification of held for sale on the Company&#8217;s Condensed Consolidated Balance Sheets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a597186da7942b78a164787ea1dea53_I20200930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMy0xLTEtMS0w_f2c487eb-fc0c-43d5-8ffa-76278c49b8c1">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5d0799400b4399a996c8da70230763_I20200331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMy0zLTEtMS0w_55345600-296e-4cbb-ad4d-7b72fe6b8a42">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a597186da7942b78a164787ea1dea53_I20200930" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfNC0xLTEtMS0w_cc94f532-f651-431d-8394-0ade477cbfc4">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5d0799400b4399a996c8da70230763_I20200331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfNC0zLTEtMS0w_1be26f77-4c52-43ad-9f46-476178bab267">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a597186da7942b78a164787ea1dea53_I20200930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfNi0xLTEtMS0w_b5afd656-6176-4585-805a-727304edc68c">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5d0799400b4399a996c8da70230763_I20200331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfNi0zLTEtMS0w_efe2396c-a260-467b-8ec7-8d5531161c83">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of business held for sale to fair value less costs to sell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a597186da7942b78a164787ea1dea53_I20200930" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfNy0xLTEtMS0w_b219617c-7bb5-4292-bd21-b9518bb24aed">296</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf5d0799400b4399a996c8da70230763_I20200331" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfNy0zLTEtMS0w_33dd10bb-be0e-4749-8094-e85447cebb68">272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a597186da7942b78a164787ea1dea53_I20200930" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfOC0xLTEtMS0w_c123a616-ffea-498e-b93d-d412c2ce7c41">781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5d0799400b4399a996c8da70230763_I20200331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfOC0zLTEtMS0w_d40d0000-8f6f-42e5-ba93-8587e29c47a5">842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a597186da7942b78a164787ea1dea53_I20200930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTItMS0xLTEtMA_952ba418-a324-4f00-a3b3-4f4fd6cc4c2a">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5d0799400b4399a996c8da70230763_I20200331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTItMy0xLTEtMA_d6475ef0-bcd0-4044-a1fa-447dd36eabeb">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a597186da7942b78a164787ea1dea53_I20200930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTMtMS0xLTEtMA_81a1dd8e-1455-49e6-9f75-63d8aab02658">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5d0799400b4399a996c8da70230763_I20200331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTMtMy0xLTEtMA_50718e74-0ab2-45be-a823-fef6dc3771d8">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a597186da7942b78a164787ea1dea53_I20200930" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTQtMS0xLTEtMA_2f22b330-d63b-447d-8398-a51f19cdfaaa">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5d0799400b4399a996c8da70230763_I20200331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTQtMy0xLTEtMA_b8a12f8d-6ad6-4208-83e4-3e6ce442817f">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a597186da7942b78a164787ea1dea53_I20200930" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTUtMS0xLTEtMA_630de06c-3c84-4ed4-ba2a-d12e9641f7b8">506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5d0799400b4399a996c8da70230763_I20200331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTUtMy0xLTEtMA_7e9d4379-83ba-4ff8-bf73-43735a2b5a81">656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes the effect of approximately $<ix:nonFraction unitRef="usd" contextRef="ia19a8a6ef0bd48e1be49afd2d6d8a75d_D20200401-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMjYxNw_0ac4a0f4-1e3d-4928-8329-1fc6f39700b4">11</ix:nonFraction> million unfavorable and $<ix:nonFraction unitRef="usd" contextRef="i49c0062ceda84079a8aac41c1f01e410_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMjYzNg_5435fd67-23cf-4089-af5b-2e04b4c7f3a7">3</ix:nonFraction> million favorable cumulative foreign currency translation adjustments as of September 30, 2020 and March 31, 2020, respectively.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020, the Company completed the contribution of the disposal group to the joint venture. The Company accounted for this transaction as a sale of the German pharmaceutical wholesale business and a subsequent purchase of a <ix:nonFraction unitRef="number" contextRef="i805f21e7f7e04fbeb97134f767b3e1a8_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTU5NDI5MTg2MDc5NTk_0591fd12-90a2-4510-ac2a-5e333302711c">30</ix:nonFraction>% interest in the newly formed joint venture in the third quarter of 2021. As a result of finalization of working capital amounts contributed and other adjustments, the Company may record additional gains or losses in future periods. These adjustments are not expected to have a material impact on the Company&#8217;s condensed consolidated financial statements.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_49"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDQ5Mw_1a563de8-989e-49f9-a490-522165dc9ca2" continuedAt="if41349ec799f46148b3869fba03dcc99" escape="true">Restructuring, Impairment, and Related Charges</ix:nonNumeric></span></div><ix:continuation id="if41349ec799f46148b3869fba03dcc99" continuedAt="i41825e4226f54e9da09d8ac3feb9d27f"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges of $<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfMjc0ODc3OTA3OTQwMQ_0d72b820-8f49-4f71-90ad-16448597adcf">60</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNTQ5NzU1ODE0MzY1OA_200b1e15-3cf2-4363-bc17-473ce3534d67">116</ix:nonFraction> million during the three and six months ended September 30, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfOTA_921de08f-4c5c-4c55-b64e-40648a8e48c3">45</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNTQ5NzU1ODE0MzY5MA_26ee0be1-e0c4-41e7-9207-3601efab1b8f">68</ix:nonFraction> million during the three and six months ended September 30, 2019, respectively. These charges are included under the caption, &#8220;Restructuring, impairment, and related charges&#8221; in Operating expenses in the Condensed Consolidated Statements of Operations. In addition, charges related to restructuring initiatives are included under the caption &#8220;Cost of sales&#8221; in its Condensed Consolidated Statements of Operations and were not material for the three and six months ended September 30, 2020 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. The Company expects to record total charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i2c678c2a6d6247e8b531105d084453a3_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfODAz_92c55573-d626-4d71-8e75-58da867b7e83">90</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i7c9ccbb6fda842ceb43fb552e0daf01e_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfODA5_535c70ba-f4ea-4ea6-ae48-c21c6df0b87a">125</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="id6656f9779e14248b3ab954ea86b6abd_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfODIy_c3390acc-f00b-4188-8366-767f233411a1">90</ix:nonFraction> million of charges were recorded to date. Charges recorded in the three and six months ended September 30, 2020 and 2019 were not material. The estimated remaining charges primarily consist of lease and other exit-related costs, and employee-related expenses. The Company anticipates that the relocation will be complete by January 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company expects to incur total charges of approximately $<ix:nonFraction unitRef="usd" contextRef="icdd739be481242018906607a0e292bcd_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfMTA0NDUzNjA0NzUxOTE_0561c1e9-bf11-4dae-8147-9864195f6f7c">300</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i0412307b393b4b31809303ea6964eadd_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfMTcxNw_354d9030-e721-4aef-b64d-7e4b0a98ea85">320</ix:nonFraction>&#160;million for these programs, of which $<ix:nonFraction unitRef="usd" contextRef="id4809ccdb789473eb416b9fdf1aea69a_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfMTc0OQ_1cb3f37f-5685-4ac7-a81f-0d317fb47c38">271</ix:nonFraction>&#160;million of charges were recorded to date. Charges recorded in the three and six months ended September 30, 2020 and 2019 were not material and primarily represented employee severance, accelerated depreciation expense, and project consulting fees. The Company anticipates these additional programs will be substantially completed in 2022. The estimated remaining charges primarily consist of facility and other exit costs and employee-related costs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which is included in the Company&#8217;s International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. The Company expects to incur total charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i1dcc43c72e854787a25695f0ff26f3e3_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfMTA0NDUzNjA0NzQ5MTc_cfe5f5a2-04c2-4c20-987b-83afd40e43b0">100</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i31f383b4585b4d15840458661a81ecf3_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfMTA0NDUzNjA0NzQ5NDk_03493320-85ef-4880-ba98-507eae10b62f">120</ix:nonFraction>&#160;million. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i46a8b56ffa35493ba482183ab526d9bd_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNTQ5NzU1ODE0NDI0OA_b465380d-a557-44ee-b7f4-badbbd2d518e">27</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4d1520f234a14153a52538db1d0fbc55_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNTQ5NzU1ODE0NDI1Ng_b5152f2e-44ad-4658-ad0c-21201122114f">41</ix:nonFraction> million, respectively, in the three and six months ended September 30, 2020, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. The initiative is expected to be substantially complete by the end of 2021 and estimated remaining charges primarily consist of accelerated amortization and impairments of long-lived assets, facility and other exit costs, and employee-related costs.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i41825e4226f54e9da09d8ac3feb9d27f" continuedAt="i55ac80f8d3f843719dfe0adea7f0c971"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDQ5OA_30f159ca-3be2-477a-bcc4-bf8a08d35afd" continuedAt="i018134a1899944a7a44c781bea7f7b02" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and six months ended September 30, 2020 consisted of the following: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia003613bb8bc483286b8644efc98f668_D20200701-20200930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMi0xLTEtMS0w_c48aa07b-c101-4279-b3eb-479d3802afb9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMi0zLTEtMS0w_a12308b0-5e66-4712-bd6b-3a7a88d1e1df">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMi01LTEtMS0w_5203308a-a9b5-4482-9ff3-8f8b9e3c0ec0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMi03LTEtMS0w_327d4541-8b74-4930-aa28-560bf9689256">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e5cc6dcf7146199a2f75c2b2ffa8af_D20200701-20200930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMi05LTEtMS0w_7054c587-ac7f-41f6-b735-dc1c1608f0ed">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMi0xMS0xLTEtMA_69aae1ba-c58c-434f-85ae-4e6208d91d0f">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia003613bb8bc483286b8644efc98f668_D20200701-20200930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMy0xLTEtMS0w_81d370e6-e6b9-4994-9285-75929ee5bc70">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMy0zLTEtMS0w_8f51b42f-748a-4c21-8034-dd8c7e7e67b7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMy01LTEtMS0w_7aa533a7-6048-4c3b-ab05-154c76bcef52">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMy03LTEtMS0w_b454e3d9-1dee-4465-91a2-6a8f5ec1cc15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e5cc6dcf7146199a2f75c2b2ffa8af_D20200701-20200930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMy05LTEtMS0w_85f001e2-84d6-408c-a135-10d2edcb0e43">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMy0xMS0xLTEtMA_9153282c-1f28-4134-8685-c2b4759097f2">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia003613bb8bc483286b8644efc98f668_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNC0xLTEtMS0w_374bdc63-7f2c-4c84-96d1-7c0faed87bc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNC0zLTEtMS0w_2f8d3a5c-4687-4375-bb85-8b5ea8423cf8">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNC01LTEtMS0w_62194266-2964-42b9-a517-f017d9754ea0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNC03LTEtMS0w_37032628-4a1e-4da7-a365-7bac4b5b0a44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e5cc6dcf7146199a2f75c2b2ffa8af_D20200701-20200930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNC05LTEtMS0w_8b0a9d59-33ab-4978-ad5a-5116352a270b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNC0xMS0xLTEtMA_cc83740a-ee70-4331-bf13-655a76a8057a">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia003613bb8bc483286b8644efc98f668_D20200701-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNS0xLTEtMS0w_ee100235-cfbe-4399-ba6e-5a59787773f8">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNS0zLTEtMS0w_8b69dd96-46b9-4cfe-aaf5-89b8360f1574">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNS01LTEtMS0w_be35db55-dad1-46f9-9844-c094c7301094">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNS03LTEtMS0w_25fb5cbb-ff69-41fb-bbf3-1232eae309da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e5cc6dcf7146199a2f75c2b2ffa8af_D20200701-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNS05LTEtMS0w_9d69a1a8-5553-4fcc-a183-beebccca7619">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNS0xMS0xLTEtMA_90c6e759-5ea6-468c-a026-5cfa5523151a">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of project consulting fees.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMi0xLTEtMS01MjQ_8d011329-be1a-4649-a1e7-7088a8372a74">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMi0zLTEtMS01MjQ_d0c4df8f-68c7-4316-a35d-4812fe9b587f">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMi01LTEtMS01MjQ_cd17f038-a9b7-407f-9e1e-1c4be8a37486">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMi03LTEtMS01MjQ_e6808e53-14e4-4e83-bdef-fbe2760c238e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMi05LTEtMS01MjQ_c4b1e117-c3eb-49d2-af8d-18ecefdd1c8e">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMi0xMS0xLTEtNTI0_70519829-f9d2-42ba-a3a3-a45e6b7d9cae">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMy0xLTEtMS01MjQ_10d65bf0-b613-46b1-a958-0f2a44befbf2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMy0zLTEtMS01MjQ_107c87ba-2e17-4c3b-91df-937d25beab96">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMy01LTEtMS01MjQ_eef0ddd3-50dc-4d78-a359-959680d07f26">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMy03LTEtMS01MjQ_637c4d96-feb9-48b1-a086-58fcc0dab373">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMy05LTEtMS01MjQ_a62dfb10-5e87-4ea7-93e2-ad0eb8c63687">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMy0xMS0xLTEtNTI0_58fdd0ee-4cae-49fe-9bd2-34c9bf047552">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNC0xLTEtMS01MjQ_ed69fec0-3c52-4ba8-8b44-2d930c09bfc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNC0zLTEtMS01MjQ_c2baae96-0f11-407b-8657-0631011103b9">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNC01LTEtMS01MjQ_5119589d-7388-43fa-871d-15206c4d8387">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNC03LTEtMS01MjQ_7bfde05d-e21f-416c-b265-3f8e8b22df55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNC05LTEtMS01MjQ_ab7184b4-a494-4cc3-a5ef-4e910cdbb100">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNC0xMS0xLTEtNTI0_490c2e24-35bf-48db-842f-16e08ed8e229">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNS0xLTEtMS01MjQ_27ba6a74-1990-4549-bd17-98adcbb306f7">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNS0zLTEtMS01MjQ_e8e1e041-5b9a-49da-b38a-a42205c1c02b">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNS01LTEtMS01MjQ_4874b972-1bf8-4694-92b4-6198eb8f9992">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNS03LTEtMS01MjQ_285e300b-c04f-4cab-910c-42e265ae3809">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNS05LTEtMS01MjQ_806dbf43-5b2d-4b2d-adb2-20735f6e1021">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNS0xMS0xLTEtNTI0_299d1369-69c2-4deb-89ce-70956bf56d08">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of project consulting fees.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i55ac80f8d3f843719dfe0adea7f0c971" continuedAt="i7f56b07c6e73436d8e950543491fbba9"><ix:continuation id="i018134a1899944a7a44c781bea7f7b02"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and six months ended September 30, 2019 consisted of the following: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMi0xLTEtMS0w_c7015ecc-728f-4fc3-a422-c42e4fc91d12">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMi0zLTEtMS0w_e7dcbe89-3f71-4f57-9f42-284dc015c640">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMi01LTEtMS0w_97510517-371f-4bc4-b52f-b6f70b10b38e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMi03LTEtMS0w_0bfe1be5-f9d8-4c76-b771-5a90459a059b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ee29e972613498aa1e93fe830d2eb8e_D20190701-20190930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMi05LTEtMS0w_43121071-7ee4-40c7-8405-8bcf6c97795e">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMi0xMS0xLTEtMA_43f180a6-49ed-4fd6-a5c6-70cf1da6bf6f">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMy0xLTEtMS0w_0eb111c6-36f7-4cf8-92fc-d774e329e4eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMy0zLTEtMS0w_f23e63bb-f442-4886-9c3b-bcda0f71c4fb">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMy01LTEtMS0w_a03b39f1-abe3-48fa-a0a2-1756a8cb23c1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMy03LTEtMS0w_f5580771-3d2b-4e3b-90ac-7d0c31259bd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ee29e972613498aa1e93fe830d2eb8e_D20190701-20190930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMy05LTEtMS0w_267afee4-067e-4c94-8f80-38cb5d618c91">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMy0xMS0xLTEtMA_d77a4d0e-c3e4-47f6-b071-654d898ae655">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNC0xLTEtMS0w_54b9b97d-d033-40ae-b1d4-26c852331684">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNC0zLTEtMS0w_c1a15da6-9d0c-4f4c-a07a-6ff4c3310140">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNC01LTEtMS0w_74da5156-63dd-48c9-97d9-1d192085455a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNC03LTEtMS0w_bce69249-077c-42b0-9d79-225277e11977">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ee29e972613498aa1e93fe830d2eb8e_D20190701-20190930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNC05LTEtMS0w_7b041725-e656-47b7-b190-a1c9c8d6bf6d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNC0xMS0xLTEtMA_dde74934-ea77-434a-9371-3043557c3e95">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNS0xLTEtMS0w_8e3d3086-039b-462c-9161-481b5e6bdc39">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNS0zLTEtMS0w_9c734139-97cf-498b-884c-86139b1f7be2">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNS01LTEtMS0w_97112a41-2852-4007-9fbb-7cd0ac9085c2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNS03LTEtMS0w_af4926dc-a215-4e9e-8523-8d76d936fa9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ee29e972613498aa1e93fe830d2eb8e_D20190701-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNS05LTEtMS0w_d11c8c93-6341-445c-9ee5-55d065c5cc90">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNS0xMS0xLTEtMA_982f3b77-f348-4639-935b-f968f1916af9">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMi0xLTEtMS03MTk_3d74336c-7961-47ff-9785-7dc83a53c540">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMi0zLTEtMS03MTk_7969f0cf-e7f3-4178-b44a-ae41d3382fb7">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMi01LTEtMS03MTk_f3c1d1ed-ba4d-4a0f-a9f7-f3e616138768">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMi03LTEtMS03MTk_c8610dc8-67e2-4304-906b-64ca52c4831d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c1d98305344009a39b536f04f12c9e_D20190401-20190930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMi05LTEtMS03MTk_ec09f684-f026-47bb-a9dc-e8fdd6655424">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMi0xMS0xLTEtNzE5_84055e1c-40e6-47cb-a489-70747a300f83">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMy0xLTEtMS03MTk_780661b2-9ff3-4aa9-96de-40e86d89ec18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMy0zLTEtMS03MTk_5668ea56-1317-4aab-aa0f-c0e30a4736d9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMy01LTEtMS03MTk_0133b27d-85c5-4cd4-97f2-bc5d778d38f4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMy03LTEtMS03MTk_acfd7f2f-293c-40d4-81f5-f010e9d0dfc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c1d98305344009a39b536f04f12c9e_D20190401-20190930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMy05LTEtMS03MTk_a74de242-2720-41d0-b9a8-32f8722bf592">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMy0xMS0xLTEtNzE5_e9e68c60-97c0-4920-ad8a-45e7bbe354d4">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNC0xLTEtMS03MTk_5ae30753-9aad-4065-b763-db78d7a1dc47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNC0zLTEtMS03MTk_ba1cf835-584e-4d3f-8974-5c9598af6f84">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNC01LTEtMS03MTk_aa0f13d9-f6d4-41c4-a5fd-cfaa589425f4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNC03LTEtMS03MTk_fbc2f788-72e4-4a73-b348-2fdd9dafe757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c1d98305344009a39b536f04f12c9e_D20190401-20190930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNC05LTEtMS03MTk_490daa22-d3ce-4d1f-a8c4-22affad84a8c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNC0xMS0xLTEtNzE5_ad583198-2256-4b46-94b8-6dac61364158">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNS0xLTEtMS03MTk_d0a25b70-09e9-42b4-85ca-0d36db847b74">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNS0zLTEtMS03MTk_e5a6e0a9-131b-45f0-8f8a-8e67104dc54a">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNS01LTEtMS03MTk_e69162ce-cfd7-4156-b3b4-75b48ba96020">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNS03LTEtMS03MTk_1d69a0c3-0866-45b2-84a9-c4bb01e61fee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c1d98305344009a39b536f04f12c9e_D20190401-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNS05LTEtMS03MTk_3e39f95b-3542-4f21-a89f-a360479cbe01">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNS0xMS0xLTEtNzE5_f7782e5e-4d25-4377-8111-f9f2437249cf">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i7f56b07c6e73436d8e950543491fbba9"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDUwMg_687967c9-6abf-470c-8d75-386a78edcb87" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the six months ended September 30, 2020: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedb569793bdf49caa63b344631feb0d0_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMS0xLTEtMS0w_9931bd46-9c2b-4ef3-a6da-7d827c27fa3f">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceed4414407b4b86847ad2d2815f97dd_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMS0zLTEtMS0w_e8f672de-581c-4ac9-9b05-d6d3b9c1c303">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f59e8d12d84c3893cbe9b46385b3ed_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMS01LTEtMS0w_f06a275a-3318-44f9-9520-7f96e47a8856">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e76a24704794920bda6de2102ffebac_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMS03LTEtMS0w_23193d80-7671-448e-8d44-f2c9e5ed3041">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73487326569472394f59d7b9300567d_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMS05LTEtMS0w_77c7e320-c6eb-41ff-b77b-6bef49ecbca9">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMS0xMS0xLTEtMA_6ad2a628-45e5-4c3c-ab1a-1088e7e59f04">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMi0xLTEtMS0w_4bb8fa69-401e-43c6-85d0-2b2914a81de2">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMi0zLTEtMS0w_2fce430f-8f7f-4457-8ea4-fd4139ca396b">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMi01LTEtMS0w_01e9e5ee-913f-445a-a4c9-62e2157e060a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMi03LTEtMS0w_94c5b2f6-56e8-45a0-bc83-13bb0e6b9661">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMi05LTEtMS0w_ca234516-df8e-4793-b5c4-fc63e73afe99">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMi0xMS0xLTEtMA_669b31d4-01ef-416d-908d-fc7ca65f6bf3">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMy0xLTEtMS0w_634d7fc0-012b-4908-89a9-4bbd9d788d0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMy0zLTEtMS0w_81a4ba3f-53cf-4520-b9a9-4448a281f52f">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMy01LTEtMS0w_1e5cc8d6-50a4-47ca-9ae2-66029395a518">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMy03LTEtMS0w_85120123-0b1c-4ea9-91a7-2a5e5434e72b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMy05LTEtMS0w_05b56468-b863-4957-8be7-df1eacd4d835">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMy0xMS0xLTEtMA_b39be95c-20c0-409d-9b06-0bcdc01d64d5">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNC0xLTEtMS0w_3d0cf406-3c13-4c6a-aba3-6887e4d9df81">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNC0zLTEtMS0w_79b9f30f-8c69-488c-be43-f916afe6e079">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNC01LTEtMS0w_4326cddf-43a0-4b1e-97f0-5a0f81a839b2">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNC03LTEtMS0w_25995da9-18a9-4465-8f76-bb2a0aa23909">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNC05LTEtMS0w_6d957bc3-0465-444d-a0b9-383d88697f5d">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNC0xMS0xLTEtMA_1794d94b-04fb-4ca3-b44c-fb16c0fecc0d">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNS0xLTEtMS0w_34a4b09b-23e6-4116-95d5-8f4ac5813587">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNS0zLTEtMS0w_6ad0ba8d-f2e1-42d7-b973-b4262f57a28e">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNS01LTEtMS0w_cc85c24b-d123-4f11-b555-05333487edae">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNS03LTEtMS0w_aca74522-3949-473c-88c3-d277815c9008">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNS05LTEtMS0w_d565745d-358f-450e-b9b7-762ac4426ba0">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNS0xMS0xLTEtMA_f2fd6039-dee6-4805-b4e5-f09cd445f96d">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0838a6f327724e01a3d66fd6fc84b706_I20200930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNi0xLTEtMS0w_861fa199-bf14-4a8e-97aa-40b5712574b8">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd88456c2f48402184d07594c1ba6eeb_I20200930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNi0zLTEtMS0w_426744cf-f671-4cf5-b171-29aa8aa4e6dd">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ff9ffbf98d4a1781d19ab625704e99_I20200930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNi01LTEtMS0w_646310b3-fc40-4675-a5dc-64e00f6360b4">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11292865b78d4742933b20217600c04b_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNi03LTEtMS0w_d554661e-aa0d-487b-ad01-5a9ff1353a8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017eaec1fb0f4fcaa8bf8c05655a17ab_I20200930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNi05LTEtMS0w_37385666-145e-4137-a93d-5db4221ff38a">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNi0xMS0xLTEtMA_091cc3ea-bb8e-430f-9d15-274036cbfc59">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2020, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDMxMQ_c6fef802-9d24-4cbf-a64a-dc32a9a90b61">157</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i4343021266684e09aac01da8724fc70e_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDMyNA_a6a1e3e5-f350-4537-9a55-48080496e444">118</ix:nonFraction> million was recorded in Other accrued liabilities and $<ix:nonFraction unitRef="usd" contextRef="i1671d32a17be409fba3f84f83e2794f7_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDM1MA_366c3770-289b-4369-b9bd-12cecc8f358b">39</ix:nonFraction> million was recorded in Other non-current liabilities. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of September 30, 2020, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDQyNQ_5fea4acb-0deb-4179-b02e-be5dabbe3115">155</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ia54b0b6c830541ae8639a2eaa798e845_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDQzOA_b21d174a-0840-4398-8755-74b8f619bf72">128</ix:nonFraction> million was recorded in Other accrued liabilities and $<ix:nonFraction unitRef="usd" contextRef="i0c961f18f05e48699a6932152d3b4bf5_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDQ2NA_c36368bd-6c70-4608-9cb9-293739c53276">27</ix:nonFraction> million was recorded in Other non-current liabilities.</span></div></ix:nonNumeric></ix:continuation><div id="iecfa0e5b7669406c886f8e2dcd87b845_52"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTMxOA_f417ff03-2623-4909-994e-4b4e0d401ccc" continuedAt="i347ddec14ba244efbc2800f9ff7d7c3e" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="i347ddec14ba244efbc2800f9ff7d7c3e"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020 and 2019, the Company recorded income tax expense of $<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfOTU_d20c0ef2-9b7e-4c68-8fa1-ce81302ce244">28</ix:nonFraction> million and an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTAy_01f96ad8-7843-4f41-a5c9-6fe4925e53e5">294</ix:nonFraction> million, respectively, related to continuing operations. During the six months ended September 30, 2020 and 2019, the Company recorded income tax expense of $<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTY0OTI2NzQ0MzI2Nw_44e1622c-21cc-483b-acba-77c93761cff1">178</ix:nonFraction> million and an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTY0OTI2NzQ0MzI4Mg_e238f5f8-f02d-42b8-bbc0-88322bcab497">158</ix:nonFraction> million, respectively, related to continuing operations. The Company&#8217;s reported income tax rates were expense of <ix:nonFraction unitRef="number" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMjA3_440dca60-3e3a-4bca-a2e8-b056c174d3eb">4.3</ix:nonFraction>% and benefit of <ix:nonFraction unitRef="number" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMjE0_4a2302df-937c-40d1-bed5-5c9d3d6a67cb">30.3</ix:nonFraction>% for the three months ended September 30, 2020 and 2019, respectively and expense of <ix:nonFraction unitRef="number" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTY0OTI2NzQ0MzMwNg_ab5297b5-c51e-4e7f-8f78-f9ae3b061ecd">13.7</ix:nonFraction>% and benefit of <ix:nonFraction unitRef="number" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTY0OTI2NzQ0MzMxMw_3499cc8c-1fb6-464b-be29-de455979daa6">45.0</ix:nonFraction>% for the six months ended September 30, 2020 and 2019, respectively. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to changes within the mix of earnings between various taxing jurisdictions and discrete items recognized in the quarters, primarily due to the impact of an intercompany sale of intellectual property during the three months ended September 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gain was eliminated upon consolidation. The acquiring entity of the intellectual property is entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#8220;Intra-Entity Transfers of Assets Other Than Inventory,&#8221; a discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTA0NDUzNjA0NjkxMDI_dbcd8891-a4f7-487e-af80-7e12cd2c6391"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:IncomeTaxExpenseBenefitDiscreteItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTA0NDUzNjA0NjkxMDI_e34a311d-e2ff-488c-833c-632adcb9630a">105</ix:nonFraction></ix:nonFraction> million, which reduced the Company&#8217;s reported income tax rates by <ix:nonFraction unitRef="number" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="INF" sign="-" name="mck:EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTA0NDUzNjA0NzE1NzA_5391c2bf-b798-4485-88e8-725280252537">16.0</ix:nonFraction> percentage points and <ix:nonFraction unitRef="number" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="INF" sign="-" name="mck:EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTA0NDUzNjA0NzE5MjE_11afea85-88c8-4b34-9beb-2a3842d7750d">8.1</ix:nonFraction> percentage points for the three and six months ended September 30, 2020, respectively, was recognized with a corresponding increase to a deferred tax asset for the temporary difference arising from the buyer&#8217;s excess tax basis. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfNDQx_66152659-03c4-4142-b6db-faba9daffaf0">1</ix:nonFraction> billion of unrecognized tax benefits, of which $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfNDgz_d2f0dcb3-77a7-4255-8e6b-796aabda4e51">882</ix:nonFraction> million would reduce income tax expense and the effective tax rate if recognized. During the next twelve months, it is reasonably possible that the Company&#8217;s unrecognized tax benefits may decrease by as much as $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTA0NDUzNjA0Njg3OTc_94e6aa27-c32e-482d-a53a-97320a2cd4b8">105</ix:nonFraction> million due to settlements of tax examinations and statute of limitations expirations in the U.S. federal and state jurisdictions and in foreign jurisdictions. However, this amount may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2016 through 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_58"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0MjA0NTQ_4fdf18b7-41af-4266-a603-d72f8b91fc59" continuedAt="i298caf72644346e8a07a727e2cdb3d13" escape="true"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0MjA0NTY_8fba3330-e3b6-4e13-958f-54ff81d6d5d4" continuedAt="ifdb05cb1f4dc4e509f243a606354461e" escape="true">Redeemable Noncontrolling Interests and Noncontrolling Interests</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i298caf72644346e8a07a727e2cdb3d13" continuedAt="i60305483ab704627967aa92afcf9f6c3"><ix:continuation id="ifdb05cb1f4dc4e509f243a606354461e" continuedAt="i22d7592bf84444d39a8cb39f6ae68225"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable noncontrolling interests primarily relate to its consolidated subsidiary, McKesson Europe AG (&#8220;McKesson Europe&#8221;). Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="idb66d47f37f94937b69269c1af59b8b9_I20200930" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfNDEw_885a4b43-247c-417a-9509-7d2dbce8c3e8">0.83</ix:nonFraction> per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $<ix:nonFraction unitRef="usd" contextRef="i47b5375d9880408783a5c35d0bf9a5a6_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfNTQ5_c725a514-e4f4-4653-a7de-c694e6fa1893">10</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia9749be689974b10b3717c1f4f66b1b7_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0NDc1Nw_af2178bd-27dc-44e2-97f1-8f945aefc728">21</ix:nonFraction> million during the three and six months ended September 30, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="id809ea9c3d4348ba9c6347b08f2823f8_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0NDg0OA_073b3171-61e1-4c09-b041-8d4cc4d9cc5d">11</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i13b7d11348f2478dbc84c872d3eeacea_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0NDg1NQ_d7c7f8ef-7ef8-4cdd-b274-3701b8f00167">22</ix:nonFraction> million during the three and six months ended September 30, 2019, respectively. All amounts were recorded in Net income attributable to noncontrolling interests in the Company&#8217;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in Other accrued liabilities in the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfOTcz_30e9493b-aa70-44f9-a645-fab72e7fc0ad">22.99</ix:nonFraction> per share, increased annually for interest in the amount of <ix:nonFraction unitRef="number" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="mck:PutRightValueInterestRateSpread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTAzNg_3836ec8a-e7c1-45cc-ad5a-236b6cb3b25d">five</ix:nonFraction> percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During the six months ended September 30, 2020, the Company paid $<ix:nonFraction unitRef="usd" contextRef="ia9749be689974b10b3717c1f4f66b1b7_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTQwMQ_00960618-c86e-4da5-b659-0627c8faa29f">49</ix:nonFraction> million to purchase <ix:nonFraction unitRef="shares" contextRef="ia9749be689974b10b3717c1f4f66b1b7_D20200401-20200930" decimals="-5" format="ixt:numdotdecimal" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTQ0Mw_269d74d3-8020-4c10-b2be-24ba48ccf475">1.8</ix:nonFraction>&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $<ix:nonFraction unitRef="usd" contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjc0ODc3OTA3MzIzNw_d962c1c2-ad2c-4ccc-a45b-297a9e6b6b33">49</ix:nonFraction> million, and the associated effect of the increase in the Company&#8217;s ownership interest on its equity of $<ix:nonFraction unitRef="usd" contextRef="i3845b80d46e4483e96a588f5092ba0ba_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0NDk0OA_d633ab39-2d71-47ad-a16d-a2d52a81d541">3</ix:nonFraction> million was recorded as a net increase to McKesson&#8217;s stockholders paid-in capital during 2021. During the three months ended September 30, 2020 and the three and six months ended September 30, 2019, there were no material exercises of the Put Right. The balance of the associated liability for Redeemable noncontrolling interests is reported as the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The Redeemable noncontrolling interest is also adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. At September 30, 2020 and March 31, 2020, the carrying value of redeemable noncontrolling interests of $<ix:nonFraction unitRef="usd" contextRef="i7f53e387d5a04f1fb44fa3972fa2143a_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTA0NDUzNjA0NjgyOTY_43607cb1-21bb-4c7c-a794-e2016ad294fc">1.3</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i2f1078720e5143e4b52c84e6e385b68b_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTA0NDUzNjA0NjgzMDQ_97f88761-f1b4-49b6-aa62-68145d209706">1.4</ix:nonFraction>&#160;billion, respectively, exceeded the maximum redemption value of $<ix:nonFraction unitRef="usd" contextRef="i2f1078720e5143e4b52c84e6e385b68b_I20200331" decimals="INF" format="ixt:numdotdecimal" name="mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjI0OQ_2998be1b-8d90-4d3a-aa51-4fb985ccbc62"><ix:nonFraction unitRef="usd" contextRef="i7f53e387d5a04f1fb44fa3972fa2143a_I20200930" decimals="INF" format="ixt:numdotdecimal" name="mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjI0OQ_87f659f6-9c8d-4156-844c-c77569562c15">1.2</ix:nonFraction></ix:nonFraction> billion. At September 30, 2020 and March 31, 2020, the Company owned approximately <ix:nonFraction unitRef="number" contextRef="i7f53e387d5a04f1fb44fa3972fa2143a_I20200930" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjI5OQ_80ca9e99-78e9-4386-8097-a41401ef23cb">78</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i2f1078720e5143e4b52c84e6e385b68b_I20200331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjMwNg_f2b85e90-1459-4538-a0e1-dac69a0c63c9">77</ix:nonFraction>%, respectively, of McKesson Europe&#8217;s outstanding common shares.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and McKesson Europe, which were $<ix:nonFraction unitRef="usd" contextRef="ifa11ecf1c6d5459db583272a482d2382_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjYwMA_757b9525-f5ab-418d-9387-6aee89961266">200</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifbdd4b3c559743d6869a9f70f2186ede_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjYwNw_a409e6f0-3a4d-42e6-93e9-c39a4825f1f2">217</ix:nonFraction> million at September 30, 2020 and March 31, 2020, respectively, in the Company&#8217;s Condensed Consolidated Balance Sheets. The Company allocated a total of $<ix:nonFraction unitRef="usd" contextRef="i0d27cf1f90fc45b3ae73b669b099480f_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjc2NQ_01ac027d-63a6-4845-8e9e-7889ccfba782">40</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9ca04e14279740e28d9b9ddcb4dba385_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0NTA3Ng_67a542a5-5d34-4cfa-8e4c-b83babaecf03">79</ix:nonFraction> million of net income to noncontrolling interests during the three and six months ended September 30, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i17d9381377c24a9ab35373e9e45ff3c0_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjc3Mg_a07b019a-4e7e-4191-bd41-1e18f5ac1fc7">42</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i52c6f40d2729407c94ff1c3df7df4ff2_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0NTExNw_03719d91-2b6f-4c6c-91fe-34048216060d">85</ix:nonFraction> million during the three and six months ended September 30, 2019, respectively.</span></div></ix:continuation></ix:continuation><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i60305483ab704627967aa92afcf9f6c3"><ix:continuation id="i22d7592bf84444d39a8cb39f6ae68225"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0MjA0NTU_f067f7e3-8865-43ae-b6e8-e4452d8ce6e6" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2020 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86b3fd731c6a451da95296357c34854c_I20200630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfMS0yLTEtMS0w_d9198d7b-1314-4ee6-8edc-e334f513ac16">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i818f8654b0e24954be9c97bd24ef37ab_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfMS00LTEtMS0w_f803685e-8dfe-4a79-881d-0c621dd5fb5f">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfMi0yLTEtMS0w_b01faaac-7f75-4944-ada3-e55e7e3b4610">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i389a8e5295ce4baf8bf99cd380e382ca_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfMi00LTEtMS0w_f6b5f3be-4c9a-42a4-82b2-b200de899e06">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfMy0yLTEtMS0w_812ba09e-a5ef-442f-bf69-8d8f7e95cbf1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i389a8e5295ce4baf8bf99cd380e382ca_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfMy00LTEtMS0w_35db4a41-9aaf-4819-a265-494a747c73e6">151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i389a8e5295ce4baf8bf99cd380e382ca_D20200701-20200930" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfNC00LTEtMS0w_9603ae09-89c8-4417-a090-83b9bee00749">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfNS0yLTEtMS0w_73dc1b0a-b7e3-42a7-b36d-ea5590b58588">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i389a8e5295ce4baf8bf99cd380e382ca_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfNS00LTEtMS0w_c6c2fe8a-2d0e-402c-8559-bfcc19ba47ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfOC0yLTEtMS0w_696f28e8-d7c3-4b7c-8d63-07d2ff592a42">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i389a8e5295ce4baf8bf99cd380e382ca_D20200701-20200930" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfOC00LTEtMS0w_761ae72f-e1e9-42f5-b921-3b3a18488ec9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadfecb50b694b9bad1fd34884a1ae60_I20200930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfOS0yLTEtMS0w_1dfcf816-95a0-4511-b005-6e322443336f">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bc860b936064f418b265dc92fb1e420_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfOS00LTEtMS0w_a88ea3c3-371a-4fce-a0c6-401624ee5785">1,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebba672c55ee4c2a87f45e310c89afba_I20200331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfMS0yLTEtMS0xMDgz_00239356-c257-48a4-95e9-156e15a3d59b">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9d9fefc80324149bd26fbe32cfb7e78_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfMS00LTEtMS0xMDgz_24e5bc8b-2e7e-4619-b973-111ce98becc1">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfMi0yLTEtMS0xMDgz_1cdec38c-4631-4f1c-8d43-0dad1c3b282d">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfMi00LTEtMS0xMDgz_f7ef1468-d03b-46b6-b4c9-ab86d25b1de2">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfMy0yLTEtMS0xMDgz_25e0eda9-01e1-4b9b-83a0-7ba9d884c9d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfMy00LTEtMS0xMDgz_7a093734-7cc5-4492-aece-5717b0ccffb4">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfNC00LTEtMS0xMDgz_b4ae47e8-8b12-473e-9991-6557aa5c76c4">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfNS0yLTEtMS0xMDgz_70dac57a-ade8-43ae-8b2e-7d014aa191c9">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfNS00LTEtMS0xMDgz_2ce6f0b3-6d6a-450a-a7bd-229cac31787b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfNy00LTEtMS0xMDgz_d962c1c2-ad2c-4ccc-a45b-297a9e6b6b33">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfOC0yLTEtMS0xMDgz_60cbf9aa-597a-46b7-95b1-de9b6b8a801e">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfOC00LTEtMS0xMDgz_1f34df92-ba0c-4bf4-aa29-72c41ca6ed03">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadfecb50b694b9bad1fd34884a1ae60_I20200930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfOS0yLTEtMS0xMDgz_ff9c0404-eae4-43b3-841b-7ee8e8b7bfd7">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bc860b936064f418b265dc92fb1e420_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfOS00LTEtMS0xMDgz_1a2c5bd1-f8c3-49c9-9184-5d44184c4dc0">1,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2019 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2019</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0e512234a3947858289f71240af0e24_I20190630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfMS0yLTEtMS0w_3096a858-8e65-4473-8885-a8da1543fe08">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib35aa222c90b4f96af5dce4124e6fa37_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfMS00LTEtMS0w_7126ecba-e4bc-4897-b100-2ede3530d01a">1,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfMi0yLTEtMS0w_feba7cf1-6bce-4df9-b6a8-12bdccb78062">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefc14ef243d44219b893fb6a33e8dec3_D20190701-20190930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfMi00LTEtMS0w_54c0188a-71f5-4d6f-b50c-7b41a59429bd">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfMy0yLTEtMS0w_681669b9-8b3d-4a30-af35-2932d40bb7dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefc14ef243d44219b893fb6a33e8dec3_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfMy00LTEtMS0w_a549c02c-9a56-4aba-b1ca-6da6df1559bd">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefc14ef243d44219b893fb6a33e8dec3_D20190701-20190930" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNC00LTEtMS0w_90186a5c-48d1-45c2-a8fb-f1247d7dcf6e">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNS0yLTEtMS0w_0712d2d7-0d22-4ff5-bf51-004f6a96ec51">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefc14ef243d44219b893fb6a33e8dec3_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNS00LTEtMS0w_9f65c55e-0e58-4183-a09e-c245fb611a49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNi0yLTEtMS0w_735fc926-93c9-4e0b-9a80-350e32cd6c52">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefc14ef243d44219b893fb6a33e8dec3_D20190701-20190930" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNi00LTEtMS0w_3074f765-ebfc-47dc-86cb-e4eee8e58624">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2019</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2ca1a2d209b4ea4a677b11a4d562bff_I20190930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNy0yLTEtMS0w_cb8e8aff-a567-423b-a247-fb48ad9a58e0">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic21c3596993443348892ffc6b8dca3b1_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNy00LTEtMS0w_9090a776-39c2-4aca-9be2-86241c3c3c14">1,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.031%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7004546d044b4049a10a34e53e7b21d2_I20190331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfMS0yLTEtMS0yMjY2_676aaaf0-706d-498f-8af7-be5d5e1faaf7">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453234fb946045ff8438628a7160ef19_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfMS00LTEtMS0yMjY2_7a18b260-050a-441f-b905-90213d0a18e6">1,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfMi0yLTEtMS0yMjY5_d4b7132f-1a3a-4478-8a41-1723a66bb8e7">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a29c719f1364338a8ee516a3a09bc49_D20190401-20190930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfMi00LTEtMS0yMjY5_ae8de1ef-a3bd-4d53-b1d3-a4c07ba75246">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfMy0yLTEtMS0yMjY5_e29aced7-bcb5-4b29-af0a-91c3bf865846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a29c719f1364338a8ee516a3a09bc49_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfMy00LTEtMS0yMjY5_248a025a-5048-4b9e-af9a-922a68c1f432">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a29c719f1364338a8ee516a3a09bc49_D20190401-20190930" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNC00LTEtMS0yMjc1_ba3619bc-0510-4c06-b509-7cac2e5fd8d0">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNS0yLTEtMS0yMjc1_f8ca69b2-033b-4511-8c93-c3b1ef2db21b">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a29c719f1364338a8ee516a3a09bc49_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNS00LTEtMS0yMjc1_faf55a99-9e3f-4132-83ce-9b2e21916c60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNi0yLTEtMS0yMjc1_8bbcca57-54d2-47b5-b41b-cd4fb01db75c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a29c719f1364338a8ee516a3a09bc49_D20190401-20190930" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNi00LTEtMS0yMjc1_4ddf1316-76b4-49fe-b001-45788e267984">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2019</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2ca1a2d209b4ea4a677b11a4d562bff_I20190930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNy0yLTEtMS0yMjc1_c16346b9-9166-41cf-8da5-e998cd7e0117">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic21c3596993443348892ffc6b8dca3b1_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNy00LTEtMS0yMjc1_947e19c7-15af-40a4-a7f7-646fa7c6154b">1,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_64"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RleHRyZWdpb246Mzg3NzQ4MTQ2YjI0NDVlZGI0MjcxNTI1MTI0OGE0MzhfOTM3_e3809f59-24dd-4d8c-8a96-679bf6f9ff6f" continuedAt="i10d2c85ae3474dc1896294f1b2f05c05" escape="true">Earnings Per Common Share</ix:nonNumeric></span></div><ix:continuation id="i10d2c85ae3474dc1896294f1b2f05c05"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings per common share is similar to that of basic earnings per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Diluted loss per common share for the three and six months ended September 30, 2019 was calculated by excluding potentially dilutive securities from the denominator of the share computation due to their anti-dilutive effects.</span></div><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RleHRyZWdpb246Mzg3NzQ4MTQ2YjI0NDVlZGI0MjcxNTI1MTI0OGE0MzhfOTQ3_64026ff6-6e24-4fb6-b634-58f5e56d5192" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:52.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.967%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMi0xLTEtMS0w_be846081-eb95-4750-82ce-a7b89cb9d90a">627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMi0zLTEtMS0w_241dd1f6-a874-4cf1-8f5e-8637dd6c13f0">676</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMi01LTEtMS0w_4b646649-0466-42e2-bbfa-0a94f0154d62">1,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMi03LTEtMS0w_a5694a91-84b9-400e-a5ba-e318bc781d34">193</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMy0xLTEtMS0w_c867085e-0ca0-48c5-bf9c-23de805e299b">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMy0zLTEtMS0w_b6a4d599-b277-4732-b4ed-f3a83a2d608a">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMy01LTEtMS0w_2fa899b8-2f70-4288-9295-f7fcd2532b55">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMy03LTEtMS0w_5b66d056-4d37-4994-9b99-f535d944a9de">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNC0xLTEtMS0w_83466db5-94c1-4b85-9e02-7ca95604484b">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNC0zLTEtMS0w_73ea95f2-8215-4bf2-a62c-8797d476ba9b">729</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNC01LTEtMS0w_9b2e08b8-9f02-412e-90ff-0fdcf925850e">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNC03LTEtMS0w_790e3554-fe0f-4959-b7c4-7473bb1ac161">300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNS0xLTEtMS0w_947d2b3d-24e4-4183-b5d7-5c084a950575">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNS0zLTEtMS0w_48d20f61-73d4-4b46-9db4-888dd87687ee">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNS01LTEtMS0w_05374361-955d-4697-86f4-684b26801cc9">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNS03LTEtMS0w_ab13d97c-f5f0-43b6-adf9-8fed833f828f">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNi0xLTEtMS0w_fbfcc0d3-d6ce-4f28-aa11-98caf756a560">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNi0zLTEtMS0w_8708f1a1-e322-400a-8d87-bed23eeb015d">730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNi01LTEtMS0w_eea9ba66-796b-43e7-86d4-f040a5eb6d70">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNi03LTEtMS0w_95354153-09c2-449a-8ed1-14d704756a2c">307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfOS0xLTEtMS0w_7ddc15ec-1709-471a-95c3-6923eb75d586">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfOS0zLTEtMS0w_1e795560-ff49-475e-a809-58ccf70ac28e">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfOS01LTEtMS0w_f0c620ee-6b4f-4939-bc07-a57fed89f91e">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfOS03LTEtMS0w_17363c6b-da6d-4685-91e6-c3fa6885828b">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTEtMS0xLTEtMA_46529b49-736e-44f2-931b-1c6376561b91">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTEtMy0xLTEtMA_853f485f-3af5-4592-99ce-f96294785872">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTEtNS0xLTEtMA_5559a341-ef93-41e2-99a5-435447c0246e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTEtNy0xLTEtMA_49840fbc-662f-45b6-91c6-8371a24c0900">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTItMS0xLTEtMA_a84d3109-a6ca-494e-be37-f5d20251ff09">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTItMy0xLTEtMA_4251ab11-b8d8-4833-a55d-257fedb00a67">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTItNS0xLTEtMA_98ee0da2-f56c-448d-a6e8-cc88333c27ae">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTItNy0xLTEtMA_91411393-97a3-4407-a783-a1294125dbf2">185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTYtMS0xLTEtMA_1b42c000-c593-4b7c-81c0-9e4f99983ce2">3.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTYtMy0xLTEtMA_02bce3d3-2d27-412f-b63e-cbca4357fbc4">3.99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTYtNS0xLTEtMA_fd918d79-c677-4f63-aadb-0cd8b07536fe">6.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTYtNy0xLTEtMA_9c8da92e-39d9-41a5-abc9-bce74b896ae8">1.62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTctMS0xLTEtMA_87684a09-4f90-4379-ae59-5b51440b392d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTctMy0xLTEtMA_55df852f-9e87-475e-b6c9-8429ee9cec79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTctNS0xLTEtMA_0a719ae8-dac4-41a8-887d-08fd48760b65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTctNy0xLTEtMA_bf108e3f-a247-4780-a624-66539b16ffd4">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTgtMS0xLTEtMA_0204ab69-db0d-4719-b7a5-8bbed38a26be">3.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTgtMy0xLTEtMA_23cf101a-bffe-41c3-b956-439357113bba">3.99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTgtNS0xLTEtMA_6dc0cf3b-b6ce-4ce6-9875-0eec68439a4a">6.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTgtNy0xLTEtMA_c2b4c8f5-fc1e-4042-b802-ebed61515bf1">1.65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjAtMS0xLTEtMA_78f4e3c9-7fed-4406-ba24-bd3e54f7906e">3.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjAtMy0xLTEtMA_eef86ded-cf18-459c-a8a4-125bb9c31b7c">3.99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjAtNS0xLTEtMA_111b0250-535a-4562-bf72-249c718f3980">6.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjAtNy0xLTEtMA_6b824e0e-db84-474d-b221-3094d195ecbd">1.62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjEtMS0xLTEtMA_b75c1d8e-5ac6-4bb4-b5b5-21e5e96f7502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjEtMy0xLTEtMA_fe10e8fb-2448-42c4-834c-3f9d729c5c36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjEtNS0xLTEtMA_897f0275-2434-45ee-a2d0-0a22e7133034">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjEtNy0xLTEtMA_463a67b6-7df4-4d91-b77d-99ac980e7f50">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjItMS0xLTEtMA_9cde2117-8bb9-4ce5-82a4-738d554b624d">3.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjItMy0xLTEtMA_1e65ebd9-6e12-476c-a468-5454af71bd8c">3.99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjItNS0xLTEtMA_e4584724-3428-4599-9fa6-84b6172571d9">6.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjItNy0xLTEtMA_fc96d374-e314-49aa-8ae6-c3ce98b08298">1.65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"> Certain computations may reflect rounding adjustments.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately <ix:nonFraction unitRef="shares" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RleHRyZWdpb246Mzg3NzQ4MTQ2YjI0NDVlZGI0MjcxNTI1MTI0OGE0MzhfMjE5OTAyMzI1NjYyOQ_5a10adad-dfa0-45d5-9abc-5ee04382c304"><ix:nonFraction unitRef="shares" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RleHRyZWdpb246Mzg3NzQ4MTQ2YjI0NDVlZGI0MjcxNTI1MTI0OGE0MzhfMjE5OTAyMzI1NjYyOQ_642492f6-1985-4171-a7e1-3d7751f55e45">2</ix:nonFraction></ix:nonFraction> million of potentially dilutive securities for the three months and six months ended September 30, 2020 were excluded from the computations of diluted net earnings per common share as they were anti-dilutive.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_67"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTUzOTMxNjI4MDU0NTc_625f505c-e65d-4fa6-93c5-e5c4d253e2c2" continuedAt="iccf6d68c7f44421eb1373ec16b7b6f9b" escape="true">Goodwill and Intangible Assets, Net </ix:nonNumeric></span></div><ix:continuation id="iccf6d68c7f44421eb1373ec16b7b6f9b" continuedAt="i826dc1ed3ac4464182d8466ef833d19d"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in <ix:nonFraction unitRef="numberofsegments" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTUzOTMxNjI4MDU0NjQ_95f1a299-f360-4a6c-9603-c86ef724affd">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTA0NDUzNjA0NzU3NDQ_be8d3794-b639-4dfd-979c-9a30950d977e"><ix:nonFraction unitRef="usd" contextRef="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTA0NDUzNjA0NzU3NDQ_c5f4c8d0-342b-4ef5-b664-ae5a63c025a1"><ix:nonFraction unitRef="usd" contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTA0NDUzNjA0NzU3NDQ_df074750-f2bf-49ae-93bc-bfa5d69949ab"><ix:nonFraction unitRef="usd" contextRef="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTA0NDUzNjA0NzU3NDQ_fe4dd822-a80c-4451-8306-bff3269f30e2">69</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million (pre-tax and after-tax) in the three and six months ended September 30, 2020 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. This impairment charge is included under the caption, &#8220;Goodwill impairment charges&#8221; in the Condensed Consolidated Statements of Operations. At September 30, 2020, the reporting units in Europe had <ix:nonFraction unitRef="usd" contextRef="i54063222c8ab42b3ae44fd8854c2bf05_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Goodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTUzOTMxNjI4MDI2NzI_b28c5881-3bc7-4ee0-b6d7-c3684360d03b">no</ix:nonFraction> remaining balance of goodwill and the remaining balance of goodwill in the International segment relates to one of its reporting units in Canada.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 12, &#8220;Fair Value Measurements,&#8221; for more information.</span></div><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTUzOTMxNjI4MDI2NzY_45ad47ca-c5a9-4deb-9834-ced94fde9e22" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.942%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March&#160;31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ba538365d5e441a82217d66cdb7223c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMS0xLTEtMS0w_7cedb6e9-74fa-4869-9533-0c2e2e5bcca7">3,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f3890eafd704e1a9986d7f4b86e0128_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMS0zLTEtMS0w_9c70c4a7-6716-4153-b88b-2e6d6bbcbea0">1,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief750a41c974485c93c0149cb17947dc_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMS01LTEtMS0w_240fb602-d91f-4bc0-aee0-fec38f3b5478">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ecbc2cba03648fcb37d779597f1e7e6_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMS03LTEtMS0w_ae30634b-e1d5-4412-8e06-1f636e5aecd0">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMS05LTEtMS0w_3cb78f65-9b1a-4df9-851f-bb0fa73ecf59">9,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ef7bc345256444fb9b45e1218e9f993_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMi0xLTEtMS0w_a1ed0e8d-fa2c-4453-8fb8-c547a22dedcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMi0zLTEtMS0w_b1bbfd70-1e78-4b44-bb94-99d85c0888ab">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf45d6fc4e38421a8db5b7f7cafe2475_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMi01LTEtMS0w_e60dad51-74dd-4e26-8b48-8de065382a18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f8c08fbc7af4c1a9f49870c08e48b80_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMi03LTEtMS0w_1f8adba5-e011-4238-8721-6714daa0ff52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMi05LTEtMS0w_b5109578-cce1-45d1-a904-03690c382f2a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ef7bc345256444fb9b45e1218e9f993_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMy0xLTEtMS0w_dce257de-f899-4b03-aa27-add52b2e9923">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMy0zLTEtMS0w_891b3a7d-7914-4fb2-8457-2dd083e0b0aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf45d6fc4e38421a8db5b7f7cafe2475_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMy01LTEtMS0w_9aa019a1-9895-43e8-a556-20be75bd3712">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f8c08fbc7af4c1a9f49870c08e48b80_D20200401-20200930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMy03LTEtMS0w_af9c7acb-4610-4beb-b69b-d505165d27d3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMy05LTEtMS0w_d4353eb4-2d37-48c7-baaa-357eead2b517">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ef7bc345256444fb9b45e1218e9f993_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS0xLTEtMS0w_e9e79687-ebe1-47ea-a0bc-f7ed5a4e401d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930" decimals="-6" name="us-gaap:GoodwillImpairmentLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS0zLTEtMS0w_be8d3794-b639-4dfd-979c-9a30950d977e"><ix:nonFraction unitRef="usd" contextRef="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930" decimals="-6" name="us-gaap:GoodwillImpairmentLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS0zLTEtMS0w_c5f4c8d0-342b-4ef5-b664-ae5a63c025a1"><ix:nonFraction unitRef="usd" contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS0zLTEtMS0w_df074750-f2bf-49ae-93bc-bfa5d69949ab"><ix:nonFraction unitRef="usd" contextRef="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS0zLTEtMS0w_fe4dd822-a80c-4451-8306-bff3269f30e2">69</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf45d6fc4e38421a8db5b7f7cafe2475_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS01LTEtMS0w_7b2a6b84-35c3-4082-9dfc-7fde60a7212c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f8c08fbc7af4c1a9f49870c08e48b80_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS03LTEtMS0w_d9a6fd87-512c-4b35-ab8d-8ab1ccf7c4ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS05LTEtMS0w_a83a2469-1d9d-4427-9e62-3b6e5e3cbbd4">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ef7bc345256444fb9b45e1218e9f993_D20200401-20200930" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNi0xLTEtMS0w_99113eb0-eb46-41aa-829e-79ff01d8bea4">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNi0zLTEtMS0w_eb91ae0f-25c0-484a-9ad4-cd18e3e9657d">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf45d6fc4e38421a8db5b7f7cafe2475_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNi01LTEtMS0w_ee6cfc4d-6bff-4c8a-8300-f76322967158">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f8c08fbc7af4c1a9f49870c08e48b80_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNi03LTEtMS0w_6a882ad0-cf8a-4da1-8ff3-86d7d43b79a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNi05LTEtMS0w_2776488c-73a6-4048-beee-d692d4180980">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic320828dd03442ee9aaea62c9ff4f7ec_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNy0xLTEtMS0w_bbfc2ed1-dc9c-473a-bf34-83c038135f2d">3,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6a7243fae845218e8fb56aa25e2fab_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNy0zLTEtMS0w_d778862b-9878-445d-8458-d836e16dfb65">1,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc04539515847199daba415d910a6b7_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNy01LTEtMS0w_c22d5ef2-ca0d-466b-9109-2ce6b96ed770">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7567972184114435b6959d8ccf29fe0a_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNy03LTEtMS0w_057d1066-9f4e-4453-b9fe-e00f3aa3572c">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNy05LTEtMS0w_26d8a125-c310-4f18-a60b-b2ebe9ac8c84">9,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfNTAx_5dca61f5-9c1d-40e6-9faa-3ab879357f4f" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if4db1b4b02324493a0d2914c618224a4_D20200401-20200930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi0xLTEtMS0w_7b5eb6e5-173a-410c-bb86-43685d159e4d">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9512d260804f718da6e350b1800535_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi0zLTEtMS0w_bd88f016-c914-452d-9312-2dc7de1586d2">3,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9512d260804f718da6e350b1800535_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi01LTEtMS0w_4c28f6c8-e40f-4195-bfaf-e905cba55169">2,127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9512d260804f718da6e350b1800535_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi03LTEtMS0w_5cd1bdc4-e27e-4731-8217-d5ffe0e34e79">1,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i784afe00169946859b02a103c522f100_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi05LTEtMS0w_6258fe2e-cd37-4b04-92b6-248ffcb647b9">3,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i784afe00169946859b02a103c522f100_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi0xMS0xLTEtMA_e8615b8e-be3e-4100-bfed-6ea619f1b67c">1,950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i784afe00169946859b02a103c522f100_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi0xMy0xLTEtMA_c68b70b0-3988-4ebd-86fb-d575116f665f">1,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2978b39e5aad4aa98f0c28c043489c2a_D20200401-20200930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy0xLTEtMS0w_ccd7c53f-c929-4d61-af3c-47529e6fed9c">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ff32fde532b4686b339b43a1460c33e_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy0zLTEtMS0w_3afeaf90-3bd4-4ac6-b373-2478e2278518">997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ff32fde532b4686b339b43a1460c33e_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy01LTEtMS0w_1455046d-4c3c-438b-98f6-93a91e5d87c7">506</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ff32fde532b4686b339b43a1460c33e_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy03LTEtMS0w_49408639-1217-4149-b222-7d3a96f72b0f">491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie295c63a512442a9a5a5f6037b32648e_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy05LTEtMS0w_f8097212-1931-4dbc-8311-bd95c36cecb0">994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie295c63a512442a9a5a5f6037b32648e_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy0xMS0xLTEtMA_81a0e637-3b5f-4dda-b248-ff80c48fe931">480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie295c63a512442a9a5a5f6037b32648e_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy0xMy0xLTEtMA_7656c399-a7fd-4938-90e2-f2084e921b13">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i13d8fa5857224b039c9983f670be125b_D20200401-20200930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC0xLTEtMS0w_5e4e6edf-c269-4b9b-b119-a237069dbe62">26</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2673c258d340f29617801db8c6fb15_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC0zLTEtMS0w_0dbd6ce6-d3d3-4d7c-b4da-5f3679b1c7ea">502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb2673c258d340f29617801db8c6fb15_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC01LTEtMS0w_3f7b51d2-1cd9-4cf3-8262-60c230f5ee2e">222</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2673c258d340f29617801db8c6fb15_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC03LTEtMS0w_8a60ad0e-88ec-4420-8a2b-0a84eeae23e8">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i910303b53ca54b109dae4facc910bf03_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC05LTEtMS0w_e8626941-a5dd-4714-bb44-4c13ed982544">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i910303b53ca54b109dae4facc910bf03_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC0xMS0xLTEtMA_1703d34b-03ae-4a71-becf-4ddf0e9b10c7">232</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i910303b53ca54b109dae4facc910bf03_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC0xMy0xLTEtMA_6329f318-2fea-4b59-b4d3-57c88e1cd22a">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i643229e9e25c45bea23409a01f621fd7_D20200401-20200930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS0xLTEtMS0w_3b636439-2aec-4307-8233-33d446768470">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i819bef3ae9cf456ab4d6f597308e2091_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS0zLTEtMS0w_26bdabb5-1a3b-4066-a66c-333c975bd199">894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i819bef3ae9cf456ab4d6f597308e2091_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS01LTEtMS0w_2e281044-1d8b-4225-b07a-6a64b6df9ab2">314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i819bef3ae9cf456ab4d6f597308e2091_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS03LTEtMS0w_26fb39ca-4d1a-469e-879f-8542d4197a62">580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1f31df78005498ca5d7cdfcef7b62ff_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS05LTEtMS0w_82bcb8c1-efc4-4059-a46b-27eb5a751f19">808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1f31df78005498ca5d7cdfcef7b62ff_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS0xMS0xLTEtMA_728c11cd-4f7c-4d48-8fee-43ce260b71fe">242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1f31df78005498ca5d7cdfcef7b62ff_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS0xMy0xLTEtMA_bc6bb527-9cdf-4ff9-817a-e0bf81c6c26f">566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3ac1d82117e34d24b3c7ace14a5f0a9c_D20200401-20200930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi0xLTEtMS0w_33646e89-5a4b-4d23-9b64-118f0ae28da7">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i923fbba79f824ad3b6ee7bbdbb9b6d22_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi0zLTEtMS0w_fbdf1dc8-2c3c-4959-bff3-6fb620e2a2d6">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i923fbba79f824ad3b6ee7bbdbb9b6d22_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi01LTEtMS0w_62752598-a12f-4734-864c-cdc917324468">113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i923fbba79f824ad3b6ee7bbdbb9b6d22_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi03LTEtMS0w_26aa4d60-38d4-4319-9251-18ca94ca309a">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1112ba0650748618ecb2605c5c0d6e4_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi05LTEtMS0w_a996fec9-0368-4ac8-bae0-59db45ade1f4">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1112ba0650748618ecb2605c5c0d6e4_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi0xMS0xLTEtMA_0ae69328-6275-4846-937a-60d209dd624a">111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1112ba0650748618ecb2605c5c0d6e4_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi0xMy0xLTEtMA_5c3bda80-c51a-46c1-90f6-39cab63eeeb7">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2a05e5e085724cafb5736c6c660887d5_D20200401-20200930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy0xLTEtMS0w_a6861a3b-7e46-43eb-917b-e9652da59249">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib26d4d498b2241b28165e3a6aa3585cc_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy0zLTEtMS0w_e0de8029-8758-41f2-bec0-044e48af07ad">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib26d4d498b2241b28165e3a6aa3585cc_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy01LTEtMS0w_55957c62-9a99-42fe-9268-a7b74825cfed">217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib26d4d498b2241b28165e3a6aa3585cc_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy03LTEtMS0w_0e8cb65c-1106-4af0-92d0-97db50dbafa5">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e3ce919cec41759ba7b04549cc3dd9_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy05LTEtMS0w_7b611525-1a37-4455-8b6d-137587c3c3fc">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87e3ce919cec41759ba7b04549cc3dd9_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy0xMS0xLTEtMA_f7521bea-40fc-47d4-8ba0-89df3e440e18">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e3ce919cec41759ba7b04549cc3dd9_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy0xMy0xLTEtMA_545ad8e9-f10c-4f6e-ac26-471d41466bbb">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfOC0zLTEtMS0w_287094bd-d49f-497b-9020-bf957aae98d7">6,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfOC01LTEtMS0w_4e69b703-16af-4f1c-a3b7-8f560d124fc2">3,499</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfOC03LTEtMS0w_62b5164a-0a31-4b36-be85-7c0313b44489">3,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfOC05LTEtMS0w_17a4df9b-5ccb-44ab-9b73-2d697b026409">6,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfOC0xMS0xLTEtMA_fa68975b-add7-454e-9681-9b0cd0b89f6f">3,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfOC0xMy0xLTEtMA_3cacf974-d03c-48c3-a77b-20c1889fad18">3,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i826dc1ed3ac4464182d8466ef833d19d">Amortization expense of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTgw_de5a31a5-0607-40ca-9ade-92be5f0d16a3">106</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTA5OTUxMTYyODI5NQ_ec2a35f7-e41e-47a0-a5bb-81a8fcf0b231">212</ix:nonFraction> million during the three and six months ended September 30, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTg3_e74fc921-3479-4db7-8c3f-721a219c99ac">118</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTA5OTUxMTYyODM5Mg_b1195dc0-0c39-421c-b50a-baf334c41327">230</ix:nonFraction> million during the three and six months ended September 30, 2019, respectively. Estimated amortization expense of these assets is as follows: $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMzAx_cdde25d5-d22b-4d40-9b64-d593155504cf">196</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMzA1_d6735344-c327-4f5b-9b33-cf3bdeb47647">367</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMzA5_ec09f891-0029-4661-a21f-503f96834d07">265</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMzEz_4ae2b891-340c-4e18-9ee8-d0a7c8e181e9">248</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMzIx_04425f4a-76e3-4a8a-8b42-ada9e1c36c95">245</ix:nonFraction> million for the remainder of 2021 and each of the succeeding years through 2025 and $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-8" format="ixt:numdotdecimal" name="mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMzk2_74543ae8-be87-482a-9e27-8e98a849a0ce">1.7</ix:nonFraction> billion thereafter. All intangible assets were subject to amortization as of September 30, 2020 and March 31, 2020.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTUzOTMxNjI3OTI1Mjc_23b8ce56-efd0-4676-9949-4ae1ab43cd41" continuedAt="i8bb0a601eaaf415094fdf3870a5c6049" escape="true">Debt and Financing Activities</ix:nonNumeric></span></div><ix:continuation id="i8bb0a601eaaf415094fdf3870a5c6049" continuedAt="i1ae4b8fdaee04568a66eb0884013a4b2"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjgwNQ_e1012f4a-5ab3-4b4e-83ba-b7dbe93c52c6" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8153b95460de463caaddc69ee4d76393_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMi0wLTEtMS0wL3RleHRyZWdpb246OTU5MWYxMWVkZTBkNDA1YTkyMDUxNWI2MTM4MzBkYjNfMTA5OTUxMTYyNzgxOA_3e821a2d-a237-4b99-9f2c-21e4d177c714">3.65</ix:nonFraction>% Notes due November 30, 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8153b95460de463caaddc69ee4d76393_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMi0xLTEtMS0w_145027f1-e326-466b-b482-16336b4453b3">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7ff3def80794627a2f81c1fa3fa88b7_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMi0zLTEtMS0w_8b8925ba-008f-4566-90d6-29c9713be906">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12cf340a696a46ccbc81980bb0ca828e_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMy0wLTEtMS0wL3RleHRyZWdpb246M2EyMmFkMjUxODU5NGVkZTgxYTAzOTg2NjJiOWVmYjBfMTA5OTUxMTYyNzgxNA_84f2f517-6293-41ab-84ef-be0dcf77c625">4.75</ix:nonFraction>% Notes due March 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12cf340a696a46ccbc81980bb0ca828e_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMy0xLTEtMS0w_4e76264b-d1d2-445c-9ffa-11d1e2f134c6">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee8abcfafb84ff798eb09d3d083a04f_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMy0zLTEtMS0w_dcdf1f92-c7a1-4325-979a-bfe7d4f7a34f">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e6d0550b478436495bc0fe4be6cba3d_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNC0wLTEtMS0wL3RleHRyZWdpb246OTk5M2YxNTgwOTY0NDkxM2E1NTM4ODc0MWE5YmFlODVfMTA5OTUxMTYyNzgxOA_d61fcf4b-c6aa-40c0-b7f2-018f8eed1f10">2.70</ix:nonFraction>% Notes due December 15, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e6d0550b478436495bc0fe4be6cba3d_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNC0xLTEtMS0w_ea991afc-ced4-4e8a-85ac-57daee0bd196">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15cc3c8cf89346e69d4e74ca74186f27_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNC0zLTEtMS0w_719f65ea-0a0c-4d71-8288-15e25448e3ba">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia3c56f40d6044473b6be9ef97877702e_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNS0wLTEtMS0wL3RleHRyZWdpb246M2YzZjY0N2Q1NTk1NDliYTk4NjIxNGZlY2YyMmI1ZTFfMTA5OTUxMTYyNzgxNQ_a8e0f845-07f3-4a20-800f-b6cd1f4ec0a8">2.85</ix:nonFraction>% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c56f40d6044473b6be9ef97877702e_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNS0xLTEtMS0w_317b7b0c-e7ab-4047-bcaf-a0317a6c5c63">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30b436690be1400f81e8c682814e47b5_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNS0zLTEtMS0w_e7acae58-f5eb-4fe1-a599-f88873911f08">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a7a25e2db1543149b28b05daeacffbe_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNi0wLTEtMS0wL3RleHRyZWdpb246YWY3OTkxM2U3ODdmNGZlZTk0NDgyZWI1YWMzNWUzNDFfMTA5OTUxMTYyNzgxNQ_9d53eae3-ac16-4b46-a63a-80cb0fb8e1c3">3.80</ix:nonFraction>% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a7a25e2db1543149b28b05daeacffbe_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNi0xLTEtMS0w_e79bb33f-5082-4271-83a7-c0b132829b90">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52812d9b87043cbb33eb38e018afe29_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNi0zLTEtMS0w_42628f5f-2272-40c9-99b6-d31cb98b6ba1">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i21479c35ac7947908fe229498bfad314_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNy0wLTEtMS0wL3RleHRyZWdpb246YTVhYmNjZDNlYTc0NGM1ZTg3Y2YyZmFlMjJkZTNmMjNfMTA5OTUxMTYyNzgxOQ_216d52ad-52a7-492d-9430-8fbd13fafcaa">7.65</ix:nonFraction>% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21479c35ac7947908fe229498bfad314_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNy0xLTEtMS0w_553a5a24-1877-40a5-9bd8-6e8c7acaa99f">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i804e09f7332d4333b3d930fc39208c0b_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNy0zLTEtMS0w_e3f947a0-3e8a-4971-a767-7a0a8f39d8f7">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i367acbb5aa6f41a89563cba34fc5e16a_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfOC0wLTEtMS0wL3RleHRyZWdpb246NDUwZjFiOTM5M2JmNDIxOWFmYjViMjczOGYzNjczNTRfMTA5OTUxMTYyNzgxOA_03b46e0f-239d-4667-86ee-e9c99a168ec6">3.95</ix:nonFraction>% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i367acbb5aa6f41a89563cba34fc5e16a_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfOC0xLTEtMS0w_75945532-aaaa-4cae-9524-9129949cdbc6">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4ba394ed964ed29284c6a42d50859e_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfOC0zLTEtMS0w_08231a5b-6b71-4990-bc58-7ecc0d961ba0">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1db34deedcb444fcafd3824ea72a77fa_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfOS0wLTEtMS0wL3RleHRyZWdpb246YmY2OWNjNDE0YjkzNDNhNTg3OTdmYzNlZDhhMTM3MDNfMTA5OTUxMTYyNzgxMw_ef293fac-9767-4b77-b6ef-0c3d3530e7a5">4.75</ix:nonFraction>% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1db34deedcb444fcafd3824ea72a77fa_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfOS0xLTEtMS0w_ef27e97e-dd31-4b62-aaec-b9c49150cf7e">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i986b499c7ecf4099ac52aa32adaf7eef_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfOS0zLTEtMS0w_160942ca-2409-4e2d-8995-34f8542ed006">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i840a57d92c2e46fca0b999599fd6e33b_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjFmZDA1MDNmYTZmYTQ5YWY5MzdmYzgxOTY2OWYzYjRjXzEwOTk1MTE2Mjc4MTQ_778f7795-0db5-46b2-9a56-00b4dd58c112">6.00</ix:nonFraction>% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i840a57d92c2e46fca0b999599fd6e33b_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTAtMS0xLTEtMA_5628f3db-fad5-4cd0-b50d-b2020faaacde">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512dab20822e47d0a0cc52e0e34781dc_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTAtMy0xLTEtMA_93be6e8d-b0be-4b55-b0dc-7ef1fe4902a0">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf662601f4324e058290f105eaa0b95f_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjc1Yzg4ZGNiNDgxMTRmMTg4OTBhZjQxZjczZDgyZTdkXzEwOTk1MTE2Mjc4MTU_e8270114-bd60-494a-ac72-2b6032276bec">4.88</ix:nonFraction>% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf662601f4324e058290f105eaa0b95f_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTEtMS0xLTEtMA_9306fb1d-4677-4ecc-98a0-e55615c37a08">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie46a2a101c1946dfad26f454b2205e3a_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTEtMy0xLTEtMA_6a1d6506-e64c-4f52-97e0-56bc5948e6ba">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767d2070f41b43f08cadfcfde4ee0193_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOmMyNjY0OWQ1NzJiYjQ3ZTY5Mjc1Y2Y3OGVkMDllNDk3XzEwOTk1MTE2Mjc4MjE_089058b0-25b4-49e4-8fde-242d63fe0d91">0.63</ix:nonFraction>% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767d2070f41b43f08cadfcfde4ee0193_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTMtMS0xLTEtMA_3eed8a36-82e3-4c23-935b-92b667bbfea3">703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0094db52755c430db5bb53ecf3675114_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTMtMy0xLTEtMA_ac548b13-322f-417d-91a8-54b34ff61b93">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3f4f9c5449c42758be9a4044c781b77_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjdjZmZiYjVkZDVkZjQ0MjNhNjFhMmUzNjA4ZDAwMzIxXzEwOTk1MTE2Mjc4MjM_31dfe312-fe05-427a-bc83-967694743dbe">1.50</ix:nonFraction>% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f4f9c5449c42758be9a4044c781b77_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTQtMS0xLTEtMA_57c66f79-eaed-41ef-8b72-18c310b83077">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c5081e1fcc46fbbaab261e039a3f10_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTQtMy0xLTEtMA_71b77635-7074-456e-bee0-efffcc32c297">659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4cd299e885c34f10b74ee273e0f81d20_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZDJiMjZkZmYyNTQzYTM5ZWIwYWEwMmQxZDIzNTVkXzEwOTk1MTE2Mjc4MjI_558ac67f-e921-49e3-9771-5cbf86466a7d">1.63</ix:nonFraction>% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cd299e885c34f10b74ee273e0f81d20_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTUtMS0xLTEtMA_e6055b7a-2b59-4ede-ae48-eaa336f7f95c">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3028d3a5bee645aaa6efb97a0e849ab2_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTUtMy0xLTEtMA_bdc815bc-1eab-40c5-8ee7-5cbd5a761ff7">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7950cda1af7346a88986fcba915ab374_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ZDFhOThiMDE0MTQxYWQ4YmQ2YTg4ZTM0ZmZjZTFmXzEwOTk1MTE2Mjc4Mjc_93df89c4-8621-456e-9f80-7cb567462a90">3.13</ix:nonFraction>% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7950cda1af7346a88986fcba915ab374_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTYtMS0xLTEtMA_6807f3c8-1550-4c32-a746-829057838caa">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3948c23924c4bb09533ac72ede98ae9_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTYtMy0xLTEtMA_028ca27b-e074-47c4-9d61-8755783b2868">557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTgtMS0xLTEtMA_d1491cc7-d5ec-411c-92ed-47871b792a70">239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTgtMy0xLTEtMA_d9bf056b-a1d0-4e8a-af1a-001dc89a42c6">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTktMS0xLTEtMA_0560648d-8f3f-45b5-aa34-726a91ac9a9b">7,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTktMy0xLTEtMA_0dd35b58-5914-4113-b564-1dd00c3cb133">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMjAtMS0xLTEtMA_ade36811-91ef-45d9-a981-fd65013fe186">1,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMjAtMy0xLTEtMA_e54541fb-2782-42ce-81cb-8c5fc7b78a6d">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMjEtMS0xLTEtMA_5e79e7de-2a2a-474b-9053-db2e6aad5698">5,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMjEtMy0xLTEtMA_fd6e3abe-a715-4c8f-996e-98a3e5d271d7">6,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMzcz_4b7b2f9b-cfdf-4ba3-a5c7-9cb15b325efc">7.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTcwNDI0MzAyMzM0OTQ_645e83fb-0d19-4c22-ae02-6db2e8ff263d">7.4</ix:nonFraction> billion at September 30, 2020 and March 31, 2020, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfNDE2_7c137e16-6b3c-46ba-8054-391a7ff2d200">1.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTcwNDI0MzAyMzM1MTI_0d820768-007e-4e54-b080-486070f0c267">1.1</ix:nonFraction> billion, respectively, was included under the caption &#8220;Current portion of long-term debt&#8221; within the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i1ae4b8fdaee04568a66eb0884013a4b2"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company entered into a syndicated $<ix:nonFraction unitRef="usd" contextRef="i39366f5479b542dfafca236d0d404772_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfNjEz_5eac2512-acb2-4544-862a-9a666ccfebeb">4</ix:nonFraction> billion <ix:nonNumeric contextRef="i154e895b81404074985fd505c76d4a57_D20190701-20190930" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTUzOTMxNjI3OTI1MTc_7984d209-0c27-4a20-9e8f-0a3f17ab97e4">five-year</ix:nonNumeric> senior unsecured credit facility (the &#8220;2020 Credit Facility&#8221;), which has a $<ix:nonFraction unitRef="usd" contextRef="i82f9efd5a22a44eba025d8456a2a8394_I20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfNjk5_520051c4-0438-4e07-b6b8-5c31f28af579">3.6</ix:nonFraction> billion aggregate sublimit of availability in Canadian dollars, British pound sterling and Euro. The 2020 Credit Facility matures in September 2024 and had <ix:nonFraction unitRef="usd" contextRef="i2fc86cfb0d1743db9420435fcbe782c0_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfODUw_8d5fd813-7983-4722-b607-7fe726fd7ac3"><ix:nonFraction unitRef="usd" contextRef="ie51ec41d88fc4fcbbb4e98a2489344d4_D20200401-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfODUw_c5862ca1-f35c-4379-8071-9f31b14adbb8">no</ix:nonFraction></ix:nonFraction>&#160;borrowings during the three and six months ended September 30, 2020 and <ix:nonFraction unitRef="usd" contextRef="i747404c509964f31988b62072dd13f33_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfODk4_e5d841a9-fd5d-40e5-bb43-f81ba13bde16"><ix:nonFraction unitRef="usd" contextRef="icfac515039344132aade2b5793055812_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfODk4_f9836b7d-80e3-4ed4-b87a-a04de81ff37d">no</ix:nonFraction></ix:nonFraction> amounts outstanding as of September 30, 2020 and March 31, 2020. The remaining terms and conditions of the 2020 Credit Facility are substantially similar to those previously in place under the&#160;$<ix:nonFraction unitRef="usd" contextRef="i6bd3593ba0404917bb09d01792baf9d6_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTA2Ng_11296bbe-288b-4115-b75b-3908b54c2565">3.5</ix:nonFraction> billion <ix:nonNumeric contextRef="i44874b5446184867b047a21535e841fb_D20190901-20190930" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTUzOTMxNjI3OTI1MjY_97f1d936-cef7-434e-809b-bcf3685a6ca0">five-year</ix:nonNumeric> senior unsecured revolving credit facility (the &#8220;Global Facility&#8221;), which was scheduled to mature in October 2020. The Global Facility was terminated in connection with the execution of the 2020 Credit Facility in September 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility contains a financial covenant which obligates the Company to maintain a debt to capital ratio of no greater than <ix:nonFraction unitRef="number" contextRef="icfac515039344132aade2b5793055812_I20200930" decimals="INF" name="mck:DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTcyMg_75d185b7-6eec-4214-ad28-76043da52654">65</ix:nonFraction>% and other customary investment grade covenants. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At September 30, 2020, the Company was in compliance with all covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euro with a committed amount of $<ix:nonFraction unitRef="usd" contextRef="ic59633479ac94c10987acde294155741_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjE0Ng_b4fdcebe-5e1b-410b-928f-7fce83eef4e4">9</ix:nonFraction> million and an uncommitted amount of $<ix:nonFraction unitRef="usd" contextRef="ic59633479ac94c10987acde294155741_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjE3OA_eb9f5c26-7da7-41ad-9559-3db61e239d8e">176</ix:nonFraction> million as of September 30, 2020. Borrowings and repayments were not material during the three and six months ended September 30, 2020 and 2019, and amounts outstanding under these credit lines were not material as of September 30, 2020 and March 31, 2020. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $<ix:nonFraction unitRef="usd" contextRef="id887e8ba801a4f9f9555dc352f23f1de_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjU1Nw_dc65a3d1-528a-4bd7-a1ac-38e518cdd8d1">4.0</ix:nonFraction> billion in outstanding commercial paper notes. During the six months ended September 30, 2020 and 2019, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="i6b5dfa0efbd542b0bd5acb63dc7fb114_D20200401-20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjY1OA_6cd84f84-822d-42de-a202-5253deab4def">5.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i5752cf5996be43f88c48f5343cf12504_D20190401-20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjY2NQ_9335f144-1c6f-4017-8cf0-31835a7edf24">8.7</ix:nonFraction> billion, respectively, and repaid $<ix:nonFraction unitRef="usd" contextRef="i6b5dfa0efbd542b0bd5acb63dc7fb114_D20200401-20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjY5NA_8a7da7ce-d184-484a-a969-b5c83d5d0255">5.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i5752cf5996be43f88c48f5343cf12504_D20190401-20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjcwMQ_9e74a707-1e9b-4de7-8083-85ed7807bee6">8.1</ix:nonFraction> billion, respectively, under the program. At September 30, 2020 and March 31, 2020, there were <ix:nonFraction unitRef="usd" contextRef="i629e2b60a9a340a78d36af765192f461_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LongTermCommercialPaperCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjc2Mw_a55199a1-3b9a-4562-8191-fd619d574425"><ix:nonFraction unitRef="usd" contextRef="id887e8ba801a4f9f9555dc352f23f1de_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LongTermCommercialPaperCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjc2Mw_d595f2ca-48e2-4506-8918-a9aef48ee4b4">no</ix:nonFraction></ix:nonFraction> commercial paper notes outstanding.</span></div></ix:continuation><div id="iecfa0e5b7669406c886f8e2dcd87b845_76"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0MTkwODM_7c06f26c-9b16-4166-a691-0fb15408d2f0" continuedAt="if5bf814b243249a4b818f5f4b2d5f39f" escape="true">Pension Benefits</ix:nonNumeric></span></div><ix:continuation id="if5bf814b243249a4b818f5f4b2d5f39f"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic expense for defined benefit pension plans was $<ix:nonFraction unitRef="usd" contextRef="ibc317023efda478c82c32736a1b73ada_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfNzU_805aeae3-40a6-48db-a74d-10a362919c62">7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0473786d65074893b89caa770decaf2f_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0Mjk1Nw_57814b09-ca1b-4fe9-b1a9-5b8eeddd0dc3">14</ix:nonFraction> million for the three and six months ended September 30, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ie58a935d3b8640fcb9895478c6828da4_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfODI_9ac9e30d-dd0c-40bf-9927-d5766ee81b3a">111</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifafe5ac3b39e4334b35a9018a18479ae_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0Mjk3Ng_85f51e76-5d2d-4e94-932c-3d97a610e722">135</ix:nonFraction> million for the three and six months ended September 30, 2019, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash contributions to these plans were $<ix:nonFraction unitRef="usd" contextRef="ibc317023efda478c82c32736a1b73ada_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTcz_b4d77fa2-689d-40bc-ad42-79286e81d657">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0473786d65074893b89caa770decaf2f_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0MzExMQ_1b2b2a80-b4c7-4d60-9815-ba20e10dbc98">11</ix:nonFraction> million for the three and six months ended September 30, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ie58a935d3b8640fcb9895478c6828da4_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTgw_a80a6434-4fa6-4a56-9d46-4b640db81bb7">7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifafe5ac3b39e4334b35a9018a18479ae_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0MzE0OA_34c12b5b-bb72-4dfd-8d30-1652742f040c">13</ix:nonFraction> million for the three and six months ended September 30, 2019, respectively. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding <ix:nonFraction unitRef="number" contextRef="i49ee6f642eb4455483bb1c23124fdf11_I20200930" decimals="INF" name="us-gaap:DefinedBenefitPlanFundedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfNDE1_266ab1b2-f283-45e6-8a86-801aca821b94">10</ix:nonFraction>% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2018, the Company&#8217;s Board of Directors approved the termination of its frozen U.S. defined benefit pension plan (&#8220;Plan&#8221;). During the first quarter of 2020, the Company offered the option of receiving a lump sum payment to certain participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately <ix:nonFraction unitRef="participant" contextRef="ic18da827aa754e04a2fad2bf8a72cc18_D20190601-20190630" decimals="-2" format="ixt:numdotdecimal" name="mck:DefinedBenefitPlanSettlementPlanParticipants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfOTY5_2f93c2a7-88a3-48a0-9ea0-e5dab5b9b12c">1,300</ix:nonFraction> participants elected to receive the settlement, and lump sum payments of approximately $<ix:nonFraction unitRef="usd" contextRef="ic18da827aa754e04a2fad2bf8a72cc18_D20190601-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTA1OQ_85a02e3f-1eb1-4dbc-b3ed-188f3da24bc9">49</ix:nonFraction> million were made from Plan assets to these participants in June 2019. The benefit obligation settled approximated payments to Plan participants and a pre-tax settlement charge of $<ix:nonFraction unitRef="usd" contextRef="i27674bc44ccc4dcc843eb0366732e666_D20190401-20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTIyNg_45e3c3bd-f16c-4e73-91ee-b9e429deeb49">17</ix:nonFraction> million was recorded during the first quarter of 2020. During the second quarter of 2020, the Company transferred the remainder of the Plan&#8217;s pension obligation to a third-party insurance provider by purchasing annuity contracts for approximately $<ix:nonFraction unitRef="usd" contextRef="i8259a0225045474dace4f33866146c8b_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="mck:DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0MzQ1NQ_91108f62-6d6d-4ef1-b45a-3ca8e8bb7f12">280</ix:nonFraction> million which was fully funded directly by Plan assets. The third-party insurance provider assumed the obligation to pay future benefits and provide administrative services on November 1, 2019. As a result, the remaining previously recorded unrecognized losses in accumulated other comprehensive loss for the Plan were recognized as expense and a pre-tax settlement charge of approximately $<ix:nonFraction unitRef="usd" contextRef="ic5be699bdd1a4617bcd28de6f863eaab_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0MzkxOA_bc48ee2e-5688-4ec6-a148-c251b93e5c6a">105</ix:nonFraction> million was recorded in Other income (expense), net in the Company&#8217;s Condensed Consolidated Statements of Operations during the second quarter of 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_79"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfOTY5NA_4468bb06-1439-43bf-a1c4-a54c06414234" continuedAt="i356c3525c04c48f2bd98563e7edcc664" escape="true">Hedging Activities </ix:nonNumeric></span></div><ix:continuation id="i356c3525c04c48f2bd98563e7edcc664" continuedAt="i74a728c5a29c40afb0fc28a3e8302b48"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. </span></div><div style="margin-bottom:6pt;padding-left:2.25pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and March 31, 2020, the Company had &#8364;<ix:nonFraction unitRef="eur" contextRef="idf0d0beda4f94c1c95f3735c727aaa99_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTUwMw_b28ef460-d179-402c-9270-f4e5d5fb3b11"><ix:nonFraction unitRef="eur" contextRef="iefe68917b64346948a4da9e249ab34f7_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTUwMw_f3d39168-88fd-4ac5-b471-b30e546ad3ca">1.7</ix:nonFraction></ix:nonFraction> billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments within Accumulated other comprehensive loss in the Condensed Consolidated Statements of Stockholders&#8217; Equity where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from net investment hedges recorded within Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="i28545f9d3bda45efaa5277b002e22e7a_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMjUyOA_8764417e-89bf-4c2a-9b7b-cee5ae445ecb">83</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i11351bf2991743d7af90b551540fc919_D20200401-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1MTM4MQ_72802e29-e007-4dbb-980c-133ea7d1bb46">117</ix:nonFraction> million during the three and six months ended September 30, 2020, respectively, and gains of $<ix:nonFraction unitRef="usd" contextRef="ib49781b522ea4f76b1513c0e998abcab_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMjUzNQ_5ce177cf-8b18-45a0-a6b1-807d5faf126a">91</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if8234a3e5eda4043b4d3fa3510856378_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1MTQyNA_3e6016e9-093e-4183-96f5-df8709014d17">67</ix:nonFraction> million during the three and six months ended September 30, 2019, respectively. There was no ineffectiveness in non-derivative net investment hedges during the three and six months ended September 30, 2020. Ineffectiveness on the Company&#8217;s non-derivative net investment hedges during the three and six months ended September 30, 2019 resulted in gains of $<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMjcxMQ_d1829ce0-688d-4fc8-a60b-de4f2e51a63d">20</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1MTU4OQ_b7e94815-19f8-4976-b007-e694da3d1ca9">30</ix:nonFraction>&#160;million, respectively, which were recorded in earnings in Other income (expense), net in the Condensed Consolidated Statements of Operations. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and March 31, 2020, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $<ix:nonFraction unitRef="cad" contextRef="i4ddc0b315b6f44b0ae7eb4080f845509_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMzA5MQ_9d84d765-8f0d-4f75-827f-847b4265a063"><ix:nonFraction unitRef="cad" contextRef="if390d59ed27b4bc8a9ae736d392c53fb_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMzA5MQ_a6f49455-6559-4c44-a69d-3f433304c0c9">1.5</ix:nonFraction></ix:nonFraction> billion Canadian dollars. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in Accumulated other comprehensive loss in the Condensed Consolidated Statements of Stockholders&#8217; Equity where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#8217;s net investment hedges for the three and six months ended September 30, 2020 and 2019. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i74a728c5a29c40afb0fc28a3e8302b48" continuedAt="i4959c976d61c4cb5999a73cfd04b5273"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, the Company terminated cross-currency swaps with a total gross notional amount of &#163;<ix:nonFraction unitRef="gbp" contextRef="iecdece7bccac464e91de8f41f5c11988_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNDQ5Ng_c75c6403-9aa8-4cdc-9d41-a6dc022eb9de">932</ix:nonFraction> million British pound sterling due to ineffectiveness in its British pound sterling hedging program that arose due to 2019 impairments of goodwill and certain long-lived assets in the U.K. businesses. Proceeds from the termination of these swaps totaled $<ix:nonFraction unitRef="usd" contextRef="ic8acb42c198243e4a41c9b1198ebd29b_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNDc0NQ_54838fe1-bd71-4b3c-b04e-b6a92c9c2665">84</ix:nonFraction> million and resulted in a settlement gain of $<ix:nonFraction unitRef="usd" contextRef="ic8acb42c198243e4a41c9b1198ebd29b_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNDc4NQ_0efbf3c1-4cec-4d92-831e-ff41eaca17c0">34</ix:nonFraction> million for the six months ended September 30, 2019. This gain was recorded in earnings in Other income (expense), net, net in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from the Company&#8217;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="i845cf95a4c8a421fafec2976a240ff82_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNTA2MA_0ce2d3c3-dc3c-43e4-ad52-90ec2878aff4">12</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8df2eff3ed674556a1b6d76ac1e2fc2b_D20200401-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1MTgyNQ_8b2b098f-fa67-4ff2-bec6-48f548b76d19">63</ix:nonFraction> million during the three and six months ended September 30, 2020, respectively, and gains of $<ix:nonFraction unitRef="usd" contextRef="ib993ed38bcaa44e992d425b235b667ba_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNTA2Nw_c5c17e67-e157-4cc2-84ac-b87284cb00f1">20</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icdb08454a4384d82896df1a6d61f11f9_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1MTg3MA_4b967f25-633f-4f5f-aee6-88497c24fc5f">9</ix:nonFraction> million during the three and six months ended September 30, 2019, respectively. There was no ineffectiveness in the Company&#8217;s cross-currency swap hedges for the three and six months ended September 30, 2020 and 2019. These cross-currency swaps will mature between November 2020 and November 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#163;<ix:nonFraction unitRef="gbp" contextRef="i88ca01400a5e4f17a31f7e6a13628bec_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNTQ0Mg_c7996fa5-a77d-4250-b80b-72736e37c5bd">450</ix:nonFraction> million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#163;<ix:nonFraction unitRef="gbp" contextRef="i88ca01400a5e4f17a31f7e6a13628bec_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNTc5NA_c7996fa5-a77d-4250-b80b-72736e37c5bd">450</ix:nonFraction> million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings for the three and six months September 30, 2020 and 2019 were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At September 30, 2020 and March 31, 2020, the Company had cross-currency swaps with total gross notional amounts of approximately $<ix:nonFraction unitRef="usd" contextRef="i31bf530a67154f4089f298f4daebb618_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNzA2MA_d965f8e7-794a-4790-a114-731710a0c78a">2.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="iccbce5482ad640f5b90191abd057ac63_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNzA2Nw_b0a77bce-d550-46e1-9cf2-e5d10953cd17">2.9</ix:nonFraction> billion, respectively, which are designated as cash flow hedges. These swaps will mature between February 2021 and January 2024. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i8ad1ff26ff3e4d089de290e9695a1cb1_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfODE0OQ_761c5bcd-3ef5-4892-8897-64c646fd48cc">500</ix:nonFraction>&#160;million and &#8364;<ix:nonFraction unitRef="eur" contextRef="i8ad1ff26ff3e4d089de290e9695a1cb1_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfODE1Ng_3bf77314-ee71-4c37-8820-3a84fdcd800a">600</ix:nonFraction>&#160;million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $<ix:nonFraction unitRef="usd" contextRef="i8ad1ff26ff3e4d089de290e9695a1cb1_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfODM4NQ_c548fefc-2ede-4807-880f-74087d17599c">500</ix:nonFraction>&#160;million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#8220;EURIBOR&#8221;) for the &#8364;<ix:nonFraction unitRef="eur" contextRef="i8ad1ff26ff3e4d089de290e9695a1cb1_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfODYxMA_50aa6cf0-b191-48d1-a68c-25e23dc0dcca">600</ix:nonFraction>&#160;million swaps. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Gains or losses from cash flow hedges recorded in Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="i2c1475ccb75f4635a9bf4d405fc5d8f5_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1NTYxNQ_be733719-b173-4d93-875a-55c1528c1840">23</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i123bf8d69a8548fda1b8942d92d2fc33_D20200401-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1NTYyMw_72351da2-6435-4a59-ac10-77e22b8ee6b9">28</ix:nonFraction> million during the three and six months ended September 30, 2020, respectively, and were gains of $<ix:nonFraction unitRef="usd" contextRef="i85cd2589de304d938cfd483404ca1653_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1NTY2MA_5ed14946-3549-4ea8-9c8b-b167fe105b29">17</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia124b703fd9c4666841454b448394b00_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1NTY2OA_b602502d-1c39-4fe6-813e-4124c9067255">35</ix:nonFraction> million during the three and six months ended September 30, 2019, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in Operating expenses in the Condensed Consolidated Statements of Operations were not material in the three and six months ended September 30, 2020 and 2019. There was no ineffectiveness in the Company&#8217;s cash flow hedges for the three and six months ended September 30, 2020 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i4959c976d61c4cb5999a73cfd04b5273" continuedAt="ifade4c8b0f624e059ed4cffe257da90f"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At September 30, 2020 and March 31, 2020, the total gross notional amounts of these contracts were $<ix:nonFraction unitRef="usd" contextRef="ia9356380a99d4079b931630ff762728b_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfOTAzOA_4d3a9a62-aeff-4950-a8cf-b84dc9e57c55">44</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i258110de1c154e9480bae6db28d0f729_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfOTA0NQ_096c2a83-9211-412e-acb3-0990eb565e26">29</ix:nonFraction> million, respectively. These contracts will predominantly mature through December 2020 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in Operating expenses. Changes in the fair values were not material in the three and six months ended September 30, 2020 and 2019. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2019, the Company also entered into a number of forward contracts to offset a portion of the earnings impacts from the ineffectiveness of the net investment hedges discussed above. These contracts matured in September 2019 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly in earnings. During the three and six months ended September 30, 2019, losses of $<ix:nonFraction unitRef="usd" contextRef="i3a7c1b74f86c479b816159c6d3ae04b0_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1NDEwMg_2d6e6362-9d2c-42e4-bcab-a9c98cf0045a">20</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1b5ddc35c76e45c7a9c189c497c848b8_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1NDExMA_1a6627eb-5d54-4cd6-8cc1-acd94ed96c6f">39</ix:nonFraction> million, respectively, were recorded in earnings within Other income (expense), net in the Condensed Consolidated Statements of Operations.</span></div><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfOTY5Nw_c1b745a9-e410-4414-9624-54bbb63b217a" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.672%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.206%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc3ab577dc7480fae3d98e14277684f_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNS0yLTEtMS0w_faa9498b-10cf-4fb6-a395-bc9eb8bb0c99">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21e4948d75de4a3baf98851aa5242f47_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNS00LTEtMS0w_6aa409b1-eca0-4094-aa03-c4b664ce894f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9949b55995c54523b05daddb017a3ac4_I20200930" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNS01LTEtMS0w_65c5e4aa-fc38-4829-b15f-02d1fa310d68">925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i206a9aeb7e4a4008803c87c65282730e_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNS03LTEtMS0w_898bc9b7-736c-44ac-8f19-a10265ce408a">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03b5f5fc26d47c3be37eff2f0e07604_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNS05LTEtMS0w_4d77bd4d-546b-4b24-93b0-d18a7c0d7a96">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba46bb814a6e4d07bedaae798f4c086c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNS0xMC0xLTEtMA_90f25b10-2d5e-4bf8-b9b1-1104facfdfc6">1,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2e52268a81f4aa28240eea26becc2ba_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNi0yLTEtMS0w_864901f7-96b0-4fc6-a0ad-c661e2fbaaa2">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f31411e76594912ad9c4c6fdc037070_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNi00LTEtMS0w_51b5eb41-4195-46b8-ba37-4a68a0121fc8">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69864efaf345415db2c3cc9adba8a027_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNi01LTEtMS0w_629034fd-8096-49be-b269-f6bd177caaf9">3,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a67d47d26e744bea5b1a64745a103ef_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNi03LTEtMS0w_34121dc1-ebb1-4824-af4f-9195eac9a4e3">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie09c8165d0db4a47be02c5ba356b27a9_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNi05LTEtMS0w_e3c2cf4a-78dd-4761-83a5-0f55ea554dfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15eb6e4eb94b4f57885a65039289f579_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNi0xMC0xLTEtMA_ba75ddb6-936c-493c-8cb8-4c2dc7dde5e2">3,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb450020edcc4eafb4f6204bd56f1294_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNy0yLTEtMS0w_dbac0e1d-d6bc-472d-b112-10093f0f86d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb450020edcc4eafb4f6204bd56f1294_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNy00LTEtMS0w_2e3a81bd-a4e6-48b3-ad13-2b219c16672d">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb450020edcc4eafb4f6204bd56f1294_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNy01LTEtMS0w_ffe18b38-3038-4c2f-9a0f-7ee72603fc8e">1,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d17d2683c04f8e978bbfeeda49522e_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNy03LTEtMS0w_7efffaca-ccb7-4488-829d-62571a401fb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d17d2683c04f8e978bbfeeda49522e_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNy05LTEtMS0w_02e3147a-7622-4c57-8503-b4ebf1f70686">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d17d2683c04f8e978bbfeeda49522e_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNy0xMC0xLTEtMA_986e8522-c763-4142-a44a-e1a53796d9a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c01ee54c64b4e738869a1a426b32be8_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfOS0yLTEtMS0w_f0447782-613e-446d-bbeb-2eb24ee3d8e4">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c01ee54c64b4e738869a1a426b32be8_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfOS00LTEtMS0w_fccdf26d-12d1-4f59-aff0-998d2685ae5d">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b838d45789a4813a7f70a4900210195_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfOS03LTEtMS0w_f0f2b3bc-9dd5-4f96-91c8-2ae627de3412">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b838d45789a4813a7f70a4900210195_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfOS05LTEtMS0w_bd55f9ca-d93a-406e-86c9-69d2dd52a631">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eaf2c336e1d400ba5e9a2c97cfb4467_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTEtMi0xLTEtMA_586de3bf-c055-471f-a5b6-a391ea8cfb5d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eaf2c336e1d400ba5e9a2c97cfb4467_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTEtNC0xLTEtMA_b2de3326-80e3-4b92-a383-64e1bb2c23c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eaf2c336e1d400ba5e9a2c97cfb4467_I20200930" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTEtNS0xLTEtMA_171d049d-4990-4923-99ad-efcc90a47f78">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e77147ea2824ec685fc498f61706e2b_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTEtNy0xLTEtMA_89f36b59-6d1e-406a-9031-146759fd2aff">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e77147ea2824ec685fc498f61706e2b_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTEtOS0xLTEtMA_b3226f3d-2062-4781-8076-d1c43e7111dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e77147ea2824ec685fc498f61706e2b_I20200331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTEtMTAtMS0xLTA_ed08ff0b-e9af-49a4-8b54-b718fa0bef0d">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i851951555ad24db390460dd6eda13a71_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTItMi0xLTEtMA_b5a02998-7903-4118-8af7-44818d3622a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i851951555ad24db390460dd6eda13a71_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTItNC0xLTEtMA_8f89881b-0f3c-4166-9f3d-12bb393fa658">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i851951555ad24db390460dd6eda13a71_I20200930" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTItNS0xLTEtMA_78c1f559-f36b-49bc-a8a3-f9a6cae3635f">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbba6884ea2d430c82bef1bffa38851e_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTItNy0xLTEtMA_d664d233-a564-41d6-9131-357697a0993d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbba6884ea2d430c82bef1bffa38851e_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTItOS0xLTEtMA_a7deef44-06db-4480-8577-caae2d45137f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbba6884ea2d430c82bef1bffa38851e_I20200331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTItMTAtMS0xLTA_1625fed0-b3e0-4e89-8a0c-d558f5bd0c40">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54c29ac67c524830b5346ac601e7912c_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTMtMi0xLTEtMA_2dce22e1-bcb5-4b2d-b33f-5da92006a270">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54c29ac67c524830b5346ac601e7912c_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTMtNC0xLTEtMA_62c12e84-726b-4714-a3a2-9f4c1de173a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1469f9d2f2f144f6ac3ea35586bb7cf0_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTMtNy0xLTEtMA_86379de6-f27a-4e13-8eda-b3c05c1b651f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1469f9d2f2f144f6ac3ea35586bb7cf0_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTMtOS0xLTEtMA_6215e6c1-8bee-4196-afd4-dd41ff5c428e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifade4c8b0f624e059ed4cffe257da90f">Refer to Financial Note 12, "Fair Value Measurements," for more information on these recurring fair value measurements.</ix:continuation> </span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_85"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfNDY4NA_c04d4351-99f5-4e96-ab3d-1b46b844416e" continuedAt="i69f00b05cc7b43de94b8a3a3c1265a63" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i69f00b05cc7b43de94b8a3a3c1265a63" continuedAt="i543ec1736f41460e9a7ebbad873d9a40"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and March 31, 2020, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is carried at amortized cost. The carrying amounts and estimated fair values of these liabilities were $<ix:nonFraction unitRef="usd" contextRef="i7b890927812447aa911816632e628829_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfNjIw_4c23af64-83bb-4c7c-8dcc-ea5115615e29">7.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i7b890927812447aa911816632e628829_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfNjI3_da39d183-ce6e-40f4-b4da-9411fddaca48">8.4</ix:nonFraction> billion at September 30, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i5badf059a14f4d8ab6f9ce6affac29bc_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfNjU1_29107fcb-576a-4ef0-8909-71b102af845d">7.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i5badf059a14f4d8ab6f9ce6affac29bc_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfNjYy_96cf336e-4210-4043-a822-e5de7d6b8ab1">7.8</ix:nonFraction> billion at March 31, 2020, respectively. The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i543ec1736f41460e9a7ebbad873d9a40" continuedAt="i8d5e9e1644524edeb45e320c7b47c322"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at September 30, 2020 and March 31, 2020 included investments in money market funds of $<ix:nonFraction unitRef="usd" contextRef="i9fa8c90408ea4e3dae6e394bf3fa943b_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTE2OA_00f40321-7340-4f90-b36b-bf698fe02ec2">129</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9b844b3b721f4a0d922cde7ae32b2875_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTE3NQ_a619ebc9-3de4-4740-bd03-f709e2b5c2c0">2.0</ix:nonFraction> billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level&#160;1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s foreign currency forward contracts were determined using observable inputs from available market information. Fair values of the Company&#8217;s cross-currency swaps were determined using quoted foreign currency exchange rates and other observable inputs from available market information. Fair values of the Company&#8217;s interest rate swaps were determined using observable inputs from available market information. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 11, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s foreign currency derivatives including forward foreign currency contracts and cross-currency swaps.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry. These investments, with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTA0NDUzNjA0NzU3OTc_6eaa5719-0f0c-45f3-9ab9-b360fa1fc416">235</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTA0NDUzNjA0NzU4MTI_01b266ca-bbd2-49c2-aa17-5829190624bd">170</ix:nonFraction>&#160;million, respectively, at September 30, 2020 and March 31, 2020, and primarily consisting of investments without readily determinable fair values, are included within Other non-current assets in the Condensed Consolidated Balance Sheets. In the second quarter of 2021, <ix:nonFraction unitRef="company" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="mck:EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTUzOTMxNjI4MDIyMDE_02755aed-bd59-48a7-85e8-24c382c03b80">three</ix:nonFraction> of the companies in which McKesson holds investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition. Net gains related to the Company&#8217;s investments in equity securities, primarily representing unrealized gains on the publicly traded securities discussed above, were $<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTIwOTQ2Mjc5MTYzNDQ_b7c62f1c-7960-49fa-ac76-616864e7533b">49</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTIwOTQ2Mjc5MTYzNTI_76ea4425-9dff-411a-93ea-af97639950b8">59</ix:nonFraction> million for the three and six months ended September 30, 2020, respectively. These gains were recorded under the caption, &#8220;Other income (expense), net,&#8221; in the Condensed Consolidated Income Statements. There were no other material changes in the carrying value of these investments during the three or six months ended September 30, 2020. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets measured at fair value on a nonrecurring basis as of September 30, 2020 included long-lived assets in the U.K. as discussed in more detail in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and goodwill of the Company&#8217;s Europe Retail Pharmacy reporting unit within the International segment. Refer to Financial Note 8, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information. At March 31, 2020, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s European and Rexall Health businesses within the International segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities includes the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i0f5ac3d5d5f4479592e96e5bf4ee0a01_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMjc1MA_2d49d8f9-ac15-4693-8ab6-b8aacb96abe4"><ix:nonFraction unitRef="usd" contextRef="i1cb4731f3b53414bac5ded8a850e5f3b_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMjc1MA_8b4ea66f-d23f-4038-bec4-d40ca99ec793">no</ix:nonFraction></ix:nonFraction> liabilities measured at fair value on a nonrecurring basis at September 30, 2020 and March 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, included within Prepaid expenses and other on the Company&#8217;s Condensed Consolidated Balance Sheet as of September 30, 2020, primarily consists of funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. The amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within Other accrued liabilities on the Company&#8217;s Condensed Consolidated Balance Sheet as of September 30, 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i8d5e9e1644524edeb45e320c7b47c322" continuedAt="i17dcf8d3224d41388c627d6ebd142073"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a discounted cash flow (&#8220;DCF&#8221;) model to determine the fair value of the reporting unit. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i17dcf8d3224d41388c627d6ebd142073">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.</ix:continuation> </span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_88"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4MjkyNDQ_b24796f2-e9ac-4ef3-8a79-547b36994f23" continuedAt="i4ced5cffc05a4ed6a7682b2f5551b6a3" escape="true">Commitments and Contingent Liabilities </ix:nonNumeric></span></div><ix:continuation id="i4ced5cffc05a4ed6a7682b2f5551b6a3" continuedAt="i1d160e3141e443298b7cecc9e0da59bb"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTc1MjY_430c7721-b3eb-4f13-9b98-b873ba473a88" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mck10k3312020.htm#sFDC7F65C03045D74BF3631026AD9426B">Financial Note 21 to the Company&#8217;s 2020 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112">Financial Note 13 to the Company</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112">&#8217;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112">s 10-Q filing for the quarterly period ended June 30, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, it is not reasonably possible for the Company to determine that a loss is probable for a claim, or to reasonably estimate the amount of loss or a range of loss, because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to be resolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the loss probability has changed and whether it can make a reasonable estimate of the possible loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability in the amount of its estimate for the ultimate loss. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, hospitals, Indian tribes, pension funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico, and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i1d160e3141e443298b7cecc9e0da59bb" continuedAt="i45372f9b361c4930a79eff495b8adb7c"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#8220;MDL&#8221;) in the United States District Court for the Northern District of Ohio captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: National Prescription Opiate Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Case No. 17-md-2804. At present, there are approximately <ix:nonFraction unitRef="case" contextRef="i7ed3f74dc0ae44f8baf2c9b085580e45_I20200930" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMzYxNQ_378466cf-3637-499b-9b97-c3d1f1bc1daa">2,800</ix:nonFraction> cases under the jurisdiction of the MDL court. In the suits filed against the Company by Cuyahoga County, Ohio in October 2017 and Summit County, Ohio in December 2017, the parties reached an agreement in principle on October 21, 2019 to settle all claims against the Company. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">County of Cuyahoga v. Purdue Pharma L.P., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Case No. 1:17-op-45004-DAP (N.D. Ohio); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">County of Summit, Ohio et al. v. Purdue Pharma L.P., et. al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Case No. 1:18-op-45090-DAP (N.D. Ohio). The Company does not admit liability and expressly denies wrongdoing. As a result, the Company recorded a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="ib06af04e28ba4e4ea6652465ca257cfe_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4NjY0NzQ_3fe14323-a0b2-4231-9aa7-c6a54d241ce8">82</ix:nonFraction>&#160;million related to <ix:nonFraction unitRef="county" contextRef="i7ed3f74dc0ae44f8baf2c9b085580e45_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofCounties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4NjY0OTE_e35a969c-2864-4fb9-896a-b53423b3ddd5">two</ix:nonFraction> Ohio counties within operating expenses for the second quarter of 2020.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="case" contextRef="ibd6d24f4b8e64a778fb5af40d017aedc_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMzY2NQ_43e8247d-2775-42c6-b7f2-ddb437f22a2c">Three</ix:nonFraction> cases involving McKesson that were previously part of the federal MDL have been remanded to other federal courts for discovery and trial. On January 14, 2020, the Judicial Panel on Multidistrict Litigation finalized its Conditional Remand Order, ordering that the cases against the <ix:nonFraction unitRef="company" contextRef="ieaaee7621692492e90da6fe2f00a5923_I20200114" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMzk1MA_fe8fe097-01a8-4d6f-9db5-895057fca196">three</ix:nonFraction> largest distributors brought by Cabell County, West Virginia and the City of Huntington, West Virginia be remanded to the U.S. District Court for the Southern District of West Virginia. A trial has been scheduled for January 4, 2021. On February 5, 2020, the case brought by the City and County of San Francisco was remanded to the U.S. District Court for the Northern District of California; trial has been set for June 28, 2021. Also on February 5, 2020, the case brought by the Cherokee Nation was remanded to the U.S. District Court for the Eastern District of Oklahoma.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also named in approximately <ix:nonFraction unitRef="case" contextRef="i3e08cb2f184f4ac491a30c4f2f86b5cd_I20200930" decimals="-2" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNDU3Ng_a3deee45-4a6a-4a10-b12d-3db70f8837ec">400</ix:nonFraction> similar state court cases pending in <ix:nonFraction unitRef="state" contextRef="i3e08cb2f184f4ac491a30c4f2f86b5cd_I20200930" decimals="INF" name="mck:LossContingencyNumberofStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNDYxNg_cd7504d0-1887-4fc0-b5be-51fe6235b9a9">36</ix:nonFraction> states plus Puerto Rico, along with <ix:nonFraction unitRef="case" contextRef="ia89ab571675d4fe1be458deb9d1756b6_I20200930" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTY0OTI2NzQ1OTQ0NQ_15353e7a-3332-44d6-a3f5-454c580e7154">3</ix:nonFraction> cases in Canada. These include actions filed by <ix:nonFraction unitRef="state_attorney" contextRef="i3e08cb2f184f4ac491a30c4f2f86b5cd_I20200930" decimals="INF" name="mck:LossContingencyNumberofStateAttorneyGenerals" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNDY3NQ_1433aadd-d526-45fe-81fa-d2b11989301d">26</ix:nonFraction> state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state cases. For example, trial was previously set to begin in March 2020 in the Supreme Court of New York, Suffolk County for a case brought by the New York attorney general and <ix:nonFraction unitRef="county" contextRef="ifef9ed0f951845c09b3a887cc0f7469f_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="mck:NumberOfCountyGovernments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNTE0OA_7efee5d4-dd4a-45c4-8d63-29dedfdd5e86">two</ix:nonFraction> New York county governments, but the trial was postponed in light of the COVID-19 pandemic.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to be involved in discussions with the objective of achieving broad resolution of opioid-related claims brought by governmental entities. For example, in October 2020, a group of state attorneys general proposed a framework for the potential settlement of opioid claims of governmental entities, including political subdivisions, and compensation for the private attorneys representing these governmental entities. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the framework proposed by the attorneys general, the <ix:nonFraction unitRef="company" contextRef="i2b88d5a3d4ab496188c56155a2880f90_I20201031" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNTgwMQ_4772394a-6a94-4d83-8d49-b47bac827ad5">three</ix:nonFraction> largest U.S. pharmaceutical distributors could be expected to pay an aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="i56fa48494eef42e2a81d8b80e6683829_D20201001-20201031" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTA5OTUxMTYzMTg2NzU_ee148ccb-4571-4e1b-bfc5-68f32ff65e39">21.0</ix:nonFraction> billion over <ix:nonNumeric contextRef="i56fa48494eef42e2a81d8b80e6683829_D20201001-20201031" format="ixt-sec:duryear" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNTg4OQ_67a3ae3d-2f62-4264-a5f4-d6f1d1429de7">18</ix:nonNumeric> years, with up to approximately $<ix:nonFraction unitRef="usd" contextRef="ic4a0fa8d9f0a41d0a8385cb9c0f43e82_D20201001-20201031" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTA5OTUxMTYzMTg3MDQ_4278e7e9-5142-4c6c-9153-a2b27f09d1e8">8.0</ix:nonFraction> billion over <ix:nonNumeric contextRef="ic4a0fa8d9f0a41d0a8385cb9c0f43e82_D20201001-20201031" format="ixt-sec:duryear" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNTkyNg_169575c0-12a1-4511-aac8-5ab2670ab61d">18</ix:nonNumeric> years expected from the Company. The proposed framework would also require the three distributors, including the Company, to adopt changes to anti-diversion programs. If the negotiating parties agree on the terms for a broad resolution, those potential terms would need to be agreed to by numerous other state and local governments before an agreement could be accepted by the Company and finalized. Under the framework, before the distributors determine whether to enter into any final settlement, they would assess the sufficiency of the scope of settlement, based in part on the number and identities of the states, political subdivisions, and governmental entities that would participate in any such settlement. If states, political subdivisions or other governmental entities did not agree to a settlement under the framework, there would be a corresponding reduction in the amount due from the Company to account for this.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussions with attorneys general and other parties continue. To be viable, a broad settlement arrangement would require participation of numerous parties and the resolution of many complex issues. Because of the many uncertainties associated with any potential settlement arrangements, and the uncertainty of the scope of potential participation by plaintiffs, the Company has not reached a point where settlement is probable, and as such has not recognized any liability related to any potential settlement framework as of September 30, 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company continues to be involved in discussions regarding a potential global settlement framework, the Company also continues to prepare for trial in these matters. The Company believes that it has valid defenses to the claims pending against it and intends to vigorously defend against all such claims. Because of the novelty of the claims asserted and the complexity of litigation, the Company has determined that liability is not probable, and is not able to reasonably estimate a loss or range of loss. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i45372f9b361c4930a79eff495b8adb7c" continuedAt="i648e2d600fc04a639ec2ee3afa6a03c0"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed by <ix:nonFraction unitRef="relator" contextRef="ife3f7c8428454d1a83b2d27fbb7084b5_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofRelatorsAllegingViolations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4MjkyNDE_c8840004-1e68-4d22-aaa7-af40abf4de51">two</ix:nonFraction> relators alleging violations of the federal False Claims Act based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-2233. On August 18, 2020, the court entered an order granting the Company&#8217;s motion to dismiss and giving the relators permission to file an amended complaint. On September 8, 2020, pursuant to the court&#8217;s order, the relators filed a Second Amended Complaint.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#8220;TCPA&#8221;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$<ix:nonFraction unitRef="usd" contextRef="ic933332211124a748e5866fc45b2d46c_D20130517-20130517" decimals="INF" name="mck:LossContingencyDamagesSoughtPerViolationValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTA2ODk_d54e5f62-60f5-4d5d-99d1-18f52ff24046">500</ix:nonFraction>&#160;to&#160;$<ix:nonFraction unitRef="usd" contextRef="i1c69b4d259c846329b91b3b6969f1004_D20130517-20130517" decimals="INF" format="ixt:numdotdecimal" name="mck:LossContingencyDamagesSoughtPerViolationValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTA2OTU_0a19737f-511c-4e23-a886-c7675c6845bb">1,500</ix:nonFraction>&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On July 16, 2015, plaintiffs filed a motion for class certification. On August 22, 2016, the court denied plaintiffs&#8217; motion. On July 17, 2018, the United States Court of Appeals for the Ninth Circuit Court affirmed in part and reversed in part the district court&#8217;s denial of class certification and remanded the case to the district court for further proceedings. On August 13, 2019, the court granted plaintiffs&#8217; renewed motion for class certification. After class notice and the opt-out period, <ix:nonFraction unitRef="fax_number" contextRef="iace4f3d9ad444347aa132bbc7bb400f2_I20190813" decimals="INF" format="ixt:numdotdecimal" name="mck:LossContingencyClassActionNumberofFaxesRemainingintheClass" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTE1NjM_e163e8f4-4dc7-437a-a20d-ae1af8b178f5">9,490</ix:nonFraction> fax numbers remain in the class, representing <ix:nonFraction unitRef="fax" contextRef="iace4f3d9ad444347aa132bbc7bb400f2_I20190813" decimals="INF" format="ixt:numdotdecimal" name="mck:LossContingencyClassActionNumberofFaxesReceived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTE2MTI_cb8b62a0-61fe-4334-a8de-4a4a7c11967a">48,769</ix:nonFraction> faxes received. On March 5, 2020, McKesson moved to decertify the class and moved for summary judgment on plaintiffs&#8217; claim for treble damages. Plaintiffs&#8217; moved for summary judgment on the same day. Due to the COVID-19 pandemic, the trial date for this case was taken off calendar to be re-scheduled during 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 5, 2018, the Company&#8217;s subsidiary, RxC Acquisition Company (d/b/a RxCrossroads), was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in July 2017 in the United States District Court for the Southern District of Illinois by a relator against RxC Acquisition Company, among others, alleging that UCB, Inc. provided illegal &#8220;kickbacks&#8221; to providers, including nurse educator services and reimbursement assistance services provided through RxC Acquisition Company, in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. CIMZNHCA, LLC v. UCB, Inc., et al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 17-cv-00765. The complaint sought treble damages, civil penalties, and further relief. The United States and the states named in the complaint declined to intervene in the suit. On December 17, 2018, the United States filed a motion to dismiss the complaint in its entirety; this motion was denied on April 15, 2019. On June 7, 2019, the court denied the United States&#8217; motion for reconsideration. On July 8, 2019, the United States appealed to the United States Court of Appeals for the Seventh Circuit seeking interlocutory review of the denial of its motion for reconsideration of the denial of the motion to dismiss the complaint. On September 3, 2019, the United States District Court for the Southern District of Illinois stayed the district court proceedings pending the appeal. On August 17, 2020, the Seventh Circuit reversed the district court&#8217;s decision on the United States&#8217; motion to dismiss and remanded the case with instructions that the district court enter judgment for the defendants on the relator&#8217;s claims under the False Claims Act. The relator sought a re-hearing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">en banc</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at the Seventh Circuit, which was denied.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The relator did not pursue any further appeals and the relator&#8217;s False Claims Act case was dismissed, with judgment entered in favor of the defendants on September 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant in an amended complaint filed on June 15, 2018 in a case pending in the United States District Court for the Southern District of Illinois alleging that the Company&#8217;s subsidiary, McKesson Medical-Surgical Inc., among others, violated the Sherman Act by restraining trade in the sale of safety and conventional syringes and safety IV catheters. M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">arion Diagnostic Center, LLC v. Becton, Dickinson, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 18:1059. The action is filed on behalf of a purported class of purchasers, and seeks treble damages and further relief, all in unspecified amounts. On July 20, 2018, the defendants filed a motion to dismiss. On November 30, 2018, the district court granted the motion to dismiss, and dismissed the complaint with prejudice. On December 27, 2018, plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit. On March 5, 2020, the United States Court of Appeals for the Seventh Circuit vacated the district court&#8217;s order, and ruled that dismissal was appropriate on alternative grounds. The case was remanded to the district court to allow the plaintiffs an opportunity to amend their complaint. Plaintiffs filed an amended complaint on August 21, 2020. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i648e2d600fc04a639ec2ee3afa6a03c0"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2019, Jean E. Henry, a purported Company shareholder, filed a shareholder derivative complaint in the Superior Court of San Francisco, California against certain current and former officers and directors of the Company, and the Company as a nominal defendant, alleging violations of fiduciary duties and waste of corporate assets with respect to an alleged conspiracy to fix the prices of generic drugs, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Henry v. Tyler, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CGC-19-576119. On May 23, 2019, the Company removed the case to the United States District Court for the Northern District of California, Case No. 19-cv-02869. On August 26, 2019, the plaintiff filed an amended complaint, removing all claims except for an alleged breach of fiduciary duty by the named current and former officers and directors of the Company. On January 21, 2020, the United States District Court for the Northern District of California granted the defendants&#8217; motion to dismiss the complaint, and on July 1, 2020, the court granted the defendant&#8217;s motion to dismiss the plaintiff&#8217;s amended complaint with prejudice. The plaintiff did not file an appeal.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2020, McKesson received correspondence from the U.S. Attorney&#8217;s Office for the Western District of Tennessee alleging reporting and documentation deficiencies in violation of the Controlled Substances Act at the Company&#8217;s former and no longer operational RxPak facility and at its Distribution Center in Memphis, Tennessee, and seeking civil penalties.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:103%">IV.  State Opioid Statutes</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory or industry measures to address the misuse of prescription opioid medications could affect the Company&#8217;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#8220;OSA&#8221;) which required the creation of an aggregate $<ix:nonFraction unitRef="usd" contextRef="ia241be660d814c9dbfbab339569e8b37_I20180430" decimals="INF" format="ixt:numdotdecimal" name="mck:OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4MjkyNzI_7050a148-59e6-439b-886a-6d5b7cd200fa">100</ix:nonFraction>&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Company has accrued a $<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4MjkyNDY_4976839c-74ce-4d60-a8db-d3bb6e862810">50</ix:nonFraction>&#160;million pre-tax charge ($<ix:nonFraction unitRef="usd" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="-6" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4MjkyNTk_cecb74f5-f5f2-4d44-a74b-213ab483d9ac">37</ix:nonFraction>&#160;million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized as Operating expenses in the accompanying condensed consolidated statement of operations and as Other accrued liabilities in the condensed consolidated balance sheets as of September 30, 2020. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0MjE5ODU_8d335b6e-42f8-4bda-aa36-344202304fdd" continuedAt="i173c90fc6b4745599c81c871565ad634" escape="true">Stockholders' Equity </ix:nonNumeric></span></div><ix:continuation id="i173c90fc6b4745599c81c871565ad634" continuedAt="i81f2717c8f5b4d0481294ad095204e38"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted <ix:nonFraction unitRef="vote" contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="mck:CommonStockVotingRightsNumberofVotesPerCommonShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfNzk_fd229708-a651-481c-b722-472f4670d60e">one</ix:nonFraction> vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2020, the Company raised its quarterly dividend from $<ix:nonFraction unitRef="usdPerShare" contextRef="ib24b30ad412f4321bcaff6b945c5ab8a_D20200728-20200728" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMzAy_b8abf6c2-125a-4472-8b3d-a5b25d555118">0.41</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="ifc731429591343fb9685ce4e3d37b71c_D20200729-20200729" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMzA4_d6f48072-34cb-4bd8-9466-1858623c2aa0">0.42</ix:nonFraction> per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2020, there were <ix:nonFraction unitRef="shares" contextRef="i094f2986d473404cb6ffd79049564a6b_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTUzOTMxNjI3OTY0MDM_1bda6627-3851-4dbb-a16c-e8b36338dac0">no</ix:nonFraction> share repurchases made under previously authorized share repurchase programs. During the three months ended September 30, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i360a0a25e36a496585c2f2d80ef31321_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTA0NDUzNjA0NzQxOTQ_a6743475-c044-486e-be14-c42460d8fb4e">1.8</ix:nonFraction>&#160;million of the Company&#8217;s shares for $<ix:nonFraction unitRef="usd" contextRef="i360a0a25e36a496585c2f2d80ef31321_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTA0NDUzNjA0NzQyMTQ_e855fae6-113f-487a-ad96-c6a6f3bc6cc7">269</ix:nonFraction> million through open market transactions at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTA0NDUzNjA0NzQyMTk_b342ee6c-d424-4e93-b718-e180948340cd">151.23</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="i5e72211ec5474ca28d33b7a18d5879c3_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTA0NDUzNjA0NzY5MDY_5d6d52a7-b3d4-4795-82e7-63d17d4117cf">21</ix:nonFraction>&#160;million was accrued within &#8220;Other accrued liabilities&#8221; on the Company&#8217;s Condensed Consolidated Balance Sheets for share repurchases that were executed in late September and settled in early October. The total authorization outstanding for repurchases of the Company&#8217;s common stock was $<ix:nonFraction unitRef="usd" contextRef="i1009c601f4d148e38fd22bf9694cd964_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTM1MA_f74b496a-950e-4fe4-81a0-ab8dd3897641">1.3</ix:nonFraction> billion at September 30, 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i81f2717c8f5b4d0481294ad095204e38" continuedAt="i9987666c5dc84137a102584e2d5f1927"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Comprehensive Income (Loss)</span></div><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMzg1NA_5cbdf780-2b45-4e68-aa03-a2de7681497f" continuedAt="ia50fdb38bfe34e5fbbe796c352fbf656" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.261%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments arising during period, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy0wLTEtMS0wL3RleHRyZWdpb246OGE4ZDM3ZjgxZWY2NDYzZTkxMmY3Y2Q0NDIzMTI1Y2FfOTg_4bb60240-73c0-4ed2-be9b-e6519c7c715b">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy0wLTEtMS0wL3RleHRyZWdpb246OGE4ZDM3ZjgxZWY2NDYzZTkxMmY3Y2Q0NDIzMTI1Y2FfMTA1_f068b934-139e-4f09-a1a3-76181f80ddf0">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy0wLTEtMS0wL3RleHRyZWdpb246OGE4ZDM3ZjgxZWY2NDYzZTkxMmY3Y2Q0NDIzMTI1Y2FfMjc0ODc3OTA2OTU2Ng_defbe7ad-50cb-4e05-ab0e-2a603d320c51">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy0wLTEtMS0wL3RleHRyZWdpb246OGE4ZDM3ZjgxZWY2NDYzZTkxMmY3Y2Q0NDIzMTI1Y2FfMjc0ODc3OTA2OTU3Ng_d6c3a818-f2ad-4565-9aec-a94e01d9fff7">nil</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy0xLTEtMS0w_350359ab-8a53-4449-b247-cad5637a800f">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy0zLTEtMS0w_08a30231-652b-446b-8b95-fb7d69dd9d61">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy01LTEtMS0w_d7356042-141b-49fe-84af-db7d279ed9ca">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy03LTEtMS0w_89954f07-0bce-4eec-b4ae-ecd2a8ddf921">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC0wLTEtMS0wL3RleHRyZWdpb246NDhlMWQ3ZjdhNzI3NDcxYTgwMmRjMWQ0ZWNlODRhNWVfNjg_985adacc-7054-4b6e-8ae1-8e42e6d4a1d4">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC0wLTEtMS0wL3RleHRyZWdpb246NDhlMWQ3ZjdhNzI3NDcxYTgwMmRjMWQ0ZWNlODRhNWVfNzU_4c548d8d-8233-400f-b758-2f9cc207c8fb">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC0wLTEtMS0wL3RleHRyZWdpb246NDhlMWQ3ZjdhNzI3NDcxYTgwMmRjMWQ0ZWNlODRhNWVfMjc0ODc3OTA2OTUyMg_833f37ff-6fcb-49d1-9692-75d0de1b1d01">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC0wLTEtMS0wL3RleHRyZWdpb246NDhlMWQ3ZjdhNzI3NDcxYTgwMmRjMWQ0ZWNlODRhNWVfMjc0ODc3OTA2OTU0Mg_1cc6ca69-59ab-4d6b-be44-565b0bdaf531">nil</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC0xLTEtMS0w_164e06ea-e471-42d8-9dc9-e35f61fb03e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC0zLTEtMS0w_5d6fe8ec-b024-4894-8647-b09baf2249a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC01LTEtMS0w_36a7984a-4def-4cf7-9360-e5f7ecca0463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC03LTEtMS0w_ef5dbd28-e0ec-47a9-964a-00e36de2864d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNS0xLTEtMS0w_efd59982-e6d4-447d-af9b-22fbff6e0605">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNS0zLTEtMS0w_bc630bff-8047-4e20-8a1c-f677a2744513">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNS01LTEtMS0w_83d37f47-21a3-4b24-8e4f-2bad0c82932f">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNS03LTEtMS0w_0c575038-ce23-4b11-b552-9bb14827138d">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on net investment hedges arising during period, net of income tax (expense) benefit of $<ix:nonFraction unitRef="usd" contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy0wLTEtMS0wL3RleHRyZWdpb246ZTA1OWU5OThjYWM3NGQ3YjhmNDNlMWQzNzc4Yjk3MjVfMTAw_96f5c01c-eab5-4871-992c-0fdf25ec9b0f">25</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy0wLTEtMS0wL3RleHRyZWdpb246ZTA1OWU5OThjYWM3NGQ3YjhmNDNlMWQzNzc4Yjk3MjVfMTA3_68831fe8-32db-418b-a1aa-ddcfe26e3e97">29</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy0wLTEtMS0wL3RleHRyZWdpb246ZTA1OWU5OThjYWM3NGQ3YjhmNDNlMWQzNzc4Yjk3MjVfMjc0ODc3OTA2OTU5OA_d3f318bc-c8f1-4517-937f-0c044b8faf21">47</ix:nonFraction>, and $(<ix:nonFraction unitRef="usd" contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy0wLTEtMS0wL3RleHRyZWdpb246ZTA1OWU5OThjYWM3NGQ3YjhmNDNlMWQzNzc4Yjk3MjVfMjc0ODc3OTA2OTYwOA_b508fb63-6d5d-436a-8f08-45c7f5b00ba3">20</ix:nonFraction>) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy0xLTEtMS0w_52ea8c7a-4d1f-4e3e-97e6-1b2f7abfce81">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy0zLTEtMS0w_f63429a7-5fcd-4fa4-80b6-7df679858d59">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy01LTEtMS0w_5bbd6c46-51b4-4d6e-bc41-1e18f815e717">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy03LTEtMS0w_6289f0e1-75dc-412f-b791-260745d37f33">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC0wLTEtMS0wL3RleHRyZWdpb246MGIwOTQ2ODE3MWFlNGI3MzhiZDhkMWVmZWFmNmM2M2FfNjg_6b384e5d-d2cb-4a2a-ae87-8a38a6d1488e">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC0wLTEtMS0wL3RleHRyZWdpb246MGIwOTQ2ODE3MWFlNGI3MzhiZDhkMWVmZWFmNmM2M2FfNzU_c7355715-ec21-4292-970f-eb0fb9c38949">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC0wLTEtMS0wL3RleHRyZWdpb246MGIwOTQ2ODE3MWFlNGI3MzhiZDhkMWVmZWFmNmM2M2FfMjc0ODc3OTA2OTUyNA_3110d249-d061-44cc-b245-80a77417ab4f">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC0wLTEtMS0wL3RleHRyZWdpb246MGIwOTQ2ODE3MWFlNGI3MzhiZDhkMWVmZWFmNmM2M2FfMjc0ODc3OTA2OTUzNA_7aa1e55a-9363-44f0-8a84-2f77103cb9f6">nil</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC0xLTEtMS0w_bff89b89-eb66-433b-9d41-8a87a8b9ce9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC0zLTEtMS0w_b8196c1e-39bc-4ce6-9e97-62983f3c6f90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC01LTEtMS0w_50208069-d6eb-4b7b-94d1-9b0a160e5f6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC03LTEtMS0w_e4d35d20-f1e4-487d-b5ac-02bb1505bbdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOS0xLTEtMS0w_d042fc15-de99-423d-a6df-99bf4aa00220">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOS0zLTEtMS0w_e2b2b02c-2223-41e0-85e0-91e4a50cbc58">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOS01LTEtMS0w_feef3f42-9289-4025-91b8-43bf15fe8bb7">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOS03LTEtMS0w_b934f94d-03a0-4fed-8783-b9987d753ddc">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjM5YTBmNGJmZDlkMDQxYTA4OTZkMWVlYzE2ZmMyNGQyXzEwMw_44394b2d-5fb8-4b24-9f6b-f112b7aa5c4b">4</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjM5YTBmNGJmZDlkMDQxYTA4OTZkMWVlYzE2ZmMyNGQyXzExMA_5afcb4f0-53a4-42a2-b173-9369ddec5def">4</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjM5YTBmNGJmZDlkMDQxYTA4OTZkMWVlYzE2ZmMyNGQyXzE2NDkyNjc0NDE3ODc_acfdfc3d-59ba-40d0-aa93-572e0c3ac3ef">4</ix:nonFraction>, and $(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjM5YTBmNGJmZDlkMDQxYTA4OTZkMWVlYzE2ZmMyNGQyXzE2NDkyNjc0NDE3OTc_6d9b560f-8a69-4c74-8bcd-8fde62bb7785">10</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtMS0xLTEtMA_164d3497-23b1-4b35-a807-687aa7b610f0">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtMy0xLTEtMA_96e500f2-d3d0-4870-a2fd-bf8b6d56d8b1">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtNS0xLTEtMA_eb92376c-c569-4a47-9336-bd4c1a230562">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtNy0xLTEtMA_31ad2b57-ff4f-4049-b367-cdd726a236c1">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjA3YmRkMjZhZDRiZDRmMDVhMTc2ZjU0ZTA3NWQ0YmUxXzY4_d2edec0b-4cda-46fa-8e89-ff79eb1ec4eb">nil</ix:nonFraction>,  <ix:nonFraction unitRef="usd" contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjA3YmRkMjZhZDRiZDRmMDVhMTc2ZjU0ZTA3NWQ0YmUxXzc1_f1c6376e-7192-4e53-8f9f-79226888694c">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjA3YmRkMjZhZDRiZDRmMDVhMTc2ZjU0ZTA3NWQ0YmUxXzE2NDkyNjc0NDE3NDk_ae330c2a-5383-4347-9cb3-d1179472a323">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjA3YmRkMjZhZDRiZDRmMDVhMTc2ZjU0ZTA3NWQ0YmUxXzE2NDkyNjc0NDE3NjM_290d2e02-b858-4246-9448-d18bd426a824">nil</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItMS0xLTEtMA_3a8853c4-fdc1-4808-b002-27f45bd80463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItMy0xLTEtMA_3235fa55-b11c-4a2a-a761-f630cb0d8ab6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItNS0xLTEtMA_edb9f7b0-67c5-4b52-9700-7951e08801a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItNy0xLTEtMA_f3bcd4b1-0805-447a-9eb4-6e0ab1862541">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTMtMS0xLTEtMA_3b4000f3-8a2b-4599-892d-33d34322fc32">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTMtMy0xLTEtMA_277d6d16-a4f5-44aa-a215-3f451c3cb093">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTMtNS0xLTEtMA_f5b201de-27a6-43ca-b7e9-1fe8148f5c3d">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTMtNy0xLTEtMA_e4231525-84e8-435a-b444-637b289260e1">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain and prior service cost arising during the period, net of income tax benefit of <ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjAyNzZkZTkxZTRmNzQxNTM4MjRkZTBjNTI5ZWQzYjQzXzEwMw_7e560865-8837-4620-9f12-c4a70c868546">nil</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjAyNzZkZTkxZTRmNzQxNTM4MjRkZTBjNTI5ZWQzYjQzXzExMA_c9f98030-425e-4474-97c5-7410d669db47">2</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjAyNzZkZTkxZTRmNzQxNTM4MjRkZTBjNTI5ZWQzYjQzXzE2NDkyNjc0NDE4MDk_1e8bd678-f44c-445e-aa99-dbca5d08d4d8">nil</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjAyNzZkZTkxZTRmNzQxNTM4MjRkZTBjNTI5ZWQzYjQzXzE2NDkyNjc0NDE4MTk_f0dfcfe9-0bbe-4796-9524-b041e5817850">1</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iade843f75deb448186e6e38895fb48b7_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtMS0xLTEtMA_fc9f1774-7262-4d7a-825d-58d87170e7a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15202989514f4acf8e987ae99a0216ba_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtMy0xLTEtMA_d794be5a-5672-4843-8f56-df5206167fbd">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3646d4cbd2ad43c3b6da83e852552ca4_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtNS0xLTEtMA_47756b02-7ecc-4dd9-aac3-4d98b507bd37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cfff32ee6a14e168c5922d492015d9b_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtNy0xLTEtMA_d7c27f16-f53d-41a7-a5af-89e02faa26fc">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense of $<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODIwNDgxNGNlMTRhOTJhMWNhMWI0YjQ1YjQ4ZTAxXzExMg_02353ca5-1c76-47e0-a843-6491176c7e4a">1</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODIwNDgxNGNlMTRhOTJhMWNhMWI0YjQ1YjQ4ZTAxXzExOQ_a9da9214-fbbd-4956-a351-dff9a4739d1b">nil</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODIwNDgxNGNlMTRhOTJhMWNhMWI0YjQ1YjQ4ZTAxXzE2NDkyNjc0NDE4MDA_5df7d99e-d8e4-42e4-9764-c56ee7c197f9">1</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODIwNDgxNGNlMTRhOTJhMWNhMWI0YjQ1YjQ4ZTAxXzE2NDkyNjc0NDE4MTA_7b4a92a7-eebf-4d30-9a50-7bac2ebe0a42">nil</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfcb285fb6b4a5c8cbbe9bd79f0a497_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtMS0xLTEtMA_5740fc68-91cf-40eb-9d3b-d8e43ea29c58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93126ac576fd4ee59dbe2a22e4b7078f_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtMy0xLTEtMA_0d285c7e-8993-4b99-86af-618887bb72dc">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24e52575e1654c46a8f81e254c90ab96_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtNS0xLTEtMA_2dd14e2a-295a-492e-99f4-ab662ef64361">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c06ecc9cc7491180bd8fb5bd26438d_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtNy0xLTEtMA_17d5c675-2970-4193-af63-dc9dd7d42135">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjRmMGJkM2E4YzJhYTRiYzRhOTc4NDVlMWM3YTg3NGEzXzg2_fb146b74-dd36-4022-84fc-14eeb22cf252">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjRmMGJkM2E4YzJhYTRiYzRhOTc4NDVlMWM3YTg3NGEzXzkz_44f45569-45d2-41ab-a65c-1b64f597b6b4">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjRmMGJkM2E4YzJhYTRiYzRhOTc4NDVlMWM3YTg3NGEzXzE2NDkyNjc0NDE3NzA_30cfa976-8fe0-4c9d-a681-6e583770f243">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjRmMGJkM2E4YzJhYTRiYzRhOTc4NDVlMWM3YTg3NGEzXzE2NDkyNjc0NDE3ODA_d05aea18-fa29-4e8e-a53d-92dd51911e5d">nil</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i081813b992464ea9ad8920cab184e999_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctMS0xLTEtMA_2dcc3b78-b3e3-44d5-9cc4-b05289bf2815">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2801f5e86df94d55bd75e10e15bf4d5b_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctMy0xLTEtMA_34e23ad2-eb48-46a5-b94d-e944af34c827">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d3a810191074649bfd35939eee1cfc4_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctNS0xLTEtMA_b98729bf-5885-44e5-b76c-be7628f4e1ab">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b41db262baa42ac85b207a7a3c6851b_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctNy0xLTEtMA_6c7374a5-aaa0-4f6a-a4dc-c17badfcf78b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="ie7ed596faccb4197854f21d92b8137b6_D20200701-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjhlODM0N2QyYTVhNjQxZTdhODhmZDZkYTBlZGIwMDZlXzY4_c8e1b37e-9a88-451c-8d00-1d80e45fed69">nil</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i364845bbc169420e8195d9305f9f4c1a_D20190701-20190930" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjhlODM0N2QyYTVhNjQxZTdhODhmZDZkYTBlZGIwMDZlXzc1_56abb99b-0855-4e53-b109-0059d39ef330">27</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i9bd48cde79e84ac4a46f6744e674f4ab_D20200401-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjhlODM0N2QyYTVhNjQxZTdhODhmZDZkYTBlZGIwMDZlXzE2NDkyNjc0NDE3NTY_26bdcce7-02b6-4d0c-9d2a-e1186aaa0b06">nil</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i8de456c9de55433dac6af26e743f73cd_D20190401-20190930" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjhlODM0N2QyYTVhNjQxZTdhODhmZDZkYTBlZGIwMDZlXzE2NDkyNjc0NDE3NjY_ba686e32-f38c-4d49-92f2-b3add74ab19e">32</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7ed596faccb4197854f21d92b8137b6_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtMS0xLTEtMA_feae9850-6928-4159-a275-1a66f28b8f45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364845bbc169420e8195d9305f9f4c1a_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtMy0xLTEtMA_4f082bcf-f9e9-4a84-81ff-d839c848d081">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bd48cde79e84ac4a46f6744e674f4ab_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtNS0xLTEtMA_870b17d6-c216-44d7-8f3d-bd1af26d93d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8de456c9de55433dac6af26e743f73cd_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtNy0xLTEtMA_59bf94e4-97f2-424e-afa1-47b82a4c3971">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7ed596faccb4197854f21d92b8137b6_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTktMS0xLTEtMA_78195e8d-12c4-441f-b756-9324beb51ac1">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364845bbc169420e8195d9305f9f4c1a_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTktMy0xLTEtMA_8850c9b0-b875-4fb9-9722-bc1240094751">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bd48cde79e84ac4a46f6744e674f4ab_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTktNS0xLTEtMA_e31ad071-6102-4677-9eda-0db671539527">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8de456c9de55433dac6af26e743f73cd_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTktNy0xLTEtMA_30a3f033-cfa2-4066-b548-0a69c008a2b3">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMjEtMS0xLTEtMA_770f7a80-c83d-4471-b970-d0f04f68d9f5">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMjEtMy0xLTEtMA_8d6922ed-ba40-4262-91c8-29446b888a58">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMjEtNS0xLTEtMA_e5134b6a-e6a4-40f5-b65d-b5aad8619c68">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMjEtNy0xLTEtMA_60b34af4-d131-4bbe-906e-7b785bc737fa">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the three and six months ended September 30, 2020, the net foreign currency translation adjustments were primarily due to the strengthening of the Canadian dollar and Euro against the U.S. dollar from April 1, 2020 to September 30, 2020. During the three and six months ended September 30, 2019, the net foreign currency translation adjustments were primarily due to the weakening of the Euro and British pound sterling against the U.S. dollar from April 1, 2019 to September 30, 2019. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and six months ended September 30, 2020 includes net foreign currency translation adjustments of $<ix:nonFraction unitRef="usd" contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjI2MA_77c69acb-3568-41ab-aa93-21a90112912f">119</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NTg0MQ_273322e0-9f03-4aa4-93c3-3459e0be934e">61</ix:nonFraction> million, respectively, and the three and six months ended September 30, 2019 includes net foreign currency translation adjustments of $<ix:nonFraction unitRef="usd" contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjM0MA_bb1bab95-8f97-4a96-8281-15bfe99c5827">19</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NTk1NA_a254a7ed-39a8-46c8-980b-a64641f47df1">13</ix:nonFraction> million, respectively, attributable to redeemable noncontrolling interests. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and six months ended September 30, 2020 includes foreign currency losses of $<ix:nonFraction unitRef="usd" contextRef="i28545f9d3bda45efaa5277b002e22e7a_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjQ1NA_8764417e-89bf-4c2a-9b7b-cee5ae445ecb">83</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i11351bf2991743d7af90b551540fc919_D20200401-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NjA0OA_72802e29-e007-4dbb-980c-133ea7d1bb46">117</ix:nonFraction> million, respectively, on the net investment hedges from the &#8364;<ix:nonFraction unitRef="eur" contextRef="idf0d0beda4f94c1c95f3735c727aaa99_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjQ5NQ_b28ef460-d179-402c-9270-f4e5d5fb3b11"><ix:nonFraction unitRef="eur" contextRef="iefe68917b64346948a4da9e249ab34f7_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjQ5NQ_f3d39168-88fd-4ac5-b471-b30e546ad3ca">1.7</ix:nonFraction></ix:nonFraction> billion&#160;Euro-denominated notes and &#163;<ix:nonFraction unitRef="gbp" contextRef="i71ac51620ddf48c0a43eb177d2b8787c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjUyNQ_59376cd6-6cc9-4be3-8141-2f51d6a9d636">450</ix:nonFraction> million&#160;British pound sterling-denominated notes, losses of $<ix:nonFraction unitRef="usd" contextRef="i845cf95a4c8a421fafec2976a240ff82_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjU4Mw_0ce2d3c3-dc3c-43e4-ad52-90ec2878aff4">12</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8df2eff3ed674556a1b6d76ac1e2fc2b_D20200401-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NjA4Ng_8b2b098f-fa67-4ff2-bec6-48f548b76d19">63</ix:nonFraction> million, respectively, on the net investment hedges from cross-currency swaps, and losses on net investment hedges of $<ix:nonFraction unitRef="usd" contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTA0NDUzNjA0NzczMjY_4ee391cc-d0da-4bf9-939f-79db68deda32"><ix:nonFraction unitRef="usd" contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTA0NDUzNjA0NzczMjY_cce21275-4660-456d-b597-5377558c48a0">1</ix:nonFraction></ix:nonFraction> million attributable to redeemable noncontrolling interests. The three and six months ended September 30, 2019 include foreign currency gains of $<ix:nonFraction unitRef="usd" contextRef="ib49781b522ea4f76b1513c0e998abcab_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjcwMA_5ce177cf-8b18-45a0-a6b1-807d5faf126a">91</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if8234a3e5eda4043b4d3fa3510856378_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NjE2Ng_3e6016e9-093e-4183-96f5-df8709014d17">67</ix:nonFraction> million, respectively, on the net investment hedges from the &#8364;<ix:nonFraction unitRef="eur" contextRef="i8566f25837414d39ba7f2dfa91ef0a42_I20190930" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjc0MQ_8647347d-3bcf-40f2-b05b-ed15a689a82b">1.95</ix:nonFraction> billion Euro-denominated notes and&#160;&#163;<ix:nonFraction unitRef="gbp" contextRef="i88ca01400a5e4f17a31f7e6a13628bec_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjc3MQ_1e5d6f94-4134-4a0d-8a95-9a298c3de7db">450</ix:nonFraction> million British pound sterling-denominated notes and gains of $<ix:nonFraction unitRef="usd" contextRef="ib993ed38bcaa44e992d425b235b667ba_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjgyOQ_c5c17e67-e157-4cc2-84ac-b87284cb00f1">20</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icdb08454a4384d82896df1a6d61f11f9_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NjE4NQ_4b967f25-633f-4f5f-aee6-88497c24fc5f">9</ix:nonFraction> million, respectively, on the net investment hedges from cross-currency swaps. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i9987666c5dc84137a102584e2d5f1927" continuedAt="i6c67a4bcca5748638d4bbdaf010af1a1"><ix:continuation id="ia50fdb38bfe34e5fbbe796c352fbf656"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and six months ended September 30, 2020 include net actuarial losses of $<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjk1MA_2c0706a7-1267-4ee6-aa59-c1a249914d38">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NjMxMg_3eb0c108-9b37-4af3-8afc-cb24c884eaa0">2</ix:nonFraction> million, respectively, and the three and six months ended September 30, 2019 include net actuarial gains of $<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjk1Nw_1eaa7f53-e6af-4c6f-a2f9-ea6bb4c33dae"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjk1Nw_415b1eac-7541-4b37-a1c7-c7b0176e1bf8">1</ix:nonFraction></ix:nonFraction> million, which are attributable to redeemable noncontrolling interests.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Pre-tax amount was reclassified into Cost of sales and Operating expenses in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into Income tax benefit (expense) in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and six months ended September 30, 2019 primarily reflects a reclassification of a pension settlement charge from Accumulated other comprehensive loss to Other income (expense), net in the Condensed Consolidated Statement of Operations.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss) </span></div><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0MjE5ODM_cc1bfb65-a0ec-4d87-9f18-c403a51ba7a7" continuedAt="i1ca1c4ac3e5542089d6057bea4556476" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three and six months ended September 30, 2020 are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08d04048582a441a9829e7d02b02b64f_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMi0xLTEtMS0w_c8c477bd-5f5a-4dbc-b67b-5da030637ff3">1,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafe0cb7d5ecb4f14bdcf107625ab76a4_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMi0zLTEtMS0w_53ed527c-f3e7-4773-baea-1cef6602c61f">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3642cd678a64ba1b231726d09a37604_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMi01LTEtMS0w_ec9ed395-f706-4716-825f-80f88760c372">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4cc9f5f8d11498da1ed9306dc8d7f7f_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMi03LTEtMS0w_9c3f6ea8-91dd-47bb-ae13-af671b8308e0">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib14ebdd9a67d42c6bff9fab1cd0291e3_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMi05LTEtMS0w_b9531010-63ed-4410-977c-6833e5e9dce0">1,735</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMy0xLTEtMS0w_33e08c6c-6e1d-4e36-885f-733f9f38f32f">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMy0zLTEtMS0w_0d63dd08-871b-44e1-9862-30ee1bda4f31">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMy01LTEtMS0w_ab7197b8-eace-4551-baf4-f79872d91e02">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2530e99848e4b36ba92e924f579d9df_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMy03LTEtMS0w_665f69d3-a2ef-42c8-a7b4-6f1db66406f5">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMy05LTEtMS0w_3ab3bd88-04ce-4af4-99c9-793c6380eb23">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNC0xLTEtMS0w_887a8444-5035-4719-8cd7-86e16a512424">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNC0zLTEtMS0w_18f23f1d-3a94-4e6e-b070-ec43f6ef6d4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNC01LTEtMS0w_cc59b1e6-3e15-4801-94d7-babe370f33cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2530e99848e4b36ba92e924f579d9df_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNC03LTEtMS0w_1b5fa0b4-a9cc-41fd-8f33-954c483acb18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNC05LTEtMS0w_cbb4eb6a-aaa7-458a-adb9-ae641dc5e775">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNS0xLTEtMS0w_06c62631-af5d-4b17-bee6-5e46eb4b02c2">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNS0zLTEtMS0w_d99f7e18-0a91-4dcd-a7eb-d8b320532ec5">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNS01LTEtMS0w_bf0a899c-ef2b-48d1-813d-a6dd0a33eb2e">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2530e99848e4b36ba92e924f579d9df_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNS03LTEtMS0w_5a7d9727-fd9c-4396-b21f-51d882108f29">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNS05LTEtMS0w_957cbac4-ff1b-4288-80b2-26d459749cc3">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNi0xLTEtMS0w_829cd636-c2fe-492d-bc64-2d6140c1064a">119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNi0zLTEtMS0w_5b46123a-2d55-4e15-9c68-ee6536b5d3f4">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNi01LTEtMS0w_19cde402-5e02-4274-9ef2-0d5beb2d4acc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2530e99848e4b36ba92e924f579d9df_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNi03LTEtMS0w_93c27987-02cb-4c59-9dd2-2540bb8159b3">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNi05LTEtMS0w_fb4c69d6-91c0-4722-b64b-e892640fcc73">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNy0xLTEtMS0w_415262ec-af5a-4cfc-bc5d-e4de4842448d">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNy0zLTEtMS0w_615745c1-8710-458e-96d3-59ac1cdee763">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNy01LTEtMS0w_03765481-f5b7-4142-9ac2-4793abf31541">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2530e99848e4b36ba92e924f579d9df_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNy03LTEtMS0w_8ea1fd73-29d8-4575-a3de-643a54fd8694">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNy05LTEtMS0w_b5f5f347-480d-48e6-9020-75f78ec3ca5b">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i785fd2b4e9024f8ea22b4baf93fe610a_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfOC0xLTEtMS0w_f65b53f2-3c5c-4e4b-b4bb-4f3337a98b4e">1,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c6aa5965ffb4e8b8ddd05a70b872808_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfOC0zLTEtMS0w_4f4546f4-0a8a-4f19-94f3-494c6b80af9e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6a19d8b0fe745be9ff1c9a795dfd0bb_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfOC01LTEtMS0w_7520cffb-e115-4d27-a931-cd3b1daca214">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d90c4a197c4d62b7688640c6c181c2_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfOC03LTEtMS0w_53e87fdc-33b3-4950-83f2-918b5f899f92">116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id56ecd8e059f4e6696b7b1cc7c7988e4_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfOC05LTEtMS0w_75cc56f4-0bbd-4ec9-aff5-e2ded235ea64">1,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584b4e2274074d37aba8cd24589cb580_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMi0xLTEtMS0xODQ2_65e9d95f-21b9-4e2e-935b-6da29f641f84">1,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i666e4b283dc645e7900ef3d3a1d91aac_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMi0zLTEtMS0xODQ2_0e7a571f-9d8c-4cfb-bdd3-81f125a33022">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i560a87a2893946699ede55eeca7bfd22_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMi01LTEtMS0xODQ2_a8046207-2c93-418f-9ec4-2244ad1f4256">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ea0dc529a904ec9a931482f59d28dd8_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMi03LTEtMS0xODQ2_f2160d10-35d2-4a25-8cf9-7bc56de520f8">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c61eeba8b38459f985453da0e8c781d_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMi05LTEtMS0xODQ2_65679ff3-7f9e-49e9-bf31-170c4051d40e">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMy0xLTEtMS0xODU3_8649bf30-2226-40d8-9b79-aa8f36930b17">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMy0zLTEtMS0xODU3_eebef5e5-3fe5-46bd-889f-a4bbed79e5a4">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMy01LTEtMS0xODU3_3f6937c1-0c27-4be3-8a85-5a2bd363e4c7">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0604a8575de4a9396ed7d28ed0294c7_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMy03LTEtMS0xODU3_789e24b4-66f2-4104-9aad-742e7b4145fc">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMy05LTEtMS0xODU3_9a85f9c6-a21c-46fd-babe-3a7473e62e67">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNC0xLTEtMS0xODQ2_f4c57f15-1d0b-444c-a9c7-28aff7537d34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNC0zLTEtMS0xODQ2_58a3a392-176e-49e5-ad47-4d9cc64a9a6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNC01LTEtMS0xODQ2_c14da902-9810-49db-b8ee-4494a7aad297">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0604a8575de4a9396ed7d28ed0294c7_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNC03LTEtMS0xODQ2_cb6f3eee-8952-4236-b441-2315c1e9720c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNC05LTEtMS0xODQ2_022b69f7-c618-489b-a81f-dfd501ab7a89">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNS0xLTEtMS0xODQ2_140bd34d-7d82-44a4-9548-0f07299141b7">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNS0zLTEtMS0xODQ2_264143cc-371d-477c-bf2a-545c265b2497">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNS01LTEtMS0xODQ2_5713cf4d-6084-4137-a89c-7b201d47a07d">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0604a8575de4a9396ed7d28ed0294c7_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNS03LTEtMS0xODQ2_83ec7fa8-723a-471d-82ca-b6af53350543">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNS05LTEtMS0xODQ2_d30273c6-8733-4f5d-8ace-6e42810b053f">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNi0xLTEtMS0xODQ2_7f1293d5-48c4-4d1e-bc86-e77959a4aa99">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNi0zLTEtMS0xODQ2_0637410d-4a04-4260-9bd5-34594ce6d56f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNi01LTEtMS0xODQ2_5ad9e91f-3517-4ace-b28a-6c100527dc43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0604a8575de4a9396ed7d28ed0294c7_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNi03LTEtMS0xODQ2_d05daf01-29d9-422c-8bb1-048059d6575c">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNi05LTEtMS0xODQ2_5aa9bf02-2924-457c-b70a-bcd0e33a85cd">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNy0xLTEtMS0xODQ2_abac7c49-19f1-4fa2-b9e4-376497f8f7fa">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNy0zLTEtMS0xODQ2_ddd4a147-7a4e-42c0-bfb6-3b73ce676ee4">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNy01LTEtMS0xODQ2_3a3c2dd0-df86-42d7-b50b-86e0265f106a">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0604a8575de4a9396ed7d28ed0294c7_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNy03LTEtMS0xODQ2_e592cad6-53d0-484c-8d65-d5ec4cfbba0b">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNy05LTEtMS0xODQ2_a8198364-262a-4f96-8496-0c7d491da6e6">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i785fd2b4e9024f8ea22b4baf93fe610a_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfOC0xLTEtMS0xODQ2_d04c3b87-0a40-48ea-bb4b-3f42a346e2c3">1,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c6aa5965ffb4e8b8ddd05a70b872808_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfOC0zLTEtMS0xODQ2_ba95b1d3-6f51-4743-8355-cb4665fa4e19">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6a19d8b0fe745be9ff1c9a795dfd0bb_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfOC01LTEtMS0xODQ2_40e4acdb-fd8e-45e4-93d2-b6e3202bf506">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d90c4a197c4d62b7688640c6c181c2_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfOC03LTEtMS0xODQ2_d296670b-5bbb-47bf-8917-c39cc05727cd">116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id56ecd8e059f4e6696b7b1cc7c7988e4_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfOC05LTEtMS0xODQ2_2ab69630-1655-46b6-8f8f-a7145c6bf701">1,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i6c67a4bcca5748638d4bbdaf010af1a1"><ix:continuation id="i1ca1c4ac3e5542089d6057bea4556476"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three and six months ended September 30, 2019 are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i152a0a34c50a4f5b95780eafe02e0ea9_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMi0xLTEtMS0w_7ff6a93a-33d2-404f-bbe4-f05406d1e2cd">1,564</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de1a24b580146c49c37a4942dd6c16c_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMi0zLTEtMS0w_db8f76ed-f55f-4bd7-9bec-6f2969825d30">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id36e3e6db92b4ddd84ae2a9af1d43fd3_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMi01LTEtMS0w_ba530e5c-4806-4156-8218-cae609cb8793">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bdc606394464f49b8531ade9f76854b_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMi03LTEtMS0w_04353e3f-f292-42fe-a8e5-5b6dc89ea7fe">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i527d69e72eba46ae8d65ce3a0001cecc_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMi05LTEtMS0w_0dac3002-cb0f-4d5a-9a87-62036a137e4e">1,778</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMy0xLTEtMS0w_99e677d1-2a12-4079-a7bc-f753e65c84a7">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMy0zLTEtMS0w_0e0629d1-ef00-44e6-84e3-9ca278519c3d">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMy01LTEtMS0w_8fc28eb4-930b-4110-a074-cfbc2017b7db">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a725751bc8343cdbc4cd04f87ce1ad6_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMy03LTEtMS0w_8fe63962-db48-4a68-a7d2-21b99262a7f0">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMy05LTEtMS0w_6dcfc84f-680c-4d8e-a714-1e8a6181cc88">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNC0xLTEtMS0w_31393217-9765-4a12-a9b9-6c797efe3ea6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNC0zLTEtMS0w_4337f5ca-94d4-42e7-af67-d5dacf9a5333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNC01LTEtMS0w_073a84dd-13f9-455f-904c-b46e2747b679">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a725751bc8343cdbc4cd04f87ce1ad6_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNC03LTEtMS0w_4c7e3750-102b-4e52-94ff-5a17db78b16f">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNC05LTEtMS0w_7349f8fe-c29c-4866-b833-b630416884a9">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNS0xLTEtMS0w_24abcfaa-2a27-434f-9bb7-a3d00e8c15c3">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNS0zLTEtMS0w_328d438f-28e4-45cb-bd91-c0718cb73d59">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNS01LTEtMS0w_760c9f96-3e99-4999-8e37-7dc446a1e3dc">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a725751bc8343cdbc4cd04f87ce1ad6_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNS03LTEtMS0w_e3afeceb-55ff-472c-bf5b-ae0b5dc08632">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNS05LTEtMS0w_3bd6fc97-2344-48fa-a018-ed3ae35aa7d9">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNi0xLTEtMS0w_00742fcb-5178-445a-aacd-ac6e2357c2ec">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNi0zLTEtMS0w_c4ddfe3d-1c2c-4855-8a0e-4d2f17571210">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNi01LTEtMS0w_aefac24b-080a-4ffd-b134-c39f27e2ac43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a725751bc8343cdbc4cd04f87ce1ad6_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNi03LTEtMS0w_463144ec-e760-4988-8d52-4f21fc6a4302">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNi05LTEtMS0w_7f09240b-e979-4c5b-84b0-e99214d6b9a6">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNy0xLTEtMS0w_1383af74-6fdc-451e-92f7-e5cbc6a5d1e4">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNy0zLTEtMS0w_13280d11-a0dc-43c3-80bb-f5435d28bb82">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNy01LTEtMS0w_fe663b9c-3d64-4b12-828d-ee1d2e59c01b">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a725751bc8343cdbc4cd04f87ce1ad6_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNy03LTEtMS0w_e7007f66-49a9-4594-90fe-585e195876fd">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNy05LTEtMS0w_e853feab-6445-4d8e-aeb4-59fa49642f90">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2019</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14767a5727ac4417a8c16be22209e0bf_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfOC0xLTEtMS0w_431aa850-1233-4b32-9d6c-fb8417efea96">1,659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0aa1d9903934d4bb44c6053ee11ca01_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfOC0zLTEtMS0w_a596bf48-1c6b-48d5-be4e-bd75e8bb979d">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f028c579ca84ba1a3fdffbd5ad2731a_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfOC01LTEtMS0w_11258a7e-1a9f-4aba-8f35-19e400fe4d78">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4471500f1af84287bc5e2719e750de11_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfOC03LTEtMS0w_f9959b95-a9c5-4870-bcb0-fbe241691fea">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1d225eb50904ac7afd16a3e52e96014_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfOC05LTEtMS0w_d7bcca02-40da-491b-9976-4236c00e8e49">1,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64bc67d401ba41cd98cdc8120660d0ca_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMi0xLTEtMS0xODg1_7b565862-4a38-4b37-ae84-9b1fc4ea0e86">1,628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4759dae41f41e98b79f41976fa69ca_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMi0zLTEtMS0xODg1_2d2debd4-ba33-4984-8055-4fcc2890f510">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e7e3d6a2fc24aba8fe36b60b9a70d8e_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMi01LTEtMS0xODg1_551e294f-3177-4ca2-89f4-994a6abcc5e2">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10878ad786c14616809f16456682cb91_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMi03LTEtMS0xODg1_2b800e20-0d7d-4b82-b999-c2c7ccf9abca">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0532330a51214e249b3b9e2fbc5ebee3_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMi05LTEtMS0xODg1_0025e7a6-00e9-4eba-82ac-437f96453f30">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMy0xLTEtMS0xODg5_0a85291e-cab8-46ea-85ea-e72db12e6976">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMy0zLTEtMS0xODg5_c1b71818-3dca-492b-9f8f-28dc66fde603">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMy01LTEtMS0xODg5_edd0e3a8-8429-4bf8-a392-05f2f9eded02">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47b46bdea51b4a518badab77507f0e56_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMy03LTEtMS0xODg5_c61802e5-5c0f-444d-af64-646f26dfe206">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMy05LTEtMS0xODg5_e018cab1-b9b6-4386-9cda-f91c23cb430a">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNC0xLTEtMS0xODg5_dff5eb0c-de01-4d89-8c80-618a37554f28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNC0zLTEtMS0xODg5_f66810e4-52f6-4ee0-b483-c5b93f156a85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNC01LTEtMS0xODg5_c090f8c7-4784-4fca-b2d2-ec5cb1b56713">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47b46bdea51b4a518badab77507f0e56_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNC03LTEtMS0xODg5_546ce3eb-f8e6-4ba5-9873-9f649e149643">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNC05LTEtMS0xODg5_f9f63e4a-5614-46f2-b040-cb95c95be07e">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNS0xLTEtMS0xODg5_862c168a-2677-4677-8f25-a301fbde3bfd">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNS0zLTEtMS0xODg5_e77b4ef7-54c6-47fb-85bc-92d0543ce043">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNS01LTEtMS0xODg5_8b0226f0-bb8c-4dc8-96ef-56707f0edfc9">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47b46bdea51b4a518badab77507f0e56_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNS03LTEtMS0xODg5_d0a0d8f6-8761-46e2-8055-f216c7f5ce47">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNS05LTEtMS0xODg5_f5d39b5d-1062-4150-bbf3-fba8164bfacd">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNi0xLTEtMS0xODkz_9b67639f-6938-4b30-8cdb-f47c2f851ed2">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNi0zLTEtMS0xODkz_d37bc01b-fe80-472a-be37-05e079cd4792">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNi01LTEtMS0xODkz_7bffc449-f786-4af8-baea-2be3a9b31566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47b46bdea51b4a518badab77507f0e56_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNi03LTEtMS0xODkz_a9748e58-6c9a-4734-88cc-4ba2c13479fa">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNi05LTEtMS0xODkz_f5a4ed70-c9c6-4c55-84c1-a1148d3c507d">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNy0xLTEtMS0xODkz_c8d53613-7dce-4a9c-b7c6-127e31e9d578">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNy0zLTEtMS0xODkz_436368ff-1b9f-49c3-93dc-28327fd85baf">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNy01LTEtMS0xODkz_ac8de551-1960-4531-9dd1-d5b9fa18e4d5">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47b46bdea51b4a518badab77507f0e56_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNy03LTEtMS0xODkz_71fc91fe-2d48-4fcb-8384-e04739c849e8">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNy05LTEtMS0xODkz_b932dbb3-a284-4579-b841-4b000efcd11a">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2019</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14767a5727ac4417a8c16be22209e0bf_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfOC0xLTEtMS0xODkz_58daa8bb-b886-4a26-9acd-1ce20ead16b8">1,659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0aa1d9903934d4bb44c6053ee11ca01_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfOC0zLTEtMS0xODkz_f619eaaa-cb17-4c91-9579-2a04c14990a4">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f028c579ca84ba1a3fdffbd5ad2731a_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfOC01LTEtMS0xODkz_35352f9c-a2e4-453b-8200-ddcd2554851e">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4471500f1af84287bc5e2719e750de11_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfOC03LTEtMS0xODkz_7a57c84a-71ba-4d96-a1c5-33423168c5ff">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1d225eb50904ac7afd16a3e52e96014_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfOC05LTEtMS0xODkz_c079d110-628e-4822-84a7-8ba754fcb759">1,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTU5NDI5MTg2NjEyNjY_70b160de-9c70-4585-ba4a-3acf61050c60" continuedAt="id3eda4af2dde407398a3d91ddcea45b2" escape="true">Segments of Business</ix:nonNumeric></span></div><ix:continuation id="id3eda4af2dde407398a3d91ddcea45b2" continuedAt="i2d4a61c8a50643369307759e32c1a681"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing in the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in <ix:nonFraction unitRef="numberofsegments" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTY0OTI2NzQ2NTA3MQ_95f1a299-f360-4a6c-9603-c86ef724affd">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. Other, for retrospective periods presented, consists of the Company&#8217;s equity method investment in Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020. All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in <ix:nonFraction unitRef="country" contextRef="ifd8554d6b3ce4907859a8adc5bfd5199_I20200930" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTY0OTI2NzQ2NTAzOQ_3c4bf9ce-49fc-4c53-b4cc-0161b6d2d077">13</ix:nonFraction> European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology services throughout Canada and includes Rexall Health retail pharmacies. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than <ix:nonFraction unitRef="numberofproducts" contextRef="i6cc04539515847199daba415d910a6b7_I20200930" decimals="-3" format="ixt:numdotdecimal" name="mck:NumberOfNationalBrandMedicalSurgicalProducts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTY0OTI2NzQ0NjIyMjc_3a2576f0-726d-409e-9084-b9bbe0a81968">275,000</ix:nonFraction> national brand medical-surgical products as well as McKesson&#8217;s own line of products through a network of distribution centers within the United States.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment brings together existing businesses, including CoverMyMeds, RelayHealth, RxCrossroads, and High Volume Solutions, to serve the Company&#8217;s biopharma and life sciences partners and patients, connecting pharmacies, providers, payers, and biopharma. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and High Volume Solutions were previously included in Other.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, for retrospective periods presented consists of the Company&#8217;s investment in the Change Healthcare JV, which was split-off from the Company in the fourth quarter of 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONCLUDED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i2d4a61c8a50643369307759e32c1a681"><ix:nonNumeric contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfNDMyNQ_34ba05cf-c275-4ab4-ab0e-d00b7570e4b1" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia003613bb8bc483286b8644efc98f668_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMy0xLTEtMS0w_aee63850-d66b-4d8d-b32b-b9c0ae257ec0">48,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMy0zLTEtMS0w_e292439b-3590-4dcf-8c8e-292c90fd3710">45,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMy01LTEtMS0w_23419cc2-d3ef-4e1a-8fb9-8cf75cae755a">92,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMy03LTEtMS0w_aaa1486f-8c7f-44e5-b574-2975d94514b4">89,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNC0xLTEtMS0w_4686e091-783d-47b1-ab84-b1698e238440">9,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNC0zLTEtMS0w_c24d05ca-c760-4d66-881e-c76b9b43d851">9,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNC01LTEtMS0w_599a384a-a1b8-4584-a95e-78b58674296d">18,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNC03LTEtMS0w_28c56ceb-9cfb-46ff-8423-6914088e2e74">18,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNS0xLTEtMS0w_aed51f48-24c3-410b-881e-210125066bd4">2,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNS0zLTEtMS0w_81c9270f-df72-4a7b-aea6-b23d4245768c">2,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNS01LTEtMS0w_491a957f-4af1-4903-9b1a-1e56e196ab2e">4,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNS03LTEtMS0w_56071ea5-a51e-4427-9773-4d22320b6080">3,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNi0xLTEtMS00NzA2_0c3dc3c3-8637-4455-9294-0fdf0266bb82">668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNi0zLTEtMS00NzE3_8d5c0dfc-9e45-4b4b-b14b-8d7905ec92c9">626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNi01LTEtMS00NzI0_3886c3a6-3504-40d9-922f-3bd406eb8c46">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNi03LTEtMS00NzI4_e70eddaa-37f3-4b72-8c55-4a52b3649119">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNy0xLTEtMS0w_e5c80e51-380d-4d9c-831e-704e17fa28c0">60,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNy0zLTEtMS0w_6ad16e3c-acb9-411e-bb1c-088a691eba35">57,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNy01LTEtMS0w_7f0e1707-421e-42f4-9a78-996a121470fe">116,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNy03LTEtMS0w_44a693b1-d89e-49db-be65-89f05fd9b116">113,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia003613bb8bc483286b8644efc98f668_D20200701-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTAtMS0xLTEtMA_fd3adfbe-d736-45c6-b294-4ed0d64b2db5">623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTAtMy0xLTEtMA_fa9c09db-f47f-43fc-8185-7d7fa7d80753">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTAtNS0xLTEtMA_f11eeb4e-3c0d-4390-83db-70ea1e3769ef">1,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTAtNy0xLTEtMA_f1f8c5da-f617-41ef-bf6b-5c9dddfd18a8">1,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTEtMS0xLTEtMA_85e7ab0d-524c-4978-914e-d8940a782173">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTEtMy0xLTEtMA_0e271c99-ee5a-4469-9a90-850bd7c57fe5">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTEtNS0xLTEtMA_d0d3bd3d-692e-4999-9a5e-e69407e1f080">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTEtNy0xLTEtMA_88cccb7f-6d2a-4e7d-8996-5d56f722f304">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTItMS0xLTEtMA_df1e1349-9a2e-445c-8242-4da85205050a">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTItMy0xLTEtMA_e7f95505-2aa8-46cc-8a72-648c9347bd92">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTItNS0xLTEtMA_8499e4e8-674b-4105-b335-af6db04b0554">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTItNy0xLTEtMA_056b911a-0f6f-42c1-b0e6-9d558664db5d">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtMS0xLTEtNDczNQ_976fd668-c172-44b3-8e66-624260e2450b">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtMy0xLTEtNDc0MA_dc14eb7f-88fb-46b2-b98a-911feebb20ee">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtNS0xLTEtNDc0NQ_46d9d40b-dd14-45f4-9ee9-6b2754d44db6">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtNy0xLTEtNDc1MA_15be923d-c267-438a-ac18-01b6c2878259">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e5cc6dcf7146199a2f75c2b2ffa8af_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTMtMS0xLTEtMA_d8abe5ea-52f7-47cc-aee0-a83ffc7ab9ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ee29e972613498aa1e93fe830d2eb8e_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTMtMy0xLTEtMA_6b62639d-1f53-415f-be5d-804e3f927a84">1,454</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTMtNS0xLTEtMA_c0c4a096-7fe8-4f09-8108-58a320a71786">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7c1d98305344009a39b536f04f12c9e_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTMtNy0xLTEtMA_cca8893d-0c50-43f7-969a-b850c7a0ff36">1,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3e327dccb0243cd8c395cc18f592326_D20200701-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtMS0xLTEtMA_c03d8616-9a3d-4217-a746-3d382c0da5d4">853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5842c602b5a9464db55d6b8a5ea2fef9_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtMy0xLTEtMA_a285b6fb-1f13-4067-bee1-5f891e5b5836">556</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e816dd3ea9489cb878840d51f8df47_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtNS0xLTEtMA_7f770858-bb3b-42dd-9f48-f94400a2d017">1,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fed2bcc3c3b42febd8b01ce2735ad1d_D20190401-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtNy0xLTEtMA_3742b4ad-da06-4f88-a7ca-d7a9838222a7">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTUtMS0xLTEtMA_89276e97-2693-494c-8ce7-6aea9993750b">148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTUtMy0xLTEtMA_2208a5c4-94cf-4cd9-bd22-37eee6afa98c">350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTUtNS0xLTEtMA_b48e87f4-e83e-47df-b5f8-f76dafe338c2">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTUtNy0xLTEtMA_813d619d-192b-4e70-a22f-5b283376d9bd">511</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTYtMS0xLTEtMA_95f4b909-3a71-4cdb-8d60-b3371e0e3a97">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTYtMy0xLTEtMA_1447ca6a-c847-4560-b96c-9e04ef0d6efa">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTYtNS0xLTEtMA_18cbb5f7-9137-4c13-bc7d-e43237dabf38">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTYtNy0xLTEtMA_6afd0e5d-2a22-4cf2-ad51-1fecc927807a">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTctMS0xLTEtMA_7c4efaae-b6b3-47df-8617-8d973244842a">655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTctMy0xLTEtMA_884b14d3-6b0e-4ff5-a422-e03c02143704">970</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTctNS0xLTEtMA_85a91115-6e0d-4954-9689-a125ee9a1c1d">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTctNy0xLTEtMA_6ad3cb15-141a-424e-b820-3f4b2fbdc33a">351</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than <ix:nonFraction unitRef="number" contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjE0Nw_6f665427-731a-433e-b288-dd0ecccae2e7"><ix:nonFraction unitRef="number" contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjE0Nw_c1f72037-fa84-4de6-8f0f-ff2818ec2543">1</ix:nonFraction></ix:nonFraction>% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjI0Nw_118e1247-d6dd-4864-ac26-c283054151e9"><ix:nonFraction unitRef="number" contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjI0Nw_f228f5ff-71e9-4a8a-bc75-b206a83ba0f0">6</ix:nonFraction></ix:nonFraction>% of the International segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjM0MQ_545867bf-a09c-43dd-9a2e-bc0ad2287d7f"><ix:nonFraction unitRef="number" contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjM0MQ_992b8a2d-5a5e-4a0d-8b4a-9e5b48fd9fab">2</ix:nonFraction></ix:nonFraction>% of the Medical-Surgical Solutions segment&#8217;s total revenues, and approximately <ix:nonFraction unitRef="number" contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2MTk_1f7a2a0c-5234-4e21-a72b-5c5bf75e7fe8"><ix:nonFraction unitRef="number" contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2MTk_84100eee-8fe2-45e4-92e1-b96431353dd7">40</ix:nonFraction></ix:nonFraction>% of the RxTS segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining <ix:nonFraction unitRef="numberofsegments" contextRef="ida57532d2ac84b80a31ba148be33330e_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTUzOTMxNjI4NDczNzQ_45f01839-762e-4d3a-b260-49b00197f94f">three</ix:nonFraction> reportable segments are domestic.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#8217;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three and six months ended September 30, 2020 includes $<ix:nonFraction unitRef="usd" contextRef="i9ea2351304814e458dca8d34103c7273_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA0ODk1MzY_b96de969-3f25-4f7c-af30-94ead4ba68bc">52</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2ef7bc345256444fb9b45e1218e9f993_D20200401-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2Mzc_9227dcf7-581c-4211-8e48-0d07151b392e">104</ix:nonFraction> million, respectively, and for the three and six months ended September 30, 2019 includes $<ix:nonFraction unitRef="usd" contextRef="i76b51bde9d3d4cb0addfd0460eab9c05_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjczMQ_638bac24-4a83-478e-9a5f-30eb62629c17">33</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i647a92415ea7432f9ea523b7b0536a18_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2NjE_cc23d5aa-a195-4b15-a8cf-8cbc35e8bad4">48</ix:nonFraction> million, respectively, of pre-tax credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories. The three and six months ended September 30, 2020 also includes a charge of $<ix:nonFraction unitRef="usd" contextRef="ib06af04e28ba4e4ea6652465ca257cfe_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyLossInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA5OTUxMTYzNDAwMzA_af0a0b42-bdd5-47ed-b135-e18be60340eb"><ix:nonFraction unitRef="usd" contextRef="i0e287f0b27c448b49c58667e8198eae1_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyLossInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA5OTUxMTYzNDAwMzA_c7daac0a-0b5e-4716-8ed5-0a012c3273e4">50</ix:nonFraction></ix:nonFraction> million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s Opioid Stewardship Act.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for the three and six months ended September 30, 2020 includes restructuring, impairment, and related charges of $<ix:nonFraction unitRef="usd" contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MjI5ODE_8b69dd96-46b9-4cfe-aaf5-89b8360f1574">35</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MjI5ODk_e8e1e041-5b9a-49da-b38a-a42205c1c02b">58</ix:nonFraction>&#160;million, respectively, primarily associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjc0ODc3OTExNTIyOA_10b8508d-766c-4200-9988-c903d0daf4ad"><ix:nonFraction unitRef="usd" contextRef="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjc0ODc3OTExNTIyOA_1a925f5a-efb1-4850-807d-6ca731f2e51a"><ix:nonFraction unitRef="usd" contextRef="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjc0ODc3OTExNTIyOA_2ffc934f-f0f5-4efd-970a-95a46aec0f64"><ix:nonFraction unitRef="usd" contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjc0ODc3OTExNTIyOA_7a3b2e94-d15b-466c-91f8-8fc5ec8228ed">69</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million (pre-tax and after-tax) related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 8, &#8220;Goodwill and Intangible Assets, Net.&#8221;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for the three and six months ended September 30, 2019 includes a pre-tax impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i3bceb76fc90f4fc4a14733d6ed803565_D20190401-20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU3MzM_c8edc0fe-f588-48ad-ac0d-bce58ac3d90e"><ix:nonFraction unitRef="usd" contextRef="i5abddbabf5c94c0fa20a7d1605f5465f_D20190701-20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU3MzM_dcd1812b-6158-496f-bdfc-8f1e323a3137">1.2</ix:nonFraction></ix:nonFraction> billion and a pre-tax dilution loss of $<ix:nonFraction unitRef="usd" contextRef="i4ed1ecc0893943d88156c671256bec07_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2Nzk_e6673afd-782e-44c9-a0e2-6b5db38176f5"><ix:nonFraction unitRef="usd" contextRef="i9cbe8bd08e2043a691eb83cc4d84f2ec_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2Nzk_fa2e65bd-67b8-49c9-9df1-c6a43b6f647a">246</ix:nonFraction></ix:nonFraction> million associated with the Company&#8217;s investment in Change Healthcare JV. Operating loss for Other also includes the Company&#8217;s proportionate share of loss from Change Healthcare JV of $<ix:nonFraction unitRef="usd" contextRef="i5abddbabf5c94c0fa20a7d1605f5465f_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2OTY_477e685e-53b8-4c0e-b514-bed4765ae71c">51</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3bceb76fc90f4fc4a14733d6ed803565_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU3MDk_b30254c2-e9ea-4d26-acf3-d374ac9cb870">47</ix:nonFraction> million for the three and six months ended September 30, 2019, respectively.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the six months ended September 30, 2020 includes a net gain of $<ix:nonFraction unitRef="usd" contextRef="i0e287f0b27c448b49c58667e8198eae1_D20200401-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjg4OA_4d9d86ce-b631-466f-b682-b89922fe24f8">131</ix:nonFraction> million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program. Corporate expenses, net, for the three and six months ended September 30, 2020 include net gains of $<ix:nonFraction unitRef="usd" contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTI2NDQzODM3Nzc4NzQ_b7c62f1c-7960-49fa-ac76-616864e7533b">49</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTI2NDQzODM3Nzc5MjQ_76ea4425-9dff-411a-93ea-af97639950b8">59</ix:nonFraction> million, respectively, associated with certain of the Company&#8217;s equity investments and, for the three and six months ended September 30, 2019, include settlement charges of $<ix:nonFraction unitRef="usd" contextRef="i8259a0225045474dace4f33866146c8b_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU3NTY_05652386-5db0-45d6-878a-b24b6353c441">105</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if891f7281b7d419086880575baba6e9d_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU4OTI_b9fb6a10-b1a3-4621-aba9-df2a1a6d13e4">122</ix:nonFraction> million, respectively, from the termination of the Company&#8217;s defined benefit pension plan and a settlement charge of $<ix:nonFraction unitRef="usd" contextRef="icf4e3d6784d447beb68308a48fff9d3c_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU5MDk_57941e73-5506-4ccf-b171-2b1ce1dd6f83"><ix:nonFraction unitRef="usd" contextRef="ie18fac8f12304381ba36b0b283d93b84_D20190401-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU5MDk_8616fd00-8547-4cac-82f7-4926324ff859">82</ix:nonFraction></ix:nonFraction> million related to opioid claims. The three and six months ended September 30, 2020 includes $<ix:nonFraction unitRef="usd" contextRef="ib06af04e28ba4e4ea6652465ca257cfe_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDc4ODU_ed4d9791-de69-4a34-b4e9-d7b202b21f02">41</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0e287f0b27c448b49c58667e8198eae1_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDc5MTE_c2447ad6-e9c0-4ca9-9497-6e3926a91bb7">84</ix:nonFraction> million, respectively, and the three and six months ended September 30, 2019 includes $<ix:nonFraction unitRef="usd" contextRef="icf4e3d6784d447beb68308a48fff9d3c_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDc4OTg_5f60722b-bfd3-4239-bdd0-fc2ed49e8635">36</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie18fac8f12304381ba36b0b283d93b84_D20190401-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDc5MjQ_9fc84208-ed0c-4e3f-bf42-43048109a45a">72</ix:nonFraction> million, respectively, of pre-tax charges opioid-related costs, primarily litigation expenses.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_103"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_106"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of financial condition and results of operations, referred to as the &#8220;Financial Review,&#8221; is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations and financial position of McKesson Corporation together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221; and other similar pronouns). This discussion and analysis should be read in conjunction with the condensed consolidated financial statements and accompanying financial notes in Item 1 of Part I of this Quarterly Report on Form 10-Q and in Item 8 of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020 previously filed with the Securities and Exchange Commission on May 22, 2020 (&#8220;2020 Annual Report&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean our fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this report constitute forward-looking statements. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Cautionary Notice About Forward-Looking Statements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Our Business:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We implemented a new segment reporting structure commencing in the second quarter of 2021, which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#8220;RxTS&#8221;). Other, for retrospective periods presented, consists of our equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020. All prior segment information has been recast to reflect our new segment structure and current period presentation. Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of individual business activities. We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021. Refer to Financial Note 15, &#8220;Segments of Business,&#8221; in the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for further information regarding our reportable segments. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">U.S. Pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, previously the U.S. Pharmaceutical and Specialty Solutions reportable segment, continues to distribute branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a new reportable segment that includes our operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provides medical-surgical supply distribution, logistics, and other services to healthcare providers in the United States and was unaffected by the segment realignment.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">RxTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a new reportable segment that brings together existing businesses, including CoverMyMeds, RelayHealth, RxCrossroads, and High Volume Solutions to serve our biopharma and life sciences partners and patients. RxCrossroads was previously included in our former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and High Volume Solutions were previously included in Other.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Summary: </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary provides highlights and key factors that impacted our business, operating results, financial condition, and liquidity for the three and six months ended September 30, 2020.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Coronavirus disease 2019 (&#8220;COVID-19&#8221;) impacted our results of operations for the three and six months ended September 30, 2020. Following the onset of the pandemic, pharmaceutical distribution volumes decreased during the first quarter as a result of the weakened and uncertain global economic environment and COVID-19 restrictions, including government shutdowns and shelter-in-place orders. While the COVID-19 pandemic continues to be fluid, we saw pharmaceutical distribution volumes begin to improve across our businesses during the second quarter as well as an increase in demand for COVID-19 tests;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the second quarter of 2021, we expanded our existing partnership with the Centers for Disease Control and Prevention (&#8220;CDC&#8221;) to support the U.S. government&#8217;s Operation Warp Speed (&#8220;OWS&#8221;) team as a centralized distributor of future COVID-19 vaccines and ancillary supplies needed to administer vaccinations. We have also partnered with the Department of Health and Human Services (&#8220;HHS&#8221;) to manage the assembly and distribution of the ancillary supplies needed to administer the future COVID-19 vaccines. For a more in-depth discussion of how COVID-19 impacted our business, operations, and outlook, refer to the COVID-19 section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Trends and Uncertainties"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included below;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Revenues of $60.8 billion for the three months ended September 30, 2020 increased 6% from the prior year, and revenues of $116.5 billion for the six months ended September 30, 2020 increased 3% from the prior year. The increase in revenues is primarily driven by market growth in our U.S. Pharmaceutical segment. Revenues for the six months ended September 30, 2020 also includes adverse impacts from COVID-19, primarily due to pharmaceutical distribution volume declines across our businesses largely during the first quarter of 2021.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Gross profit increased 5% for the three months ended September 30, 2020 compared to the prior year primarily driven by sales of COVID-19 tests in our Medical-Surgical Solutions segment and growth in our U.S. Pharmaceutical segment. Gross profit increased 1% for the six months ended September 30, 2020 compared to the prior year primarily due to higher LIFO credits and growth in our U.S. Pharmaceutical segment, partially offset by the net adverse impacts of COVID-19;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Total operating expenses for the three and six months ended September 30, 2020 includes a goodwill impairment charge of $69 million recorded in connection with our segment realignment that commenced in the second quarter of 2021. Refer to the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Goodwill Impairment&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section below for further details;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Total operating expenses for the three and six months ended September 30, 2020 reflects a charge of $50 million related to our estimated liability under the State of New York&#8217;s Opioid Stewardship Act (the &#8220;OSA&#8221;). Refer to the State Opioid Statutes section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for further details;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses for the six months ended September 30, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Diluted earnings per common share from continuing operations attributable to McKesson Corporation for the three and six months ended September 30, 2020 of $3.54 and $6.26, respectively, reflects the aforementioned items, a lower tax rate, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">We returned $388 million of cash to shareholders through $248 million of common stock repurchases, excluding shares surrendered for tax withholding, and $140 million of dividend payments during the six months ended September 30, 2020. On July 29, 2020, we raised our quarterly dividend from $0.41 to $0.42 per common share; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">On November 1, 2020, we completed the contribution of our German pharmaceutical wholesale business to a newly formed joint venture with Walgreens Boots Alliance and the subsequent purchase of a 30% interest in this joint venture. Future equity earnings and charges from the joint venture will be included in other income (expense), net.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trends and Uncertainties:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, a novel strain of coronavirus, which causes the infectious disease known as COVID-19, was reported in Wuhan, China. The World Health Organization declared COVID-19 a &#8220;Public Health Emergency of International Concern&#8221; on January 30, 2020 and a global pandemic on March 11, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to evaluate the nature and extent COVID-19 has on our business and operations. The pandemic developed rapidly during our fourth quarter of 2020 and continues to evolve. Infection rates and COVID-19 cases have increased to higher levels throughout our first two quarters of 2021, particularly in the United States (&#8220;U.S.&#8221;). The full extent to which COVID-19 will impact us depends on future developments, including the continued duration and spread of the virus, as well as potential new outbreaks.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, federal, state, and local government directives and policies have been put in place in the U.S. to enhance availability of medications and supplies to meet the increased demand, assist front-line healthcare providers, manage public health concerns by creating social distancing, and address the economic impacts, including sharply reduced business activity, increased unemployment, and overall uncertainty presented by this new healthcare emergency. Similar governmental actions have occurred in Canada and Europe, the timing of which has varied across geographies. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe. We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure supplies, including personal protective equipment, and medicine reached our customers and patients. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have taken the necessary steps to ensure that we continue to supply our customers and protect the safety of our employees. The various responses we put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel requirements, employee support programs, and enhanced safety measures are intended to limit exposure to COVID-19. We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to not only protect employee safety, but to provide further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19. We have taken steps to enhance employee safety within our facilities by promoting the practice of social distancing where feasible, providing reminders to wash or disinfect their hands, avoiding unnecessary face touching, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities. We have also added technology resources to support our employees working remotely. These responses were initially put in place during our fourth quarter of 2020, which we maintained through the first half of 2021. During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic. These steps to protect the safety of our employees have resulted in limited disruption of our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have evaluated the impact of our telecommuting and work-from-home policies on our system of internal controls and we have concluded that these policies did not have a material effect on our internal control over financial reporting during the six months ended September 30, 2020. We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter, we experienced growth in pharmaceutical distribution and specialty drug volumes at a lower rate in the U.S., while pharmaceutical distribution volumes decreased in Europe and Canada due to the COVID-19 pandemic, as compared to the same prior year period. Specialty drug volumes increased, but were negatively impacted by lower demand for elective specialty drugs, as compared to the same prior year period. We also experienced continued decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures in doctors&#8217; offices, which was partially offset by increased demand for COVID-19 tests and personal protective equipment. Additionally, the decreased traffic in doctors&#8217; offices and general shelter-in-place guidance by governmental authorities negatively impacted retail pharmacy foot traffic in both Europe and Canada. These trends improved during the second quarter as we experienced stabilization of prescription volumes across the enterprise and improved frequency of primary care patient visits. Additionally, we saw improvements in both operations of doctor&#8217;s offices and retail pharmacy foot traffic in Europe and Canada as well as continued sales of personal protective equipment and increased demand for COVID-19 tests.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The demand for COVID-19 tests and personal protective equipment had a favorable impact to revenues for the three and six months ended September 30, 2020. However, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits which had a negative impact on consolidated revenues for the six months ended September 30, 2020. During the three and six months ended September 30, 2020, operating expenses decreased as a result of the pandemic largely due to savings from restricted travel requirements, decreased meetings, and decreased payroll-related expenses. The favorable reduction in operating expenses was partially offset by increased costs of transport, costs for enhanced sterilization procedures to sanitize operating facilities, and costs of personal protective equipment for our employees. The aforementioned items had a favorable impact on consolidated income from continuing operations before income taxes for the three months ended September 30, 2020, but an unfavorable impact on the six months ended September 30, 2020, when compared to the same prior year periods. Additionally, supplier price increases on certain personal protective equipment continue to compress our margins. These personal protective equipment items have been recognized within our inventory at increased supplier prices, which, if not supported by future market prices, would require a write-down to net realizable value. While we have not recognized a material write-down of inventory in our financial results to date, we are not able to predict whether future market price volatility may require such write-downs in future periods. Impacts to future periods due to COVID-19 may differ based on future developments, including the duration and spread of the virus, potential seasonality of new outbreaks, as well as the approval and subsequent distribution of a vaccine. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) to address the economic impact of the COVID-19 pandemic. Among other things, the CARES Act provides certain changes to tax laws and includes provisions to provide relief for healthcare providers and patients. We have taken advantage of the provision to defer certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act. We anticipate changes in the timing of certain cash flows, with no material impact to our financial results for the three and six months ending September 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2020, we expanded our partnership with the CDC through an amendment to our existing Vaccines for Children Program contract for the distribution of certain COVID-19 vaccines. While the terms of the final vaccine distribution agreement are subject to further negotiation and finalization, we will support the U.S. government&#8217;s OWS team as a centralized distributor of future COVID-19 vaccines and ancillary supplies needed to administer vaccinations. In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country. We make no decisions on where products are to be distributed. We will utilize our expertise and capabilities to support the CDC&#8217;s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine. The CDC and McKesson collaborated similarly in response to the H1N1 pandemic. The related results of operations in future periods will be reflected in our U.S. Pharmaceutical segment. During the second quarter of 2021 we commenced initial capital expenditures to prepare for future vaccine distribution which were not material to our financial condition or liquidity. We currently cannot estimate the entire financial impact that the vaccine distribution agreement with the CDC will have on our future financial condition, results of operations, and liquidity.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 23, 2020, we announced our contract with the HHS where our Medical-Surgical Solutions segment will leverage its expertise to manage the assembly of supply kits needed to administer COVID-19 vaccines, including sourcing of some of those supplies. The kits will be produced and distributed to other HHS contractors at the direction of HHS. Ancillary supply kits will include alcohol prep pads, face shields, surgical masks, additional personal protective equipment, needles and syringes, and vaccine administrative items. The financial impact of these arrangements with the CDC and HHS depend on numerous uncertainties, including timing of when a vaccine will be approved and made available for production and distribution to the public.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated balance sheets and ability to maintain financial liquidity remains strong. We have experienced no material impacts to our liquidity or net working capital. With many of our customers anticipating extended declines in their businesses due to the COVID-19 pandemic, we are monitoring closely for trends that may impact their timing or ability to pay amounts owed to us. We remain well-capitalized with access to liquidity from our revolving credit facility. Long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open during the COVID-19 pandemic. We believe we have the ability to meet the covenants of our credit agreements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor the COVID-19 pandemic impact on our supply chain. Although the availability of various products is dependent on our suppliers, their location, and the extent to which they are impacted by the COVID-19 pandemic, we are proactively working with manufacturers, industry partners, and government agencies to meet the needs of our customers during the pandemic. We have assembled a Critical Care Drug Task Force, made up of our procurement specialists, clinical health systems pharmacists, and supply chain professionals, focused on securing additional product where available, sourcing back-up products, adjusting allocations to ensure equitable distribution, and to protect our operations across all locations and facilities. We are also working with manufacturers through several channels, including our ClarusONE and global sourcing teams in London, and our leaders are actively engaged in addressing potential shortages. We have a robust Business Continuity and Disaster Recovery Program (&#8220;BCRP&#8221;) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to support our priorities to protect our customers, ensure the safety and security of our employees and workplaces, and ensure the continuity of critical business processes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were able to maintain appropriate labor and overall vendor supply levels during the first half of 2021. Our inventory levels have fluctuated in response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio of offerings. We collaborated closely with the federal government and other healthcare stakeholders to source more critical personal protective equipment to the U.S. This collaboration expedited the shipment of critical medical supplies to areas hit hardest by COVID-19, as identified by the Federal Emergency Management Agency. We are closely monitoring demand and usage of personal protective equipment. As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity. Additionally, continued responses from authorities and regulators at all levels of government may materially impact us in future periods. Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will return remains challenging. Refer to Item 1A - Risk Factors in Part I of our 2020 Annual Report and Item 1A - Risk Factors in Part II of this Quarterly Report on Form 10-Q for a disclosure of risk factors related to COVID-19.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioid-Related Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a defendant in over 3,100 legal proceedings asserting claims related to distribution of controlled substances (opioids) in federal and state courts throughout the U.S., and in Puerto Rico and Canada. We are vigorously defending ourselves against such claims and proceedings and are a party to discussions with the objective of achieving broad resolution of the remaining claims. Because of the large number of parties involved, together with the novelty and complexity of the issues, for which there may be different considerations among the parties, we cannot predict the successful resolution through a negotiated settlement. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on our financial position, cash flows or liquidity, or results of operations. Refer to Financial Note 13, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Opioid Statutes </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory, or industry measures to address the misuse of prescription opioid medications could affect our business in ways that we may not be able to predict. In April 2018, the State of New York adopted the OSA which required the imposition of an annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State of New York appealed to the U.S. Court of Appeals to the Second Circuit. The State of New York has subsequently adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018. The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. If the appellate court&#8217;s decision stands, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years. We reflected an estimated liability for the OSA surcharge in our accompanying condensed consolidated financial statements on the assumption that the appellate court&#8217;s decision will stand. Refer to Financial Note 13, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Consolidated Results:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.977%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,808&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,487&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,700&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,654&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,366)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total operating expenses as a percentage of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity earnings and charges from investment in Change Healthcare Joint Venture</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,454)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,450)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(970)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(677)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.54&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.65)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 18pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NM - computation not meaningful</span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues increased for the three and six months ended September 30, 2020 compared to the same prior year periods primarily due to market growth in our U.S. Pharmaceutical segment. Revenues were unfavorably impacted for the six months ended September 30, 2020 due to reduced customer demand as a result of COVID-19, which drove declines in pharmaceutical distribution volumes across our businesses largely during the first quarter of 2021. Market growth includes growing drug utilization, price increases and newly launched products, partially offset by price deflation associated with branded to generic drug conversion. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased for the three months ended September 30, 2020 compared to the same prior year period primarily due to increased demand for COVID-19 tests in our Medical-Surgical Solutions segment and growth of specialty pharmaceuticals in our U.S. Pharmaceutical segment. Gross profit and gross profit margin were favorably impacted by the effects of foreign currency exchange fluctuations and higher last-in, first-out (&#8220;LIFO&#8221;) credits in the second quarter of 2021, as further described below. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased for the six months ended September 30, 2020 compared to the same prior year period primarily due to higher LIFO credits for the first half of 2021 compared to the same prior year period and growth of specialty pharmaceuticals in our U.S. Pharmaceutical segment. Gross profit and gross profit margin were adversely impacted from COVID-19 largely during the first quarter of 2021, including disruptions of doctors&#8217; office operations, deferred or cancelled elective procedures, lower demand for pharmaceuticals, and overall reduction of foot traffic in pharmacies, partially offset by demand for COVID-19 tests and personal protective equipment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFO inventory credits were $52 million and $33 million for the three months ended September 30, 2020 and 2019, respectively, and $104 million and $48 million for the six months ended September 30, 2020 and 2019, respectively, which favorably impacted our gross profit margin both in the second quarter and first half of 2021 compared to the same prior year periods. Our U.S. Pharmaceutical business uses the LIFO method of accounting for the majority of its inventories, which results in cost of sales that more closely reflects replacement cost than under other accounting methods. The business&#8217; practice is to pass on to customers published price changes from suppliers. Manufacturers generally provide us with price protection, which limits price related inventory losses. A LIFO expense is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. Our quarterly LIFO credit is based on our estimates of the annual LIFO credit which is impacted by expected changes in year-end inventory quantities, product mix, and manufacturer pricing practices, which may be influenced by market and other external influences. Changes to any of the above factors could have a material impact to our annual LIFO credit. The actual valuation of inventory under the LIFO method is calculated at the end of the fiscal year. LIFO credits are higher in the second quarter and first half of 2021 compared to the same prior year periods primarily due to relatively lower estimated brand inflation and higher generic deflation.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Operating Expenses</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the components of our total operating expenses for the three and six months ended September 30, 2020 and 2019 is as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">NM    </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM    </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,241&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,388&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">-    </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Percent of revenues</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.89&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.89&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.77&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.88&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NM - computation not meaningful</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2020, total operating expenses increased and total operating expenses as a percentage of revenues remained flat compared to the same prior year period. For the six months ended September 30, 2020, total operating expenses remained flat and total operating expenses as a percentage of revenues decreased compared to the same prior year period. Total operating expenses were impacted by the following significant items:</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses for the three and six months ended September 30, 2020 includes a charge of $50 million related to our estimated liability under the OSA as previously discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses for the three months ended September 30, 2020 and 2019 includes opioid-related expenses of $41 million and $36 million, respectively, and $84 million and $72 million for the six months ended September 30, 2020 and 2019, respectively, primarily related to litigation expenses;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses for the six months ended September 30, 2020 includes a net gain of $131 million reflecting insurance proceeds received, net of attorneys' fees and expenses awarded to plaintiffs' counsel, in connection with the previously reported $175 million settlement of the shareholder derivative action related to our controlled substances monitoring program;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses for three and six months ended September 30, 2019 includes a settlement charge of $82 million recorded in connection with an agreement to settle all opioid-related claims filed by two Ohio counties; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Operating expenses for the three and six months ended September 30, 2020 reflects cost savings of $20 million and $52 million, respectively, on travel and entertainment due to travel restrictions associated with COVID-19;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Operating expenses for the three and six months ended September 30, 2020 when compared to the same prior year periods includes higher corporate expenses and increased costs to support business growth, particularly in our Medical-Surgical Solutions and RxTS segments. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Goodwill impairment charges of $69 million for the three and six months ended September 30, 2020 was recorded in connection with our segment realignment that commenced in the second quarter of 2021. Refer to the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Goodwill Impairment&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below for further details;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restructuring, impairment, and related charges for three and six months ended September 30, 2020 and 2019 primarily includes charges related to our European businesses and Corporate expenses, net. In addition, charges related to restructuring initiatives are included under the caption &#8220;Cost of sales&#8221; in our Condensed Consolidated Statements of Operations and were not material for the three and six months ended September 30, 2020 and 2019. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Restructuring Initiatives&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below and Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses were unfavorably impacted by foreign currency exchange fluctuations for the three and six months ended September 30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed in our 2020 Annual Report, the estimated fair value of our McKesson Canada reporting unit exceeded the carrying value as part of our 2020 annual goodwill impairment test. However, other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment, where the risk of a material goodwill impairment is higher than other reporting units.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Overview of Our Business&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section, our operating structure was realigned commencing in the second quarter of 2021 into four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. These reportable segments encompass all operating segments of the Company. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The segment realignment resulted in changes in multiple reporting units across the Company, as previously disclosed in the Company&#8217;s Quarterly Report on Form 10-Q for the three months ended June 30, 2020. As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our Europe Retail Pharmacy reporting unit of $69 million for the three and six months ended September 30, 2020. At September 30, 2020, the Europe Retail Pharmacy reporting unit had no remaining balance of goodwill. These reporting units are included within the International reportable segment. Other risks, expenses and future developments that we were unable to anticipate as of the testing date may require us to further revise the future projected cash flows, which could adversely affect the fair value of our reporting units in future periods. As a result, we may be required to record additional impairment charges. Refer to Financial Note 8, &#8220;Goodwill and Intangible Assets, Net&#8221; to the accompanying condensed financial statements appearing in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the first quarter of 2021, we committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which forms part of the International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. The initiative is expected to be substantially completed by the end of 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we committed to certain programs to continue our operating model and cost optimization efforts. We continue to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. We anticipate these additional programs will be substantially completed in 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we committed to certain actions in connection with the previously announced relocation of our corporate headquarters from San Francisco, California to Irving, Texas, which became effective April 1, 2019. We anticipate that the relocation will be completed by January 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the above initiatives, we expect to record total charges of approximately</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$490 million</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to $565 million, of which $402 million of charges were recorded to date primarily representing employee severance, exit-related costs, asset impairment charges, and accelerated depreciation. Estimated remaining charges primarily consist of accelerated amortization and impairments of long-lived assets, facility, lease, and other exit costs and employee-related costs. Refer to Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information on various initiatives.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in other income, net for the three and six months ended September 30, 2020 compared to other expense, net for the same prior year periods was primarily due to pension settlement charges of $105 million and $122 million recognized during the three and six months ended September 30, 2019, respectively, related to our previously approved termination of the frozen U.S. defined benefit pension plan. In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net for the three and six months ended September 30, 2020 also includes net gains recognized from our equity investments of $49 million and $59 million, respectively. This primarily reflects mark-to-market gains on our investments in publicly traded securities as further described in Financial Note 12, &#8220;Fair Value Measurements,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. In future periods, fair value adjustments recognized in our operating results for these types of investments may be adversely impacted by market volatility. Other expense, net for the six months ended September 30, 2019 includes net settlement gains of $26 million from our derivative contracts. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Earnings and Charges from Investment in Change Healthcare Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting. Our proportionate share of income from our investment in Change Healthcare JV was $51 million and $47 million for the three and six months ended September 30, 2019, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2019, common stock and certain other securities of Change Healthcare, Inc. (&#8220;Change&#8221;) began trading on the NASDAQ (&#8220;IPO&#8221;). On July 1, 2019, upon the completion of its IPO, Change contributed net cash proceeds it received from its offering of common stock to Change Healthcare JV in exchange for additional membership interests of Change Healthcare JV (&#8220;LLC Units&#8221;) at the equivalent of its offering price of $13 per share. The proceeds from the concurrent offering of other securities were also used by Change to acquire certain securities of Change Healthcare JV. As a result, McKesson&#8217;s equity interest in Change Healthcare JV was reduced from 70% to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020. As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020. Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, we recorded an other-than-temporary-impairment (&#8220;OTTI&#8221;) charge of $1.2 billion to our investment in Change Healthcare JV, representing the difference between the carrying value of our investment and the fair value derived from the corresponding closing price of Change&#8217;s common stock at September 30, 2019. This charge was included within equity earnings and charges from investment in Change Healthcare joint venture in our condensed consolidated statements of operations for the three and six months ended September 30, 2019. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The March 10, 2020 split-off transaction eliminated our investment in the joint venture. During the fourth quarter of 2020 in conjunction with the split-off transaction, we recorded a reversal of the deferred tax liability related to our investment. Under the agreement with Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed. Any such change is not expected to be material.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the separation, Change Healthcare JV is required under the tax receivable agreement (&#8220;TRA&#8221;) to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, resulting from depreciation or amortization allocated to Change by McKesson. The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing, and probability of the gain recognized. As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of September 30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense decreased for the three and six months ended September 30, 2020 compared to the same prior year periods primarily due to a decrease in the issuance of commercial paper. Interest expense may also fluctuate based on timing, amounts, and interest rates of term debt repaid and new term debt issued, as well as amounts incurred associated with financing fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit (Expense)</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020 and 2019, we recorded income tax expense of $28 million and income tax benefit of $294 million, respectively, related to continuing operations. During the six months ended September 30, 2020 and 2019, we recorded income tax expense of $178 million and income tax benefit of $158 million, respectively, related to continuing operations. Our reported income tax rates were 4.3% and 30.3% for the three months ended September 30, 2020 and 2019, respectively, and 13.7% and 45.0% for the six months ended September 30, 2020 and 2019, respectively. Fluctuations in our reported income tax rates are primarily due to changes within our business mix of income and discrete items recognized. Refer to Financial Note 5, &#8220;Income Taxes,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests for the three and six months ended September 30, 2020 and 2019 primarily represents ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and the accrual of the annual recurring compensation amount of &#8364;0.83 per McKesson Europe AG (&#8220;McKesson Europe&#8221;) share that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe under a domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;). Noncontrolling interests with redemption features, such as put rights, that are not solely within our control are considered redeemable noncontrolling interests.&#160;Redeemable noncontrolling interests are presented outside of McKesson Corporation stockholders&#8217; equity on our condensed consolidated balance sheets. Refer to Financial Note 6, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Attributable to McKesson Corporation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to McKesson Corporation was $577 million and $(730) million for the three months ended September 30, 2020 and 2019, respectively, and $1.0 billion and $(307) million for the six months ended September 30, 2020 and 2019, respectively. Diluted earnings (loss) per common share attributable to McKesson Corporation was $3.54 and $(3.99) for the three months ended September 30, 2020 and 2019, respectively, and $6.26 and $(1.65) for the six months ended September 30, 2020 and 2019, respectively. Additionally, our diluted earnings per share for the for the three and six months ended September 30, 2020 and 2019 reflects the cumulative effects of share repurchases. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted-Average Diluted Common Shares</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings (loss) per common share was calculated based on a weighted-average number of shares outstanding of</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163 million and 183 million for the three months ended September 30, 2020 and 2019, respectively, and 163 million and 185 million for the six months ended September 30, 2020 and 2019, respectively. Net loss per diluted share for the three and six months ended September 30, 2019 is calculated by excluding dilutive securities from the denominator due to their antidilutive effects. Weighted-average diluted shares for three and six months ended September 30, 2020 decreased from the same prior year periods primarily due to the separation from our investment in Change Healthcare JV on March 10, 2020.</span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_109"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Segment Results:</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Revenues:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,808&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,616&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,487&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,344&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the three months ended September 30, 2020 increased</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5% compared to the same prior year period primarily due to market growth, including branded pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic drug conversions. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the six months ended September 30, 2020 increased 4% compared to the same prior year period primarily due to market growth, including branded pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic drug conversions. Revenues for this segment were unfavorably impacted by the loss of customers and reduced demand for pharmaceuticals in retail pharmacies and institutional healthcare providers due to COVID-19, particularly during the first quarter of 2021. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the three months ended September 30, 2020 increased 2% compared to the same prior year period. Excluding the favorable effects of foreign currency exchange fluctuations, revenues for this segment decreased 1% primarily due to the exit of unprofitable customers in our Canadian business, partially offset by one additional sales day this quarter in our European pharmaceutical distribution business compared to the same prior year period and market growth in our European retail business.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the six months ended September 30, 2020 decreased 3% compared to the same prior year period. Excluding the favorable effects of foreign currency exchange fluctuations, revenues for this segment decreased 4% primarily due to lower pharmaceutical distribution volumes resulting from the adverse impacts from COVID-19 largely during the first quarter of 2021 and the exit of unprofitable customers in our Canadian business. These decreases were partially offset by favorability due to additional sales days for the six months ended September 30, 2020 compared to the same prior year period in our European operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the three months ended September 30, 2020 increased 23% compared to the same prior year period primarily due to sales of COVID-19 tests and personal protective equipment, as well as organic growth across the segment. Revenues for this segment were unfavorably impacted by a divestiture that closed during the fourth quarter of 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the six months ended September 30, 2020 increased 9% compared to the same prior year period primarily due to sales of COVID-19 tests and personal protective equipment, partially offset by lower demand due to customer closures in our primary care business largely during the first quarter of 2021. Revenues for this segment were unfavorably impacted by a divestiture that closed during the fourth quarter of 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the three months ended September 30, 2020 increased 7% compared to the same prior year period primarily driven by increased volume with new and existing customers, partially offset by a change in mix of certain biopharma brands within our programs. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2020 vs. 2019</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the six months ended September 30, 2020 increased 5% compared to the same prior year period primarily driven by increased volume with new and existing customers. This was partially offset by the adverse impacts of COVID-19 largely during the first quarter of 2021. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_112"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Operating Profit (Loss) and Corporate Expenses, Net:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.975%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,454)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(511)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(970)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.17&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.65&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.78&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.78&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments. For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our U.S. Pharmaceutical segment includes a charge of $50 million for the three and six months ended September 30, 2020 related to our estimated liability under the OSA.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for our International segment includes restructuring, impairment, and related charges of $35 million and $58 million for the three and six months ended September 30, 2020, respectively, associated with the closure of retail pharmacy stores within the U.K. business and a goodwill impairment charge of $69 million for the three and six months ended September 30, 2020 related to our European retail business.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for the three and six months ended September 30, 2019 includes an impairment charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the three and six months ended September 30, 2020 includes net gains from our equity investments of $49 million and $59 million, respectively. Corporate expenses, net for the six months ended September 30, 2020 also includes a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program. Corporate expenses, net for the three and six months ended September 30, 2019 includes pension settlement charges of $105 million and $122 million, respectively, and a settlement charge of $82 million related to opioid claims.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin decreased for this segment for the three months ended September 30, 2020 compared to the same prior year period primarily due to a charge of $50 million recorded during the second quarter of 2021 related to our estimated liability under the OSA and increased costs for strategic growth initiatives. This was partially offset by higher LIFO credits and growth in specialty pharmaceuticals.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for this segment for the six months ended September 30, 2020 compared to the same prior year period primarily resulting from higher LIFO credits and growth in specialty pharmaceuticals, partially offset by increased costs for strategic growth initiatives. Additionally, the aforementioned OSA charge of $50 million adversely impacted our operating profit and operating profit margin for the six months ended September 30, 2020. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in operating loss and operating loss margin for this segment for the three months ended September 30, 2020 compared to operating profit and operating profit margin for the same prior year period was primarily due to a goodwill impairment charge of $69 million related to our European retail business and higher restructuring charges related to our initiative in the U.K., partially offset by lower operating expenses across our European businesses.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in operating loss and operating loss margin for this segment for the six months ended September 30, 2020 compared to operating profit and operating profit margin for the same prior year period was primarily due to a goodwill impairment charge of $69 million related to our European retail business and higher restructuring charges related to our initiative in the U.K., partially offset by lower operating expenses across our European businesses.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin for this segment increased for the three months ended September 30, 2020 compared to the same prior year period primarily due to sales of COVID-19 tests. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the six months ended September 30, 2020 compared to the same prior year period primarily due to sales of COVID-19 tests and personal protective equipment, partially offset by customer closures in our primary care business largely during the first quarter of 2021. Operating profit margin for the six months ended September 30, 2020 was also negatively impacted by supplier price increases on personal protective equipment and changes in our product mix.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin for this segment decreased for the three months ended September 30, 2020 compared to the same prior year period primarily driven by higher operating expenses to support business growth. Operating profit margin for this segment also decreased due to changes in our product mix.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Six Months Ended September 30, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin for this segment decreased for the six months ended September 30, 2020 compared to the same prior year period primarily due to higher operating expenses to support business growth. Operating profit margin for this segment also decreased due to changes in our product mix.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss for Other for the three and six months ended September 30, 2019 includes an impairment charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV. Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $51 million and $47 million for the three and six months ended September 30, 2019, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Expenses, Net</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net, decreased for the three and six months ended September 30, 2020 compared to the same prior year periods primarily due to pension settlement charges of $105 million and $122 million recognized during the three and six months ended September 30, 2019, respectively, and an opioid claim settlement charge of $82 million recognized in the second quarter of 2020. Additionally, we recognized net gains from our equity investments of $49 million and $59 million during the three and six months ended September 30, 2020, respectively, and a net gain of $131 million during the six months ended September 30, 2020 in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program. Corporate expenses, net for the six months ended September 30, 2019 includes net settlement gains of $26 million from our derivative contracts. </span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_118"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New accounting pronouncements that we have recently adopted as well as those that have been recently issued but not yet adopted by us are included in Financial Note 1, &#8220;Significant Accounting Policies,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.</span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_121"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our available cash generated from operations and our short-term investment portfolio, together with our existing sources of liquidity from our credit facilities and commercial paper program, will be sufficient to fund our long-term and short-term capital expenditures, working capital, and other cash requirements. As described within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section above, the COVID-19 pandemic is developing rapidly. We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us. We remain well-capitalized with access to liquidity from our revolving credit facility. Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open during the COVID-19 pandemic. We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets. We believe we have the ability to meet the covenants of our credit agreements.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net change in cash, cash equivalents, and restricted cash for the periods shown: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(401)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(783)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities used cash of $41 million and $159 million during the six months ended September 30, 2020 and 2019, respectively.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from operations can be significantly impacted by factors such as timing of receipts from customers, inventory receipts, and payments to vendors. Additionally, working capital is primarily a function of sale and purchase volumes, inventory requirements, and vendor payment terms. Operating activities for the six months ended September 30, 2020 were affected by increases in inventory of $1.4 billion due to higher stock levels to meet sales demand, decreases in drafts and accounts payable of $1.3 billion primarily from effective working capital management at year end, and decreases in receivables of $981 million primarily due to higher sales recognized at the end of March 2020. Operating activities for the six months ended September 30, 2019 were affected by decreases in drafts and accounts payable of $1.2 billion primarily associated with timing and increases in receivables of $866 million due to revenue growth. Operating activities for the six months ended September 30, 2019 also includes a non-cash pension settlement charge of $122 million. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities used cash of $278 million and $285 million during the six months ended September 30, 2020 and 2019, respectively. Investing activities for the six months ended September 30, 2020 and 2019 includes $265 million and $184 million, respectively, in capital expenditures for property, plant, and equipment, and capitalized software. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities used cash of $401 million and $1.2 billion during the six months ended September 30, 2020 and 2019, respectively. Financing activities for the six months ended September 30, 2020 includes cash receipts and payments of $5.3 billion for short-term borrowings, primarily commercial paper. Financing activities for the six months ended September 30, 2019 includes cash receipts of $8.7 billion and payments of $8.1 billion for short-term borrowings, primarily commercial paper. Financing activities for the six months ended September 30, 2020 and 2019 includes $272 million and $1.5 billion, respectively, of cash paid for stock repurchases, including shares surrendered for tax withholding. Additionally, financing activities for the six months ended September 30, 2020 and 2019 includes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$140 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $148 million of cash paid for dividends, respectively. Cash used for other financing activities generally includes payments to noncontrolling interests. Other financing activities for the six months ended September 30, 2020 also includes restricted cash inflow related to funds temporarily held on behalf of unaffiliated medical practice groups and a payment of $49 million to purchase shares of McKesson Europe through exercises of a put right option by noncontrolling shareholders. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors (the &#8220;Board&#8221;) has authorized the repurchase of McKesson&#8217;s common stock from time to time in open market transactions, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, we entered into an ASR program with a third-party financial institution to repurchase $600 million of the Company&#8217;s common stock. We repurchased a total of 4.7 million shares at an average price per share of $127.68 during the six months ended September 30, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2019, we repurchased 0.7 million of the Company&#8217;s shares for $84 million through open market transactions at an average price per share of $128.64. During the three months ended September 30, 2019, we repurchased 5.2 million of the Company&#8217;s shares for $750 million through open market transactions at an average price per share of $144.28.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2020, there were no share repurchases made under previously authorized share repurchase programs. During the three months ended September 30, 2020, the Company repurchased 1.8&#160;million of the Company&#8217;s shares for $269 million through open market transactions at an average price per share of $151.23, of which $21&#160;million was accrued within &#8220;Other accrued liabilities&#8221; on our Condensed Consolidated Balance Sheets for share repurchases that were executed in late September and settled in early October.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total authorization outstanding for repurchases of the Company&#8217;s common stock was $1.3 billion at September 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future operating cash flow, financial assets, and current access to capital and credit markets, including our existing credit facilities, will give us the ability to meet our financing needs for the foreseeable future. However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing. As described within the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, the COVID-19 pandemic is developing rapidly. We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.</span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_124"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selected Measures of Liquidity and Capital Resources</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:55.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt to capital ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on McKesson stockholders&#8217; equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Ratio is computed as total debt divided by the sum of total debt and McKesson stockholders&#8217; equity, which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders&#8217; equity, which excludes noncontrolling and redeemable noncontrolling interests.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents balance as of September 30, 2020 and March 31, 2020 included approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.6 billion and $1.7 billion of cash held by our subsidiaries outside of the U.S., respectively. Our primary intent is to utilize this cash for foreign operations for an indefinite period of time. Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.&#160;Following enactment of the 2017 Tax Cuts and Jobs Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital primarily includes cash and cash equivalents, receivables, and inventories, net of drafts and accounts payable, short-term borrowings, current portion of long-term debt, and other current liabilities. Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands. Inventory purchase activity is a function of sales activity and other requirements. The COVID-19 pandemic has potential to increase the variations in our working capital, which we will continue to monitor closely.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated working capital improved at September 30, 2020 compared to March 31, 2020 primarily due to an increase in inventory and a decrease in drafts and accounts payable, partially offset by decreases in cash and cash equivalents and receivables and an increase in our current portion of long-term debt.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt to capital ratio decreased for the six months ended September 30, 2020 primarily due to an increase in stockholders&#8217; equity driven by net income for the first half of 2021, partially offset by share repurchases. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2020, we raised our quarterly dividend from $0.41 to $0.42 per common share for dividends declared on or after such date by the Board. We anticipate that we will continue to pay quarterly cash dividends in the future. However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONCLUDED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and March 31, 2020, the carrying value of redeemable noncontrolling interests related to McKesson Europe of $1.3 billion and $1.4&#160;billion, respectively, exceeded the maximum redemption value of $1.2 billion. The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date. Upon the effectiveness of the Domination Agreement on December 2, 2014, the noncontrolling shareholders of McKesson Europe received a put right that enables them to put their McKesson Europe shares to McKesson at &#8364;22.99 per share, which price is increased annually for interest in the amount of 5 percentage points above a base rate published semiannually by the German Bundesbank, less any compensation amount or guaranteed dividend already paid (&#8220;Put Amount&#8221;). The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. During the six months ended September 30, 2020, we paid $49 million to purchase 1.8&#160;million shares of McKesson Europe through exercises of the put right by the noncontrolling shareholders. The ultimate amount and timing of any future cash payments related to the Put Amount are uncertain. Additionally, we are obligated to pay an annual recurring compensation of &#8364;0.83 per McKesson Europe share (the &#8220;Compensation Amount&#8221;) to the noncontrolling shareholders of McKesson Europe under the Domination Agreement. The Compensation Amount is recognized ratably during the applicable annual period. The Domination Agreement does not expire, but it may be terminated at the end of any fiscal year by giving at least six month&#8217;s advance notice. Refer to Financial Note 6, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Resources</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We fund our working capital requirements primarily with cash and cash equivalents as well as short-term borrowings from our credit facilities and commercial paper issuances. Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions. Detailed information regarding our debt and financing activities is included in Financial Note 9, &#8220;Debt and Financing Activities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. </span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_127"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTICE ABOUT FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q, including &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 2 of Part I of this report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Some of these statements can be identified by the use of terminology such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; &#8220;approximately,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; or the negative of these words and other comparable terminology. The discussion of financial trends, strategy, plans or intentions may also include forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date such statements were first made. We undertake no obligation to publicly release any updates or revisions to our forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. Although it is not possible to predict or identify all such risks and uncertainties, they include factors described in the Risk Factors discussion in Item 1A of Part I of our most recent Annual Report on Form 10-K, as updated in Item 1A of Part II of this report. The reader should not consider that discussion to be a complete statement of all potential risks and uncertainties.</span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_130"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Quantitative and Qualitative Disclosures about Market Risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe there has been no material change in our exposure to risks associated with fluctuations in interest and foreign currency exchange rates as disclosed in our 2020 Annual Report. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_133"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Controls and Procedures. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and our Chief Financial Officer, with the participation of other members of the Company&#8217;s management, have evaluated the effectiveness of the Company&#8217;s &#8220;disclosure controls and procedures&#8221; (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;)) as of the end of the period covered by this quarterly report, and our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective based on their evaluation of these controls and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our &#8220;internal control over financial reporting&#8221; (as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that occurred during the three months ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_136"></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_139"></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Legal Proceedings.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth in Financial Note 13, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q is incorporated herein by reference. </span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_142"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.8pt">Risk Factors.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as noted below, there have been no material changes during the period covered by this Quarterly Report on Form 10-Q to the risk factors disclosed in Part I, Item 1A, of our 2020 Annual Report.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate as a distributor in government-sponsored vaccination programs, such as the U.S. government&#8217;s Vaccines for Children program for childhood disease immunization and its Operation Warp Speed (&#8220;OWS&#8221;) program for COVID-19 vaccines. We also provide supplies used for vaccine administration in those programs. Our participation in such programs exposes us to various uncertainties. For example, the novel nature of the SARS-CoV&#8209;2 virus and the broad scope of the planned COVID-19 vaccine distribution program introduce uncertainty about which vaccine candidates may be approved, when such approvals may occur, what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution. Because of such uncertainties, our operating results may be subject to variability. Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges. Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business. Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.</span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_145"></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions,  accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2020, there were no share repurchases made under previously authorized share repurchase programs. During the three months ended September 30, 2020, the Company repurchased 1.8&#160;million of the Company&#8217;s shares for $269 million through open market transactions at an average price per share of $151.23. The total authorization outstanding for repurchases of the Company&#8217;s common stock was $1.3 billion at September 30, 2020.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on the Company&#8217;s share repurchases during the three months ended September 30, 2020.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.165%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.165%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price<br/>Paid&#160;Per&#160;Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased<br/>As Part of Publicly<br/>Announced<br/>Program</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate<br/>Dollar&#160;Value&#160;of<br/>Shares&#160;that&#160;May<br/>Yet Be Purchased Under the Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2020 &#8211; July 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2020 &#8211; August 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.66</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2020 &#8211; September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.93</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,267</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include shares tendered to satisfy the exercise price in connection with cashless exercises of employee stock options or shares tendered to satisfy tax withholding obligations in connection with employee equity awards. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_151"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Defaults Upon Senior Securities.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_154"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Mine Safety Disclosures.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_157"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Other Information.</span></div><div style="margin-bottom:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:24.75pt"><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_160"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Exhibits. </span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits identified in parentheses below are on file with the SEC and are incorporated by reference as exhibits hereto. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mckexhibit1019302020.htm">Forms of Statement of Terms and Conditions and Grant Notices Applicable to Awards Pursuant to the McKesson Corporation 2013 Stock Plan.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mckexhibit3119302020.htm">Certification of the Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mckexhibit3129302020.htm">Certification of the Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#8224;&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mckexhibit329302020.htm">Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the McKesson Corporation Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Statements of Operations, (ii) Condensed Consolidated Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Stockholders&#8217; Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) related Financial Notes.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Management contract or compensation plan or arrangement in which directors and/or executive officers are eligible to participate.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#8224;&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="iecfa0e5b7669406c886f8e2dcd87b845_163"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#iecfa0e5b7669406c886f8e2dcd87b845_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.217%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ORPORATION</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Britt J. Vitalone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.217%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ORPORATION</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Sundeep G. Reddy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sundeep G. Reddy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Controller</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>mckexhibit1019302020.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ia56010ee8cbf4f3b9bcb4e87e1909879_1"></div><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="padding-left:346.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">OUTSIDE DIRECTOR Div Equiv Cash</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">McKESSON CORPORATION  <br>STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO  <br>RESTRICTED STOCK UNITS GRANTED TO  <br>OUTSIDE DIRECTORS PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:136%">For Grants Beginning October 28, 2020</font></div><div style="margin-top:38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:136%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:136%;padding-left:28.34pt">INTRODUCTION</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The following terms and conditions shall apply to Restricted Stock Unit Awards granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:136%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:136%;padding-left:23.68pt">RESTRICTED STOCK UNITS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:27pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. A Restricted Stock Unit Award granted to an Outside Director under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Outside Director and the Corporation setting forth the terms and conditions of the Restricted Stock Unit Award. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions and together both documents shall constitute the Restricted Stock Unit Agreement. The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:27pt;text-decoration:underline">Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or times at which, grants of Restricted Stock Units will be made, the number of Units to be awarded, and all other terms and conditions of such awards. With respect to annual Restricted Stock Unit Awards granted to Outside Directors under the Plan, such awards shall be subject to the following terms, conditions and restrictions.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:19.36pt;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. Each Outside Director may be granted a Restricted Stock Unit Award on the date of each annual meeting of stockholders. An Outside Director that is elected to the Board between annual meetings of stockholders may also be granted a Restricted Stock Unit Award on the date that the Board determines in its sole discretion.</font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2013 Stock Plan STC (Outside Director)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:20.02pt;text-decoration:underline">Number of Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. Unless otherwise determined by the Board or the Governance Committee of the Board (the &#8220;Governance Committee&#8221;), the number of Units granted for the annual meeting grant will be determined by dividing the Fair Market Value of a Share on the date of grant into $180,000 (with any fractional Unit rounded up to the nearest whole Unit). In addition to such grant, unless otherwise determined by the Board or the Governance Committee, the Independent Chair shall be granted an annual meeting grant determined by dividing the Fair Market Value of a Share on the date of grant into $120,000 (with any fractional Unit rounded up to the nearest whole Unit). Notwithstanding the foregoing, in no event shall the aggregate number of Units granted to any Outside Director pursuant to such annual meeting grant or grants exceed 5,000. A newly elected Outside Director may receive a prorated annual meeting grant effective upon the date of the Outside Director&#8217;s election to the Board.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">No Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. Each Restricted Stock Unit Award granted to an Outside Director will be fully vested on the date of grant.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:27pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such units, will be credited on behalf of an Outside Director to a deferred cash account until such time as the underlying Shares are issued.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:27pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. An Outside Director shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:27pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Neither an Outside Director nor any person entitled to exercise an Outside Director&#8217;s rights in the event of the Outside Director&#8217;s death shall have any of the rights of a stockholder with respect to a Restricted Stock Unit Award except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the underlying Shares paid upon the settlement of any Restricted Stock Unit Award as described in Section II.6 below.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:27pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Except as noted in Section II.7 below, Restricted Stock Units granted to Outside Directors shall not be paid until after the Outside Director&#8217;s separation of service with the Corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Automatic Deferral Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Separation of service&#8221; shall have the meaning provided under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline"> the McKesson Corporation Deferred Compensation Administration Plan III (&#8220;DCAP III&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Payment shall be made in Shares in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Outside Director&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Unit Award.</font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:27pt;text-decoration:underline">Satisfaction of Director Stock Ownership Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. For those Outside Directors who have met the Director Stock Ownership Guidelines in effect at the time, Restricted Stock Unit grants shall not be subject to the Automatic Deferral Requirement and such grants will be immediately converted into Shares and distributed to the Outside Director&#59; provided, however, that the Outside Director may elect to defer receipt of the Shares underlying the Restricted Stock Units.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:27pt;text-decoration:underline">Deferrals of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. Deferrals of Restricted Stock Units, whether elective or pursuant to the Automatic Deferral Requirement, shall be subject to the terms and conditions of DCAP III.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">III. MISCELLANEOUS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Effect on Terms of Service with the Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Nothing contained in this Statement of Terms and Conditions, the Plan or a Restricted Stock Unit Agreement shall affect the Corporation&#8217;s right to terminate the service of any Outside Director.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Grants to Outside Directors in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If an Outside Director is not a United States citizen, the Board has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust a Restricted Stock Unit Award to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Outside Director&#8217;s participation in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Outside Director to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Any information required to be given under the terms of a Restricted Stock Unit Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 State Highway 161, Irving, Texas 75039, and any notice to be given to an Outside Director shall be addressed to the Outside Director at the address indicated beneath the Outside Director&#8217;s name on the Restricted Stock Unit Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office. The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein. Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient. Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.</font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. All decisions of the Administrator administering the Plan upon any questions arising under the Plan, under this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Nothing herein contained shall affect an Outside Director&#8217;s right, if any, to participate in and receive benefits from and in accordance with the then current provisions of any benefit plan or program offered by the Corporation.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal, state or local income tax withholding requirements or payroll tax requirements, if any is required.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%;padding-left:22.5pt">Data Privacy Information and Consent.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%;padding-left:15.52pt">Data Collection and Usage. The Corporation and the Employer may collect, process and use certain personal information about the Outside Director, including, but not limited to, the Outside Director&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares held in the Corporation, details of all Restricted Stock Units or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Outside Director&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Outside Director&#8217;s consent.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%;padding-left:15.52pt">Stock Plan Administration Service Providers. The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Outside Director may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%;padding-left:15.52pt">International Data Transfers. The Corporation and its service providers are based in the United States. The Outside Director&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. For example, the European Commission has issued a limited adequacy finding with respect to the United States that applies only to the extent companies register for the EU-U.S. Privacy Shield program. The Corporation&#8217;s legal basis, where required, for the transfer of Data is the Outside Director&#8217;s consent.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%;padding-left:14.86pt">Data Retention. The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Outside Director&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws. In the latter case, the Outside Director understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Outside Director&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Outside Director&#8217;s interests, rights or freedoms. When the Corporation no longer needs the Outside Director&#8217;s Data for any of the above purposes, the Outside Director understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:18pt;margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%;padding-left:15.52pt">Voluntariness and Consequences of Consent Denial or Withdrawal. Participation in the Plan is voluntary and the Outside Director is providing the consents herein on a purely voluntary basis. If the Outside Director does not consent, or if the Outside Director later seeks to revoke the Outside Director&#8217;s consent, the Outside Director&#8217;s retainer and fees from or services with the Corporation will not be affected&#59; the only consequence of refusing or withdrawing the Outside Director&#8217;s consent is that the Corporation would not be able to grant Awards to the Outside Director or administer or maintain such Awards.</font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(F)&#160;&#160;&#160;&#160;Data Subject Rights. The Outside Director may have a number of rights under data privacy laws in the Outside Director&#8217;s jurisdiction. Depending on where the Outside Director is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Outside Director and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Outside Director that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Outside Director&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Outside Director feels its processing is inappropriate, (v) request portability of the Outside Director&#8217;s Data that the Outside Director has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Outside Director&#8217;s service on the Board and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Outside Director&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data. To receive clarification regarding these rights or to exercise these rights, the Outside Director can contact the Corporate Secretary.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Outside Director is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Outside Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; as used herein shall include the Outside Director&#8217;s Beneficiary.</font></div><div style="margin-bottom:97pt;margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. The interpretation, performance, and enforcement of this Statement of Terms and Conditions and all Restricted Stock Unit Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><div id="ia56010ee8cbf4f3b9bcb4e87e1909879_31"></div><hr style="page-break-after:always"><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:1pt;padding-left:346.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">OUTSIDE DIRECTOR Div Equiv Units</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">McKESSON CORPORATION  <br>STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO  <br>RESTRICTED STOCK UNITS GRANTED TO  <br>OUTSIDE DIRECTORS PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:136%">For Grants Beginning October 28, 2020</font></div><div style="margin-top:38pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:136%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:136%;padding-left:23.84pt">INTRODUCTION</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">The following terms and conditions shall apply to Restricted Stock Unit Awards granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:136%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:136%;padding-left:19.18pt">RESTRICTED STOCK UNITS</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:27pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. A Restricted Stock Unit Award granted to an Outside Director under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Outside Director and the Corporation setting forth the terms and conditions of the Restricted Stock Unit Award. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions and together both documents shall constitute the Restricted Stock Unit Agreement. The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:27pt;text-decoration:underline">Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or times at which, grants of Restricted Stock Units will be made, the number of Units to be awarded, and all other terms and conditions of such awards. With respect to annual Restricted Stock Unit Awards granted to Outside Directors under the Plan, such awards shall be subject to the following terms, conditions and restrictions.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:14.86pt;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. Each Outside Director may be granted a Restricted Stock Unit Award on the date of each annual meeting of stockholders. An Outside Director that is elected to the Board between annual meetings of stockholders may also be granted a Restricted Stock Unit Award on the date that the Board determines in its sole discretion.</font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2013 Stock Plan STC (Outside Director)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:15.52pt;text-decoration:underline">Number of Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. Unless otherwise determined by the Board or the Governance Committee of the Board (the &#8220;Governance Committee&#8221;), the number of Units granted for the annual meeting grant will be determined by dividing the Fair Market Value of a Share on the date of grant into $180,000 (with any fractional Unit rounded up to the nearest whole Unit). In addition to such grant, unless otherwise determined by the Board or the Governance Committee, the Independent Chair shall be granted an annual meeting grant determined by dividing the Fair Market Value of a Share on the date of grant into $120,000 (with any fractional Unit rounded up to the nearest whole Unit). Notwithstanding the foregoing, in no event shall the aggregate number of Units granted to any Outside Director pursuant to such annual meeting grant or grants exceed 5,000. A newly elected Outside Director may receive a prorated annual meeting grant effective upon the date of the Outside Director&#8217;s election to the Board.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">No Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Each Restricted Stock Unit Award granted to an Outside Director will be fully vested on the date of grant.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Dividend equivalents in respect of Restricted Stock Units,</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">if granted in tandem with such units, will be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award. The number of such additional Restricted Stock Units shall be calculated by dividing</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.7pt">the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.02pt">the Fair Market Value per Share on the payment date for such dividend.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. An Outside Director shall not be permitted to sell, transfer, pledge,</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Neither an Outside Director nor any person entitled to</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">exercise an Outside Director&#8217;s rights in the event of the Outside Director&#8217;s death shall have any of the rights of a stockholder with respect to a Restricted Stock Unit Award except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the underlying Shares paid upon the settlement of any Restricted Stock Unit Award as described in Section II.6 below.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Except as noted in Section II.7 below,</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Restricted Stock Units granted to Outside Directors shall not be paid until after the Outside Director&#8217;s separation of service with the Corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Automatic Deferral Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Separation of service&#8221; shall have the meaning provided under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline"> the McKesson Corporation Deferred Compensation Administration Plan III (&#8220;DCAP III&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Payment shall be made in Shares in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Outside Director&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Unit Award. Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Satisfaction of Director Stock Ownership Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. For those Outside Directors</font></div><div style="margin-bottom:18pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">who have met the Director Stock Ownership Guidelines in effect at the time, Restricted Stock Unit grants shall not be subject to the Automatic Deferral Requirement and such grants will be immediately converted into Shares and distributed to the Outside Director&#59; provided, however, that the Outside Director may elect to defer receipt of the Shares underlying the Restricted Stock Units.</font></div><div style="margin-bottom:18pt;margin-top:1pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Deferrals of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Deferrals of Restricted Stock Units, whether elective or pursuant to the Automatic Deferral Requirement, shall be subject to the terms and conditions of DCAP III.</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">III. MISCELLANEOUS</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Effect on Terms of Service with the Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Nothing contained in this Statement of Terms and Conditions, the Plan or a Restricted Stock Unit Agreement shall affect the Corporation&#8217;s right to terminate the service of any Outside Director.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Grants to Outside Directors in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If an Outside Director is not a United States citizen, the Board has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust a Restricted Stock Unit Award to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Outside Director&#8217;s participation in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Outside Director to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Any information required to be given under the terms of a Restricted Stock Unit Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 State Highway 161, Irving, Texas 75039, and any notice to be given to an Outside Director shall be addressed to the Outside Director at the address indicated beneath the Outside Director&#8217;s name on the Restricted Stock Unit Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office. The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein. Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient. Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. All decisions of the Administrator administering the Plan upon any questions arising under the Plan, under this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:22.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. Nothing herein contained shall affect an Outside Director&#8217;s right, if any, to participate in and receive benefits from and in accordance with the then current provisions of any benefit plan or program offered by the Corporation.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:22.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal, state or local income tax withholding requirements or payroll tax requirements, if any is required.</font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:22.5pt">Data Privacy Information and Consent.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Data Collection and Usage. The Corporation and the Employer may collect, process and use certain personal information about the Outside Director, including, but not limited to, the Outside Director&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares held in the Corporation, details of all Restricted Stock Units or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Outside Director&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Outside Director&#8217;s consent.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Stock Plan Administration Service Providers. The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Outside Director may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">International Data Transfers. The Corporation and its service providers are based in the United States. The Outside Director&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. For example, the European Commission has issued a limited adequacy finding with respect to the United States that applies only to the extent companies register for the EU-U.S. Privacy Shield program. The Corporation&#8217;s legal basis, where required, for the transfer of Data is the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:18pt;margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:14.86pt">Data Retention. The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Outside Director&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws. In the latter case, the Outside Director understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Outside Director&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Outside Director&#8217;s interests, rights or freedoms. When the Corporation no longer needs the Outside Director&#8217;s Data for any of the above purposes, the Outside Director understands the Corporation will remove it from its systems.</font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:18pt;margin-top:1pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Voluntariness and Consequences of Consent Denial or Withdrawal. Participation in the Plan is voluntary and the Outside Director is providing the consents herein on a purely voluntary basis. If the Outside Director does not consent, or if the Outside Director later seeks to revoke the Outside Director&#8217;s consent, the Outside Director&#8217;s retainer and fees from or services with the Corporation will not be affected&#59; the only consequence of refusing or withdrawing the Outside Director&#8217;s consent is that the Corporation would not be able to grant Awards to the Outside Director or administer or maintain such Awards.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Data Subject Rights. The Outside Director may have a number of rights under data privacy laws in the Outside Director&#8217;s jurisdiction. Depending on where the Outside Director is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Outside Director and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Outside Director that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Outside Director&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Outside Director feels its processing is inappropriate, (v) request portability of the Outside Director&#8217;s Data that the Outside Director has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Outside Director&#8217;s service on the Board and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Outside Director&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data. To receive clarification regarding these rights or to exercise these rights, the Outside Director can contact the Corporate Secretary.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Outside Director is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:22.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Outside Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; as used herein shall include the Outside Director&#8217;s Beneficiary.</font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:83.25pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:56pt;margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The interpretation, performance, and enforcement of this Statement of Terms and Conditions and all Restricted Stock Unit Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:56pt;margin-top:12pt"><font><br></font></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><div id="ia56010ee8cbf4f3b9bcb4e87e1909879_61"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:1pt;padding-left:4.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">EXECUTIVE OFFICERS</font></div><div style="margin-top:14pt;padding-left:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">McKESSON CORPORATION  <br>STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO  <br>OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS  <br>AND PERFORMANCE STOCK UNITS GRANTED TO EXECUTIVE OFFICERS  <br>PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">Effective for Grants Beginning May 26, 2020</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%;padding-left:23.84pt">INTRODUCTION</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%;padding-left:19.18pt">OPTIONS</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option. Each Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement. The Option is also subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section II.4 as modified by the rules set forth in Sections II.5 and VI. The Option Period shall be not more than seven years from the Grant Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Vesting of Right to Exercise Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline"> </font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Subject to Sections II.5 and VI, an Option shall be exercisable during the Option Period in accordance with the vesting terms and conditions established on the Grant Date and specified in the Option Grant Notice.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2013 Stock Plan STC (EO)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections II.5 and VI. No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option. In no event shall the Corporation be required to issue fractional Shares.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Limits on Option Period and Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section VI), as follows&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long-Term Disability, Normal Retirement, Early Retirement, Severance under the circumstances provided in Section II.5(F)(ii), or death, the Option Period shall end on the earlier of (i) 90 days after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable at the time of such termination of employment. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">Notwithstanding any other provision in this Section II.5, if a Participant&#8217;s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:15.52pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Long-Term Disability, the vesting schedule of the Participant&#8217;s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Early Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.19pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Normal Retirement&#58;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:15.69pt">If such Normal Retirement occurs prior to the first anniversary of the Grant Date of the Option, such Option shall be subject to the provisions of Section II.5(D) as though the Participant were eligible for Early Retirement&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:12.36pt">If such Normal Retirement occurs on or after the first anniversary of the Grant Date of an Option, (a) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and</font></div><div style="margin-bottom:26pt;margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(b) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(F)&#160;&#160;&#160;&#160;If a Participant ceases to be a bona fide employee of the Corporation or of</font></div><div style="padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">its Affiliates during the Option Period by reason of Severance, and</font></div><div style="margin-top:12pt;padding-left:108pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(i)&#160;&#160;&#160;&#160;The Participant has attained the requirements for Normal</font></div><div style="padding-left:36pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Retirement on or prior to the Participant&#8217;s termination date, then such Option shall be subject to the Normal Retirement provisions of Section II.5(E)&#59; or</font></div><div style="margin-top:12pt;padding-left:108pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(ii)&#160;&#160;&#160;&#160;The Participant has not attained the requirements for Normal</font></div><div style="padding-left:36pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, and</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:4.7pt">The first anniversary of the Grant Date of the applicable Award has not occurred on or prior to the termination date, then such Option shall be subject to the Early Retirement provision in Section II.5(D)&#59; or</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:4.02pt">The first anniversary of the Grant Date of the applicable Award has occurred on or prior to the termination date, then (x) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (y) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date&#59; or</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:144pt"><font><br></font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(iii) The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then (a) the vesting schedule of the Participant&#8217;s Option shall be accelerated as to the portion of the Option that would have vested in accordance with the original vesting schedule as though the Participant had continued to be employed by the Corporation or one of its Affiliates six months after the termination date, and (b) the expiration of the Option Period provided in Section II.5(A) shall apply&#59; provided that if the Participant is also eligible for Early Retirement at the time of the termination of employment, then the expiration of the Option Period provided in Section II.5(D) shall apply.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(G)&#160;&#160;&#160;&#160;If a Participant should die (i) while in the employ of the Corporation or</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant&#8217;s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (a) three years after the date of death and (b) the Expiration Date, and the Participant&#8217;s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount) remaining on the date of death.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(H)&#160;&#160;&#160;&#160;If a Participant who ceases to be a bona fide employee of the Corporation</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (i) such time as the Participant subsequently terminates employment and (ii) the Expiration Date. Upon the Participant&#8217;s subsequent termination of employment, the post-termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant&#8217;s initial termination of employment and the Participant's re-hire date&#59; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (G) and shall not be adjusted as described in this Section II.5(H).</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised. Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following&#58; cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States. Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise. The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant&#8217;s personal check. Payment may also be made by delivery (including by FAX transmission) to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VIII.6) and to transfer the proceeds of such sale to the Corporation.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof&#59; provided that such assurance shall be deemed inapplicable to (i) any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be) filed and become effective under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and with respect to which no stop order suspending the effectiveness thereof has been issued, and (ii) any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:18pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">As soon as practicable after receipt of the notice and the assurance described in Sections II.6(A) and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section VIII.6) and without other incidental expense to the Participant, credit the purchased Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the purchased Shares&#59; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Limitations on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. An Option shall, during a Participant&#8217;s lifetime, be exercisable only by the Participant. No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution. Notwithstanding the foregoing&#58; (A) a Participant may designate a beneficiary to succeed, after the Participant&#8217;s death, to all of the Participant&#8217;s Options outstanding on the date of death&#59; (B) a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act&#59; and (C) any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant) in exchange for an interest in that entity. In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to such Shares upon the exercise of an Option.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">III. RESTRICTED STOCK</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award. Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement. The Restricted Stock Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:20pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Rights with Respect to Shares of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s interest in the Restricted Stock. From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator&#59; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Until the restrictions imposed on any Restricted Stock grant shall lapse (the &#8220;Restriction Period&#8221;), Shares of Restricted Stock granted to a Participant (i) shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii) shall, if the Participant&#8217;s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan, or in Section III.3(B) or Section III.3(C)) be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">Death or Long-Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Award, the restrictions applicable to such Restricted Stock Award shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period&#59; provided, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-top:14pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b) would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Award shall be subject to the Normal Retirement provisions of Section III.3(B)(ii)&#59; or</font></div><div style="margin-top:14pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Award shall lapse upon the Participant&#8217;s termination date, as to such Shares of Restricted Stock that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the Participant&#8217;s termination date.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:14pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding the foregoing, this Section III.3(C) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="margin-top:14pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the vesting and settlement of a Restricted Stock Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award. Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Election to Recognize Gross Income in the Year of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If any Participant validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section VIII.6, and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Restrictive Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Each book entry in the records of the Corporation&#8217;s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and&#47;or the Restricted Stock Agreement.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Expiration of Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant&#8217;s interest in the unrestricted Shares shall be entered on the records of the Corporation&#8217;s transfer agent.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">IV.&#160;&#160;&#160;&#160;RESTRICTED STOCK UNITS</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement. The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Restricted Stock Units granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section IV.2(B) or Section IV.2(C)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision contained to the contrary in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:20.19pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.86pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Units, the restrictions applicable to such Restricted Stock Units shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:14pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Unit Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-top:14pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b) would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Unit Award shall be subject to the Normal Retirement provisions of Section IV.2(B)(ii)&#59; or</font></div><div style="margin-top:14pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Unit Award shall lapse upon the termination date, as to such Restricted Stock Units that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the termination date.</font></div><div style="margin-top:14pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of Restricted Stock Units, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Subject to the discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units. Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units, and cash dividends shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit Award, and to which the cash dividends relate, are distributed. Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units, including the same vesting restrictions as the underlying Award.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Upon the lapse of the restriction imposed on Restricted Stock Units, all Restricted Stock Units that were not forfeited pursuant to Section IV.2(A), Section IV.2(B)(i), Section IV.2(C)(i), or Section VI shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse. Payment shall be made in Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement, or is eligible for additional vesting under Section IV.2(C)(ii), prior to the date of the lapse of restrictions imposed on Restricted Stock Units and the vesting provisions of Section IV.2(B)(ii) or Section IV.2(C)(ii) apply, then such Restricted Stock Units shall be paid to the Participant&#8217;s brokerage account of record as soon as reasonably practicable after the earlier of the Participant&#8217;s Separation from Service or the originally scheduled vesting date (in any event before the end of the calendar year in which such date occurs), subject to the delay of payment (if applicable) provided in Section VIII.14. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Unit Award due to a Participant&#8217;s Normal Retirement eligibility or additional vesting as provided in Section IV.2(C)(ii).</font></div><div style="margin-top:12pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">V.&#160;&#160;&#160;&#160;PERFORMANCE STOCK UNITS</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Performance Stock Unit Awards shall be evidenced by a Performance Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Stock Unit Award. Performance Stock Unit Awards are &#8220;Other Share-Based Awards&#8221; as provided under Section 11 of the Plan. Each Performance Stock Unit Agreement shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Stock Unit Agreement. Performance Stock Unit Awards are also subject to the terms and conditions of the Plan.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Number of Shares Granted Based on Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The performance period of a Performance Stock Unit Award shall be greater than one year, and performance shall be based on such criteria as the Compensation Committee shall determine in its discretion at the beginning of the performance period. Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved, and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Special Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Performance Stock Unit Awards shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Compensation Committee, consistent with the terms of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section V.3(B) or Section V.3(C)) prior to the end of the performance period, any then-outstanding Performance Stock Units shall be canceled, and all the rights of the Participant to such Award shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Compensation Committee may otherwise expressly determine.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision contained herein or in the Plan or the Award Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the applicable performance period, a prorated portion of each such Performance Stock Unit Award, equal to (1) the target number of Performance Stock Units subject to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:138%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(2) the performance criteria determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:138%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(3) a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period applicable to such Award, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause (3), &#8220;whole calendar months&#8221; shall be calculated commencing on the applicable Grant Date&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in the Performance Stock Unit Grant Notice&#59; or</font></div><div style="margin-bottom:20pt;margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through the date on which the Compensation Committee determines performance against the applicable performance goals.</font></div><div style="margin-bottom:20pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Amounts, if any, to be paid under this Section V.3(B) shall be paid in accordance with Section V.7 and, if applicable, Section VIII.14.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b) would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any Performance Stock Unit Award shall be subject to the Normal Retirement provisions of Section V.3(B)(ii)&#59; or</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:126pt"><font><br></font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then if such Participant&#8217;s termination date is no greater than six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, such Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through such performance determination date.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">Amounts, if any, to be paid under this Section V.3(C) shall be paid in accordance with Section V.7 and, if applicable, Section VIII.14.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Restriction on Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives with respect to the settlement of a Performance Stock Unit Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be accrued with respect to Performance Stock Unit Awards during the performance period.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:22.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">. A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit Award.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to a Performance Stock Unit Award, except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any Performance Stock Unit Award.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt;text-decoration:underline">Time of Payment of Performance Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. The Compensation Committee shall determine the extent to which Shares are payable pursuant to a Performance Stock Unit Award as soon as practicable following the end of the performance period, and such Shares shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A. Payment shall be made in the form of Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares earned pursuant to the Performance Stock Unit Award.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">VI.&#160;&#160;&#160;&#160;SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation. In addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise. In addition, if the restrictions imposed on any Award of Restricted Stock or Restricted Stock Units (including any unpaid dividends or Dividend Equivalents) lapsed, or any Performance Stock Unit Award was settled, within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)&#160;&#160;&#160;&#160;Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know-how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product. Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:15.52pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">Fails to provide the Corporation with at least 30 days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates. As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.19pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.85pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Fails to meet the Participant&#8217;s continuing obligations with respect to nondisclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Any provision of this Section VI which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">VII. CHANGE IN CONTROL</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;) which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option&#59; (ii) in the case of a Performance Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Performance Stock Unit Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such Replacement Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Stock Unit Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Stock Unit Award shall be replaced with a Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Unit Award shall be equal to the number of Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the replacement Award&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14).</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">VIII. MISCELLANEOUS</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Grants to Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office. The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein, and a delivery receipt and a read receipt are made part of the message. Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient. Emails to the Corporation shall be delivered to CorpSecretary&#64;mckesson.com.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Nothing herein contained shall affect a Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:24pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (1) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (2) withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; or (3) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined. In no event, however, shall the Corporation be required to issue fractional Shares. With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">To avoid negative accounting treatment, the Corporation may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:22.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">. The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:15.52pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%;padding-left:14.86pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.19pt">the Award and the Shares subject to the Award, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.85pt">the Award will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:14.86pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:14.86pt">if the underlying Shares do not increase in value, the Options will have no value&#59;</font></div><div style="margin-bottom:19pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:19.53pt">in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever, and whether or not such forfeiture is later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; provided that, notwithstanding the foregoing, in the event any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:18.86pt">for purposes of an Award, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law (for example, the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee for purposes of an Award (including whether the Participant may still be considered to be providing services while on a leave of absence)&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.19pt">Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-top:12pt;padding-left:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;text-decoration:underline"> </font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Data Collection and Usage. The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Stock Plan Administration Service Providers. The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">International Data Transfers. The Corporation and its service providers are based in the United States. The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. For example, the European Commission has issued a limited adequacy finding with respect to the United States that applies only to the extent companies register for the EU-U.S. Privacy Shield program. The Corporation&#8217;s legal basis, where required, for the transfer of Data is the Participant&#8217;s consent.</font></div><div style="margin-top:13pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:14.86pt">Data Retention. The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws. In the latter case, the Participant understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Participant&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Participant&#8217;s interests, rights or freedoms. When the Corporation no longer needs the Participant&#8217;s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Voluntariness and Consequences of Consent Denial or Withdrawal. Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:13pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Data Subject Rights. The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction. Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Participant and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Participant that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Participant feels its processing is inappropriate, (v) request portability of the Participant&#8217;s Data that the Participant has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant&#8217;s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data. To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">Finally, the Participant understands that the Corporation may rely on a different legal basis for the processing or transfer of Data in the future and&#47;or request that the Participant provide another data privacy consent form. If applicable and upon request of the Corporation, the Participant agrees to provide an executed acknowledgement or data privacy consent form to the Employer or the Corporation (or any other acknowledgements, agreements or consents that may be required by the Employer or the Corporation) that the Corporation and&#47;or the Employer may deem necessary to obtain under the data privacy laws in the Participant&#8217;s country, either now or in the future. The Participant understands that the Participant will not be able to participate in the Plan if the Participant fails to execute any such acknowledgement, agreement or consent requested by the Corporation and&#47;or the Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of the Plan and this Statement of Terms and Conditions. If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:22pt;margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.5pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. If (A) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (B) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">IX. DEFINITIONS</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Early Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means a termination of employment (other than due to death, Long-Term Disability or for Cause) which occurs prior to Normal Retirement but on or after the date on which the Participant&#8217;s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term &#8220;service&#8221; shall include years and completed whole months of service.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)-1(e) of the Exchange Act, as such Rule may be amended from time to time. Notwithstanding the foregoing, the Administrator may designate any other person(s) or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:19.36pt">Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:20.02pt">Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:15.52pt">Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59; or</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.19pt">Any change in the person to whom the Participant reports, as this relationship existed immediately prior to a Change in Control&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means the date that an Option expires as set forth in the Option Grant Notice as the &#8220;Expiration Date.&#8221;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means termination of employment (other than due to death, Long-Term Disability or for Cause) at or after age 60 (57, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, &#8220;service&#8221; shall mean completed whole years of service (12 consecutive months).</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">&#8221; means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section II.5, ending on the Expiration Date.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means termination of employment with the Corporation or an affiliate, and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan, in accordance with the terms and conditions of such plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div style="margin-bottom:432pt;margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Stock Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means the Corporation&#8217;s Stock Ownership Policy, as amended from time to time, which can be found on McKNet. A Participant or a Participant&#8217;s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></div></div></div><div id="ia56010ee8cbf4f3b9bcb4e87e1909879_187"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:1pt;padding-left:4.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">EMPLOYEES SUBJECT TO STOCK OWNERSHIP POLICY</font></div><div style="margin-top:14pt;padding-left:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">McKESSON CORPORATION  <br>STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO  <br>OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS  <br>AND PERFORMANCE STOCK UNITS GRANTED TO EMPLOYEES SUBJECT TO  <br>STOCK OWNERSHIP POLICY PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">Effective for Grants Beginning May 26, 2020</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%;padding-left:23.84pt">INTRODUCTION</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%;padding-left:19.18pt">OPTIONS</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option. Each Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement. The Option is also subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section II.4 as modified by the rules set forth in Sections II.5 and VI. The Option Period shall be not more than seven years from the Grant Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Vesting of Right to Exercise Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline"> </font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Subject to Sections II.5 and VI, an Option shall be exercisable during the Option Period in accordance with the vesting terms and conditions established on the Grant Date and specified in the Option Grant Notice.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2013 Stock Plan STC (Emp Subj to SOP)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections II.5 and VI. No Option may be exercised for less than 5% of the total</font></div><div style="margin-top:1pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">number of Shares then available for exercise under such Option. In no event shall the Corporation be required to issue fractional Shares.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Limits on Option Period and Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section VI), as follows&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long-Term Disability, Normal Retirement, Early Retirement, Severance under the circumstances provided in Section II.5(F)(ii), or death, the Option Period shall end on the earlier of (i) 90 days after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable at the time of such termination of employment. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">Notwithstanding any other provision in this Section II.5, if a Participant&#8217;s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:15.52pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Long-Term Disability, the vesting schedule of the Participant&#8217;s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Early Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.19pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Normal Retirement&#58;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:15.69pt">If such Normal Retirement occurs prior to the first anniversary of the Grant Date of the Option, such Option shall be subject to the provisions of Section II.5(D) as though the Participant were eligible for Early Retirement&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:12.36pt">If such Normal Retirement occurs on or after the first anniversary of the Grant Date of an Option, (a) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and</font></div><div style="margin-bottom:26pt;margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(b) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(F)&#160;&#160;&#160;&#160;If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Severance, and</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(i)&#160;&#160;&#160;&#160;The Participant has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, then such Option shall be subject to the Normal Retirement provisions of Section II.5(E)&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(ii)  The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, and</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:4.7pt">The first anniversary of the Grant Date of the applicable Award has not occurred on or prior to the termination date, then such Option shall be subject to the Early Retirement provision in Section II.5(D)&#59; or</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:4.02pt">The first anniversary of the Grant Date of the applicable Award has occurred on or prior to the termination date, then (x) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (y) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date&#59; or</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:144pt"><font><br></font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(iii) The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then (a) the vesting schedule of the Participant&#8217;s Option shall be accelerated as to the portion of the Option that would have vested in accordance with the original vesting schedule as though the Participant had continued to be employed by the Corporation or one of its Affiliates six months after the termination date, and (b) the expiration of the Option Period provided in Section II.5(A) shall apply&#59; provided that if the Participant is also eligible for Early Retirement at the time of the termination of employment, then the expiration of the Option Period provided in Section II.5(D) shall apply.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(G)&#160;&#160;&#160;&#160;If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant&#8217;s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (a) three years after the date of death and (b) the Expiration Date, and the Participant&#8217;s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount) remaining on the date of death.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(H)&#160;&#160;&#160;&#160;If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (i) such time as the Participant subsequently terminates employment and (ii) the Expiration Date. Upon the Participant&#8217;s subsequent termination of employment, the post-termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant&#8217;s initial termination of employment and the Participant's re-hire date&#59; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (G) and shall not be adjusted as described in this Section II.5(H).</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised. Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following&#58; cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States. Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise. The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant&#8217;s personal check. Payment may also be made by delivery (including by FAX transmission) to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VIII.6) and to transfer the proceeds of such sale to the Corporation.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof&#59; provided that such assurance shall be deemed inapplicable to (i) any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be) filed and become effective under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and with respect to which no stop order suspending the effectiveness thereof has been issued, and (ii) any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:18pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">As soon as practicable after receipt of the notice and the assurance described in Sections II.6(A) and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section VIII.6) and without other incidental expense to the Participant, credit the purchased Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the purchased Shares&#59; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Limitations on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. An Option shall, during a Participant&#8217;s lifetime, be exercisable only by the Participant. No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution. Notwithstanding the foregoing&#58; (A) a Participant may designate a beneficiary to succeed, after the Participant&#8217;s death, to all of the Participant&#8217;s Options outstanding on the date of death&#59; (B) a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act&#59; and (C) any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant) in exchange for an interest in that entity. In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to such Shares upon the exercise of an Option.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">III. RESTRICTED STOCK</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award. Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement. The Restricted Stock Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:20pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Rights with Respect to Shares of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s interest in the Restricted Stock. From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator&#59; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Until the restrictions imposed on any Restricted Stock grant shall lapse (the &#8220;Restriction Period&#8221;), Shares of Restricted Stock granted to a Participant (i) shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii) shall, if the Participant&#8217;s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan, or in Section III.3(B) or Section III.3(C)) be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">Death or Long-Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Award, the restrictions applicable to such Restricted Stock Award shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period&#59; provided, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-top:14pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b) would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Award shall be subject to the Normal Retirement provisions of Section III.3(B)(ii)&#59; or</font></div><div style="margin-top:14pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Award shall lapse upon the Participant&#8217;s termination date, as to such Shares of Restricted Stock that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the Participant&#8217;s termination date.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:14pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding the foregoing, this Section III.3(C) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="margin-top:14pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the vesting and settlement of a Restricted Stock Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award. Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Election to Recognize Gross Income in the Year of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If any Participant validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section VIII.6, and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Restrictive Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Each book entry in the records of the Corporation&#8217;s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and&#47;or the Restricted Stock Agreement.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Expiration of Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant&#8217;s interest in the unrestricted Shares shall be entered on the records of the Corporation&#8217;s transfer agent.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">IV.&#160;&#160;&#160;&#160;RESTRICTED STOCK UNITS</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement. The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Restricted Stock Units granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section IV.2(B) or Section IV.2(C)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision contained to the contrary in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:20.19pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.86pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Units, the restrictions applicable to such Restricted Stock Units shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:14pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Unit Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-top:14pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b) would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Unit Award shall be subject to the Normal Retirement provisions of Section IV.2(B)(ii)&#59; or</font></div><div style="margin-top:14pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Unit Award shall lapse upon the termination date, as to such Restricted Stock Units that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the termination date.</font></div><div style="margin-top:14pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of Restricted Stock Units, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Subject to the discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units. Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units, and cash dividends shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit Award, and to which the cash dividends relate, are distributed. Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units, including the same vesting restrictions as the underlying Award.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Upon the lapse of the restriction imposed on Restricted Stock Units, all Restricted Stock Units that were not forfeited pursuant to Section IV.2(A), Section IV.2(B)(i), Section IV.2(C)(i), or Section VI shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse. Payment shall be made in Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement, or is eligible for additional vesting under Section IV.2(C)(ii), prior to the date of the lapse of restrictions imposed on Restricted Stock Units and the vesting provisions of Section IV.2(B)(ii) or Section IV.2(C)(ii) apply, then such Restricted Stock Units shall be paid to the Participant&#8217;s brokerage account of record as soon as reasonably practicable after the earlier of the Participant&#8217;s Separation from Service or the originally scheduled vesting date (in any event before the end of the calendar year in which such date occurs), subject to the delay of payment (if applicable) provided in Section VIII.14. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Unit Award due to a Participant&#8217;s Normal Retirement eligibility or additional vesting as provided in Section IV.2(C)(ii).</font></div><div style="margin-top:12pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">V.&#160;&#160;&#160;&#160;PERFORMANCE STOCK UNITS</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Performance Stock Unit Awards shall be evidenced by a Performance Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Stock Unit Award. Performance Stock Unit Awards are &#8220;Other Share-Based Awards&#8221; as provided under Section 11 of the Plan. Each Performance Stock Unit Agreement shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Stock Unit Agreement. Performance Stock Unit Awards are also subject to the terms and conditions of the Plan.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Number of Shares Granted Based on Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The performance period of a Performance Stock Unit Award shall be greater than one year, and performance shall be based on such criteria as the Compensation Committee shall determine in its discretion at the beginning of the performance period. Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved, and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Special Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Performance Stock Unit Awards shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Compensation Committee, consistent with the terms of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section V.3(B) or Section V.3(C)) prior to the end of the performance period, any then-outstanding Performance Stock Units shall be canceled, and all the rights of the Participant to such Award shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Compensation Committee may otherwise expressly determine.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision contained herein or in the Plan or the Award Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the applicable performance period, a prorated portion of each such Performance Stock Unit Award, equal to (1) the target number of Performance Stock Units subject to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:138%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(2) the performance criteria determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:138%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(3) a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period applicable to such Award, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause (3), &#8220;whole calendar months&#8221; shall be calculated commencing on the applicable Grant Date&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in the Performance Stock Unit Grant Notice&#59; or</font></div><div style="margin-bottom:20pt;margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through the date on which the Compensation Committee determines performance against the applicable performance goals.</font></div><div style="margin-bottom:20pt;margin-top:1pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">Amounts, if any, to be paid under this Section V.3(B) shall be paid in accordance with Section V.7 and, if applicable, Section VIII.14.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b) would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any Performance Stock Unit Award shall be subject to the Normal Retirement provisions of Section V.3(B)(ii)&#59; or</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then if such Participant&#8217;s termination date is no greater than six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, such Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through such performance determination date.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">Amounts, if any, to be paid under this Section V.3(C) shall be paid in accordance with Section V.7 and, if applicable, Section VIII.14.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Restriction on Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives with respect to the settlement of a Performance Stock Unit Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be accrued with respect to Performance Stock Unit Awards during the performance period.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:22.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">. A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit Award.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to a Performance Stock Unit Award, except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any Performance Stock Unit Award.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt;text-decoration:underline">Time of Payment of Performance Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. The Compensation Committee shall determine the extent to which Shares are payable pursuant to a Performance Stock Unit Award as soon as practicable following the end of the performance period, and such Shares shall </font></div><div style="margin-top:1pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A. Payment shall be made in the form of Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares earned pursuant to the Performance Stock Unit Award.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:1pt;padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="margin-top:12pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">VI.&#160;&#160;&#160;&#160;SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation. In addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise. In addition, if the restrictions imposed on any Award of Restricted Stock or Restricted Stock Units (including any unpaid dividends or Dividend Equivalents) lapsed, or any Performance Stock Unit Award was settled, within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)&#160;&#160;&#160;&#160;Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know-how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product. Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:15.52pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">Fails to provide the Corporation with at least 30 days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates. As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.19pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.85pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Fails to meet the Participant&#8217;s continuing obligations with respect to nondisclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Any provision of this Section VI which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">VII. CHANGE IN CONTROL</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;) which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option&#59; (ii) in the case of a Performance Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Performance Stock Unit Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such Replacement Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Stock Unit Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Stock Unit Award shall be replaced with a Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Unit Award shall be equal to the number of Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14).</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">VIII. MISCELLANEOUS</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Grants to Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office. The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein, and a delivery receipt and a read receipt are made part of the message. Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient. Emails to the Corporation shall be delivered to CorpSecretary&#64;mckesson.com.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Nothing herein contained shall affect a Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:24pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (1) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (2) withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; or (3) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined. In no event, however, shall the Corporation be required to issue fractional Shares. With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">To avoid negative accounting treatment, the Corporation may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:22.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">. The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:15.52pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%;padding-left:14.86pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.19pt">the Award and the Shares subject to the Award, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.85pt">the Award will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:14.86pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:14.86pt">if the underlying Shares do not increase in value, the Options will have no value&#59;</font></div><div style="margin-bottom:19pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:19.53pt">in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever, and whether or not such forfeiture is later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; provided that, notwithstanding the foregoing, in the event any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:18.86pt">for purposes of an Award, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law (for example, the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee for purposes of an Award (including whether the Participant may still be considered to be providing services while on a leave of absence)&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.19pt">Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-top:12pt;padding-left:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;text-decoration:underline"> </font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Data Collection and Usage. The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:22pt;margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Stock Plan Administration Service Providers. The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">International Data Transfers. The Corporation and its service providers are based in the United States. The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. For example, the European Commission has issued a limited adequacy finding with respect to the United States that applies only to the extent companies register for the EU-U.S. Privacy Shield program. The Corporation&#8217;s legal basis, where required, for the transfer of Data is the Participant&#8217;s consent.</font></div><div style="margin-top:13pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:14.86pt">Data Retention. The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws. In the latter case, the Participant understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Participant&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Participant&#8217;s interests, rights or freedoms. When the Corporation no longer needs the Participant&#8217;s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Voluntariness and Consequences of Consent Denial or Withdrawal. Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:13pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Data Subject Rights. The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction. Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Participant and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Participant that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Participant feels its processing is inappropriate, (v) request portability of the Participant&#8217;s Data that the Participant has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant&#8217;s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data. To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">Finally, the Participant understands that the Corporation may rely on a different legal basis for the processing or transfer of Data in the future and&#47;or request that the Participant provide another data privacy consent form. If applicable and upon request of the Corporation, the Participant agrees to provide an executed acknowledgement or data privacy consent form to the Employer or the Corporation (or any other acknowledgements, agreements or consents that may be required by the Employer or the Corporation) that the Corporation and&#47;or the Employer may deem necessary to obtain under the data privacy laws in the Participant&#8217;s country, either now or in the future. The Participant understands that the Participant will not be able to participate in the Plan if the Participant fails to execute any such acknowledgement, agreement or consent requested by the Corporation and&#47;or the Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of the Plan and this Statement of Terms and Conditions. If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:22pt;margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.5pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. If (A) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (B) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:22pt;margin-top:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">IX. DEFINITIONS</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Early Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means a termination of employment (other than due to death, Long-Term Disability or for Cause) which occurs prior to Normal Retirement but on or after the date on which the Participant&#8217;s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term &#8220;service&#8221; shall include years and completed whole months of service.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)-1(e) of the Exchange Act, as such Rule may be amended from time to time. Notwithstanding the foregoing, the Administrator may designate any other person(s) or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)&#160;&#160;&#160;&#160;Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59; provided, however, that, any such change attributable to the Corporation&#8217;s no longer being a company with publicly traded common stock shall not constitute Good Reason&#59; and provided, further, that a reduction in the Participant&#8217;s functions, duties or responsibilities solely by virtue of the Corporation being acquired and made part of a larger entity (for example, if following a Change in Control the Participant retains the Participant&#8217;s position, or has a comparable position, with respect to a division or subsidiary of the acquirer that contains the Corporation&#8217;s business) shall not constitute Good Reason&#59;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:20.02pt">Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:20.02pt">Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; or</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:19.36pt">The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means the date that an Option expires as set forth in the Option Grant Notice as the &#8220;Expiration Date.&#8221;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">&#8221; means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means termination of employment (other than due to death, Long-Term Disability or for Cause) at or after age 60 (57, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, &#8220;service&#8221; shall mean completed whole years of service (12 consecutive months).</font></div><div style="margin-bottom:29pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">&#8221; means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section II.5, ending on the Expiration Date.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:1pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means termination of employment with the Corporation or an affiliate, and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan, in accordance with the terms and conditions of such plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div style="margin-bottom:377pt;margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Stock Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means the Corporation&#8217;s Stock Ownership Policy, as amended from time to time, which can be found on McKNet. A Participant or a Participant&#8217;s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</font></div></div></div><div id="ia56010ee8cbf4f3b9bcb4e87e1909879_310"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:1pt;padding-left:4.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">EMPLOYEES</font></div><div style="margin-top:14pt;padding-left:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">McKESSON CORPORATION  <br>STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO  <br>OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS  <br>AND PERFORMANCE STOCK UNITS GRANTED TO EMPLOYEES  <br>PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">Effective for Grants Beginning May 26, 2020</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%;padding-left:23.84pt">INTRODUCTION</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%;padding-left:19.18pt">OPTIONS</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option. Each Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement. The Option is also subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section II.4 as modified by the rules set forth in Sections II.5 and VI. The Option Period shall be not more than seven years from the Grant Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Vesting of Right to Exercise Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline"> </font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Subject to Sections II.5 and VI, an Option shall be exercisable during the Option Period in accordance with the vesting terms and conditions established on the Grant Date and specified in the Option Grant Notice.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2013 Stock Plan STC (Employee)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections II.5 and VI. No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option. In no event shall the Corporation be required to issue fractional Shares.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Limits on Option Period and Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section VI), as follows&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long-Term Disability, Normal Retirement, Early Retirement, Severance under the circumstances provided in Section II.5(F)(ii), or death, the Option Period shall end on the earlier of (i) 90 days after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable at the time of such termination of employment. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">Notwithstanding any other provision in this Section II.5, if a Participant&#8217;s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:15.52pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Long-Term Disability, the vesting schedule of the Participant&#8217;s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Early Retirement, (i) the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii) the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.19pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Normal Retirement&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:15.69pt">If such Normal Retirement occurs prior to the first anniversary of the Grant Date of the Option, such Option shall be subject to the provisions of Section II.5(D) as though the Participant were eligible for Early Retirement&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:12.36pt">If such Normal Retirement occurs on or after the first anniversary of the Grant Date of an Option, (a) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(b) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(F)&#160;&#160;&#160;&#160;If a Participant ceases to be a bona fide employee of the Corporation or of</font></div><div style="padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">its Affiliates during the Option Period by reason of Severance, and</font></div><div style="margin-top:12pt;padding-left:108pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(i)&#160;&#160;&#160;&#160;The Participant has attained the requirements for Normal</font></div><div style="padding-left:36pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Retirement on or prior to the Participant&#8217;s termination date, then such Option shall be subject to the Normal Retirement provisions of Section II.5(E)&#59; or</font></div><div style="margin-top:12pt;padding-left:108pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(ii)&#160;&#160;&#160;&#160;The Participant has not attained the requirements for Normal</font></div><div style="padding-left:36pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, and</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:4.7pt">The first anniversary of the Grant Date of the applicable Award has not occurred on or prior to the termination date, then such Option shall be subject to the Early Retirement provision in Section II.5(D)&#59; or</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-align:justify;text-indent:126pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:4.02pt">The first anniversary of the Grant Date of the applicable Award has occurred on or prior to the termination date, then (x) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (y) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date&#59; or</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:144pt"><font><br></font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(iii) The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then (a) the vesting schedule of the Participant&#8217;s Option shall be accelerated as to the portion of the Option that would have vested in accordance with the original vesting schedule as though the Participant had continued to be employed by the Corporation or one of its Affiliates six months after the termination date, and (b) the expiration of the Option Period provided in Section II.5(A) shall apply&#59; provided that if the Participant is also eligible for Early Retirement at the time of the termination of employment, then the expiration of the Option Period provided in Section II.5(D) shall apply.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(G)&#160;&#160;&#160;&#160;If a Participant should die (i) while in the employ of the Corporation or</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant&#8217;s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (a) three years after the date of death and (b) the Expiration Date, and the Participant&#8217;s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount) remaining on the date of death.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(H)&#160;&#160;&#160;&#160;If a Participant who ceases to be a bona fide employee of the Corporation</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (i) such time as the Participant subsequently terminates employment and (ii) the Expiration Date. Upon the Participant&#8217;s subsequent termination of employment, the post-termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant&#8217;s initial termination of employment and the Participant's re-hire date&#59; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (G) and shall not be adjusted as described in this Section II.5(H).</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised. Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following&#58; cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States. Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise. The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant&#8217;s personal check. Payment may also be made by delivery (including by FAX transmission) to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VIII.6) and to transfer the proceeds of such sale to the Corporation.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof&#59; provided that such assurance shall be deemed inapplicable to (i) any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be) filed and become effective under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and with respect to which no stop order suspending the effectiveness thereof has been issued, and (ii) any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:18pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">As soon as practicable after receipt of the notice and the assurance described in Sections II.6(A) and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section VIII.6) and without other incidental expense to the Participant, credit the purchased Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the purchased Shares&#59; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Limitations on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. An Option shall, during a Participant&#8217;s lifetime, be exercisable only by the Participant. No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution. Notwithstanding the foregoing&#58; (A) a Participant may designate a beneficiary to succeed, after the Participant&#8217;s death, to all of the Participant&#8217;s Options outstanding on the date of death&#59; (B) a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act&#59; and (C) any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant) in exchange for an interest in that entity. In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to such Shares upon the exercise of an Option.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">III. RESTRICTED STOCK</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award. Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement. The Restricted Stock Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Rights with Respect to Shares of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s interest in the Restricted Stock. From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator&#59; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Until the restrictions imposed on any Restricted Stock grant shall lapse (the &#8220;Restriction Period&#8221;), Shares of Restricted Stock granted to a Participant (i) shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii) shall, if the Participant&#8217;s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan, or in Section III.3(B) or Section III.3(C)) be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">Death or Long-Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Award, the restrictions applicable to such Restricted Stock Award shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period&#59; provided, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-top:14pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b) would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Award shall be subject to the Normal Retirement provisions of Section III.3(B)(ii)&#59; or</font></div><div style="margin-top:14pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Award shall lapse upon the Participant&#8217;s termination date, as to such Shares of Restricted Stock that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the Participant&#8217;s termination date.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:14pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding the foregoing, this Section III.3(C) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="margin-top:14pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award. Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Election to Recognize Gross Income in the Year of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If any Participant validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section VIII.6, and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.</font></div><div style="margin-top:15pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Restrictive Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Each book entry in the records of the Corporation&#8217;s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and&#47;or the Restricted Stock Agreement.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Expiration of Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant&#8217;s interest in the unrestricted Shares shall be entered on the records of the Corporation&#8217;s transfer agent.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">IV.&#160;&#160;&#160;&#160;RESTRICTED STOCK UNITS</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement. The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Restricted Stock Units granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section IV.2(B) or Section IV.2(C)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision contained to the contrary in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Units, the restrictions applicable to such</font></div><div style="margin-top:1pt;padding-left:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Restricted Stock Units shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:1pt;padding-left:40.5pt;text-align:justify"><font><br></font></div><div style="margin-top:14pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Unit Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-top:14pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b) would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Unit Award shall be subject to the Normal Retirement provisions of Section IV.2(B)(ii)&#59; or&#59;</font></div><div style="margin-top:14pt;padding-left:40.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Unit Award shall lapse upon the termination date, as to such Restricted Stock Units that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the termination date.</font></div><div style="margin-top:14pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Subject to the discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units. Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units, and cash dividends shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit Award, and to which the cash dividends relate, are distributed. Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units, including the same vesting restrictions as the underlying Award.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.</font></div><div style="margin-bottom:42pt;margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:1pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Upon the lapse of the restriction imposed on Restricted Stock Units, all Restricted Stock Units that were not forfeited pursuant to Section IV.2(A), Section IV.2(B)(i), Section IV.2(C)(i), or Section VI shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse. Payment shall be made in Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement, or is eligible for additional vesting under Section IV.2(C)(ii), prior to the date of the lapse of restrictions imposed on Restricted Stock Units and the vesting provisions of Section IV.2(B)(ii) or Section IV.2(C)(ii) apply, then such Restricted Stock Units shall be paid to the Participant&#8217;s brokerage account of record as soon as reasonably practicable after the earlier of the Participant&#8217;s Separation from Service or the originally scheduled vesting date (in any event before the end of the calendar year in which such date occurs), subject to the delay of payment (if applicable) provided in Section VIII.14. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility or additional vesting as provided in Section IV.2(C)(ii).</font></div><div style="margin-top:12pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">V.&#160;&#160;&#160;&#160;PERFORMANCE STOCK UNITS</font></div><div style="margin-top:13pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Performance Stock Unit Awards shall be evidenced by a Performance Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Stock Unit Award. Performance Stock Unit Awards are &#8220;Other Share-Based Awards&#8221; as provided under Section 11 of the Plan. Each Performance Stock Unit Agreement shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Stock Unit Agreement. Performance Stock Unit Awards are also subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Number of Shares Granted Based on Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The performance period of a Performance Stock Unit Award shall be greater than one year, and performance shall be based on such criteria as the Compensation Committee shall determine in its discretion at the beginning of the performance period. Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved, and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Special Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Performance Stock Unit Awards shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Compensation Committee, consistent with the terms of the Plan.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section V.3(B) or Section V.3(C)) prior to the end of the performance period, any then-outstanding Performance Stock Units shall be canceled, and all the rights of the Participant to such Award shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Compensation Committee may otherwise expressly determine.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision contained herein or in the Plan or the Award Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the applicable performance period, a prorated portion of each such Performance Stock Unit Award, equal to (1) the target number of Performance Stock Units subject to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:138%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(2) the performance criteria determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:138%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(3) a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period applicable to such Award, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause (3), &#8220;whole calendar months&#8221; shall be calculated commencing on the applicable Grant Date&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in the Performance Stock Unit Grant Notice&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through the date on which the Compensation Committee determines performance against the applicable performance goals.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Amounts, if any, to be paid under this Section V.3(B) shall be paid in accordance with Section V.7 and, if applicable, Section VIII.14.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:72pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-top:12pt;padding-left:148.5pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)&#160;&#160;&#160;&#160;The Participant either (a) has attained the requirements for</font></div><div style="padding-left:40.5pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Normal Retirement on or prior to the Participant&#8217;s termination date or (b) would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any Performance Stock Unit Award shall be subject to the Normal Retirement provisions of Section V.3(B)(ii)&#59; or</font></div><div style="margin-top:12pt;padding-left:144pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(ii)&#160;&#160;&#160;&#160;The Participant has not attained the requirements for</font></div><div style="padding-left:36pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then if such Participant&#8217;s termination date is no greater than six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, such Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through such performance determination date.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">Amounts, if any, to be paid under this Section V.3(C) shall be paid in accordance with Section V.7 and, if applicable, Section VIII.14.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be accrued with respect to Performance Stock Unit Awards during the performance period.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit Award.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:22.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to a Performance Stock Unit Award, except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any Performance Stock Unit Award.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:58.5pt"><font><br></font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Time of Payment of Performance Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Compensation Committee shall determine the extent to which Shares are payable pursuant to a Performance Stock Unit Award as soon as practicable following the end of the performance period, and such Shares shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A. Payment shall be made in the form of Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares earned pursuant to the Performance Stock Unit Award.</font></div><div style="margin-top:12pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">VI.&#160;&#160;&#160;&#160;SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">1.&#160;&#160;&#160;&#160;Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation. In addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise. In addition, if the restrictions imposed on any Award of Restricted Stock or Restricted Stock Units (including any unpaid dividends or Dividend Equivalents) lapsed, or any Performance Stock Unit Award was settled, within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know-how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product. Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">Fails to provide the Corporation with at least 30 days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates. As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-bottom:22pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.19pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.85pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Fails to meet the Participant&#8217;s continuing obligations with respect to nondisclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Any provision of this Section VI which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section VI.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">VII. CHANGE IN CONTROL</font></div><div style="margin-bottom:24pt;margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;) which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option&#59; (ii) in the case of a Performance Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Performance Stock Unit Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such Replacement Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Stock Unit Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Stock Unit Award shall be replaced with a Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Unit Award shall be equal to the number of Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14).</font></div><div style="margin-top:12pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">VIII. MISCELLANEOUS</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.</font></div><div style="margin-bottom:18pt;margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Grants to Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:18pt;margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:58.5pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office. The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein, and a delivery receipt and a read receipt are made part of the message. Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient. Emails to the Corporation shall be delivered to CorpSecretary&#64;mckesson.com.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Nothing herein contained shall affect a Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:46pt;margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:1pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (1) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (2) withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; or (3) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined. In no event, however, shall the Corporation be required to issue fractional Shares. With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">To avoid negative accounting treatment, the Corporation may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:27pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:27pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:27pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:15.52pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%;padding-left:14.86pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.19pt">the Award and the Shares subject to the Award, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.85pt">the Award will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:14.86pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:14.86pt">if the underlying Shares do not increase in value, the Options will have no value&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:19.53pt">in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever, and whether or not such forfeiture is later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; provided that, notwithstanding the foregoing, in the event any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:18.86pt">for purposes of an Award, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law (for example, the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee for purposes of an Award (including whether the Participant may still be considered to be providing services while on a leave of absence)&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:14.86pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.19pt">Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-top:12pt;padding-left:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:139%;text-decoration:underline"> </font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Data Collection and Usage. The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Stock Plan Administration Service Providers. The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">International Data Transfers. The Corporation and its service providers are based in the United States. The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. For example, the European Commission has issued a limited adequacy finding with respect to the United States that applies only to the extent companies register for the EU-U.S. Privacy Shield program. The Corporation&#8217;s legal basis, where required, for the transfer of Data is the Participant&#8217;s consent.</font></div><div style="margin-top:13pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:14.86pt">Data Retention. The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws. In the latter case, the Participant understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Participant&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Participant&#8217;s interests, rights or freedoms. When the Corporation no longer needs the Participant&#8217;s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Voluntariness and Consequences of Consent Denial or Withdrawal. Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:13pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Data Subject Rights. The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction. Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Participant and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Participant that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Participant feels its processing is inappropriate, (v) request portability of the Participant&#8217;s Data that the Participant has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant&#8217;s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data. To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">Finally, the Participant understands that the Corporation may rely on a different legal basis for the processing or transfer of Data in the future and&#47;or request that the Participant provide another data privacy consent form. If applicable and upon request of the Corporation, the Participant agrees to provide an executed acknowledgement or data privacy consent form to the Employer or the Corporation (or any other acknowledgements, agreements or consents that may be required by the Employer or the Corporation) that the Corporation and&#47;or the Employer may deem necessary to obtain under the data privacy laws in the Participant&#8217;s country, either now or in the future. The Participant understands that the Participant will not be able to participate in the Plan if the Participant fails to execute any such acknowledgement, agreement or consent requested by the Corporation and&#47;or the Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.5pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of the Plan and this Statement of Terms and Conditions. If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.5pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. If (A) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (B) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">IX. DEFINITIONS</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Early Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means a termination of employment (other than due to death, Long-Term Disability or for Cause) which occurs prior to Normal Retirement but on or after the date on which the Participant&#8217;s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term &#8220;service&#8221; shall include years and completed whole months of service.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)-1(e) of the Exchange Act, as such Rule may be amended from time to time. Notwithstanding the foregoing, the Administrator may designate any other person(s) or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59; provided, however, that, any such change attributable to the Corporation&#8217;s no longer being a company with publicly traded common stock shall not constitute Good Reason&#59; and provided, further, that a reduction in the Participant&#8217;s functions, duties or responsibilities solely by virtue of the Corporation being acquired and made part of a larger entity (for example, if following a Change in Control the Participant retains the Participant&#8217;s position, or has a comparable position, with respect to a division or subsidiary of the acquirer that contains the Corporation&#8217;s business) shall not constitute Good Reason&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:15.52pt">Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:15.52pt">Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; or</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)&#160;&#160;&#160;&#160;The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">&#8221; means the date that an Option expires as set forth in the Option Grant Notice as the &#8220;Expiration Date.&#8221;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means termination of employment (other than due to death, Long-Term Disability or for Cause) at or after age 60 (57, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, &#8220;service&#8221; shall mean completed whole years of service (12 consecutive months).</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section II.5, ending on the Expiration Date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means termination of employment with the Corporation or an affiliate, and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan, in accordance with the terms and conditions of such plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan.</font></div><div style="margin-bottom:593pt;margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></div></div></div><div id="ia56010ee8cbf4f3b9bcb4e87e1909879_430"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:1pt;padding-left:4.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:132%">SPECIAL INCENTIVE AWARD</font></div><div style="margin-top:14pt;padding-left:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">McKESSON CORPORATION  <br>STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO  <br>FY 2019 SPECIAL INCENTIVE AWARD  <br>PERFORMANCE STOCK UNITS AND RESTRICTED STOCK UNITS  <br>GRANTED PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-top:38pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:132%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:23.84pt">INTRODUCTION&#59; GRANT DATE</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The following terms and conditions shall apply to the special incentive (the &#8220;Special Incentive Award&#8221;) of Performance Stock Units (&#8220;PSUs&#8221;) and Restricted Stock Units (&#8220;RSUs&#8221;) granted under the Plan and subject to the terms and conditions of the Plan. The Grant Date of the</font></div><div style="padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Special Incentive Award is &#91;&#160;&#160;&#160;&#160;&#93;, 2018. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:132%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:19.18pt">PERFORMANCE STOCK UNITS</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">The Special Incentive Award includes a target Award of &#91;&#160;&#160;&#160;&#160;&#93; Performance Stock Units (the &#8220;PSU Award&#8221;), which is subject to the terms and conditions set forth herein. The PSU Award is an &#8220;Other Share-Based Award&#8221; as provided under Section 11 of the Plan. The PSU Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Lapse of Performance Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline"> </font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt;text-decoration:underline">Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The performance goals applicable to the PSU Award are attached as Exhibit A to this Statement of Terms and Conditions. The vesting and payment of the PSU Award is also subject to Section II.3, Section II.4 and Section IV.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt;text-decoration:underline">Payment of Earned PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. As soon as practicable following the end of the performance period, Compensation Committee shall determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Fifty percent (50%) of the Shares underlying earned PSUs shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A. The remaining fifty percent (50%) of such earned PSUs shall be subject to one additional year of vesting service and shall be evidenced by the issuance of a One-Year RSU Award on the terms and conditions set forth in Section II.4.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2013 Stock Plan 2018 Special Incentive</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Service Prior to Determination of Performance Against Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline"> </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section II.3(B) or Section II.3(C)) prior to the lapse of the performance restrictions imposed on the PSU Award, this PSU Award shall be canceled, and all the rights of the Participant to the PSU Award shall immediately terminate. If the Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision contained herein or in the Plan, if the Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of the PSU Award ceases to be a bona fide employee of the Corporation or an Affiliate prior to completion of the performance period as a result of&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:20.19pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the performance period, an amount in cash equal to the value of a prorated portion of the PSU Award, equal to (1) the target number of PSUs subject to the PSU Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:138%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(2) the performance results determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:138%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(3) a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause (3), &#8220;whole calendar months&#8221; shall be calculated commencing on April 1, 2018&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in Exhibit A&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.86pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to receive, following completion of the performance period, an amount in cash equal to the value of the earned PSUs, paid in installments at the same times as actively employed holders of PSU Awards and calculated as though the Participant had continued to be employed by the Corporation or one of its Affiliates during the entire performance period and additional one-year vesting period applicable to the One-Year RSU Award as set forth in Section II.4.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and the Participant&#8217;s termination date is within six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, and&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.69pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then the Participant shall be eligible to receive an amount in cash equal to one-half (1&#47;2) of the value of the earned PSUs, paid at the same time as actively employed holders of PSU Awards are paid the first installment of Shares, and calculated as though the Participant had continued to be employed by the Corporation or one of its Affiliates during the entire performance period&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:12.36pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, such Participant shall be eligible for the Normal Retirement benefit set forth in Section II.3(B)(ii).</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Grant of One-Year RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the PSU Award, if any, an award of Restricted Stock Units with respect to one-half (50%) of such earned PSUs (the &#8220;One-Year RSU Award&#8221;) will be granted to the Participant on the terms and conditions set forth below and subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">The restrictions applicable to the One-Year RSU Award shall lapse with respect to 100% of the underlying Shares on the first anniversary of the Grant Date with respect to such One-Year RSU Award, subject to Section II.4(C) and Section IV.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Dividend equivalents shall be credited in respect of the One-Year RSU Award. Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the One-Year RSU Award, and cash dividends, along with accrued interest (if any) on such cash dividends, shall be paid in a lump sum at the same time that the Shares underlying the One-Year RSU Award are distributed. Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the One-Year RSU Award.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline"> </font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section II.4(C)(ii) or Section II.4(C)(iii)) prior to the lapse of the restrictions imposed on the One-Year RSU Award, any unvested Restricted Stock Units subject to the One-Year RSU Award shall be canceled, and all the rights of the Participant to the One-Year RSU Award shall immediately terminate. If the Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-top:12pt;padding-left:108pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. Notwithstanding any provision contained to the contrary herein, if the Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of the One-Year RSU Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of</font></div><div style="margin-top:12pt;padding-left:112.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:18.2pt">Death or Long-Term Disability, then the restrictions imposed on the One-Year RSU Award shall lapse on the date of such termination&#59; or</font></div><div style="margin-top:12pt;padding-left:112.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:17.52pt">Normal Retirement, the One-Year RSU Award shall not be cancelled and will vest and be paid on the first anniversary of such Grant Date, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="padding-left:76.5pt;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the applicable Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and the Participant&#8217;s termination date is within six months prior to the date on which such RSU Award is scheduled to vest and be paid, the restrictions applicable to such RSU Award shall lapse upon the termination date.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font><br></font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Payment of Performance Stock Units and Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Except as provided with respect to the payment of earned PSUs in cash following certain terminations of employment under Section II.3, payment shall be made in Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Performance Stock Units or Restricted Stock Units, as applicable.</font></div><div style="margin-top:12pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">III. THREE-YEAR RESTRICTED STOCK UNITS</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Special Incentive Award includes an Award of &#91;&#160;&#160;&#160;&#160;&#93; Restricted Stock Units (the &#8220;RSU Award&#8221;), which is subject to the terms and conditions set forth herein. The RSU Award also subject to the terms and conditions of the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third anniversary of the Grant Date, subject to Sections III.4 and IV.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III. Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on such RSU Award, and cash dividends, along with accrued interest (if any) on such cash dividends, shall be paid in a lump sum at the same time that the Shares underlying such RSU Award are distributed. Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the applicable RSU Award, including the same vesting restrictions as the RSU Award.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:4.5pt;text-indent:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline"> </font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(A)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section III.4(B) or Section III.4(C)) prior to the lapse of the restrictions imposed on the Award, any unvested Restricted Stock Units subject to the RSU Award shall be canceled, and all the rights of the Participant to such portion of the RSU Award shall immediately terminate. If the Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(B)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. Notwithstanding any provision contained to the contrary herein, if the Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of the RSU Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:20.19pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.86pt">Normal Retirement on or after the first anniversary of the Grant Date of the RSU Award, such award shall not be cancelled and will vest and be paid on the third anniversary of such Grant Date, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(C)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the applicable Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and the Participant&#8217;s termination date is within six months prior to the date on which such RSU Award is scheduled to vest and be paid, the restrictions applicable to such RSU Award shall lapse upon the termination date.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">. Upon the lapse of the restriction imposed on the Restricted Stock Units, such units that were not otherwise forfeited pursuant to the terms of the Plan and this Award Agreement shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse. Payment shall be made in Shares to the Participant&#8217;s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.</font></div><div style="margin-top:12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">IV.&#160;&#160;&#160;&#160;SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that the Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:22.5pt">Performance Stock Units and Restricted Stock Units, to the extent the restrictions have not lapsed, shall immediately and automatically be forfeited.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">If the restrictions imposed on an RSU Award (including any unpaid Dividend Equivalents) lapsed within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to the PSU Award and any RSU Award, measured at the date on which Shares (or cash, if applicable) was paid in respect of the PSU Award or on which such RSU Award vested.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-top:13pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know-how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product. Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">Fails to provide the Corporation with at least 30 days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates. As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.19pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.85pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="margin-top:12pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Fails to meet the Participant&#8217;s continuing obligations with respect to nondisclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Any provision of this Section IV which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section IV.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">V.&#160;&#160;&#160;&#160;CHANGE IN CONTROL</font></div><div style="margin-bottom:24pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any portion of the PSU Award or an RSU Award granted hereby (for purposes of this Section V, &#8220;RSU Award&#8221; shall include time-vesting RSU awards granted under Section III or Section IV) that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;), which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of the PSU Award, shall consist of restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the PSU Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such restricted stock units lapsing at the end of the PSU Award&#8217;s performance period, with continued vesting after the Change in Control based only on continued service to the Corporation or an Affiliate, as though a time-based vesting award&#59; and (ii) in the case of an RSU Award, shall consist of restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the RSU Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VI.17), based on the fair market value of the underlying shares on the vesting date. If any portion of the PSU Award or an RSU Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of the PSU Award, such Award shall vest based upon deemed attainment of target performance or actual performance achieved, if greater, if such Change in Control occurs during the performance period.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, (i) any unvested portion of the PSU Award shall continue to vest with respect to that number of Shares that reflects the deemed attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control, such vesting occurring at such time or times as (x) performance would have been measured and (y) the related RSU Award would have vested absent such Change in Control, and (ii) any unvested portion of an RSU Award shall continue to vest according to the terms and conditions of such Award and&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of this PSU Award or an RSU Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VI.17), based on the fair market value of the underlying Shares on the vesting date.</font></div><div style="margin-top:12pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:132%">VI.&#160;&#160;&#160;&#160;PARTICIPANT RIGHTS&#59; MISCELLANEOUS</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If the Participant is covered by the Stock Ownership Policy at the time of settlement of an Award granted hereunder, the Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Participant shall not be permitted to sell, transfer, pledge, assign or encumber the Performance Stock Units or Restricted Stock Units granted hereby, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Neither the Participant nor any person entitled to exercise the Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Performance Stock Units or Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any such Award.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of the Participant at any time.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards granted hereby to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the Awards granted hereby and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Any information required to be given under the terms of the Awards granted hereby shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, California 94104, and any notice to be given to the Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under this Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Nothing herein contained shall affect the Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant or vesting of the Award, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (ii) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (i) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (ii) withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; or (iii) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined. In no event, however, shall the Corporation be required to issue fractional Shares. If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">To avoid negative accounting treatment, the Corporation may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Plan, this Statement of Terms and Conditions and applicable Grant Notices shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.5pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">. In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:15.52pt">the grant of the Awards is voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:15.52pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:136%;padding-left:14.86pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.19pt">the Special Incentive Award is not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:16.85pt">the Awards will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Awards will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:14.86pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">in consideration of the grant of the Awards, no claim or entitlement to compensation or damages shall arise from forfeiture of the Awards which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Awards, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:19.53pt">for purposes of the Awards, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:18.86pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:14.86pt">Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-top:12pt;padding-left:40.5pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;text-decoration:underline"> </font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Data Collection and Usage. The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Stock Plan Administration Service Providers. The Corporation transfers Data to Merrill Lynch and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">International Data Transfers. The Corporation and its service providers are based in the United States. The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. For example, the European Commission has issued a limited adequacy finding with respect to the United States that applies only to the extent companies register for the EU-U.S. Privacy Shield program. The Corporation&#8217;s legal basis, where required, for the transfer of Data is the Participant&#8217;s consent.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:14.86pt">Data Retention. The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%;padding-left:15.52pt">Voluntariness and Consequences of Consent Denial or Withdrawal. Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">(F)&#160;&#160;&#160;&#160;Data Subject Rights. The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction. Depending on where the Participant is based, such rights may include the right to (i) request access or copies of Data the Corporation processes, (ii) rectification of incorrect Data, (iii) deletion of Data, (iv) restrictions on processing of Data, (v) portability of Data, (vi) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (vii) receive a list with the names and addresses of any potential recipients of Data. To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">Finally, the Participant understands that the Corporation may rely on a different legal basis for the processing or transfer of Data in the future and&#47;or request that the Participant provide another data privacy consent form. If applicable and upon request of the Corporation, the Participant agrees to provide an executed acknowledgement or data privacy consent form to the Employer or the Corporation (or any other acknowledgements, agreements or consents that may be required by the Employer or the Corporation) that the Corporation and&#47;or the Employer may deem necessary to obtain under the data privacy laws in the Participant&#8217;s country, either now or in the future. The Participant understands that the Participant will not be able to participate in the Plan if the Participant fails to execute any such acknowledgement, agreement or consent requested by the Corporation and&#47;or the Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If the Participant has received this Award Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:58.5pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">. If (i) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (ii) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:137%">VII. DEFINITIONS</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">When capitalized in this Award Agreement, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#8221; means the documents between the Participant and the Corporation evidencing the grant of the PSU Award and the RSU Award, the terms of which are set forth herein and in the Plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)-1(e) of the Exchange Act, as such Rule may be amended from time to time. Notwithstanding the foregoing, the Administrator may designate any other person(s) or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:19.36pt">Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:140%;padding-left:20.02pt">Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:20.02pt">Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:19.36pt">The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59; or</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:16.19pt">Any change in the person to whom the Participant reports, as this relationship existed immediately prior to a Change in Control&#59;</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means termination of employment with the Corporation or an Affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an Affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an Affiliate (or, if providing service to the Corporation or an Affiliate for less than three years, such lesser period).</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;padding-left:22.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:137%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div style="margin-bottom:95pt;margin-top:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:16.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;text-decoration:underline">Stock Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means the Corporation&#8217;s Stock Ownership Policy, as amended from time to time, which can be found on McKNet. A Participant or the Participant&#8217;s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, CA 94104.</font></div><div style="margin-bottom:95pt;margin-top:12pt"><font><br></font></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><div id="ia56010ee8cbf4f3b9bcb4e87e1909879_508"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">OUTSIDE DIRECTOR</font></div><div style="padding-left:27pt;text-align:center"><font><br></font></div><div style="padding-left:27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">FORM OF</font></div><div style="padding-left:27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">MCKESSON CORPORATION 2013 STOCK PLAN</font></div><div style="margin-bottom:23pt;padding-left:27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">RESTRICTED STOCK UNIT GRANT </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:70.993%"><tr><td style="width:1.0%"></td><td style="width:49.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.336%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grantee Name&#58;</font></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Number of RSUs Granted&#58;</font></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Vesting Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">100% vested on grant date.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">McKesson Corporation (the &#8220;Company&#8221;) is pleased to grant you restricted stock units (&#8220;RSUs&#8221;) under the Company&#8217;s 2013 Stock Plan, as may be amended from time to time (the &#8220;Plan&#8221;) to receive shares of common stock of the Company (&#8220;Shares&#8221;). This Grant Notice (&#8220;Notice&#8221;), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the &#8220;ST&#38;Cs&#8221;), constitute your Restricted Stock Unit Agreement, which along with the Plan set forth the terms of your grant.</font></div><div style="margin-top:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Below is a list of documents that are made available to you in connection with this Notice. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This grant, along with any other outstanding awards under the Plan, can be viewed on the Fidelity web site at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">www.Netbenefits.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">By signing below, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; </font></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.75pt">I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of the McKesson website at www.mckesson.com&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.75pt">I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360)&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.75pt">I have access to the Company&#8217;s web site&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.75pt">I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.75pt">The Plan and ST&#38;Cs are incorporated by reference to this Notice&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.75pt">The Company recommends that the Grantee consult with a tax advisor prior to accepting or vesting of this grant of RSUs&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.75pt">I accept ALL the terms and conditions as set forth in the Plan and the ST&#38;Cs applicable to this grant of RSUs.</font></div><div style="margin-top:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:91.025%"><tr><td style="width:1.0%"></td><td style="width:28.301%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.733%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grantee Signature</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ATTACHMENTS&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">* 2013 Stock Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">* 2013 Stock Plan Prospectus for Non-Employee Directors</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">* ST&#38;Cs</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">* Hedging and Pledging Policy</font></div><div style="margin-top:23pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:102%">July 2019</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ia56010ee8cbf4f3b9bcb4e87e1909879_514"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:1pt;padding-right:13.5pt;text-align:right"><font style="color:#16365d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">Employee</font></div><div style="margin-top:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">FORM OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">MCKESSON CORPORATION 2013 STOCK PLAN</font></div><div style="margin-bottom:23pt;padding-left:27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">RESTRICTED STOCK UNIT GRANT NOTICE</font></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:70.317%"><tr><td style="width:1.0%"></td><td style="width:49.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.336%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grantee Name&#58;</font></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Number of RSUs Granted&#58;</font></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Please see Appendix</font></td></tr></table></div><div style="padding-right:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">McKesson Corporation (the &#8220;Company&#8221;) is pleased to grant you restricted stock units (&#8220;RSUs&#8221;) under the Company&#8217;s 2013 Stock Plan (the &#8220;Plan&#8221;) which represent the contingent right to receive shares of common stock of the Company (&#8220;Shares&#8221;). This Grant Notice (&#8220;Notice&#8221;), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the &#8220;ST&#38;Cs&#8221;), constitute your Restricted Stock Unit Agreement. Your Restricted Stock Unit Agreement and your RSUs are subject to the terms of the Plan, which incorporates by reference the Company&#8217;s Compensation Recoupment Policy (the &#8220;Recoupment Policy&#8221;) and the Company&#8217;s Stock Ownership Policy (the &#8220;Stock Ownership Policy&#8221;), as both are amended from time to time).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a list of documents that are made available to you in connection with this Notice. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This grant, along with any other outstanding awards under the Plan, can be viewed on the Fidelity web site at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.Netbenefits.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">By signing below, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> </font></div><div style="margin-top:3pt;padding-left:18pt;padding-right:13.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">I agree to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with the laws outside the United States, from the Company&#8217;s website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of the McKesson website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">www.mckesson.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#59; and</font></div><div style="padding-left:18pt;padding-right:13.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%;padding-left:10.5pt">I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360)&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">I have access to the Company&#8217;s web site&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice&#59; and</font></div><div style="padding-left:18pt;padding-right:13.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">The Plan (including the Recoupment Policy and Stock Ownership Policy) and ST&#38;Cs are incorporated by reference to this Notice&#59; and</font></div><div style="padding-left:18pt;padding-right:13.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">The Company recommends that the Grantee consult with a tax advisor prior to accepting or vesting of this grant of RSUs&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">I accept ALL the terms and conditions as set forth in the Plan and ST&#38;Cs applicable to this grant of RSUs.</font></div><div style="margin-bottom:11pt;margin-top:12pt;padding-right:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div style="margin-bottom:11pt;margin-top:12pt;padding-right:13.5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:90.158%"><tr><td style="width:1.0%"></td><td style="width:28.301%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.733%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grantee Signature</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:14pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:102%">ATTACHMENTS&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:103%">* 2013 Stock Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:103%">* 2013 Stock Plan Prospectus</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:103%">* ST&#38;Cs</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:103%">* Compensation Recoupment Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:103%">* Hedging and Pledging Policy (Section 16 only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:103%">* Stock Ownership Policy (EOT only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:103%">* Appendix (Outside U.S. &#8211; country-specific)</font></div><div style="margin-top:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:103%">May 2019</font></div><div><font><br></font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ia56010ee8cbf4f3b9bcb4e87e1909879_520"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:118%">FORM OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:118%">MCKESSON CORPORATION 2013 STOCK PLAN</font></div><div style="margin-bottom:23pt;padding-left:27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">PERFORMANCE STOCK UNIT GRANT NOTICE</font></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:62.836%"><tr><td style="width:1.0%"></td><td style="width:49.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.336%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grantee Name&#58;</font></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Target PSUs Granted&#58;</font></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Performance Period</font></td><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:0 1pt"></td></tr></table></div><div style="padding-right:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">McKesson Corporation (the &#8220;Company&#8221;) is pleased to grant you target performance stock units (&#8220;PSUs&#8221;) under the Company&#8217;s 2013 Stock Plan (the &#8220;Plan&#8221;). This Grant Notice (&#8220;Notice&#8221;), together with the Statement of Terms and Conditions, as provided with this Notice (the &#8220;ST&#38;Cs&#8221;), constitute your Performance Stock Unit Agreement. Your Performance Stock Unit Agreement and your PSUs are subject to the terms of the Plan, which incorporates by reference the Company&#8217;s Compensation Recoupment Policy (the &#8220;Recoupment Policy&#8221;), and the Company&#8217;s Stock Ownership Policy (the &#8220;Stock Ownership Policy&#8221;), as both are amended from time to time.</font></div><div><font><br></font></div><div style="padding-right:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Your PSUs will be earned subject to the Company&#8217;s attainment of performance goals that have been pre-established by the Compensation Committee (the &#8220;Committee&#8221;) of the Company&#8217;s Board of Directors. You may receive 0% - 200% of the target number of PSUs set forth above. PSUs, if earned, will be paid in the form of shares of the Company&#8217;s Common Stock (&#8220;Shares&#8221;) that are not subject to any further vesting restrictions. The Committee has the sole discretion to determine the Company&#8217;s performance against the pre-established goals after completion of the performance period, and to authorize the grant of Shares.</font></div><div style="margin-top:11pt;padding-right:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">Below is a list of documents that are made available to you in connection with this Notice. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:117%">PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">This grant, along with any other outstanding awards under the Plan, can be viewed on the Fidelity web site at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:117%">www.Netbenefits.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">.</font></div><div style="margin-top:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">By signing below, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> </font></div><div style="margin-top:3pt;padding-left:18pt;padding-right:13.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">I agree to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with the laws outside the United States, from the Company&#8217;s website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of the McKesson website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">www.mckesson.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#59; and</font></div><div style="padding-left:18pt;padding-right:13.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360)&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%;padding-left:10.5pt">I have access to the Company&#8217;s web site&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice&#59; and</font></div><div style="padding-left:18pt;padding-right:13.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%;padding-left:10.5pt">The Plan (including the Recoupment Policy and Stock Ownership Policy) and ST&#38;Cs are incorporated by reference to this Notice&#59; and</font></div><div style="padding-left:18pt;padding-right:13.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%;padding-left:10.5pt">I accept ALL the terms and conditions as set forth in the Plan and ST&#38;Cs applicable to this grant of PSUs.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-right:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:80.567%"><tr><td style="width:1.0%"></td><td style="width:28.301%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.733%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grantee Signature</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Plan Documents and Related Policies</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:104%">* 2013 Stock Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:103%">* 2013 Stock Plan Prospectus</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:104%">* ST&#38;Cs</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:104%">* Compensation Recoupment Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:103%">* Hedging and Pledging Policy (Section 16 only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:101%">* Stock Ownership Policy (EOT only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:104%">* Appendix (Outside U.S. - country specific)</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:104%">May 2019</font></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>mckexhibit3119302020.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i958695adff0d46f2b70fee2964eab58a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian S. Tyler, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>mckexhibit3129302020.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i9d3828feafb14d5cbbd63f1ac6a6dfa7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Britt J. Vitalone, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>mckexhibit329302020.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="icbb766ef12704401919f9724e34a6d0e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the quarterly report of McKesson Corporation (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, in the capacities and on the dates indicated below, each hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:29pt;padding-left:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160; Brian S. Tyler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:41pt;padding-left:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Report pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to McKesson Corporation and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>mck-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:f15aa9b5-be6e-4b9d-af45-f9d5f89227d0,g:ffd6c493-ffba-42d6-bea4-20131f0e9c42-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mck="http://mckesson123.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mckesson123.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://mckesson123.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentinChangeHealthcareJointVenture" roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture">
        <link:definition>2104102 - Disclosure - Investment in Change Healthcare Joint Venture</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentinChangeHealthcareJointVentureDetails" roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails">
        <link:definition>2405402 - Disclosure - Investment in Change Healthcare Joint Venture (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSale" roleURI="http://mckesson123.com/role/HeldforSale">
        <link:definition>2106103 - Disclosure - Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleTables" roleURI="http://mckesson123.com/role/HeldforSaleTables">
        <link:definition>2307301 - Disclosure - Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleNarrativeDetails" roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails">
        <link:definition>2408403 - Disclosure - Held for Sale - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails">
        <link:definition>2409404 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedCharges" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges">
        <link:definition>2110104 - Disclosure - Restructuring, Impairment and Related Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesTables" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables">
        <link:definition>2311302 - Disclosure - Restructuring, Impairment and Related Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNarrativeDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails">
        <link:definition>2412405 - Disclosure - Restructuring, Impairment and Related Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails">
        <link:definition>2413406 - Disclosure - Restructuring, Impairment and Related Charges - Summary of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails">
        <link:definition>2414407 - Disclosure - Restructuring, Impairment and Related Charges - Summary of Restructuring Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://mckesson123.com/role/IncomeTaxes">
        <link:definition>2115105 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://mckesson123.com/role/IncomeTaxesDetails">
        <link:definition>2416408 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterests" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests">
        <link:definition>2117106 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables">
        <link:definition>2318303 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
        <link:definition>2419409 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails">
        <link:definition>2420410 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerCommonShare" roleURI="http://mckesson123.com/role/EarningsPerCommonShare">
        <link:definition>2121107 - Disclosure - Earnings Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerCommonShareTables" roleURI="http://mckesson123.com/role/EarningsPerCommonShareTables">
        <link:definition>2322304 - Disclosure - Earnings Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails" roleURI="http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails">
        <link:definition>2423411 - Disclosure - Earnings Per Common Share - Schedule of Computation for Basic and Diluted Earnings per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNet" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet">
        <link:definition>2124108 - Disclosure - Goodwill and Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetTables" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables">
        <link:definition>2325305 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>2426412 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
        <link:definition>2427413 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails">
        <link:definition>2428414 - Disclosure - Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivities" roleURI="http://mckesson123.com/role/DebtandFinancingActivities">
        <link:definition>2129109 - Disclosure - Debt and Financing Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesTables" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables">
        <link:definition>2330306 - Disclosure - Debt and Financing Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
        <link:definition>2431415 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1">
        <link:definition>2431415 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesLongTermDebtNarrativeDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails">
        <link:definition>2432416 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
        <link:definition>2433417 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesCommercialPaperDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails">
        <link:definition>2434418 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefits" roleURI="http://mckesson123.com/role/PensionBenefits">
        <link:definition>2135110 - Disclosure - Pension Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsNarrativeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails">
        <link:definition>2436419 - Disclosure - Pension Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivities" roleURI="http://mckesson123.com/role/HedgingActivities">
        <link:definition>2137111 - Disclosure - Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesTables" roleURI="http://mckesson123.com/role/HedgingActivitiesTables">
        <link:definition>2338307 - Disclosure - Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesNarrativeDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails">
        <link:definition>2439420 - Disclosure - Hedging Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesDerivativeInstrumentsFairValueDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails">
        <link:definition>2440421 - Disclosure - Hedging Activities - Derivative Instruments Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://mckesson123.com/role/FairValueMeasurements">
        <link:definition>2141112 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsDetails">
        <link:definition>2442422 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilities" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities">
        <link:definition>2143113 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesNarrativeDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails">
        <link:definition>2444423 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://mckesson123.com/role/StockholdersEquity">
        <link:definition>2145114 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://mckesson123.com/role/StockholdersEquityTables">
        <link:definition>2346308 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://mckesson123.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>2447424 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails">
        <link:definition>2448425 - Disclosure - Stockholders' Equity - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails">
        <link:definition>2449426 - Disclosure - Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusiness" roleURI="http://mckesson123.com/role/SegmentsofBusiness">
        <link:definition>2150115 - Disclosure - Segments of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessTables" roleURI="http://mckesson123.com/role/SegmentsofBusinessTables">
        <link:definition>2351309 - Disclosure - Segments of Business (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessDetails">
        <link:definition>2452427 - Disclosure - Segments of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" abstract="false" name="RedeemableNoncontrollingInterestsMaximumRedemptionValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" abstract="true" name="TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_TaxReceivableAgreementTRAMember" abstract="true" name="TaxReceivableAgreementTRAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" abstract="false" name="NoncontrollingInterestIncreaseDecreaseDuetoOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" abstract="false" name="DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" abstract="false" name="LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory" abstract="false" name="EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" abstract="true" name="AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A3125NotesDue2029Member" abstract="true" name="A3125NotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_BritishPoundSterlingDenominatedNotesMember" abstract="true" name="BritishPoundSterlingDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_VantageandClarusOneSourcingServicesLLCMember" abstract="true" name="VantageandClarusOneSourcingServicesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" abstract="true" name="ThreeLargestU.S.PharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" abstract="false" name="EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_A488NotesDueMarch152044Member" abstract="true" name="A488NotesDueMarch152044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_RestructuringImpairmentandOtherRelatedCharges" abstract="false" name="RestructuringImpairmentandOtherRelatedCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" abstract="false" name="TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_CommonStockVotingRightsNumberofVotesPerCommonShare" abstract="false" name="CommonStockVotingRightsNumberofVotesPerCommonShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePrice" abstract="false" name="NoncontrollingInterestsPutRightExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mck_RetailPharmacyReportingUnitMember" abstract="true" name="RetailPharmacyReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A150EuroNotesDueNovember172025Member" abstract="true" name="A150EuroNotesDueNovember172025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofStates" abstract="false" name="LossContingencyNumberofStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" abstract="true" name="AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A365NotesDueNovember302020Member" abstract="true" name="A365NotesDueNovember302020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A475NotesDueMarch12021Member" abstract="true" name="A475NotesDueMarch12021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_PharmacyLicensesMember" abstract="true" name="PharmacyLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" abstract="false" name="RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" abstract="false" name="LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_PutRightValueInterestRateSpread" abstract="false" name="PutRightValueInterestRateSpread" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_CurrentAssetLiabilityMember" abstract="true" name="CurrentAssetLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio" abstract="false" name="DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" abstract="false" name="NoncontrollingInterestDecreaseForExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofRelatorsAllegingViolations" abstract="false" name="LossContingencyNumberofRelatorsAllegingViolations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ChangeHealthcareInc.Member" abstract="true" name="ChangeHealthcareInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" abstract="false" name="OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" abstract="true" name="SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_InreNationalPrescriptionOpiateLitigationMember" abstract="true" name="InreNationalPrescriptionOpiateLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" abstract="true" name="AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NoncurrentAssetLiabilityMember" abstract="true" name="NoncurrentAssetLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A765DebenturesDueMarch12027Member" abstract="true" name="A765DebenturesDueMarch12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A0625NotesDue2021Member" abstract="true" name="A0625NotesDue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A1625NotesDue2026Member" abstract="true" name="A1625NotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestMember" abstract="true" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A270NotesDueDecember152022Member" abstract="true" name="A270NotesDueDecember152022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A600NotesDueMarch12041Member" abstract="true" name="A600NotesDueMarch12041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" abstract="true" name="ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_USPharmaceuticalSegmentMember" abstract="true" name="USPharmaceuticalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_GermanPharmaceuticalWholesaleJointVentureMember" abstract="true" name="GermanPharmaceuticalWholesaleJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_OperatingModelAndCostOptimizationProgramsMember" abstract="true" name="OperatingModelAndCostOptimizationProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_InternationalSegmentMember" abstract="true" name="InternationalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_CorporateOperatingExpenseandOtherIncomeNet" abstract="false" name="CorporateOperatingExpenseandOtherIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NumberOfNationalBrandMedicalSurgicalProducts" abstract="false" name="NumberOfNationalBrandMedicalSurgicalProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DefinedBenefitPlanSettlementPlanParticipants" abstract="false" name="DefinedBenefitPlanSettlementPlanParticipants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LossContingencyClassActionNumberofFaxesReceived" abstract="false" name="LossContingencyClassActionNumberofFaxesReceived" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" abstract="false" name="DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GermanWholesaleBusinessMember" abstract="true" name="GermanWholesaleBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_MedicalSurgicalSolutionsSegmentMember" abstract="true" name="MedicalSurgicalSolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A380NotesDueMarch152024Member" abstract="true" name="A380NotesDueMarch152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_OpenMarketShareRepurchaseTransactionsMember" abstract="true" name="OpenMarketShareRepurchaseTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyAccrualAfterTax" abstract="false" name="LossContingencyAccrualAfterTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A395NotesDueFebruary162028Member" abstract="true" name="A395NotesDueFebruary162028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" abstract="false" name="LossContingencyClassActionNumberofFaxesRemainingintheClass" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_November2018CrossCurrencySwapsMember" abstract="true" name="November2018CrossCurrencySwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencySettlementAgreementAwardPaymentPeriod" abstract="false" name="LossContingencySettlementAgreementAwardPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_RevenueDerivedFromServicesPercentage" abstract="false" name="RevenueDerivedFromServicesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_A285NotesDueMarch152023Member" abstract="true" name="A285NotesDueMarch152023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A063EuroNotesDueAugust172021Member" abstract="true" name="A063EuroNotesDueAugust172021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A1500NotesDue2025Member" abstract="true" name="A1500NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ChangeHealthcareLLCChangeHealthcareMember" abstract="true" name="ChangeHealthcareLLCChangeHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_StrategicGrowthInitiativePlanMember" abstract="true" name="StrategicGrowthInitiativePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ReclassificationofTemporaryEquitytoLiability" abstract="false" name="ReclassificationofTemporaryEquitytoLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofCounties" abstract="false" name="LossContingencyNumberofCounties" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LossContingencyDamagesSoughtPerViolationValue" abstract="false" name="LossContingencyDamagesSoughtPerViolationValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_IncomeTaxExpenseBenefitDiscreteItems" abstract="false" name="IncomeTaxExpenseBenefitDiscreteItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" abstract="false" name="NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A475NotesDueMay302029Member" abstract="true" name="A475NotesDueMay302029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_MckessonEuropeSubsidiaryMember" abstract="true" name="MckessonEuropeSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" abstract="false" name="AssetImpairmentChargesIncludingAcceleratedDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PrescriptionTechnologySolutionsSegmentMember" abstract="true" name="PrescriptionTechnologySolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" abstract="false" name="AnnualRecurringCompensationPerSharetoNoncontrollingInterests" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mck_UnitedStatesExRelKelley19Cv2233Member" abstract="true" name="UnitedStatesExRelKelley19Cv2233Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A163EuroNotesDueOctober302026Member" abstract="true" name="A163EuroNotesDueOctober302026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_IncreaseDecreaseinOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseinOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NumberOfCountyGovernments" abstract="false" name="NumberOfCountyGovernments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" abstract="false" name="OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofStateAttorneyGenerals" abstract="false" name="LossContingencyNumberofStateAttorneyGenerals" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_A313SterlingNotesDueFebruary172029Member" abstract="true" name="A313SterlingNotesDueFebruary172029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" abstract="true" name="StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EuroDenominatedNotesMember" abstract="true" name="EuroDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>mck-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:f15aa9b5-be6e-4b9d-af45-f9d5f89227d0,g:ffd6c493-ffba-42d6-bea4-20131f0e9c42-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20200930.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f65939c7-66fb-4f37-848f-05b895c427c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d7c6fc23-db1b-4486-95ab-4c9a0dba3bf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f65939c7-66fb-4f37-848f-05b895c427c2" xlink:to="loc_us-gaap_OperatingExpenses_d7c6fc23-db1b-4486-95ab-4c9a0dba3bf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c424e3a2-1f4c-4805-bf4a-ba6002e7590f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f65939c7-66fb-4f37-848f-05b895c427c2" xlink:to="loc_us-gaap_GrossProfit_c424e3a2-1f4c-4805-bf4a-ba6002e7590f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f5ba9b17-7c3d-4bf8-88ba-1fca3175efcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_28a9789e-1c24-4970-9936-61066edc7c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_f5ba9b17-7c3d-4bf8-88ba-1fca3175efcb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_28a9789e-1c24-4970-9936-61066edc7c0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_51d91590-7ad8-466d-964f-10b648c1d8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_f5ba9b17-7c3d-4bf8-88ba-1fca3175efcb" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_51d91590-7ad8-466d-964f-10b648c1d8b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b00be6a7-3704-4ecd-91e4-232853114b96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_916ffa8f-3f93-4a98-acff-3a49eb2d7397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b00be6a7-3704-4ecd-91e4-232853114b96" xlink:to="loc_us-gaap_ProfitLoss_916ffa8f-3f93-4a98-acff-3a49eb2d7397" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8612c503-d628-46ee-9e30-515dc6048a6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b00be6a7-3704-4ecd-91e4-232853114b96" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8612c503-d628-46ee-9e30-515dc6048a6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1c21c1d9-5326-47aa-a8af-a77498220b98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_f5048e9c-8bf9-4ea0-afe3-cddd79e00c46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_1c21c1d9-5326-47aa-a8af-a77498220b98" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_f5048e9c-8bf9-4ea0-afe3-cddd79e00c46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_b91299d1-1064-44df-a380-63e1e9490c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_1c21c1d9-5326-47aa-a8af-a77498220b98" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_b91299d1-1064-44df-a380-63e1e9490c7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2b8796c3-5d78-46c6-aab3-94aebe2060c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_122b6a00-0ed1-44e4-9451-00c58b637325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2b8796c3-5d78-46c6-aab3-94aebe2060c4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_122b6a00-0ed1-44e4-9451-00c58b637325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_28015de5-f7cf-4b2e-a877-64d6024e7e04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2b8796c3-5d78-46c6-aab3-94aebe2060c4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_28015de5-f7cf-4b2e-a877-64d6024e7e04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_daf34840-39de-4dc4-b3db-63bca26eed1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_71e534a5-defb-4fc4-8f67-004961835ae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_daf34840-39de-4dc4-b3db-63bca26eed1c" xlink:to="loc_us-gaap_OperatingIncomeLoss_71e534a5-defb-4fc4-8f67-004961835ae3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a6b81b47-84b4-4fb0-9059-23b3b47ab1b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_daf34840-39de-4dc4-b3db-63bca26eed1c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a6b81b47-84b4-4fb0-9059-23b3b47ab1b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_18e7a875-59a6-41e7-a3a6-2a7c16cf5fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_daf34840-39de-4dc4-b3db-63bca26eed1c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_18e7a875-59a6-41e7-a3a6-2a7c16cf5fc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_23e2da3d-40bc-4609-9edb-ebd6bf73c0f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_daf34840-39de-4dc4-b3db-63bca26eed1c" xlink:to="loc_us-gaap_InterestAndDebtExpense_23e2da3d-40bc-4609-9edb-ebd6bf73c0f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bdc46634-86e9-443a-bc13-6a0496edcdea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c9b81a75-28d9-471d-b2a8-52be9be378b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_bdc46634-86e9-443a-bc13-6a0496edcdea" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c9b81a75-28d9-471d-b2a8-52be9be378b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_79b6a44d-0640-450b-8e72-6630016478e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_bdc46634-86e9-443a-bc13-6a0496edcdea" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_79b6a44d-0640-450b-8e72-6630016478e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f75f7bfb-7156-4d02-85fc-d32264e8638f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_31e09bb5-672b-4bef-b7e4-45a5c1eb3db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_f75f7bfb-7156-4d02-85fc-d32264e8638f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_31e09bb5-672b-4bef-b7e4-45a5c1eb3db8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5248f43b-2ea1-4fde-9556-18738758a020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_f75f7bfb-7156-4d02-85fc-d32264e8638f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5248f43b-2ea1-4fde-9556-18738758a020" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_996f5f39-7498-45f2-9fdf-7fadefc5465f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_7c52e9dd-f231-4411-bb64-7bbb66a84f81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_996f5f39-7498-45f2-9fdf-7fadefc5465f" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_7c52e9dd-f231-4411-bb64-7bbb66a84f81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_4085db79-7b17-482e-83c1-5b80c52cb336" xlink:href="mck-20200930.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_996f5f39-7498-45f2-9fdf-7fadefc5465f" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_4085db79-7b17-482e-83c1-5b80c52cb336" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c5db86cc-0a44-402a-a15e-1c0f1f108978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_996f5f39-7498-45f2-9fdf-7fadefc5465f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c5db86cc-0a44-402a-a15e-1c0f1f108978" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ed2e99e5-09b6-4639-9ff9-9ac8fc561e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b28e65df-7901-4589-a1c4-f7f0bb4bc8db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ed2e99e5-09b6-4639-9ff9-9ac8fc561e06" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b28e65df-7901-4589-a1c4-f7f0bb4bc8db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0d96cdfe-3329-4be9-a9ce-345220b8d8b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ed2e99e5-09b6-4639-9ff9-9ac8fc561e06" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0d96cdfe-3329-4be9-a9ce-345220b8d8b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_495f44dc-ff1d-411d-b51e-3c824fe8913b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e4c92608-f4e8-479e-9ce0-7f89be9ab821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_495f44dc-ff1d-411d-b51e-3c824fe8913b" xlink:to="loc_us-gaap_ProfitLoss_e4c92608-f4e8-479e-9ce0-7f89be9ab821" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6b367fc8-1f21-4eb6-8f21-dc23b671bf66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_495f44dc-ff1d-411d-b51e-3c824fe8913b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6b367fc8-1f21-4eb6-8f21-dc23b671bf66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3059208d-7a8a-405c-94d7-757c8f017035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4383be94-b264-4042-ac11-5c16157a1bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3059208d-7a8a-405c-94d7-757c8f017035" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4383be94-b264-4042-ac11-5c16157a1bdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_906a6782-2d6d-4a3a-b390-351486aefda6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3059208d-7a8a-405c-94d7-757c8f017035" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_906a6782-2d6d-4a3a-b390-351486aefda6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e351aca5-322d-430a-ac05-81aece40b99a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3059208d-7a8a-405c-94d7-757c8f017035" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e351aca5-322d-430a-ac05-81aece40b99a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a28b3202-25a9-42d1-a083-e752642cf68d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_5bbba444-1572-49ce-9766-526f473af806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a28b3202-25a9-42d1-a083-e752642cf68d" xlink:to="loc_us-gaap_AccountsPayableCurrent_5bbba444-1572-49ce-9766-526f473af806" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7e221224-009b-4df8-917c-f15a65a0ac35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a28b3202-25a9-42d1-a083-e752642cf68d" xlink:to="loc_us-gaap_LongTermDebtCurrent_7e221224-009b-4df8-917c-f15a65a0ac35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_92dd7c89-d425-4768-a8fe-636fab7514d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a28b3202-25a9-42d1-a083-e752642cf68d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_92dd7c89-d425-4768-a8fe-636fab7514d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6eeb6243-8874-44e9-9b2c-612c77448034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a28b3202-25a9-42d1-a083-e752642cf68d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6eeb6243-8874-44e9-9b2c-612c77448034" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_c7590ddb-b666-4b6d-af25-de1701e659a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a28b3202-25a9-42d1-a083-e752642cf68d" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_c7590ddb-b666-4b6d-af25-de1701e659a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f1847b96-0733-4ed0-bd29-47a5d8ed579d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_228d7cab-9c69-4024-aa5d-8b4982ce7e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f1847b96-0733-4ed0-bd29-47a5d8ed579d" xlink:to="loc_us-gaap_PreferredStockValue_228d7cab-9c69-4024-aa5d-8b4982ce7e0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0da5081c-42aa-418b-bb47-5664e5708dfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f1847b96-0733-4ed0-bd29-47a5d8ed579d" xlink:to="loc_us-gaap_CommonStockValue_0da5081c-42aa-418b-bb47-5664e5708dfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_da8b875c-fbdb-4809-8ced-e6a36d065693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f1847b96-0733-4ed0-bd29-47a5d8ed579d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_da8b875c-fbdb-4809-8ced-e6a36d065693" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0845e09c-657d-481c-a5c4-cecbac774114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f1847b96-0733-4ed0-bd29-47a5d8ed579d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0845e09c-657d-481c-a5c4-cecbac774114" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_29afaad0-1364-4ff6-ab72-cde198593875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f1847b96-0733-4ed0-bd29-47a5d8ed579d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_29afaad0-1364-4ff6-ab72-cde198593875" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_a8ec530c-ae6c-460d-bba8-04d2a472b1c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f1847b96-0733-4ed0-bd29-47a5d8ed579d" xlink:to="loc_us-gaap_TreasuryStockValue_a8ec530c-ae6c-460d-bba8-04d2a472b1c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc564d65-1101-4286-9894-9e19b28b750e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1e8fb952-de71-4041-bce4-6bbfbebaecef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc564d65-1101-4286-9894-9e19b28b750e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1e8fb952-de71-4041-bce4-6bbfbebaecef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dc493150-eb9c-4874-aed9-2ec872ea3cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc564d65-1101-4286-9894-9e19b28b750e" xlink:to="loc_us-gaap_LiabilitiesCurrent_dc493150-eb9c-4874-aed9-2ec872ea3cd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_100ebc78-b4d3-45d0-898b-5708518394be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc564d65-1101-4286-9894-9e19b28b750e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_100ebc78-b4d3-45d0-898b-5708518394be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_860ff3c3-39a1-4fcf-9cfe-e0eaaa7452d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc564d65-1101-4286-9894-9e19b28b750e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_860ff3c3-39a1-4fcf-9cfe-e0eaaa7452d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_cca0acac-9ce9-4e8a-9a8f-0f77ba5a8b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc564d65-1101-4286-9894-9e19b28b750e" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_cca0acac-9ce9-4e8a-9a8f-0f77ba5a8b59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c0b4f4ea-c235-4e68-872e-f23af0c59c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc564d65-1101-4286-9894-9e19b28b750e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c0b4f4ea-c235-4e68-872e-f23af0c59c6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_94338067-5d09-46a9-abc5-f9c07d378a51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc564d65-1101-4286-9894-9e19b28b750e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_94338067-5d09-46a9-abc5-f9c07d378a51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_434a7724-beb4-42a7-9250-2fdf6fa65f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_61b08393-b4d1-4d4b-868b-7c29744e6c17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_434a7724-beb4-42a7-9250-2fdf6fa65f5c" xlink:to="loc_us-gaap_AssetsCurrent_61b08393-b4d1-4d4b-868b-7c29744e6c17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_94bcaf5a-ed95-4e41-ba66-07032726ebdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_434a7724-beb4-42a7-9250-2fdf6fa65f5c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_94bcaf5a-ed95-4e41-ba66-07032726ebdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_51c76626-5c0f-4f93-9074-b59b4ec914fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_434a7724-beb4-42a7-9250-2fdf6fa65f5c" xlink:to="loc_us-gaap_Goodwill_51c76626-5c0f-4f93-9074-b59b4ec914fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_532ccc52-1987-43aa-a79c-f33b4b37a202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_434a7724-beb4-42a7-9250-2fdf6fa65f5c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_532ccc52-1987-43aa-a79c-f33b4b37a202" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bdf33b8d-81ea-44a2-ae81-14c2b947c4d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_434a7724-beb4-42a7-9250-2fdf6fa65f5c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bdf33b8d-81ea-44a2-ae81-14c2b947c4d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4984a029-fe9d-436c-912c-2f26c34cfc0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_434a7724-beb4-42a7-9250-2fdf6fa65f5c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4984a029-fe9d-436c-912c-2f26c34cfc0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3837ffe2-7712-42ab-9161-d7385526d907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52976743-db9a-4c4f-9c5d-c8784f62e090" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3837ffe2-7712-42ab-9161-d7385526d907" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52976743-db9a-4c4f-9c5d-c8784f62e090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_5ce327c0-b4b0-4354-b9dd-4ff57280b6d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3837ffe2-7712-42ab-9161-d7385526d907" xlink:to="loc_us-gaap_ReceivablesNetCurrent_5ce327c0-b4b0-4354-b9dd-4ff57280b6d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_24a4eb84-cdd8-448f-9830-5e014e2bb784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3837ffe2-7712-42ab-9161-d7385526d907" xlink:to="loc_us-gaap_InventoryNet_24a4eb84-cdd8-448f-9830-5e014e2bb784" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ea458b21-2c90-464e-8c8a-3132b0a54e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3837ffe2-7712-42ab-9161-d7385526d907" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ea458b21-2c90-464e-8c8a-3132b0a54e4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ca73d5be-ecfe-4cdf-8d64-96a62bbafa32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3837ffe2-7712-42ab-9161-d7385526d907" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ca73d5be-ecfe-4cdf-8d64-96a62bbafa32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_722fabf1-c36e-4158-97db-143b519f6037" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_232d42b5-82d1-4e35-adca-79734738c82b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_722fabf1-c36e-4158-97db-143b519f6037" xlink:to="loc_us-gaap_StockholdersEquity_232d42b5-82d1-4e35-adca-79734738c82b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a1a2e19c-dbda-4fa0-b557-2ee91b3a9c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_722fabf1-c36e-4158-97db-143b519f6037" xlink:to="loc_us-gaap_MinorityInterest_a1a2e19c-dbda-4fa0-b557-2ee91b3a9c40" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67cf8a55-1d59-409d-90f1-83d1f4c1bb6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1b016317-9556-47c0-aa57-0bfec53ceede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67cf8a55-1d59-409d-90f1-83d1f4c1bb6f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1b016317-9556-47c0-aa57-0bfec53ceede" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_0d42fdc6-f138-4d2d-881c-3c5c8d498d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67cf8a55-1d59-409d-90f1-83d1f4c1bb6f" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_0d42fdc6-f138-4d2d-881c-3c5c8d498d00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cc1553c0-2ad2-4268-878c-93d94d438cd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67cf8a55-1d59-409d-90f1-83d1f4c1bb6f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cc1553c0-2ad2-4268-878c-93d94d438cd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_1a0d1f4a-02be-47cc-8cda-287a7a48112f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67cf8a55-1d59-409d-90f1-83d1f4c1bb6f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_1a0d1f4a-02be-47cc-8cda-287a7a48112f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_159ca888-ad2f-4c39-aea0-148c030f57f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67cf8a55-1d59-409d-90f1-83d1f4c1bb6f" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_159ca888-ad2f-4c39-aea0-148c030f57f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_31d7219f-6d65-48e9-a183-f2017e3e5c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7852317c-da00-4ca8-a9e3-43ccddd38606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_31d7219f-6d65-48e9-a183-f2017e3e5c6e" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7852317c-da00-4ca8-a9e3-43ccddd38606" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_148ecc78-7db3-4184-9216-03906ad2affa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_31d7219f-6d65-48e9-a183-f2017e3e5c6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_148ecc78-7db3-4184-9216-03906ad2affa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e72815f4-21f7-4f67-a9a2-a81933ba95d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_31d7219f-6d65-48e9-a183-f2017e3e5c6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e72815f4-21f7-4f67-a9a2-a81933ba95d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_93c12377-6ae9-47e8-a439-a790fa56ccb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_31d7219f-6d65-48e9-a183-f2017e3e5c6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_93c12377-6ae9-47e8-a439-a790fa56ccb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e51b2eba-c77b-42b8-b918-61dec82a5cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_ProfitLoss_e51b2eba-c77b-42b8-b918-61dec82a5cd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_4312ddbe-50f4-4cd3-9615-59151cbf6c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_Depreciation_4312ddbe-50f4-4cd3-9615-59151cbf6c3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_2e9f35db-ac76-4e31-ba87-032666ee942b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_AssetImpairmentCharges_2e9f35db-ac76-4e31-ba87-032666ee942b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_bf0cf060-37c2-401c-a7eb-59ca64e472ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_AdjustmentForAmortization_bf0cf060-37c2-401c-a7eb-59ca64e472ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_3fd6364d-908f-46bb-8099-ed81c37da656" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_3fd6364d-908f-46bb-8099-ed81c37da656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_796ecdc3-08ce-45f5-93b5-bfd391c4daf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_796ecdc3-08ce-45f5-93b5-bfd391c4daf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_7272a923-9efa-491e-a39c-1bb967756e87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_7272a923-9efa-491e-a39c-1bb967756e87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_bb628679-b897-4fe6-977b-977741d0506e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_bb628679-b897-4fe6-977b-977741d0506e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_965096e2-fcf0-4200-ac2a-3d54c255c497" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_OperatingLeaseExpense_965096e2-fcf0-4200-ac2a-3d54c255c497" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_a99cbfc9-f083-465d-9cbc-5b825b0cca0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_a99cbfc9-f083-465d-9cbc-5b825b0cca0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_c189275f-8e79-4a8b-b273-c1a2a1e597a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_c189275f-8e79-4a8b-b273-c1a2a1e597a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_00d5dda8-6736-485a-96c3-137c3f26fce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_00d5dda8-6736-485a-96c3-137c3f26fce9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2deee4d8-27fd-43eb-9d40-2778bd40d2cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2deee4d8-27fd-43eb-9d40-2778bd40d2cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_6ff53b96-091f-4047-8b47-3368fa5a8ace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_6ff53b96-091f-4047-8b47-3368fa5a8ace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities_87f2bb63-9430-4877-987c-0fcb3089fa6e" xlink:href="mck-20200930.xsd#mck_IncreaseDecreaseinOperatingLeaseLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities_87f2bb63-9430-4877-987c-0fcb3089fa6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_136ee0c1-c5b3-44f9-86bd-851fc67e11cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a45c955f-9711-48d8-9661-0c80341899b8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_136ee0c1-c5b3-44f9-86bd-851fc67e11cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59b4000f-5cc8-42cf-a4b3-554e6946a6ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_d0c0b08e-b3af-4c14-9cbd-234fcba5d5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59b4000f-5cc8-42cf-a4b3-554e6946a6ec" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_d0c0b08e-b3af-4c14-9cbd-234fcba5d5e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_3bc745c9-494d-4346-9033-fe0f756278b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59b4000f-5cc8-42cf-a4b3-554e6946a6ec" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_3bc745c9-494d-4346-9033-fe0f756278b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_3e56e29c-8ac3-4dbe-9b7e-b8869b61c7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59b4000f-5cc8-42cf-a4b3-554e6946a6ec" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_3e56e29c-8ac3-4dbe-9b7e-b8869b61c7c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e3e53896-606a-47ec-a44d-e4586a289d69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59b4000f-5cc8-42cf-a4b3-554e6946a6ec" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e3e53896-606a-47ec-a44d-e4586a289d69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_512cc483-b14a-4345-a0b9-9feb0efae61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59b4000f-5cc8-42cf-a4b3-554e6946a6ec" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_512cc483-b14a-4345-a0b9-9feb0efae61e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_52de52ca-a1f1-46ea-8a3e-0f382fcd4fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59b4000f-5cc8-42cf-a4b3-554e6946a6ec" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_52de52ca-a1f1-46ea-8a3e-0f382fcd4fb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ef63b6be-0a4d-40f0-b777-ecbd1dbcd40d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59b4000f-5cc8-42cf-a4b3-554e6946a6ec" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ef63b6be-0a4d-40f0-b777-ecbd1dbcd40d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1f32cac0-a4a8-484b-b22d-b09c57706e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_3c05e8b0-c60f-4f3b-a403-9513629df540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1f32cac0-a4a8-484b-b22d-b09c57706e01" xlink:to="loc_us-gaap_RestrictedCashCurrent_3c05e8b0-c60f-4f3b-a403-9513629df540" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f6d19f01-3a53-47e7-833f-e9aa0e605e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1f32cac0-a4a8-484b-b22d-b09c57706e01" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f6d19f01-3a53-47e7-833f-e9aa0e605e4c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20200930.xsd#SignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20200930.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="simple" xlink:href="mck-20200930.xsd#InvestmentinChangeHealthcareJointVenture"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#InvestmentinChangeHealthcareJointVentureDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20200930.xsd#HeldforSale"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleTables" xlink:type="simple" xlink:href="mck-20200930.xsd#HeldforSaleTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSaleTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#HeldforSaleNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0b2102e9-1604-47d9-bbe3-00ee2faf55a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_623520f6-5074-4b7f-99b3-1ae7c90a051c" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0b2102e9-1604-47d9-bbe3-00ee2faf55a1" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_623520f6-5074-4b7f-99b3-1ae7c90a051c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_118da1eb-f6e4-4f76-85a1-3bc0212b46f4" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0b2102e9-1604-47d9-bbe3-00ee2faf55a1" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_118da1eb-f6e4-4f76-85a1-3bc0212b46f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_06c866f2-0fe0-4f15-bd64-f37d5913934a" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0b2102e9-1604-47d9-bbe3-00ee2faf55a1" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_06c866f2-0fe0-4f15-bd64-f37d5913934a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_36dc074d-1e7c-45fd-bad9-d4d0a29783cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_1ad25ac8-02cf-4681-8386-6b2733ad1bc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_36dc074d-1e7c-45fd-bad9-d4d0a29783cb" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_1ad25ac8-02cf-4681-8386-6b2733ad1bc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_31f5a21b-a49b-4bbb-9638-72849e42c0ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_36dc074d-1e7c-45fd-bad9-d4d0a29783cb" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_31f5a21b-a49b-4bbb-9638-72849e42c0ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_5c21d21b-6f37-44d0-b2bf-adc3938127b6" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_36dc074d-1e7c-45fd-bad9-d4d0a29783cb" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_5c21d21b-6f37-44d0-b2bf-adc3938127b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_9de6c28a-fd57-485a-ae5f-950ecc93af24" xlink:href="mck-20200930.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_36dc074d-1e7c-45fd-bad9-d4d0a29783cb" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_9de6c28a-fd57-485a-ae5f-950ecc93af24" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_00f9142e-7579-44ae-aed0-a8aa4b4fd268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_2bbc3929-252b-4b48-9a19-6bf744b42ba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_00f9142e-7579-44ae-aed0-a8aa4b4fd268" xlink:to="loc_us-gaap_SeveranceCosts1_2bbc3929-252b-4b48-9a19-6bf744b42ba3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_d1931bf8-5040-49c1-a1b6-6d6468e1c160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_00f9142e-7579-44ae-aed0-a8aa4b4fd268" xlink:to="loc_us-gaap_BusinessExitCosts1_d1931bf8-5040-49c1-a1b6-6d6468e1c160" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_725af8d0-b574-40bd-b48a-1be11e0c6dd9" xlink:href="mck-20200930.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_00f9142e-7579-44ae-aed0-a8aa4b4fd268" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_725af8d0-b574-40bd-b48a-1be11e0c6dd9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20200930.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20200930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20200930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsPerCommonShare" xlink:type="simple" xlink:href="mck-20200930.xsd#EarningsPerCommonShare"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsPerCommonShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsPerCommonShareTables" xlink:type="simple" xlink:href="mck-20200930.xsd#EarningsPerCommonShareTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsPerCommonShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_738348fb-9b40-4b3e-a9a5-0714fd6a665e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c8a6563f-af22-430f-81be-8a7c6e41d5e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_738348fb-9b40-4b3e-a9a5-0714fd6a665e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c8a6563f-af22-430f-81be-8a7c6e41d5e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b0bb7cb9-5842-4ae8-9a4d-2033463fdaec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_738348fb-9b40-4b3e-a9a5-0714fd6a665e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b0bb7cb9-5842-4ae8-9a4d-2033463fdaec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d309cde8-483b-4366-81d2-2ce6e3cdcccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f7ce7af8-ca10-4290-be9c-fc2aa390426d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d309cde8-483b-4366-81d2-2ce6e3cdcccb" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f7ce7af8-ca10-4290-be9c-fc2aa390426d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ff624bd6-5f88-4fdf-ab2f-2259b4d52390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d309cde8-483b-4366-81d2-2ce6e3cdcccb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ff624bd6-5f88-4fdf-ab2f-2259b4d52390" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f52c2236-d95a-414f-9172-b27f3b9cfec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_7e36c028-9eef-4970-95c2-63b698e36894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f52c2236-d95a-414f-9172-b27f3b9cfec8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_7e36c028-9eef-4970-95c2-63b698e36894" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_f50a8647-e559-4dbf-9464-1ab6a032daf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f52c2236-d95a-414f-9172-b27f3b9cfec8" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_f50a8647-e559-4dbf-9464-1ab6a032daf5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1f763879-ab1b-423d-ba14-ed2997c39679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_959889dd-caaf-4c1c-a4c1-08abde3f9217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1f763879-ab1b-423d-ba14-ed2997c39679" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_959889dd-caaf-4c1c-a4c1-08abde3f9217" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4ceea256-e7bb-4db7-9238-c620c8c502ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1f763879-ab1b-423d-ba14-ed2997c39679" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4ceea256-e7bb-4db7-9238-c620c8c502ca" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivities"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_f80849c2-4923-41f6-a00f-6de9e3000290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7cfd9e9d-3f5a-47c7-a797-ea0b24f5ba12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_f80849c2-4923-41f6-a00f-6de9e3000290" xlink:to="loc_us-gaap_FinanceLeaseLiability_7cfd9e9d-3f5a-47c7-a797-ea0b24f5ba12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b3d87005-9df8-4e96-bbed-c831fd39c353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_f80849c2-4923-41f6-a00f-6de9e3000290" xlink:to="loc_us-gaap_LongTermDebt_b3d87005-9df8-4e96-bbed-c831fd39c353" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_3f4b167b-481b-417a-a2c6-dd5fc0fbb425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a37aef8c-78e5-4877-8778-9b19a9009994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_3f4b167b-481b-417a-a2c6-dd5fc0fbb425" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a37aef8c-78e5-4877-8778-9b19a9009994" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1a7bce99-fb8b-47dc-b45a-55498b498f3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_3f4b167b-481b-417a-a2c6-dd5fc0fbb425" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1a7bce99-fb8b-47dc-b45a-55498b498f3d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20200930.xsd#PensionBenefits"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#PensionBenefitsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20200930.xsd#HedgingActivities"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20200930.xsd#HedgingActivitiesTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#HedgingActivitiesDerivativeInstrumentsFairValueDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20200930.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20200930.xsd#CommitmentsandContingentLiabilities"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquity" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_439ca330-1292-4eed-8447-09dc7f896b4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_3be8341b-4588-40ed-ad4b-76150ccb1604" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_439ca330-1292-4eed-8447-09dc7f896b4b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_3be8341b-4588-40ed-ad4b-76150ccb1604" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b7ece52c-732e-4331-b774-a0cec0022b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_439ca330-1292-4eed-8447-09dc7f896b4b" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b7ece52c-732e-4331-b774-a0cec0022b8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bd9b8f4e-3fa9-4abd-91eb-47add1a35215" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e6520cd0-77ea-446b-80bc-8b8c49790ab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bd9b8f4e-3fa9-4abd-91eb-47add1a35215" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e6520cd0-77ea-446b-80bc-8b8c49790ab7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_a3a2f714-6baf-441d-8d31-e81b8b06986a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bd9b8f4e-3fa9-4abd-91eb-47add1a35215" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_a3a2f714-6baf-441d-8d31-e81b8b06986a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20200930.xsd#SegmentsofBusiness"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20200930.xsd#SegmentsofBusinessTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#SegmentsofBusinessDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ebd7b76-07c3-4550-a819-d4a1d809ed05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d0902f11-23da-42c0-8623-bfdbceee74b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ebd7b76-07c3-4550-a819-d4a1d809ed05" xlink:to="loc_us-gaap_OperatingIncomeLoss_d0902f11-23da-42c0-8623-bfdbceee74b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_e5d38757-25d1-4ef9-935f-58fcd328984a" xlink:href="mck-20200930.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ebd7b76-07c3-4550-a819-d4a1d809ed05" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_e5d38757-25d1-4ef9-935f-58fcd328984a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_14839d48-4972-4557-98c3-a4818ce658b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ebd7b76-07c3-4550-a819-d4a1d809ed05" xlink:to="loc_us-gaap_InterestAndDebtExpense_14839d48-4972-4557-98c3-a4818ce658b1" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>mck-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:f15aa9b5-be6e-4b9d-af45-f9d5f89227d0,g:ffd6c493-ffba-42d6-bea4-20131f0e9c42-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20200930.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended" id="id679519a916841cdaa08fa5808b3ed60_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ea058087-e432-44a0-a994-c4efded0ddb7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_DocumentType_ea058087-e432-44a0-a994-c4efded0ddb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_d8fbd4d2-5007-4dc3-ae49-bb22c919c741" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_DocumentQuarterlyReport_d8fbd4d2-5007-4dc3-ae49-bb22c919c741" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_df4613b4-3a8e-4169-8951-e07b8c583230" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_DocumentPeriodEndDate_df4613b4-3a8e-4169-8951-e07b8c583230" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_3d0e19f2-1b24-4c5f-aeb9-f434b9c6f457" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_DocumentTransitionReport_3d0e19f2-1b24-4c5f-aeb9-f434b9c6f457" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_44cf9eb8-d3ba-4947-ae31-0668935eb721" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityFileNumber_44cf9eb8-d3ba-4947-ae31-0668935eb721" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d6b5ab29-102f-45b9-8484-df603d9604a1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityRegistrantName_d6b5ab29-102f-45b9-8484-df603d9604a1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8500a1b3-fda6-46cc-af4e-2627bb27c771" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8500a1b3-fda6-46cc-af4e-2627bb27c771" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7c2a34d6-7a43-4240-b838-17bf3c6becc5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityTaxIdentificationNumber_7c2a34d6-7a43-4240-b838-17bf3c6becc5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_19e6b13b-c7d0-490f-8b44-009decb6ef47" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityAddressAddressLine1_19e6b13b-c7d0-490f-8b44-009decb6ef47" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_05ef4c72-333c-45b4-81fc-fdd5cea4e71d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityAddressCityOrTown_05ef4c72-333c-45b4-81fc-fdd5cea4e71d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4c36c5ce-3a44-4cb0-8053-21babd827e08" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityAddressStateOrProvince_4c36c5ce-3a44-4cb0-8053-21babd827e08" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2bce3a31-5f14-4c82-8a97-eaddbab33d4e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityAddressPostalZipCode_2bce3a31-5f14-4c82-8a97-eaddbab33d4e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9dd7203e-b4e5-4662-9dac-6ef0f442ddf8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_CityAreaCode_9dd7203e-b4e5-4662-9dac-6ef0f442ddf8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_99af8740-0d6e-46fa-bf2b-20ed4bb31047" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_LocalPhoneNumber_99af8740-0d6e-46fa-bf2b-20ed4bb31047" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ed15f31d-d17e-493a-8f73-357bfe9da91d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_Security12bTitle_ed15f31d-d17e-493a-8f73-357bfe9da91d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d0400c1e-b75f-42a3-bccc-54a11df556c0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_TradingSymbol_d0400c1e-b75f-42a3-bccc-54a11df556c0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6e547e72-3772-4a86-93bf-b930047294f0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_SecurityExchangeName_6e547e72-3772-4a86-93bf-b930047294f0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7a66bb3e-95b7-418b-b724-db2238953392" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityCurrentReportingStatus_7a66bb3e-95b7-418b-b724-db2238953392" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_a688e0cd-8fdc-4d8d-9a28-7fb6c943b6d3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityInteractiveDataCurrent_a688e0cd-8fdc-4d8d-9a28-7fb6c943b6d3" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_ef5c9fe3-3fe4-48ad-a864-b63633423d20" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityFilerCategory_ef5c9fe3-3fe4-48ad-a864-b63633423d20" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_5c283f3d-12bc-44ef-b39c-0f5006209a9f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntitySmallBusiness_5c283f3d-12bc-44ef-b39c-0f5006209a9f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_58dc0425-49c8-4536-ba54-06574a4b4091" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityEmergingGrowthCompany_58dc0425-49c8-4536-ba54-06574a4b4091" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_cb9b6d3e-8500-4cfa-ac28-e0bc8355ee21" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityShellCompany_cb9b6d3e-8500-4cfa-ac28-e0bc8355ee21" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_aaaade02-1d64-44c4-9130-ce2bfdc18166" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_aaaade02-1d64-44c4-9130-ce2bfdc18166" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_364d5199-2d4a-4d66-88e5-23fb9ec9c91a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityCentralIndexKey_364d5199-2d4a-4d66-88e5-23fb9ec9c91a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7118eaf4-c67c-421c-aa99-1df0bdb504c0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_DocumentFiscalYearFocus_7118eaf4-c67c-421c-aa99-1df0bdb504c0" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7d7bd68b-c373-4962-8d83-a858792610e1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7d7bd68b-c373-4962-8d83-a858792610e1" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_94f88ecd-10fb-413f-8626-fef6090ec651" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_AmendmentFlag_94f88ecd-10fb-413f-8626-fef6090ec651" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f7a54a51-1c85-4c1c-867e-0411896738f5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_CurrentFiscalYearEndDate_f7a54a51-1c85-4c1c-867e-0411896738f5" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_4fddfdf5-82cd-4435-94e6-366b1ef09949" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntitiesTable_4fddfdf5-82cd-4435-94e6-366b1ef09949" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3f2f5130-84ec-45bf-bd67-3d961732bf2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_4fddfdf5-82cd-4435-94e6-366b1ef09949" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3f2f5130-84ec-45bf-bd67-3d961732bf2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3f2f5130-84ec-45bf-bd67-3d961732bf2e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3f2f5130-84ec-45bf-bd67-3d961732bf2e" xlink:to="loc_us-gaap_ClassOfStockDomain_3f2f5130-84ec-45bf-bd67-3d961732bf2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3f2f5130-84ec-45bf-bd67-3d961732bf2e" xlink:to="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cb5b5a52-2adb-4846-8bfd-fdf3ce53c18c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:to="loc_us-gaap_CommonStockMember_cb5b5a52-2adb-4846-8bfd-fdf3ce53c18c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A0625NotesDue2021Member_72a0a9d9-c47f-468e-a0b1-9a22ec27d004" xlink:href="mck-20200930.xsd#mck_A0625NotesDue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:to="loc_mck_A0625NotesDue2021Member_72a0a9d9-c47f-468e-a0b1-9a22ec27d004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member_a1af8091-5b6e-44df-a435-a37366314133" xlink:href="mck-20200930.xsd#mck_A1500NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:to="loc_mck_A1500NotesDue2025Member_a1af8091-5b6e-44df-a435-a37366314133" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member_2bc8ab0f-3070-43b1-98b4-033dbd7b7fbb" xlink:href="mck-20200930.xsd#mck_A1625NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:to="loc_mck_A1625NotesDue2026Member_2bc8ab0f-3070-43b1-98b4-033dbd7b7fbb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member_5775cb45-5eec-42ec-a0b3-b792b8eff4c6" xlink:href="mck-20200930.xsd#mck_A3125NotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:to="loc_mck_A3125NotesDue2029Member_5775cb45-5eec-42ec-a0b3-b792b8eff4c6" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="ia56d7f9c32d74504a9fb7e524556be56_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended" id="iddd84b496dd149ab8e3bd45602d7de93_CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="i05bdc70987db4052b54a56d54af7bdbc_CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" xlink:type="extended" id="ic7f8509e8780443ea6f3d04fa468e8d8_CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="id650d6b122a042e79fc3731589e8830d_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a24c6325-ac37-4cea-be96-5ac2a31e3325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a24c6325-ac37-4cea-be96-5ac2a31e3325" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5fa7fd7a-695c-4d18-a458-e39641ae7471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_SharesOutstanding_5fa7fd7a-695c-4d18-a458-e39641ae7471" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_c9d28486-03b3-4454-9b20-531a6d16ab8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_TreasuryStockShares_c9d28486-03b3-4454-9b20-531a6d16ab8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5593bc32-611c-493c-bf74-31fca8c45dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5593bc32-611c-493c-bf74-31fca8c45dec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e1675cfc-1cde-4e2c-87e7-35497d69aa19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e1675cfc-1cde-4e2c-87e7-35497d69aa19" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c7066218-0297-4e76-b94d-a8b4f1ef26ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c7066218-0297-4e76-b94d-a8b4f1ef26ae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_39db16dd-fd9a-4e6c-b574-e53a509fee6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_39db16dd-fd9a-4e6c-b574-e53a509fee6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3e023404-a29a-4ad3-bd28-539bb5414f79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3e023404-a29a-4ad3-bd28-539bb5414f79" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d4f3deb9-6cad-4da4-8ca2-415cdc94cd30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d4f3deb9-6cad-4da4-8ca2-415cdc94cd30" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_dd222be1-e107-48a6-9812-180eaea655fa" xlink:href="mck-20200930.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_dd222be1-e107-48a6-9812-180eaea655fa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_e524d410-3ac6-4c51-960e-62325209efd4" xlink:href="mck-20200930.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_e524d410-3ac6-4c51-960e-62325209efd4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_3ef3b11d-bfd0-4762-8f8e-5fbd6e9b6d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_3ef3b11d-bfd0-4762-8f8e-5fbd6e9b6d6a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_d1099663-03ae-42f1-a305-dea72f050a64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_d1099663-03ae-42f1-a305-dea72f050a64" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_9bccaa49-62de-4937-ba74-560a9c26d116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_DividendsCommonStockCash_9bccaa49-62de-4937-ba74-560a9c26d116" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_58b226a5-adc1-4cc6-83ff-756a637acd97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockholdersEquityOther_58b226a5-adc1-4cc6-83ff-756a637acd97" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_33e5e6d4-87d0-40cf-96a8-12b1d5d302e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_1dba6c66-ea9e-41d5-a494-556d2936fa49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4d200576-b581-4a71-812b-ec776eea6c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ee35f64e-5cd0-442d-a222-d7bc8f243d3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a24c6325-ac37-4cea-be96-5ac2a31e3325" xlink:to="loc_us-gaap_StatementTable_ee35f64e-5cd0-442d-a222-d7bc8f243d3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2e9b75b5-2d8c-44c9-9f2c-9ca5ad51b0ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ee35f64e-5cd0-442d-a222-d7bc8f243d3d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2e9b75b5-2d8c-44c9-9f2c-9ca5ad51b0ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_2e9b75b5-2d8c-44c9-9f2c-9ca5ad51b0ec_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2e9b75b5-2d8c-44c9-9f2c-9ca5ad51b0ec" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_2e9b75b5-2d8c-44c9-9f2c-9ca5ad51b0ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_511deee2-24a1-4224-bb4c-7c88d3ddcc4a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2e9b75b5-2d8c-44c9-9f2c-9ca5ad51b0ec" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_511deee2-24a1-4224-bb4c-7c88d3ddcc4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7f276ff5-12d7-4489-851a-ff8745297d05" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_511deee2-24a1-4224-bb4c-7c88d3ddcc4a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7f276ff5-12d7-4489-851a-ff8745297d05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_49a6cee4-79d3-4107-b9c4-9283c7d37a89" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_511deee2-24a1-4224-bb4c-7c88d3ddcc4a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_49a6cee4-79d3-4107-b9c4-9283c7d37a89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_12cb63ab-d587-43e3-9e16-4d47faea1bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ee35f64e-5cd0-442d-a222-d7bc8f243d3d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_12cb63ab-d587-43e3-9e16-4d47faea1bde" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_12cb63ab-d587-43e3-9e16-4d47faea1bde_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_12cb63ab-d587-43e3-9e16-4d47faea1bde" xlink:to="loc_us-gaap_EquityComponentDomain_12cb63ab-d587-43e3-9e16-4d47faea1bde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_12cb63ab-d587-43e3-9e16-4d47faea1bde" xlink:to="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_311a1312-96e8-4c1c-a8f3-fa751fc1b5f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_CommonStockMember_311a1312-96e8-4c1c-a8f3-fa751fc1b5f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2f174bde-c9f7-4471-b475-60409a38d638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2f174bde-c9f7-4471-b475-60409a38d638" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAdditionalCapitalMember_73d104b1-5498-43c3-8a6a-6a36d8c23b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAdditionalCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_OtherAdditionalCapitalMember_73d104b1-5498-43c3-8a6a-6a36d8c23b03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_841df994-5501-49d9-bbbd-7f0e2b6ab4b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_RetainedEarningsMember_841df994-5501-49d9-bbbd-7f0e2b6ab4b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8b87f636-f300-4b3b-96cc-ef50d6e36f85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8b87f636-f300-4b3b-96cc-ef50d6e36f85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_80340b57-5ecf-4ab0-91d4-574e111720aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_TreasuryStockMember_80340b57-5ecf-4ab0-91d4-574e111720aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6a6d4786-ffbf-4987-ad44-9257542841c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_NoncontrollingInterestMember_6a6d4786-ffbf-4987-ad44-9257542841c1" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="extended" id="ie46f923e130c4c01a1bd7254b1ea6c32_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i019b2bc85fad4e1392fc82bbdf1704ae_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20200930.xsd#SignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended" id="i44f36a3de5b140c18ae3739d4aa36a4a_SignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20200930.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended" id="i6b1930e684224dfdb61b213529c3dbc2_SignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i158a510c1ab046f197b1e8be8c9f5809_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5e400369-7f06-49c3-a839-8ac37c28dd35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3dd1ade8-002d-452f-9961-a65388fbd205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5e400369-7f06-49c3-a839-8ac37c28dd35" xlink:to="loc_us-gaap_NumberOfReportableSegments_3dd1ade8-002d-452f-9961-a65388fbd205" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_88ac541c-60fe-49a1-b56f-4ff112f10d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5e400369-7f06-49c3-a839-8ac37c28dd35" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_88ac541c-60fe-49a1-b56f-4ff112f10d90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_623d673b-c823-4fe4-9da1-34c0c2959407" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5e400369-7f06-49c3-a839-8ac37c28dd35" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_623d673b-c823-4fe4-9da1-34c0c2959407" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b5f22ea9-4a88-4a27-8c44-90c441711122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5e400369-7f06-49c3-a839-8ac37c28dd35" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b5f22ea9-4a88-4a27-8c44-90c441711122" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f4e110af-ad73-4e73-ba1c-e611f74b74af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5e400369-7f06-49c3-a839-8ac37c28dd35" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f4e110af-ad73-4e73-ba1c-e611f74b74af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ca4c335a-a0be-4e49-925b-ee0373d2971f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f4e110af-ad73-4e73-ba1c-e611f74b74af" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ca4c335a-a0be-4e49-925b-ee0373d2971f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_ca4c335a-a0be-4e49-925b-ee0373d2971f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ca4c335a-a0be-4e49-925b-ee0373d2971f" xlink:to="loc_us-gaap_TypeOfAdoptionMember_ca4c335a-a0be-4e49-925b-ee0373d2971f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_1c94d341-cd5e-4376-b874-0eec63696ecb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ca4c335a-a0be-4e49-925b-ee0373d2971f" xlink:to="loc_us-gaap_TypeOfAdoptionMember_1c94d341-cd5e-4376-b874-0eec63696ecb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_e64f79d8-7b4f-4773-beb1-bf987d1a7649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_1c94d341-cd5e-4376-b874-0eec63696ecb" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_e64f79d8-7b4f-4773-beb1-bf987d1a7649" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f385eba8-64d0-45b5-8166-8aedaca58b1b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f4e110af-ad73-4e73-ba1c-e611f74b74af" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f385eba8-64d0-45b5-8166-8aedaca58b1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f385eba8-64d0-45b5-8166-8aedaca58b1b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f385eba8-64d0-45b5-8166-8aedaca58b1b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f385eba8-64d0-45b5-8166-8aedaca58b1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8343ca69-753c-4b9c-968f-0d675edc3464" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f385eba8-64d0-45b5-8166-8aedaca58b1b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8343ca69-753c-4b9c-968f-0d675edc3464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6c3c096c-a6f6-40e1-89c6-51e193c27e25" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8343ca69-753c-4b9c-968f-0d675edc3464" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6c3c096c-a6f6-40e1-89c6-51e193c27e25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5cac0c24-5973-4f01-b6d6-00e6585db751" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f4e110af-ad73-4e73-ba1c-e611f74b74af" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5cac0c24-5973-4f01-b6d6-00e6585db751" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5cac0c24-5973-4f01-b6d6-00e6585db751_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5cac0c24-5973-4f01-b6d6-00e6585db751" xlink:to="loc_us-gaap_EquityComponentDomain_5cac0c24-5973-4f01-b6d6-00e6585db751_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_90531109-fd70-471f-b0ef-74f6e3bd478d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5cac0c24-5973-4f01-b6d6-00e6585db751" xlink:to="loc_us-gaap_EquityComponentDomain_90531109-fd70-471f-b0ef-74f6e3bd478d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d4a48a79-2b5a-4aee-914d-fb352f122e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_90531109-fd70-471f-b0ef-74f6e3bd478d" xlink:to="loc_us-gaap_RetainedEarningsMember_d4a48a79-2b5a-4aee-914d-fb352f122e58" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="simple" xlink:href="mck-20200930.xsd#InvestmentinChangeHealthcareJointVenture"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="extended" id="i7b4c28f54f87464d83dbdccccab1ea6d_InvestmentinChangeHealthcareJointVenture"/>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#InvestmentinChangeHealthcareJointVentureDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="extended" id="i8661191ec7634acc9c16777ab7c3bc06_InvestmentinChangeHealthcareJointVentureDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cd8bb198-a149-4480-a0ba-1de6a3bf525b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cd8bb198-a149-4480-a0ba-1de6a3bf525b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_e5c68cfc-4d10-468a-8f93-9846fb19c1ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_e5c68cfc-4d10-468a-8f93-9846fb19c1ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_ed71d4ae-4475-43b0-9aee-0ca0c6082536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_ed71d4ae-4475-43b0-9aee-0ca0c6082536" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_513e9f7c-51c0-4dce-8ab9-e13a3d375e11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_513e9f7c-51c0-4dce-8ab9-e13a3d375e11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_bfcecae0-774f-4e28-be27-c7c06efcf349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_bfcecae0-774f-4e28-be27-c7c06efcf349" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a0ccf17c-a03d-4b90-80e9-3d35931fc314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a0ccf17c-a03d-4b90-80e9-3d35931fc314" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_a173aa14-a979-45e4-bae7-453c2bf3b58c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_a173aa14-a979-45e4-bae7-453c2bf3b58c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_ea3c2b68-7258-471f-9c5b-38038626c8af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_ea3c2b68-7258-471f-9c5b-38038626c8af" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_795d475c-a095-4df6-87b6-45480f32031d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_795d475c-a095-4df6-87b6-45480f32031d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_cdb4b3ac-d488-48eb-a620-a4319d053c87" xlink:href="mck-20200930.xsd#mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_cdb4b3ac-d488-48eb-a620-a4319d053c87" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763dc8bc-99e4-481f-8a55-f4f219568706" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763dc8bc-99e4-481f-8a55-f4f219568706" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_763dc8bc-99e4-481f-8a55-f4f219568706_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763dc8bc-99e4-481f-8a55-f4f219568706" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_763dc8bc-99e4-481f-8a55-f4f219568706_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_bfac36c8-124d-442f-8723-803daca17e44" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763dc8bc-99e4-481f-8a55-f4f219568706" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_bfac36c8-124d-442f-8723-803daca17e44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_326061bc-83e0-488a-9169-c3afb455727b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_bfac36c8-124d-442f-8723-803daca17e44" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_326061bc-83e0-488a-9169-c3afb455727b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_27329d22-6857-4d43-b2a0-3f2fd4114980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_27329d22-6857-4d43-b2a0-3f2fd4114980" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_27329d22-6857-4d43-b2a0-3f2fd4114980_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_27329d22-6857-4d43-b2a0-3f2fd4114980" xlink:to="loc_us-gaap_TypeOfAdoptionMember_27329d22-6857-4d43-b2a0-3f2fd4114980_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_d598d587-f36e-4897-b704-5a60a2c1c47b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_27329d22-6857-4d43-b2a0-3f2fd4114980" xlink:to="loc_us-gaap_TypeOfAdoptionMember_d598d587-f36e-4897-b704-5a60a2c1c47b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_e76f3674-d95e-46ce-af1f-494d325e86fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_d598d587-f36e-4897-b704-5a60a2c1c47b" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_e76f3674-d95e-46ce-af1f-494d325e86fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d9fb0095-3457-4b3e-af76-6d9d07b9e448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d9fb0095-3457-4b3e-af76-6d9d07b9e448" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d9fb0095-3457-4b3e-af76-6d9d07b9e448_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9fb0095-3457-4b3e-af76-6d9d07b9e448" xlink:to="loc_us-gaap_EquityComponentDomain_d9fb0095-3457-4b3e-af76-6d9d07b9e448_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_94e9f2cd-5a57-41f3-a433-948e934ee4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9fb0095-3457-4b3e-af76-6d9d07b9e448" xlink:to="loc_us-gaap_EquityComponentDomain_94e9f2cd-5a57-41f3-a433-948e934ee4f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_adfac03e-2dc4-4bf5-99e7-731c467109d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_94e9f2cd-5a57-41f3-a433-948e934ee4f4" xlink:to="loc_us-gaap_RetainedEarningsMember_adfac03e-2dc4-4bf5-99e7-731c467109d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff2ef07a-e265-4624-9e3b-2dce930b942f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff2ef07a-e265-4624-9e3b-2dce930b942f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ff2ef07a-e265-4624-9e3b-2dce930b942f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff2ef07a-e265-4624-9e3b-2dce930b942f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ff2ef07a-e265-4624-9e3b-2dce930b942f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c8496917-7083-426f-a725-e49e2e47d4d9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff2ef07a-e265-4624-9e3b-2dce930b942f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c8496917-7083-426f-a725-e49e2e47d4d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_b1942e58-b4b1-472e-bb2a-cd2668ba58a5" xlink:href="mck-20200930.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c8496917-7083-426f-a725-e49e2e47d4d9" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_b1942e58-b4b1-472e-bb2a-cd2668ba58a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3d16305-431d-41b3-a839-ec69c85cdcc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3d16305-431d-41b3-a839-ec69c85cdcc1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b3d16305-431d-41b3-a839-ec69c85cdcc1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3d16305-431d-41b3-a839-ec69c85cdcc1" xlink:to="loc_us-gaap_RelatedPartyDomain_b3d16305-431d-41b3-a839-ec69c85cdcc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2a436810-04b3-44ea-bddf-7ea96037bc4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3d16305-431d-41b3-a839-ec69c85cdcc1" xlink:to="loc_us-gaap_RelatedPartyDomain_2a436810-04b3-44ea-bddf-7ea96037bc4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_e81019cb-a289-4ee0-bc91-0de6998cf1e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_2a436810-04b3-44ea-bddf-7ea96037bc4a" xlink:to="loc_us-gaap_CorporateJointVentureMember_e81019cb-a289-4ee0-bc91-0de6998cf1e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_d423fec1-3217-4fac-93e4-6492df75dfcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_d423fec1-3217-4fac-93e4-6492df75dfcf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d423fec1-3217-4fac-93e4-6492df75dfcf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_d423fec1-3217-4fac-93e4-6492df75dfcf" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d423fec1-3217-4fac-93e4-6492df75dfcf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_676c38fd-48d1-4bd6-b180-59e7dbabaf1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_d423fec1-3217-4fac-93e4-6492df75dfcf" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_676c38fd-48d1-4bd6-b180-59e7dbabaf1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_1564ae2c-d447-4e1e-a9df-e3aed6fb3f8c" xlink:href="mck-20200930.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_676c38fd-48d1-4bd6-b180-59e7dbabaf1f" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_1564ae2c-d447-4e1e-a9df-e3aed6fb3f8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a9992b6f-15bb-48f7-9f09-4cd19e2f4a79" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_dei_LegalEntityAxis_a9992b6f-15bb-48f7-9f09-4cd19e2f4a79" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a9992b6f-15bb-48f7-9f09-4cd19e2f4a79_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_a9992b6f-15bb-48f7-9f09-4cd19e2f4a79" xlink:to="loc_dei_EntityDomain_a9992b6f-15bb-48f7-9f09-4cd19e2f4a79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0d094730-0ee8-474c-977a-7cca3a418ca4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_a9992b6f-15bb-48f7-9f09-4cd19e2f4a79" xlink:to="loc_dei_EntityDomain_0d094730-0ee8-474c-977a-7cca3a418ca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareInc.Member_3a5879c7-07b1-41f8-b938-1110f92665c4" xlink:href="mck-20200930.xsd#mck_ChangeHealthcareInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_0d094730-0ee8-474c-977a-7cca3a418ca4" xlink:to="loc_mck_ChangeHealthcareInc.Member_3a5879c7-07b1-41f8-b938-1110f92665c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_31f92628-5cbe-474f-b100-83fdf5ff6093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_31f92628-5cbe-474f-b100-83fdf5ff6093" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_31f92628-5cbe-474f-b100-83fdf5ff6093_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_31f92628-5cbe-474f-b100-83fdf5ff6093" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_31f92628-5cbe-474f-b100-83fdf5ff6093_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c736ed02-45e4-4c60-ae0c-b0fd7a376a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_31f92628-5cbe-474f-b100-83fdf5ff6093" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c736ed02-45e4-4c60-ae0c-b0fd7a376a60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_b0f1a0ae-7c8f-4563-84aa-e483110046e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c736ed02-45e4-4c60-ae0c-b0fd7a376a60" xlink:to="loc_us-gaap_IPOMember_b0f1a0ae-7c8f-4563-84aa-e483110046e7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20200930.xsd#HeldforSale"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended" id="id81f24f7464e4caba0fc9626e4c24e6e_HeldforSale"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleTables" xlink:type="simple" xlink:href="mck-20200930.xsd#HeldforSaleTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleTables" xlink:type="extended" id="i901a4df8933a4f99a74fb46a7210ff45_HeldforSaleTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#HeldforSaleNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended" id="ida2bc0ad675a43478aa6767b8f42dc3f_HeldforSaleNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_269a3b00-d3a2-452b-98ff-36f6f8b7f10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_269a3b00-d3a2-452b-98ff-36f6f8b7f10a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_b8c388d7-eb85-4456-9886-75031b4b9671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_b8c388d7-eb85-4456-9886-75031b4b9671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_d1c01ebd-5c1f-40ab-bd6c-278e74b0c456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_d1c01ebd-5c1f-40ab-bd6c-278e74b0c456" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_6d6ebc53-4766-4bf5-b561-3c19ff71e690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_6d6ebc53-4766-4bf5-b561-3c19ff71e690" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_68cf8f63-045f-4f76-b780-e66b8be87674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_68cf8f63-045f-4f76-b780-e66b8be87674" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_58c86dfb-49c9-459d-923c-ac67d5ef26f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_58c86dfb-49c9-459d-923c-ac67d5ef26f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_58c86dfb-49c9-459d-923c-ac67d5ef26f6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_58c86dfb-49c9-459d-923c-ac67d5ef26f6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_58c86dfb-49c9-459d-923c-ac67d5ef26f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_579e8c30-bd67-4563-a6bb-4ac8c6c2a625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_58c86dfb-49c9-459d-923c-ac67d5ef26f6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_579e8c30-bd67-4563-a6bb-4ac8c6c2a625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b1062a21-4785-40fb-8ca4-aa0ba5f863f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_579e8c30-bd67-4563-a6bb-4ac8c6c2a625" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b1062a21-4785-40fb-8ca4-aa0ba5f863f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_360c8330-b25c-44ac-9166-b64317b6dc8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_360c8330-b25c-44ac-9166-b64317b6dc8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_360c8330-b25c-44ac-9166-b64317b6dc8d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_360c8330-b25c-44ac-9166-b64317b6dc8d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_360c8330-b25c-44ac-9166-b64317b6dc8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ea396945-278e-486a-a222-452760ef22df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_360c8330-b25c-44ac-9166-b64317b6dc8d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ea396945-278e-486a-a222-452760ef22df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_ffe80b3b-aad8-4116-aea3-a7c3f33ca1db" xlink:href="mck-20200930.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ea396945-278e-486a-a222-452760ef22df" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_ffe80b3b-aad8-4116-aea3-a7c3f33ca1db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7f2d2b4e-4328-4c3c-a609-155928964a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7f2d2b4e-4328-4c3c-a609-155928964a8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7f2d2b4e-4328-4c3c-a609-155928964a8c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7f2d2b4e-4328-4c3c-a609-155928964a8c" xlink:to="loc_us-gaap_RelatedPartyDomain_7f2d2b4e-4328-4c3c-a609-155928964a8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c80e290c-87bd-4484-8084-ac0661542bc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7f2d2b4e-4328-4c3c-a609-155928964a8c" xlink:to="loc_us-gaap_RelatedPartyDomain_c80e290c-87bd-4484-8084-ac0661542bc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_ef03f1f3-6b0b-4f38-8470-8de105f7caa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c80e290c-87bd-4484-8084-ac0661542bc5" xlink:to="loc_us-gaap_CorporateJointVentureMember_ef03f1f3-6b0b-4f38-8470-8de105f7caa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_71aab068-0071-4fc4-bacf-a2aab39be8d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_71aab068-0071-4fc4-bacf-a2aab39be8d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_71aab068-0071-4fc4-bacf-a2aab39be8d1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_71aab068-0071-4fc4-bacf-a2aab39be8d1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_71aab068-0071-4fc4-bacf-a2aab39be8d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_57bc5d19-1a81-4c70-91b8-fb0a2eb22708" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_71aab068-0071-4fc4-bacf-a2aab39be8d1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_57bc5d19-1a81-4c70-91b8-fb0a2eb22708" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_14b0e884-3ae7-4e9f-84ce-5b2a694f7981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_57bc5d19-1a81-4c70-91b8-fb0a2eb22708" xlink:to="loc_us-gaap_SubsequentEventMember_14b0e884-3ae7-4e9f-84ce-5b2a694f7981" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended" id="id7a961bd0e634d7b844588955c879d40_HeldforSaleAssetsandLiabilitiesHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_88b35a4e-1587-41c4-b4cf-676b726a569b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_88b35a4e-1587-41c4-b4cf-676b726a569b" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_1fba373e-24c8-48a5-b28b-1972d9bc5797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_1fba373e-24c8-48a5-b28b-1972d9bc5797" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_f7c2b778-4347-4d58-9151-24e1272f61ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_f7c2b778-4347-4d58-9151-24e1272f61ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_11a931dc-7231-4813-aaf5-b60a4d3a0c41" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_11a931dc-7231-4813-aaf5-b60a4d3a0c41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_2a9b4a54-7d5d-4706-ac73-57427394d9f2" xlink:href="mck-20200930.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_2a9b4a54-7d5d-4706-ac73-57427394d9f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_eb806b87-eeab-4c9a-a3fc-eaeb2182917f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_eb806b87-eeab-4c9a-a3fc-eaeb2182917f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fdb95bb-6c62-48f1-bace-e00dd395ea8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_88b35a4e-1587-41c4-b4cf-676b726a569b" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fdb95bb-6c62-48f1-bace-e00dd395ea8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_dbd2cc3e-5802-45f6-b45a-965b814c78d1" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fdb95bb-6c62-48f1-bace-e00dd395ea8d" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_dbd2cc3e-5802-45f6-b45a-965b814c78d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_c8201904-9241-425a-81e8-3460623faf01" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fdb95bb-6c62-48f1-bace-e00dd395ea8d" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_c8201904-9241-425a-81e8-3460623faf01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_acee19f7-e4f0-4d13-a4d6-2f4eaf7b61cb" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fdb95bb-6c62-48f1-bace-e00dd395ea8d" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_acee19f7-e4f0-4d13-a4d6-2f4eaf7b61cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_6c9137fc-adfe-41e5-80c9-39cb99fcd59c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fdb95bb-6c62-48f1-bace-e00dd395ea8d" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_6c9137fc-adfe-41e5-80c9-39cb99fcd59c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1fb01072-8f3e-4465-bd7d-6ba6651831d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_88b35a4e-1587-41c4-b4cf-676b726a569b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1fb01072-8f3e-4465-bd7d-6ba6651831d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0338956d-bf43-443f-95fa-22920aa12b2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1fb01072-8f3e-4465-bd7d-6ba6651831d8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0338956d-bf43-443f-95fa-22920aa12b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0338956d-bf43-443f-95fa-22920aa12b2f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0338956d-bf43-443f-95fa-22920aa12b2f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0338956d-bf43-443f-95fa-22920aa12b2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f0b98ec-4384-49e8-8cad-5a34330e6543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0338956d-bf43-443f-95fa-22920aa12b2f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f0b98ec-4384-49e8-8cad-5a34330e6543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_166b6713-f2fe-4886-a4d2-7fe4a4d7aaa4" xlink:href="mck-20200930.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f0b98ec-4384-49e8-8cad-5a34330e6543" xlink:to="loc_mck_GermanWholesaleBusinessMember_166b6713-f2fe-4886-a4d2-7fe4a4d7aaa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b13cdaed-7a25-4983-b1ab-79cd8743c108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1fb01072-8f3e-4465-bd7d-6ba6651831d8" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b13cdaed-7a25-4983-b1ab-79cd8743c108" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b13cdaed-7a25-4983-b1ab-79cd8743c108_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b13cdaed-7a25-4983-b1ab-79cd8743c108" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b13cdaed-7a25-4983-b1ab-79cd8743c108_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_808ef91e-50de-4a46-b3e7-bcf5398e26d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b13cdaed-7a25-4983-b1ab-79cd8743c108" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_808ef91e-50de-4a46-b3e7-bcf5398e26d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_21fd7b7a-454b-4c89-938c-cbd1ec3a8778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_808ef91e-50de-4a46-b3e7-bcf5398e26d0" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_21fd7b7a-454b-4c89-938c-cbd1ec3a8778" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended" id="i7807cbc8bbea45a4b1b29e6bcb90f0bd_RestructuringImpairmentandRelatedCharges"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended" id="i53fde79c315b43fb91bad8bb9307778b_RestructuringImpairmentandRelatedChargesTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended" id="i5526fe9224c4405a974dfa4cf5b0182c_RestructuringImpairmentandRelatedChargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_02ed3f97-3835-43ac-af7b-535f74945c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_df83e545-2007-409f-9831-9d2d2dbe6c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_02ed3f97-3835-43ac-af7b-535f74945c79" xlink:to="loc_us-gaap_RestructuringCharges_df83e545-2007-409f-9831-9d2d2dbe6c40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_7eaf68db-0aea-49ba-9ec4-22ebdac02b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_02ed3f97-3835-43ac-af7b-535f74945c79" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_7eaf68db-0aea-49ba-9ec4-22ebdac02b8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_b117785d-d3cb-4304-b1a7-fdab86a7eca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_02ed3f97-3835-43ac-af7b-535f74945c79" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_b117785d-d3cb-4304-b1a7-fdab86a7eca5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_078ee7db-1737-4901-8199-00ff8eda03c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_02ed3f97-3835-43ac-af7b-535f74945c79" xlink:to="loc_us-gaap_RestructuringReserve_078ee7db-1737-4901-8199-00ff8eda03c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1968f3b5-e929-4332-84de-8b2b1743e99f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_02ed3f97-3835-43ac-af7b-535f74945c79" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1968f3b5-e929-4332-84de-8b2b1743e99f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_bd28223f-1d96-4f00-a9d8-eef33e58db18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1968f3b5-e929-4332-84de-8b2b1743e99f" xlink:to="loc_us-gaap_RestructuringPlanAxis_bd28223f-1d96-4f00-a9d8-eef33e58db18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bd28223f-1d96-4f00-a9d8-eef33e58db18_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_bd28223f-1d96-4f00-a9d8-eef33e58db18" xlink:to="loc_us-gaap_RestructuringPlanDomain_bd28223f-1d96-4f00-a9d8-eef33e58db18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8f9e8aa6-c0f7-4042-8538-8432ac559459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_bd28223f-1d96-4f00-a9d8-eef33e58db18" xlink:to="loc_us-gaap_RestructuringPlanDomain_8f9e8aa6-c0f7-4042-8538-8432ac559459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_83f73fe6-0198-40a9-9ae2-182681850498" xlink:href="mck-20200930.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_8f9e8aa6-c0f7-4042-8538-8432ac559459" xlink:to="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_83f73fe6-0198-40a9-9ae2-182681850498" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingModelAndCostOptimizationProgramsMember_cb051174-0e6f-49dc-8dbb-fd480477a3c3" xlink:href="mck-20200930.xsd#mck_OperatingModelAndCostOptimizationProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_8f9e8aa6-c0f7-4042-8538-8432ac559459" xlink:to="loc_mck_OperatingModelAndCostOptimizationProgramsMember_cb051174-0e6f-49dc-8dbb-fd480477a3c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanMember_4140ee9b-cae4-4a30-a61d-3dd8f09b4b73" xlink:href="mck-20200930.xsd#mck_StrategicGrowthInitiativePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_8f9e8aa6-c0f7-4042-8538-8432ac559459" xlink:to="loc_mck_StrategicGrowthInitiativePlanMember_4140ee9b-cae4-4a30-a61d-3dd8f09b4b73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_be9a8a33-b7da-4096-9ec7-c40a9a006602" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1968f3b5-e929-4332-84de-8b2b1743e99f" xlink:to="loc_srt_RangeAxis_be9a8a33-b7da-4096-9ec7-c40a9a006602" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_be9a8a33-b7da-4096-9ec7-c40a9a006602_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_be9a8a33-b7da-4096-9ec7-c40a9a006602" xlink:to="loc_srt_RangeMember_be9a8a33-b7da-4096-9ec7-c40a9a006602_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b8b96670-0903-4c0b-b3c7-7a4bc9f3974a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_be9a8a33-b7da-4096-9ec7-c40a9a006602" xlink:to="loc_srt_RangeMember_b8b96670-0903-4c0b-b3c7-7a4bc9f3974a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b8eedc61-48fa-4c46-af03-69c4d03dedba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b8b96670-0903-4c0b-b3c7-7a4bc9f3974a" xlink:to="loc_srt_MinimumMember_b8eedc61-48fa-4c46-af03-69c4d03dedba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_74bd00b9-3870-4d5c-9cbf-1730f5511a59" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b8b96670-0903-4c0b-b3c7-7a4bc9f3974a" xlink:to="loc_srt_MaximumMember_74bd00b9-3870-4d5c-9cbf-1730f5511a59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bf6b5560-2c03-4d32-96d2-a2ff352650b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1968f3b5-e929-4332-84de-8b2b1743e99f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bf6b5560-2c03-4d32-96d2-a2ff352650b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bf6b5560-2c03-4d32-96d2-a2ff352650b5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bf6b5560-2c03-4d32-96d2-a2ff352650b5" xlink:to="loc_us-gaap_SegmentDomain_bf6b5560-2c03-4d32-96d2-a2ff352650b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4830b32b-32f6-4fb2-88bb-8cc80030d368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bf6b5560-2c03-4d32-96d2-a2ff352650b5" xlink:to="loc_us-gaap_SegmentDomain_4830b32b-32f6-4fb2-88bb-8cc80030d368" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_0170c9ae-6e04-4f9a-b894-355155de6519" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4830b32b-32f6-4fb2-88bb-8cc80030d368" xlink:to="loc_mck_InternationalSegmentMember_0170c9ae-6e04-4f9a-b894-355155de6519" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended" id="ibbee7b3c28b543db973a17215b79ea55_RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_12c2f6e3-7739-4f17-8a6c-f794bd791430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_2cc9d6f7-a73f-4099-b23d-3f53faadacfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_12c2f6e3-7739-4f17-8a6c-f794bd791430" xlink:to="loc_us-gaap_SeveranceCosts1_2cc9d6f7-a73f-4099-b23d-3f53faadacfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_97da04a4-d0b4-451a-a3b0-ad54fec7f933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_12c2f6e3-7739-4f17-8a6c-f794bd791430" xlink:to="loc_us-gaap_BusinessExitCosts1_97da04a4-d0b4-451a-a3b0-ad54fec7f933" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_d092e991-48c8-4024-85b9-cfca99b410eb" xlink:href="mck-20200930.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_12c2f6e3-7739-4f17-8a6c-f794bd791430" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_d092e991-48c8-4024-85b9-cfca99b410eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_79316ddf-3276-40b7-adce-46d14ce13ac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_12c2f6e3-7739-4f17-8a6c-f794bd791430" xlink:to="loc_us-gaap_RestructuringCharges_79316ddf-3276-40b7-adce-46d14ce13ac3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7055e7dc-3cfc-4d05-afe5-880c63c548fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_12c2f6e3-7739-4f17-8a6c-f794bd791430" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7055e7dc-3cfc-4d05-afe5-880c63c548fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6336235b-20cc-4a42-8fe6-5c76ec34d9fb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7055e7dc-3cfc-4d05-afe5-880c63c548fb" xlink:to="loc_srt_ConsolidationItemsAxis_6336235b-20cc-4a42-8fe6-5c76ec34d9fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6336235b-20cc-4a42-8fe6-5c76ec34d9fb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_6336235b-20cc-4a42-8fe6-5c76ec34d9fb" xlink:to="loc_srt_ConsolidationItemsDomain_6336235b-20cc-4a42-8fe6-5c76ec34d9fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d2e6c958-4b12-4162-945d-9265ab7da049" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_6336235b-20cc-4a42-8fe6-5c76ec34d9fb" xlink:to="loc_srt_ConsolidationItemsDomain_d2e6c958-4b12-4162-945d-9265ab7da049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_df9f9b9d-26e3-4d78-94e2-f89fcc77cbf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d2e6c958-4b12-4162-945d-9265ab7da049" xlink:to="loc_us-gaap_OperatingSegmentsMember_df9f9b9d-26e3-4d78-94e2-f89fcc77cbf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b7c1a307-c5b7-4a9e-bd7b-2b41e666a989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d2e6c958-4b12-4162-945d-9265ab7da049" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b7c1a307-c5b7-4a9e-bd7b-2b41e666a989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_35311cad-9e49-4116-b4a5-846b53ef95ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7055e7dc-3cfc-4d05-afe5-880c63c548fb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_35311cad-9e49-4116-b4a5-846b53ef95ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_35311cad-9e49-4116-b4a5-846b53ef95ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_35311cad-9e49-4116-b4a5-846b53ef95ee" xlink:to="loc_us-gaap_SegmentDomain_35311cad-9e49-4116-b4a5-846b53ef95ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c662afdc-a99d-4381-92e7-28f764f28841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_35311cad-9e49-4116-b4a5-846b53ef95ee" xlink:to="loc_us-gaap_SegmentDomain_c662afdc-a99d-4381-92e7-28f764f28841" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_6d12b0a1-0694-4ce6-89ac-6a1f6b1403d1" xlink:href="mck-20200930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c662afdc-a99d-4381-92e7-28f764f28841" xlink:to="loc_mck_USPharmaceuticalSegmentMember_6d12b0a1-0694-4ce6-89ac-6a1f6b1403d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_a40fcf29-9386-43bc-9440-7158bad2bbf6" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c662afdc-a99d-4381-92e7-28f764f28841" xlink:to="loc_mck_InternationalSegmentMember_a40fcf29-9386-43bc-9440-7158bad2bbf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_c1dbd5f8-92b7-4f2f-a4e8-b4be80111f2a" xlink:href="mck-20200930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c662afdc-a99d-4381-92e7-28f764f28841" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_c1dbd5f8-92b7-4f2f-a4e8-b4be80111f2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_52de49fd-dcad-4921-aa45-630e4366fbe3" xlink:href="mck-20200930.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c662afdc-a99d-4381-92e7-28f764f28841" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_52de49fd-dcad-4921-aa45-630e4366fbe3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="extended" id="i7391acb8d98f41cebcdce88c67e22770_RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_cf1c6d7b-2cc7-4cda-98cb-20625b349ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cf1c6d7b-2cc7-4cda-98cb-20625b349ee6" xlink:to="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_3ca91efc-8c0e-4053-9d56-904e611ffb20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:to="loc_us-gaap_RestructuringReserve_3ca91efc-8c0e-4053-9d56-904e611ffb20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_06496fda-f848-45b9-831f-68d2781851f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:to="loc_us-gaap_RestructuringCharges_06496fda-f848-45b9-831f-68d2781851f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_ba414191-8931-41d6-9929-c71568f4d5d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_ba414191-8931-41d6-9929-c71568f4d5d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_886fbff6-edb5-45d7-9fcd-d55ae869bf8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:to="loc_us-gaap_PaymentsForRestructuring_886fbff6-edb5-45d7-9fcd-d55ae869bf8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_603bc3a6-4210-45da-8490-b967ed9c2d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_603bc3a6-4210-45da-8490-b967ed9c2d02" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_8ef3ab2f-1fa4-45b6-a7bf-53549fd83d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee51b070-278a-493f-b6e2-6d8771378ae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cf1c6d7b-2cc7-4cda-98cb-20625b349ee6" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee51b070-278a-493f-b6e2-6d8771378ae5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a18003d3-dfe9-43d3-aadb-7fe6a50197c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee51b070-278a-493f-b6e2-6d8771378ae5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a18003d3-dfe9-43d3-aadb-7fe6a50197c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a18003d3-dfe9-43d3-aadb-7fe6a50197c1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a18003d3-dfe9-43d3-aadb-7fe6a50197c1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a18003d3-dfe9-43d3-aadb-7fe6a50197c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0ea84210-5ec8-4d6e-8071-b81dfadfcead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a18003d3-dfe9-43d3-aadb-7fe6a50197c1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0ea84210-5ec8-4d6e-8071-b81dfadfcead" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b4089ada-f826-41a5-b04d-33f95110ff40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ea84210-5ec8-4d6e-8071-b81dfadfcead" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b4089ada-f826-41a5-b04d-33f95110ff40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_53b47018-a8b6-4a03-8691-2a393525b6f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ea84210-5ec8-4d6e-8071-b81dfadfcead" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_53b47018-a8b6-4a03-8691-2a393525b6f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2704f2b8-ba0f-4e48-9e47-497ca734a620" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee51b070-278a-493f-b6e2-6d8771378ae5" xlink:to="loc_srt_ConsolidationItemsAxis_2704f2b8-ba0f-4e48-9e47-497ca734a620" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2704f2b8-ba0f-4e48-9e47-497ca734a620_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_2704f2b8-ba0f-4e48-9e47-497ca734a620" xlink:to="loc_srt_ConsolidationItemsDomain_2704f2b8-ba0f-4e48-9e47-497ca734a620_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c4ed5c1d-2cf3-487c-972d-c6913790a35e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_2704f2b8-ba0f-4e48-9e47-497ca734a620" xlink:to="loc_srt_ConsolidationItemsDomain_c4ed5c1d-2cf3-487c-972d-c6913790a35e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e7693f02-db6e-424e-9af7-5b91ce168eb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c4ed5c1d-2cf3-487c-972d-c6913790a35e" xlink:to="loc_us-gaap_OperatingSegmentsMember_e7693f02-db6e-424e-9af7-5b91ce168eb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_eb476d3f-b0f1-4c47-890b-d7cdb5172f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c4ed5c1d-2cf3-487c-972d-c6913790a35e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_eb476d3f-b0f1-4c47-890b-d7cdb5172f2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_04cea13a-e42e-4a65-b3cc-f61819fb5d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee51b070-278a-493f-b6e2-6d8771378ae5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_04cea13a-e42e-4a65-b3cc-f61819fb5d17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_04cea13a-e42e-4a65-b3cc-f61819fb5d17_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_04cea13a-e42e-4a65-b3cc-f61819fb5d17" xlink:to="loc_us-gaap_SegmentDomain_04cea13a-e42e-4a65-b3cc-f61819fb5d17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e50ad500-ad1d-46b9-beb0-3fb63b65000f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_04cea13a-e42e-4a65-b3cc-f61819fb5d17" xlink:to="loc_us-gaap_SegmentDomain_e50ad500-ad1d-46b9-beb0-3fb63b65000f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_3c98922f-a2cd-43d4-bec9-f8b9d6603537" xlink:href="mck-20200930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e50ad500-ad1d-46b9-beb0-3fb63b65000f" xlink:to="loc_mck_USPharmaceuticalSegmentMember_3c98922f-a2cd-43d4-bec9-f8b9d6603537" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_64c91b10-6712-4504-a2cc-81e8dffcb5c8" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e50ad500-ad1d-46b9-beb0-3fb63b65000f" xlink:to="loc_mck_InternationalSegmentMember_64c91b10-6712-4504-a2cc-81e8dffcb5c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_806d7c70-60e4-4e47-9d09-9b833ba394b2" xlink:href="mck-20200930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e50ad500-ad1d-46b9-beb0-3fb63b65000f" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_806d7c70-60e4-4e47-9d09-9b833ba394b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_9f65c70a-abc5-4c60-807c-0e4d2928bc72" xlink:href="mck-20200930.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e50ad500-ad1d-46b9-beb0-3fb63b65000f" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_9f65c70a-abc5-4c60-807c-0e4d2928bc72" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20200930.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended" id="i24f6cdfec8e642dea68673c5d78b3fe1_IncomeTaxes"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="extended" id="i45a419443d364013969c603c42a50391_IncomeTaxesDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20200930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended" id="ieed65415e46446308955328423fdde39_RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20200930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended" id="ib688a817c8c042e8aa7f76d1b9ad138a_RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended" id="i2e0a273b6c47420b81401a5c7ce7fd95_RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_49391eb9-7b99-4eb0-893c-6ad0fc183085" xlink:href="mck-20200930.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_49391eb9-7b99-4eb0-893c-6ad0fc183085" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_dca278f9-edc8-462b-9dd1-dea5be8b2261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_dca278f9-edc8-462b-9dd1-dea5be8b2261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_36e60093-5473-4413-98a8-e84700a4d8bc" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_36e60093-5473-4413-98a8-e84700a4d8bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_2fd6d9b1-9926-4b43-aff9-ef35ec08a532" xlink:href="mck-20200930.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_PutRightValueInterestRateSpread_2fd6d9b1-9926-4b43-aff9-ef35ec08a532" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_decc34ff-7989-48c1-9725-429e5813e876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_decc34ff-7989-48c1-9725-429e5813e876" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_418dceef-06ab-4fa5-9a81-8904e1ca1acf" xlink:href="mck-20200930.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_418dceef-06ab-4fa5-9a81-8904e1ca1acf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3b912bee-781d-4c2d-a6fe-cac4160f7557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3b912bee-781d-4c2d-a6fe-cac4160f7557" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_5e01c6d4-8127-4184-9662-ab6ec8ab8ad3" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_5e01c6d4-8127-4184-9662-ab6ec8ab8ad3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_ecbe2244-c822-4f03-9b3c-69a5e5b0e7eb" xlink:href="mck-20200930.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_ecbe2244-c822-4f03-9b3c-69a5e5b0e7eb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_acd5fe9e-0e9d-4882-a730-606707a6cb8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_acd5fe9e-0e9d-4882-a730-606707a6cb8a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_cf5cb4ca-6629-4cbe-883d-7fe229786bb1" xlink:href="mck-20200930.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_cf5cb4ca-6629-4cbe-883d-7fe229786bb1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_0e9a147d-aed2-4877-b97a-09380a69f543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_0e9a147d-aed2-4877-b97a-09380a69f543" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ae089dfe-ebf4-43ad-91b0-21e3d6c2eedc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_MinorityInterest_ae089dfe-ebf4-43ad-91b0-21e3d6c2eedc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_af824cb1-e64d-42f5-8047-7d7b9046cd36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_af824cb1-e64d-42f5-8047-7d7b9046cd36" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_6eb17d07-eefe-4c10-820c-df159eb06c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_MinorityInterestTable_6eb17d07-eefe-4c10-820c-df159eb06c71" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_6cc73c0a-6423-4d24-9150-7533f426a1ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_6eb17d07-eefe-4c10-820c-df159eb06c71" xlink:to="loc_srt_OwnershipAxis_6cc73c0a-6423-4d24-9150-7533f426a1ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_6cc73c0a-6423-4d24-9150-7533f426a1ea_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_6cc73c0a-6423-4d24-9150-7533f426a1ea" xlink:to="loc_srt_OwnershipDomain_6cc73c0a-6423-4d24-9150-7533f426a1ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_68e1343d-9d55-4a77-baeb-a2f600b45aed" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_6cc73c0a-6423-4d24-9150-7533f426a1ea" xlink:to="loc_srt_OwnershipDomain_68e1343d-9d55-4a77-baeb-a2f600b45aed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_18cba496-a1e7-4a55-ac38-dadc8e749d2c" xlink:href="mck-20200930.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_68e1343d-9d55-4a77-baeb-a2f600b45aed" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_18cba496-a1e7-4a55-ac38-dadc8e749d2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_be09944e-9c2b-450e-b3ec-74fc3b64d2a2" xlink:href="mck-20200930.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_68e1343d-9d55-4a77-baeb-a2f600b45aed" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_be09944e-9c2b-450e-b3ec-74fc3b64d2a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_73044d6c-8ea3-4b99-8140-f9d0e01fd687" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_6eb17d07-eefe-4c10-820c-df159eb06c71" xlink:to="loc_dei_LegalEntityAxis_73044d6c-8ea3-4b99-8140-f9d0e01fd687" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_73044d6c-8ea3-4b99-8140-f9d0e01fd687_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_73044d6c-8ea3-4b99-8140-f9d0e01fd687" xlink:to="loc_dei_EntityDomain_73044d6c-8ea3-4b99-8140-f9d0e01fd687_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_921f5b84-0eb6-4d32-ba90-1c45215404e0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_73044d6c-8ea3-4b99-8140-f9d0e01fd687" xlink:to="loc_dei_EntityDomain_921f5b84-0eb6-4d32-ba90-1c45215404e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_423c97f6-2572-47d6-89e0-ade632e93c0f" xlink:href="mck-20200930.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_921f5b84-0eb6-4d32-ba90-1c45215404e0" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_423c97f6-2572-47d6-89e0-ade632e93c0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_80055c24-4bb9-4480-9c46-c85ee4e345fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_6eb17d07-eefe-4c10-820c-df159eb06c71" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_80055c24-4bb9-4480-9c46-c85ee4e345fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_80055c24-4bb9-4480-9c46-c85ee4e345fe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_80055c24-4bb9-4480-9c46-c85ee4e345fe" xlink:to="loc_us-gaap_EquityComponentDomain_80055c24-4bb9-4480-9c46-c85ee4e345fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_28c51043-7459-4fa1-a381-56c04e4845dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_80055c24-4bb9-4480-9c46-c85ee4e345fe" xlink:to="loc_us-gaap_EquityComponentDomain_28c51043-7459-4fa1-a381-56c04e4845dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_65c4c3d4-f683-4e39-a0bb-43ef7704fb2c" xlink:href="mck-20200930.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_28c51043-7459-4fa1-a381-56c04e4845dc" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_65c4c3d4-f683-4e39-a0bb-43ef7704fb2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_be0a230f-33d9-486c-827d-c5d98d5e1b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_28c51043-7459-4fa1-a381-56c04e4845dc" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_be0a230f-33d9-486c-827d-c5d98d5e1b35" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended" id="if6542b3f53a84f76bd31bdf0de566e83_RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_488a4f1f-ffa2-4dee-b745-0271c4f617ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_488a4f1f-ffa2-4dee-b745-0271c4f617ed" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_cd46841b-03be-4dd9-827e-625a44c7dfff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:to="loc_us-gaap_MinorityInterest_cd46841b-03be-4dd9-827e-625a44c7dfff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e8077b60-9a2d-4eee-a330-feb5de514149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e8077b60-9a2d-4eee-a330-feb5de514149" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_133d1f16-205c-446b-bc06-9837f2c7e6fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_133d1f16-205c-446b-bc06-9837f2c7e6fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_163323e9-a1f9-4bf0-9776-0a1022863e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_163323e9-a1f9-4bf0-9776-0a1022863e88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_7eb77ee1-f70c-454a-bf67-39cbe943f6df" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_7eb77ee1-f70c-454a-bf67-39cbe943f6df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e7c694f2-5d35-479e-8325-b660f3939ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_488a4f1f-ffa2-4dee-b745-0271c4f617ed" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_30f238ac-7a17-435e-8b59-2aabbd4b16f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_30f238ac-7a17-435e-8b59-2aabbd4b16f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_68c36449-0046-400a-ad6b-b9e9bdd32100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_68c36449-0046-400a-ad6b-b9e9bdd32100" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_1268937b-5e02-4d33-a069-3724ef724f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_3950b430-6bd7-4be6-8e80-b86a912aaa43" xlink:href="mck-20200930.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_3950b430-6bd7-4be6-8e80-b86a912aaa43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93cc11fb-b65b-4f33-aae7-1207baa82534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_f166437b-8edc-45a6-8c8c-3471fe5f2226" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_f166437b-8edc-45a6-8c8c-3471fe5f2226" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_9a9c590d-d2bf-470f-8df5-7fab6ac7d0e7" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0cc394f8-465d-43a4-b62b-8e9ee4ce4d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_d37edc49-b124-4a00-b7dc-8d240b7120ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_488a4f1f-ffa2-4dee-b745-0271c4f617ed" xlink:to="loc_us-gaap_MinorityInterestTable_d37edc49-b124-4a00-b7dc-8d240b7120ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_01e44cf2-23f3-4b49-98b8-d2752c6d3f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_d37edc49-b124-4a00-b7dc-8d240b7120ce" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_01e44cf2-23f3-4b49-98b8-d2752c6d3f31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_01e44cf2-23f3-4b49-98b8-d2752c6d3f31_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_01e44cf2-23f3-4b49-98b8-d2752c6d3f31" xlink:to="loc_us-gaap_EquityComponentDomain_01e44cf2-23f3-4b49-98b8-d2752c6d3f31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_383a8dc7-c0ac-466d-ab7c-ffccc96407b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_01e44cf2-23f3-4b49-98b8-d2752c6d3f31" xlink:to="loc_us-gaap_EquityComponentDomain_383a8dc7-c0ac-466d-ab7c-ffccc96407b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c95aeaca-e846-43a2-ae9a-20b03b4ca9ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_383a8dc7-c0ac-466d-ab7c-ffccc96407b6" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c95aeaca-e846-43a2-ae9a-20b03b4ca9ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_296a3447-904e-430e-889d-b996df8126f7" xlink:href="mck-20200930.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_383a8dc7-c0ac-466d-ab7c-ffccc96407b6" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_296a3447-904e-430e-889d-b996df8126f7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsPerCommonShare" xlink:type="simple" xlink:href="mck-20200930.xsd#EarningsPerCommonShare"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsPerCommonShare" xlink:type="extended" id="i2315f57080204832b49e2ac0809c315d_EarningsPerCommonShare"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsPerCommonShareTables" xlink:type="simple" xlink:href="mck-20200930.xsd#EarningsPerCommonShareTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsPerCommonShareTables" xlink:type="extended" id="i5b32340459d743a899d217034972b81c_EarningsPerCommonShareTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended" id="i6af136c9f8d64f39bce6490c99062dd9_EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended" id="i853c3730378b44b78f8e80b58c15be70_GoodwillandIntangibleAssetsNet"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended" id="i56ecc71dd3ee4ae887c1721faecf4c85_GoodwillandIntangibleAssetsNetTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended" id="i6d4128d9ea3e43c39460d2cdccc9ba30_GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_1cc81340-5d6b-4788-b167-db670f8183d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1cc81340-5d6b-4788-b167-db670f8183d2" xlink:to="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ca61a5cf-a470-4738-bff8-312d6f40ac26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:to="loc_us-gaap_Goodwill_ca61a5cf-a470-4738-bff8-312d6f40ac26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_25ca028c-5221-4117-a09a-78798b491e57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_25ca028c-5221-4117-a09a-78798b491e57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_ade4dea4-be35-47e4-88c0-e69dfef07cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_ade4dea4-be35-47e4-88c0-e69dfef07cd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9cf0d0c7-755b-4397-ab07-fda3efe3d503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9cf0d0c7-755b-4397-ab07-fda3efe3d503" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_4cbc3fe7-7c42-4c3c-8ef8-fa7b09346fc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_4cbc3fe7-7c42-4c3c-8ef8-fa7b09346fc0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_76a1979e-2d4b-4e16-9e13-6d53d30023ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_35664989-7d30-424c-923e-940c792049ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_1cc81340-5d6b-4788-b167-db670f8183d2" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_35664989-7d30-424c-923e-940c792049ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f65a52d4-6d95-4c54-af4d-2dd42be17e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_35664989-7d30-424c-923e-940c792049ec" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f65a52d4-6d95-4c54-af4d-2dd42be17e99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f65a52d4-6d95-4c54-af4d-2dd42be17e99_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f65a52d4-6d95-4c54-af4d-2dd42be17e99" xlink:to="loc_us-gaap_SegmentDomain_f65a52d4-6d95-4c54-af4d-2dd42be17e99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b89bb3dd-5687-41c6-9586-88fe237b7058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f65a52d4-6d95-4c54-af4d-2dd42be17e99" xlink:to="loc_us-gaap_SegmentDomain_b89bb3dd-5687-41c6-9586-88fe237b7058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_82b08e42-f7d7-4612-b389-fab9645a8f48" xlink:href="mck-20200930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b89bb3dd-5687-41c6-9586-88fe237b7058" xlink:to="loc_mck_USPharmaceuticalSegmentMember_82b08e42-f7d7-4612-b389-fab9645a8f48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_bd057322-10dc-4511-ae7a-91311f779f83" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b89bb3dd-5687-41c6-9586-88fe237b7058" xlink:to="loc_mck_InternationalSegmentMember_bd057322-10dc-4511-ae7a-91311f779f83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_70792db0-91dc-4db6-88c8-0dd5f0d13fbe" xlink:href="mck-20200930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b89bb3dd-5687-41c6-9586-88fe237b7058" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_70792db0-91dc-4db6-88c8-0dd5f0d13fbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_89841b84-a231-4385-9445-0354b2186094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b89bb3dd-5687-41c6-9586-88fe237b7058" xlink:to="loc_us-gaap_AllOtherSegmentsMember_89841b84-a231-4385-9445-0354b2186094" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended" id="ic9d9d471717249fd8d352e930802624c_GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_791ba7d3-0360-4587-ac48-5e358dedc093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_748d2478-39cc-4b2f-8daa-ee5bac3611d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_791ba7d3-0360-4587-ac48-5e358dedc093" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_748d2478-39cc-4b2f-8daa-ee5bac3611d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3f3f43a4-c7dd-47cb-8578-8ffdae5e5b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_791ba7d3-0360-4587-ac48-5e358dedc093" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3f3f43a4-c7dd-47cb-8578-8ffdae5e5b1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_78d83740-4500-4090-b287-b73a77598584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_791ba7d3-0360-4587-ac48-5e358dedc093" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_78d83740-4500-4090-b287-b73a77598584" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5252650d-5fdd-4023-a42e-4e8e67105046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_791ba7d3-0360-4587-ac48-5e358dedc093" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5252650d-5fdd-4023-a42e-4e8e67105046" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aefbd0b0-372d-4e59-9733-016418352f1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_791ba7d3-0360-4587-ac48-5e358dedc093" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aefbd0b0-372d-4e59-9733-016418352f1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_73a16dd7-9003-47a7-81b8-595645a530d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aefbd0b0-372d-4e59-9733-016418352f1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_73a16dd7-9003-47a7-81b8-595645a530d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73a16dd7-9003-47a7-81b8-595645a530d1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_73a16dd7-9003-47a7-81b8-595645a530d1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_73a16dd7-9003-47a7-81b8-595645a530d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_73a16dd7-9003-47a7-81b8-595645a530d1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_2645187d-2369-42c3-94aa-4dab4079719a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_2645187d-2369-42c3-94aa-4dab4079719a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_9ad50638-a94f-4efd-ae2e-0a80dcfb1cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:to="loc_us-gaap_ServiceAgreementsMember_9ad50638-a94f-4efd-ae2e-0a80dcfb1cd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember_d88abd27-27e3-4761-8f18-f39830e9f72a" xlink:href="mck-20200930.xsd#mck_PharmacyLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:to="loc_mck_PharmacyLicensesMember_d88abd27-27e3-4761-8f18-f39830e9f72a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_7fedf573-86d3-4b32-bd3e-4e4dba74dcc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_7fedf573-86d3-4b32-bd3e-4e4dba74dcc4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2f120128-918d-4d09-9e53-486c9c88d057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2f120128-918d-4d09-9e53-486c9c88d057" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_2789f3c4-c257-454e-8006-146774792ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_2789f3c4-c257-454e-8006-146774792ff4" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="extended" id="if71d1ced7e664dffb15674ce098be600_GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_225967b5-50d9-40bc-a372-74d5da24263a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_NumberOfReportableSegments_225967b5-50d9-40bc-a372-74d5da24263a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c5aac8fa-ef35-4aaa-ba5f-805982481c8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c5aac8fa-ef35-4aaa-ba5f-805982481c8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax_65d3976e-642e-4703-8968-172cef4c2b17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_GoodwillImpairmentLossNetOfTax_65d3976e-642e-4703-8968-172cef4c2b17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f69efbba-3af8-4591-a100-0b3e7e2985fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_Goodwill_f69efbba-3af8-4591-a100-0b3e7e2985fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1a748ec9-747b-4eea-9d18-4ba764b71132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1a748ec9-747b-4eea-9d18-4ba764b71132" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_7bf9d62c-ddc2-4cf4-b63a-c70219b28f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_7bf9d62c-ddc2-4cf4-b63a-c70219b28f31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_afb7773c-a3d5-44a9-9174-cfa9b8322228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_afb7773c-a3d5-44a9-9174-cfa9b8322228" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d729c1cc-af69-460c-b0a6-d6d5ec004561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d729c1cc-af69-460c-b0a6-d6d5ec004561" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8e8efc6d-eabb-4c53-9f47-7617328b3aff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8e8efc6d-eabb-4c53-9f47-7617328b3aff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9cd9bfc8-332f-4815-af35-176b3c058dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9cd9bfc8-332f-4815-af35-176b3c058dd6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_c66a7ac4-ba5c-4ce5-81ca-00ab10b731ab" xlink:href="mck-20200930.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:to="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_c66a7ac4-ba5c-4ce5-81ca-00ab10b731ab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_06d60399-1cdb-4314-afda-bf17b8212b2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_06d60399-1cdb-4314-afda-bf17b8212b2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_e67728fd-5cec-4adf-9c75-784dc298c28d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_06d60399-1cdb-4314-afda-bf17b8212b2f" xlink:to="loc_us-gaap_ReportingUnitAxis_e67728fd-5cec-4adf-9c75-784dc298c28d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_e67728fd-5cec-4adf-9c75-784dc298c28d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_e67728fd-5cec-4adf-9c75-784dc298c28d" xlink:to="loc_us-gaap_ReportingUnitDomain_e67728fd-5cec-4adf-9c75-784dc298c28d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_16968a3c-e7c6-454a-baf3-38e6b69adb77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_e67728fd-5cec-4adf-9c75-784dc298c28d" xlink:to="loc_us-gaap_ReportingUnitDomain_16968a3c-e7c6-454a-baf3-38e6b69adb77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_4ea1bbf0-99bd-443b-8144-b95843fb26dc" xlink:href="mck-20200930.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_16968a3c-e7c6-454a-baf3-38e6b69adb77" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_4ea1bbf0-99bd-443b-8144-b95843fb26dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f3904e61-5f21-4364-9486-4f1e3c1e9250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_06d60399-1cdb-4314-afda-bf17b8212b2f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f3904e61-5f21-4364-9486-4f1e3c1e9250" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f3904e61-5f21-4364-9486-4f1e3c1e9250_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f3904e61-5f21-4364-9486-4f1e3c1e9250" xlink:to="loc_us-gaap_SegmentDomain_f3904e61-5f21-4364-9486-4f1e3c1e9250_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_26d0c332-c285-4085-91bf-bc25035befe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f3904e61-5f21-4364-9486-4f1e3c1e9250" xlink:to="loc_us-gaap_SegmentDomain_26d0c332-c285-4085-91bf-bc25035befe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_5f7e16e1-9670-4bc3-9485-6cbc3c31dac9" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_26d0c332-c285-4085-91bf-bc25035befe7" xlink:to="loc_mck_InternationalSegmentMember_5f7e16e1-9670-4bc3-9485-6cbc3c31dac9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5a27738b-d1be-457b-befb-7562ee5ebf2a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_06d60399-1cdb-4314-afda-bf17b8212b2f" xlink:to="loc_srt_StatementGeographicalAxis_5a27738b-d1be-457b-befb-7562ee5ebf2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5a27738b-d1be-457b-befb-7562ee5ebf2a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_5a27738b-d1be-457b-befb-7562ee5ebf2a" xlink:to="loc_srt_SegmentGeographicalDomain_5a27738b-d1be-457b-befb-7562ee5ebf2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e9ef95f0-1654-40be-899f-5cfcd76a70f2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_5a27738b-d1be-457b-befb-7562ee5ebf2a" xlink:to="loc_srt_SegmentGeographicalDomain_e9ef95f0-1654-40be-899f-5cfcd76a70f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_47f9df4a-3730-4bea-928f-d8f387562968" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e9ef95f0-1654-40be-899f-5cfcd76a70f2" xlink:to="loc_srt_EuropeMember_47f9df4a-3730-4bea-928f-d8f387562968" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivities"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended" id="i2ed8d62fe1be4223929cad72cfea3037_DebtandFinancingActivities"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended" id="i00bf8df73d2541a49bbb4a94e38f25ca_DebtandFinancingActivitiesTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended" id="i05acef63f0ad44cb985f506212445055_DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_172faa87-d84b-438a-a38b-13fe425c3ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_172faa87-d84b-438a-a38b-13fe425c3ebf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d38dfcf7-5ee1-46eb-95be-8eb671dbcd9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_LongTermDebt_d38dfcf7-5ee1-46eb-95be-8eb671dbcd9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_46d9e7f8-fa16-4bee-97d0-36b9d664b027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_FinanceLeaseLiability_46d9e7f8-fa16-4bee-97d0-36b9d664b027" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_89be03dc-662b-460a-8ce5-db4bca482a94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_89be03dc-662b-460a-8ce5-db4bca482a94" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d5d0fd8f-04e2-4e0a-94c4-2f9d61a32485" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d5d0fd8f-04e2-4e0a-94c4-2f9d61a32485" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_1ce8152d-b5ed-42ed-bd24-c8f0c0fed494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_1ce8152d-b5ed-42ed-bd24-c8f0c0fed494" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3da3a8e8-a362-4184-a9fa-7ebcfe8b04a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_DebtInstrumentTable_3da3a8e8-a362-4184-a9fa-7ebcfe8b04a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_824db88b-2510-432a-bbd8-6b01510f83e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3da3a8e8-a362-4184-a9fa-7ebcfe8b04a8" xlink:to="loc_us-gaap_DebtInstrumentAxis_824db88b-2510-432a-bbd8-6b01510f83e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_824db88b-2510-432a-bbd8-6b01510f83e4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_824db88b-2510-432a-bbd8-6b01510f83e4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_824db88b-2510-432a-bbd8-6b01510f83e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_824db88b-2510-432a-bbd8-6b01510f83e4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A365NotesDueNovember302020Member_6e68b673-f8cc-45a9-8936-3cb77e4ee412" xlink:href="mck-20200930.xsd#mck_A365NotesDueNovember302020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A365NotesDueNovember302020Member_6e68b673-f8cc-45a9-8936-3cb77e4ee412" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member_2d454046-0f32-4b46-a843-d50431034b2d" xlink:href="mck-20200930.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A475NotesDueMarch12021Member_2d454046-0f32-4b46-a843-d50431034b2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_6aa76920-8d42-4587-97bc-d4267b0e3555" xlink:href="mck-20200930.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A270NotesDueDecember152022Member_6aa76920-8d42-4587-97bc-d4267b0e3555" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_3c9c4f86-a6a5-4fba-95bc-732323bca715" xlink:href="mck-20200930.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A285NotesDueMarch152023Member_3c9c4f86-a6a5-4fba-95bc-732323bca715" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_4ea80889-7b79-40bd-8d75-1065253a9f83" xlink:href="mck-20200930.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A380NotesDueMarch152024Member_4ea80889-7b79-40bd-8d75-1065253a9f83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_193e5f95-2961-4df4-a897-6dddaf4bb4d3" xlink:href="mck-20200930.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_193e5f95-2961-4df4-a897-6dddaf4bb4d3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_be53c81d-fd77-4d08-9575-c42e4771ec0b" xlink:href="mck-20200930.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A395NotesDueFebruary162028Member_be53c81d-fd77-4d08-9575-c42e4771ec0b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_c6ff5bab-c175-46b1-b453-0e8a5f1f0aca" xlink:href="mck-20200930.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A475NotesDueMay302029Member_c6ff5bab-c175-46b1-b453-0e8a5f1f0aca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_e74e818d-6972-4489-bc36-e6d20555c89d" xlink:href="mck-20200930.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A600NotesDueMarch12041Member_e74e818d-6972-4489-bc36-e6d20555c89d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_94efbe0b-3b68-4930-9f26-5009cbb2c546" xlink:href="mck-20200930.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A488NotesDueMarch152044Member_94efbe0b-3b68-4930-9f26-5009cbb2c546" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_eddeb050-bf84-4dc8-bb6b-115627e5664c" xlink:href="mck-20200930.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_eddeb050-bf84-4dc8-bb6b-115627e5664c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_55d7ef95-c8c9-4120-ba34-caa4496a14c8" xlink:href="mck-20200930.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_55d7ef95-c8c9-4120-ba34-caa4496a14c8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_ff63446f-6fd3-4a95-8fd4-17136edd857b" xlink:href="mck-20200930.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_ff63446f-6fd3-4a95-8fd4-17136edd857b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_24d1a7b6-764a-4234-a2df-8f903fc3e6e7" xlink:href="mck-20200930.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_24d1a7b6-764a-4234-a2df-8f903fc3e6e7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2f3e490f-5a57-4ee1-82cb-581f00b9bc43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3da3a8e8-a362-4184-a9fa-7ebcfe8b04a8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2f3e490f-5a57-4ee1-82cb-581f00b9bc43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2f3e490f-5a57-4ee1-82cb-581f00b9bc43_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2f3e490f-5a57-4ee1-82cb-581f00b9bc43" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2f3e490f-5a57-4ee1-82cb-581f00b9bc43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f80c6a09-7357-4eaf-b35d-80b29b24e756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2f3e490f-5a57-4ee1-82cb-581f00b9bc43" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f80c6a09-7357-4eaf-b35d-80b29b24e756" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_56234cd3-e8c5-4ace-b2b9-3de85be5ba63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f80c6a09-7357-4eaf-b35d-80b29b24e756" xlink:to="loc_us-gaap_LoansPayableMember_56234cd3-e8c5-4ace-b2b9-3de85be5ba63" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended" id="i43638d02f71349f09c94d8b28599e805_DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended" id="id0d84a12f7674cd791ab37e3f171a7c2_DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a7c57131-7ecc-45c1-88a3-17c4b0a2040a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a7c57131-7ecc-45c1-88a3-17c4b0a2040a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_ee2bd337-9719-415b-bb7d-f8dae1f3a236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_DebtInstrumentTerm_ee2bd337-9719-415b-bb7d-f8dae1f3a236" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_23bfd6ba-ba09-4d7f-90b2-172dc54f7279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_23bfd6ba-ba09-4d7f-90b2-172dc54f7279" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_18fef436-1ae0-4b7c-aec2-d2c532ea5422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_LineOfCredit_18fef436-1ae0-4b7c-aec2-d2c532ea5422" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio_ce39fd82-4c1e-4ea2-8367-0593fbcc0493" xlink:href="mck-20200930.xsd#mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio_ce39fd82-4c1e-4ea2-8367-0593fbcc0493" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_a67bb352-f6d3-4deb-80a5-0617f47169a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_a67bb352-f6d3-4deb-80a5-0617f47169a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_df72bbff-519f-4b20-a353-6c9175747bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_df72bbff-519f-4b20-a353-6c9175747bfd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_4332c8fe-560b-4fb1-929b-71d152f372c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_4332c8fe-560b-4fb1-929b-71d152f372c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9ef8d4a7-1487-44db-879d-3b3c9c1f3997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4332c8fe-560b-4fb1-929b-71d152f372c3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9ef8d4a7-1487-44db-879d-3b3c9c1f3997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9ef8d4a7-1487-44db-879d-3b3c9c1f3997_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9ef8d4a7-1487-44db-879d-3b3c9c1f3997" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9ef8d4a7-1487-44db-879d-3b3c9c1f3997_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e197b375-7a30-4783-9f77-975dbae84d16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9ef8d4a7-1487-44db-879d-3b3c9c1f3997" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e197b375-7a30-4783-9f77-975dbae84d16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_c8e6e7f7-5dc3-4b90-a499-aa78cb6fb46c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e197b375-7a30-4783-9f77-975dbae84d16" xlink:to="loc_us-gaap_UnsecuredDebtMember_c8e6e7f7-5dc3-4b90-a499-aa78cb6fb46c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_76660495-0079-4fa1-97f1-d52bf1a1fce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4332c8fe-560b-4fb1-929b-71d152f372c3" xlink:to="loc_us-gaap_CreditFacilityAxis_76660495-0079-4fa1-97f1-d52bf1a1fce2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_76660495-0079-4fa1-97f1-d52bf1a1fce2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_76660495-0079-4fa1-97f1-d52bf1a1fce2" xlink:to="loc_us-gaap_CreditFacilityDomain_76660495-0079-4fa1-97f1-d52bf1a1fce2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_be4fb198-edee-4dd4-bcee-c9fed08d4f51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_76660495-0079-4fa1-97f1-d52bf1a1fce2" xlink:to="loc_us-gaap_CreditFacilityDomain_be4fb198-edee-4dd4-bcee-c9fed08d4f51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_afe1bab2-f873-4570-90e9-be2a23546755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_be4fb198-edee-4dd4-bcee-c9fed08d4f51" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_afe1bab2-f873-4570-90e9-be2a23546755" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_adf64b34-236d-43fd-9f22-0e58d39552f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_be4fb198-edee-4dd4-bcee-c9fed08d4f51" xlink:to="loc_us-gaap_LineOfCreditMember_adf64b34-236d-43fd-9f22-0e58d39552f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_29480684-ea3b-46a6-9ba3-9ef8faf6966c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4332c8fe-560b-4fb1-929b-71d152f372c3" xlink:to="loc_us-gaap_DebtInstrumentAxis_29480684-ea3b-46a6-9ba3-9ef8faf6966c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_29480684-ea3b-46a6-9ba3-9ef8faf6966c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_29480684-ea3b-46a6-9ba3-9ef8faf6966c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_29480684-ea3b-46a6-9ba3-9ef8faf6966c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_10127687-98aa-4982-82d1-ddc350cb2cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_29480684-ea3b-46a6-9ba3-9ef8faf6966c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_10127687-98aa-4982-82d1-ddc350cb2cf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_e20760d6-e96c-4a47-a245-8d1e58f7bc58" xlink:href="mck-20200930.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_10127687-98aa-4982-82d1-ddc350cb2cf5" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_e20760d6-e96c-4a47-a245-8d1e58f7bc58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_68d462af-7915-4dec-a597-30d5d534fd28" xlink:href="mck-20200930.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_10127687-98aa-4982-82d1-ddc350cb2cf5" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_68d462af-7915-4dec-a597-30d5d534fd28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_6c6e9911-617f-4c58-be48-7783da57a084" xlink:href="mck-20200930.xsd#mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_10127687-98aa-4982-82d1-ddc350cb2cf5" xlink:to="loc_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_6c6e9911-617f-4c58-be48-7783da57a084" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended" id="i91a2d0b3332d49ea82e9dd34312908f3_DebtandFinancingActivitiesCommercialPaperDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ed543981-bf9f-46e2-8c1d-4f226c6dddf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b8ad2ef1-490c-4d2e-9529-12f601376936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed543981-bf9f-46e2-8c1d-4f226c6dddf8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b8ad2ef1-490c-4d2e-9529-12f601376936" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_f15e5903-82ca-404f-805b-c8a0d820bd03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed543981-bf9f-46e2-8c1d-4f226c6dddf8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_f15e5903-82ca-404f-805b-c8a0d820bd03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_6e3d0e3c-e648-4cd6-82c6-e628437188ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed543981-bf9f-46e2-8c1d-4f226c6dddf8" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_6e3d0e3c-e648-4cd6-82c6-e628437188ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent_3ed97507-ffd5-494d-9a41-09ab9531da3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed543981-bf9f-46e2-8c1d-4f226c6dddf8" xlink:to="loc_us-gaap_LongTermCommercialPaperCurrent_3ed97507-ffd5-494d-9a41-09ab9531da3f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_df7cc70b-619b-465a-a82c-b8fee0d789cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed543981-bf9f-46e2-8c1d-4f226c6dddf8" xlink:to="loc_us-gaap_DebtInstrumentTable_df7cc70b-619b-465a-a82c-b8fee0d789cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f60ab9d2-6b64-4a1a-80c4-a73e9e4c18e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_df7cc70b-619b-465a-a82c-b8fee0d789cf" xlink:to="loc_us-gaap_CreditFacilityAxis_f60ab9d2-6b64-4a1a-80c4-a73e9e4c18e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f60ab9d2-6b64-4a1a-80c4-a73e9e4c18e3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f60ab9d2-6b64-4a1a-80c4-a73e9e4c18e3" xlink:to="loc_us-gaap_CreditFacilityDomain_f60ab9d2-6b64-4a1a-80c4-a73e9e4c18e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e337825d-9f72-4f1f-936f-9ae240192712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f60ab9d2-6b64-4a1a-80c4-a73e9e4c18e3" xlink:to="loc_us-gaap_CreditFacilityDomain_e337825d-9f72-4f1f-936f-9ae240192712" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_575897f2-f4bf-4a4b-b6f6-a030a47b8eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e337825d-9f72-4f1f-936f-9ae240192712" xlink:to="loc_us-gaap_CommercialPaperMember_575897f2-f4bf-4a4b-b6f6-a030a47b8eaf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20200930.xsd#PensionBenefits"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended" id="ib480d1def4f74f41838daeb16b972518_PensionBenefits"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#PensionBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended" id="iad4d9dece14a40afa666a24ea5224960_PensionBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_783a7732-c870-4913-8ec8-783f97eca3f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_783a7732-c870-4913-8ec8-783f97eca3f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_7ee19d11-acc2-4f62-8d64-4bf3d19371b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_7ee19d11-acc2-4f62-8d64-4bf3d19371b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage_eaed4238-0b5b-47c3-ac14-1f832c64868a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedPercentage_eaed4238-0b5b-47c3-ac14-1f832c64868a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_3bd2eb7b-ced2-4e99-a6bf-d7dfdbcd66d8" xlink:href="mck-20200930.xsd#mck_DefinedBenefitPlanSettlementPlanParticipants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_3bd2eb7b-ced2-4e99-a6bf-d7dfdbcd66d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_bf5a640f-ff32-4006-8fb8-93f78f7ecf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_bf5a640f-ff32-4006-8fb8-93f78f7ecf5d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_621672e0-aff9-44ae-838a-c1c71ea23e72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_621672e0-aff9-44ae-838a-c1c71ea23e72" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_65a381e7-1031-4975-9359-c411f4f11565" xlink:href="mck-20200930.xsd#mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_65a381e7-1031-4975-9359-c411f4f11565" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e13bdec6-9e4f-4118-bab3-1e448816fe3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e13bdec6-9e4f-4118-bab3-1e448816fe3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ae52d35d-7435-4892-aff2-4e1b56814439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e13bdec6-9e4f-4118-bab3-1e448816fe3c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ae52d35d-7435-4892-aff2-4e1b56814439" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ae52d35d-7435-4892-aff2-4e1b56814439_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ae52d35d-7435-4892-aff2-4e1b56814439" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ae52d35d-7435-4892-aff2-4e1b56814439_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b9eeb509-b8d0-498f-bb49-1832b4685d8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ae52d35d-7435-4892-aff2-4e1b56814439" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b9eeb509-b8d0-498f-bb49-1832b4685d8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f51f4bed-89ed-402a-a929-76d52245a91c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b9eeb509-b8d0-498f-bb49-1832b4685d8a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f51f4bed-89ed-402a-a929-76d52245a91c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_f70a6861-d68c-44d9-8b35-28cbcc1dae11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e13bdec6-9e4f-4118-bab3-1e448816fe3c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_f70a6861-d68c-44d9-8b35-28cbcc1dae11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_f70a6861-d68c-44d9-8b35-28cbcc1dae11_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_f70a6861-d68c-44d9-8b35-28cbcc1dae11" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_f70a6861-d68c-44d9-8b35-28cbcc1dae11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca9a03f5-1238-4a72-83bd-d41d007943fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_f70a6861-d68c-44d9-8b35-28cbcc1dae11" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca9a03f5-1238-4a72-83bd-d41d007943fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_e5daf3e4-c9ed-4aec-9564-d10e997f1412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca9a03f5-1238-4a72-83bd-d41d007943fd" xlink:to="loc_us-gaap_DomesticPlanMember_e5daf3e4-c9ed-4aec-9564-d10e997f1412" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b04576dc-331a-46d3-b4d0-8a5ba1da3b85" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_e5daf3e4-c9ed-4aec-9564-d10e997f1412" xlink:to="loc_country_US_b04576dc-331a-46d3-b4d0-8a5ba1da3b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_643ae6a9-01d7-4c49-9522-769195678e72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e13bdec6-9e4f-4118-bab3-1e448816fe3c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_643ae6a9-01d7-4c49-9522-769195678e72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_643ae6a9-01d7-4c49-9522-769195678e72_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_643ae6a9-01d7-4c49-9522-769195678e72" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_643ae6a9-01d7-4c49-9522-769195678e72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a079b787-dab6-48ea-a6a0-a40effda29d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_643ae6a9-01d7-4c49-9522-769195678e72" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a079b787-dab6-48ea-a6a0-a40effda29d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9f14f032-1ef9-4e05-918f-ab62c8ea4e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a079b787-dab6-48ea-a6a0-a40effda29d9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9f14f032-1ef9-4e05-918f-ab62c8ea4e29" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20200930.xsd#HedgingActivities"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended" id="i71fb0b88c702452c99fc6f61e90350db_HedgingActivities"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20200930.xsd#HedgingActivitiesTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended" id="ib02a4a6a0704471fa773f9a3f2adc9a0_HedgingActivitiesTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended" id="ib0b73a1add694a75b410ea15d2668064_HedgingActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_520cd492-3682-4b6f-a3d1-55477d09732a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_LongTermDebt_520cd492-3682-4b6f-a3d1-55477d09732a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_f1aad434-c95e-4eef-bab1-76a8e6861c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_f1aad434-c95e-4eef-bab1-76a8e6861c2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_baa703d6-87c9-4a35-81a7-19c1c193503e" xlink:href="mck-20200930.xsd#mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_baa703d6-87c9-4a35-81a7-19c1c193503e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6840b6e5-7e5a-4ef4-ad28-bf7736b30ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6840b6e5-7e5a-4ef4-ad28-bf7736b30ab0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_f50c7047-3975-4065-80e4-5e1fe968a8e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_f50c7047-3975-4065-80e4-5e1fe968a8e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_758262ca-f4fe-4dc9-9c5a-74449cdce43f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_758262ca-f4fe-4dc9-9c5a-74449cdce43f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_7a0b3105-52cf-4c90-b0ce-8c7303c56d68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_7a0b3105-52cf-4c90-b0ce-8c7303c56d68" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_0c3abbcf-229f-4de7-9dd3-925475f518b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_0c3abbcf-229f-4de7-9dd3-925475f518b2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_532885af-9dcb-461f-a246-6df964ada32c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:to="loc_us-gaap_DebtInstrumentAxis_532885af-9dcb-461f-a246-6df964ada32c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_532885af-9dcb-461f-a246-6df964ada32c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_532885af-9dcb-461f-a246-6df964ada32c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_532885af-9dcb-461f-a246-6df964ada32c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4bb11af0-2928-4f01-bd48-761c64f38733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_532885af-9dcb-461f-a246-6df964ada32c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4bb11af0-2928-4f01-bd48-761c64f38733" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_081965f6-d298-46bb-a863-6bcaa49f4304" xlink:href="mck-20200930.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4bb11af0-2928-4f01-bd48-761c64f38733" xlink:to="loc_mck_EuroDenominatedNotesMember_081965f6-d298-46bb-a863-6bcaa49f4304" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_d51add86-8661-4d4c-87f1-edac711669d5" xlink:href="mck-20200930.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4bb11af0-2928-4f01-bd48-761c64f38733" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_d51add86-8661-4d4c-87f1-edac711669d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d530b877-de31-47aa-9314-9a75c0485e11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d530b877-de31-47aa-9314-9a75c0485e11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d530b877-de31-47aa-9314-9a75c0485e11_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d530b877-de31-47aa-9314-9a75c0485e11" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d530b877-de31-47aa-9314-9a75c0485e11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4662f552-c803-4757-9aba-6acd850e5983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d530b877-de31-47aa-9314-9a75c0485e11" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4662f552-c803-4757-9aba-6acd850e5983" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b8130e2b-42c4-4b4c-a501-ca7a9585f587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4662f552-c803-4757-9aba-6acd850e5983" xlink:to="loc_us-gaap_LoansPayableMember_b8130e2b-42c4-4b4c-a501-ca7a9585f587" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0db00d95-ea48-4bb9-8363-842246c9d643" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0db00d95-ea48-4bb9-8363-842246c9d643" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0db00d95-ea48-4bb9-8363-842246c9d643_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0db00d95-ea48-4bb9-8363-842246c9d643" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0db00d95-ea48-4bb9-8363-842246c9d643_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7db81415-0b78-423a-a20e-02d4be0c936d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0db00d95-ea48-4bb9-8363-842246c9d643" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7db81415-0b78-423a-a20e-02d4be0c936d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_195d8f19-535b-49e7-8e7f-10366a92edac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7db81415-0b78-423a-a20e-02d4be0c936d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_195d8f19-535b-49e7-8e7f-10366a92edac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_01f3e311-2db4-43ba-9598-161895d064e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7db81415-0b78-423a-a20e-02d4be0c936d" xlink:to="loc_us-gaap_CashFlowHedgingMember_01f3e311-2db4-43ba-9598-161895d064e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_774a9a8a-c3b4-4f03-9175-24002bd8d8bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_774a9a8a-c3b4-4f03-9175-24002bd8d8bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_774a9a8a-c3b4-4f03-9175-24002bd8d8bb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_774a9a8a-c3b4-4f03-9175-24002bd8d8bb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_774a9a8a-c3b4-4f03-9175-24002bd8d8bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6446085c-db4b-415e-9b90-daa75a5eaa92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_774a9a8a-c3b4-4f03-9175-24002bd8d8bb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6446085c-db4b-415e-9b90-daa75a5eaa92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember_efa35ea8-0055-4165-8b50-a52128641074" xlink:href="mck-20200930.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6446085c-db4b-415e-9b90-daa75a5eaa92" xlink:to="loc_mck_November2018CrossCurrencySwapsMember_efa35ea8-0055-4165-8b50-a52128641074" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_3c763f32-8281-4823-90ff-77884691656b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6446085c-db4b-415e-9b90-daa75a5eaa92" xlink:to="loc_us-gaap_CurrencySwapMember_3c763f32-8281-4823-90ff-77884691656b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f067ae9d-8374-4261-980e-c09018f89a75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6446085c-db4b-415e-9b90-daa75a5eaa92" xlink:to="loc_us-gaap_InterestRateSwapMember_f067ae9d-8374-4261-980e-c09018f89a75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_6151634b-e5f7-4355-adc2-b66c5ffffa25" xlink:href="mck-20200930.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6446085c-db4b-415e-9b90-daa75a5eaa92" xlink:to="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_6151634b-e5f7-4355-adc2-b66c5ffffa25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_347933be-9ced-417e-a3e4-c8a32c78b5c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:to="loc_us-gaap_HedgingDesignationAxis_347933be-9ced-417e-a3e4-c8a32c78b5c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_347933be-9ced-417e-a3e4-c8a32c78b5c2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_347933be-9ced-417e-a3e4-c8a32c78b5c2" xlink:to="loc_us-gaap_HedgingDesignationDomain_347933be-9ced-417e-a3e4-c8a32c78b5c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_84ff6e6e-42ff-4cc0-a3c1-a7e024e9bb51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_347933be-9ced-417e-a3e4-c8a32c78b5c2" xlink:to="loc_us-gaap_HedgingDesignationDomain_84ff6e6e-42ff-4cc0-a3c1-a7e024e9bb51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_12d656d5-91ff-4e52-b011-ae1cf173c859" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_84ff6e6e-42ff-4cc0-a3c1-a7e024e9bb51" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_12d656d5-91ff-4e52-b011-ae1cf173c859" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_874878d4-dbb7-41c0-b456-fffa1108abe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_84ff6e6e-42ff-4cc0-a3c1-a7e024e9bb51" xlink:to="loc_us-gaap_NondesignatedMember_874878d4-dbb7-41c0-b456-fffa1108abe6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#HedgingActivitiesDerivativeInstrumentsFairValueDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="extended" id="i1d56c2fa3e63438f87dea8871c42015e_HedgingActivitiesDerivativeInstrumentsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_f907b210-a9c8-4106-9583-b4562648a709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5bdfa689-1225-4519-8ce8-fbe65141ce77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f907b210-a9c8-4106-9583-b4562648a709" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5bdfa689-1225-4519-8ce8-fbe65141ce77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a57bf075-6971-45d5-bb7e-6dec33f44693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f907b210-a9c8-4106-9583-b4562648a709" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a57bf075-6971-45d5-bb7e-6dec33f44693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_8fa40cee-441f-422f-bb06-43122beea92b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f907b210-a9c8-4106-9583-b4562648a709" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_8fa40cee-441f-422f-bb06-43122beea92b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_abc8dc77-2e86-4145-9c9f-af19d85f48a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f907b210-a9c8-4106-9583-b4562648a709" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_abc8dc77-2e86-4145-9c9f-af19d85f48a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_66f02702-b79e-4e03-aaca-04f596d8402a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f907b210-a9c8-4106-9583-b4562648a709" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_66f02702-b79e-4e03-aaca-04f596d8402a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_64e96bc7-5217-43d7-ba9a-f6f8e30d7a3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_66f02702-b79e-4e03-aaca-04f596d8402a" xlink:to="loc_us-gaap_HedgingDesignationAxis_64e96bc7-5217-43d7-ba9a-f6f8e30d7a3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_64e96bc7-5217-43d7-ba9a-f6f8e30d7a3e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_64e96bc7-5217-43d7-ba9a-f6f8e30d7a3e" xlink:to="loc_us-gaap_HedgingDesignationDomain_64e96bc7-5217-43d7-ba9a-f6f8e30d7a3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_25916c37-ab94-4d9a-8d47-0b831f7bc4ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_64e96bc7-5217-43d7-ba9a-f6f8e30d7a3e" xlink:to="loc_us-gaap_HedgingDesignationDomain_25916c37-ab94-4d9a-8d47-0b831f7bc4ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_26e05373-744f-4cbf-b213-ee2a23fbb509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_25916c37-ab94-4d9a-8d47-0b831f7bc4ed" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_26e05373-744f-4cbf-b213-ee2a23fbb509" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_fc3c77e0-9a55-45e1-9a3e-8a84feaaac98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_25916c37-ab94-4d9a-8d47-0b831f7bc4ed" xlink:to="loc_us-gaap_NondesignatedMember_fc3c77e0-9a55-45e1-9a3e-8a84feaaac98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6bb07814-38df-496c-a109-609c2b4bf9fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_66f02702-b79e-4e03-aaca-04f596d8402a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6bb07814-38df-496c-a109-609c2b4bf9fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6bb07814-38df-496c-a109-609c2b4bf9fd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6bb07814-38df-496c-a109-609c2b4bf9fd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6bb07814-38df-496c-a109-609c2b4bf9fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0eb9401b-f57e-4f59-b80a-299f08203821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6bb07814-38df-496c-a109-609c2b4bf9fd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0eb9401b-f57e-4f59-b80a-299f08203821" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_caa4b2c0-2866-4c96-8710-476281f9cc86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0eb9401b-f57e-4f59-b80a-299f08203821" xlink:to="loc_us-gaap_CurrencySwapMember_caa4b2c0-2866-4c96-8710-476281f9cc86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_17bab195-c16b-45cf-a851-3ab614c8a072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0eb9401b-f57e-4f59-b80a-299f08203821" xlink:to="loc_us-gaap_InterestRateSwapMember_17bab195-c16b-45cf-a851-3ab614c8a072" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a82a6a0f-522a-4907-aa11-50f16a022cc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0eb9401b-f57e-4f59-b80a-299f08203821" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a82a6a0f-522a-4907-aa11-50f16a022cc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b7fb3214-94ad-46e8-9d44-6faffbb6850f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_66f02702-b79e-4e03-aaca-04f596d8402a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b7fb3214-94ad-46e8-9d44-6faffbb6850f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b7fb3214-94ad-46e8-9d44-6faffbb6850f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b7fb3214-94ad-46e8-9d44-6faffbb6850f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b7fb3214-94ad-46e8-9d44-6faffbb6850f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b7fb3214-94ad-46e8-9d44-6faffbb6850f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_e9c25f62-79b7-4559-819e-ace00c964b0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_e9c25f62-79b7-4559-819e-ace00c964b0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_29f7c8bb-f682-46d9-aac1-954ecb179a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_29f7c8bb-f682-46d9-aac1-954ecb179a48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_08ca91cb-4763-4589-8dd7-f9e77c823d9e" xlink:href="mck-20200930.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:to="loc_mck_CurrentAssetLiabilityMember_08ca91cb-4763-4589-8dd7-f9e77c823d9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_d25e6ea2-987e-4a44-be2d-9bd440cc1034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_d25e6ea2-987e-4a44-be2d-9bd440cc1034" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7cb07350-83dc-41f6-a5df-92e32fb9d673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7cb07350-83dc-41f6-a5df-92e32fb9d673" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncurrentAssetLiabilityMember_b247630f-cc62-4a73-bb4d-3b8206f65dbb" xlink:href="mck-20200930.xsd#mck_NoncurrentAssetLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:to="loc_mck_NoncurrentAssetLiabilityMember_b247630f-cc62-4a73-bb4d-3b8206f65dbb" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20200930.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended" id="i1d0dddf129714a0cbaadb8cedf805074_FairValueMeasurements"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="ia346bf96b26c41d9962b7243415f0d8f_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a7a5e991-a451-445e-96e6-70ffda6d1a85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_LongTermDebt_a7a5e991-a451-445e-96e6-70ffda6d1a85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_f390de62-13e7-4eeb-bd50-f14fdd777ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_DebtInstrumentFairValue_f390de62-13e7-4eeb-bd50-f14fdd777ec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_3bd3408c-0507-4f61-bedd-f783a02446fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_3bd3408c-0507-4f61-bedd-f783a02446fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_04ff3787-9bc6-4c41-8ff0-4e7fe358e186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_04ff3787-9bc6-4c41-8ff0-4e7fe358e186" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_39eebc01-e915-45a6-9846-cf1376b615ec" xlink:href="mck-20200930.xsd#mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_39eebc01-e915-45a6-9846-cf1376b615ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_f5e69d2f-b10c-43ea-8e4f-02b5ba4a18d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_f5e69d2f-b10c-43ea-8e4f-02b5ba4a18d7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_f100c91c-d6d1-4652-a142-c8cf0248b232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_f100c91c-d6d1-4652-a142-c8cf0248b232" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_868c19bd-d956-4aa1-b299-f5c96aa9a401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_868c19bd-d956-4aa1-b299-f5c96aa9a401" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f03920db-19fa-4e73-af69-80b54dc49c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_868c19bd-d956-4aa1-b299-f5c96aa9a401" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f03920db-19fa-4e73-af69-80b54dc49c57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f03920db-19fa-4e73-af69-80b54dc49c57_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f03920db-19fa-4e73-af69-80b54dc49c57" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f03920db-19fa-4e73-af69-80b54dc49c57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5032461a-9bd8-4779-ab40-d28fb9365869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f03920db-19fa-4e73-af69-80b54dc49c57" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5032461a-9bd8-4779-ab40-d28fb9365869" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b274c5a8-4246-42aa-9289-6d8668f0ab53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5032461a-9bd8-4779-ab40-d28fb9365869" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b274c5a8-4246-42aa-9289-6d8668f0ab53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_700ba709-7a1b-43bf-a936-3e4338c1d983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5032461a-9bd8-4779-ab40-d28fb9365869" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_700ba709-7a1b-43bf-a936-3e4338c1d983" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593c4e70-f927-48f3-930f-ef9a6424d2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_868c19bd-d956-4aa1-b299-f5c96aa9a401" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593c4e70-f927-48f3-930f-ef9a6424d2c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_593c4e70-f927-48f3-930f-ef9a6424d2c9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593c4e70-f927-48f3-930f-ef9a6424d2c9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_593c4e70-f927-48f3-930f-ef9a6424d2c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_020b87d1-c1d9-4267-9116-e981fcba7d20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593c4e70-f927-48f3-930f-ef9a6424d2c9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_020b87d1-c1d9-4267-9116-e981fcba7d20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0ccaf851-a18d-447c-a095-0a8914dbf5a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_020b87d1-c1d9-4267-9116-e981fcba7d20" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0ccaf851-a18d-447c-a095-0a8914dbf5a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4003965e-5f13-4e91-b7d8-191ce74e0521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_020b87d1-c1d9-4267-9116-e981fcba7d20" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4003965e-5f13-4e91-b7d8-191ce74e0521" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20200930.xsd#CommitmentsandContingentLiabilities"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended" id="i6078086ff5d24a488fe4ab8b6146c9df_CommitmentsandContingentLiabilities"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended" id="iddb3f50b42df41948c25b01499b7485c_CommitmentsandContingentLiabilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_23d48317-2e7b-4fd4-9ba0-9bf56571d0b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_23d48317-2e7b-4fd4-9ba0-9bf56571d0b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_d7be8acf-4159-40c5-bec8-1c1a46967efa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_d7be8acf-4159-40c5-bec8-1c1a46967efa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCounties_f20bdbc8-e3d4-48c2-a7a2-3d074cc4426b" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofCounties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyNumberofCounties_f20bdbc8-e3d4-48c2-a7a2-3d074cc4426b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_5149ac07-1434-4614-8d8b-0bf8ff684635" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_5149ac07-1434-4614-8d8b-0bf8ff684635" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_31a65388-a103-425d-b944-9458ac6fee08" xlink:href="mck-20200930.xsd#mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_31a65388-a103-425d-b944-9458ac6fee08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_fb01d176-9352-497c-86b4-2c0b88d4f1fa" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyNumberofStates_fb01d176-9352-497c-86b4-2c0b88d4f1fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStateAttorneyGenerals_8633a66c-e6cf-4d04-b689-18343b5b24e8" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofStateAttorneyGenerals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyNumberofStateAttorneyGenerals_8633a66c-e6cf-4d04-b689-18343b5b24e8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfCountyGovernments_50768f14-8350-446a-a18e-f96a97e26642" xlink:href="mck-20200930.xsd#mck_NumberOfCountyGovernments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_NumberOfCountyGovernments_50768f14-8350-446a-a18e-f96a97e26642" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_bdc78785-acee-48af-8afd-c76b09740590" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_bdc78785-acee-48af-8afd-c76b09740590" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_f4724c61-be53-4377-8c03-4944a7fbb210" xlink:href="mck-20200930.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_f4724c61-be53-4377-8c03-4944a7fbb210" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofRelatorsAllegingViolations_9c6acadc-198d-4d77-ad0f-cb9b22933e28" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofRelatorsAllegingViolations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyNumberofRelatorsAllegingViolations_9c6acadc-198d-4d77-ad0f-cb9b22933e28" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue_ebb9da6e-454b-4b56-b5fb-da1955c460b6" xlink:href="mck-20200930.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyDamagesSoughtPerViolationValue_ebb9da6e-454b-4b56-b5fb-da1955c460b6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_761186a3-5cbc-449f-93c7-ec0525d4ad70" xlink:href="mck-20200930.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_761186a3-5cbc-449f-93c7-ec0525d4ad70" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived_86155213-6a97-468e-aee2-5685b3a0eefa" xlink:href="mck-20200930.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesReceived_86155213-6a97-468e-aee2-5685b3a0eefa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_c56415eb-3bcb-45e0-adb8-22ca7139e15f" xlink:href="mck-20200930.xsd#mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_c56415eb-3bcb-45e0-adb8-22ca7139e15f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_6f272927-d7a3-458a-9abd-e30ec5a2a313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_6f272927-d7a3-458a-9abd-e30ec5a2a313" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualAfterTax_fe7e864b-f998-492d-a5e1-a0f6b69cc2d2" xlink:href="mck-20200930.xsd#mck_LossContingencyAccrualAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyAccrualAfterTax_fe7e864b-f998-492d-a5e1-a0f6b69cc2d2" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_cf520a59-c8ed-4f73-847d-17a7226edb7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_us-gaap_LitigationStatusAxis_cf520a59-c8ed-4f73-847d-17a7226edb7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_cf520a59-c8ed-4f73-847d-17a7226edb7b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_cf520a59-c8ed-4f73-847d-17a7226edb7b" xlink:to="loc_us-gaap_LitigationStatusDomain_cf520a59-c8ed-4f73-847d-17a7226edb7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_302f2f3f-80dc-480e-93a8-2fa438014f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_cf520a59-c8ed-4f73-847d-17a7226edb7b" xlink:to="loc_us-gaap_LitigationStatusDomain_302f2f3f-80dc-480e-93a8-2fa438014f37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_c267e7a5-35b8-4d86-a048-02d496b8c23b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_302f2f3f-80dc-480e-93a8-2fa438014f37" xlink:to="loc_us-gaap_PendingLitigationMember_c267e7a5-35b8-4d86-a048-02d496b8c23b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_098a9c69-9613-467d-a5ff-5fd31e6296bd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_dei_LegalEntityAxis_098a9c69-9613-467d-a5ff-5fd31e6296bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_098a9c69-9613-467d-a5ff-5fd31e6296bd_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_098a9c69-9613-467d-a5ff-5fd31e6296bd" xlink:to="loc_dei_EntityDomain_098a9c69-9613-467d-a5ff-5fd31e6296bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_565254e4-52b6-4eaf-b49a-ff51efda6d6b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_098a9c69-9613-467d-a5ff-5fd31e6296bd" xlink:to="loc_dei_EntityDomain_565254e4-52b6-4eaf-b49a-ff51efda6d6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_19b98690-5eb0-4f96-916d-8265c686ce03" xlink:href="mck-20200930.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_565254e4-52b6-4eaf-b49a-ff51efda6d6b" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_19b98690-5eb0-4f96-916d-8265c686ce03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2e97acf4-efa3-4112-86c0-3ae7b044ed8c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_srt_StatementGeographicalAxis_2e97acf4-efa3-4112-86c0-3ae7b044ed8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2e97acf4-efa3-4112-86c0-3ae7b044ed8c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2e97acf4-efa3-4112-86c0-3ae7b044ed8c" xlink:to="loc_srt_SegmentGeographicalDomain_2e97acf4-efa3-4112-86c0-3ae7b044ed8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_125e7454-c6da-4445-85e4-df2bc03d2627" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2e97acf4-efa3-4112-86c0-3ae7b044ed8c" xlink:to="loc_srt_SegmentGeographicalDomain_125e7454-c6da-4445-85e4-df2bc03d2627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_d98ff233-722b-4743-bbb6-eeaf1e6bf46a" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_125e7454-c6da-4445-85e4-df2bc03d2627" xlink:to="loc_country_CA_d98ff233-722b-4743-bbb6-eeaf1e6bf46a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7c546df8-f076-4675-a202-166ba7fbb170" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_srt_LitigationCaseAxis_7c546df8-f076-4675-a202-166ba7fbb170" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7c546df8-f076-4675-a202-166ba7fbb170_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_7c546df8-f076-4675-a202-166ba7fbb170" xlink:to="loc_srt_LitigationCaseTypeDomain_7c546df8-f076-4675-a202-166ba7fbb170_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_77feadd7-894b-4503-a0b3-8d681aaacab6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_7c546df8-f076-4675-a202-166ba7fbb170" xlink:to="loc_srt_LitigationCaseTypeDomain_77feadd7-894b-4503-a0b3-8d681aaacab6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InreNationalPrescriptionOpiateLitigationMember_cdce6d0a-1938-49bd-acb0-30bb7387b3f3" xlink:href="mck-20200930.xsd#mck_InreNationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_77feadd7-894b-4503-a0b3-8d681aaacab6" xlink:to="loc_mck_InreNationalPrescriptionOpiateLitigationMember_cdce6d0a-1938-49bd-acb0-30bb7387b3f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelKelley19Cv2233Member_7b362900-ff48-49a3-a870-ea590c32e8f3" xlink:href="mck-20200930.xsd#mck_UnitedStatesExRelKelley19Cv2233Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_77feadd7-894b-4503-a0b3-8d681aaacab6" xlink:to="loc_mck_UnitedStatesExRelKelley19Cv2233Member_7b362900-ff48-49a3-a870-ea590c32e8f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_472f52f5-4ce8-40a7-b193-3cde603d946a" xlink:href="mck-20200930.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_77feadd7-894b-4503-a0b3-8d681aaacab6" xlink:to="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_472f52f5-4ce8-40a7-b193-3cde603d946a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_da59ad76-3cd5-45df-b6b3-9a99dc636c77" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_srt_RangeAxis_da59ad76-3cd5-45df-b6b3-9a99dc636c77" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_da59ad76-3cd5-45df-b6b3-9a99dc636c77_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_da59ad76-3cd5-45df-b6b3-9a99dc636c77" xlink:to="loc_srt_RangeMember_da59ad76-3cd5-45df-b6b3-9a99dc636c77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8bdd5cb1-6f65-45e9-be25-eb15aaa2b20c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_da59ad76-3cd5-45df-b6b3-9a99dc636c77" xlink:to="loc_srt_RangeMember_8bdd5cb1-6f65-45e9-be25-eb15aaa2b20c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_95a20301-3681-4bda-bdd4-6062dd7a4859" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8bdd5cb1-6f65-45e9-be25-eb15aaa2b20c" xlink:to="loc_srt_MinimumMember_95a20301-3681-4bda-bdd4-6062dd7a4859" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_788f7e5a-66ca-4d68-85ba-915a2322f249" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8bdd5cb1-6f65-45e9-be25-eb15aaa2b20c" xlink:to="loc_srt_MaximumMember_788f7e5a-66ca-4d68-85ba-915a2322f249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bb711659-5336-4fbe-ad9b-cbee8046385c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bb711659-5336-4fbe-ad9b-cbee8046385c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bb711659-5336-4fbe-ad9b-cbee8046385c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bb711659-5336-4fbe-ad9b-cbee8046385c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bb711659-5336-4fbe-ad9b-cbee8046385c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_88ebd4e1-57f7-4c82-87a3-c619d383601f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bb711659-5336-4fbe-ad9b-cbee8046385c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_88ebd4e1-57f7-4c82-87a3-c619d383601f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a913cdd6-c9f6-4839-ad65-0d2bbdc6fb87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_88ebd4e1-57f7-4c82-87a3-c619d383601f" xlink:to="loc_us-gaap_SubsequentEventMember_a913cdd6-c9f6-4839-ad65-0d2bbdc6fb87" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquity" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquity"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquity" xlink:type="extended" id="if429b9aab92049f89cd82638fbdfd6c9_StockholdersEquity"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquityTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="extended" id="icf9550024b9142328ae57ff7529128b9_StockholdersEquityTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="ib357237311f944528d67449afe5e82c9_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_400d3925-18cc-446f-ae4d-eea79dac6b22" xlink:href="mck-20200930.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_400d3925-18cc-446f-ae4d-eea79dac6b22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_21be9dd3-08b0-48e2-a1de-7cb2920eb524" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_21be9dd3-08b0-48e2-a1de-7cb2920eb524" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_fddd1f5a-adbf-4950-a1e5-186838cdf13c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_fddd1f5a-adbf-4950-a1e5-186838cdf13c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_94c7cc0c-a75e-49bc-b014-02db7276a8ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_94c7cc0c-a75e-49bc-b014-02db7276a8ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_fcb768bd-da26-437f-b4e8-eec2fb953b46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_fcb768bd-da26-437f-b4e8-eec2fb953b46" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_71bbf4f4-7688-4ee0-9e48-084bad7bfba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_71bbf4f4-7688-4ee0-9e48-084bad7bfba7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_e854893c-ada6-49c1-988d-2cb45d332c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_e854893c-ada6-49c1-988d-2cb45d332c62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_24986445-1787-4d8b-a1e2-808421646fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_e854893c-ada6-49c1-988d-2cb45d332c62" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_24986445-1787-4d8b-a1e2-808421646fdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_24986445-1787-4d8b-a1e2-808421646fdf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_24986445-1787-4d8b-a1e2-808421646fdf" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_24986445-1787-4d8b-a1e2-808421646fdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_3e5903a0-0fe7-4ea7-be3d-8c2b2b767f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_24986445-1787-4d8b-a1e2-808421646fdf" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_3e5903a0-0fe7-4ea7-be3d-8c2b2b767f05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketShareRepurchaseTransactionsMember_cfa38578-ebe3-4eb7-bdcc-db569857a71d" xlink:href="mck-20200930.xsd#mck_OpenMarketShareRepurchaseTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_3e5903a0-0fe7-4ea7-be3d-8c2b2b767f05" xlink:to="loc_mck_OpenMarketShareRepurchaseTransactionsMember_cfa38578-ebe3-4eb7-bdcc-db569857a71d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_50119de6-1221-407e-ae58-6326c4317d1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_e854893c-ada6-49c1-988d-2cb45d332c62" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_50119de6-1221-407e-ae58-6326c4317d1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_50119de6-1221-407e-ae58-6326c4317d1a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_50119de6-1221-407e-ae58-6326c4317d1a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_50119de6-1221-407e-ae58-6326c4317d1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8b487251-02a8-4ae1-834e-111572cedc9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_50119de6-1221-407e-ae58-6326c4317d1a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8b487251-02a8-4ae1-834e-111572cedc9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_82730e18-6fc3-49d2-9f57-81ddbc1fbb35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8b487251-02a8-4ae1-834e-111572cedc9c" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_82730e18-6fc3-49d2-9f57-81ddbc1fbb35" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="extended" id="ia23b7780c12a4f9ba33a2d56470838c1_StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_caaac9ed-6571-4fce-a6a2-d6dd4d6ae12b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_caaac9ed-6571-4fce-a6a2-d6dd4d6ae12b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f6740d1d-ea75-40bd-9a95-6fc510915660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f6740d1d-ea75-40bd-9a95-6fc510915660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_22e04535-d290-4c49-88bc-8f15b4782043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_22e04535-d290-4c49-88bc-8f15b4782043" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_f6790787-014a-4666-ad31-26075f62d1f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_f6790787-014a-4666-ad31-26075f62d1f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_2c172a6a-a710-49e5-9271-26ad7c5d53ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_2c172a6a-a710-49e5-9271-26ad7c5d53ea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_20387319-ffcc-4d08-bb51-410ad084db1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_20387319-ffcc-4d08-bb51-410ad084db1a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3d789bfa-6f49-49ab-b1ed-b8d7ce054559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3d789bfa-6f49-49ab-b1ed-b8d7ce054559" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_7768147b-8e40-4830-8e5d-3c6e69f0b61f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_7768147b-8e40-4830-8e5d-3c6e69f0b61f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_9ea37134-90cc-4a1f-ac8f-6e60b77cf2d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_9ea37134-90cc-4a1f-ac8f-6e60b77cf2d6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_51059992-b268-4439-833f-ffdded3972bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_51059992-b268-4439-833f-ffdded3972bf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_1872728b-70b7-4bcc-abde-4de63f41bd81" xlink:href="mck-20200930.xsd#mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_1872728b-70b7-4bcc-abde-4de63f41bd81" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_426e0de6-b5e7-4d50-b08a-b044f3f4abd5" xlink:href="mck-20200930.xsd#mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_426e0de6-b5e7-4d50-b08a-b044f3f4abd5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_5d24c8c0-0a5e-40f3-ab13-4aaea6642b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_5d24c8c0-0a5e-40f3-ab13-4aaea6642b7a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_66ecd93b-303f-4a80-a2ef-1115be105e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_LongTermDebt_66ecd93b-303f-4a80-a2ef-1115be105e44" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_691f9457-30ad-4024-92c9-9f61355c12ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_691f9457-30ad-4024-92c9-9f61355c12ed" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_fda18aab-b034-4655-a8e5-565d2d49f1bd" xlink:href="mck-20200930.xsd#mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_fda18aab-b034-4655-a8e5-565d2d49f1bd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f7085f1e-f7b2-491f-b480-bf5a842235db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:to="loc_us-gaap_HedgingDesignationAxis_f7085f1e-f7b2-491f-b480-bf5a842235db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f7085f1e-f7b2-491f-b480-bf5a842235db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f7085f1e-f7b2-491f-b480-bf5a842235db" xlink:to="loc_us-gaap_HedgingDesignationDomain_f7085f1e-f7b2-491f-b480-bf5a842235db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a16eedb8-45ac-424e-8f15-c43c2e2d91aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f7085f1e-f7b2-491f-b480-bf5a842235db" xlink:to="loc_us-gaap_HedgingDesignationDomain_a16eedb8-45ac-424e-8f15-c43c2e2d91aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_938a73d8-c045-42f8-9a70-07220a1f3aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a16eedb8-45ac-424e-8f15-c43c2e2d91aa" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_938a73d8-c045-42f8-9a70-07220a1f3aa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dc995973-57d8-4dd9-b838-6345cc7b2e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dc995973-57d8-4dd9-b838-6345cc7b2e6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dc995973-57d8-4dd9-b838-6345cc7b2e6a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dc995973-57d8-4dd9-b838-6345cc7b2e6a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dc995973-57d8-4dd9-b838-6345cc7b2e6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_88f36ac0-971a-4b38-8e28-5aa9ca58c320" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dc995973-57d8-4dd9-b838-6345cc7b2e6a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_88f36ac0-971a-4b38-8e28-5aa9ca58c320" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_5b10102b-f973-4e70-89b1-0286c5f5e945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_88f36ac0-971a-4b38-8e28-5aa9ca58c320" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_5b10102b-f973-4e70-89b1-0286c5f5e945" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3d281ebc-8f77-4513-96d1-03eedd75c446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:to="loc_us-gaap_DebtInstrumentAxis_3d281ebc-8f77-4513-96d1-03eedd75c446" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3d281ebc-8f77-4513-96d1-03eedd75c446_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3d281ebc-8f77-4513-96d1-03eedd75c446" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3d281ebc-8f77-4513-96d1-03eedd75c446_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5927e631-f212-4b4c-8c8c-a44023fdf7ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3d281ebc-8f77-4513-96d1-03eedd75c446" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5927e631-f212-4b4c-8c8c-a44023fdf7ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_502f16a8-412d-4114-8d13-d2b95e4d908d" xlink:href="mck-20200930.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5927e631-f212-4b4c-8c8c-a44023fdf7ad" xlink:to="loc_mck_EuroDenominatedNotesMember_502f16a8-412d-4114-8d13-d2b95e4d908d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_105ea7d3-65a7-4a15-8e20-2f3c458962d1" xlink:href="mck-20200930.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5927e631-f212-4b4c-8c8c-a44023fdf7ad" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_105ea7d3-65a7-4a15-8e20-2f3c458962d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_33744f91-4137-4701-9b01-a2e09e8cc258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_33744f91-4137-4701-9b01-a2e09e8cc258" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_33744f91-4137-4701-9b01-a2e09e8cc258_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_33744f91-4137-4701-9b01-a2e09e8cc258" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_33744f91-4137-4701-9b01-a2e09e8cc258_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d1af3131-1277-428a-adc8-1ea7987c0270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_33744f91-4137-4701-9b01-a2e09e8cc258" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d1af3131-1277-428a-adc8-1ea7987c0270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_a39e65b0-ff1f-4aa6-a5d8-86d953ad6476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d1af3131-1277-428a-adc8-1ea7987c0270" xlink:to="loc_us-gaap_LoansPayableMember_a39e65b0-ff1f-4aa6-a5d8-86d953ad6476" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_511e643b-8e04-47d8-9bec-da90e22cf3ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_511e643b-8e04-47d8-9bec-da90e22cf3ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_511e643b-8e04-47d8-9bec-da90e22cf3ed_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_511e643b-8e04-47d8-9bec-da90e22cf3ed" xlink:to="loc_us-gaap_EquityComponentDomain_511e643b-8e04-47d8-9bec-da90e22cf3ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_511e643b-8e04-47d8-9bec-da90e22cf3ed" xlink:to="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_25fa7230-c51d-4ddb-977c-873ffa2eca00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_25fa7230-c51d-4ddb-977c-873ffa2eca00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_fb9b2e34-7775-49f6-99c0-63fe287fc6f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_fb9b2e34-7775-49f6-99c0-63fe287fc6f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_6bfcbff2-6b84-4065-86e0-7be3f835d5b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_6bfcbff2-6b84-4065-86e0-7be3f835d5b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_12875ff7-02ec-484a-972d-375f32c02dce" xlink:href="mck-20200930.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_12875ff7-02ec-484a-972d-375f32c02dce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_648561d5-a74f-4420-8b88-6062736dbd38" xlink:href="mck-20200930.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_648561d5-a74f-4420-8b88-6062736dbd38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_1583df73-7b04-45b9-ac71-3b916ddfda06" xlink:href="mck-20200930.xsd#mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_1583df73-7b04-45b9-ac71-3b916ddfda06" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_da99804f-5a63-4071-a6f6-e0798202f8b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_da99804f-5a63-4071-a6f6-e0798202f8b3" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended" id="i625f337e13624e82854b6d7a755df932_StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_123878ec-4316-4f6c-a4a9-886d8993796e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_123878ec-4316-4f6c-a4a9-886d8993796e" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6b7a2b21-a3a5-4d81-be63-6fcc4ac2668f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6b7a2b21-a3a5-4d81-be63-6fcc4ac2668f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_35e411bd-cc07-4ea9-90ac-a367f17ea46d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_35e411bd-cc07-4ea9-90ac-a367f17ea46d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_751e08ef-9eae-4502-8231-ed0b3f141cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_751e08ef-9eae-4502-8231-ed0b3f141cec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d6685b2-1d7f-406f-a34b-4533e22ea1a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d6685b2-1d7f-406f-a34b-4533e22ea1a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3c5a1d5f-02b6-46a3-976c-48c3e9e8cbcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3c5a1d5f-02b6-46a3-976c-48c3e9e8cbcb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7ff99d42-141d-483c-83c0-4fc9fabb463a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7ff99d42-141d-483c-83c0-4fc9fabb463a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9cc2bbf2-74ae-4b71-af2a-74ec72cf87e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b9a00b75-9a0e-44d2-9704-d32210c2b143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_123878ec-4316-4f6c-a4a9-886d8993796e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b9a00b75-9a0e-44d2-9704-d32210c2b143" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9ddef733-6d11-45a0-af9f-3e583c220b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b9a00b75-9a0e-44d2-9704-d32210c2b143" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9ddef733-6d11-45a0-af9f-3e583c220b1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9ddef733-6d11-45a0-af9f-3e583c220b1a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9ddef733-6d11-45a0-af9f-3e583c220b1a" xlink:to="loc_us-gaap_EquityComponentDomain_9ddef733-6d11-45a0-af9f-3e583c220b1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9ddef733-6d11-45a0-af9f-3e583c220b1a" xlink:to="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_e2931e0d-3994-4163-9d1c-c35565de892b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_e2931e0d-3994-4163-9d1c-c35565de892b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_b6afc538-adee-454e-883b-954c3cd92aff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_b6afc538-adee-454e-883b-954c3cd92aff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_43c47265-23e7-4428-a345-abb8f03df00a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_43c47265-23e7-4428-a345-abb8f03df00a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_40bf4d9d-0159-4ba0-809b-44afdbb1561a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_40bf4d9d-0159-4ba0-809b-44afdbb1561a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9a3f18a6-9954-45f9-aa10-d58a93ef35cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9a3f18a6-9954-45f9-aa10-d58a93ef35cf" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20200930.xsd#SegmentsofBusiness"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended" id="i8fc3224a2866400e8a56ec1aac2f161e_SegmentsofBusiness"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20200930.xsd#SegmentsofBusinessTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended" id="ieae7f95625bc4f1ba8d8ddda3379cc4c_SegmentsofBusinessTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#SegmentsofBusinessDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="extended" id="if3d2064b6d7d41a096a969b8fc4062ea_SegmentsofBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_2ff3dc27-e9a8-41a3-9339-51fc018625ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_NumberOfReportableSegments_2ff3dc27-e9a8-41a3-9339-51fc018625ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_8f794fea-89b6-49e2-a07a-73b7ab6746a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_8f794fea-89b6-49e2-a07a-73b7ab6746a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_fbe224a8-a463-464c-a485-03e1149aa02d" xlink:href="mck-20200930.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_fbe224a8-a463-464c-a485-03e1149aa02d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_e530dd94-3b64-4f7e-a783-1a81290a8823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:to="loc_us-gaap_RevenuesAbstract_e530dd94-3b64-4f7e-a783-1a81290a8823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2254541b-a892-4a44-a307-f606e1342d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_e530dd94-3b64-4f7e-a783-1a81290a8823" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2254541b-a892-4a44-a307-f606e1342d55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_b5882988-cc28-435a-bbf1-21d1eb418afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_b5882988-cc28-435a-bbf1-21d1eb418afb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bca43756-6ba1-4b38-9714-5bf30a65fb71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_b5882988-cc28-435a-bbf1-21d1eb418afb" xlink:to="loc_us-gaap_OperatingIncomeLoss_bca43756-6ba1-4b38-9714-5bf30a65fb71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_c8f20488-8ce1-4b09-966c-64db2dcb44d8" xlink:href="mck-20200930.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_c8f20488-8ce1-4b09-966c-64db2dcb44d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_6ec73e65-fc21-4d3d-892f-9d8d492bdb1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:to="loc_us-gaap_InterestAndDebtExpense_6ec73e65-fc21-4d3d-892f-9d8d492bdb1c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_968fc366-fab7-44a1-a4d2-7530f30ff41b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_968fc366-fab7-44a1-a4d2-7530f30ff41b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_63ed114b-6695-4264-8e35-e7f139726cfa" xlink:href="mck-20200930.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_63ed114b-6695-4264-8e35-e7f139726cfa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_6a206331-a3b6-490c-a5ec-69231e8c6ae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_6a206331-a3b6-490c-a5ec-69231e8c6ae3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_70b49d08-06c5-4853-a3e8-c3a17dcaf296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_RestructuringCharges_70b49d08-06c5-4853-a3e8-c3a17dcaf296" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_79aa426d-ee24-4e8e-a86a-fcd329046008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_79aa426d-ee24-4e8e-a86a-fcd329046008" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax_a6834b62-ebce-413e-aeac-fe48404d365a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_GoodwillImpairmentLossNetOfTax_a6834b62-ebce-413e-aeac-fe48404d365a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_f7312799-5da0-4556-aefe-0e9bb65ee2c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_f7312799-5da0-4556-aefe-0e9bb65ee2c5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_9c12974d-e953-4e2e-bb64-0a3838785cc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_9c12974d-e953-4e2e-bb64-0a3838785cc9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f9c1e8dd-0b1b-4e3d-bc1e-a94e01dea26d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f9c1e8dd-0b1b-4e3d-bc1e-a94e01dea26d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_5921cdc7-2e89-4545-9e63-cd2b05a4a9db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_5921cdc7-2e89-4545-9e63-cd2b05a4a9db" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_9b8a5dd0-7340-459e-8a5e-51f613acabd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_9b8a5dd0-7340-459e-8a5e-51f613acabd6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_d7d74aab-a149-425d-9ba1-f2f0fa1fb981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_d7d74aab-a149-425d-9ba1-f2f0fa1fb981" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_1262d302-6659-4179-a799-0a058375d90a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_LitigationSettlementExpense_1262d302-6659-4179-a799-0a058375d90a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3030e5a9-cfdc-43b6-a5dd-2b5970388288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3030e5a9-cfdc-43b6-a5dd-2b5970388288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3030e5a9-cfdc-43b6-a5dd-2b5970388288_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3030e5a9-cfdc-43b6-a5dd-2b5970388288" xlink:to="loc_us-gaap_SegmentDomain_3030e5a9-cfdc-43b6-a5dd-2b5970388288_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_68a3e760-dd8b-4c6f-bf21-48131e76b69b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3030e5a9-cfdc-43b6-a5dd-2b5970388288" xlink:to="loc_us-gaap_SegmentDomain_68a3e760-dd8b-4c6f-bf21-48131e76b69b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_d9cc754d-72fc-4f48-a4af-9be85b156cd1" xlink:href="mck-20200930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_68a3e760-dd8b-4c6f-bf21-48131e76b69b" xlink:to="loc_mck_USPharmaceuticalSegmentMember_d9cc754d-72fc-4f48-a4af-9be85b156cd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_2b31e70a-e6a2-4e30-ae27-bb0ae86d028e" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_68a3e760-dd8b-4c6f-bf21-48131e76b69b" xlink:to="loc_mck_InternationalSegmentMember_2b31e70a-e6a2-4e30-ae27-bb0ae86d028e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_4b6ab439-c48d-44e4-97a1-c2df77276929" xlink:href="mck-20200930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_68a3e760-dd8b-4c6f-bf21-48131e76b69b" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_4b6ab439-c48d-44e4-97a1-c2df77276929" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_c20c928b-1548-4438-abb5-012235694630" xlink:href="mck-20200930.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_68a3e760-dd8b-4c6f-bf21-48131e76b69b" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_c20c928b-1548-4438-abb5-012235694630" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_1b7b5368-e2b7-484e-8b5d-4e44dd54ef0b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_srt_ConsolidationItemsAxis_1b7b5368-e2b7-484e-8b5d-4e44dd54ef0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1b7b5368-e2b7-484e-8b5d-4e44dd54ef0b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_1b7b5368-e2b7-484e-8b5d-4e44dd54ef0b" xlink:to="loc_srt_ConsolidationItemsDomain_1b7b5368-e2b7-484e-8b5d-4e44dd54ef0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4c155354-dd08-4fd2-8efb-7b90414f984e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_1b7b5368-e2b7-484e-8b5d-4e44dd54ef0b" xlink:to="loc_srt_ConsolidationItemsDomain_4c155354-dd08-4fd2-8efb-7b90414f984e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_64c1a65d-5785-4158-83ed-aadf30fdb2ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4c155354-dd08-4fd2-8efb-7b90414f984e" xlink:to="loc_us-gaap_OperatingSegmentsMember_64c1a65d-5785-4158-83ed-aadf30fdb2ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e6ed692d-621f-44d5-97d7-5410a947f3c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4c155354-dd08-4fd2-8efb-7b90414f984e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e6ed692d-621f-44d5-97d7-5410a947f3c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_aecbc80e-5f6c-4823-aa11-7db927663a01" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_srt_StatementGeographicalAxis_aecbc80e-5f6c-4823-aa11-7db927663a01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_aecbc80e-5f6c-4823-aa11-7db927663a01_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_aecbc80e-5f6c-4823-aa11-7db927663a01" xlink:to="loc_srt_SegmentGeographicalDomain_aecbc80e-5f6c-4823-aa11-7db927663a01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_93619373-169c-4536-8e29-884579bd8e8f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_aecbc80e-5f6c-4823-aa11-7db927663a01" xlink:to="loc_srt_SegmentGeographicalDomain_93619373-169c-4536-8e29-884579bd8e8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_58c11e1c-07aa-4f49-8091-4d6d3fc51b9d" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93619373-169c-4536-8e29-884579bd8e8f" xlink:to="loc_country_US_58c11e1c-07aa-4f49-8091-4d6d3fc51b9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_46a93ffe-3217-4df3-ba04-6118814c7002" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93619373-169c-4536-8e29-884579bd8e8f" xlink:to="loc_srt_EuropeMember_46a93ffe-3217-4df3-ba04-6118814c7002" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_99afb7ff-a0f2-4030-a0af-ea11e0c835f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_srt_LitigationCaseAxis_99afb7ff-a0f2-4030-a0af-ea11e0c835f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_99afb7ff-a0f2-4030-a0af-ea11e0c835f8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_99afb7ff-a0f2-4030-a0af-ea11e0c835f8" xlink:to="loc_srt_LitigationCaseTypeDomain_99afb7ff-a0f2-4030-a0af-ea11e0c835f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8deff12a-3d0b-47df-91e5-55c2bbe8a0b0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_99afb7ff-a0f2-4030-a0af-ea11e0c835f8" xlink:to="loc_srt_LitigationCaseTypeDomain_8deff12a-3d0b-47df-91e5-55c2bbe8a0b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InreNationalPrescriptionOpiateLitigationMember_ce614e36-0c5e-4591-a286-231c98936630" xlink:href="mck-20200930.xsd#mck_InreNationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_8deff12a-3d0b-47df-91e5-55c2bbe8a0b0" xlink:to="loc_mck_InreNationalPrescriptionOpiateLitigationMember_ce614e36-0c5e-4591-a286-231c98936630" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6aa63033-021f-41a5-85b8-3d8db0f1a7c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6aa63033-021f-41a5-85b8-3d8db0f1a7c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6aa63033-021f-41a5-85b8-3d8db0f1a7c0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6aa63033-021f-41a5-85b8-3d8db0f1a7c0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6aa63033-021f-41a5-85b8-3d8db0f1a7c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_1820d0c8-0f27-4bee-a363-14813d972de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6aa63033-021f-41a5-85b8-3d8db0f1a7c0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_1820d0c8-0f27-4bee-a363-14813d972de2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_4daadd74-ad80-4434-866e-6b77190062c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_1820d0c8-0f27-4bee-a363-14813d972de2" xlink:to="loc_us-gaap_DomesticPlanMember_4daadd74-ad80-4434-866e-6b77190062c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_820265fb-4f41-4e9f-878e-e56201e84ae8" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_4daadd74-ad80-4434-866e-6b77190062c6" xlink:to="loc_country_US_820265fb-4f41-4e9f-878e-e56201e84ae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_8fc9351d-bd31-47ce-9c04-f3cca8c03234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_8fc9351d-bd31-47ce-9c04-f3cca8c03234" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8fc9351d-bd31-47ce-9c04-f3cca8c03234_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8fc9351d-bd31-47ce-9c04-f3cca8c03234" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8fc9351d-bd31-47ce-9c04-f3cca8c03234_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6a308797-d2a6-44b9-bc7e-0ffe1cdbd2f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8fc9351d-bd31-47ce-9c04-f3cca8c03234" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6a308797-d2a6-44b9-bc7e-0ffe1cdbd2f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2d55a338-e94c-4b1d-8e6c-87c326758ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6a308797-d2a6-44b9-bc7e-0ffe1cdbd2f5" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2d55a338-e94c-4b1d-8e6c-87c326758ec2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8f2a688b-4f00-4e1a-a893-afe376172aa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8f2a688b-4f00-4e1a-a893-afe376172aa6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8f2a688b-4f00-4e1a-a893-afe376172aa6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8f2a688b-4f00-4e1a-a893-afe376172aa6" xlink:to="loc_us-gaap_RelatedPartyDomain_8f2a688b-4f00-4e1a-a893-afe376172aa6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5d3a055e-937c-4123-b28b-ff915c78e4ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8f2a688b-4f00-4e1a-a893-afe376172aa6" xlink:to="loc_us-gaap_RelatedPartyDomain_5d3a055e-937c-4123-b28b-ff915c78e4ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_e0f6d344-a688-4772-b771-6c8897ab94e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5d3a055e-937c-4123-b28b-ff915c78e4ba" xlink:to="loc_us-gaap_CorporateJointVentureMember_e0f6d344-a688-4772-b771-6c8897ab94e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_405d972a-2d22-45e0-9b19-159547d39c1a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_405d972a-2d22-45e0-9b19-159547d39c1a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_405d972a-2d22-45e0-9b19-159547d39c1a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_405d972a-2d22-45e0-9b19-159547d39c1a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_405d972a-2d22-45e0-9b19-159547d39c1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1d57b3f4-c647-49ef-b011-20609e5aa96e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_405d972a-2d22-45e0-9b19-159547d39c1a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1d57b3f4-c647-49ef-b011-20609e5aa96e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_311e211c-5a01-47fc-9057-cccef51903ba" xlink:href="mck-20200930.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1d57b3f4-c647-49ef-b011-20609e5aa96e" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_311e211c-5a01-47fc-9057-cccef51903ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_a0949138-f115-4a02-bb5a-9841d3270522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_us-gaap_RestructuringPlanAxis_a0949138-f115-4a02-bb5a-9841d3270522" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_a0949138-f115-4a02-bb5a-9841d3270522_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_a0949138-f115-4a02-bb5a-9841d3270522" xlink:to="loc_us-gaap_RestructuringPlanDomain_a0949138-f115-4a02-bb5a-9841d3270522_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_87df9b85-b140-4db9-9825-2bd251489f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_a0949138-f115-4a02-bb5a-9841d3270522" xlink:to="loc_us-gaap_RestructuringPlanDomain_87df9b85-b140-4db9-9825-2bd251489f1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanMember_d7fb94ba-866d-4898-8193-ec212ca75ab3" xlink:href="mck-20200930.xsd#mck_StrategicGrowthInitiativePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_87df9b85-b140-4db9-9825-2bd251489f1b" xlink:to="loc_mck_StrategicGrowthInitiativePlanMember_d7fb94ba-866d-4898-8193-ec212ca75ab3" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>mck-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:f15aa9b5-be6e-4b9d-af45-f9d5f89227d0,g:ffd6c493-ffba-42d6-bea4-20131f0e9c42-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_75f8810c-3d51-4312-b9b2-a09e137bb63c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_0579967d-45f0-478a-b6e2-9977cb5f5f42_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_28823a4c-6490-4846-a50a-a62fc4ebfb86_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingent Liabilities</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_fbcb370c-0434-4dec-b864-cd83aa6e49a2_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48f76da5-acfb-45f0-b2cf-a4184c613c47_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_fb9e57c7-baf2-4350-a3c8-897bf1b6cd8f_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_6b06f1c8-00bb-460f-8c8a-329565de2f42_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_label_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Debt Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDebtExpense" xlink:to="lab_us-gaap_InterestAndDebtExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_c8deda8c-76dc-4fd6-9814-53bd835fbc2c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_98b064bc-1601-458e-96a3-62369046dbcd_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_abf7c53e-9829-4414-bd1e-c26d86455787_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_1ad17b76-d9c3-4b2f-9bce-eda1b06412aa_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_8848f373-4d81-4b66-93fc-cb23ae2b05b2_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_fafcbc33-f9ac-49e5-ba10-3bd5671a3fc6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0346572-c0ec-4011-925a-5b2f9ad50618_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_854831d2-25ca-4cfb-8d2e-da726ffbcf09_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition accounting, transfers and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_b44358c2-015a-4cef-8c71-593d24f5197f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncurrentAssetLiabilityMember_f14a7809-e948-4393-b5c5-d3dc86942fa1_terseLabel_en-US" xlink:label="lab_mck_NoncurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Asset / Liability</link:label>
    <link:label id="lab_mck_NoncurrentAssetLiabilityMember_label_en-US" xlink:label="lab_mck_NoncurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Asset / Liability [Member]</link:label>
    <link:label id="lab_mck_NoncurrentAssetLiabilityMember_documentation_en-US" xlink:label="lab_mck_NoncurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Asset / Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncurrentAssetLiabilityMember" xlink:href="mck-20200930.xsd#mck_NoncurrentAssetLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncurrentAssetLiabilityMember" xlink:to="lab_mck_NoncurrentAssetLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_884d9307-9317-44d2-8a49-df30f6994ca0_terseLabel_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;)</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_label_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;) [Member]</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_documentation_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember" xlink:href="mck-20200930.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TaxReceivableAgreementTRAMember" xlink:to="lab_mck_TaxReceivableAgreementTRAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_6c4217fd-86cd-4d25-8265-4cc848c0344c_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_49ac21af-fb42-4bb8-beff-a8a36f3c2476_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_e54999e2-370e-4c8c-8147-cad85e213a05_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_791dc38c-9fe4-4f65-b9e8-2e95bcdcd96c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e49a3a45-2982-4327-96fe-34a3050ec5d3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_f4a15200-4ef2-4e54-82c8-566d11d4ca4e_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in carrying value of non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_be91833c-e074-43a0-b29d-bff813df5070_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_c1a1ff97-8d73-4864-9595-e2f85902b8db_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_23f4759b-abe0-4f1a-8b67-7bc9386437ba_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3df25673-93b8-4da9-aa3c-b6fa3d18577e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_8ad0a10b-116b-4a29-b5d9-f191a0691565_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and trade names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8f57a145-5e92-4d69-b11d-bc4dc05b8f31_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_847ad7c4-8d16-48db-a9f1-ec9abb2f57cd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_508b447c-7bdf-4945-85e5-1f714dd8b039_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1a29bef7-0064-4f0a-abcb-6a1d9131bca3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_c9f74521-f093-4fb5-bb62-341e00c45bed_terseLabel_en-US" xlink:label="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate annual surcharge on licensed manufacturers and distributors of opioids</link:label>
    <link:label id="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_label_en-US" xlink:label="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids</link:label>
    <link:label id="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_documentation_en-US" xlink:label="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:href="mck-20200930.xsd#mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:to="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_1c55bb52-bae8-4a42-afc2-9de17ad01113_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_f79c078c-b516-46bf-a2d4-755409469d3c_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and employee-related costs, net</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_349a72a7-00ff-4d09-a98d-d5ad06259320_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lump sum payments under settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b958f174-2918-43ed-9b45-fe16a5c0ca67_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ChangeHealthcareInc.Member_0da19a92-90b6-4f91-9ce3-a3cb5b15425c_terseLabel_en-US" xlink:label="lab_mck_ChangeHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, Inc.</link:label>
    <link:label id="lab_mck_ChangeHealthcareInc.Member_label_en-US" xlink:label="lab_mck_ChangeHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, Inc. [Member]</link:label>
    <link:label id="lab_mck_ChangeHealthcareInc.Member_documentation_en-US" xlink:label="lab_mck_ChangeHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareInc.Member" xlink:href="mck-20200930.xsd#mck_ChangeHealthcareInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ChangeHealthcareInc.Member" xlink:to="lab_mck_ChangeHealthcareInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1a988256-edfe-4af0-90af-df77f9dfccb7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases, including shares surrendered for tax withholding</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_0fb3e38f-3fbb-4b02-8dff-c4e6f4101e58_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_417c3177-b85a-4167-a824-ab78c3e030f1_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_aec91d2c-c670-4c00-a591-09b1e5f5f539_terseLabel_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (shares)</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_label_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_documentation_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:href="mck-20200930.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:to="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_9c35988f-7bfb-4a03-b247-13c04c3db283_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStateAttorneyGenerals_9a1d7b22-20d1-4d8f-a431-9a729156bb51_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of attorney generals that have filed claims</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStateAttorneyGenerals_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of State Attorney Generals</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStateAttorneyGenerals_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of State Attorney Generals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofStateAttorneyGenerals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:to="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory_4354c636-06e2-46e9-ba77-f609a3f43e7c_negatedTerseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of discrete tax benefit on reported income tax rates (percent)</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intra-entity Transfer, Assets Other Than Inventory</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intra-entity Transfer, Assets Other Than Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory" xlink:href="mck-20200930.xsd#mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_22c8f240-4a11-4a93-bf0a-99234819a3cd_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_62e8920a-2a6c-40ab-820d-af617ced59d8_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_9622ffd6-d7e0-46cc-a20c-3217c8a9e65d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_286f6213-4d5f-4c0b-9629-d62d0854d903_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, net</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e4c0455b-1f9f-4a78-823f-2e22ff409259_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfCountyGovernments_b0e94538-1d38-45e4-b066-8538f1d5f588_terseLabel_en-US" xlink:label="lab_mck_NumberOfCountyGovernments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of county government plaintiffs</link:label>
    <link:label id="lab_mck_NumberOfCountyGovernments_label_en-US" xlink:label="lab_mck_NumberOfCountyGovernments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of County Governments</link:label>
    <link:label id="lab_mck_NumberOfCountyGovernments_documentation_en-US" xlink:label="lab_mck_NumberOfCountyGovernments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of County Governments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfCountyGovernments" xlink:href="mck-20200930.xsd#mck_NumberOfCountyGovernments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfCountyGovernments" xlink:to="lab_mck_NumberOfCountyGovernments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_335a6152-7a00-41cd-ae5f-dedd0ee31058_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_bcd0cbf4-656a-48c1-aef4-d63e28d259a8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_9f15e868-0bc3-4be5-860b-75761a296b17_terseLabel_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_label_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:href="mck-20200930.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:to="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_1cbf9c0b-3ee1-4b74-aeee-cce9ee23066f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax charges</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_ce75bd35-01b3-4a6a-8792-279397c9f6c0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_cb127e1a-a51d-416a-8269-26bb6fbbf85b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions made in exchange for additional membership interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_ea925a44-48ca-4f3c-8c51-7c650d19869c_terseLabel_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes due March 15, 2024</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_label_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024 [Member]</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_documentation_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member" xlink:href="mck-20200930.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A380NotesDueMarch152024Member" xlink:to="lab_mck_A380NotesDueMarch152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_cb626a17-80b6-4fa5-bf57-7bfa85bcc432_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_d802b944-9bd3-4414-9633-fb04bf121cc6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar, notional amount, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_8701c7b6-1c12-4228-a421-e28f263bea5a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_274a561e-5790-4058-8a28-3a18354f5a33_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_637a0b4f-4d1e-4ede-9cc4-f8e8cae576a8_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_13c04cbc-ee0b-46bb-8382-dd4655ddd5d9_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_acc3b0b0-0b82-4236-b45c-af88dfba9c80_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_c4b4d876-90ee-4cb1-ae41-5fe93ee75a6a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_af82278b-578a-4ae5-b5d1-646ef9cf8732_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1390dd17-0ade-4d25-a6af-4d452630ed28_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_67059b5f-adf6-4cd3-8c31-a930164dea5b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_021c77e7-a1f6-4e3c-bd4f-538db30499ed_terseLabel_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes per share of common stock permitted on proposals presented to stockholders (vote)</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_label_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_documentation_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:href="mck-20200930.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:to="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_99368b3b-7841-4972-8e21-21f4e5b94787_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_f492ae10-5781-4783-8b0f-3623689ad776_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_621ba482-4af5-4a1a-9b04-76c4958c7a37_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_d3b7e90b-3734-4787-b067-8d4cf4e1664e_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_dd22eb4e-3e3f-4838-a62f-0352d94c6e4f_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_3d4bda23-c2a4-4437-98c9-355001e06561_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_a75c1297-d4d4-44ae-9453-747ba3e030cb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_5ae679e7-d94a-4e87-b1ff-c5824ba1d926_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ce28bf79-ecf1-4d82-86fb-fd41c171c829_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d2bb78c0-dc8c-4525-afb9-68c3ac6f8f3d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_52849596-57d1-4bb3-bed8-696dc3e296e3_terseLabel_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contracts to hedge Euro against British Pound cash flows</link:label>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_label_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]</link:label>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_documentation_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:href="mck-20200930.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:to="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_3380f705-8081-4ec2-834a-5234f15f04c0_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMay302029Member_db883fa6-7857-4520-8a3b-1546524bc8bc_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes due May 30, 2029</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_label_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member" xlink:href="mck-20200930.xsd#mck_A475NotesDueMay302029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMay302029Member" xlink:to="lab_mck_A475NotesDueMay302029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_61b0af2e-74f8-4b15-abc3-6def6db584b4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3c82bd18-6558-49d6-bffb-a52c7b84f2cb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_4c4cea46-dba9-413a-bcf8-927ac60921e4_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted balance, April 1</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_c62ae0dc-6abb-4dc2-adb7-216d15c688be_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_6cdb53c8-150d-4150-9285-1d1c7908b776_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e60463bd-bf78-4745-8772-b1e36749f00f_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4374c894-e473-43e2-b480-98979c7098dc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_324f79a1-b4e5-4143-9dce-4b9a0fd8b4f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c4c9a67c-0920-499f-a7e7-55b5f177a3e5_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_67258848-e16b-4029-aea0-35608b2cffd2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_961863c3-3f25-487e-b1f2-5a4cc0c5fc93_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_581d4c71-31d0-4332-9733-4b68f3948a14_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_222b5c71-4fe5-4e5b-8347-f82427e2ab06_terseLabel_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual recurring dividend (in euro per share)</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_label_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_documentation_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:href="mck-20200930.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:to="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_ea01c0b3-b8b9-438f-b95f-41046e916373_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax settlement expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofCounties_c2e1c274-4441-4cc2-b749-a97d3545d47b_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofCounties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of counties that filed claims</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCounties_label_en-US" xlink:label="lab_mck_LossContingencyNumberofCounties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Counties</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCounties_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofCounties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Counties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCounties" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofCounties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofCounties" xlink:to="lab_mck_LossContingencyNumberofCounties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_c5a5b91c-7be1-4dd8-9ab5-c1a909aa880c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_27b66e33-1b45-434a-917b-1ce3537df793_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_94266e08-8253-4eff-953b-abac160f9ad4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_958bd683-0122-4479-a6aa-7eceffa732a0_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6d1dc248-8ebd-4b08-a363-a04f8c9e93f6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_d3d48b16-5e5d-472b-8ec7-54bca5e07bc0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated senior unsecured revolving credit facility term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_37097506-0816-4c51-aefd-f050290a6455_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_61aa1640-ed87-4ed8-89ec-8147000345f8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_3209c2a6-c0a0-4c35-8101-488b71137026_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_d8af1fde-e399-4cdc-b729-b03d8f0b78b7_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_e82c7cef-0f9e-4f2e-87ed-4f2c45da186b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair values of liabilities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_71b4f3d1-af12-4e0d-b04e-4674230fa947_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_10a1a834-4b4d-47c6-87f5-bc37bb7d4821_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock transactions:</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_7195e8cd-e1bc-4cce-a1df-5b73e0b16a97_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_a10b7682-c327-46ba-b107-61a5d4f0d23a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio_34b761b2-efb9-43e6-8414-c0b5854d0ebb_terseLabel_en-US" xlink:label="lab_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to capital covenant ratio (no greater than)</link:label>
    <link:label id="lab_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio_label_en-US" xlink:label="lab_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Terms, Maximum Debt To Capital Ratio</link:label>
    <link:label id="lab_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio_documentation_en-US" xlink:label="lab_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Terms, Maximum Debt To Capital Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio" xlink:href="mck-20200930.xsd#mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio" xlink:to="lab_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_c4809cbd-bdd5-4389-abf9-a4a8beed0f12_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4d699a26-4cec-4954-a637-15ee7ed64989_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_552a302d-3b33-4e92-913d-51547c7049e3_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6d3411f0-5a58-4c35-b378-2d63db1cb275_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_2cb871d3-2ba0-4091-9e67-74948d864145_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Financing Activities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_cc46927e-91e6-4bf9-aa11-fb2f68f5533a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_bfec4b1c-ba11-46fe-80bc-2e0f08ee2294_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a4704a29-8423-4df2-b5ad-e3f48037968d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of computations for basic and diluted earnings per common share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_9e3912d1-994c-4f95-8b42-b3e7b14e2cf1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to income statement, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ba0e55dc-a314-4644-b25f-b4b0fb79d08b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ac4b0ec5-6334-4c7b-bb02-1d0cfe49ff13_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d0c24c59-88ed-4457-baa0-b373b48bec45_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A365NotesDueNovember302020Member_c291b2e4-337b-4848-b769-6721d8567e60_terseLabel_en-US" xlink:label="lab_mck_A365NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.65% Notes due November 30, 2020</link:label>
    <link:label id="lab_mck_A365NotesDueNovember302020Member_label_en-US" xlink:label="lab_mck_A365NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.65% Notes Due November 30, 2020 [Member]</link:label>
    <link:label id="lab_mck_A365NotesDueNovember302020Member_documentation_en-US" xlink:label="lab_mck_A365NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.65% Notes Due November 30, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A365NotesDueNovember302020Member" xlink:href="mck-20200930.xsd#mck_A365NotesDueNovember302020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A365NotesDueNovember302020Member" xlink:to="lab_mck_A365NotesDueNovember302020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLossNetOfTax_b475221d-ef84-4bb7-90f3-e2599ecf43dd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:to="lab_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_09bb4049-bf93-44a1-98e9-b9a019c17799_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e222b81c-c403-4bb8-a22a-be9f48077511_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ChangeHealthcareLLCChangeHealthcareMember_ebbdc752-a636-481a-9f49-ca7e72b98c59_terseLabel_en-US" xlink:label="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare JV</link:label>
    <link:label id="lab_mck_ChangeHealthcareLLCChangeHealthcareMember_label_en-US" xlink:label="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, LLC (&#8220;Change Healthcare&#8221;) [Member]</link:label>
    <link:label id="lab_mck_ChangeHealthcareLLCChangeHealthcareMember_documentation_en-US" xlink:label="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, LLC (&#8220;Change Healthcare&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:href="mck-20200930.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:to="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_a844d36d-76cf-44ce-8bbc-fed052a4b0b1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts outstanding under facility</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7c37a9da-feab-479c-ba1e-2a0dbb00065f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_8dc27e58-4580-4870-a052-2c6381e81bdb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Related Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_2484552a-ac3f-41a3-8578-baf4887ee884_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_2c0280c0-591f-4e37-8acd-865572520b44_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax litigation expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_727c9867-93d6-4194-a935-0004b1aa0370_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_877f7b7d-96fd-443a-a78d-71cf932cd14d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_804cd205-8774-48ed-82c0-9e2ca54e29f3_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Credit Facility</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:href="mck-20200930.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_5bd9e95b-368e-4b57-b550-30070963bb52_negatedTerseLabel_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax benefit recognized due to temporary difference arising from buyer's excess tax basis</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_label_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Discrete Items</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_documentation_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Discrete Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:href="mck-20200930.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:to="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_c8a6a925-0c23-4e83-a6e9-dea92469605e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, by Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_c6e3bf35-150b-4468-9465-a7bd516e3f7d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:to="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c0102f2f-1c51-460f-ba5a-14546581f09a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_0757ffbe-a7de-4ff8-9351-5b984cebb1f7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding the fair value of derivatives on a gross basis</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_0ff306b2-208d-4661-a9b4-8e4ad84d6a6b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_df6bfd1a-8fae-4259-9a4e-6ad2aae3ccc0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_f4826beb-f55d-4345-9b9e-a3cf0caa0d14_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_80993a84-e029-4106-b420-5a27a7a25dda_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_4834a71c-793d-4476-a799-39ad63d70e27_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to income statement, tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_94fa30c2-3cdb-4a75-a3bf-e55c51649317_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_cb5b3c46-e00d-4c32-a79e-258d94464cf0_terseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation gain (loss) attributable to redeemable noncontrolling interest</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:href="mck-20200930.xsd#mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_943037c3-c667-46c7-a186-3e8a7e676ebf_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_752a502e-e173-4733-bf3a-7c2083074070_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_b2d9dccc-368f-440d-a651-c2f9717edc1e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanMember_c8e1388a-fb10-48e6-affe-5c13ac2b10e0_terseLabel_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanMember_label_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan [Member]</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanMember_documentation_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanMember" xlink:href="mck-20200930.xsd#mck_StrategicGrowthInitiativePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StrategicGrowthInitiativePlanMember" xlink:to="lab_mck_StrategicGrowthInitiativePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_4eeea43e-1b1c-4a3a-b2a9-a32ff20b2397_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_5196aa2e-5a4d-4ca4-860d-d454816cd998_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_4d0ed579-13fe-4f16-a010-cd3bc28f5393_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_aa332879-529b-4e15-a8dc-ff739ae85319_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_aa849856-d861-451c-9b58-d4b633670945_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price of shares repurchased (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_a64d477a-d8ed-495e-9374-e04d657d0bc7_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_d228c57f-23f8-49ba-9e01-0ca071e1c220_verboseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_label_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:to="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4b25a6cc-57e6-4579-ad30-b805cdb464a7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_b339f768-7732-46bb-996b-8234ed7a35c6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional values of financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_dffde2db-72f7-4d16-b56c-c09218c9dfc0_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_f07b6cf0-b1da-4de9-8be9-69925902bee7_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_53cf6985-bc58-47ff-a0d1-cd17397463e5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_bf5b7117-c82f-4efe-ac32-6ebc919c880b_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_bd0d315c-3123-431b-8fd1-3d08bec77090_terseLabel_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_label_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_documentation_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember" xlink:href="mck-20200930.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MckessonEuropeSubsidiaryMember" xlink:to="lab_mck_MckessonEuropeSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_c7373142-9a08-4855-a193-30b25014e753_terseLabel_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments and other, net of income tax expense of nil, nil, nil, and nil</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:href="mck-20200930.xsd#mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:to="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_f3775797-f3aa-439b-884c-c20f75b1a20a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_11c61c16-031a-46dc-a965-454cd2bec07f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_d409fa0e-a299-4903-9554-26b5537681e3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments of Business</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_caa08154-e1d4-4094-a1d9-b440542399d5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_15c9f7a9-87c9-4850-aa8b-174ef34f2795_terseLabel_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_label_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:href="mck-20200930.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:to="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_7a9cbe94-c9d3-4fae-a172-49c28b699c7e_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_3408d55f-2dbe-4fe8-b9d5-8cedea80dced_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_c18139af-f9c3-4e20-ae9f-f01b189c7620_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_17e4a375-51b6-49b0-8e42-1eea9cab69b7_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_08b9c4cf-2d32-4329-9397-3d361a303ffd_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_eee5f15d-89dc-4737-b748-00af2497290b_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_a3ea64eb-f67f-4936-ae36-cbfe425901f0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_33f9ed31-6c5a-42d5-816c-8e0fe0ba5cf0_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_ce38cd63-f884-403c-bb30-66bcd1b5e50d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit and other-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_36b5cce7-f0e4-482c-b963-21a9833517d4_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_6146a0bc-2b36-41d6-8d69-432f08bdfa49_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7c6d6e4d-29c7-433e-adbb-5af9c8171889_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_056088a7-313a-41ee-88b7-a706139a0238_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_7e2f2eeb-47c4-455b-9f11-1e09fc6a6418_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_f9f2af2b-ebea-4bb1-bfed-050041bd8bd0_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_dea880d6-ae93-4f8c-9385-7d13dc154a2f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_368631ba-9e99-4b08-993c-79503af18c44_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum redemption value of redeemable noncontrolling interest</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests, Maximum Redemption Value</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests, Maximum Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:href="mck-20200930.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:to="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f6fed515-c36e-4198-a621-9598912b243e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_868a57f5-7ce1-4e54-b0b0-09aa0029d791_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_8195376a-5c74-4195-a39b-a37d8c906a47_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_d1154afe-9908-4caa-872f-1044f6fe0758_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_28a6c71a-9ea7-4c8e-a6d7-a59e4e13c5b9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for purchase shares of Mckesson Europe</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A0625NotesDue2021Member_08d0fe67-557c-4e54-bc6d-b19b2e0e5ba7_terseLabel_en-US" xlink:label="lab_mck_A0625NotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.625% notes Due 2021</link:label>
    <link:label id="lab_mck_A0625NotesDue2021Member_label_en-US" xlink:label="lab_mck_A0625NotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.625% notes Due 2021 [Member]</link:label>
    <link:label id="lab_mck_A0625NotesDue2021Member_documentation_en-US" xlink:label="lab_mck_A0625NotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.625% notes Due 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A0625NotesDue2021Member" xlink:href="mck-20200930.xsd#mck_A0625NotesDue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A0625NotesDue2021Member" xlink:to="lab_mck_A0625NotesDue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a5608a6a-a6c1-4ee1-9196-1eebffa1238a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_15afea8b-9249-4548-9852-4f102f7223b9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, inputs, level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_40e6b164-2159-4cfb-9ef0-a7edeadfdae7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_de930a94-d605-4762-a25e-65b7121d5ab0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in retirement-related benefit plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_7e4137cd-fe39-49c2-a594-6b49396e0064_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e2b6bac9-e797-4e45-b96c-0b86f5b27777_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_fb2ca59d-c43b-4ed5-946d-f364731633a1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OperatingModelAndCostOptimizationProgramsMember_f5e5259a-018c-4ddb-ae96-8fa01f515d41_terseLabel_en-US" xlink:label="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model and Cost Optimization Programs</link:label>
    <link:label id="lab_mck_OperatingModelAndCostOptimizationProgramsMember_label_en-US" xlink:label="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model and Cost Optimization Programs [Member]</link:label>
    <link:label id="lab_mck_OperatingModelAndCostOptimizationProgramsMember_documentation_en-US" xlink:label="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model and Cost Optimization Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:href="mck-20200930.xsd#mck_OperatingModelAndCostOptimizationProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:to="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_a29431dc-8002-40ae-ae67-273b4a9e2d0f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_756aee7d-160f-46b9-8d78-c43c1683b8c1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_58617424-64c8-465e-9dec-14d76a90911b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_2e9f1534-455b-4f47-868a-5d2a827d493e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_61fcb60b-3376-4981-bf3d-d4bd00572461_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_6c7beb00-4d4b-4412-bf39-c6da45b66eae_terseLabel_en-US" xlink:label="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on non-derivative net investment hedge</link:label>
    <link:label id="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_label_en-US" xlink:label="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:label id="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_documentation_en-US" xlink:label="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:href="mck-20200930.xsd#mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:to="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a70c921-89d0-4979-b687-931dc1e335d6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4b61cf61-86f2-4091-b575-338d80e03622_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_1975f3ed-80ee-418e-bf3c-fad5026743db_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_5ce3d246-9573-4ea9-aec3-3e59b27ebc20_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_0a749841-21d5-4b2a-9667-fa08c130ed3a_terseLabel_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:href="mck-20200930.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_36ce2826-bc35-4172-a28b-846795df06e1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_5c7f60f5-332b-4127-95fe-298442ea284b_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_9c07a169-f629-4c66-a9f9-aa8ee4dba8f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_36f8de5b-c211-4d3c-b31d-909939ef560a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_6a893a20-93a9-4542-8e44-bb425235030b_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedPercentage_06c2d0e0-1037-4b46-a85c-35e2a2470918_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage threshold of greater of projected benefit obligation or market value of assets (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_aa39804a-d374-44b2-9ad5-a24bd583864b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_0224340d-4002-4cd1-89ce-96f74cde9d8c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_66ee499b-2785-4250-8488-e24e0e1e79e3_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_88a5b6c4-e73f-4278-9b14-e73004c3d95c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_d31c03fb-d502-4274-932c-f6cea3037908_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8659a01b-6352-40ee-9e87-7c4db180279e_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0410e644-1579-4e18-af7e-c6f9e94bb1a4_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_57da0c5a-cdc6-49da-b0f4-cdc37de9fa75_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_3f022ca5-ad7e-4336-89a4-b84a4ff34e64_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_da65763c-2cd3-48c3-831e-6c04c4fd59bc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_14b7e5ff-bc3f-4317-8030-b549e90a0bde_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5294fd53-e261-4f83-b3cb-f3e2a9ee038b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_51cd14cf-a48b-4aa4-952f-9028fa5a684f_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annuity contracts purchased</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment For Annuity Contract</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment For Annuity Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:href="mck-20200930.xsd#mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:to="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_038c6885-655b-46b1-aed2-9285a38ab43f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_b41d15ef-4e4c-4b18-9449-8b8711b201b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a5ae1152-b6f8-475f-bea5-e8e438771347_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6c5a7ab6-6a46-422b-87f5-46f207183b58_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_34f843ae-3ea5-47c4-86ad-d10aed3ccf20_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_111886b8-921d-4d6d-8978-7d3ee4719742_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_27c51c6f-547b-4c04-b9da-6c30770d2de6_terseLabel_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial gain and prior service cost arising during the period, net of income tax benefit of nil, $2, nil, and $1</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:href="mck-20200930.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:to="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7a424f49-510e-49b8-bfa3-14c5919f8afa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in retirement-related benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_2611912d-52b0-4595-b0e0-d223f10f040b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial (gain) loss and prior service costs, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ae97c95-d546-4e69-90a3-1dc495387a23_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_e31d23d7-76cc-4f6a-b443-fbce7ba56e88_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_defcafd4-6b75-4056-8d8c-01fb50bc4639_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_cc1ba9ea-df9f-4aa7-a37e-a6efdc4a1137_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_d901571c-5959-4569-87a1-84514227cdae_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_926e668c-e8ea-401f-9da5-4c85c18c0ea3_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized amount available for future repurchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_a981e54d-7ef9-4745-99fc-9fc2e5ef46c7_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_ee721c65-b3e8-4d37-8497-e4baba676ae1_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_2fb65351-c38f-474f-b04b-404ef681aab3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_c936c508-3b6b-478f-9694-026f421822f9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_0e5cf302-b62c-4716-afb9-39b1de6ad624_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_86ef9d73-c433-4af0-9136-42e40236760b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from termination of derivative instruments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Derivative Instrument, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_dbe93495-4a8a-412c-aa54-94649512473b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which entity segment operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b7eb14f0-8ff6-4b83-9304-773f9ddeb2b1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_b82da1f2-bd2a-4a9b-bafe-ff3af089ce49_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_89c46403-2892-4bee-9919-cbdc1d8f44a5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_c888ecdc-313e-4ab2-858a-d3564bd6ce7f_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_7a1bd955-0129-47da-90db-b960435b25c7_terseLabel_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes due March 1, 2041</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_label_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041 [Member]</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_documentation_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member" xlink:href="mck-20200930.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A600NotesDueMarch12041Member" xlink:to="lab_mck_A600NotesDueMarch12041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_3c9e5af3-d9d5-4402-a242-45f62f5fdc1c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_132edb9b-1247-4a37-813d-039b31fde34e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_4e86a6a5-bb6e-4644-9c52-57fd3fd42a8f_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_7e2a1db0-f468-4811-a675-a090da090c61_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_label_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_documentation_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:href="mck-20200930.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:to="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_1e4fe395-0f33-4433-bcf4-aadd98038450_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity earnings and charges from investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_da20ef17-7dbc-49f5-8f5a-ed71ea768cdc_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity earnings and charges from investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_eced70cd-3d07-494b-8a54-9825a1cb5aa9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportionate loss from investment in Change Healthcare</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_e8e1d5b4-a4d4-4173-a721-ead23a804b3f_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_05772227-9cb2-458e-b30b-71a4440b0477_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_565625a7-8a68-4b39-8042-af10a67f9528_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5eae9f9c-1d06-4315-b3d5-9e99cc62e54c_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_9df2699e-84d2-40ff-b499-cd78025f4641_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to income statement, net of income tax expense</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_44dcca93-5a17-4c76-8f33-b0940a1cbadd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to earnings and other</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_58999917-3ba7-4bfc-84da-320996022f4e_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_4a53afb5-131a-4fb0-aceb-975c1c1fae9f_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_b7ddfa23-7cac-4d81-968c-26ee55faf431_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract" xlink:to="lab_us-gaap_OperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_c5aee5aa-c46b-4cb3-a048-0a763cc98d4b_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_1b5c08da-1994-4698-9920-745bbc338db2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net and other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_2c1bb80f-8465-47e5-b96b-e7d9bd0115ac_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on net investment hedges arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_b63a9d89-8eb5-4e08-b8f9-af7c4c08d406_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_a7687c1a-7062-48c2-958e-d8682bb0cc08_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_7043620d-9880-4a0e-8d30-b285c2878e5b_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_99407efc-3846-47e0-82b6-231299f15c5a_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_096bece7-c7ea-4acb-a641-b00677fcb875_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_b06e82da-8d75-47da-878f-a365e6bfb39f_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_895a601e-4c58-4374-8c12-fb46b51abb27_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_1a3921c7-e360-4582-846b-f5d79065c9a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_f741d068-dda5-4b7c-944f-e6a9e4ce8dd8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_ab2c8fed-98ed-4a9d-bccf-7133facd388f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d5fed2a6-be57-4c84-a080-cbbbf606f36d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_6760b49c-437d-4800-9f0f-bc060516570a_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_8b5c0651-ed3f-45b2-bec3-90242d10fc51_verboseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_a663e1ee-a7c6-4a1e-a7d7-e9d96271a1de_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_e433e29d-c956-47a3-957a-c6b39d09f98f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_02730ba8-4462-493e-a4f4-dafeae6af750_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of liabilities</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_da6270eb-2f81-4469-b773-4dd435008465_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_1bbdb3a2-17f9-4ac7-b7ac-b214d0f6f3e5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_8f8e8e22-7708-4c40-9f02-09ab76929a52_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_4bc31fdc-54ba-4175-b525-e81acd506f28_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1500NotesDue2025Member_e63b5a8f-daae-4a22-b2bf-932f019f4d28_terseLabel_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025</link:label>
    <link:label id="lab_mck_A1500NotesDue2025Member_label_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mck_A1500NotesDue2025Member_documentation_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member" xlink:href="mck-20200930.xsd#mck_A1500NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1500NotesDue2025Member" xlink:to="lab_mck_A1500NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_e36ed88c-7408-4246-ac46-315acedf8316_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Favorable (unfavorable) cumulative foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_9b236f29-4c45-4c9f-8b03-aebf95653f25_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases selected for possible remand to other federal courts</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_label_en-US" xlink:label="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:to="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_e33b6c9c-c64b-4cf4-b0e9-83ac34609376_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_09f7d155-b14d-4152-a69c-4c54247cdf81_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_75cd491e-0bf2-4dab-a8e4-7b154fa929f0_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_5df9647b-e989-415a-8337-9f21734032ca_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities_4955be5c-c5b3-4ae9-8a6a-aea509f608a3_terseLabel_en-US" xlink:label="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities_label_en-US" xlink:label="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:href="mck-20200930.xsd#mck_IncreaseDecreaseinOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:to="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_aa80b8d0-642c-455a-88ca-44d3fb2eba86_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_00b8bb03-0696-4f65-8e88-4aa439892853_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_720ac1e1-83ea-44e8-b7b6-ed2ec9ccaa3c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) from cash flow hedges recorded within other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_766c9082-41f6-4b98-91e1-3385992219b0_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_3926a490-8a7a-4b59-9f1a-6a2a25d7c1bb_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complaints filed against the entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_1a258019-9b09-41e8-b1c6-3f5568928fcd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_9a31c937-8a00-488d-8e7b-df23431f2cd5_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_2cb5004a-eb19-4410-8837-4f765fd69c3c_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right redemption price per share (in euros per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_9404bf44-80d0-4801-bd94-9933454b50ff_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_69afeac3-7bbc-4add-a9e2-a4681dabfcb3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_ef93a41c-b1ff-44bf-90cd-50f9ab95c475_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad0da5e4-e2e6-4651-a443-454b30ca61d4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_e20d1206-b903-4822-b59b-16ffcfa01acb_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c05f2af0-bacf-4029-875f-527db0b62985_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7be98576-1296-4fbb-9a28-0c1dca3f77aa_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c1020db2-3914-444e-822b-17bdc1d17b70_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_6044a56e-b129-44e6-972a-ca88e08c8bfd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_64c675b3-46ec-4f54-85a3-4156113c0b4e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) from sales of businesses and investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1c0ca523-6d3e-4e76-bf43-05864f7f05a8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_71ef04f1-0499-4267-8680-ec3044fc284d_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_b0ccfd69-b895-4f35-bea4-38e9868fd801_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_fa75f151-43a6-4845-851b-ebf853e36498_negatedTerseLabel_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate income (expenses), net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_label_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_documentation_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:href="mck-20200930.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:to="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d0e648d1-7089-467d-a72a-fac7bc791c72_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2a8be93-91e1-4157-8e1e-76a727341847_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0f795f81-308f-4190-afe3-7bc40b743210_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_16b91fff-a951-47bc-a70e-4b0a4935aabc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_90678562-7385-4ea1-b3b7-2a7141af89f9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_6e2adf81-11bb-441c-8c36-04ee97bc6792_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward starting interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_76748da1-0363-4bc5-803b-f7a950dbff80_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, remainder of 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_74a13f58-b8d9-456a-bce5-618c35835429_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_82e849ed-c763-4f63-96a0-2733eca9307e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_7fcc654b-1eef-4e1d-ae0e-75f332e77797_terseLabel_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_label_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:href="mck-20200930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:to="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_c0cca256-ba24-43c2-8f97-7f0fde61adf9_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening retained earnings adjustment: adoption of new accounting standard</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_54f05b44-f920-42de-9ca3-3de99d3083dc_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_401fce2e-880a-4a2b-985e-b8dc29f7d964_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award payable under proposed framework</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_656cb414-10e1-4783-b455-35d8cdf1ee80_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_da85215c-cc8b-4ecb-91a8-1920986bd98a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b4e9c9d4-ec00-4f77-9797-b2da6158c05f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_cc3aaca0-2158-4db9-80c5-1569b6b78b01_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other asset impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_c87e0b49-8898-473d-8b5e-c828dfc703fd_terseLabel_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al</link:label>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_label_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]</link:label>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_documentation_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:href="mck-20200930.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:to="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_94f972ee-7af2-4ca1-b992-693bb1072230_terseLabel_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures due March 1, 2027</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_label_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027 [Member]</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_documentation_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member" xlink:href="mck-20200930.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A765DebenturesDueMarch12027Member" xlink:to="lab_mck_A765DebenturesDueMarch12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_eee44832-12c8-4b2d-bdf3-d93ca7b75d9a_negatedLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in noncontrolling interest</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_b2d8f5df-a649-4d53-8011-09a34e5d76c2_negatedTerseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercises of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:to="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStates_548637f3-da96-4aac-9559-71c966ee57c5_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which court cases are pending</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStates" xlink:to="lab_mck_LossContingencyNumberofStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_26ff4b41-0434-4dab-b56e-b3c9618872e2_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_cb7454b4-7065-4952-bb61-6cf330a4ac13_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_e23899df-e743-4a4f-8f28-753472584d77_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible decrease in unrecognized tax benefits during the next twelve months</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_e2a63b7a-b4ec-443c-a51b-fa50c9109fa9_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b24c19b4-6311-40aa-8226-4f1620dde46c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_6552664e-0efb-43d5-8ed5-40f7651e6506_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_8f4fd8af-ec83-4c49-8434-9418b19a690b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_a75930fd-d853-45bc-afa4-32c699d7054b_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_1333cea5-85c4-4fbe-9280-19255f2c8ab2_verboseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not Designated for Hedge Accounting</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_db90e9b6-82dd-4c53-9106-ae0ff6c72193_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_5d50c3ba-0b00-46ee-8225-c9d615c2b23d_terseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments and other, tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Translation Impact On Pension Plans, Tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Translation Impact On Pension Plans, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:href="mck-20200930.xsd#mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:to="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_96a4cbc7-d750-4058-81d3-c91e7f99e1a7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_aad4dea1-12c5-45df-ace8-2f8d785cf43d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_05af6fad-d867-4831-8db3-f1608d61be79_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_504e430a-ce48-4c16-8b60-e11e5b9fdd84_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage (as a percent)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_2807afe0-62b6-427a-8bf4-0b19c298c20b_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAdditionalCapitalMember_282b1914-4a28-4055-b184-8d7d3b392db7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAdditionalCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Capital</link:label>
    <link:label id="lab_us-gaap_OtherAdditionalCapitalMember_label_en-US" xlink:label="lab_us-gaap_OtherAdditionalCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Additional Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAdditionalCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAdditionalCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAdditionalCapitalMember" xlink:to="lab_us-gaap_OtherAdditionalCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_d01db3ce-2b11-4e5e-ac84-15f782fa9d8f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring liabilities</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_f3ca46a0-eaeb-42ec-a1de-4b902824cc4c_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_103801e3-b16c-4244-9e4c-da161a4ae9ad_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6455689a-fac2-473e-a924-d806c3ee89e3_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_fa0ad9b9-27a9-4b17-91da-98bd3bd37a47_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of faxes received</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_label_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Received</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_documentation_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:href="mck-20200930.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:to="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermCommercialPaperCurrent_9f836e1e-e9bc-4451-b31d-6c82111e6645_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_LongTermCommercialPaperCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Commercial Paper, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermCommercialPaperCurrent" xlink:to="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_e14bd96c-61ac-4a58-a3a5-f01481de6ef5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset for the temporary difference arising from buyer's excess tax basis</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:to="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_2bd5b78c-f6eb-4541-96e0-f8f3955ca5b4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_9b504dfd-a0ad-4dec-9740-a56f4d1cc501_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Dollar, British Pound Sterling, and Euros Sublimit</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:href="mck-20200930.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_cfea4c2e-a3ff-449d-9dfe-5885631bf0aa_terseLabel_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of national brand medical-surgical products offered (more than)</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_label_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical-Surgical Products</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_documentation_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical-Surgical Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:href="mck-20200930.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:to="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PharmacyLicensesMember_06dc84f9-057a-4628-8006-267cbb73a884_terseLabel_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy licenses</link:label>
    <link:label id="lab_mck_PharmacyLicensesMember_label_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Licenses [Member]</link:label>
    <link:label id="lab_mck_PharmacyLicensesMember_documentation_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy licenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember" xlink:href="mck-20200930.xsd#mck_PharmacyLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PharmacyLicensesMember" xlink:to="lab_mck_PharmacyLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_0d86971d-8d2a-4f4b-9410-6b3eabdc1f0a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding other comprehensive income (loss) including noncontrolling and redeemable noncontrolling interests, net of tax, by component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_47e200cf-caaa-48fd-9bc0-e0572a6e420a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_a5e0e9f8-4757-4170-8b7b-b9bee5bcabd6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_20af4218-1b98-41ca-9bbd-3fd50fb8feb0_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_36472aec-c59a-4855-9ed9-6f4a285db04d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_349cafbe-dd90-4ddf-9c8b-7d0f5b75c612_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7e254481-2b7c-49a6-a81b-d0d6ad7f23f7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_44d2831e-c407-423c-aa0e-b71f45e0770d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_c2d84720-e4b6-417a-9279-3e1b35731dc9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A3125NotesDue2029Member_4c7206a3-3cbd-44f7-8f99-b7b950d400fc_terseLabel_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029</link:label>
    <link:label id="lab_mck_A3125NotesDue2029Member_label_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029 [Member]</link:label>
    <link:label id="lab_mck_A3125NotesDue2029Member_documentation_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member" xlink:href="mck-20200930.xsd#mck_A3125NotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A3125NotesDue2029Member" xlink:to="lab_mck_A3125NotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_e887cb16-cc12-4ce1-8c53-917534beb12a_terseLabel_en-US" xlink:label="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net cash tax savings realized or deemed realized under TRA (percent)</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_label_en-US" xlink:label="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_documentation_en-US" xlink:label="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:href="mck-20200930.xsd#mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:to="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_99cfe8d8-7417-4431-ba03-82f6c0565991_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b7b5dff0-99f5-4168-9cb4-874f02820b78_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, inputs, level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_d64b193f-71a0-4db9-b653-c49d97df269c_negatedTerseLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of assets of business held for sale to fair value less costs to sell</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:href="mck-20200930.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_167f7a66-cc49-41c1-9bb3-2f8748e54e55_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in the carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InreNationalPrescriptionOpiateLitigationMember_33966f97-bcff-4f65-b68a-6fc6f31cb086_terseLabel_en-US" xlink:label="lab_mck_InreNationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opioid Litigation</link:label>
    <link:label id="lab_mck_InreNationalPrescriptionOpiateLitigationMember_label_en-US" xlink:label="lab_mck_InreNationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:label id="lab_mck_InreNationalPrescriptionOpiateLitigationMember_documentation_en-US" xlink:label="lab_mck_InreNationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InreNationalPrescriptionOpiateLitigationMember" xlink:href="mck-20200930.xsd#mck_InreNationalPrescriptionOpiateLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InreNationalPrescriptionOpiateLitigationMember" xlink:to="lab_mck_InreNationalPrescriptionOpiateLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_9508002e-d47d-40c7-a930-4f03ff7e1355_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_a3c5ef94-5eeb-4982-ad41-8d5deb99bd04_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_ecfdb5f8-b5dd-43c8-aa53-89ef7bdc8e7f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_0ffef676-b3d8-49da-b3f8-e0323ea25104_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of largest pharmaceutical distributors to adopt anti-diversion programs under proposed framework</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_label_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:href="mck-20200930.xsd#mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:to="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_360cc840-a0bd-42e6-98d6-292eb79b1324_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_3e55c2d6-32c1-4e13-9ea5-9c4dd302b087_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar notional amount, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_6112f639-ed0a-43a5-8393-e828e350cff9_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_887fa7d1-06bd-4a31-9473-7f7738042dc2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d0f5cbac-a710-4890-a47c-5ef79f74af3d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_27a8bffd-3d80-443d-91e0-d6c5562b32d6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_360a676b-c0ed-46b4-944c-5251364db394_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_a38c92e9-8483-4453-a9fd-27714d3b8232_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_1fbdeac8-5605-4775-bc82-83be85ec1875_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_1f3b176a-9113-4ee9-a7dd-2e83062583dd_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_08609e17-e137-4fe3-a065-904f93794dc0_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_5326e18a-7954-4ec0-9455-be183754ec28_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_d8dfc345-5f7d-488a-8a6b-0fad3933680a_terseLabel_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_label_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_documentation_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:href="mck-20200930.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:to="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_77946ca2-05a0-4859-95ae-6afc21e9b95f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f0ee0786-0d86-4d8f-a243-3c64692d3179_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_764d78b1-d7fe-4568-a6da-d3851bade73c_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8151218c-00e9-445a-b578-76f0b0acd896_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_c2f7851b-84bb-4cc0-b1cf-06717a9c40d2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_25d6d7f5-420e-4060-8554-508b02036d01_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would reduce income tax expense and the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_821c4e23-5d8d-4206-bf87-fe58043c89e3_terseLabel_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes due October 30, 2026</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_label_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026 [Member]</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_documentation_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member" xlink:href="mck-20200930.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A163EuroNotesDueOctober302026Member" xlink:to="lab_mck_A163EuroNotesDueOctober302026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_23dcdef7-6720-4e20-b0dc-3eefa02d5adf_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from net investment hedges recorded within other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_3d62f6d4-f6fb-4807-ad8a-b45db9828ffc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_4a7c5839-45b7-4a1e-874a-dc591d6fdbc4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_489f85f0-dc1d-4aa5-a7e4-ee6b8b972dd9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_9a9f431d-adb5-4b6c-9733-4779edd95c09_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_faf79a58-ebb2-48b9-a771-158ac0d2f655_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_c5bc2243-453b-43be-af84-813a4444fd3a_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_4936e6e8-c06a-487a-92b3-8646adf46349_terseLabel_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit</link:label>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_label_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_documentation_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember" xlink:href="mck-20200930.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RetailPharmacyReportingUnitMember" xlink:to="lab_mck_RetailPharmacyReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_4692848c-dbee-47e1-82a6-7187cc2813f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_7c16bc05-0b70-4464-b8c9-053fa43aa11d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_d2f250ae-da6f-455b-b01a-b3f4a28879cb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_388a3b17-a6c0-45d4-a33e-9db53699d859_terseLabel_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes due March 15, 2044</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_label_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044 [Member]</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_documentation_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member" xlink:href="mck-20200930.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A488NotesDueMarch152044Member" xlink:to="lab_mck_A488NotesDueMarch152044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_ea9ba5ef-a802-4311-ba54-4268573d257c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_d1403b7c-6f6e-4e74-8b93-4a2b02f98fe2_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_be3f992f-f9c6-4cdf-88b7-687054563148_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_04ff3dfa-13e8-4ca9-8531-c720b2b233e9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_174cddb0-42bd-43d1-ad5b-d99e3669c068_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value, 800 shares authorized and 273 and 272 shares issued at September 30, 2020 and March 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_d62e2c61-e706-408a-a88f-a949abe06f82_terseLabel_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes due February 16, 2028</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_label_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028 [Member]</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_documentation_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member" xlink:href="mck-20200930.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A395NotesDueFebruary162028Member" xlink:to="lab_mck_A395NotesDueFebruary162028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8719d506-0eb8-40d3-ae07-757b6942c5bc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_042c0d1b-ad31-4f7a-a5fe-16b19fcda3b2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_bf8d104a-6738-41c5-bea4-87717e853d51_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e1a91b5d-57d0-4cd4-94c0-75b8c7be0924_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_c2c2b253-9e66-4f97-8753-b9c7f6c6bec1_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_6b4d80d3-6d77-4a05-bacd-7e2cfceb07a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Restricted cash at end of period included in Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_7bc11ffc-693b-4c7d-a4b5-1d8ab4ccaa94_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_cc5b158e-f338-4de1-9168-11906c2ba91c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_75d7a9cd-55bd-4962-a8b0-da75ee5742d8_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_05456560-57c0-4444-9ad8-c542e6e30e14_terseLabel_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory damages sought per violation</link:label>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_label_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought Per Violation, Value</link:label>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_documentation_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought Per Violation, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:href="mck-20200930.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:to="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_e1b336c7-16b3-42c7-8564-0f1e63ee58dc_terseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_dcda2906-f407-4f3d-8a5f-912faf6552d4_verboseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associated increase in Company's ownership interest on its equity</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_label_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:href="mck-20200930.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:to="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_4d0f0a68-1d66-4f48-96a5-756c9fafa63e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected total pre-tax charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_6dbfc9d9-3852-430e-9f4d-c0f2ff7d1b2b_terseLabel_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes due November 17, 2025</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_label_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025 [Member]</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_documentation_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member" xlink:href="mck-20200930.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A150EuroNotesDueNovember172025Member" xlink:to="lab_mck_A150EuroNotesDueNovember172025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_dc8d29f0-a571-45c0-a5a8-af22e8b314e3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_8591b838-3413-4e9b-9244-7eda11146e84_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_ba935a56-fee6-4b05-bcba-3f67f0907b1f_terseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial gain (losses) attributable to redeemable noncontrolling interest</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:href="mck-20200930.xsd#mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:to="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_944cfba0-5758-4c50-9b1f-a7e2d0e4dfad_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_8796f60e-8750-4c2f-95d6-4ff29d37f0c0_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Facility</link:label>
    <link:label id="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Revolving Credit Facility (Global Facility) [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Revolving Credit Facility (Global Facility) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" xlink:href="mck-20200930.xsd#mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" xlink:to="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_b763c5fa-0ef3-4cdb-a440-a2227762a5d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_2ca13753-58be-4060-813c-baaa182f8004_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_d48c7d5b-2fbf-474e-b0fe-9749bf2152e2_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_b7dbf5a8-684d-4414-8fa9-5ba38d18635a_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6595ccec-9bfa-472b-8427-71346a8531cf_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_24024835-5abc-458b-9645-5060eba4e339_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e6de56bc-a4e4-47ef-ade4-89c273286034_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_d1b4919f-fdca-4cf4-aacf-5aded4d9e7c5_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6640e657-1516-44e4-a8d9-18164ae96d02_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c05c239c-1924-48a3-9969-c0ad51df48e6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_5902cce8-e4ae-4a1d-94e6-c8940dcd9624_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_d46f0ec0-3d8b-4bd9-adc2-c6bcf084b873_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireSoftware" xlink:to="lab_us-gaap_PaymentsToAcquireSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_731a2a3c-9e75-4733-a9a9-808cac4610c8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_0de23d74-9eef-4509-993a-00f890573369_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_c7617ce7-97b5-4136-ad7d-04717c0f10f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_cbfa601f-f8e7-4e5c-868d-abb470c176b7_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which award would be payable under proposed framework</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_label_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:href="mck-20200930.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:to="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e73989a5-db60-42a9-bf30-5a8046a0b85c_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_2c40a5b5-5a54-4a2b-9ac3-3749a1004197_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_964cc5a2-0f12-4479-b2bf-8993a86f25b6_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total McKesson Corporation stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1caf037d-b16c-4ba6-97a0-672cb727a63d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_4f702431-daa1-4c5a-b07a-f92772c02848_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0230e4bc-42af-49e1-a6a8-5dd6742b1c7d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1030b3e5-a3d4-44fd-8db5-1e5caebba161_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, redeemable noncontrolling interests, and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_9dc00256-515b-47a0-9d8a-3f766589d51c_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember" xlink:href="mck-20200930.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestMember" xlink:to="lab_mck_RedeemableNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_710a0d66-a30c-48aa-b2f2-347f30f0bbc9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_0fb7fd7a-73b0-497a-a033-52440731294d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9a818e0e-1267-45d4-9131-788d45375d7b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_becf68f6-70d4-4db0-9251-bcd58374c305_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (loss) on cash flow hedges arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_102a3c56-1308-4c8c-98b0-48dd86d6d7ce_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_2233808b-3f58-455d-a679-23435e569442_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes due March 1, 2021</link:label>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_label_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member" xlink:href="mck-20200930.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMarch12021Member" xlink:to="lab_mck_A475NotesDueMarch12021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_76bc5978-1448-4464-8ace-876966cd26fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanSettlementPlanParticipants_5b7de7fb-d587-4549-abe3-8e0cf7747535_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of participants elected to receive settlement</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanSettlementPlanParticipants_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Settlement, Plan Participants</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanSettlementPlanParticipants_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Settlement, Plan Participants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:href="mck-20200930.xsd#mck_DefinedBenefitPlanSettlementPlanParticipants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:to="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_4f04e84f-6da7-45c8-a337-475bbabd05c2_terseLabel_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business</link:label>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_label_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business [Member]</link:label>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_documentation_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember" xlink:href="mck-20200930.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GermanWholesaleBusinessMember" xlink:to="lab_mck_GermanWholesaleBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_82defa05-e770-4f0e-b1cf-daa4b626b6b7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_b92d9239-fae8-4560-8bd0-0a58df5fb235_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_e1a93b58-68df-49a6-985a-d1076c688203_terseLabel_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:href="mck-20200930.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:to="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_2285f450-12e1-4f9e-ba35-03c16ae69cb1_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_7c40b234-5d74-490e-8500-4a7075322340_verboseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_245eb846-37ab-4450-9327-e478d80b93a3_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_d7dc0434-eeea-4708-b088-b25366d72ebb_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4979fa6f-cead-462e-8d5d-bf458b76c9df_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_4a62616d-7f12-41a9-ae4f-1b4d3d285d48_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss and prior service cost arising during the period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_406a2113-c166-4a70-9350-4abe492ce9ed_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofRelatorsAllegingViolations_7cee3668-1cae-430c-b824-2e2d47d54a0d_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofRelatorsAllegingViolations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of relators alleging violations</link:label>
    <link:label id="lab_mck_LossContingencyNumberofRelatorsAllegingViolations_label_en-US" xlink:label="lab_mck_LossContingencyNumberofRelatorsAllegingViolations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Relators Alleging Violations</link:label>
    <link:label id="lab_mck_LossContingencyNumberofRelatorsAllegingViolations_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofRelatorsAllegingViolations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Relators Alleging Violations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofRelatorsAllegingViolations" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofRelatorsAllegingViolations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofRelatorsAllegingViolations" xlink:to="lab_mck_LossContingencyNumberofRelatorsAllegingViolations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_25ccf4d2-4022-4f7a-a965-e1159c0a4bf0_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_8b8377fc-0b4e-4bc3-8b7a-2bb4e59fea48_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_34f96c89-07ef-49e7-ab38-a031c461b526_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service agreements</link:label>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_label_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceAgreementsMember" xlink:to="lab_us-gaap_ServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_187594bd-c2ff-4408-bbe7-f590e482cf02_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_8ab2b863-5a5a-410f-9a04-f21db5cca546_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_ea740f10-1a14-4eae-9863-3af249974488_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_6acaf6de-35fe-42c3-97bb-80a176e60d35_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_fdf8066c-09ac-48f5-b3cc-d6c78c396935_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_9ad46f84-bd90-45fe-ab8c-295df2f4daae_terseLabel_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments and accelerated depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_label_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_documentation_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:href="mck-20200930.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:to="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_95f3bb03-d840-4c65-bb30-0d134e92e276_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_cbb89379-2f31-4a37-807d-b024b66c163c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_a53ead62-3f7f-4484-8943-56f20056015b_terseLabel_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:href="mck-20200930.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:to="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_d24e7b19-bd0d-4584-9335-f9e29520ce76_terseLabel_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other/Other accrued liabilities</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_label_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_documentation_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember" xlink:href="mck-20200930.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CurrentAssetLiabilityMember" xlink:to="lab_mck_CurrentAssetLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_ca8d57e8-6063-4c2e-b122-dc292be44036_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_58caaa29-73a5-4bc0-832e-c274d5271f0a_terseLabel_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue derived from services, percentage (less than)</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_label_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_documentation_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage" xlink:href="mck-20200930.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RevenueDerivedFromServicesPercentage" xlink:to="lab_mck_RevenueDerivedFromServicesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_ba458498-8073-4a78-a888-f9c4cf6cda5a_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_df65ba0e-1a2d-4cfa-a97a-19bd7bc994f4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_c20a2cfa-351d-4ce9-8308-75fdc454f92c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_93eebf60-a27d-45e8-a45c-f2550bed19c2_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_c317548c-4fe2-45f4-95be-7ebe486eb3af_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3db267a0-3db0-4ffe-a098-e7c5d27bf7ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_2430204c-e3af-4a22-b3cd-e56e9071f42b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_0dbb1f04-152b-40e8-ada8-5d23222cdc40_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net restructuring, impairment and related charges recognized</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_ffda5736-3eca-41d2-b90a-8422cb947ee7_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_01c2f12a-bcc8-4f70-87ed-64af66f53348_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_93a9f2aa-cafe-4fb0-bb25-ffff5adbb121_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and other obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9468902e-4aaa-457d-b7f7-ce5ecc6f0722_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1625NotesDue2026Member_89a83b29-7fec-42cd-9afa-144a9a2375d1_terseLabel_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026</link:label>
    <link:label id="lab_mck_A1625NotesDue2026Member_label_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026 [Member]</link:label>
    <link:label id="lab_mck_A1625NotesDue2026Member_documentation_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member" xlink:href="mck-20200930.xsd#mck_A1625NotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1625NotesDue2026Member" xlink:to="lab_mck_A1625NotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_35424354-16a5-4f16-8f97-337f37a7a20d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_48058438-44fe-46a4-868f-9d88b4c9f5fc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_fb7d69d5-871b-458b-b4b5-7962216283ae_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b2644dd7-7b2f-4cc4-b61e-dc0e6d43c494_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_bf1e32c4-8658-400e-831f-a0899c7b9a55_terseLabel_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 cross currency swaps</link:label>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_label_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps [Member]</link:label>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_documentation_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember" xlink:href="mck-20200930.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_November2018CrossCurrencySwapsMember" xlink:to="lab_mck_November2018CrossCurrencySwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_9666f5c8-cbfd-49f2-b30e-73286f31305b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid-related settlement charges</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpenMarketShareRepurchaseTransactionsMember_e0a72262-807d-4c0b-8bb0-de9781dfd351_terseLabel_en-US" xlink:label="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Share Repurchase Transactions</link:label>
    <link:label id="lab_mck_OpenMarketShareRepurchaseTransactionsMember_label_en-US" xlink:label="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Share Repurchase Transactions [Member]</link:label>
    <link:label id="lab_mck_OpenMarketShareRepurchaseTransactionsMember_documentation_en-US" xlink:label="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Share Repurchase Transactions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:href="mck-20200930.xsd#mck_OpenMarketShareRepurchaseTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:to="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_408602ae-2b89-4f49-bdef-cb640d45fdb8_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_378fcf26-ccbd-4afd-9d0d-007ea6488a80_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_bdeb4719-8691-4368-be74-7bbc5b6db6d4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash contributions to the plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_d57661a5-ec39-43fc-8099-3d909d84a383_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax charges recorded to-date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_7f8ea2b3-1a74-49f9-861d-65de0883ae24_negatedTerseLabel_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_label_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Other Related Charges</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_documentation_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Other Related Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:href="mck-20200930.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:to="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_38539b89-cee9-4466-9e61-9da27920ad02_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_bace4fec-8f59-4c41-babf-dbffffb30c2a_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture</link:label>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_label_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateJointVentureMember" xlink:to="lab_us-gaap_CorporateJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_9c1812c7-1adf-4394-99a1-71f3e7398552_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_2a94271c-2255-45be-9b60-561c1b83aaba_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_44722721-ef50-453b-bedf-cddbc8aa5ba8_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of faxes remaining in the class</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_label_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Remaining in the Class</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_documentation_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Remaining in the Class</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:href="mck-20200930.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:to="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_b1f3602b-bcbb-4284-81be-ce281435f2f7_terseLabel_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, thereafter</link:label>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="mck-20200930.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_8508da31-7e77-4db1-9800-40de945b2826_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_461a2d57-72e4-401c-a1e3-2f4be55e4f15_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyAccrualAfterTax_e46784d3-d93d-4969-925f-b8a3bb3af2c7_terseLabel_en-US" xlink:label="lab_mck_LossContingencyAccrualAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax accrual</link:label>
    <link:label id="lab_mck_LossContingencyAccrualAfterTax_label_en-US" xlink:label="lab_mck_LossContingencyAccrualAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, After Tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualAfterTax_documentation_en-US" xlink:label="lab_mck_LossContingencyAccrualAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualAfterTax" xlink:href="mck-20200930.xsd#mck_LossContingencyAccrualAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyAccrualAfterTax" xlink:to="lab_mck_LossContingencyAccrualAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_b7302c22-d0cc-4511-910f-237041264d86_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_1f5a44a5-a49f-49a7-a3c2-c2e98cf8412f_verboseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in net investment hedge, gains (loss) gross</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_8eb22e0b-7a38-41e2-9794-90a8db717356_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9b6f4b80-4e9f-4dd9-801a-969f7425c174_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_69060252-a9c3-4581-9f1b-41419be0e0f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on debt instrument (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_837a1752-3eae-454e-bb1e-0463d8a725b1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_eb19731b-1c2c-4a5c-a335-9e9e328c2503_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_56c1db90-236e-4a81-aa7b-eed4241609d0_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ff7ec282-6083-4cc9-a967-805ce9cb6889_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_d1be637d-e37d-4a22-8f3a-1279dda569f9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_6637c732-fb74-4581-8a9a-4cc65702cb1d_terseLabel_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Joint Venture</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_label_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Joint Venture [Member]</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_documentation_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:href="mck-20200930.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:to="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_befd5d2a-817d-4776-a2be-5d2fe38e0602_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_814c4792-a296-4301-9a05-fe1c5ebdeecb_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_0e8eb407-42d8-4cda-971a-0f2a1bf5feb9_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternationalSegmentMember_14e0f7af-14ff-487f-9945-035cb40478aa_terseLabel_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_label_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_documentation_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternationalSegmentMember" xlink:to="lab_mck_InternationalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_00c8b941-80ed-4ff2-a0e3-a7bf82f56647_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_ab17dabc-c130-43a6-9ade-58123f6dd076_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_5e8683a1-7331-4d19-a01d-91365862b86e_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3f1e7a0f-bb16-4666-9a12-777a521e9f22_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21a75851-421f-4d82-9429-1d54a03b6c5e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_9155247c-08a7-467c-a7db-de9a2d0bc1ee_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains on Net Investment Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_f24af496-641d-4a43-9d2f-5c8a02c79e43_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_ee1cd9c9-0ca4-42be-b047-9ef8129f525c_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_6a7cf3ce-0b7e-4f57-aa37-92b73744195b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_6e839e1c-1160-4b64-b67e-790cc91061fd_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_0eeb61e7-83fc-448f-9785-70212a1a33e2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest (percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_d8bc31be-4fc1-4cca-99e2-4a2a333c40b8_terseLabel_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_label_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_documentation_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember" xlink:href="mck-20200930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_USPharmaceuticalSegmentMember" xlink:to="lab_mck_USPharmaceuticalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_e8f6a2ad-4e73-4d9c-83f4-d5090e907223_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax dilution loss</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:to="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6868cd11-d276-41df-a997-651167375426_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57d1741c-8c96-45e7-b6fe-3912bc26da9b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5699c2e3-fc62-467a-8523-bb5959be27cf_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c7fc99ce-1b53-4111-9cbd-907fdccf7cdc_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative-effect adjustment to beginning retained earnings</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_630a908c-29d6-4d80-a8f6-e15bf174af0a_terseLabel_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes due February 17, 2029</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_label_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029 [Member]</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_documentation_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:href="mck-20200930.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:to="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_f4cb2ffd-790f-400b-8056-8f7888609269_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_d9963b6e-726a-436d-8ac5-b005350b2c34_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_708f623a-e352-467e-bf80-b1a182caf3e6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_4134ff28-c63e-46ba-8238-d4bc226a3898_terseLabel_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_label_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters [Member]</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_documentation_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan Relocation of Corporate Headquarters [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:href="mck-20200930.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:to="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_760cbac1-c530-4446-9d79-18f9c31ae4d2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_06a519bb-2d39-4317-bf1e-4ce846642a6c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ac834321-96fa-4d1b-ae9f-7326a38a9b7b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) related to continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f7263490-5926-4c8c-9928-8e5a713341e4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0163b784-5cd6-41e0-9563-efc4e4bbb9d3_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cb8accf5-140a-45ad-9b7d-da6e9b67e497_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_ee95901c-302f-4ee2-85d0-bec236102a4b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_c3e9b292-7821-464c-b137-10f8ac3a1a5c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6462069f-384a-4a59-a3e3-62da1d5a34f5_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0537f41e-f0f7-4f56-a7f4-44f47d68db2f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_639920ed-ebea-46a3-a30e-d3b6ceebb513_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesExRelKelley19Cv2233Member_a456b947-4296-4241-afdb-23cb5032f5a9_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesExRelKelley19Cv2233Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Kelley, 19-cv-2233</link:label>
    <link:label id="lab_mck_UnitedStatesExRelKelley19Cv2233Member_label_en-US" xlink:label="lab_mck_UnitedStatesExRelKelley19Cv2233Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Kelley, 19-cv-2233 [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesExRelKelley19Cv2233Member_documentation_en-US" xlink:label="lab_mck_UnitedStatesExRelKelley19Cv2233Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Kelley, 19-cv-2233</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelKelley19Cv2233Member" xlink:href="mck-20200930.xsd#mck_UnitedStatesExRelKelley19Cv2233Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesExRelKelley19Cv2233Member" xlink:to="lab_mck_UnitedStatesExRelKelley19Cv2233Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_a56faf00-aa6a-4c9e-9f94-0e9e3205d1fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_0dd3f366-5368-49b1-8087-da426c8d6d37_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_8830ba41-36ad-4aee-8511-7a96f3a2259f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_cfacda7c-3a44-4f49-aeed-e1fe06c92262_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_3afe5e0d-4335-4282-91dc-e79977bf4a25_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_3aa4842c-d043-49f4-8f3b-5a0192a70413_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_aeb0bb95-5f28-4388-aeaa-956e7d104c5e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge in connection with State of New York's Opioid Stewardship Act</link:label>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_label_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyLossInPeriod" xlink:to="lab_us-gaap_LossContingencyLossInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_6c66b90d-1110-47b0-9029-5d7e560a2604_terseLabel_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes due December 15, 2022</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_label_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022 [Member]</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_documentation_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member" xlink:href="mck-20200930.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A270NotesDueDecember152022Member" xlink:to="lab_mck_A270NotesDueDecember152022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_75e11e22-689e-45c8-942e-6dd84684af76_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated senior unsecured revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ca1182ea-d005-4cab-9dd1-0854022aad61_netLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding notes (up to)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0b16c1e9-f2e2-48da-973d-ba0293289a72_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b3122172-fbff-4758-b5de-5052d93bd5c3_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_dc0b032c-a4ee-46e7-b674-fdaad2683011_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromOtherEquity_4366f5eb-5999-4af2-a49b-f99160e80dd8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from concurrent offering of other securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromOtherEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Other Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherEquity" xlink:to="lab_us-gaap_ProceedsFromOtherEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_5889c5c8-9525-460e-8850-f2fc0dee3e65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7e5de210-c955-404a-bd4c-84d3778f6c04_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_8f8c5553-fa45-4682-89f8-b85cf3724533_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_d6f9b18e-ffd7-41fc-bfd2-5e95f4c82bed_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_b06b3df5-a12b-4bd6-b259-e8e4b4e262e9_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_b8d6c29c-ff26-4da1-bf25-2c76c8b2cfe5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_d77e920f-60b0-427c-98b0-732c193d3b07_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_85653731-1696-4b16-872c-a4e159127e3f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_344f3d49-1547-4b7c-8332-8e9220a156cb_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of commercial paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_60d8a2b1-eb0c-451d-a97b-8550f5498497_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f2f1f920-e0fd-469e-b36d-debe4ed2bf71_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported income tax rates (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_28fe893a-93ec-4af6-9f95-4e09656e3ef9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_8241ee5e-51f9-4542-b4c8-b11593617900_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_17638e74-1792-4d74-8137-9bbb360dd877_terseLabel_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes due August 17, 2021</link:label>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_label_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021 [Member]</link:label>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_documentation_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member" xlink:href="mck-20200930.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A063EuroNotesDueAugust172021Member" xlink:to="lab_mck_A063EuroNotesDueAugust172021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_26f1e0d6-25b3-4864-a7f8-cfbedc76561f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_b7b037c7-2f45-43c0-bc7c-ad199bb7e05d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_d0c8172e-f7fc-420d-81bc-62333f45f5b3_terseLabel_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes due March 15, 2023</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_label_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023 [Member]</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_documentation_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member" xlink:href="mck-20200930.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A285NotesDueMarch152023Member" xlink:to="lab_mck_A285NotesDueMarch152023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9ebfae3a-04f7-4264-9f6e-aba7d904c121_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f60a8bbb-fec0-4f4f-8c44-5b554c5b7bbb_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_c2bbfc4b-f510-41b1-84ac-f4453463bd14_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_f4288191-43b6-4034-b24c-ee49f18cd2bd_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e6f857b1-7403-4845-b3d5-fc2de4e5bd85_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_8de7c73e-6857-42d6-bff6-5d995edaef6b_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares, at cost, 112 and 110 shares at September 30, 2020 and March 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_44d3f9c5-1020-42a9-be4d-efc7d14ee7a0_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_4d4624d4-b30e-47a2-a582-d01586e54a19_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_af0ec650-dc70-48cf-8cea-c10dd1894d4e_terseLabel_en-US" xlink:label="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of companies in which equity securities were converted into public common stock</link:label>
    <link:label id="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_label_en-US" xlink:label="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, Equity Security Investments Converted Into Public Common Stock, Number of Companies</link:label>
    <link:label id="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_documentation_en-US" xlink:label="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, Equity Security Investments Converted Into Public Common Stock, Number of Companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" xlink:href="mck-20200930.xsd#mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" xlink:to="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_eda3b2e8-15cb-42b3-8997-a7ad862b1f7b_terseLabel_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right value, interest rate spread (as a percent)</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_label_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_documentation_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread" xlink:href="mck-20200930.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PutRightValueInterestRateSpread" xlink:to="lab_mck_PutRightValueInterestRateSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_b178e82a-55dc-4d08-a177-4c5cc18dbfc1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_8949ae53-25ec-48ef-adf4-66c78b7deaa4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_e807c106-49bd-4e8b-9e48-2317fd417180_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_633a455b-1a62-4504-9c06-6a044d8d3e8b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_b0c79c07-e2a5-4b11-9601-bc22517068f2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits associated with last-in, first-out inventory method</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_6cd7e56d-da20-4df7-9793-aac31af6fd65_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax credits related to LIFO accounting</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve, Period Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuroDenominatedNotesMember_6de39a92-cd69-4ed5-ac87-2a2f95613db6_terseLabel_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_label_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember" xlink:href="mck-20200930.xsd#mck_EuroDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuroDenominatedNotesMember" xlink:to="lab_mck_EuroDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_c085833e-6201-4334-bc62-c70480fa08c7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_cb49d60c-0033-4a34-8a5e-3d14c2e05fec_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_7496ec3d-0e2b-4b27-a90c-47696bd2b602_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of businesses and investments, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses and Interests in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_dca20965-d5dc-469e-baf8-6c61b25ce29e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_cae68860-b8cf-4658-9c66-84e75952b07f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>mck-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:f15aa9b5-be6e-4b9d-af45-f9d5f89227d0,g:ffd6c493-ffba-42d6-bea4-20131f0e9c42-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20200930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1e7e8475-fa0b-4d08-a0c1-edcfe278d1bc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_4fddfdf5-82cd-4435-94e6-366b1ef09949" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1e7e8475-fa0b-4d08-a0c1-edcfe278d1bc" xlink:to="loc_dei_EntitiesTable_4fddfdf5-82cd-4435-94e6-366b1ef09949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3f2f5130-84ec-45bf-bd67-3d961732bf2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_4fddfdf5-82cd-4435-94e6-366b1ef09949" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3f2f5130-84ec-45bf-bd67-3d961732bf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3f2f5130-84ec-45bf-bd67-3d961732bf2e" xlink:to="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cb5b5a52-2adb-4846-8bfd-fdf3ce53c18c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:to="loc_us-gaap_CommonStockMember_cb5b5a52-2adb-4846-8bfd-fdf3ce53c18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A0625NotesDue2021Member_72a0a9d9-c47f-468e-a0b1-9a22ec27d004" xlink:href="mck-20200930.xsd#mck_A0625NotesDue2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:to="loc_mck_A0625NotesDue2021Member_72a0a9d9-c47f-468e-a0b1-9a22ec27d004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member_a1af8091-5b6e-44df-a435-a37366314133" xlink:href="mck-20200930.xsd#mck_A1500NotesDue2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:to="loc_mck_A1500NotesDue2025Member_a1af8091-5b6e-44df-a435-a37366314133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member_2bc8ab0f-3070-43b1-98b4-033dbd7b7fbb" xlink:href="mck-20200930.xsd#mck_A1625NotesDue2026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:to="loc_mck_A1625NotesDue2026Member_2bc8ab0f-3070-43b1-98b4-033dbd7b7fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member_5775cb45-5eec-42ec-a0b3-b792b8eff4c6" xlink:href="mck-20200930.xsd#mck_A3125NotesDue2029Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_30aeaa08-61ff-49c9-afd9-a199638486c4" xlink:to="loc_mck_A3125NotesDue2029Member_5775cb45-5eec-42ec-a0b3-b792b8eff4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_4fddfdf5-82cd-4435-94e6-366b1ef09949" xlink:to="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ea058087-e432-44a0-a994-c4efded0ddb7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_DocumentType_ea058087-e432-44a0-a994-c4efded0ddb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_d8fbd4d2-5007-4dc3-ae49-bb22c919c741" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_DocumentQuarterlyReport_d8fbd4d2-5007-4dc3-ae49-bb22c919c741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_df4613b4-3a8e-4169-8951-e07b8c583230" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_DocumentPeriodEndDate_df4613b4-3a8e-4169-8951-e07b8c583230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_3d0e19f2-1b24-4c5f-aeb9-f434b9c6f457" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_DocumentTransitionReport_3d0e19f2-1b24-4c5f-aeb9-f434b9c6f457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_44cf9eb8-d3ba-4947-ae31-0668935eb721" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityFileNumber_44cf9eb8-d3ba-4947-ae31-0668935eb721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d6b5ab29-102f-45b9-8484-df603d9604a1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityRegistrantName_d6b5ab29-102f-45b9-8484-df603d9604a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8500a1b3-fda6-46cc-af4e-2627bb27c771" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8500a1b3-fda6-46cc-af4e-2627bb27c771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7c2a34d6-7a43-4240-b838-17bf3c6becc5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityTaxIdentificationNumber_7c2a34d6-7a43-4240-b838-17bf3c6becc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_19e6b13b-c7d0-490f-8b44-009decb6ef47" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityAddressAddressLine1_19e6b13b-c7d0-490f-8b44-009decb6ef47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_05ef4c72-333c-45b4-81fc-fdd5cea4e71d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityAddressCityOrTown_05ef4c72-333c-45b4-81fc-fdd5cea4e71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4c36c5ce-3a44-4cb0-8053-21babd827e08" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityAddressStateOrProvince_4c36c5ce-3a44-4cb0-8053-21babd827e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2bce3a31-5f14-4c82-8a97-eaddbab33d4e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityAddressPostalZipCode_2bce3a31-5f14-4c82-8a97-eaddbab33d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9dd7203e-b4e5-4662-9dac-6ef0f442ddf8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_CityAreaCode_9dd7203e-b4e5-4662-9dac-6ef0f442ddf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_99af8740-0d6e-46fa-bf2b-20ed4bb31047" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_LocalPhoneNumber_99af8740-0d6e-46fa-bf2b-20ed4bb31047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ed15f31d-d17e-493a-8f73-357bfe9da91d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_Security12bTitle_ed15f31d-d17e-493a-8f73-357bfe9da91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d0400c1e-b75f-42a3-bccc-54a11df556c0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_TradingSymbol_d0400c1e-b75f-42a3-bccc-54a11df556c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6e547e72-3772-4a86-93bf-b930047294f0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_SecurityExchangeName_6e547e72-3772-4a86-93bf-b930047294f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7a66bb3e-95b7-418b-b724-db2238953392" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityCurrentReportingStatus_7a66bb3e-95b7-418b-b724-db2238953392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_a688e0cd-8fdc-4d8d-9a28-7fb6c943b6d3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityInteractiveDataCurrent_a688e0cd-8fdc-4d8d-9a28-7fb6c943b6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_ef5c9fe3-3fe4-48ad-a864-b63633423d20" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityFilerCategory_ef5c9fe3-3fe4-48ad-a864-b63633423d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_5c283f3d-12bc-44ef-b39c-0f5006209a9f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntitySmallBusiness_5c283f3d-12bc-44ef-b39c-0f5006209a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_58dc0425-49c8-4536-ba54-06574a4b4091" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityEmergingGrowthCompany_58dc0425-49c8-4536-ba54-06574a4b4091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_cb9b6d3e-8500-4cfa-ac28-e0bc8355ee21" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityShellCompany_cb9b6d3e-8500-4cfa-ac28-e0bc8355ee21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_aaaade02-1d64-44c4-9130-ce2bfdc18166" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_aaaade02-1d64-44c4-9130-ce2bfdc18166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_364d5199-2d4a-4d66-88e5-23fb9ec9c91a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_EntityCentralIndexKey_364d5199-2d4a-4d66-88e5-23fb9ec9c91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7118eaf4-c67c-421c-aa99-1df0bdb504c0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_DocumentFiscalYearFocus_7118eaf4-c67c-421c-aa99-1df0bdb504c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7d7bd68b-c373-4962-8d83-a858792610e1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7d7bd68b-c373-4962-8d83-a858792610e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_94f88ecd-10fb-413f-8626-fef6090ec651" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_AmendmentFlag_94f88ecd-10fb-413f-8626-fef6090ec651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f7a54a51-1c85-4c1c-867e-0411896738f5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f2515211-1cde-4464-b477-5269ad09bd53" xlink:to="loc_dei_CurrentFiscalYearEndDate_f7a54a51-1c85-4c1c-867e-0411896738f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e9b6f14-377f-4593-932c-b260b917ac32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e9b6f14-377f-4593-932c-b260b917ac32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ac41a4b3-ca33-4418-83fb-7fe3193751bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ac41a4b3-ca33-4418-83fb-7fe3193751bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_991d1daa-18c8-44d7-91c2-d127c18ad51d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_GrossProfit_991d1daa-18c8-44d7-91c2-d127c18ad51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_88d8bbd1-41b2-428e-8ab2-d61c7089278b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_88d8bbd1-41b2-428e-8ab2-d61c7089278b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_09689bc4-2828-4b92-bed1-77622fc38ce6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_09689bc4-2828-4b92-bed1-77622fc38ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_26c96ecd-d514-41d2-90d4-d15cafe5b69b" xlink:href="mck-20200930.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_26c96ecd-d514-41d2-90d4-d15cafe5b69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_832c7c25-1d85-4d14-88a4-4bb32392e72a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_OperatingExpenses_832c7c25-1d85-4d14-88a4-4bb32392e72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ff656ebd-c05d-4b0f-a772-29200f39887f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_OperatingIncomeLoss_ff656ebd-c05d-4b0f-a772-29200f39887f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5c4a04b5-dc34-466a-89da-6aeea8a0ccdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5c4a04b5-dc34-466a-89da-6aeea8a0ccdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_973b1b9d-b1bb-484a-91b8-75a5445fe87c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_973b1b9d-b1bb-484a-91b8-75a5445fe87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_67c1ab2b-be6f-454f-a989-34e4ab2c9921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_InterestAndDebtExpense_67c1ab2b-be6f-454f-a989-34e4ab2c9921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_91fddd95-52a7-40c5-aa3d-f229edac0b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_91fddd95-52a7-40c5-aa3d-f229edac0b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_daab3ca6-51b5-43a0-a573-58b990aeb616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_daab3ca6-51b5-43a0-a573-58b990aeb616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_8500d076-59c1-4979-811b-ed11d8c75955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_8500d076-59c1-4979-811b-ed11d8c75955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_37121e7d-f31b-413d-9c74-ec67cb1a23ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_37121e7d-f31b-413d-9c74-ec67cb1a23ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9f7e81f8-2664-43e8-af7e-c6c1b33e8661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_ProfitLoss_9f7e81f8-2664-43e8-af7e-c6c1b33e8661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_14aca203-19bb-4f7d-891b-e46c4b4f1848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_14aca203-19bb-4f7d-891b-e46c4b4f1848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_da18560a-f2da-4132-8f27-1ef729340890" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_NetIncomeLoss_da18560a-f2da-4132-8f27-1ef729340890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_067a8472-d0e2-440f-81ac-9f9eae46e558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_EarningsPerShareAbstract_067a8472-d0e2-440f-81ac-9f9eae46e558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_dee2685f-8d96-40b9-be11-944035dfcde2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_067a8472-d0e2-440f-81ac-9f9eae46e558" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_dee2685f-8d96-40b9-be11-944035dfcde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_bfc61672-6874-478b-abfc-2fd603bcb4b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_dee2685f-8d96-40b9-be11-944035dfcde2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_bfc61672-6874-478b-abfc-2fd603bcb4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_3acb3e6a-2ba2-4337-8cb0-f9e11374a723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_dee2685f-8d96-40b9-be11-944035dfcde2" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_3acb3e6a-2ba2-4337-8cb0-f9e11374a723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b1cf6bc6-e2b8-497c-8f7d-969311e289cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_dee2685f-8d96-40b9-be11-944035dfcde2" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b1cf6bc6-e2b8-497c-8f7d-969311e289cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_da92889b-a39e-4b07-aaa1-685f2d6b2aca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_067a8472-d0e2-440f-81ac-9f9eae46e558" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_da92889b-a39e-4b07-aaa1-685f2d6b2aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_373da984-e02b-4373-be1b-09640acc1482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_da92889b-a39e-4b07-aaa1-685f2d6b2aca" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_373da984-e02b-4373-be1b-09640acc1482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_bbf67e56-94a5-4040-996d-478e2854b016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_da92889b-a39e-4b07-aaa1-685f2d6b2aca" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_bbf67e56-94a5-4040-996d-478e2854b016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_80fb499f-6bc3-4d6b-9cda-d62cc847cc33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_da92889b-a39e-4b07-aaa1-685f2d6b2aca" xlink:to="loc_us-gaap_EarningsPerShareBasic_80fb499f-6bc3-4d6b-9cda-d62cc847cc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f9081eb3-1014-4050-ab9f-5e6a7bf2d4f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8aa70531-d012-4edd-b083-faeeae666cc9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f9081eb3-1014-4050-ab9f-5e6a7bf2d4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8b197e28-24a5-4e85-9e3c-0ec9caada675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f9081eb3-1014-4050-ab9f-5e6a7bf2d4f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8b197e28-24a5-4e85-9e3c-0ec9caada675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5e69f4b5-a7f6-4c8b-9e74-bac70e966c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f9081eb3-1014-4050-ab9f-5e6a7bf2d4f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5e69f4b5-a7f6-4c8b-9e74-bac70e966c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dc1b9a97-fce4-47cb-998e-a0fda1cf83b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_93a23de6-bdea-4f2d-8937-1551c7a47c4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dc1b9a97-fce4-47cb-998e-a0fda1cf83b0" xlink:to="loc_us-gaap_ProfitLoss_93a23de6-bdea-4f2d-8937-1551c7a47c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_21cc3ee6-7fbb-4fa8-89ca-45add34bb0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dc1b9a97-fce4-47cb-998e-a0fda1cf83b0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_21cc3ee6-7fbb-4fa8-89ca-45add34bb0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f31110f0-b8e5-4044-97d6-5b3fd79e8af4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_21cc3ee6-7fbb-4fa8-89ca-45add34bb0f5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f31110f0-b8e5-4044-97d6-5b3fd79e8af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b7c2945f-c087-4ec6-aeb1-c50be1eb0fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_21cc3ee6-7fbb-4fa8-89ca-45add34bb0f5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b7c2945f-c087-4ec6-aeb1-c50be1eb0fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e5970494-6ec1-4a68-bc46-b9fd9497761e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_21cc3ee6-7fbb-4fa8-89ca-45add34bb0f5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e5970494-6ec1-4a68-bc46-b9fd9497761e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b0c563c7-765f-4d11-805f-33171505e5f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dc1b9a97-fce4-47cb-998e-a0fda1cf83b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b0c563c7-765f-4d11-805f-33171505e5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e0038f7f-58cc-4a9a-80d4-de88f9c5c3c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dc1b9a97-fce4-47cb-998e-a0fda1cf83b0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e0038f7f-58cc-4a9a-80d4-de88f9c5c3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_65e09fc4-c10c-4e8f-a80f-9e6fd26414a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dc1b9a97-fce4-47cb-998e-a0fda1cf83b0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_65e09fc4-c10c-4e8f-a80f-9e6fd26414a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_53f6bcf0-c360-4fcf-bc40-77e9e288ffe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dc1b9a97-fce4-47cb-998e-a0fda1cf83b0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_53f6bcf0-c360-4fcf-bc40-77e9e288ffe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4e84c1ab-7d66-459f-8645-0da04a75f301" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0f7b4106-6163-48d1-88bd-b85442d414ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e84c1ab-7d66-459f-8645-0da04a75f301" xlink:to="loc_us-gaap_AssetsAbstract_0f7b4106-6163-48d1-88bd-b85442d414ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_2dc5c419-64f5-40bd-83f6-a7b514de21bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f7b4106-6163-48d1-88bd-b85442d414ee" xlink:to="loc_us-gaap_AssetsCurrentAbstract_2dc5c419-64f5-40bd-83f6-a7b514de21bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0ab2431a-7cbc-4eb9-80d2-bc3dd22aca05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2dc5c419-64f5-40bd-83f6-a7b514de21bb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0ab2431a-7cbc-4eb9-80d2-bc3dd22aca05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_9dd0970c-d570-4a54-8a68-762334536647" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2dc5c419-64f5-40bd-83f6-a7b514de21bb" xlink:to="loc_us-gaap_ReceivablesNetCurrent_9dd0970c-d570-4a54-8a68-762334536647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_dc8ecd0d-c8c9-4d0c-bad7-8077ecf66382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2dc5c419-64f5-40bd-83f6-a7b514de21bb" xlink:to="loc_us-gaap_InventoryNet_dc8ecd0d-c8c9-4d0c-bad7-8077ecf66382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_68d1c42c-bf10-4d2e-b3c5-07a57966abed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2dc5c419-64f5-40bd-83f6-a7b514de21bb" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_68d1c42c-bf10-4d2e-b3c5-07a57966abed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cb6f7d2a-a0a1-4e67-8006-9c0d0a84f4d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2dc5c419-64f5-40bd-83f6-a7b514de21bb" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cb6f7d2a-a0a1-4e67-8006-9c0d0a84f4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a64c8816-7d00-4e9a-be3c-57edaaa67f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2dc5c419-64f5-40bd-83f6-a7b514de21bb" xlink:to="loc_us-gaap_AssetsCurrent_a64c8816-7d00-4e9a-be3c-57edaaa67f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_df2f9e5c-5672-48d9-8908-8ca2bbca26bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f7b4106-6163-48d1-88bd-b85442d414ee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_df2f9e5c-5672-48d9-8908-8ca2bbca26bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_902f955c-2d5c-4090-b14b-e78c6e58817b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f7b4106-6163-48d1-88bd-b85442d414ee" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_902f955c-2d5c-4090-b14b-e78c6e58817b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ebb62cbe-718d-46da-b038-1000323ee7b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f7b4106-6163-48d1-88bd-b85442d414ee" xlink:to="loc_us-gaap_Goodwill_ebb62cbe-718d-46da-b038-1000323ee7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b8a265a2-945f-4eb8-af6a-8d8276e94d19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f7b4106-6163-48d1-88bd-b85442d414ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b8a265a2-945f-4eb8-af6a-8d8276e94d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3d16f90f-6bb0-4ef5-837d-1919f768b179" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f7b4106-6163-48d1-88bd-b85442d414ee" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3d16f90f-6bb0-4ef5-837d-1919f768b179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_26385df0-90f6-4432-a27f-9f80494c5f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f7b4106-6163-48d1-88bd-b85442d414ee" xlink:to="loc_us-gaap_Assets_26385df0-90f6-4432-a27f-9f80494c5f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d4a3ccde-32e4-40a2-b70d-2f131596ed16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e84c1ab-7d66-459f-8645-0da04a75f301" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d4a3ccde-32e4-40a2-b70d-2f131596ed16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_aeecff1a-e0ab-485a-8c02-1038b5e2eff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d4a3ccde-32e4-40a2-b70d-2f131596ed16" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_aeecff1a-e0ab-485a-8c02-1038b5e2eff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f1fdb917-67bd-4f2e-ba1d-4d788c967763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aeecff1a-e0ab-485a-8c02-1038b5e2eff7" xlink:to="loc_us-gaap_AccountsPayableCurrent_f1fdb917-67bd-4f2e-ba1d-4d788c967763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_357ed44a-38c3-464a-af50-a13903c01ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aeecff1a-e0ab-485a-8c02-1038b5e2eff7" xlink:to="loc_us-gaap_LongTermDebtCurrent_357ed44a-38c3-464a-af50-a13903c01ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_00fb90eb-30a2-4668-b6a3-db71bd4c98c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aeecff1a-e0ab-485a-8c02-1038b5e2eff7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_00fb90eb-30a2-4668-b6a3-db71bd4c98c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_9a5295b4-8953-472b-8681-f82431f4af81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aeecff1a-e0ab-485a-8c02-1038b5e2eff7" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_9a5295b4-8953-472b-8681-f82431f4af81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f3e6a905-af54-479c-a82b-0a4053d28b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aeecff1a-e0ab-485a-8c02-1038b5e2eff7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f3e6a905-af54-479c-a82b-0a4053d28b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c7bb9367-30ca-4482-bfda-bc530c13f555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aeecff1a-e0ab-485a-8c02-1038b5e2eff7" xlink:to="loc_us-gaap_LiabilitiesCurrent_c7bb9367-30ca-4482-bfda-bc530c13f555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e0bd5016-38fc-4587-a869-869e35824c31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d4a3ccde-32e4-40a2-b70d-2f131596ed16" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e0bd5016-38fc-4587-a869-869e35824c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3816713c-ef73-4329-b28e-86b0c50ad7f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d4a3ccde-32e4-40a2-b70d-2f131596ed16" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3816713c-ef73-4329-b28e-86b0c50ad7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0a445c1e-afe2-4ad4-a2c6-c70775f8fce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d4a3ccde-32e4-40a2-b70d-2f131596ed16" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0a445c1e-afe2-4ad4-a2c6-c70775f8fce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_950dfbf6-2588-465f-bc77-5371a2d90ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d4a3ccde-32e4-40a2-b70d-2f131596ed16" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_950dfbf6-2588-465f-bc77-5371a2d90ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_fec71676-189d-417a-b1f8-d6fb39ec9138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d4a3ccde-32e4-40a2-b70d-2f131596ed16" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_fec71676-189d-417a-b1f8-d6fb39ec9138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_34506087-7c3b-4592-ba51-423d8c2ade9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d4a3ccde-32e4-40a2-b70d-2f131596ed16" xlink:to="loc_us-gaap_StockholdersEquityAbstract_34506087-7c3b-4592-ba51-423d8c2ade9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b6a77c12-8eeb-4bc5-b9f6-a98d50ac29a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_34506087-7c3b-4592-ba51-423d8c2ade9e" xlink:to="loc_us-gaap_PreferredStockValue_b6a77c12-8eeb-4bc5-b9f6-a98d50ac29a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_eb12afa3-329d-4860-8d48-5fb947e867ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_34506087-7c3b-4592-ba51-423d8c2ade9e" xlink:to="loc_us-gaap_CommonStockValue_eb12afa3-329d-4860-8d48-5fb947e867ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b20eeb37-2fd4-4513-ba42-4f9fd422feb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_34506087-7c3b-4592-ba51-423d8c2ade9e" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b20eeb37-2fd4-4513-ba42-4f9fd422feb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ff617748-3b95-49a4-95b5-6cb2c3476f95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_34506087-7c3b-4592-ba51-423d8c2ade9e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ff617748-3b95-49a4-95b5-6cb2c3476f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b23d3e88-2e8c-445f-abeb-7c91dea3d838" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_34506087-7c3b-4592-ba51-423d8c2ade9e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b23d3e88-2e8c-445f-abeb-7c91dea3d838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_51b28fdf-1c5c-4aec-952f-cbb1680964aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_34506087-7c3b-4592-ba51-423d8c2ade9e" xlink:to="loc_us-gaap_TreasuryStockValue_51b28fdf-1c5c-4aec-952f-cbb1680964aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1eeac421-a5ce-49bd-b617-fba19c81fccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_34506087-7c3b-4592-ba51-423d8c2ade9e" xlink:to="loc_us-gaap_StockholdersEquity_1eeac421-a5ce-49bd-b617-fba19c81fccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e69abceb-bb0c-4f95-8464-857f219829ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_34506087-7c3b-4592-ba51-423d8c2ade9e" xlink:to="loc_us-gaap_MinorityInterest_e69abceb-bb0c-4f95-8464-857f219829ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4dda20e7-980c-4d6a-997a-86d550101645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_34506087-7c3b-4592-ba51-423d8c2ade9e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4dda20e7-980c-4d6a-997a-86d550101645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_24f9b835-65ee-4f9f-9e4f-abbb2e2c4989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d4a3ccde-32e4-40a2-b70d-2f131596ed16" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_24f9b835-65ee-4f9f-9e4f-abbb2e2c4989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a2c9bacc-2baf-427d-9578-338f415a96be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_44e8e03e-20a0-44ab-9cde-5148a57bcf1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a2c9bacc-2baf-427d-9578-338f415a96be" xlink:to="loc_us-gaap_StockholdersEquityAbstract_44e8e03e-20a0-44ab-9cde-5148a57bcf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_fa6c97f2-a1c4-46dd-bc5e-13bb768b92f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44e8e03e-20a0-44ab-9cde-5148a57bcf1e" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_fa6c97f2-a1c4-46dd-bc5e-13bb768b92f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_14d763ff-f086-4c9c-b5c4-92f9205514bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44e8e03e-20a0-44ab-9cde-5148a57bcf1e" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_14d763ff-f086-4c9c-b5c4-92f9205514bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_2b33b4a2-0189-4482-a614-f93fcdb44705" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44e8e03e-20a0-44ab-9cde-5148a57bcf1e" xlink:to="loc_us-gaap_PreferredStockSharesIssued_2b33b4a2-0189-4482-a614-f93fcdb44705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_c30fe438-6b15-4b9c-9e94-dd6302a2c58f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44e8e03e-20a0-44ab-9cde-5148a57bcf1e" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_c30fe438-6b15-4b9c-9e94-dd6302a2c58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a53273b3-6e8e-438b-a919-47cbfb214992" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44e8e03e-20a0-44ab-9cde-5148a57bcf1e" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a53273b3-6e8e-438b-a919-47cbfb214992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_05492f3c-d27c-43bf-b0ba-52b9059bebe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44e8e03e-20a0-44ab-9cde-5148a57bcf1e" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_05492f3c-d27c-43bf-b0ba-52b9059bebe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7a2e17f2-2ddb-4ea2-8a8a-2d31727a2667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44e8e03e-20a0-44ab-9cde-5148a57bcf1e" xlink:to="loc_us-gaap_CommonStockSharesIssued_7a2e17f2-2ddb-4ea2-8a8a-2d31727a2667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_4dd9fd85-f665-467c-981c-c0c7852dc801" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44e8e03e-20a0-44ab-9cde-5148a57bcf1e" xlink:to="loc_us-gaap_TreasuryStockShares_4dd9fd85-f665-467c-981c-c0c7852dc801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_25117a69-ec57-4343-a524-ce8f40374280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ee35f64e-5cd0-442d-a222-d7bc8f243d3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_25117a69-ec57-4343-a524-ce8f40374280" xlink:to="loc_us-gaap_StatementTable_ee35f64e-5cd0-442d-a222-d7bc8f243d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2e9b75b5-2d8c-44c9-9f2c-9ca5ad51b0ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ee35f64e-5cd0-442d-a222-d7bc8f243d3d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2e9b75b5-2d8c-44c9-9f2c-9ca5ad51b0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_511deee2-24a1-4224-bb4c-7c88d3ddcc4a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2e9b75b5-2d8c-44c9-9f2c-9ca5ad51b0ec" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_511deee2-24a1-4224-bb4c-7c88d3ddcc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7f276ff5-12d7-4489-851a-ff8745297d05" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_511deee2-24a1-4224-bb4c-7c88d3ddcc4a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7f276ff5-12d7-4489-851a-ff8745297d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_49a6cee4-79d3-4107-b9c4-9283c7d37a89" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_511deee2-24a1-4224-bb4c-7c88d3ddcc4a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_49a6cee4-79d3-4107-b9c4-9283c7d37a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_12cb63ab-d587-43e3-9e16-4d47faea1bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ee35f64e-5cd0-442d-a222-d7bc8f243d3d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_12cb63ab-d587-43e3-9e16-4d47faea1bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_12cb63ab-d587-43e3-9e16-4d47faea1bde" xlink:to="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_311a1312-96e8-4c1c-a8f3-fa751fc1b5f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_CommonStockMember_311a1312-96e8-4c1c-a8f3-fa751fc1b5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2f174bde-c9f7-4471-b475-60409a38d638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2f174bde-c9f7-4471-b475-60409a38d638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAdditionalCapitalMember_73d104b1-5498-43c3-8a6a-6a36d8c23b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAdditionalCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_OtherAdditionalCapitalMember_73d104b1-5498-43c3-8a6a-6a36d8c23b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_841df994-5501-49d9-bbbd-7f0e2b6ab4b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_RetainedEarningsMember_841df994-5501-49d9-bbbd-7f0e2b6ab4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8b87f636-f300-4b3b-96cc-ef50d6e36f85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8b87f636-f300-4b3b-96cc-ef50d6e36f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_80340b57-5ecf-4ab0-91d4-574e111720aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_TreasuryStockMember_80340b57-5ecf-4ab0-91d4-574e111720aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6a6d4786-ffbf-4987-ad44-9257542841c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f360447d-0d3a-4a33-99a0-52aad608a481" xlink:to="loc_us-gaap_NoncontrollingInterestMember_6a6d4786-ffbf-4987-ad44-9257542841c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a24c6325-ac37-4cea-be96-5ac2a31e3325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ee35f64e-5cd0-442d-a222-d7bc8f243d3d" xlink:to="loc_us-gaap_StatementLineItems_a24c6325-ac37-4cea-be96-5ac2a31e3325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a24c6325-ac37-4cea-be96-5ac2a31e3325" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5fa7fd7a-695c-4d18-a458-e39641ae7471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_SharesOutstanding_5fa7fd7a-695c-4d18-a458-e39641ae7471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_c9d28486-03b3-4454-9b20-531a6d16ab8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_TreasuryStockShares_c9d28486-03b3-4454-9b20-531a6d16ab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5593bc32-611c-493c-bf74-31fca8c45dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5593bc32-611c-493c-bf74-31fca8c45dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e1675cfc-1cde-4e2c-87e7-35497d69aa19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e1675cfc-1cde-4e2c-87e7-35497d69aa19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c7066218-0297-4e76-b94d-a8b4f1ef26ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c7066218-0297-4e76-b94d-a8b4f1ef26ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_39db16dd-fd9a-4e6c-b574-e53a509fee6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_39db16dd-fd9a-4e6c-b574-e53a509fee6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3e023404-a29a-4ad3-bd28-539bb5414f79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3e023404-a29a-4ad3-bd28-539bb5414f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d4f3deb9-6cad-4da4-8ca2-415cdc94cd30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d4f3deb9-6cad-4da4-8ca2-415cdc94cd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_dd222be1-e107-48a6-9812-180eaea655fa" xlink:href="mck-20200930.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_dd222be1-e107-48a6-9812-180eaea655fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_e524d410-3ac6-4c51-960e-62325209efd4" xlink:href="mck-20200930.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_e524d410-3ac6-4c51-960e-62325209efd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_3ef3b11d-bfd0-4762-8f8e-5fbd6e9b6d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_3ef3b11d-bfd0-4762-8f8e-5fbd6e9b6d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_d1099663-03ae-42f1-a305-dea72f050a64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_d1099663-03ae-42f1-a305-dea72f050a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_9bccaa49-62de-4937-ba74-560a9c26d116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_DividendsCommonStockCash_9bccaa49-62de-4937-ba74-560a9c26d116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_58b226a5-adc1-4cc6-83ff-756a637acd97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockholdersEquityOther_58b226a5-adc1-4cc6-83ff-756a637acd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_33e5e6d4-87d0-40cf-96a8-12b1d5d302e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_SharesOutstanding_33e5e6d4-87d0-40cf-96a8-12b1d5d302e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_1dba6c66-ea9e-41d5-a494-556d2936fa49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_TreasuryStockShares_1dba6c66-ea9e-41d5-a494-556d2936fa49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4d200576-b581-4a71-812b-ec776eea6c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_92da04c5-affc-41fd-b228-c04b868bd4f7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4d200576-b581-4a71-812b-ec776eea6c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b6db86bb-647b-405d-9aee-c71c38a01988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_ebf501e5-9f88-46b2-a521-6a30f19b3699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b6db86bb-647b-405d-9aee-c71c38a01988" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_ebf501e5-9f88-46b2-a521-6a30f19b3699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a53541ea-ce27-4aae-b08d-5d73cdcf4f56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_087fe73e-cd0a-4e43-8e61-229bdc250e31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a53541ea-ce27-4aae-b08d-5d73cdcf4f56" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_087fe73e-cd0a-4e43-8e61-229bdc250e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1ec77544-ed6b-43a1-9e09-edb9dac1826b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_087fe73e-cd0a-4e43-8e61-229bdc250e31" xlink:to="loc_us-gaap_ProfitLoss_1ec77544-ed6b-43a1-9e09-edb9dac1826b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f61f72-3da7-49f7-9d48-60132c63cbe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_087fe73e-cd0a-4e43-8e61-229bdc250e31" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f61f72-3da7-49f7-9d48-60132c63cbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_65f0210b-87ba-496a-91a4-fbdf7f13ae33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f61f72-3da7-49f7-9d48-60132c63cbe0" xlink:to="loc_us-gaap_Depreciation_65f0210b-87ba-496a-91a4-fbdf7f13ae33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_7ccbe447-87f8-45f8-ab21-284c35bcf9ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f61f72-3da7-49f7-9d48-60132c63cbe0" xlink:to="loc_us-gaap_AdjustmentForAmortization_7ccbe447-87f8-45f8-ab21-284c35bcf9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_db0ecc08-6813-4989-a220-3eae46a29f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f61f72-3da7-49f7-9d48-60132c63cbe0" xlink:to="loc_us-gaap_AssetImpairmentCharges_db0ecc08-6813-4989-a220-3eae46a29f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_89d6d3c9-45da-447b-a99e-2fdd0980a9dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f61f72-3da7-49f7-9d48-60132c63cbe0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_89d6d3c9-45da-447b-a99e-2fdd0980a9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9f3c2ac8-e812-4ee6-946d-21a65da05f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f61f72-3da7-49f7-9d48-60132c63cbe0" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9f3c2ac8-e812-4ee6-946d-21a65da05f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_08fe0a91-3266-4fff-a0e3-a2263d533f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f61f72-3da7-49f7-9d48-60132c63cbe0" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_08fe0a91-3266-4fff-a0e3-a2263d533f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_a3332743-9c81-4e8f-937d-c8a04d82d730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f61f72-3da7-49f7-9d48-60132c63cbe0" xlink:to="loc_us-gaap_OperatingLeaseExpense_a3332743-9c81-4e8f-937d-c8a04d82d730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_19832f13-b79f-4928-9907-5bb479465f41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f61f72-3da7-49f7-9d48-60132c63cbe0" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_19832f13-b79f-4928-9907-5bb479465f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_fae8c089-df89-42e0-923d-4186fb23c864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f61f72-3da7-49f7-9d48-60132c63cbe0" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_fae8c089-df89-42e0-923d-4186fb23c864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_9f87ef84-caaf-4006-8669-323f1bc76f2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_33f61f72-3da7-49f7-9d48-60132c63cbe0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_9f87ef84-caaf-4006-8669-323f1bc76f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_fb9a4bd9-da20-49a3-80dd-382ad2ec907c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_9f87ef84-caaf-4006-8669-323f1bc76f2d" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_fb9a4bd9-da20-49a3-80dd-382ad2ec907c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_20d16908-c3fa-4195-993f-fb1ee9474b10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_9f87ef84-caaf-4006-8669-323f1bc76f2d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_20d16908-c3fa-4195-993f-fb1ee9474b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_9df472b3-1c5f-48e3-98bd-1b08c353ce38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_9f87ef84-caaf-4006-8669-323f1bc76f2d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_9df472b3-1c5f-48e3-98bd-1b08c353ce38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities_aa561b63-2faa-4611-92f3-aa1880a50dbb" xlink:href="mck-20200930.xsd#mck_IncreaseDecreaseinOperatingLeaseLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_9f87ef84-caaf-4006-8669-323f1bc76f2d" xlink:to="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities_aa561b63-2faa-4611-92f3-aa1880a50dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_c251177b-1c8f-4dc7-a9e4-8c699e05fa4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_9f87ef84-caaf-4006-8669-323f1bc76f2d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_c251177b-1c8f-4dc7-a9e4-8c699e05fa4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_df0fd534-86ae-48cf-a602-5eb8f6d622eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_9f87ef84-caaf-4006-8669-323f1bc76f2d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_df0fd534-86ae-48cf-a602-5eb8f6d622eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4040fab5-7c72-4aa3-8061-40d5e15c5b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_087fe73e-cd0a-4e43-8e61-229bdc250e31" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4040fab5-7c72-4aa3-8061-40d5e15c5b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_67a0ad21-c6ff-44b5-9627-b39ee62448b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a53541ea-ce27-4aae-b08d-5d73cdcf4f56" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_67a0ad21-c6ff-44b5-9627-b39ee62448b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_11b75c63-35f9-4e96-987c-f734e0cb43fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_67a0ad21-c6ff-44b5-9627-b39ee62448b1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_11b75c63-35f9-4e96-987c-f734e0cb43fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_d9336c8e-941b-4ef2-ac09-9e20a3188fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_67a0ad21-c6ff-44b5-9627-b39ee62448b1" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_d9336c8e-941b-4ef2-ac09-9e20a3188fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_32294f5e-0526-48b2-b7e9-eb7ff8d4f536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_67a0ad21-c6ff-44b5-9627-b39ee62448b1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_32294f5e-0526-48b2-b7e9-eb7ff8d4f536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_ba11d987-d557-4bc0-91c9-8a870f2a6af4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_67a0ad21-c6ff-44b5-9627-b39ee62448b1" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_ba11d987-d557-4bc0-91c9-8a870f2a6af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_76395317-b4a6-4db1-a421-f8c98193d00a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_67a0ad21-c6ff-44b5-9627-b39ee62448b1" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_76395317-b4a6-4db1-a421-f8c98193d00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c48050a3-6e73-43ec-b06d-4b40a912370e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_67a0ad21-c6ff-44b5-9627-b39ee62448b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c48050a3-6e73-43ec-b06d-4b40a912370e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c4545fe4-9b64-48ca-b009-960cc5d49695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a53541ea-ce27-4aae-b08d-5d73cdcf4f56" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c4545fe4-9b64-48ca-b009-960cc5d49695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_56d78278-e77e-4948-bd74-f1a69ce53fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c4545fe4-9b64-48ca-b009-960cc5d49695" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_56d78278-e77e-4948-bd74-f1a69ce53fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_db0ac083-7ab4-4b9e-9b7f-a79784644f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c4545fe4-9b64-48ca-b009-960cc5d49695" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_db0ac083-7ab4-4b9e-9b7f-a79784644f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_72680f75-5259-482c-bec6-a17a417bbd5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c4545fe4-9b64-48ca-b009-960cc5d49695" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_72680f75-5259-482c-bec6-a17a417bbd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_dbcf35cb-1b7f-46fe-87b0-fa3d2b3d4f38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c4545fe4-9b64-48ca-b009-960cc5d49695" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_dbcf35cb-1b7f-46fe-87b0-fa3d2b3d4f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0c04d197-e9c2-4442-bc02-cb5ffee32fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_dbcf35cb-1b7f-46fe-87b0-fa3d2b3d4f38" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_0c04d197-e9c2-4442-bc02-cb5ffee32fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_56ed581f-bde6-4439-b03f-09e4a596ef98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_dbcf35cb-1b7f-46fe-87b0-fa3d2b3d4f38" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_56ed581f-bde6-4439-b03f-09e4a596ef98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_46549783-9454-4db8-963f-8fd4f4ac8cf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c4545fe4-9b64-48ca-b009-960cc5d49695" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_46549783-9454-4db8-963f-8fd4f4ac8cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b067679e-2a91-4e2f-8813-1d9567588373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c4545fe4-9b64-48ca-b009-960cc5d49695" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b067679e-2a91-4e2f-8813-1d9567588373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_31f0d6cb-ddac-4759-9040-9fb45234a80b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c4545fe4-9b64-48ca-b009-960cc5d49695" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_31f0d6cb-ddac-4759-9040-9fb45234a80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50e0c7a5-97f5-48bf-9b94-704fd6dcf5f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a53541ea-ce27-4aae-b08d-5d73cdcf4f56" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50e0c7a5-97f5-48bf-9b94-704fd6dcf5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5b6d037a-3762-4ed6-89cf-ec888178ea7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a53541ea-ce27-4aae-b08d-5d73cdcf4f56" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5b6d037a-3762-4ed6-89cf-ec888178ea7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_821cdf9b-7356-461d-9eee-db61e63600aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a53541ea-ce27-4aae-b08d-5d73cdcf4f56" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_821cdf9b-7356-461d-9eee-db61e63600aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a0351a70-4546-439b-8f22-c499b7cbf591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a53541ea-ce27-4aae-b08d-5d73cdcf4f56" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a0351a70-4546-439b-8f22-c499b7cbf591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_ad607513-17bc-47a8-b447-589dea82cf50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a53541ea-ce27-4aae-b08d-5d73cdcf4f56" xlink:to="loc_us-gaap_RestrictedCashCurrent_ad607513-17bc-47a8-b447-589dea82cf50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_24ea153a-11f1-4f8e-8727-836f54d1e7d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a53541ea-ce27-4aae-b08d-5d73cdcf4f56" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_24ea153a-11f1-4f8e-8727-836f54d1e7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20200930.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_05bf7bd4-a126-462e-b554-914d68c117ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_85392f8b-728c-4862-98cd-f2edd1285b52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_05bf7bd4-a126-462e-b554-914d68c117ee" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_85392f8b-728c-4862-98cd-f2edd1285b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20200930.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_91896aca-1a1b-4c28-a604-af13f7c9bbee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_462f9950-7b95-4f20-ae44-4aa959f141b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_91896aca-1a1b-4c28-a604-af13f7c9bbee" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_462f9950-7b95-4f20-ae44-4aa959f141b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a3c82bd0-d2e3-4e06-99fb-acb5b8130471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_91896aca-1a1b-4c28-a604-af13f7c9bbee" xlink:to="loc_us-gaap_UseOfEstimates_a3c82bd0-d2e3-4e06-99fb-acb5b8130471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_db503edb-197d-4355-9245-e70e887ab7a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_91896aca-1a1b-4c28-a604-af13f7c9bbee" xlink:to="loc_us-gaap_FiscalPeriod_db503edb-197d-4355-9245-e70e887ab7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_a8d12b6b-f042-4150-9927-8bb8ad5101c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_91896aca-1a1b-4c28-a604-af13f7c9bbee" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_a8d12b6b-f042-4150-9927-8bb8ad5101c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ea48336f-86b1-4b74-8cc6-715fa305059f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_91896aca-1a1b-4c28-a604-af13f7c9bbee" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ea48336f-86b1-4b74-8cc6-715fa305059f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_dd6f8367-4ddf-4eda-ad02-bbcdcd541e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_91896aca-1a1b-4c28-a604-af13f7c9bbee" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_dd6f8367-4ddf-4eda-ad02-bbcdcd541e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cc564775-3f8f-4251-97df-85f406800181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f4e110af-ad73-4e73-ba1c-e611f74b74af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cc564775-3f8f-4251-97df-85f406800181" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f4e110af-ad73-4e73-ba1c-e611f74b74af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ca4c335a-a0be-4e49-925b-ee0373d2971f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f4e110af-ad73-4e73-ba1c-e611f74b74af" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ca4c335a-a0be-4e49-925b-ee0373d2971f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_1c94d341-cd5e-4376-b874-0eec63696ecb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ca4c335a-a0be-4e49-925b-ee0373d2971f" xlink:to="loc_us-gaap_TypeOfAdoptionMember_1c94d341-cd5e-4376-b874-0eec63696ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_e64f79d8-7b4f-4773-beb1-bf987d1a7649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_1c94d341-cd5e-4376-b874-0eec63696ecb" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_e64f79d8-7b4f-4773-beb1-bf987d1a7649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f385eba8-64d0-45b5-8166-8aedaca58b1b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f4e110af-ad73-4e73-ba1c-e611f74b74af" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f385eba8-64d0-45b5-8166-8aedaca58b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8343ca69-753c-4b9c-968f-0d675edc3464" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f385eba8-64d0-45b5-8166-8aedaca58b1b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8343ca69-753c-4b9c-968f-0d675edc3464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6c3c096c-a6f6-40e1-89c6-51e193c27e25" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8343ca69-753c-4b9c-968f-0d675edc3464" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6c3c096c-a6f6-40e1-89c6-51e193c27e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5cac0c24-5973-4f01-b6d6-00e6585db751" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f4e110af-ad73-4e73-ba1c-e611f74b74af" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5cac0c24-5973-4f01-b6d6-00e6585db751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_90531109-fd70-471f-b0ef-74f6e3bd478d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5cac0c24-5973-4f01-b6d6-00e6585db751" xlink:to="loc_us-gaap_EquityComponentDomain_90531109-fd70-471f-b0ef-74f6e3bd478d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d4a48a79-2b5a-4aee-914d-fb352f122e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_90531109-fd70-471f-b0ef-74f6e3bd478d" xlink:to="loc_us-gaap_RetainedEarningsMember_d4a48a79-2b5a-4aee-914d-fb352f122e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5e400369-7f06-49c3-a839-8ac37c28dd35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f4e110af-ad73-4e73-ba1c-e611f74b74af" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5e400369-7f06-49c3-a839-8ac37c28dd35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3dd1ade8-002d-452f-9961-a65388fbd205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5e400369-7f06-49c3-a839-8ac37c28dd35" xlink:to="loc_us-gaap_NumberOfReportableSegments_3dd1ade8-002d-452f-9961-a65388fbd205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_88ac541c-60fe-49a1-b56f-4ff112f10d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5e400369-7f06-49c3-a839-8ac37c28dd35" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_88ac541c-60fe-49a1-b56f-4ff112f10d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_623d673b-c823-4fe4-9da1-34c0c2959407" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5e400369-7f06-49c3-a839-8ac37c28dd35" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_623d673b-c823-4fe4-9da1-34c0c2959407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b5f22ea9-4a88-4a27-8c44-90c441711122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5e400369-7f06-49c3-a839-8ac37c28dd35" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b5f22ea9-4a88-4a27-8c44-90c441711122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="simple" xlink:href="mck-20200930.xsd#InvestmentinChangeHealthcareJointVenture"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_67d22276-db18-4426-ab32-a4f45e27a221" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_e8a9cc5c-ae7a-403f-8db2-e6527c083418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_67d22276-db18-4426-ab32-a4f45e27a221" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_e8a9cc5c-ae7a-403f-8db2-e6527c083418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#InvestmentinChangeHealthcareJointVentureDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_5afa4940-766b-44a4-908a-f1a33f353733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_5afa4940-766b-44a4-908a-f1a33f353733" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763dc8bc-99e4-481f-8a55-f4f219568706" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763dc8bc-99e4-481f-8a55-f4f219568706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_bfac36c8-124d-442f-8723-803daca17e44" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763dc8bc-99e4-481f-8a55-f4f219568706" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_bfac36c8-124d-442f-8723-803daca17e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_326061bc-83e0-488a-9169-c3afb455727b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_bfac36c8-124d-442f-8723-803daca17e44" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_326061bc-83e0-488a-9169-c3afb455727b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_27329d22-6857-4d43-b2a0-3f2fd4114980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_27329d22-6857-4d43-b2a0-3f2fd4114980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_d598d587-f36e-4897-b704-5a60a2c1c47b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_27329d22-6857-4d43-b2a0-3f2fd4114980" xlink:to="loc_us-gaap_TypeOfAdoptionMember_d598d587-f36e-4897-b704-5a60a2c1c47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_e76f3674-d95e-46ce-af1f-494d325e86fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_d598d587-f36e-4897-b704-5a60a2c1c47b" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_e76f3674-d95e-46ce-af1f-494d325e86fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d9fb0095-3457-4b3e-af76-6d9d07b9e448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d9fb0095-3457-4b3e-af76-6d9d07b9e448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_94e9f2cd-5a57-41f3-a433-948e934ee4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9fb0095-3457-4b3e-af76-6d9d07b9e448" xlink:to="loc_us-gaap_EquityComponentDomain_94e9f2cd-5a57-41f3-a433-948e934ee4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_adfac03e-2dc4-4bf5-99e7-731c467109d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_94e9f2cd-5a57-41f3-a433-948e934ee4f4" xlink:to="loc_us-gaap_RetainedEarningsMember_adfac03e-2dc4-4bf5-99e7-731c467109d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff2ef07a-e265-4624-9e3b-2dce930b942f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff2ef07a-e265-4624-9e3b-2dce930b942f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c8496917-7083-426f-a725-e49e2e47d4d9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff2ef07a-e265-4624-9e3b-2dce930b942f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c8496917-7083-426f-a725-e49e2e47d4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_b1942e58-b4b1-472e-bb2a-cd2668ba58a5" xlink:href="mck-20200930.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c8496917-7083-426f-a725-e49e2e47d4d9" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_b1942e58-b4b1-472e-bb2a-cd2668ba58a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3d16305-431d-41b3-a839-ec69c85cdcc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3d16305-431d-41b3-a839-ec69c85cdcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2a436810-04b3-44ea-bddf-7ea96037bc4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3d16305-431d-41b3-a839-ec69c85cdcc1" xlink:to="loc_us-gaap_RelatedPartyDomain_2a436810-04b3-44ea-bddf-7ea96037bc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_e81019cb-a289-4ee0-bc91-0de6998cf1e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2a436810-04b3-44ea-bddf-7ea96037bc4a" xlink:to="loc_us-gaap_CorporateJointVentureMember_e81019cb-a289-4ee0-bc91-0de6998cf1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_d423fec1-3217-4fac-93e4-6492df75dfcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_d423fec1-3217-4fac-93e4-6492df75dfcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_676c38fd-48d1-4bd6-b180-59e7dbabaf1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_d423fec1-3217-4fac-93e4-6492df75dfcf" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_676c38fd-48d1-4bd6-b180-59e7dbabaf1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_1564ae2c-d447-4e1e-a9df-e3aed6fb3f8c" xlink:href="mck-20200930.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_676c38fd-48d1-4bd6-b180-59e7dbabaf1f" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_1564ae2c-d447-4e1e-a9df-e3aed6fb3f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a9992b6f-15bb-48f7-9f09-4cd19e2f4a79" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_dei_LegalEntityAxis_a9992b6f-15bb-48f7-9f09-4cd19e2f4a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0d094730-0ee8-474c-977a-7cca3a418ca4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a9992b6f-15bb-48f7-9f09-4cd19e2f4a79" xlink:to="loc_dei_EntityDomain_0d094730-0ee8-474c-977a-7cca3a418ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareInc.Member_3a5879c7-07b1-41f8-b938-1110f92665c4" xlink:href="mck-20200930.xsd#mck_ChangeHealthcareInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0d094730-0ee8-474c-977a-7cca3a418ca4" xlink:to="loc_mck_ChangeHealthcareInc.Member_3a5879c7-07b1-41f8-b938-1110f92665c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_31f92628-5cbe-474f-b100-83fdf5ff6093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_31f92628-5cbe-474f-b100-83fdf5ff6093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c736ed02-45e4-4c60-ae0c-b0fd7a376a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_31f92628-5cbe-474f-b100-83fdf5ff6093" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c736ed02-45e4-4c60-ae0c-b0fd7a376a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_b0f1a0ae-7c8f-4563-84aa-e483110046e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c736ed02-45e4-4c60-ae0c-b0fd7a376a60" xlink:to="loc_us-gaap_IPOMember_b0f1a0ae-7c8f-4563-84aa-e483110046e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_70cac997-8acf-4bf2-bb20-1fb6eb7ab5e7" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cd8bb198-a149-4480-a0ba-1de6a3bf525b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cd8bb198-a149-4480-a0ba-1de6a3bf525b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_e5c68cfc-4d10-468a-8f93-9846fb19c1ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_e5c68cfc-4d10-468a-8f93-9846fb19c1ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_ed71d4ae-4475-43b0-9aee-0ca0c6082536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_ed71d4ae-4475-43b0-9aee-0ca0c6082536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_513e9f7c-51c0-4dce-8ab9-e13a3d375e11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_513e9f7c-51c0-4dce-8ab9-e13a3d375e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_bfcecae0-774f-4e28-be27-c7c06efcf349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_bfcecae0-774f-4e28-be27-c7c06efcf349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a0ccf17c-a03d-4b90-80e9-3d35931fc314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a0ccf17c-a03d-4b90-80e9-3d35931fc314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_a173aa14-a979-45e4-bae7-453c2bf3b58c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_a173aa14-a979-45e4-bae7-453c2bf3b58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_ea3c2b68-7258-471f-9c5b-38038626c8af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_ea3c2b68-7258-471f-9c5b-38038626c8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_795d475c-a095-4df6-87b6-45480f32031d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_795d475c-a095-4df6-87b6-45480f32031d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_cdb4b3ac-d488-48eb-a620-a4319d053c87" xlink:href="mck-20200930.xsd#mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_33017c46-fc7b-47e5-858f-a03766c0b2d5" xlink:to="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_cdb4b3ac-d488-48eb-a620-a4319d053c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20200930.xsd#HeldforSale"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_484ba903-f320-4133-8cdb-824f70a0e656" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_ef5b606c-8d86-49f1-a5fc-2a02bf1874df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_484ba903-f320-4133-8cdb-824f70a0e656" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_ef5b606c-8d86-49f1-a5fc-2a02bf1874df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleTables" xlink:type="simple" xlink:href="mck-20200930.xsd#HeldforSaleTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_8028e02d-c945-4b9c-8a1b-c1496e426b6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_e45cd53b-688f-45ca-ad55-b48e7a79dba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_8028e02d-c945-4b9c-8a1b-c1496e426b6b" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_e45cd53b-688f-45ca-ad55-b48e7a79dba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#HeldforSaleNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ceac1e3b-3093-42e6-a012-9ae662383686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ceac1e3b-3093-42e6-a012-9ae662383686" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_58c86dfb-49c9-459d-923c-ac67d5ef26f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_58c86dfb-49c9-459d-923c-ac67d5ef26f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_579e8c30-bd67-4563-a6bb-4ac8c6c2a625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_58c86dfb-49c9-459d-923c-ac67d5ef26f6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_579e8c30-bd67-4563-a6bb-4ac8c6c2a625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b1062a21-4785-40fb-8ca4-aa0ba5f863f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_579e8c30-bd67-4563-a6bb-4ac8c6c2a625" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b1062a21-4785-40fb-8ca4-aa0ba5f863f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_360c8330-b25c-44ac-9166-b64317b6dc8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_360c8330-b25c-44ac-9166-b64317b6dc8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ea396945-278e-486a-a222-452760ef22df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_360c8330-b25c-44ac-9166-b64317b6dc8d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ea396945-278e-486a-a222-452760ef22df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_ffe80b3b-aad8-4116-aea3-a7c3f33ca1db" xlink:href="mck-20200930.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ea396945-278e-486a-a222-452760ef22df" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_ffe80b3b-aad8-4116-aea3-a7c3f33ca1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7f2d2b4e-4328-4c3c-a609-155928964a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7f2d2b4e-4328-4c3c-a609-155928964a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c80e290c-87bd-4484-8084-ac0661542bc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7f2d2b4e-4328-4c3c-a609-155928964a8c" xlink:to="loc_us-gaap_RelatedPartyDomain_c80e290c-87bd-4484-8084-ac0661542bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_ef03f1f3-6b0b-4f38-8470-8de105f7caa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c80e290c-87bd-4484-8084-ac0661542bc5" xlink:to="loc_us-gaap_CorporateJointVentureMember_ef03f1f3-6b0b-4f38-8470-8de105f7caa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_71aab068-0071-4fc4-bacf-a2aab39be8d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_71aab068-0071-4fc4-bacf-a2aab39be8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_57bc5d19-1a81-4c70-91b8-fb0a2eb22708" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_71aab068-0071-4fc4-bacf-a2aab39be8d1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_57bc5d19-1a81-4c70-91b8-fb0a2eb22708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_14b0e884-3ae7-4e9f-84ce-5b2a694f7981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_57bc5d19-1a81-4c70-91b8-fb0a2eb22708" xlink:to="loc_us-gaap_SubsequentEventMember_14b0e884-3ae7-4e9f-84ce-5b2a694f7981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d7a99981-8767-4b85-8fda-16b4c34becfe" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_269a3b00-d3a2-452b-98ff-36f6f8b7f10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_269a3b00-d3a2-452b-98ff-36f6f8b7f10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_b8c388d7-eb85-4456-9886-75031b4b9671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_b8c388d7-eb85-4456-9886-75031b4b9671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_d1c01ebd-5c1f-40ab-bd6c-278e74b0c456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_d1c01ebd-5c1f-40ab-bd6c-278e74b0c456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_6d6ebc53-4766-4bf5-b561-3c19ff71e690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_6d6ebc53-4766-4bf5-b561-3c19ff71e690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_68cf8f63-045f-4f76-b780-e66b8be87674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_59748446-f06d-4709-b228-c67dafadcb28" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_68cf8f63-045f-4f76-b780-e66b8be87674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_05c26833-aaaf-4cfe-9729-0007bea01d76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1fb01072-8f3e-4465-bd7d-6ba6651831d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_05c26833-aaaf-4cfe-9729-0007bea01d76" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1fb01072-8f3e-4465-bd7d-6ba6651831d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0338956d-bf43-443f-95fa-22920aa12b2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1fb01072-8f3e-4465-bd7d-6ba6651831d8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0338956d-bf43-443f-95fa-22920aa12b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f0b98ec-4384-49e8-8cad-5a34330e6543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0338956d-bf43-443f-95fa-22920aa12b2f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f0b98ec-4384-49e8-8cad-5a34330e6543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_166b6713-f2fe-4886-a4d2-7fe4a4d7aaa4" xlink:href="mck-20200930.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f0b98ec-4384-49e8-8cad-5a34330e6543" xlink:to="loc_mck_GermanWholesaleBusinessMember_166b6713-f2fe-4886-a4d2-7fe4a4d7aaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b13cdaed-7a25-4983-b1ab-79cd8743c108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1fb01072-8f3e-4465-bd7d-6ba6651831d8" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b13cdaed-7a25-4983-b1ab-79cd8743c108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_808ef91e-50de-4a46-b3e7-bcf5398e26d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b13cdaed-7a25-4983-b1ab-79cd8743c108" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_808ef91e-50de-4a46-b3e7-bcf5398e26d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_21fd7b7a-454b-4c89-938c-cbd1ec3a8778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_808ef91e-50de-4a46-b3e7-bcf5398e26d0" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_21fd7b7a-454b-4c89-938c-cbd1ec3a8778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_88b35a4e-1587-41c4-b4cf-676b726a569b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1fb01072-8f3e-4465-bd7d-6ba6651831d8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_88b35a4e-1587-41c4-b4cf-676b726a569b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_88b35a4e-1587-41c4-b4cf-676b726a569b" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_1fba373e-24c8-48a5-b28b-1972d9bc5797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_1fba373e-24c8-48a5-b28b-1972d9bc5797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_f7c2b778-4347-4d58-9151-24e1272f61ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_f7c2b778-4347-4d58-9151-24e1272f61ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_11a931dc-7231-4813-aaf5-b60a4d3a0c41" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_11a931dc-7231-4813-aaf5-b60a4d3a0c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_2a9b4a54-7d5d-4706-ac73-57427394d9f2" xlink:href="mck-20200930.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_2a9b4a54-7d5d-4706-ac73-57427394d9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_eb806b87-eeab-4c9a-a3fc-eaeb2182917f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ad03b38d-0696-4e34-a1f6-34985fa74738" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_eb806b87-eeab-4c9a-a3fc-eaeb2182917f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fdb95bb-6c62-48f1-bace-e00dd395ea8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_88b35a4e-1587-41c4-b4cf-676b726a569b" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fdb95bb-6c62-48f1-bace-e00dd395ea8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_dbd2cc3e-5802-45f6-b45a-965b814c78d1" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fdb95bb-6c62-48f1-bace-e00dd395ea8d" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_dbd2cc3e-5802-45f6-b45a-965b814c78d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_c8201904-9241-425a-81e8-3460623faf01" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fdb95bb-6c62-48f1-bace-e00dd395ea8d" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_c8201904-9241-425a-81e8-3460623faf01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_acee19f7-e4f0-4d13-a4d6-2f4eaf7b61cb" xlink:href="mck-20200930.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fdb95bb-6c62-48f1-bace-e00dd395ea8d" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_acee19f7-e4f0-4d13-a4d6-2f4eaf7b61cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_6c9137fc-adfe-41e5-80c9-39cb99fcd59c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fdb95bb-6c62-48f1-bace-e00dd395ea8d" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_6c9137fc-adfe-41e5-80c9-39cb99fcd59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d254a6e7-c58b-4416-b5a8-3914084c9480" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_530261a0-ad13-4e97-b063-7d2244f9bb7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d254a6e7-c58b-4416-b5a8-3914084c9480" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_530261a0-ad13-4e97-b063-7d2244f9bb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b6559784-5f6e-443e-8b0d-cbbe93e46e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c6c9bcf6-dda4-4cd8-8469-3c8c692cacb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b6559784-5f6e-443e-8b0d-cbbe93e46e1e" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c6c9bcf6-dda4-4cd8-8469-3c8c692cacb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_37d7d70f-c6c4-40f3-803c-45c0271bdaaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b6559784-5f6e-443e-8b0d-cbbe93e46e1e" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_37d7d70f-c6c4-40f3-803c-45c0271bdaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c2fad057-089d-4e57-8477-ec56989385a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1968f3b5-e929-4332-84de-8b2b1743e99f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c2fad057-089d-4e57-8477-ec56989385a1" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1968f3b5-e929-4332-84de-8b2b1743e99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_bd28223f-1d96-4f00-a9d8-eef33e58db18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1968f3b5-e929-4332-84de-8b2b1743e99f" xlink:to="loc_us-gaap_RestructuringPlanAxis_bd28223f-1d96-4f00-a9d8-eef33e58db18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8f9e8aa6-c0f7-4042-8538-8432ac559459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_bd28223f-1d96-4f00-a9d8-eef33e58db18" xlink:to="loc_us-gaap_RestructuringPlanDomain_8f9e8aa6-c0f7-4042-8538-8432ac559459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_83f73fe6-0198-40a9-9ae2-182681850498" xlink:href="mck-20200930.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_8f9e8aa6-c0f7-4042-8538-8432ac559459" xlink:to="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_83f73fe6-0198-40a9-9ae2-182681850498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingModelAndCostOptimizationProgramsMember_cb051174-0e6f-49dc-8dbb-fd480477a3c3" xlink:href="mck-20200930.xsd#mck_OperatingModelAndCostOptimizationProgramsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_8f9e8aa6-c0f7-4042-8538-8432ac559459" xlink:to="loc_mck_OperatingModelAndCostOptimizationProgramsMember_cb051174-0e6f-49dc-8dbb-fd480477a3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanMember_4140ee9b-cae4-4a30-a61d-3dd8f09b4b73" xlink:href="mck-20200930.xsd#mck_StrategicGrowthInitiativePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_8f9e8aa6-c0f7-4042-8538-8432ac559459" xlink:to="loc_mck_StrategicGrowthInitiativePlanMember_4140ee9b-cae4-4a30-a61d-3dd8f09b4b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_be9a8a33-b7da-4096-9ec7-c40a9a006602" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1968f3b5-e929-4332-84de-8b2b1743e99f" xlink:to="loc_srt_RangeAxis_be9a8a33-b7da-4096-9ec7-c40a9a006602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b8b96670-0903-4c0b-b3c7-7a4bc9f3974a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_be9a8a33-b7da-4096-9ec7-c40a9a006602" xlink:to="loc_srt_RangeMember_b8b96670-0903-4c0b-b3c7-7a4bc9f3974a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b8eedc61-48fa-4c46-af03-69c4d03dedba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b8b96670-0903-4c0b-b3c7-7a4bc9f3974a" xlink:to="loc_srt_MinimumMember_b8eedc61-48fa-4c46-af03-69c4d03dedba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_74bd00b9-3870-4d5c-9cbf-1730f5511a59" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b8b96670-0903-4c0b-b3c7-7a4bc9f3974a" xlink:to="loc_srt_MaximumMember_74bd00b9-3870-4d5c-9cbf-1730f5511a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bf6b5560-2c03-4d32-96d2-a2ff352650b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1968f3b5-e929-4332-84de-8b2b1743e99f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bf6b5560-2c03-4d32-96d2-a2ff352650b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4830b32b-32f6-4fb2-88bb-8cc80030d368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bf6b5560-2c03-4d32-96d2-a2ff352650b5" xlink:to="loc_us-gaap_SegmentDomain_4830b32b-32f6-4fb2-88bb-8cc80030d368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_0170c9ae-6e04-4f9a-b894-355155de6519" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4830b32b-32f6-4fb2-88bb-8cc80030d368" xlink:to="loc_mck_InternationalSegmentMember_0170c9ae-6e04-4f9a-b894-355155de6519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_02ed3f97-3835-43ac-af7b-535f74945c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1968f3b5-e929-4332-84de-8b2b1743e99f" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_02ed3f97-3835-43ac-af7b-535f74945c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_df83e545-2007-409f-9831-9d2d2dbe6c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_02ed3f97-3835-43ac-af7b-535f74945c79" xlink:to="loc_us-gaap_RestructuringCharges_df83e545-2007-409f-9831-9d2d2dbe6c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_7eaf68db-0aea-49ba-9ec4-22ebdac02b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_02ed3f97-3835-43ac-af7b-535f74945c79" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_7eaf68db-0aea-49ba-9ec4-22ebdac02b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_b117785d-d3cb-4304-b1a7-fdab86a7eca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_02ed3f97-3835-43ac-af7b-535f74945c79" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_b117785d-d3cb-4304-b1a7-fdab86a7eca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_078ee7db-1737-4901-8199-00ff8eda03c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_02ed3f97-3835-43ac-af7b-535f74945c79" xlink:to="loc_us-gaap_RestructuringReserve_078ee7db-1737-4901-8199-00ff8eda03c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_579a565c-0363-4f88-a82c-049ef632631b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7055e7dc-3cfc-4d05-afe5-880c63c548fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_579a565c-0363-4f88-a82c-049ef632631b" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7055e7dc-3cfc-4d05-afe5-880c63c548fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6336235b-20cc-4a42-8fe6-5c76ec34d9fb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7055e7dc-3cfc-4d05-afe5-880c63c548fb" xlink:to="loc_srt_ConsolidationItemsAxis_6336235b-20cc-4a42-8fe6-5c76ec34d9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d2e6c958-4b12-4162-945d-9265ab7da049" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_6336235b-20cc-4a42-8fe6-5c76ec34d9fb" xlink:to="loc_srt_ConsolidationItemsDomain_d2e6c958-4b12-4162-945d-9265ab7da049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_df9f9b9d-26e3-4d78-94e2-f89fcc77cbf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d2e6c958-4b12-4162-945d-9265ab7da049" xlink:to="loc_us-gaap_OperatingSegmentsMember_df9f9b9d-26e3-4d78-94e2-f89fcc77cbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b7c1a307-c5b7-4a9e-bd7b-2b41e666a989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d2e6c958-4b12-4162-945d-9265ab7da049" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b7c1a307-c5b7-4a9e-bd7b-2b41e666a989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_35311cad-9e49-4116-b4a5-846b53ef95ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7055e7dc-3cfc-4d05-afe5-880c63c548fb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_35311cad-9e49-4116-b4a5-846b53ef95ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c662afdc-a99d-4381-92e7-28f764f28841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_35311cad-9e49-4116-b4a5-846b53ef95ee" xlink:to="loc_us-gaap_SegmentDomain_c662afdc-a99d-4381-92e7-28f764f28841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_6d12b0a1-0694-4ce6-89ac-6a1f6b1403d1" xlink:href="mck-20200930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c662afdc-a99d-4381-92e7-28f764f28841" xlink:to="loc_mck_USPharmaceuticalSegmentMember_6d12b0a1-0694-4ce6-89ac-6a1f6b1403d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_a40fcf29-9386-43bc-9440-7158bad2bbf6" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c662afdc-a99d-4381-92e7-28f764f28841" xlink:to="loc_mck_InternationalSegmentMember_a40fcf29-9386-43bc-9440-7158bad2bbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_c1dbd5f8-92b7-4f2f-a4e8-b4be80111f2a" xlink:href="mck-20200930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c662afdc-a99d-4381-92e7-28f764f28841" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_c1dbd5f8-92b7-4f2f-a4e8-b4be80111f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_52de49fd-dcad-4921-aa45-630e4366fbe3" xlink:href="mck-20200930.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c662afdc-a99d-4381-92e7-28f764f28841" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_52de49fd-dcad-4921-aa45-630e4366fbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_12c2f6e3-7739-4f17-8a6c-f794bd791430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7055e7dc-3cfc-4d05-afe5-880c63c548fb" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_12c2f6e3-7739-4f17-8a6c-f794bd791430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_2cc9d6f7-a73f-4099-b23d-3f53faadacfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_12c2f6e3-7739-4f17-8a6c-f794bd791430" xlink:to="loc_us-gaap_SeveranceCosts1_2cc9d6f7-a73f-4099-b23d-3f53faadacfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_97da04a4-d0b4-451a-a3b0-ad54fec7f933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_12c2f6e3-7739-4f17-8a6c-f794bd791430" xlink:to="loc_us-gaap_BusinessExitCosts1_97da04a4-d0b4-451a-a3b0-ad54fec7f933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_d092e991-48c8-4024-85b9-cfca99b410eb" xlink:href="mck-20200930.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_12c2f6e3-7739-4f17-8a6c-f794bd791430" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_d092e991-48c8-4024-85b9-cfca99b410eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_79316ddf-3276-40b7-adce-46d14ce13ac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_12c2f6e3-7739-4f17-8a6c-f794bd791430" xlink:to="loc_us-gaap_RestructuringCharges_79316ddf-3276-40b7-adce-46d14ce13ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7ca2947a-ec41-4d8d-87b2-cd3f36736873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee51b070-278a-493f-b6e2-6d8771378ae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7ca2947a-ec41-4d8d-87b2-cd3f36736873" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee51b070-278a-493f-b6e2-6d8771378ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a18003d3-dfe9-43d3-aadb-7fe6a50197c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee51b070-278a-493f-b6e2-6d8771378ae5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a18003d3-dfe9-43d3-aadb-7fe6a50197c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0ea84210-5ec8-4d6e-8071-b81dfadfcead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a18003d3-dfe9-43d3-aadb-7fe6a50197c1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0ea84210-5ec8-4d6e-8071-b81dfadfcead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b4089ada-f826-41a5-b04d-33f95110ff40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ea84210-5ec8-4d6e-8071-b81dfadfcead" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b4089ada-f826-41a5-b04d-33f95110ff40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_53b47018-a8b6-4a03-8691-2a393525b6f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ea84210-5ec8-4d6e-8071-b81dfadfcead" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_53b47018-a8b6-4a03-8691-2a393525b6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2704f2b8-ba0f-4e48-9e47-497ca734a620" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee51b070-278a-493f-b6e2-6d8771378ae5" xlink:to="loc_srt_ConsolidationItemsAxis_2704f2b8-ba0f-4e48-9e47-497ca734a620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c4ed5c1d-2cf3-487c-972d-c6913790a35e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_2704f2b8-ba0f-4e48-9e47-497ca734a620" xlink:to="loc_srt_ConsolidationItemsDomain_c4ed5c1d-2cf3-487c-972d-c6913790a35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e7693f02-db6e-424e-9af7-5b91ce168eb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c4ed5c1d-2cf3-487c-972d-c6913790a35e" xlink:to="loc_us-gaap_OperatingSegmentsMember_e7693f02-db6e-424e-9af7-5b91ce168eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_eb476d3f-b0f1-4c47-890b-d7cdb5172f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c4ed5c1d-2cf3-487c-972d-c6913790a35e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_eb476d3f-b0f1-4c47-890b-d7cdb5172f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_04cea13a-e42e-4a65-b3cc-f61819fb5d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee51b070-278a-493f-b6e2-6d8771378ae5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_04cea13a-e42e-4a65-b3cc-f61819fb5d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e50ad500-ad1d-46b9-beb0-3fb63b65000f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_04cea13a-e42e-4a65-b3cc-f61819fb5d17" xlink:to="loc_us-gaap_SegmentDomain_e50ad500-ad1d-46b9-beb0-3fb63b65000f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_3c98922f-a2cd-43d4-bec9-f8b9d6603537" xlink:href="mck-20200930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e50ad500-ad1d-46b9-beb0-3fb63b65000f" xlink:to="loc_mck_USPharmaceuticalSegmentMember_3c98922f-a2cd-43d4-bec9-f8b9d6603537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_64c91b10-6712-4504-a2cc-81e8dffcb5c8" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e50ad500-ad1d-46b9-beb0-3fb63b65000f" xlink:to="loc_mck_InternationalSegmentMember_64c91b10-6712-4504-a2cc-81e8dffcb5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_806d7c70-60e4-4e47-9d09-9b833ba394b2" xlink:href="mck-20200930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e50ad500-ad1d-46b9-beb0-3fb63b65000f" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_806d7c70-60e4-4e47-9d09-9b833ba394b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_9f65c70a-abc5-4c60-807c-0e4d2928bc72" xlink:href="mck-20200930.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e50ad500-ad1d-46b9-beb0-3fb63b65000f" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_9f65c70a-abc5-4c60-807c-0e4d2928bc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_cf1c6d7b-2cc7-4cda-98cb-20625b349ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee51b070-278a-493f-b6e2-6d8771378ae5" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_cf1c6d7b-2cc7-4cda-98cb-20625b349ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cf1c6d7b-2cc7-4cda-98cb-20625b349ee6" xlink:to="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_3ca91efc-8c0e-4053-9d56-904e611ffb20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:to="loc_us-gaap_RestructuringReserve_3ca91efc-8c0e-4053-9d56-904e611ffb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_06496fda-f848-45b9-831f-68d2781851f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:to="loc_us-gaap_RestructuringCharges_06496fda-f848-45b9-831f-68d2781851f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_ba414191-8931-41d6-9929-c71568f4d5d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_ba414191-8931-41d6-9929-c71568f4d5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_886fbff6-edb5-45d7-9fcd-d55ae869bf8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:to="loc_us-gaap_PaymentsForRestructuring_886fbff6-edb5-45d7-9fcd-d55ae869bf8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_603bc3a6-4210-45da-8490-b967ed9c2d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_603bc3a6-4210-45da-8490-b967ed9c2d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_8ef3ab2f-1fa4-45b6-a7bf-53549fd83d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_094b36e8-f5bb-4f09-8939-415f13ad3047" xlink:to="loc_us-gaap_RestructuringReserve_8ef3ab2f-1fa4-45b6-a7bf-53549fd83d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20200930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_20dd14b4-3b92-4ce2-8fc0-2d68eb6fce16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_b99a56e7-86b6-4b43-a849-73c97b88de81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_20dd14b4-3b92-4ce2-8fc0-2d68eb6fce16" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_b99a56e7-86b6-4b43-a849-73c97b88de81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_aad7fcc7-4ed7-484e-9c08-a129f7322671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d2adc317-6f44-4f16-9126-ef0633ebcd2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aad7fcc7-4ed7-484e-9c08-a129f7322671" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d2adc317-6f44-4f16-9126-ef0633ebcd2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c2503643-5436-4ace-8234-4b9d7b6087fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aad7fcc7-4ed7-484e-9c08-a129f7322671" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c2503643-5436-4ace-8234-4b9d7b6087fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_24f42b2e-5f3d-4230-a4da-7d1a74527881" xlink:href="mck-20200930.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aad7fcc7-4ed7-484e-9c08-a129f7322671" xlink:to="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_24f42b2e-5f3d-4230-a4da-7d1a74527881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_2dcf5407-a742-49b6-a194-ed508a04e512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aad7fcc7-4ed7-484e-9c08-a129f7322671" xlink:to="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_2dcf5407-a742-49b6-a194-ed508a04e512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory_aadfb957-3004-44fc-a8c9-3b4dccaa7da0" xlink:href="mck-20200930.xsd#mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aad7fcc7-4ed7-484e-9c08-a129f7322671" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory_aadfb957-3004-44fc-a8c9-3b4dccaa7da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_f897aa7b-da87-41c9-8eff-8abdd93e3a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aad7fcc7-4ed7-484e-9c08-a129f7322671" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_f897aa7b-da87-41c9-8eff-8abdd93e3a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_77656d98-50ff-4df9-9bf9-b3719fb3940a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aad7fcc7-4ed7-484e-9c08-a129f7322671" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_77656d98-50ff-4df9-9bf9-b3719fb3940a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_a7bbbacf-74c0-4528-aeb3-3acd71434af5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aad7fcc7-4ed7-484e-9c08-a129f7322671" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_a7bbbacf-74c0-4528-aeb3-3acd71434af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20200930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_58b831c2-defb-4bd6-be8f-46c73f1562aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_325871e2-1f18-45f0-a739-4a3165849675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_58b831c2-defb-4bd6-be8f-46c73f1562aa" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_325871e2-1f18-45f0-a739-4a3165849675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20200930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_e4ca83c1-ec88-4f4b-a844-4c5ce550310d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_380f3cda-1f88-48a1-82e9-724e25803c70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_e4ca83c1-ec88-4f4b-a844-4c5ce550310d" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_380f3cda-1f88-48a1-82e9-724e25803c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_e67deffa-5b5d-4a96-8b1b-36a4b4d4c849" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_6eb17d07-eefe-4c10-820c-df159eb06c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_e67deffa-5b5d-4a96-8b1b-36a4b4d4c849" xlink:to="loc_us-gaap_MinorityInterestTable_6eb17d07-eefe-4c10-820c-df159eb06c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_6cc73c0a-6423-4d24-9150-7533f426a1ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_6eb17d07-eefe-4c10-820c-df159eb06c71" xlink:to="loc_srt_OwnershipAxis_6cc73c0a-6423-4d24-9150-7533f426a1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_68e1343d-9d55-4a77-baeb-a2f600b45aed" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_6cc73c0a-6423-4d24-9150-7533f426a1ea" xlink:to="loc_srt_OwnershipDomain_68e1343d-9d55-4a77-baeb-a2f600b45aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_18cba496-a1e7-4a55-ac38-dadc8e749d2c" xlink:href="mck-20200930.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_68e1343d-9d55-4a77-baeb-a2f600b45aed" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_18cba496-a1e7-4a55-ac38-dadc8e749d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_be09944e-9c2b-450e-b3ec-74fc3b64d2a2" xlink:href="mck-20200930.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_68e1343d-9d55-4a77-baeb-a2f600b45aed" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_be09944e-9c2b-450e-b3ec-74fc3b64d2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_73044d6c-8ea3-4b99-8140-f9d0e01fd687" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_6eb17d07-eefe-4c10-820c-df159eb06c71" xlink:to="loc_dei_LegalEntityAxis_73044d6c-8ea3-4b99-8140-f9d0e01fd687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_921f5b84-0eb6-4d32-ba90-1c45215404e0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_73044d6c-8ea3-4b99-8140-f9d0e01fd687" xlink:to="loc_dei_EntityDomain_921f5b84-0eb6-4d32-ba90-1c45215404e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_423c97f6-2572-47d6-89e0-ade632e93c0f" xlink:href="mck-20200930.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_921f5b84-0eb6-4d32-ba90-1c45215404e0" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_423c97f6-2572-47d6-89e0-ade632e93c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_80055c24-4bb9-4480-9c46-c85ee4e345fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_6eb17d07-eefe-4c10-820c-df159eb06c71" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_80055c24-4bb9-4480-9c46-c85ee4e345fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_28c51043-7459-4fa1-a381-56c04e4845dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_80055c24-4bb9-4480-9c46-c85ee4e345fe" xlink:to="loc_us-gaap_EquityComponentDomain_28c51043-7459-4fa1-a381-56c04e4845dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_65c4c3d4-f683-4e39-a0bb-43ef7704fb2c" xlink:href="mck-20200930.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_28c51043-7459-4fa1-a381-56c04e4845dc" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_65c4c3d4-f683-4e39-a0bb-43ef7704fb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_be0a230f-33d9-486c-827d-c5d98d5e1b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_28c51043-7459-4fa1-a381-56c04e4845dc" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_be0a230f-33d9-486c-827d-c5d98d5e1b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_6eb17d07-eefe-4c10-820c-df159eb06c71" xlink:to="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_49391eb9-7b99-4eb0-893c-6ad0fc183085" xlink:href="mck-20200930.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_49391eb9-7b99-4eb0-893c-6ad0fc183085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_dca278f9-edc8-462b-9dd1-dea5be8b2261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_dca278f9-edc8-462b-9dd1-dea5be8b2261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_36e60093-5473-4413-98a8-e84700a4d8bc" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_36e60093-5473-4413-98a8-e84700a4d8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_2fd6d9b1-9926-4b43-aff9-ef35ec08a532" xlink:href="mck-20200930.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_PutRightValueInterestRateSpread_2fd6d9b1-9926-4b43-aff9-ef35ec08a532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_decc34ff-7989-48c1-9725-429e5813e876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_decc34ff-7989-48c1-9725-429e5813e876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_418dceef-06ab-4fa5-9a81-8904e1ca1acf" xlink:href="mck-20200930.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_418dceef-06ab-4fa5-9a81-8904e1ca1acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3b912bee-781d-4c2d-a6fe-cac4160f7557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3b912bee-781d-4c2d-a6fe-cac4160f7557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_5e01c6d4-8127-4184-9662-ab6ec8ab8ad3" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_5e01c6d4-8127-4184-9662-ab6ec8ab8ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_ecbe2244-c822-4f03-9b3c-69a5e5b0e7eb" xlink:href="mck-20200930.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_ecbe2244-c822-4f03-9b3c-69a5e5b0e7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_acd5fe9e-0e9d-4882-a730-606707a6cb8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_acd5fe9e-0e9d-4882-a730-606707a6cb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_cf5cb4ca-6629-4cbe-883d-7fe229786bb1" xlink:href="mck-20200930.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_cf5cb4ca-6629-4cbe-883d-7fe229786bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_0e9a147d-aed2-4877-b97a-09380a69f543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_0e9a147d-aed2-4877-b97a-09380a69f543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ae089dfe-ebf4-43ad-91b0-21e3d6c2eedc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_MinorityInterest_ae089dfe-ebf4-43ad-91b0-21e3d6c2eedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_af824cb1-e64d-42f5-8047-7d7b9046cd36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_af8b4d28-bfab-471d-8188-8cb51ef7fc8d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_af824cb1-e64d-42f5-8047-7d7b9046cd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_82f8cc0b-0ac0-4f53-a6ff-105dfb44e6dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_d37edc49-b124-4a00-b7dc-8d240b7120ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_82f8cc0b-0ac0-4f53-a6ff-105dfb44e6dc" xlink:to="loc_us-gaap_MinorityInterestTable_d37edc49-b124-4a00-b7dc-8d240b7120ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_01e44cf2-23f3-4b49-98b8-d2752c6d3f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_d37edc49-b124-4a00-b7dc-8d240b7120ce" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_01e44cf2-23f3-4b49-98b8-d2752c6d3f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_383a8dc7-c0ac-466d-ab7c-ffccc96407b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_01e44cf2-23f3-4b49-98b8-d2752c6d3f31" xlink:to="loc_us-gaap_EquityComponentDomain_383a8dc7-c0ac-466d-ab7c-ffccc96407b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c95aeaca-e846-43a2-ae9a-20b03b4ca9ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_383a8dc7-c0ac-466d-ab7c-ffccc96407b6" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c95aeaca-e846-43a2-ae9a-20b03b4ca9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_296a3447-904e-430e-889d-b996df8126f7" xlink:href="mck-20200930.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_383a8dc7-c0ac-466d-ab7c-ffccc96407b6" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_296a3447-904e-430e-889d-b996df8126f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_488a4f1f-ffa2-4dee-b745-0271c4f617ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_d37edc49-b124-4a00-b7dc-8d240b7120ce" xlink:to="loc_us-gaap_MinorityInterestLineItems_488a4f1f-ffa2-4dee-b745-0271c4f617ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_488a4f1f-ffa2-4dee-b745-0271c4f617ed" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_cd46841b-03be-4dd9-827e-625a44c7dfff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:to="loc_us-gaap_MinorityInterest_cd46841b-03be-4dd9-827e-625a44c7dfff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e8077b60-9a2d-4eee-a330-feb5de514149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e8077b60-9a2d-4eee-a330-feb5de514149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_133d1f16-205c-446b-bc06-9837f2c7e6fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_133d1f16-205c-446b-bc06-9837f2c7e6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_163323e9-a1f9-4bf0-9776-0a1022863e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_163323e9-a1f9-4bf0-9776-0a1022863e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_7eb77ee1-f70c-454a-bf67-39cbe943f6df" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_7eb77ee1-f70c-454a-bf67-39cbe943f6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e7c694f2-5d35-479e-8325-b660f3939ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_34e7a167-58ed-4ac3-be6a-33ebd286cdc5" xlink:to="loc_us-gaap_MinorityInterest_e7c694f2-5d35-479e-8325-b660f3939ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_488a4f1f-ffa2-4dee-b745-0271c4f617ed" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_30f238ac-7a17-435e-8b59-2aabbd4b16f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_30f238ac-7a17-435e-8b59-2aabbd4b16f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_68c36449-0046-400a-ad6b-b9e9bdd32100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_68c36449-0046-400a-ad6b-b9e9bdd32100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_1268937b-5e02-4d33-a069-3724ef724f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_1268937b-5e02-4d33-a069-3724ef724f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_3950b430-6bd7-4be6-8e80-b86a912aaa43" xlink:href="mck-20200930.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_3950b430-6bd7-4be6-8e80-b86a912aaa43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93cc11fb-b65b-4f33-aae7-1207baa82534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93cc11fb-b65b-4f33-aae7-1207baa82534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_f166437b-8edc-45a6-8c8c-3471fe5f2226" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_f166437b-8edc-45a6-8c8c-3471fe5f2226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_9a9c590d-d2bf-470f-8df5-7fab6ac7d0e7" xlink:href="mck-20200930.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_9a9c590d-d2bf-470f-8df5-7fab6ac7d0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0cc394f8-465d-43a4-b62b-8e9ee4ce4d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_07c958d6-093c-4f33-bc46-4ee035888720" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0cc394f8-465d-43a4-b62b-8e9ee4ce4d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsPerCommonShare" xlink:type="simple" xlink:href="mck-20200930.xsd#EarningsPerCommonShare"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0261f44f-c2d7-4d9d-b989-d6c604f1b317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_8bf2d7a5-54ac-4eee-a092-41be4f471235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0261f44f-c2d7-4d9d-b989-d6c604f1b317" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_8bf2d7a5-54ac-4eee-a092-41be4f471235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsPerCommonShareTables" xlink:type="simple" xlink:href="mck-20200930.xsd#EarningsPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_93d714ec-de4f-4c67-8534-b0e8eb657ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_05773c1b-e45d-4b56-8400-8e432742a0dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_93d714ec-de4f-4c67-8534-b0e8eb657ff7" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_05773c1b-e45d-4b56-8400-8e432742a0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ee8a0822-7e55-4120-a4d1-9b233d5c154c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_9bf71e9e-bee8-4c0a-963e-f7c370b214f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ee8a0822-7e55-4120-a4d1-9b233d5c154c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_9bf71e9e-bee8-4c0a-963e-f7c370b214f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6fd27afe-1d67-4472-bcc9-7662ead86936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ee8a0822-7e55-4120-a4d1-9b233d5c154c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6fd27afe-1d67-4472-bcc9-7662ead86936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_7ab5f39a-f99c-4ebf-83a2-d09ee2744c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ee8a0822-7e55-4120-a4d1-9b233d5c154c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_7ab5f39a-f99c-4ebf-83a2-d09ee2744c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8b2d3e37-05e9-43a8-b6f8-b09d68ddf911" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ee8a0822-7e55-4120-a4d1-9b233d5c154c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8b2d3e37-05e9-43a8-b6f8-b09d68ddf911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d06a526b-0955-49f1-a3d6-c3ce0ee0a33f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ee8a0822-7e55-4120-a4d1-9b233d5c154c" xlink:to="loc_us-gaap_NetIncomeLoss_d06a526b-0955-49f1-a3d6-c3ce0ee0a33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_27426815-172b-4eaf-8c73-5ddbcbc76d8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ee8a0822-7e55-4120-a4d1-9b233d5c154c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_27426815-172b-4eaf-8c73-5ddbcbc76d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5fde4cc4-a2ba-4a35-9f38-6e4ed08079c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_27426815-172b-4eaf-8c73-5ddbcbc76d8a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5fde4cc4-a2ba-4a35-9f38-6e4ed08079c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_8206b879-72dc-4064-b975-94b277b5cc55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_27426815-172b-4eaf-8c73-5ddbcbc76d8a" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_8206b879-72dc-4064-b975-94b277b5cc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1959e3ed-a0be-4f51-aa87-951ca8f56621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_8206b879-72dc-4064-b975-94b277b5cc55" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1959e3ed-a0be-4f51-aa87-951ca8f56621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3b08083c-65ed-4a4b-9f18-40e79faa527a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_27426815-172b-4eaf-8c73-5ddbcbc76d8a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3b08083c-65ed-4a4b-9f18-40e79faa527a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_69d5304a-9c6b-4985-b6f0-504afb458ae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ee8a0822-7e55-4120-a4d1-9b233d5c154c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_69d5304a-9c6b-4985-b6f0-504afb458ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_43eb02e0-8b71-45ba-88f3-6976bb1ec072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_69d5304a-9c6b-4985-b6f0-504afb458ae0" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_43eb02e0-8b71-45ba-88f3-6976bb1ec072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_9c0a93e2-eb0f-4241-adef-80a79e01f003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_43eb02e0-8b71-45ba-88f3-6976bb1ec072" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_9c0a93e2-eb0f-4241-adef-80a79e01f003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1092bfa5-a06f-496b-8c3f-d518bead7559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_43eb02e0-8b71-45ba-88f3-6976bb1ec072" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1092bfa5-a06f-496b-8c3f-d518bead7559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4c1d4fef-0f8a-42c1-a0f7-1e21b0b483f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_43eb02e0-8b71-45ba-88f3-6976bb1ec072" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4c1d4fef-0f8a-42c1-a0f7-1e21b0b483f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_fd246b6e-9073-4098-923c-7edcd3f2f34a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_69d5304a-9c6b-4985-b6f0-504afb458ae0" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_fd246b6e-9073-4098-923c-7edcd3f2f34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3ccbc687-ad75-4829-be31-dd703d5d8e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_fd246b6e-9073-4098-923c-7edcd3f2f34a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3ccbc687-ad75-4829-be31-dd703d5d8e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_cd4bd59e-1d86-4fe4-bb8c-cb9ac0a34f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_fd246b6e-9073-4098-923c-7edcd3f2f34a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_cd4bd59e-1d86-4fe4-bb8c-cb9ac0a34f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_5344787a-50bc-43d8-b174-2d70523e3cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_fd246b6e-9073-4098-923c-7edcd3f2f34a" xlink:to="loc_us-gaap_EarningsPerShareBasic_5344787a-50bc-43d8-b174-2d70523e3cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_82b928a0-6fbe-4ceb-9649-817e4bda083a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ee8a0822-7e55-4120-a4d1-9b233d5c154c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_82b928a0-6fbe-4ceb-9649-817e4bda083a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b5872cc6-6afe-4d01-8166-c589c495ac9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d5669325-ddf2-4d31-8831-9abfd04efc37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b5872cc6-6afe-4d01-8166-c589c495ac9e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d5669325-ddf2-4d31-8831-9abfd04efc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_69e9a797-c6bf-4a48-9a21-85859f88e542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_158f0cd7-e613-4bbc-b13e-4c28f0d1214c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_69e9a797-c6bf-4a48-9a21-85859f88e542" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_158f0cd7-e613-4bbc-b13e-4c28f0d1214c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_50f22ce1-57b6-4c7d-873e-8bac36f5afc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_69e9a797-c6bf-4a48-9a21-85859f88e542" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_50f22ce1-57b6-4c7d-873e-8bac36f5afc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7a43eaf4-052f-4704-b75e-b14573e91e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_35664989-7d30-424c-923e-940c792049ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7a43eaf4-052f-4704-b75e-b14573e91e43" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_35664989-7d30-424c-923e-940c792049ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f65a52d4-6d95-4c54-af4d-2dd42be17e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_35664989-7d30-424c-923e-940c792049ec" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f65a52d4-6d95-4c54-af4d-2dd42be17e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b89bb3dd-5687-41c6-9586-88fe237b7058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f65a52d4-6d95-4c54-af4d-2dd42be17e99" xlink:to="loc_us-gaap_SegmentDomain_b89bb3dd-5687-41c6-9586-88fe237b7058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_82b08e42-f7d7-4612-b389-fab9645a8f48" xlink:href="mck-20200930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b89bb3dd-5687-41c6-9586-88fe237b7058" xlink:to="loc_mck_USPharmaceuticalSegmentMember_82b08e42-f7d7-4612-b389-fab9645a8f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_bd057322-10dc-4511-ae7a-91311f779f83" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b89bb3dd-5687-41c6-9586-88fe237b7058" xlink:to="loc_mck_InternationalSegmentMember_bd057322-10dc-4511-ae7a-91311f779f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_70792db0-91dc-4db6-88c8-0dd5f0d13fbe" xlink:href="mck-20200930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b89bb3dd-5687-41c6-9586-88fe237b7058" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_70792db0-91dc-4db6-88c8-0dd5f0d13fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_89841b84-a231-4385-9445-0354b2186094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b89bb3dd-5687-41c6-9586-88fe237b7058" xlink:to="loc_us-gaap_AllOtherSegmentsMember_89841b84-a231-4385-9445-0354b2186094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_1cc81340-5d6b-4788-b167-db670f8183d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_35664989-7d30-424c-923e-940c792049ec" xlink:to="loc_us-gaap_GoodwillLineItems_1cc81340-5d6b-4788-b167-db670f8183d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1cc81340-5d6b-4788-b167-db670f8183d2" xlink:to="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ca61a5cf-a470-4738-bff8-312d6f40ac26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:to="loc_us-gaap_Goodwill_ca61a5cf-a470-4738-bff8-312d6f40ac26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_25ca028c-5221-4117-a09a-78798b491e57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_25ca028c-5221-4117-a09a-78798b491e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_ade4dea4-be35-47e4-88c0-e69dfef07cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_ade4dea4-be35-47e4-88c0-e69dfef07cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9cf0d0c7-755b-4397-ab07-fda3efe3d503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9cf0d0c7-755b-4397-ab07-fda3efe3d503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_4cbc3fe7-7c42-4c3c-8ef8-fa7b09346fc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_4cbc3fe7-7c42-4c3c-8ef8-fa7b09346fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_76a1979e-2d4b-4e16-9e13-6d53d30023ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_34f783dc-a67f-4909-81c7-0535b15540fb" xlink:to="loc_us-gaap_Goodwill_76a1979e-2d4b-4e16-9e13-6d53d30023ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_90af7612-cf50-4046-96bc-c09a692b0025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aefbd0b0-372d-4e59-9733-016418352f1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_90af7612-cf50-4046-96bc-c09a692b0025" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aefbd0b0-372d-4e59-9733-016418352f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_73a16dd7-9003-47a7-81b8-595645a530d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aefbd0b0-372d-4e59-9733-016418352f1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_73a16dd7-9003-47a7-81b8-595645a530d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_73a16dd7-9003-47a7-81b8-595645a530d1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_2645187d-2369-42c3-94aa-4dab4079719a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_2645187d-2369-42c3-94aa-4dab4079719a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_9ad50638-a94f-4efd-ae2e-0a80dcfb1cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:to="loc_us-gaap_ServiceAgreementsMember_9ad50638-a94f-4efd-ae2e-0a80dcfb1cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember_d88abd27-27e3-4761-8f18-f39830e9f72a" xlink:href="mck-20200930.xsd#mck_PharmacyLicensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:to="loc_mck_PharmacyLicensesMember_d88abd27-27e3-4761-8f18-f39830e9f72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_7fedf573-86d3-4b32-bd3e-4e4dba74dcc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_7fedf573-86d3-4b32-bd3e-4e4dba74dcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2f120128-918d-4d09-9e53-486c9c88d057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2f120128-918d-4d09-9e53-486c9c88d057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_2789f3c4-c257-454e-8006-146774792ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5801ce93-473d-41c1-9dcb-e7fa96c1389c" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_2789f3c4-c257-454e-8006-146774792ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_791ba7d3-0360-4587-ac48-5e358dedc093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_aefbd0b0-372d-4e59-9733-016418352f1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_791ba7d3-0360-4587-ac48-5e358dedc093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_748d2478-39cc-4b2f-8daa-ee5bac3611d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_791ba7d3-0360-4587-ac48-5e358dedc093" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_748d2478-39cc-4b2f-8daa-ee5bac3611d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3f3f43a4-c7dd-47cb-8578-8ffdae5e5b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_791ba7d3-0360-4587-ac48-5e358dedc093" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3f3f43a4-c7dd-47cb-8578-8ffdae5e5b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_78d83740-4500-4090-b287-b73a77598584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_791ba7d3-0360-4587-ac48-5e358dedc093" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_78d83740-4500-4090-b287-b73a77598584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5252650d-5fdd-4023-a42e-4e8e67105046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_791ba7d3-0360-4587-ac48-5e358dedc093" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5252650d-5fdd-4023-a42e-4e8e67105046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1d104ffe-8793-4564-a92b-99de81f0a7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_06d60399-1cdb-4314-afda-bf17b8212b2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1d104ffe-8793-4564-a92b-99de81f0a7fc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_06d60399-1cdb-4314-afda-bf17b8212b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_e67728fd-5cec-4adf-9c75-784dc298c28d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_06d60399-1cdb-4314-afda-bf17b8212b2f" xlink:to="loc_us-gaap_ReportingUnitAxis_e67728fd-5cec-4adf-9c75-784dc298c28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_16968a3c-e7c6-454a-baf3-38e6b69adb77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_e67728fd-5cec-4adf-9c75-784dc298c28d" xlink:to="loc_us-gaap_ReportingUnitDomain_16968a3c-e7c6-454a-baf3-38e6b69adb77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_4ea1bbf0-99bd-443b-8144-b95843fb26dc" xlink:href="mck-20200930.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_16968a3c-e7c6-454a-baf3-38e6b69adb77" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_4ea1bbf0-99bd-443b-8144-b95843fb26dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f3904e61-5f21-4364-9486-4f1e3c1e9250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_06d60399-1cdb-4314-afda-bf17b8212b2f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f3904e61-5f21-4364-9486-4f1e3c1e9250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_26d0c332-c285-4085-91bf-bc25035befe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f3904e61-5f21-4364-9486-4f1e3c1e9250" xlink:to="loc_us-gaap_SegmentDomain_26d0c332-c285-4085-91bf-bc25035befe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_5f7e16e1-9670-4bc3-9485-6cbc3c31dac9" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_26d0c332-c285-4085-91bf-bc25035befe7" xlink:to="loc_mck_InternationalSegmentMember_5f7e16e1-9670-4bc3-9485-6cbc3c31dac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5a27738b-d1be-457b-befb-7562ee5ebf2a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_06d60399-1cdb-4314-afda-bf17b8212b2f" xlink:to="loc_srt_StatementGeographicalAxis_5a27738b-d1be-457b-befb-7562ee5ebf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e9ef95f0-1654-40be-899f-5cfcd76a70f2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_5a27738b-d1be-457b-befb-7562ee5ebf2a" xlink:to="loc_srt_SegmentGeographicalDomain_e9ef95f0-1654-40be-899f-5cfcd76a70f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_47f9df4a-3730-4bea-928f-d8f387562968" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e9ef95f0-1654-40be-899f-5cfcd76a70f2" xlink:to="loc_srt_EuropeMember_47f9df4a-3730-4bea-928f-d8f387562968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_06d60399-1cdb-4314-afda-bf17b8212b2f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_225967b5-50d9-40bc-a372-74d5da24263a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_NumberOfReportableSegments_225967b5-50d9-40bc-a372-74d5da24263a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c5aac8fa-ef35-4aaa-ba5f-805982481c8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c5aac8fa-ef35-4aaa-ba5f-805982481c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax_65d3976e-642e-4703-8968-172cef4c2b17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_GoodwillImpairmentLossNetOfTax_65d3976e-642e-4703-8968-172cef4c2b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f69efbba-3af8-4591-a100-0b3e7e2985fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_Goodwill_f69efbba-3af8-4591-a100-0b3e7e2985fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1a748ec9-747b-4eea-9d18-4ba764b71132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1a748ec9-747b-4eea-9d18-4ba764b71132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2e4497f4-c696-4bd5-b9dc-770d3eea71ed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_7bf9d62c-ddc2-4cf4-b63a-c70219b28f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_7bf9d62c-ddc2-4cf4-b63a-c70219b28f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_afb7773c-a3d5-44a9-9174-cfa9b8322228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_afb7773c-a3d5-44a9-9174-cfa9b8322228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d729c1cc-af69-460c-b0a6-d6d5ec004561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d729c1cc-af69-460c-b0a6-d6d5ec004561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8e8efc6d-eabb-4c53-9f47-7617328b3aff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8e8efc6d-eabb-4c53-9f47-7617328b3aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9cd9bfc8-332f-4815-af35-176b3c058dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9cd9bfc8-332f-4815-af35-176b3c058dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_c66a7ac4-ba5c-4ce5-81ca-00ab10b731ab" xlink:href="mck-20200930.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_dfcb75bb-340f-4745-b65a-c90c37bb62a1" xlink:to="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_c66a7ac4-ba5c-4ce5-81ca-00ab10b731ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_93f15b17-a1a7-4eff-95f2-85b3dd75b847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_e2b29dcc-ca44-4bff-b65d-89ac6ec2b15c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_93f15b17-a1a7-4eff-95f2-85b3dd75b847" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_e2b29dcc-ca44-4bff-b65d-89ac6ec2b15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_00ff73d6-16a5-4746-8d5e-7e2f75457848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_d35ee621-de81-434c-8e3e-99e867dc4919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_00ff73d6-16a5-4746-8d5e-7e2f75457848" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_d35ee621-de81-434c-8e3e-99e867dc4919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_77c840bb-431a-4c8b-868d-ed24062564b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3da3a8e8-a362-4184-a9fa-7ebcfe8b04a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77c840bb-431a-4c8b-868d-ed24062564b4" xlink:to="loc_us-gaap_DebtInstrumentTable_3da3a8e8-a362-4184-a9fa-7ebcfe8b04a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_824db88b-2510-432a-bbd8-6b01510f83e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3da3a8e8-a362-4184-a9fa-7ebcfe8b04a8" xlink:to="loc_us-gaap_DebtInstrumentAxis_824db88b-2510-432a-bbd8-6b01510f83e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_824db88b-2510-432a-bbd8-6b01510f83e4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A365NotesDueNovember302020Member_6e68b673-f8cc-45a9-8936-3cb77e4ee412" xlink:href="mck-20200930.xsd#mck_A365NotesDueNovember302020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A365NotesDueNovember302020Member_6e68b673-f8cc-45a9-8936-3cb77e4ee412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member_2d454046-0f32-4b46-a843-d50431034b2d" xlink:href="mck-20200930.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A475NotesDueMarch12021Member_2d454046-0f32-4b46-a843-d50431034b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_6aa76920-8d42-4587-97bc-d4267b0e3555" xlink:href="mck-20200930.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A270NotesDueDecember152022Member_6aa76920-8d42-4587-97bc-d4267b0e3555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_3c9c4f86-a6a5-4fba-95bc-732323bca715" xlink:href="mck-20200930.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A285NotesDueMarch152023Member_3c9c4f86-a6a5-4fba-95bc-732323bca715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_4ea80889-7b79-40bd-8d75-1065253a9f83" xlink:href="mck-20200930.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A380NotesDueMarch152024Member_4ea80889-7b79-40bd-8d75-1065253a9f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_193e5f95-2961-4df4-a897-6dddaf4bb4d3" xlink:href="mck-20200930.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_193e5f95-2961-4df4-a897-6dddaf4bb4d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_be53c81d-fd77-4d08-9575-c42e4771ec0b" xlink:href="mck-20200930.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A395NotesDueFebruary162028Member_be53c81d-fd77-4d08-9575-c42e4771ec0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_c6ff5bab-c175-46b1-b453-0e8a5f1f0aca" xlink:href="mck-20200930.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A475NotesDueMay302029Member_c6ff5bab-c175-46b1-b453-0e8a5f1f0aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_e74e818d-6972-4489-bc36-e6d20555c89d" xlink:href="mck-20200930.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A600NotesDueMarch12041Member_e74e818d-6972-4489-bc36-e6d20555c89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_94efbe0b-3b68-4930-9f26-5009cbb2c546" xlink:href="mck-20200930.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A488NotesDueMarch152044Member_94efbe0b-3b68-4930-9f26-5009cbb2c546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_eddeb050-bf84-4dc8-bb6b-115627e5664c" xlink:href="mck-20200930.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_eddeb050-bf84-4dc8-bb6b-115627e5664c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_55d7ef95-c8c9-4120-ba34-caa4496a14c8" xlink:href="mck-20200930.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_55d7ef95-c8c9-4120-ba34-caa4496a14c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_ff63446f-6fd3-4a95-8fd4-17136edd857b" xlink:href="mck-20200930.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_ff63446f-6fd3-4a95-8fd4-17136edd857b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_24d1a7b6-764a-4234-a2df-8f903fc3e6e7" xlink:href="mck-20200930.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6e9f71f-4d03-4d69-8c45-d179f1ecf383" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_24d1a7b6-764a-4234-a2df-8f903fc3e6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2f3e490f-5a57-4ee1-82cb-581f00b9bc43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3da3a8e8-a362-4184-a9fa-7ebcfe8b04a8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2f3e490f-5a57-4ee1-82cb-581f00b9bc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f80c6a09-7357-4eaf-b35d-80b29b24e756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2f3e490f-5a57-4ee1-82cb-581f00b9bc43" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f80c6a09-7357-4eaf-b35d-80b29b24e756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_56234cd3-e8c5-4ace-b2b9-3de85be5ba63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f80c6a09-7357-4eaf-b35d-80b29b24e756" xlink:to="loc_us-gaap_LoansPayableMember_56234cd3-e8c5-4ace-b2b9-3de85be5ba63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3da3a8e8-a362-4184-a9fa-7ebcfe8b04a8" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_172faa87-d84b-438a-a38b-13fe425c3ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_172faa87-d84b-438a-a38b-13fe425c3ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d38dfcf7-5ee1-46eb-95be-8eb671dbcd9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_LongTermDebt_d38dfcf7-5ee1-46eb-95be-8eb671dbcd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_46d9e7f8-fa16-4bee-97d0-36b9d664b027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_FinanceLeaseLiability_46d9e7f8-fa16-4bee-97d0-36b9d664b027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_89be03dc-662b-460a-8ce5-db4bca482a94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_89be03dc-662b-460a-8ce5-db4bca482a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d5d0fd8f-04e2-4e0a-94c4-2f9d61a32485" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d5d0fd8f-04e2-4e0a-94c4-2f9d61a32485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_1ce8152d-b5ed-42ed-bd24-c8f0c0fed494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bd49d73e-e787-4e66-89f2-df0b42fe5cec" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_1ce8152d-b5ed-42ed-bd24-c8f0c0fed494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3306a712-25f9-4ea9-934e-051d5f9d845a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_74ddce14-2066-4324-80d2-a44fdbe79bd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3306a712-25f9-4ea9-934e-051d5f9d845a" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_74ddce14-2066-4324-80d2-a44fdbe79bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_7f2015ad-80dc-40cf-9dec-1b2fc0eb887d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3306a712-25f9-4ea9-934e-051d5f9d845a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_7f2015ad-80dc-40cf-9dec-1b2fc0eb887d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_6d94a25f-d146-4808-8e44-3877a59bfcc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3306a712-25f9-4ea9-934e-051d5f9d845a" xlink:to="loc_us-gaap_DebtInstrumentTerm_6d94a25f-d146-4808-8e44-3877a59bfcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d6dbaa81-04e3-419f-8f77-f9b5dfafbec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_4332c8fe-560b-4fb1-929b-71d152f372c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d6dbaa81-04e3-419f-8f77-f9b5dfafbec1" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_4332c8fe-560b-4fb1-929b-71d152f372c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9ef8d4a7-1487-44db-879d-3b3c9c1f3997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4332c8fe-560b-4fb1-929b-71d152f372c3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9ef8d4a7-1487-44db-879d-3b3c9c1f3997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e197b375-7a30-4783-9f77-975dbae84d16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9ef8d4a7-1487-44db-879d-3b3c9c1f3997" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e197b375-7a30-4783-9f77-975dbae84d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_c8e6e7f7-5dc3-4b90-a499-aa78cb6fb46c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e197b375-7a30-4783-9f77-975dbae84d16" xlink:to="loc_us-gaap_UnsecuredDebtMember_c8e6e7f7-5dc3-4b90-a499-aa78cb6fb46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_76660495-0079-4fa1-97f1-d52bf1a1fce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4332c8fe-560b-4fb1-929b-71d152f372c3" xlink:to="loc_us-gaap_CreditFacilityAxis_76660495-0079-4fa1-97f1-d52bf1a1fce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_be4fb198-edee-4dd4-bcee-c9fed08d4f51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_76660495-0079-4fa1-97f1-d52bf1a1fce2" xlink:to="loc_us-gaap_CreditFacilityDomain_be4fb198-edee-4dd4-bcee-c9fed08d4f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_afe1bab2-f873-4570-90e9-be2a23546755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_be4fb198-edee-4dd4-bcee-c9fed08d4f51" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_afe1bab2-f873-4570-90e9-be2a23546755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_adf64b34-236d-43fd-9f22-0e58d39552f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_be4fb198-edee-4dd4-bcee-c9fed08d4f51" xlink:to="loc_us-gaap_LineOfCreditMember_adf64b34-236d-43fd-9f22-0e58d39552f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_29480684-ea3b-46a6-9ba3-9ef8faf6966c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4332c8fe-560b-4fb1-929b-71d152f372c3" xlink:to="loc_us-gaap_DebtInstrumentAxis_29480684-ea3b-46a6-9ba3-9ef8faf6966c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_10127687-98aa-4982-82d1-ddc350cb2cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_29480684-ea3b-46a6-9ba3-9ef8faf6966c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_10127687-98aa-4982-82d1-ddc350cb2cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_e20760d6-e96c-4a47-a245-8d1e58f7bc58" xlink:href="mck-20200930.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_10127687-98aa-4982-82d1-ddc350cb2cf5" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_e20760d6-e96c-4a47-a245-8d1e58f7bc58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_68d462af-7915-4dec-a597-30d5d534fd28" xlink:href="mck-20200930.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_10127687-98aa-4982-82d1-ddc350cb2cf5" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_68d462af-7915-4dec-a597-30d5d534fd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_6c6e9911-617f-4c58-be48-7783da57a084" xlink:href="mck-20200930.xsd#mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_10127687-98aa-4982-82d1-ddc350cb2cf5" xlink:to="loc_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_6c6e9911-617f-4c58-be48-7783da57a084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4332c8fe-560b-4fb1-929b-71d152f372c3" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a7c57131-7ecc-45c1-88a3-17c4b0a2040a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a7c57131-7ecc-45c1-88a3-17c4b0a2040a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_ee2bd337-9719-415b-bb7d-f8dae1f3a236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_DebtInstrumentTerm_ee2bd337-9719-415b-bb7d-f8dae1f3a236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_23bfd6ba-ba09-4d7f-90b2-172dc54f7279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_23bfd6ba-ba09-4d7f-90b2-172dc54f7279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_18fef436-1ae0-4b7c-aec2-d2c532ea5422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_LineOfCredit_18fef436-1ae0-4b7c-aec2-d2c532ea5422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio_ce39fd82-4c1e-4ea2-8367-0593fbcc0493" xlink:href="mck-20200930.xsd#mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio_ce39fd82-4c1e-4ea2-8367-0593fbcc0493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_a67bb352-f6d3-4deb-80a5-0617f47169a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_a67bb352-f6d3-4deb-80a5-0617f47169a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_df72bbff-519f-4b20-a353-6c9175747bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_16258259-34b3-4720-a30f-ad90966e3187" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_df72bbff-519f-4b20-a353-6c9175747bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_af01ec7c-bd1a-4f90-9335-32d54b9aeeac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_df7cc70b-619b-465a-a82c-b8fee0d789cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_af01ec7c-bd1a-4f90-9335-32d54b9aeeac" xlink:to="loc_us-gaap_DebtInstrumentTable_df7cc70b-619b-465a-a82c-b8fee0d789cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f60ab9d2-6b64-4a1a-80c4-a73e9e4c18e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_df7cc70b-619b-465a-a82c-b8fee0d789cf" xlink:to="loc_us-gaap_CreditFacilityAxis_f60ab9d2-6b64-4a1a-80c4-a73e9e4c18e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e337825d-9f72-4f1f-936f-9ae240192712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f60ab9d2-6b64-4a1a-80c4-a73e9e4c18e3" xlink:to="loc_us-gaap_CreditFacilityDomain_e337825d-9f72-4f1f-936f-9ae240192712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_575897f2-f4bf-4a4b-b6f6-a030a47b8eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e337825d-9f72-4f1f-936f-9ae240192712" xlink:to="loc_us-gaap_CommercialPaperMember_575897f2-f4bf-4a4b-b6f6-a030a47b8eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ed543981-bf9f-46e2-8c1d-4f226c6dddf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_df7cc70b-619b-465a-a82c-b8fee0d789cf" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ed543981-bf9f-46e2-8c1d-4f226c6dddf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b8ad2ef1-490c-4d2e-9529-12f601376936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed543981-bf9f-46e2-8c1d-4f226c6dddf8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b8ad2ef1-490c-4d2e-9529-12f601376936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_f15e5903-82ca-404f-805b-c8a0d820bd03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed543981-bf9f-46e2-8c1d-4f226c6dddf8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_f15e5903-82ca-404f-805b-c8a0d820bd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_6e3d0e3c-e648-4cd6-82c6-e628437188ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed543981-bf9f-46e2-8c1d-4f226c6dddf8" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_6e3d0e3c-e648-4cd6-82c6-e628437188ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent_3ed97507-ffd5-494d-9a41-09ab9531da3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed543981-bf9f-46e2-8c1d-4f226c6dddf8" xlink:to="loc_us-gaap_LongTermCommercialPaperCurrent_3ed97507-ffd5-494d-9a41-09ab9531da3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20200930.xsd#PensionBenefits"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fb501833-33cf-4485-97af-3f9f0f9a484f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f1d5503a-fcac-4efe-ab46-5bba01bcac0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fb501833-33cf-4485-97af-3f9f0f9a484f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f1d5503a-fcac-4efe-ab46-5bba01bcac0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#PensionBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6ce2ca58-8957-44cf-a8a3-87f80a02fb92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e13bdec6-9e4f-4118-bab3-1e448816fe3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6ce2ca58-8957-44cf-a8a3-87f80a02fb92" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e13bdec6-9e4f-4118-bab3-1e448816fe3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ae52d35d-7435-4892-aff2-4e1b56814439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e13bdec6-9e4f-4118-bab3-1e448816fe3c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ae52d35d-7435-4892-aff2-4e1b56814439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b9eeb509-b8d0-498f-bb49-1832b4685d8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ae52d35d-7435-4892-aff2-4e1b56814439" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b9eeb509-b8d0-498f-bb49-1832b4685d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f51f4bed-89ed-402a-a929-76d52245a91c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b9eeb509-b8d0-498f-bb49-1832b4685d8a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f51f4bed-89ed-402a-a929-76d52245a91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_f70a6861-d68c-44d9-8b35-28cbcc1dae11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e13bdec6-9e4f-4118-bab3-1e448816fe3c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_f70a6861-d68c-44d9-8b35-28cbcc1dae11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca9a03f5-1238-4a72-83bd-d41d007943fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_f70a6861-d68c-44d9-8b35-28cbcc1dae11" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca9a03f5-1238-4a72-83bd-d41d007943fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_e5daf3e4-c9ed-4aec-9564-d10e997f1412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca9a03f5-1238-4a72-83bd-d41d007943fd" xlink:to="loc_us-gaap_DomesticPlanMember_e5daf3e4-c9ed-4aec-9564-d10e997f1412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b04576dc-331a-46d3-b4d0-8a5ba1da3b85" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_e5daf3e4-c9ed-4aec-9564-d10e997f1412" xlink:to="loc_country_US_b04576dc-331a-46d3-b4d0-8a5ba1da3b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_643ae6a9-01d7-4c49-9522-769195678e72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e13bdec6-9e4f-4118-bab3-1e448816fe3c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_643ae6a9-01d7-4c49-9522-769195678e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a079b787-dab6-48ea-a6a0-a40effda29d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_643ae6a9-01d7-4c49-9522-769195678e72" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a079b787-dab6-48ea-a6a0-a40effda29d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9f14f032-1ef9-4e05-918f-ab62c8ea4e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a079b787-dab6-48ea-a6a0-a40effda29d9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9f14f032-1ef9-4e05-918f-ab62c8ea4e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e13bdec6-9e4f-4118-bab3-1e448816fe3c" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_783a7732-c870-4913-8ec8-783f97eca3f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_783a7732-c870-4913-8ec8-783f97eca3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_7ee19d11-acc2-4f62-8d64-4bf3d19371b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_7ee19d11-acc2-4f62-8d64-4bf3d19371b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage_eaed4238-0b5b-47c3-ac14-1f832c64868a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedPercentage_eaed4238-0b5b-47c3-ac14-1f832c64868a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_3bd2eb7b-ced2-4e99-a6bf-d7dfdbcd66d8" xlink:href="mck-20200930.xsd#mck_DefinedBenefitPlanSettlementPlanParticipants"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_3bd2eb7b-ced2-4e99-a6bf-d7dfdbcd66d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_bf5a640f-ff32-4006-8fb8-93f78f7ecf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_bf5a640f-ff32-4006-8fb8-93f78f7ecf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_621672e0-aff9-44ae-838a-c1c71ea23e72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_621672e0-aff9-44ae-838a-c1c71ea23e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_65a381e7-1031-4975-9359-c411f4f11565" xlink:href="mck-20200930.xsd#mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_71a7a727-a9f3-4c53-98d2-00b9d60c3e09" xlink:to="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_65a381e7-1031-4975-9359-c411f4f11565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20200930.xsd#HedgingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c62a0fb4-578f-4aef-91c0-6a453a575dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b920b7a3-900d-4cd3-9c84-4864fa58fdc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c62a0fb4-578f-4aef-91c0-6a453a575dc8" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b920b7a3-900d-4cd3-9c84-4864fa58fdc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20200930.xsd#HedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_84add31f-1913-4ead-bf5c-6d78f3742cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_5b6ed77e-8ab3-48c4-8614-1439f426cc15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_84add31f-1913-4ead-bf5c-6d78f3742cd6" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_5b6ed77e-8ab3-48c4-8614-1439f426cc15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_05856163-9959-4af4-adc9-aa58bc814e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_05856163-9959-4af4-adc9-aa58bc814e6a" xlink:to="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_532885af-9dcb-461f-a246-6df964ada32c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:to="loc_us-gaap_DebtInstrumentAxis_532885af-9dcb-461f-a246-6df964ada32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4bb11af0-2928-4f01-bd48-761c64f38733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_532885af-9dcb-461f-a246-6df964ada32c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4bb11af0-2928-4f01-bd48-761c64f38733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_081965f6-d298-46bb-a863-6bcaa49f4304" xlink:href="mck-20200930.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4bb11af0-2928-4f01-bd48-761c64f38733" xlink:to="loc_mck_EuroDenominatedNotesMember_081965f6-d298-46bb-a863-6bcaa49f4304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_d51add86-8661-4d4c-87f1-edac711669d5" xlink:href="mck-20200930.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4bb11af0-2928-4f01-bd48-761c64f38733" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_d51add86-8661-4d4c-87f1-edac711669d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d530b877-de31-47aa-9314-9a75c0485e11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d530b877-de31-47aa-9314-9a75c0485e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4662f552-c803-4757-9aba-6acd850e5983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d530b877-de31-47aa-9314-9a75c0485e11" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4662f552-c803-4757-9aba-6acd850e5983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b8130e2b-42c4-4b4c-a501-ca7a9585f587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4662f552-c803-4757-9aba-6acd850e5983" xlink:to="loc_us-gaap_LoansPayableMember_b8130e2b-42c4-4b4c-a501-ca7a9585f587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0db00d95-ea48-4bb9-8363-842246c9d643" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0db00d95-ea48-4bb9-8363-842246c9d643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7db81415-0b78-423a-a20e-02d4be0c936d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0db00d95-ea48-4bb9-8363-842246c9d643" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7db81415-0b78-423a-a20e-02d4be0c936d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_195d8f19-535b-49e7-8e7f-10366a92edac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7db81415-0b78-423a-a20e-02d4be0c936d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_195d8f19-535b-49e7-8e7f-10366a92edac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_01f3e311-2db4-43ba-9598-161895d064e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7db81415-0b78-423a-a20e-02d4be0c936d" xlink:to="loc_us-gaap_CashFlowHedgingMember_01f3e311-2db4-43ba-9598-161895d064e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_774a9a8a-c3b4-4f03-9175-24002bd8d8bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_774a9a8a-c3b4-4f03-9175-24002bd8d8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6446085c-db4b-415e-9b90-daa75a5eaa92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_774a9a8a-c3b4-4f03-9175-24002bd8d8bb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6446085c-db4b-415e-9b90-daa75a5eaa92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember_efa35ea8-0055-4165-8b50-a52128641074" xlink:href="mck-20200930.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6446085c-db4b-415e-9b90-daa75a5eaa92" xlink:to="loc_mck_November2018CrossCurrencySwapsMember_efa35ea8-0055-4165-8b50-a52128641074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_3c763f32-8281-4823-90ff-77884691656b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6446085c-db4b-415e-9b90-daa75a5eaa92" xlink:to="loc_us-gaap_CurrencySwapMember_3c763f32-8281-4823-90ff-77884691656b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f067ae9d-8374-4261-980e-c09018f89a75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6446085c-db4b-415e-9b90-daa75a5eaa92" xlink:to="loc_us-gaap_InterestRateSwapMember_f067ae9d-8374-4261-980e-c09018f89a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_6151634b-e5f7-4355-adc2-b66c5ffffa25" xlink:href="mck-20200930.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6446085c-db4b-415e-9b90-daa75a5eaa92" xlink:to="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_6151634b-e5f7-4355-adc2-b66c5ffffa25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_347933be-9ced-417e-a3e4-c8a32c78b5c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:to="loc_us-gaap_HedgingDesignationAxis_347933be-9ced-417e-a3e4-c8a32c78b5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_84ff6e6e-42ff-4cc0-a3c1-a7e024e9bb51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_347933be-9ced-417e-a3e4-c8a32c78b5c2" xlink:to="loc_us-gaap_HedgingDesignationDomain_84ff6e6e-42ff-4cc0-a3c1-a7e024e9bb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_12d656d5-91ff-4e52-b011-ae1cf173c859" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_84ff6e6e-42ff-4cc0-a3c1-a7e024e9bb51" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_12d656d5-91ff-4e52-b011-ae1cf173c859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_874878d4-dbb7-41c0-b456-fffa1108abe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_84ff6e6e-42ff-4cc0-a3c1-a7e024e9bb51" xlink:to="loc_us-gaap_NondesignatedMember_874878d4-dbb7-41c0-b456-fffa1108abe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c59ecdab-ca56-45a6-bede-9f5ee533b8d2" xlink:to="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_520cd492-3682-4b6f-a3d1-55477d09732a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_LongTermDebt_520cd492-3682-4b6f-a3d1-55477d09732a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_f1aad434-c95e-4eef-bab1-76a8e6861c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_f1aad434-c95e-4eef-bab1-76a8e6861c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_baa703d6-87c9-4a35-81a7-19c1c193503e" xlink:href="mck-20200930.xsd#mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_baa703d6-87c9-4a35-81a7-19c1c193503e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6840b6e5-7e5a-4ef4-ad28-bf7736b30ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6840b6e5-7e5a-4ef4-ad28-bf7736b30ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_f50c7047-3975-4065-80e4-5e1fe968a8e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_f50c7047-3975-4065-80e4-5e1fe968a8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_758262ca-f4fe-4dc9-9c5a-74449cdce43f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_758262ca-f4fe-4dc9-9c5a-74449cdce43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_7a0b3105-52cf-4c90-b0ce-8c7303c56d68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_7a0b3105-52cf-4c90-b0ce-8c7303c56d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_0c3abbcf-229f-4de7-9dd3-925475f518b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_678bc764-c74b-4be4-bf25-6e24355fbb8a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_0c3abbcf-229f-4de7-9dd3-925475f518b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#HedgingActivitiesDerivativeInstrumentsFairValueDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3246df27-d49a-4168-94cb-a1adfa5806fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_66f02702-b79e-4e03-aaca-04f596d8402a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3246df27-d49a-4168-94cb-a1adfa5806fd" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_66f02702-b79e-4e03-aaca-04f596d8402a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_64e96bc7-5217-43d7-ba9a-f6f8e30d7a3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_66f02702-b79e-4e03-aaca-04f596d8402a" xlink:to="loc_us-gaap_HedgingDesignationAxis_64e96bc7-5217-43d7-ba9a-f6f8e30d7a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_25916c37-ab94-4d9a-8d47-0b831f7bc4ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_64e96bc7-5217-43d7-ba9a-f6f8e30d7a3e" xlink:to="loc_us-gaap_HedgingDesignationDomain_25916c37-ab94-4d9a-8d47-0b831f7bc4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_26e05373-744f-4cbf-b213-ee2a23fbb509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_25916c37-ab94-4d9a-8d47-0b831f7bc4ed" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_26e05373-744f-4cbf-b213-ee2a23fbb509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_fc3c77e0-9a55-45e1-9a3e-8a84feaaac98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_25916c37-ab94-4d9a-8d47-0b831f7bc4ed" xlink:to="loc_us-gaap_NondesignatedMember_fc3c77e0-9a55-45e1-9a3e-8a84feaaac98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6bb07814-38df-496c-a109-609c2b4bf9fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_66f02702-b79e-4e03-aaca-04f596d8402a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6bb07814-38df-496c-a109-609c2b4bf9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0eb9401b-f57e-4f59-b80a-299f08203821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6bb07814-38df-496c-a109-609c2b4bf9fd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0eb9401b-f57e-4f59-b80a-299f08203821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_caa4b2c0-2866-4c96-8710-476281f9cc86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0eb9401b-f57e-4f59-b80a-299f08203821" xlink:to="loc_us-gaap_CurrencySwapMember_caa4b2c0-2866-4c96-8710-476281f9cc86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_17bab195-c16b-45cf-a851-3ab614c8a072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0eb9401b-f57e-4f59-b80a-299f08203821" xlink:to="loc_us-gaap_InterestRateSwapMember_17bab195-c16b-45cf-a851-3ab614c8a072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a82a6a0f-522a-4907-aa11-50f16a022cc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0eb9401b-f57e-4f59-b80a-299f08203821" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a82a6a0f-522a-4907-aa11-50f16a022cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b7fb3214-94ad-46e8-9d44-6faffbb6850f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_66f02702-b79e-4e03-aaca-04f596d8402a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b7fb3214-94ad-46e8-9d44-6faffbb6850f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b7fb3214-94ad-46e8-9d44-6faffbb6850f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_e9c25f62-79b7-4559-819e-ace00c964b0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_e9c25f62-79b7-4559-819e-ace00c964b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_29f7c8bb-f682-46d9-aac1-954ecb179a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_29f7c8bb-f682-46d9-aac1-954ecb179a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_08ca91cb-4763-4589-8dd7-f9e77c823d9e" xlink:href="mck-20200930.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:to="loc_mck_CurrentAssetLiabilityMember_08ca91cb-4763-4589-8dd7-f9e77c823d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_d25e6ea2-987e-4a44-be2d-9bd440cc1034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_d25e6ea2-987e-4a44-be2d-9bd440cc1034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7cb07350-83dc-41f6-a5df-92e32fb9d673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7cb07350-83dc-41f6-a5df-92e32fb9d673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncurrentAssetLiabilityMember_b247630f-cc62-4a73-bb4d-3b8206f65dbb" xlink:href="mck-20200930.xsd#mck_NoncurrentAssetLiabilityMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c999898f-5672-4dd1-8032-5ec3ce21bdf3" xlink:to="loc_mck_NoncurrentAssetLiabilityMember_b247630f-cc62-4a73-bb4d-3b8206f65dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_f907b210-a9c8-4106-9583-b4562648a709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_66f02702-b79e-4e03-aaca-04f596d8402a" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_f907b210-a9c8-4106-9583-b4562648a709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5bdfa689-1225-4519-8ce8-fbe65141ce77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f907b210-a9c8-4106-9583-b4562648a709" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5bdfa689-1225-4519-8ce8-fbe65141ce77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a57bf075-6971-45d5-bb7e-6dec33f44693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f907b210-a9c8-4106-9583-b4562648a709" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a57bf075-6971-45d5-bb7e-6dec33f44693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_8fa40cee-441f-422f-bb06-43122beea92b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f907b210-a9c8-4106-9583-b4562648a709" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_8fa40cee-441f-422f-bb06-43122beea92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_abc8dc77-2e86-4145-9c9f-af19d85f48a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f907b210-a9c8-4106-9583-b4562648a709" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_abc8dc77-2e86-4145-9c9f-af19d85f48a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20200930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0139f337-c3e9-4fa2-89a5-b7ea794bf080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_11de71b4-4bcb-468a-bc02-762444ea3fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0139f337-c3e9-4fa2-89a5-b7ea794bf080" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_11de71b4-4bcb-468a-bc02-762444ea3fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0f0824f1-1eb0-4b02-89e2-64557ddbe3fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_868c19bd-d956-4aa1-b299-f5c96aa9a401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0f0824f1-1eb0-4b02-89e2-64557ddbe3fb" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_868c19bd-d956-4aa1-b299-f5c96aa9a401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f03920db-19fa-4e73-af69-80b54dc49c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_868c19bd-d956-4aa1-b299-f5c96aa9a401" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f03920db-19fa-4e73-af69-80b54dc49c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5032461a-9bd8-4779-ab40-d28fb9365869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f03920db-19fa-4e73-af69-80b54dc49c57" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5032461a-9bd8-4779-ab40-d28fb9365869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b274c5a8-4246-42aa-9289-6d8668f0ab53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5032461a-9bd8-4779-ab40-d28fb9365869" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b274c5a8-4246-42aa-9289-6d8668f0ab53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_700ba709-7a1b-43bf-a936-3e4338c1d983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5032461a-9bd8-4779-ab40-d28fb9365869" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_700ba709-7a1b-43bf-a936-3e4338c1d983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593c4e70-f927-48f3-930f-ef9a6424d2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_868c19bd-d956-4aa1-b299-f5c96aa9a401" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593c4e70-f927-48f3-930f-ef9a6424d2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_020b87d1-c1d9-4267-9116-e981fcba7d20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593c4e70-f927-48f3-930f-ef9a6424d2c9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_020b87d1-c1d9-4267-9116-e981fcba7d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0ccaf851-a18d-447c-a095-0a8914dbf5a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_020b87d1-c1d9-4267-9116-e981fcba7d20" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0ccaf851-a18d-447c-a095-0a8914dbf5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4003965e-5f13-4e91-b7d8-191ce74e0521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_020b87d1-c1d9-4267-9116-e981fcba7d20" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4003965e-5f13-4e91-b7d8-191ce74e0521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_868c19bd-d956-4aa1-b299-f5c96aa9a401" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a7a5e991-a451-445e-96e6-70ffda6d1a85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_LongTermDebt_a7a5e991-a451-445e-96e6-70ffda6d1a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_f390de62-13e7-4eeb-bd50-f14fdd777ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_DebtInstrumentFairValue_f390de62-13e7-4eeb-bd50-f14fdd777ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_3bd3408c-0507-4f61-bedd-f783a02446fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_3bd3408c-0507-4f61-bedd-f783a02446fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_04ff3787-9bc6-4c41-8ff0-4e7fe358e186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_04ff3787-9bc6-4c41-8ff0-4e7fe358e186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_39eebc01-e915-45a6-9846-cf1376b615ec" xlink:href="mck-20200930.xsd#mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_39eebc01-e915-45a6-9846-cf1376b615ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_f5e69d2f-b10c-43ea-8e4f-02b5ba4a18d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_f5e69d2f-b10c-43ea-8e4f-02b5ba4a18d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_f100c91c-d6d1-4652-a142-c8cf0248b232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07016829-497d-4d48-b61f-bfc39dbe0c36" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_f100c91c-d6d1-4652-a142-c8cf0248b232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20200930.xsd#CommitmentsandContingentLiabilities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fc1f6c9d-82f6-4f33-9362-44b544c975bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f1bbb8ed-6852-44ce-ac0f-239991a09122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fc1f6c9d-82f6-4f33-9362-44b544c975bb" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f1bbb8ed-6852-44ce-ac0f-239991a09122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8eee98a6-180d-4f99-888c-17280ec31628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8eee98a6-180d-4f99-888c-17280ec31628" xlink:to="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_cf520a59-c8ed-4f73-847d-17a7226edb7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_us-gaap_LitigationStatusAxis_cf520a59-c8ed-4f73-847d-17a7226edb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_302f2f3f-80dc-480e-93a8-2fa438014f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_cf520a59-c8ed-4f73-847d-17a7226edb7b" xlink:to="loc_us-gaap_LitigationStatusDomain_302f2f3f-80dc-480e-93a8-2fa438014f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_c267e7a5-35b8-4d86-a048-02d496b8c23b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_302f2f3f-80dc-480e-93a8-2fa438014f37" xlink:to="loc_us-gaap_PendingLitigationMember_c267e7a5-35b8-4d86-a048-02d496b8c23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_098a9c69-9613-467d-a5ff-5fd31e6296bd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_dei_LegalEntityAxis_098a9c69-9613-467d-a5ff-5fd31e6296bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_565254e4-52b6-4eaf-b49a-ff51efda6d6b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_098a9c69-9613-467d-a5ff-5fd31e6296bd" xlink:to="loc_dei_EntityDomain_565254e4-52b6-4eaf-b49a-ff51efda6d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_19b98690-5eb0-4f96-916d-8265c686ce03" xlink:href="mck-20200930.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_565254e4-52b6-4eaf-b49a-ff51efda6d6b" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_19b98690-5eb0-4f96-916d-8265c686ce03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2e97acf4-efa3-4112-86c0-3ae7b044ed8c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_srt_StatementGeographicalAxis_2e97acf4-efa3-4112-86c0-3ae7b044ed8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_125e7454-c6da-4445-85e4-df2bc03d2627" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2e97acf4-efa3-4112-86c0-3ae7b044ed8c" xlink:to="loc_srt_SegmentGeographicalDomain_125e7454-c6da-4445-85e4-df2bc03d2627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_d98ff233-722b-4743-bbb6-eeaf1e6bf46a" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_125e7454-c6da-4445-85e4-df2bc03d2627" xlink:to="loc_country_CA_d98ff233-722b-4743-bbb6-eeaf1e6bf46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7c546df8-f076-4675-a202-166ba7fbb170" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_srt_LitigationCaseAxis_7c546df8-f076-4675-a202-166ba7fbb170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_77feadd7-894b-4503-a0b3-8d681aaacab6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_7c546df8-f076-4675-a202-166ba7fbb170" xlink:to="loc_srt_LitigationCaseTypeDomain_77feadd7-894b-4503-a0b3-8d681aaacab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InreNationalPrescriptionOpiateLitigationMember_cdce6d0a-1938-49bd-acb0-30bb7387b3f3" xlink:href="mck-20200930.xsd#mck_InreNationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_77feadd7-894b-4503-a0b3-8d681aaacab6" xlink:to="loc_mck_InreNationalPrescriptionOpiateLitigationMember_cdce6d0a-1938-49bd-acb0-30bb7387b3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelKelley19Cv2233Member_7b362900-ff48-49a3-a870-ea590c32e8f3" xlink:href="mck-20200930.xsd#mck_UnitedStatesExRelKelley19Cv2233Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_77feadd7-894b-4503-a0b3-8d681aaacab6" xlink:to="loc_mck_UnitedStatesExRelKelley19Cv2233Member_7b362900-ff48-49a3-a870-ea590c32e8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_472f52f5-4ce8-40a7-b193-3cde603d946a" xlink:href="mck-20200930.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_77feadd7-894b-4503-a0b3-8d681aaacab6" xlink:to="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_472f52f5-4ce8-40a7-b193-3cde603d946a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_da59ad76-3cd5-45df-b6b3-9a99dc636c77" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_srt_RangeAxis_da59ad76-3cd5-45df-b6b3-9a99dc636c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8bdd5cb1-6f65-45e9-be25-eb15aaa2b20c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_da59ad76-3cd5-45df-b6b3-9a99dc636c77" xlink:to="loc_srt_RangeMember_8bdd5cb1-6f65-45e9-be25-eb15aaa2b20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_95a20301-3681-4bda-bdd4-6062dd7a4859" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8bdd5cb1-6f65-45e9-be25-eb15aaa2b20c" xlink:to="loc_srt_MinimumMember_95a20301-3681-4bda-bdd4-6062dd7a4859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_788f7e5a-66ca-4d68-85ba-915a2322f249" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8bdd5cb1-6f65-45e9-be25-eb15aaa2b20c" xlink:to="loc_srt_MaximumMember_788f7e5a-66ca-4d68-85ba-915a2322f249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bb711659-5336-4fbe-ad9b-cbee8046385c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bb711659-5336-4fbe-ad9b-cbee8046385c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_88ebd4e1-57f7-4c82-87a3-c619d383601f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bb711659-5336-4fbe-ad9b-cbee8046385c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_88ebd4e1-57f7-4c82-87a3-c619d383601f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a913cdd6-c9f6-4839-ad65-0d2bbdc6fb87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_88ebd4e1-57f7-4c82-87a3-c619d383601f" xlink:to="loc_us-gaap_SubsequentEventMember_a913cdd6-c9f6-4839-ad65-0d2bbdc6fb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b8676889-f5bc-4d55-b20d-8f359f855ad6" xlink:to="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_23d48317-2e7b-4fd4-9ba0-9bf56571d0b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_23d48317-2e7b-4fd4-9ba0-9bf56571d0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_d7be8acf-4159-40c5-bec8-1c1a46967efa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_d7be8acf-4159-40c5-bec8-1c1a46967efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCounties_f20bdbc8-e3d4-48c2-a7a2-3d074cc4426b" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofCounties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyNumberofCounties_f20bdbc8-e3d4-48c2-a7a2-3d074cc4426b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_5149ac07-1434-4614-8d8b-0bf8ff684635" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_5149ac07-1434-4614-8d8b-0bf8ff684635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_31a65388-a103-425d-b944-9458ac6fee08" xlink:href="mck-20200930.xsd#mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_31a65388-a103-425d-b944-9458ac6fee08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_fb01d176-9352-497c-86b4-2c0b88d4f1fa" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofStates"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyNumberofStates_fb01d176-9352-497c-86b4-2c0b88d4f1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStateAttorneyGenerals_8633a66c-e6cf-4d04-b689-18343b5b24e8" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofStateAttorneyGenerals"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyNumberofStateAttorneyGenerals_8633a66c-e6cf-4d04-b689-18343b5b24e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfCountyGovernments_50768f14-8350-446a-a18e-f96a97e26642" xlink:href="mck-20200930.xsd#mck_NumberOfCountyGovernments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_NumberOfCountyGovernments_50768f14-8350-446a-a18e-f96a97e26642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_bdc78785-acee-48af-8afd-c76b09740590" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_bdc78785-acee-48af-8afd-c76b09740590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_f4724c61-be53-4377-8c03-4944a7fbb210" xlink:href="mck-20200930.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_f4724c61-be53-4377-8c03-4944a7fbb210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofRelatorsAllegingViolations_9c6acadc-198d-4d77-ad0f-cb9b22933e28" xlink:href="mck-20200930.xsd#mck_LossContingencyNumberofRelatorsAllegingViolations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyNumberofRelatorsAllegingViolations_9c6acadc-198d-4d77-ad0f-cb9b22933e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue_ebb9da6e-454b-4b56-b5fb-da1955c460b6" xlink:href="mck-20200930.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyDamagesSoughtPerViolationValue_ebb9da6e-454b-4b56-b5fb-da1955c460b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_761186a3-5cbc-449f-93c7-ec0525d4ad70" xlink:href="mck-20200930.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_761186a3-5cbc-449f-93c7-ec0525d4ad70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived_86155213-6a97-468e-aee2-5685b3a0eefa" xlink:href="mck-20200930.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesReceived_86155213-6a97-468e-aee2-5685b3a0eefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_c56415eb-3bcb-45e0-adb8-22ca7139e15f" xlink:href="mck-20200930.xsd#mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_c56415eb-3bcb-45e0-adb8-22ca7139e15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_6f272927-d7a3-458a-9abd-e30ec5a2a313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_6f272927-d7a3-458a-9abd-e30ec5a2a313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualAfterTax_fe7e864b-f998-492d-a5e1-a0f6b69cc2d2" xlink:href="mck-20200930.xsd#mck_LossContingencyAccrualAfterTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_82437b3c-fd8f-4be7-bf30-438a3d072a53" xlink:to="loc_mck_LossContingencyAccrualAfterTax_fe7e864b-f998-492d-a5e1-a0f6b69cc2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquity" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_cd7361fc-e857-4a97-ab8c-24013cb77077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ab1c5c12-0db4-425d-a441-ec79f6d5bf96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cd7361fc-e857-4a97-ab8c-24013cb77077" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ab1c5c12-0db4-425d-a441-ec79f6d5bf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_85855b97-9be1-4e60-b1cd-56e83587b132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_6f73ec7f-fb85-4123-afc0-be528c38e988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_85855b97-9be1-4e60-b1cd-56e83587b132" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_6f73ec7f-fb85-4123-afc0-be528c38e988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6edc623d-1c50-49f9-bddb-26237414becc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_85855b97-9be1-4e60-b1cd-56e83587b132" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6edc623d-1c50-49f9-bddb-26237414becc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ab271c75-470e-4e3d-81c5-8c771210c3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_e854893c-ada6-49c1-988d-2cb45d332c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ab271c75-470e-4e3d-81c5-8c771210c3c3" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_e854893c-ada6-49c1-988d-2cb45d332c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_24986445-1787-4d8b-a1e2-808421646fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_e854893c-ada6-49c1-988d-2cb45d332c62" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_24986445-1787-4d8b-a1e2-808421646fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_3e5903a0-0fe7-4ea7-be3d-8c2b2b767f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_24986445-1787-4d8b-a1e2-808421646fdf" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_3e5903a0-0fe7-4ea7-be3d-8c2b2b767f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketShareRepurchaseTransactionsMember_cfa38578-ebe3-4eb7-bdcc-db569857a71d" xlink:href="mck-20200930.xsd#mck_OpenMarketShareRepurchaseTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_3e5903a0-0fe7-4ea7-be3d-8c2b2b767f05" xlink:to="loc_mck_OpenMarketShareRepurchaseTransactionsMember_cfa38578-ebe3-4eb7-bdcc-db569857a71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_50119de6-1221-407e-ae58-6326c4317d1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_e854893c-ada6-49c1-988d-2cb45d332c62" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_50119de6-1221-407e-ae58-6326c4317d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8b487251-02a8-4ae1-834e-111572cedc9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_50119de6-1221-407e-ae58-6326c4317d1a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8b487251-02a8-4ae1-834e-111572cedc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_82730e18-6fc3-49d2-9f57-81ddbc1fbb35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8b487251-02a8-4ae1-834e-111572cedc9c" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_82730e18-6fc3-49d2-9f57-81ddbc1fbb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_e854893c-ada6-49c1-988d-2cb45d332c62" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_400d3925-18cc-446f-ae4d-eea79dac6b22" xlink:href="mck-20200930.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_400d3925-18cc-446f-ae4d-eea79dac6b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_21be9dd3-08b0-48e2-a1de-7cb2920eb524" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_21be9dd3-08b0-48e2-a1de-7cb2920eb524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_fddd1f5a-adbf-4950-a1e5-186838cdf13c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_fddd1f5a-adbf-4950-a1e5-186838cdf13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_94c7cc0c-a75e-49bc-b014-02db7276a8ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_94c7cc0c-a75e-49bc-b014-02db7276a8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_fcb768bd-da26-437f-b4e8-eec2fb953b46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_fcb768bd-da26-437f-b4e8-eec2fb953b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_71bbf4f4-7688-4ee0-9e48-084bad7bfba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_83d63894-9b08-422b-aa73-27c0e882627b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_71bbf4f4-7688-4ee0-9e48-084bad7bfba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_02a5601a-18a8-4f4e-8619-3886ccdf00b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_02a5601a-18a8-4f4e-8619-3886ccdf00b1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f7085f1e-f7b2-491f-b480-bf5a842235db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:to="loc_us-gaap_HedgingDesignationAxis_f7085f1e-f7b2-491f-b480-bf5a842235db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a16eedb8-45ac-424e-8f15-c43c2e2d91aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f7085f1e-f7b2-491f-b480-bf5a842235db" xlink:to="loc_us-gaap_HedgingDesignationDomain_a16eedb8-45ac-424e-8f15-c43c2e2d91aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_938a73d8-c045-42f8-9a70-07220a1f3aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a16eedb8-45ac-424e-8f15-c43c2e2d91aa" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_938a73d8-c045-42f8-9a70-07220a1f3aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dc995973-57d8-4dd9-b838-6345cc7b2e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dc995973-57d8-4dd9-b838-6345cc7b2e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_88f36ac0-971a-4b38-8e28-5aa9ca58c320" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dc995973-57d8-4dd9-b838-6345cc7b2e6a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_88f36ac0-971a-4b38-8e28-5aa9ca58c320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_5b10102b-f973-4e70-89b1-0286c5f5e945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_88f36ac0-971a-4b38-8e28-5aa9ca58c320" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_5b10102b-f973-4e70-89b1-0286c5f5e945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3d281ebc-8f77-4513-96d1-03eedd75c446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:to="loc_us-gaap_DebtInstrumentAxis_3d281ebc-8f77-4513-96d1-03eedd75c446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5927e631-f212-4b4c-8c8c-a44023fdf7ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3d281ebc-8f77-4513-96d1-03eedd75c446" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5927e631-f212-4b4c-8c8c-a44023fdf7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_502f16a8-412d-4114-8d13-d2b95e4d908d" xlink:href="mck-20200930.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5927e631-f212-4b4c-8c8c-a44023fdf7ad" xlink:to="loc_mck_EuroDenominatedNotesMember_502f16a8-412d-4114-8d13-d2b95e4d908d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_105ea7d3-65a7-4a15-8e20-2f3c458962d1" xlink:href="mck-20200930.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5927e631-f212-4b4c-8c8c-a44023fdf7ad" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_105ea7d3-65a7-4a15-8e20-2f3c458962d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_33744f91-4137-4701-9b01-a2e09e8cc258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_33744f91-4137-4701-9b01-a2e09e8cc258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d1af3131-1277-428a-adc8-1ea7987c0270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_33744f91-4137-4701-9b01-a2e09e8cc258" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d1af3131-1277-428a-adc8-1ea7987c0270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_a39e65b0-ff1f-4aa6-a5d8-86d953ad6476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d1af3131-1277-428a-adc8-1ea7987c0270" xlink:to="loc_us-gaap_LoansPayableMember_a39e65b0-ff1f-4aa6-a5d8-86d953ad6476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_511e643b-8e04-47d8-9bec-da90e22cf3ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_511e643b-8e04-47d8-9bec-da90e22cf3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_511e643b-8e04-47d8-9bec-da90e22cf3ed" xlink:to="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_25fa7230-c51d-4ddb-977c-873ffa2eca00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_25fa7230-c51d-4ddb-977c-873ffa2eca00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_fb9b2e34-7775-49f6-99c0-63fe287fc6f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_fb9b2e34-7775-49f6-99c0-63fe287fc6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_6bfcbff2-6b84-4065-86e0-7be3f835d5b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_6bfcbff2-6b84-4065-86e0-7be3f835d5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_12875ff7-02ec-484a-972d-375f32c02dce" xlink:href="mck-20200930.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_12875ff7-02ec-484a-972d-375f32c02dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_648561d5-a74f-4420-8b88-6062736dbd38" xlink:href="mck-20200930.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_648561d5-a74f-4420-8b88-6062736dbd38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_1583df73-7b04-45b9-ac71-3b916ddfda06" xlink:href="mck-20200930.xsd#mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_1583df73-7b04-45b9-ac71-3b916ddfda06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_da99804f-5a63-4071-a6f6-e0798202f8b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0fc87a2-8c51-424e-ab51-5815b3086095" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_da99804f-5a63-4071-a6f6-e0798202f8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1a59e03-82cd-4e8f-b129-c52231dd2474" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_caaac9ed-6571-4fce-a6a2-d6dd4d6ae12b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_caaac9ed-6571-4fce-a6a2-d6dd4d6ae12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f6740d1d-ea75-40bd-9a95-6fc510915660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f6740d1d-ea75-40bd-9a95-6fc510915660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_22e04535-d290-4c49-88bc-8f15b4782043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_22e04535-d290-4c49-88bc-8f15b4782043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_f6790787-014a-4666-ad31-26075f62d1f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_f6790787-014a-4666-ad31-26075f62d1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_2c172a6a-a710-49e5-9271-26ad7c5d53ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_2c172a6a-a710-49e5-9271-26ad7c5d53ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_20387319-ffcc-4d08-bb51-410ad084db1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_20387319-ffcc-4d08-bb51-410ad084db1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3d789bfa-6f49-49ab-b1ed-b8d7ce054559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3d789bfa-6f49-49ab-b1ed-b8d7ce054559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_7768147b-8e40-4830-8e5d-3c6e69f0b61f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_7768147b-8e40-4830-8e5d-3c6e69f0b61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_9ea37134-90cc-4a1f-ac8f-6e60b77cf2d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_9ea37134-90cc-4a1f-ac8f-6e60b77cf2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_51059992-b268-4439-833f-ffdded3972bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_51059992-b268-4439-833f-ffdded3972bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_1872728b-70b7-4bcc-abde-4de63f41bd81" xlink:href="mck-20200930.xsd#mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_1872728b-70b7-4bcc-abde-4de63f41bd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_426e0de6-b5e7-4d50-b08a-b044f3f4abd5" xlink:href="mck-20200930.xsd#mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_426e0de6-b5e7-4d50-b08a-b044f3f4abd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_5d24c8c0-0a5e-40f3-ab13-4aaea6642b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_5d24c8c0-0a5e-40f3-ab13-4aaea6642b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_66ecd93b-303f-4a80-a2ef-1115be105e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_LongTermDebt_66ecd93b-303f-4a80-a2ef-1115be105e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_691f9457-30ad-4024-92c9-9f61355c12ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_691f9457-30ad-4024-92c9-9f61355c12ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_fda18aab-b034-4655-a8e5-565d2d49f1bd" xlink:href="mck-20200930.xsd#mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_abc3c778-9f08-4f67-9cdf-5a79f115b6f0" xlink:to="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_fda18aab-b034-4655-a8e5-565d2d49f1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_640eacea-e2cb-43c4-a0b5-2d855fb9889c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b9a00b75-9a0e-44d2-9704-d32210c2b143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_640eacea-e2cb-43c4-a0b5-2d855fb9889c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b9a00b75-9a0e-44d2-9704-d32210c2b143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9ddef733-6d11-45a0-af9f-3e583c220b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b9a00b75-9a0e-44d2-9704-d32210c2b143" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9ddef733-6d11-45a0-af9f-3e583c220b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9ddef733-6d11-45a0-af9f-3e583c220b1a" xlink:to="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_e2931e0d-3994-4163-9d1c-c35565de892b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_e2931e0d-3994-4163-9d1c-c35565de892b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_b6afc538-adee-454e-883b-954c3cd92aff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_b6afc538-adee-454e-883b-954c3cd92aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_43c47265-23e7-4428-a345-abb8f03df00a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_43c47265-23e7-4428-a345-abb8f03df00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_40bf4d9d-0159-4ba0-809b-44afdbb1561a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_40bf4d9d-0159-4ba0-809b-44afdbb1561a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9a3f18a6-9954-45f9-aa10-d58a93ef35cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a3746c85-2998-491a-ae5e-058a97cf2f26" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9a3f18a6-9954-45f9-aa10-d58a93ef35cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_123878ec-4316-4f6c-a4a9-886d8993796e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b9a00b75-9a0e-44d2-9704-d32210c2b143" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_123878ec-4316-4f6c-a4a9-886d8993796e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_123878ec-4316-4f6c-a4a9-886d8993796e" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6b7a2b21-a3a5-4d81-be63-6fcc4ac2668f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6b7a2b21-a3a5-4d81-be63-6fcc4ac2668f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_35e411bd-cc07-4ea9-90ac-a367f17ea46d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_35e411bd-cc07-4ea9-90ac-a367f17ea46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_751e08ef-9eae-4502-8231-ed0b3f141cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_751e08ef-9eae-4502-8231-ed0b3f141cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d6685b2-1d7f-406f-a34b-4533e22ea1a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d6685b2-1d7f-406f-a34b-4533e22ea1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3c5a1d5f-02b6-46a3-976c-48c3e9e8cbcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3c5a1d5f-02b6-46a3-976c-48c3e9e8cbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7ff99d42-141d-483c-83c0-4fc9fabb463a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7ff99d42-141d-483c-83c0-4fc9fabb463a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9cc2bbf2-74ae-4b71-af2a-74ec72cf87e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d3aaf053-76eb-465d-ba32-e8a868dafeeb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9cc2bbf2-74ae-4b71-af2a-74ec72cf87e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20200930.xsd#SegmentsofBusiness"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dfb18775-cb11-40c7-9e4b-91a202d69a79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_f90c0b50-ee8a-4387-9560-7d01ba03d890" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dfb18775-cb11-40c7-9e4b-91a202d69a79" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_f90c0b50-ee8a-4387-9560-7d01ba03d890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20200930.xsd#SegmentsofBusinessTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_723a086e-c5a2-4ccc-b81d-61c85cd077cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_02df4a6f-6681-4d6d-b339-d11c29142d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_723a086e-c5a2-4ccc-b81d-61c85cd077cf" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_02df4a6f-6681-4d6d-b339-d11c29142d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="simple" xlink:href="mck-20200930.xsd#SegmentsofBusinessDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8dcb8b40-5b09-4088-b06a-9bb40d7c8dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8dcb8b40-5b09-4088-b06a-9bb40d7c8dff" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3030e5a9-cfdc-43b6-a5dd-2b5970388288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3030e5a9-cfdc-43b6-a5dd-2b5970388288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_68a3e760-dd8b-4c6f-bf21-48131e76b69b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3030e5a9-cfdc-43b6-a5dd-2b5970388288" xlink:to="loc_us-gaap_SegmentDomain_68a3e760-dd8b-4c6f-bf21-48131e76b69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_d9cc754d-72fc-4f48-a4af-9be85b156cd1" xlink:href="mck-20200930.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_68a3e760-dd8b-4c6f-bf21-48131e76b69b" xlink:to="loc_mck_USPharmaceuticalSegmentMember_d9cc754d-72fc-4f48-a4af-9be85b156cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_2b31e70a-e6a2-4e30-ae27-bb0ae86d028e" xlink:href="mck-20200930.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_68a3e760-dd8b-4c6f-bf21-48131e76b69b" xlink:to="loc_mck_InternationalSegmentMember_2b31e70a-e6a2-4e30-ae27-bb0ae86d028e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_4b6ab439-c48d-44e4-97a1-c2df77276929" xlink:href="mck-20200930.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_68a3e760-dd8b-4c6f-bf21-48131e76b69b" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_4b6ab439-c48d-44e4-97a1-c2df77276929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_c20c928b-1548-4438-abb5-012235694630" xlink:href="mck-20200930.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_68a3e760-dd8b-4c6f-bf21-48131e76b69b" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_c20c928b-1548-4438-abb5-012235694630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_1b7b5368-e2b7-484e-8b5d-4e44dd54ef0b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_srt_ConsolidationItemsAxis_1b7b5368-e2b7-484e-8b5d-4e44dd54ef0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4c155354-dd08-4fd2-8efb-7b90414f984e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_1b7b5368-e2b7-484e-8b5d-4e44dd54ef0b" xlink:to="loc_srt_ConsolidationItemsDomain_4c155354-dd08-4fd2-8efb-7b90414f984e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_64c1a65d-5785-4158-83ed-aadf30fdb2ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4c155354-dd08-4fd2-8efb-7b90414f984e" xlink:to="loc_us-gaap_OperatingSegmentsMember_64c1a65d-5785-4158-83ed-aadf30fdb2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e6ed692d-621f-44d5-97d7-5410a947f3c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4c155354-dd08-4fd2-8efb-7b90414f984e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e6ed692d-621f-44d5-97d7-5410a947f3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_aecbc80e-5f6c-4823-aa11-7db927663a01" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_srt_StatementGeographicalAxis_aecbc80e-5f6c-4823-aa11-7db927663a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_93619373-169c-4536-8e29-884579bd8e8f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_aecbc80e-5f6c-4823-aa11-7db927663a01" xlink:to="loc_srt_SegmentGeographicalDomain_93619373-169c-4536-8e29-884579bd8e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_58c11e1c-07aa-4f49-8091-4d6d3fc51b9d" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93619373-169c-4536-8e29-884579bd8e8f" xlink:to="loc_country_US_58c11e1c-07aa-4f49-8091-4d6d3fc51b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_46a93ffe-3217-4df3-ba04-6118814c7002" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93619373-169c-4536-8e29-884579bd8e8f" xlink:to="loc_srt_EuropeMember_46a93ffe-3217-4df3-ba04-6118814c7002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_99afb7ff-a0f2-4030-a0af-ea11e0c835f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_srt_LitigationCaseAxis_99afb7ff-a0f2-4030-a0af-ea11e0c835f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8deff12a-3d0b-47df-91e5-55c2bbe8a0b0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_99afb7ff-a0f2-4030-a0af-ea11e0c835f8" xlink:to="loc_srt_LitigationCaseTypeDomain_8deff12a-3d0b-47df-91e5-55c2bbe8a0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InreNationalPrescriptionOpiateLitigationMember_ce614e36-0c5e-4591-a286-231c98936630" xlink:href="mck-20200930.xsd#mck_InreNationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_8deff12a-3d0b-47df-91e5-55c2bbe8a0b0" xlink:to="loc_mck_InreNationalPrescriptionOpiateLitigationMember_ce614e36-0c5e-4591-a286-231c98936630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6aa63033-021f-41a5-85b8-3d8db0f1a7c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6aa63033-021f-41a5-85b8-3d8db0f1a7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_1820d0c8-0f27-4bee-a363-14813d972de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6aa63033-021f-41a5-85b8-3d8db0f1a7c0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_1820d0c8-0f27-4bee-a363-14813d972de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_4daadd74-ad80-4434-866e-6b77190062c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_1820d0c8-0f27-4bee-a363-14813d972de2" xlink:to="loc_us-gaap_DomesticPlanMember_4daadd74-ad80-4434-866e-6b77190062c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_820265fb-4f41-4e9f-878e-e56201e84ae8" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_4daadd74-ad80-4434-866e-6b77190062c6" xlink:to="loc_country_US_820265fb-4f41-4e9f-878e-e56201e84ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_8fc9351d-bd31-47ce-9c04-f3cca8c03234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_8fc9351d-bd31-47ce-9c04-f3cca8c03234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6a308797-d2a6-44b9-bc7e-0ffe1cdbd2f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8fc9351d-bd31-47ce-9c04-f3cca8c03234" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6a308797-d2a6-44b9-bc7e-0ffe1cdbd2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2d55a338-e94c-4b1d-8e6c-87c326758ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6a308797-d2a6-44b9-bc7e-0ffe1cdbd2f5" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2d55a338-e94c-4b1d-8e6c-87c326758ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8f2a688b-4f00-4e1a-a893-afe376172aa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8f2a688b-4f00-4e1a-a893-afe376172aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5d3a055e-937c-4123-b28b-ff915c78e4ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8f2a688b-4f00-4e1a-a893-afe376172aa6" xlink:to="loc_us-gaap_RelatedPartyDomain_5d3a055e-937c-4123-b28b-ff915c78e4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_e0f6d344-a688-4772-b771-6c8897ab94e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_5d3a055e-937c-4123-b28b-ff915c78e4ba" xlink:to="loc_us-gaap_CorporateJointVentureMember_e0f6d344-a688-4772-b771-6c8897ab94e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_405d972a-2d22-45e0-9b19-159547d39c1a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_405d972a-2d22-45e0-9b19-159547d39c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1d57b3f4-c647-49ef-b011-20609e5aa96e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_405d972a-2d22-45e0-9b19-159547d39c1a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1d57b3f4-c647-49ef-b011-20609e5aa96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_311e211c-5a01-47fc-9057-cccef51903ba" xlink:href="mck-20200930.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1d57b3f4-c647-49ef-b011-20609e5aa96e" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_311e211c-5a01-47fc-9057-cccef51903ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_a0949138-f115-4a02-bb5a-9841d3270522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_us-gaap_RestructuringPlanAxis_a0949138-f115-4a02-bb5a-9841d3270522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_87df9b85-b140-4db9-9825-2bd251489f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_a0949138-f115-4a02-bb5a-9841d3270522" xlink:to="loc_us-gaap_RestructuringPlanDomain_87df9b85-b140-4db9-9825-2bd251489f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanMember_d7fb94ba-866d-4898-8193-ec212ca75ab3" xlink:href="mck-20200930.xsd#mck_StrategicGrowthInitiativePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_87df9b85-b140-4db9-9825-2bd251489f1b" xlink:to="loc_mck_StrategicGrowthInitiativePlanMember_d7fb94ba-866d-4898-8193-ec212ca75ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_941cb553-a6cb-47f2-af4d-39bfd507be04" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_2ff3dc27-e9a8-41a3-9339-51fc018625ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_NumberOfReportableSegments_2ff3dc27-e9a8-41a3-9339-51fc018625ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_8f794fea-89b6-49e2-a07a-73b7ab6746a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_8f794fea-89b6-49e2-a07a-73b7ab6746a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_fbe224a8-a463-464c-a485-03e1149aa02d" xlink:href="mck-20200930.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_fbe224a8-a463-464c-a485-03e1149aa02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_e530dd94-3b64-4f7e-a783-1a81290a8823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:to="loc_us-gaap_RevenuesAbstract_e530dd94-3b64-4f7e-a783-1a81290a8823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2254541b-a892-4a44-a307-f606e1342d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_e530dd94-3b64-4f7e-a783-1a81290a8823" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2254541b-a892-4a44-a307-f606e1342d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_b5882988-cc28-435a-bbf1-21d1eb418afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_b5882988-cc28-435a-bbf1-21d1eb418afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bca43756-6ba1-4b38-9714-5bf30a65fb71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_b5882988-cc28-435a-bbf1-21d1eb418afb" xlink:to="loc_us-gaap_OperatingIncomeLoss_bca43756-6ba1-4b38-9714-5bf30a65fb71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_c8f20488-8ce1-4b09-966c-64db2dcb44d8" xlink:href="mck-20200930.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_c8f20488-8ce1-4b09-966c-64db2dcb44d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_6ec73e65-fc21-4d3d-892f-9d8d492bdb1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:to="loc_us-gaap_InterestAndDebtExpense_6ec73e65-fc21-4d3d-892f-9d8d492bdb1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_968fc366-fab7-44a1-a4d2-7530f30ff41b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_a1933de7-d27d-4111-8b64-af0ae44a34a7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_968fc366-fab7-44a1-a4d2-7530f30ff41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_63ed114b-6695-4264-8e35-e7f139726cfa" xlink:href="mck-20200930.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_63ed114b-6695-4264-8e35-e7f139726cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_6a206331-a3b6-490c-a5ec-69231e8c6ae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_6a206331-a3b6-490c-a5ec-69231e8c6ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_70b49d08-06c5-4853-a3e8-c3a17dcaf296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_RestructuringCharges_70b49d08-06c5-4853-a3e8-c3a17dcaf296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_79aa426d-ee24-4e8e-a86a-fcd329046008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_79aa426d-ee24-4e8e-a86a-fcd329046008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax_a6834b62-ebce-413e-aeac-fe48404d365a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_GoodwillImpairmentLossNetOfTax_a6834b62-ebce-413e-aeac-fe48404d365a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_f7312799-5da0-4556-aefe-0e9bb65ee2c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_f7312799-5da0-4556-aefe-0e9bb65ee2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_9c12974d-e953-4e2e-bb64-0a3838785cc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_9c12974d-e953-4e2e-bb64-0a3838785cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f9c1e8dd-0b1b-4e3d-bc1e-a94e01dea26d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f9c1e8dd-0b1b-4e3d-bc1e-a94e01dea26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_5921cdc7-2e89-4545-9e63-cd2b05a4a9db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_5921cdc7-2e89-4545-9e63-cd2b05a4a9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_9b8a5dd0-7340-459e-8a5e-51f613acabd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_9b8a5dd0-7340-459e-8a5e-51f613acabd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_d7d74aab-a149-425d-9ba1-f2f0fa1fb981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_d7d74aab-a149-425d-9ba1-f2f0fa1fb981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_1262d302-6659-4179-a799-0a058375d90a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2369c656-f7ce-411c-b490-33150fc7551d" xlink:to="loc_us-gaap_LitigationSettlementExpense_1262d302-6659-4179-a799-0a058375d90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>mck-20200930_g1.jpg
<TEXT>
begin 644 mck-20200930_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ^ 9@# 2(  A$! Q$!_\0
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M?$#XA>(?$4S;FU&]DG'7A2QV@>V,5CE& CC:DO:?"C;/,RGE].*I?$S]#O\
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MOK:UCTK71)/(L2EH(P,DX!^_ZFOJ^&430I(O1E##Z&OPG\+C_BIM(_Z^XO\
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MD5^IL,R7$*2QL'C<!E93D$'H:^+QV"G@JG)+;H?H&6YC3S"ESQW6Z/&/CO\
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M6=^U=\!E^/OPRETJV=(=;L9/M>G3/]WS ""C'L&!(]N#VKP\'..$QL7/9/\
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M1_>4?F,USYKE\<935:C\7YG5DV:2P%7V%;X7^!^P'\J^0?\ @I?_ ,D;T?\
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M/!(K8XW*\B,,^N%4_P# A7=?\$P/"%Q)KGC+Q2T96TB@BTV.0YP[LPD=0?\
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M)?LB,Z_1F!(KNU4*-H  [ "N;$<0RE&U&%KG5A>%XQES8B=_)''?"/X6Z/\
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HTLX+"W2"UACMH%^['$H51WX Z45\G5G[6<I]V?:T:?L*4:6]E8__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>mck-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mck="http://mckesson123.com/20200930"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mck-20200930.xsd" xlink:type="simple"/>
    <context id="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0ef51821948842009566650c1ce108b0_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if8b77cedb5a047039f862615e00010a3_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A0625NotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3322bd7072c84251b61b81da05e4e706_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1500NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia5cc1815dee34619a8e2ef3a22a42bf7_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1625NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ied6bc4345b4a4bd99bae269ad7084d51_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3125NotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0ab19df7575e4779a1875a5d7ee85303_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i66de38bda2a744608a06a9b06ebf6645_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iabc3b5f8046b48bdbf4349b5c0383f8a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9dff60c859bc426a838f894b4001b9d9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i56da4268cdee4c4a9b797e2a40feb4ae_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i85c629cca8f64e44b872aac957b63d76_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib14ebdd9a67d42c6bff9fab1cd0291e3_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i81a912f5f9a04d1ca5e7cb90f142a641_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i86b3fd731c6a451da95296357c34854c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i624020a8d4c24a6faaadd5ffc919e8d5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i86e7603b06d743728a36650859d04420_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iff67f3d353954a34b18bf9eacb22eb74_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3307f8c1c01d4ecd976da193c588305c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1dd3918b313740288772fde625402248_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3419ea2dc9594c8db2d6ab1f18fb857a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia6d260abae684b3ea39deb99f2accdd9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9648da59dbf240cc901798b3fb380aac_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3a499ada4b6a4143af9f09f3d2d3773d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8b83385881344e4aaa0f55d53948d509_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id56ecd8e059f4e6696b7b1cc7c7988e4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ife081627cfce4fe3accedd30e135266f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idadfecb50b694b9bad1fd34884a1ae60_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i750ef09c38ef490d90ed96590f8d7966_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1b44c64ad2334280876102b25c03fa42_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie29e4f7dbe464f82b90c57337a3111f3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8a50be3402444652b3cf2b02bc8f0cc8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3c61eeba8b38459f985453da0e8c781d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie8e660e321e04b6ea0ec390e4691fed2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iebba672c55ee4c2a87f45e310c89afba_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if984c282fc6a4300aa9745b9ad1fd08a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1cda9b3c50e4403fa7bbac61edca84dd_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i07103e6d5410451f92642b65d23b443c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if90923f0cdf346f99356c5f1b103aa11_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iaac2ef7159664221a50c14397114988b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib75098dd74134d5a900a9f389f1d593c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8628eafe53c44bb99de6a01f4fe1ec09_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3ef50364db694bba8732ee06158ca2c4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie29be4b914d54b66b7225683b6f4fcab_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8f826e5b14454ea8a2ada91a6bda9f6f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5d91f70852e349d78d41746fc9b3a841_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3845b80d46e4483e96a588f5092ba0ba_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i151045664f014db396ec4d1388abafec_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic98282253ac24d17bb300a34d9842800_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i837e1a2cf1964b3c874339affc1c8eac_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7ab0556aa9f340e3ac3f07efb1786652_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="idd49ad70765946169fa5a2c37504d223_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="id27e19e091c34eb9b9768fcff47f09e6_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6f0ea496105b47b2be2796a2ab03ad9b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i527d69e72eba46ae8d65ce3a0001cecc_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i055c7fe4fa114e6fa2ee03924ec916e5_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie0e512234a3947858289f71240af0e24_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i56a82c257d8b45a3beba6b2dfcf0cceb_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i9c459fbda98f4d89b895296afc039b3e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4e227831a81048e1a8c4e713692e6037_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5d9f213396824bbc864a45e30a5b1379_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i14715badbe50426696183870464fb77d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5ccc82d868704bdeabe6b0ed81650efa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iebfb081bd626464390ff45f5fef68f5e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ida674b76527d474486ce8b22743056d8_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i066d88a46b864f71bd116fd264f47155_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i6b95a05a13af42d5b440fef8def022b9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i1ef9e0529026452082cff03d5ad3ef31_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ia1d225eb50904ac7afd16a3e52e96014_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="id047fe71417d4ba0a432ed05ef05fedc_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ie2ca1a2d209b4ea4a677b11a4d562bff_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ia0bd0811c0224eb6a8188a2281171287_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i1038eaf9e8794cbcbded983f8ccfcb9a_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i74dbf3756e304d92aeaccdcd0a323a87_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i519675db2894462f940aec3609198a9f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="if8a280e4073e4978b428ac6b0c0dd2be_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i0532330a51214e249b3b9e2fbc5ebee3_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i0a26b872a65c49fbab22d3dd61751d4c_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7004546d044b4049a10a34e53e7b21d2_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i793953b750ac4456be2099940de03f04_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ie193bb9fa6704fa3acc5751bc7472c22_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i9726c90f483c47acb129d2e23e982038_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i153fe9ad0eb8417e837f3785055c6ed3_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7ba7615df4f54c9394bdceec616f160b_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i4f906acdf8544001a98097ca5fefee5f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="if7f4bc7c87de41ec95337b9a9c2a5980_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="iffa749c811f44f839ea4c4218238ca96_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i1414642232a64093b59196114d7bbe81_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ia8097b9305824e04b33569a91abcc550_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ifb9ee476d3394ecc80affa02786a5506_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i27e2aad7746c41ebb5c5c95a5334fdd4_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iee4f408f0d454849b9073de0b78b77a9_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i95551ce68b8e47f0bba655aea0ee5f0c_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia3093e8b5aa4420189b9a3f12efb6235_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6278551f7fc3480497a143f010615c9c_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic8770d32fa2448e1a5a96bbcbabee231_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i72068016134b43bfacb6383f8d1e74f7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4cf42a143b384f7684c59e0d55a8c9b9_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4506d920ace04fa991e79fe64d985216_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="ic83c30e7937b464a894f08434c22f5e9_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="i8f8e385f66604149983dba6c977a6283_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="ifafa59fc61fa4be8b5cec6e15a260447_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="i0ceed8f44d4e4223932f42e65df7847c_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="id0a54c8ec69a4c91a3f3e8c1893a07aa_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="idf37a667c0ec40628d54cc1c80d639b0_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="i4ed1ecc0893943d88156c671256bec07_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9cbe8bd08e2043a691eb83cc4d84f2ec_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3bceb76fc90f4fc4a14733d6ed803565_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5abddbabf5c94c0fa20a7d1605f5465f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id816b0893be348beafb61bf8e5f30f0b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia2bab316f14f4a24b71fb9d74d18cdf3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia19a8a6ef0bd48e1be49afd2d6d8a75d_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5b52e33cd5364b31ad0004abbc59b28d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5a597186da7942b78a164787ea1dea53_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iaf5d0799400b4399a996c8da70230763_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i49c0062ceda84079a8aac41c1f01e410_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i805f21e7f7e04fbeb97134f767b3e1a8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c678c2a6d6247e8b531105d084453a3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7c9ccbb6fda842ceb43fb552e0daf01e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id6656f9779e14248b3ab954ea86b6abd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icdd739be481242018906607a0e292bcd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0412307b393b4b31809303ea6964eadd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id4809ccdb789473eb416b9fdf1aea69a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1dcc43c72e854787a25695f0ff26f3e3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i31f383b4585b4d15840458661a81ecf3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i46a8b56ffa35493ba482183ab526d9bd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4d1520f234a14153a52538db1d0fbc55_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia003613bb8bc483286b8644efc98f668_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i27e5cc6dcf7146199a2f75c2b2ffa8af_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5f261a46293d4fd982faa133f2983858_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib875ce3800a84805974094ef7390c47b_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1ee29e972613498aa1e93fe830d2eb8e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if7c1d98305344009a39b536f04f12c9e_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iedb569793bdf49caa63b344631feb0d0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iceed4414407b4b86847ad2d2815f97dd_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id8f59e8d12d84c3893cbe9b46385b3ed_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3e76a24704794920bda6de2102ffebac_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib73487326569472394f59d7b9300567d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0838a6f327724e01a3d66fd6fc84b706_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idd88456c2f48402184d07594c1ba6eeb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i68ff9ffbf98d4a1781d19ab625704e99_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i11292865b78d4742933b20217600c04b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i017eaec1fb0f4fcaa8bf8c05655a17ab_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4343021266684e09aac01da8724fc70e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1671d32a17be409fba3f84f83e2794f7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia54b0b6c830541ae8639a2eaa798e845_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0c961f18f05e48699a6932152d3b4bf5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idb66d47f37f94937b69269c1af59b8b9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i47b5375d9880408783a5c35d0bf9a5a6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia9749be689974b10b3717c1f4f66b1b7_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id809ea9c3d4348ba9c6347b08f2823f8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i13b7d11348f2478dbc84c872d3eeacea_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7f53e387d5a04f1fb44fa3972fa2143a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2f1078720e5143e4b52c84e6e385b68b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifa11ecf1c6d5459db583272a482d2382_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifbdd4b3c559743d6869a9f70f2186ede_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0d27cf1f90fc45b3ae73b669b099480f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9ca04e14279740e28d9b9ddcb4dba385_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i17d9381377c24a9ab35373e9e45ff3c0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i52c6f40d2729407c94ff1c3df7df4ff2_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i818f8654b0e24954be9c97bd24ef37ab_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i389a8e5295ce4baf8bf99cd380e382ca_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4bc860b936064f418b265dc92fb1e420_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic9d9fefc80324149bd26fbe32cfb7e78_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib35aa222c90b4f96af5dce4124e6fa37_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="iefc14ef243d44219b893fb6a33e8dec3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic21c3596993443348892ffc6b8dca3b1_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i453234fb946045ff8438628a7160ef19_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7a29c719f1364338a8ee516a3a09bc49_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i660c5557487b4523bf470784c38e3aac_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i54063222c8ab42b3ae44fd8854c2bf05_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9ba538365d5e441a82217d66cdb7223c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8f3890eafd704e1a9986d7f4b86e0128_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ief750a41c974485c93c0149cb17947dc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4ecbc2cba03648fcb37d779597f1e7e6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2ef7bc345256444fb9b45e1218e9f993_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idf45d6fc4e38421a8db5b7f7cafe2475_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4f8c08fbc7af4c1a9f49870c08e48b80_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic320828dd03442ee9aaea62c9ff4f7ec_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iff6a7243fae845218e8fb56aa25e2fab_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6cc04539515847199daba415d910a6b7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7567972184114435b6959d8ccf29fe0a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if4db1b4b02324493a0d2914c618224a4_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7a9512d260804f718da6e350b1800535_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i784afe00169946859b02a103c522f100_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2978b39e5aad4aa98f0c28c043489c2a_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7ff32fde532b4686b339b43a1460c33e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie295c63a512442a9a5a5f6037b32648e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i13d8fa5857224b039c9983f670be125b_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieb2673c258d340f29617801db8c6fb15_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i910303b53ca54b109dae4facc910bf03_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i643229e9e25c45bea23409a01f621fd7_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i819bef3ae9cf456ab4d6f597308e2091_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib1f31df78005498ca5d7cdfcef7b62ff_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3ac1d82117e34d24b3c7ace14a5f0a9c_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i923fbba79f824ad3b6ee7bbdbb9b6d22_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie1112ba0650748618ecb2605c5c0d6e4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2a05e5e085724cafb5736c6c660887d5_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib26d4d498b2241b28165e3a6aa3585cc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i87e3ce919cec41759ba7b04549cc3dd9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8153b95460de463caaddc69ee4d76393_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A365NotesDueNovember302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie7ff3def80794627a2f81c1fa3fa88b7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A365NotesDueNovember302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i12cf340a696a46ccbc81980bb0ca828e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iaee8abcfafb84ff798eb09d3d083a04f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1e6d0550b478436495bc0fe4be6cba3d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i15cc3c8cf89346e69d4e74ca74186f27_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia3c56f40d6044473b6be9ef97877702e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i30b436690be1400f81e8c682814e47b5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6a7a25e2db1543149b28b05daeacffbe_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia52812d9b87043cbb33eb38e018afe29_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i21479c35ac7947908fe229498bfad314_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i804e09f7332d4333b3d930fc39208c0b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i367acbb5aa6f41a89563cba34fc5e16a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ied4ba394ed964ed29284c6a42d50859e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1db34deedcb444fcafd3824ea72a77fa_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i986b499c7ecf4099ac52aa32adaf7eef_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i840a57d92c2e46fca0b999599fd6e33b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i512dab20822e47d0a0cc52e0e34781dc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idf662601f4324e058290f105eaa0b95f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie46a2a101c1946dfad26f454b2205e3a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i767d2070f41b43f08cadfcfde4ee0193_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0094db52755c430db5bb53ecf3675114_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib3f4f9c5449c42758be9a4044c781b77_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i70c5081e1fcc46fbbaab261e039a3f10_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4cd299e885c34f10b74ee273e0f81d20_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3028d3a5bee645aaa6efb97a0e849ab2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7950cda1af7346a88986fcba915ab374_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic3948c23924c4bb09533ac72ede98ae9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i39366f5479b542dfafca236d0d404772_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i154e895b81404074985fd505c76d4a57_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i82f9efd5a22a44eba025d8456a2a8394_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i2fc86cfb0d1743db9420435fcbe782c0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie51ec41d88fc4fcbbb4e98a2489344d4_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i747404c509964f31988b62072dd13f33_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="icfac515039344132aade2b5793055812_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6bd3593ba0404917bb09d01792baf9d6_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i44874b5446184867b047a21535e841fb_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic59633479ac94c10987acde294155741_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id887e8ba801a4f9f9555dc352f23f1de_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6b5dfa0efbd542b0bd5acb63dc7fb114_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5752cf5996be43f88c48f5343cf12504_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i629e2b60a9a340a78d36af765192f461_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibc317023efda478c82c32736a1b73ada_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0473786d65074893b89caa770decaf2f_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie58a935d3b8640fcb9895478c6828da4_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifafe5ac3b39e4334b35a9018a18479ae_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i49ee6f642eb4455483bb1c23124fdf11_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic18da827aa754e04a2fad2bf8a72cc18_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i27674bc44ccc4dcc843eb0366732e666_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8259a0225045474dace4f33866146c8b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic5be699bdd1a4617bcd28de6f863eaab_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idf0d0beda4f94c1c95f3735c727aaa99_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iefe68917b64346948a4da9e249ab34f7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i28545f9d3bda45efaa5277b002e22e7a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i11351bf2991743d7af90b551540fc919_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib49781b522ea4f76b1513c0e998abcab_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if8234a3e5eda4043b4d3fa3510856378_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4ddc0b315b6f44b0ae7eb4080f845509_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if390d59ed27b4bc8a9ae736d392c53fb_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iecdece7bccac464e91de8f41f5c11988_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ic8acb42c198243e4a41c9b1198ebd29b_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i845cf95a4c8a421fafec2976a240ff82_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8df2eff3ed674556a1b6d76ac1e2fc2b_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib993ed38bcaa44e992d425b235b667ba_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icdb08454a4384d82896df1a6d61f11f9_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i88ca01400a5e4f17a31f7e6a13628bec_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i31bf530a67154f4089f298f4daebb618_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iccbce5482ad640f5b90191abd057ac63_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8ad1ff26ff3e4d089de290e9695a1cb1_I20200427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-27</instant>
        </period>
    </context>
    <context id="i2c1475ccb75f4635a9bf4d405fc5d8f5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i123bf8d69a8548fda1b8942d92d2fc33_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i85cd2589de304d938cfd483404ca1653_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia124b703fd9c4666841454b448394b00_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia9356380a99d4079b931630ff762728b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i258110de1c154e9480bae6db28d0f729_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3a7c1b74f86c479b816159c6d3ae04b0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1b5ddc35c76e45c7a9c189c497c848b8_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6bc3ab577dc7480fae3d98e14277684f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i21e4948d75de4a3baf98851aa5242f47_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9949b55995c54523b05daddb017a3ac4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i206a9aeb7e4a4008803c87c65282730e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic03b5f5fc26d47c3be37eff2f0e07604_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iba46bb814a6e4d07bedaae798f4c086c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib2e52268a81f4aa28240eea26becc2ba_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8f31411e76594912ad9c4c6fdc037070_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i69864efaf345415db2c3cc9adba8a027_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4a67d47d26e744bea5b1a64745a103ef_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie09c8165d0db4a47be02c5ba356b27a9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i15eb6e4eb94b4f57885a65039289f579_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifb450020edcc4eafb4f6204bd56f1294_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i48d17d2683c04f8e978bbfeeda49522e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6c01ee54c64b4e738869a1a426b32be8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1b838d45789a4813a7f70a4900210195_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6eaf2c336e1d400ba5e9a2c97cfb4467_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0e77147ea2824ec685fc498f61706e2b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i851951555ad24db390460dd6eda13a71_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idbba6884ea2d430c82bef1bffa38851e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i54c29ac67c524830b5346ac601e7912c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1469f9d2f2f144f6ac3ea35586bb7cf0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7b890927812447aa911816632e628829_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5badf059a14f4d8ab6f9ce6affac29bc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9fa8c90408ea4e3dae6e394bf3fa943b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9b844b3b721f4a0d922cde7ae32b2875_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0f5ac3d5d5f4479592e96e5bf4ee0a01_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1cb4731f3b53414bac5ded8a850e5f3b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7ed3f74dc0ae44f8baf2c9b085580e45_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib06af04e28ba4e4ea6652465ca257cfe_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibd6d24f4b8e64a778fb5af40d017aedc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ieaaee7621692492e90da6fe2f00a5923_I20200114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-14</instant>
        </period>
    </context>
    <context id="i3e08cb2f184f4ac491a30c4f2f86b5cd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia89ab571675d4fe1be458deb9d1756b6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifef9ed0f951845c09b3a887cc0f7469f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2b88d5a3d4ab496188c56155a2880f90_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i56fa48494eef42e2a81d8b80e6683829_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ic4a0fa8d9f0a41d0a8385cb9c0f43e82_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ife3f7c8428454d1a83b2d27fbb7084b5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelKelley19Cv2233Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic933332211124a748e5866fc45b2d46c_D20130517-20130517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-17</startDate>
            <endDate>2013-05-17</endDate>
        </period>
    </context>
    <context id="i1c69b4d259c846329b91b3b6969f1004_D20130517-20130517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-17</startDate>
            <endDate>2013-05-17</endDate>
        </period>
    </context>
    <context id="iace4f3d9ad444347aa132bbc7bb400f2_I20190813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-13</instant>
        </period>
    </context>
    <context id="ia241be660d814c9dbfbab339569e8b37_I20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="ib24b30ad412f4321bcaff6b945c5ab8a_D20200728-20200728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-28</startDate>
            <endDate>2020-07-28</endDate>
        </period>
    </context>
    <context id="ifc731429591343fb9685ce4e3d37b71c_D20200729-20200729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-29</startDate>
            <endDate>2020-07-29</endDate>
        </period>
    </context>
    <context id="i094f2986d473404cb6ffd79049564a6b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i360a0a25e36a496585c2f2d80ef31321_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5e72211ec5474ca28d33b7a18d5879c3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1009c601f4d148e38fd22bf9694cd964_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic3801a94ee254dec8814967fb501debd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iade843f75deb448186e6e38895fb48b7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i15202989514f4acf8e987ae99a0216ba_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3646d4cbd2ad43c3b6da83e852552ca4_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1cfff32ee6a14e168c5922d492015d9b_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4dfcb285fb6b4a5c8cbbe9bd79f0a497_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i93126ac576fd4ee59dbe2a22e4b7078f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i24e52575e1654c46a8f81e254c90ab96_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i94c06ecc9cc7491180bd8fb5bd26438d_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i081813b992464ea9ad8920cab184e999_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2801f5e86df94d55bd75e10e15bf4d5b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0d3a810191074649bfd35939eee1cfc4_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1b41db262baa42ac85b207a7a3c6851b_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie7ed596faccb4197854f21d92b8137b6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i364845bbc169420e8195d9305f9f4c1a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9bd48cde79e84ac4a46f6744e674f4ab_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8de456c9de55433dac6af26e743f73cd_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i71ac51620ddf48c0a43eb177d2b8787c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8566f25837414d39ba7f2dfa91ef0a42_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i08d04048582a441a9829e7d02b02b64f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iafe0cb7d5ecb4f14bdcf107625ab76a4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic3642cd678a64ba1b231726d09a37604_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id4cc9f5f8d11498da1ed9306dc8d7f7f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie2530e99848e4b36ba92e924f579d9df_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i785fd2b4e9024f8ea22b4baf93fe610a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3c6aa5965ffb4e8b8ddd05a70b872808_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if6a19d8b0fe745be9ff1c9a795dfd0bb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i64d90c4a197c4d62b7688640c6c181c2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i584b4e2274074d37aba8cd24589cb580_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i666e4b283dc645e7900ef3d3a1d91aac_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i560a87a2893946699ede55eeca7bfd22_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4ea0dc529a904ec9a931482f59d28dd8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia0604a8575de4a9396ed7d28ed0294c7_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i152a0a34c50a4f5b95780eafe02e0ea9_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i3de1a24b580146c49c37a4942dd6c16c_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="id36e3e6db92b4ddd84ae2a9af1d43fd3_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i4bdc606394464f49b8531ade9f76854b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i4a725751bc8343cdbc4cd04f87ce1ad6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i14767a5727ac4417a8c16be22209e0bf_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ib0aa1d9903934d4bb44c6053ee11ca01_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i5f028c579ca84ba1a3fdffbd5ad2731a_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i4471500f1af84287bc5e2719e750de11_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i64bc67d401ba41cd98cdc8120660d0ca_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7f4759dae41f41e98b79f41976fa69ca_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i8e7e3d6a2fc24aba8fe36b60b9a70d8e_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i10878ad786c14616809f16456682cb91_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i47b46bdea51b4a518badab77507f0e56_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifd8554d6b3ce4907859a8adc5bfd5199_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id3e327dccb0243cd8c395cc18f592326_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5842c602b5a9464db55d6b8a5ea2fef9_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i02e816dd3ea9489cb878840d51f8df47_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9fed2bcc3c3b42febd8b01ce2735ad1d_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ida57532d2ac84b80a31ba148be33330e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9ea2351304814e458dca8d34103c7273_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i76b51bde9d3d4cb0addfd0460eab9c05_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i647a92415ea7432f9ea523b7b0536a18_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0e287f0b27c448b49c58667e8198eae1_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if891f7281b7d419086880575baba6e9d_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icf4e3d6784d447beb68308a48fff9d3c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie18fac8f12304381ba36b0b283d93b84_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="numberofsegments">
        <measure>mck:numberOfSegments</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="participant">
        <measure>mck:participant</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="company">
        <measure>mck:company</measure>
    </unit>
    <unit id="case">
        <measure>mck:case</measure>
    </unit>
    <unit id="county">
        <measure>mck:county</measure>
    </unit>
    <unit id="state">
        <measure>mck:state</measure>
    </unit>
    <unit id="state_attorney">
        <measure>mck:state_attorney</measure>
    </unit>
    <unit id="relator">
        <measure>mck:relator</measure>
    </unit>
    <unit id="fax_number">
        <measure>mck:fax_number</measure>
    </unit>
    <unit id="fax">
        <measure>mck:fax</measure>
    </unit>
    <unit id="vote">
        <measure>mck:vote</measure>
    </unit>
    <unit id="country">
        <measure>mck:country</measure>
    </unit>
    <unit id="numberofproducts">
        <measure>mck:numberOfProducts</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80L2ZyYWc6ZTU5NTg2ODlmMGYwNDdjMjlhNGU3NjlkODBlODk2MzIvdGFibGU6Nzc0Y2M2NGFhZWJmNDVlZTk5MDU1MmY1OGMwNGIzZTUvdGFibGVyYW5nZTo3NzRjYzY0YWFlYmY0NWVlOTkwNTUyZjU4YzA0YjNlNV8zLTItMS0xLTA_7e32a88c-6a1f-4b61-aca5-37b5d5312087">0000927653</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80L2ZyYWc6ZTU5NTg2ODlmMGYwNDdjMjlhNGU3NjlkODBlODk2MzIvdGFibGU6Nzc0Y2M2NGFhZWJmNDVlZTk5MDU1MmY1OGMwNGIzZTUvdGFibGVyYW5nZTo3NzRjYzY0YWFlYmY0NWVlOTkwNTUyZjU4YzA0YjNlNV80LTQtMS0xLTA_92fe6136-e7e8-476a-b1af-aa19ea5ea2d0">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80L2ZyYWc6ZTU5NTg2ODlmMGYwNDdjMjlhNGU3NjlkODBlODk2MzIvdGFibGU6Nzc0Y2M2NGFhZWJmNDVlZTk5MDU1MmY1OGMwNGIzZTUvdGFibGVyYW5nZTo3NzRjYzY0YWFlYmY0NWVlOTkwNTUyZjU4YzA0YjNlNV8xMS0yLTEtMS0w_71d010e3-4c62-4b27-acb1-82eb9f2ff533">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80L2ZyYWc6ZTU5NTg2ODlmMGYwNDdjMjlhNGU3NjlkODBlODk2MzIvdGFibGU6Nzc0Y2M2NGFhZWJmNDVlZTk5MDU1MmY1OGMwNGIzZTUvdGFibGVyYW5nZTo3NzRjYzY0YWFlYmY0NWVlOTkwNTUyZjU4YzA0YjNlNV8xMi0yLTEtMS0w_c0036654-e436-4d6b-bfe7-c8e6d3ff12b9">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80L2ZyYWc6ZTU5NTg2ODlmMGYwNDdjMjlhNGU3NjlkODBlODk2MzIvdGFibGU6Nzc0Y2M2NGFhZWJmNDVlZTk5MDU1MmY1OGMwNGIzZTUvdGFibGVyYW5nZTo3NzRjYzY0YWFlYmY0NWVlOTkwNTUyZjU4YzA0YjNlNV8xMy0yLTEtMS0w_6252257b-6ed9-478e-aba8-c254c5e5f955">false</dei:AmendmentFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i4cf42a143b384f7684c59e0d55a8c9b9_D20200401-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1OTA_ef5deb27-a7a7-4410-a2df-e6fb8d4e63c9">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <dei:DocumentType
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTU1_7f344c05-565e-41fc-af8f-f9311bd33fa2">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6OTA0MDhkNGJkMTlkNDNlOGJkODZlZjUzMWJiZmY2YjcvdGFibGVyYW5nZTo5MDQwOGQ0YmQxOWQ0M2U4YmQ4NmVmNTMxYmJmZjZiN18wLTAtMS0xLTA_d336c2fd-6559-4cbf-af89-1b3ca1176f93">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8xMjQ_dddfae91-c4be-4a4b-b50a-3e81645a1e11">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6ZmVlYTkwOTZjMDllNGUxZThjZGJhZDE3MjNmZjY1NTcvdGFibGVyYW5nZTpmZWVhOTA5NmMwOWU0ZTFlOGNkYmFkMTcyM2ZmNjU1N18wLTAtMS0xLTA_c55b7159-39fc-4835-bcc4-97e8ebed65b2">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTQ3_8fa1c23c-5cb2-4f61-ae1d-58d76a3f021f">1-13252</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTQ4_204cb848-7938-456f-991d-b2771fac0dd0">McKESSON CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6ZWNmZjhjNTE4Yzk4NDA3NTg4ZmFlYTZlNDQ4NTUzNzkvdGFibGVyYW5nZTplY2ZmOGM1MThjOTg0MDc1ODhmYWVhNmU0NDg1NTM3OV8wLTAtMS0xLTA_35d9fd66-7868-47d8-82f5-5b0e1179e541">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6ZWNmZjhjNTE4Yzk4NDA3NTg4ZmFlYTZlNDQ4NTUzNzkvdGFibGVyYW5nZTplY2ZmOGM1MThjOTg0MDc1ODhmYWVhNmU0NDg1NTM3OV8wLTItMS0xLTA_0593c3f2-a926-4756-b502-7f2cb02a613a">94-3207296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTQ5_b351bf4c-7c12-4445-9766-2e3366ccfbed">6555 State Hwy 161</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTU2_24a9ef06-b182-4bff-98e6-5fa03370c9f4">Irving</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTUw_0e07738c-8569-4d31-88bd-d7ab314ab538">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTUx_78630802-2f80-41a5-9218-9bcc30acb433">75039</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTU3_44bb97df-8f48-41b5-ba23-8a77eb99a940">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTUy_02f1673c-79b7-4809-817f-cb8256e08ed5">446-4800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i0ef51821948842009566650c1ce108b0_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18xLTAtMS0xLTA_044808d1-6826-44ef-ac2e-74ed905bda01">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0ef51821948842009566650c1ce108b0_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18xLTEtMS0xLTA_ce7744dd-c145-4531-9499-46f7be883e7f">MCK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0ef51821948842009566650c1ce108b0_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18xLTItMS0xLTA_c46e87d6-2908-4119-b080-10f77c03566a">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="if8b77cedb5a047039f862615e00010a3_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18yLTAtMS0xLTA_615d984c-fd24-41bb-923a-2f07ca49fb1b">0.625% Notes due 2021</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if8b77cedb5a047039f862615e00010a3_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18yLTEtMS0xLTA_7a3c3150-4bcd-4b89-a838-a56224882b32">MCK21A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if8b77cedb5a047039f862615e00010a3_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18yLTItMS0xLTA_12145c4a-6433-4b29-af47-f34d6932e44c">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i3322bd7072c84251b61b81da05e4e706_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18zLTAtMS0xLTA_dba528be-37f7-4f68-a108-4c8009249861">1.500% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3322bd7072c84251b61b81da05e4e706_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18zLTEtMS0xLTA_b3110639-d78a-4447-a871-d67062ffb68d">MCK25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3322bd7072c84251b61b81da05e4e706_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N18zLTItMS0xLTA_e7e97a92-82b1-4c3a-a391-13dd85368d8c">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ia5cc1815dee34619a8e2ef3a22a42bf7_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N180LTAtMS0xLTA_98a27405-396e-40ab-aa37-018725f07762">1.625% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia5cc1815dee34619a8e2ef3a22a42bf7_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N180LTEtMS0xLTA_71e957b5-2c7c-4b94-a1ac-71019114a35d">MCK26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia5cc1815dee34619a8e2ef3a22a42bf7_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N180LTItMS0xLTA_df0faaa5-22f8-48aa-a666-f9bdee92dc7c">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ied6bc4345b4a4bd99bae269ad7084d51_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N181LTAtMS0xLTA_6d2864a1-041b-4983-84d6-3fe5519d662c">3.125% Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ied6bc4345b4a4bd99bae269ad7084d51_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N181LTEtMS0xLTA_93d77702-e1f4-4fce-89dd-4b8be1e1a23d">MCK29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ied6bc4345b4a4bd99bae269ad7084d51_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6NWVmOGYzZmQ2NWU1NGIwOTg5MmQ5MDI2MjQyNWZjODcvdGFibGVyYW5nZTo1ZWY4ZjNmZDY1ZTU0YjA5ODkyZDkwMjYyNDI1ZmM4N181LTItMS0xLTA_78bee83f-6ac5-4625-b3f3-d6d89757a122">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTUz_b070e9c2-c9d3-40d4-99af-f79ab814f26d">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTQ2_ec0153d1-ff9a-4c67-b266-51ad99ba70fa">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6M2YxODUxMzMzMmViNDBjZmI0MTJkYmI4ZDRjMmQ1YjAvdGFibGVyYW5nZTozZjE4NTEzMzMyZWI0MGNmYjQxMmRiYjhkNGMyZDViMF8wLTAtMS0xLTA_2e4e438b-3b4c-4002-b2ce-5be052f2eff7">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6M2YxODUxMzMzMmViNDBjZmI0MTJkYmI4ZDRjMmQ1YjAvdGFibGVyYW5nZTozZjE4NTEzMzMyZWI0MGNmYjQxMmRiYjhkNGMyZDViMF8xLTYtMS0xLTA_19f3f165-732f-4731-94a3-06bc9200253e">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGFibGU6M2YxODUxMzMzMmViNDBjZmI0MTJkYmI4ZDRjMmQ1YjAvdGFibGVyYW5nZTozZjE4NTEzMzMyZWI0MGNmYjQxMmRiYjhkNGMyZDViMF8yLTYtMS0xLTA_55de63ef-f71b-465f-a2eb-bbe821f3fd29">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMTU0_ea6b644b-eac1-4f50-9dfd-8743b28aa1ec">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xL2ZyYWc6M2U2YTIwMWNmM2FhNGYxOWFmNjI3ZjI5NzBkYzcwZTQvdGV4dHJlZ2lvbjozZTZhMjAxY2YzYWE0ZjE5YWY2MjdmMjk3MGRjNzBlNF8yMDc5_300239a9-c9aa-4683-81df-9b4ac842b777"
      unitRef="shares">160564425</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMi0xLTEtMS0w_41ae867b-eb1f-4dd1-8286-55910d610dc9"
      unitRef="usd">60808000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMi0zLTEtMS0w_c8825bc7-341e-463b-8219-7053aa4564e8"
      unitRef="usd">57616000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMi01LTEtMS0w_303aaa0d-3a3f-48be-9b56-3bf242ea6e23"
      unitRef="usd">116487000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMi03LTEtMS0w_d5047290-3921-48f9-85c0-b4b167d8a4c6"
      unitRef="usd">113344000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMy0xLTEtMS0w_a04754ca-b21e-4a8e-830c-7b75f85bc1ea"
      unitRef="usd">57808000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMy0zLTEtMS0w_b7d18708-567e-4ba0-b035-2f20943e5510"
      unitRef="usd">54749000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMy01LTEtMS0w_1e73971f-9bfb-42ae-8cda-993b7056fa30"
      unitRef="usd">110787000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMy03LTEtMS0w_617f1125-9097-4de2-b83a-5fb0f5c2122a"
      unitRef="usd">107690000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNC0xLTEtMS0w_0099352e-224f-49c6-8f83-dfbebc3b64c4"
      unitRef="usd">3000000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNC0zLTEtMS0w_17d32651-e08d-47ba-9c99-f5d02dd02040"
      unitRef="usd">2867000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNC01LTEtMS0w_71d03c36-f90a-4bfa-8d27-f588a94c72d5"
      unitRef="usd">5700000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNC03LTEtMS0w_8322990d-ff42-49b9-aabf-c71cb5254a65"
      unitRef="usd">5654000000</us-gaap:GrossProfit>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNS0xLTEtMS0w_c99babe2-1e8a-4d35-973b-b65a5a2b6fdd"
      unitRef="usd">2237000000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNS0zLTEtMS0w_8722ab5e-dec7-4008-af68-21bb93ed56bc"
      unitRef="usd">2196000000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNS01LTEtMS0w_ca39750b-029b-4600-ba71-32cb659b9eb8"
      unitRef="usd">4203000000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNS03LTEtMS0w_86ef6198-75e4-453d-aa58-42868b6d3dc8"
      unitRef="usd">4326000000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNi0xLTEtMS0w_368afc1d-aa3b-4c0a-a4c0-8e6adaa09e22"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNi0zLTEtMS0w_3ce0b150-3d14-442a-a64e-e0e39ce1d862"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNi01LTEtMS0w_29334946-38c3-4d65-a662-06a9d583ddc9"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNi03LTEtMS0w_a710cc48-a0db-4079-8b46-e1d6dfb16e18"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNy0xLTEtMS0w_f81affba-ef54-481d-a00e-e41eb1230f5a"
      unitRef="usd">60000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNy0zLTEtMS0w_4831df33-a490-4390-9318-0d7afaa018d6"
      unitRef="usd">45000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNy01LTEtMS0w_df831478-91a8-4b5d-b405-621cdeacd2b6"
      unitRef="usd">116000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfNy03LTEtMS0w_d7462138-9158-4fc4-93a3-28d4a540ab57"
      unitRef="usd">68000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <us-gaap:OperatingExpenses
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfOS0xLTEtMS0w_fdf1c8c3-45b7-42cf-8754-a9cac4c8029a"
      unitRef="usd">2366000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfOS0zLTEtMS0w_6adf24c2-daf5-423f-a259-d24d848b857c"
      unitRef="usd">2241000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfOS01LTEtMS0w_f7f243ed-224e-48bf-9a82-ad24b5b54e11"
      unitRef="usd">4388000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfOS03LTEtMS0w_d195d81d-5408-448d-8652-b6604720f51a"
      unitRef="usd">4394000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTAtMS0xLTEtMA_8acaceea-724b-491d-9e53-08bae9a85640"
      unitRef="usd">634000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTAtMy0xLTEtMA_aa49a6c8-f221-424c-b9df-bbd744c468bf"
      unitRef="usd">626000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTAtNS0xLTEtMA_3e390ad6-1f44-4cd8-a559-44aa6eb95e34"
      unitRef="usd">1312000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTAtNy0xLTEtMA_d8d1d695-b54b-411d-a221-ea165faeb774"
      unitRef="usd">1260000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTEtMS0xLTEtMA_ad39ba36-5d86-42da-bb2c-16d0233a1466"
      unitRef="usd">71000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTEtMy0xLTEtMA_fc6a8f88-9c77-4c48-be2b-bd3b057ad536"
      unitRef="usd">-78000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTEtNS0xLTEtMA_1abb6bdd-7431-42fc-b4f0-6c0fadb6253d"
      unitRef="usd">98000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTEtNy0xLTEtMA_f8c664b4-e2f0-4054-9d8a-bfe6d66a3114"
      unitRef="usd">-41000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTItMS0xLTEtMA_0377fdc8-8359-4543-b185-350ba8cc2025"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTItMy0xLTEtMA_e5deaaf8-ebd0-449d-9ffc-da2d6e33dff9"
      unitRef="usd">-1454000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTItNS0xLTEtMA_42650225-fe20-4564-9dcc-821bca3948f0"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTItNy0xLTEtMA_0d2e73be-8ecb-4190-9454-3a962c046b0d"
      unitRef="usd">-1450000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InterestAndDebtExpense
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTMtMS0xLTEtMA_377b459b-adc6-4e04-8da7-363e533871bf"
      unitRef="usd">50000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTMtMy0xLTEtMA_b0eb8e54-534c-4ccd-9421-5ee06cfc3b71"
      unitRef="usd">64000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTMtNS0xLTEtMA_c19bf850-f6ae-4c3d-93f0-3e744b8c6a7f"
      unitRef="usd">110000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTMtNy0xLTEtMA_8b81855d-abfd-46dd-a184-089ff6ea5961"
      unitRef="usd">120000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTQtMS0xLTEtMA_bf8fb90f-f916-4747-bd63-61a5e382d7d5"
      unitRef="usd">655000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTQtMy0xLTEtMA_9cdcc040-2613-444d-9238-9614232a3f40"
      unitRef="usd">-970000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTQtNS0xLTEtMA_8ad0e3a7-d630-4886-9bc5-9e08adbe1fd3"
      unitRef="usd">1300000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTQtNy0xLTEtMA_87195ee3-5c53-4ec7-bc79-4d0a95019c08"
      unitRef="usd">-351000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTUtMS0xLTEtMA_50806244-12f5-426e-96a6-2682a76d33b5"
      unitRef="usd">28000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTUtMy0xLTEtMA_45027bf9-30b6-45b7-b490-606b4f1c7375"
      unitRef="usd">-294000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTUtNS0xLTEtMA_f1f99336-39de-4717-b0bc-f9a8077dc2b7"
      unitRef="usd">178000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTUtNy0xLTEtMA_cd055d23-563d-4541-b1a5-f96dea206dfe"
      unitRef="usd">-158000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTYtMS0xLTEtMA_5d3e1ae2-4c56-432a-9888-f5d15873262c"
      unitRef="usd">627000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTYtMy0xLTEtMA_a3db7ac6-d468-4e7d-8749-9c132897f530"
      unitRef="usd">-676000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTYtNS0xLTEtMA_5f6f9193-cd8d-494e-b168-5152e3e18996"
      unitRef="usd">1122000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTYtNy0xLTEtMA_78e1f0d3-8c1c-4006-9fcb-b49a8af1f21b"
      unitRef="usd">-193000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTctMS0xLTEtMA_88a43354-20f2-41ce-9956-c40b256a5271"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTctMy0xLTEtMA_1a07d8bf-7e79-4955-adca-6ff91ac8bd23"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTctNS0xLTEtMA_8b64fd77-eaab-4ade-82ae-d8d1b6a528ce"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTctNy0xLTEtMA_1d7cf47d-7194-4cc8-a1b7-1bfd1df945e1"
      unitRef="usd">-7000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTgtMS0xLTEtMA_79bd6b40-9013-4eee-b32c-e78989510210"
      unitRef="usd">627000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTgtMy0xLTEtMA_1286c29d-3daf-4dc3-9b79-926ba3764d8b"
      unitRef="usd">-677000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTgtNS0xLTEtMA_41c64d66-ab20-4687-8202-d3b961e19831"
      unitRef="usd">1121000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTgtNy0xLTEtMA_67cd62a1-90a9-4489-ba6f-930b74b402f9"
      unitRef="usd">-200000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTktMS0xLTEtMA_c867085e-0ca0-48c5-bf9c-23de805e299b"
      unitRef="usd">50000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTktMy0xLTEtMA_b6a4d599-b277-4732-b4ed-f3a83a2d608a"
      unitRef="usd">53000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTktNS0xLTEtMA_2fa899b8-2f70-4288-9295-f7fcd2532b55"
      unitRef="usd">100000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMTktNy0xLTEtMA_5b66d056-4d37-4994-9b99-f535d944a9de"
      unitRef="usd">107000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjAtMS0xLTEtMA_8aada90a-0403-4c1d-908e-9285b9a6ebe1"
      unitRef="usd">577000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjAtMy0xLTEtMA_655af68e-abec-4001-94a8-39e838d51974"
      unitRef="usd">-730000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjAtNS0xLTEtMA_efe5e655-bf53-4a47-88b7-0f5c48c91952"
      unitRef="usd">1021000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjAtNy0xLTEtMA_6a8597f4-662a-469b-8eef-48c7c4b28eb0"
      unitRef="usd">-307000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjQtMS0xLTEtMA_1b42c000-c593-4b7c-81c0-9e4f99983ce2"
      unitRef="usdPerShare">3.54</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjQtMy0xLTEtMA_02bce3d3-2d27-412f-b63e-cbca4357fbc4"
      unitRef="usdPerShare">-3.99</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjQtNS0xLTEtMA_fd918d79-c677-4f63-aadb-0cd8b07536fe"
      unitRef="usdPerShare">6.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjQtNy0xLTEtMA_9c8da92e-39d9-41a5-abc9-bce74b896ae8"
      unitRef="usdPerShare">-1.62</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjUtMS0xLTEtMA_87684a09-4f90-4379-ae59-5b51440b392d"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjUtMy0xLTEtMA_55df852f-9e87-475e-b6c9-8429ee9cec79"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjUtNS0xLTEtMA_0a719ae8-dac4-41a8-887d-08fd48760b65"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjUtNy0xLTEtMA_bf108e3f-a247-4780-a624-66539b16ffd4"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjYtMS0xLTEtMA_f944bf8d-4b43-4723-be69-40b2b1e08ae0"
      unitRef="usdPerShare">3.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjYtMy0xLTEtMA_0abeb36c-bf94-4c28-bdc3-d5e61d94c376"
      unitRef="usdPerShare">-3.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjYtNS0xLTEtMA_dc3dfd56-fbea-4994-b048-1f3c9f4c62e9"
      unitRef="usdPerShare">6.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjYtNy0xLTEtMA_8707952e-7505-4795-a798-9ab1f799d3a2"
      unitRef="usdPerShare">-1.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjgtMS0xLTEtMA_78f4e3c9-7fed-4406-ba24-bd3e54f7906e"
      unitRef="usdPerShare">3.56</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjgtMy0xLTEtMA_eef86ded-cf18-459c-a8a4-125bb9c31b7c"
      unitRef="usdPerShare">-3.99</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjgtNS0xLTEtMA_111b0250-535a-4562-bf72-249c718f3980"
      unitRef="usdPerShare">6.31</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjgtNy0xLTEtMA_6b824e0e-db84-474d-b221-3094d195ecbd"
      unitRef="usdPerShare">-1.62</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjktMS0xLTEtMA_b75c1d8e-5ac6-4bb4-b5b5-21e5e96f7502"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjktMy0xLTEtMA_fe10e8fb-2448-42c4-834c-3f9d729c5c36"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjktNS0xLTEtMA_897f0275-2434-45ee-a2d0-0a22e7133034"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMjktNy0xLTEtMA_463a67b6-7df4-4d91-b77d-99ac980e7f50"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzAtMS0xLTEtMA_8ea48245-225b-44c6-a30d-bc070bb71038"
      unitRef="usdPerShare">3.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzAtMy0xLTEtMA_a2eb293c-b8e4-4429-af16-b8951c0dfaa1"
      unitRef="usdPerShare">-3.99</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzAtNS0xLTEtMA_142504c6-fdcc-402a-bf74-7623742e3514"
      unitRef="usdPerShare">6.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzAtNy0xLTEtMA_e41e576b-7145-4e4e-9d41-db59dc7a5ef2"
      unitRef="usdPerShare">-1.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzMtMS0xLTEtMA_74e5bc0b-fc1e-40c7-8c66-651e8efd1d99"
      unitRef="shares">163000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzMtMy0xLTEtMA_e6639797-8229-481a-a2bf-239747334293"
      unitRef="shares">183000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzMtNS0xLTEtMA_86ba8bce-a256-4192-8a50-e4c1c6a8e06a"
      unitRef="shares">163000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzMtNy0xLTEtMA_19d353cf-765b-4471-a640-2110c603feeb"
      unitRef="shares">185000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzQtMS0xLTEtMA_7ddc15ec-1709-471a-95c3-6923eb75d586"
      unitRef="shares">162000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzQtMy0xLTEtMA_1e795560-ff49-475e-a809-58ccf70ac28e"
      unitRef="shares">183000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzQtNS0xLTEtMA_f0c620ee-6b4f-4939-bc07-a57fed89f91e"
      unitRef="shares">162000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xMy9mcmFnOjU2YjQ3YzdjODliMTQ2ZGY4MzQ1YzY5MWIwY2JiYzY1L3RhYmxlOjQ5NTUzYmM0YTA2YTRkNmNhYzRlYzRkNzM5OTJiYTllL3RhYmxlcmFuZ2U6NDk1NTNiYzRhMDZhNGQ2Y2FjNGVjNGQ3Mzk5MmJhOWVfMzQtNy0xLTEtMA_17363c6b-da6d-4685-91e6-c3fa6885828b"
      unitRef="shares">185000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMi0xLTEtMS0w_14513f4c-0441-4e23-8b9b-661a754ff4c5"
      unitRef="usd">627000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMi0zLTEtMS0w_e61e9e54-3e6d-42b1-b720-656dc878de8f"
      unitRef="usd">-677000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMi01LTEtMS0w_d0e80d98-e0ce-4b54-afea-e9a9a3d56bff"
      unitRef="usd">1121000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMi03LTEtMS0w_a9007bae-1e7f-4643-a398-b90bc0a8719e"
      unitRef="usd">-200000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNS0xLTEtMS0w_b899c9a6-4a6e-4521-8866-2d8a595f20bc"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNS0zLTEtMS0w_fe7aada3-5292-4f06-a567-0192d0c83c12"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNS01LTEtMS0w_31548b78-1fb3-4e02-afae-1bb20fa3e5ef"
      unitRef="usd">74000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNS03LTEtMS0w_34d25982-bec5-4147-a6bf-fead6621ba22"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNi0xLTEtMS0w_342d34ec-2960-41f1-973d-455a901a7d9a"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNi0zLTEtMS0w_eb5315d7-669e-4d17-a9af-70c2ea983be6"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNi01LTEtMS0w_e0480c1b-abe1-4292-bdb2-cc770f503cc0"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNi03LTEtMS0w_210539dd-eb86-4d0f-a142-048913a99ef2"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNy0xLTEtMS0w_52233141-fa58-4061-9150-464ca17c053c"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNy0zLTEtMS0w_58aa9c71-1fdb-45fc-84f1-57280a0d8ac4"
      unitRef="usd">-75000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNy01LTEtMS0w_4425c353-681e-4b73-a1d2-7732fa7549e7"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfNy03LTEtMS0w_2ca82175-78c8-44e5-864f-62875a49f04c"
      unitRef="usd">-96000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfOC0xLTEtMS0w_eb953ad6-de9f-40eb-8fc6-c59ec2bb6715"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfOC0zLTEtMS0w_c0762406-817f-4882-9d4c-aec89dd4e10d"
      unitRef="usd">56000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfOC01LTEtMS0w_f92e75e9-552f-45a5-85e5-388ffae7f12d"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfOC03LTEtMS0w_bec23aa3-3b1e-4391-ae54-0fc15bc793f5"
      unitRef="usd">133000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTAtMS0xLTEtMA_2b0c1636-6e09-4ccf-9aa7-534e3f40a2d5"
      unitRef="usd">640000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTAtMy0xLTEtMA_b676f501-06c6-4a76-9624-55298aa690ed"
      unitRef="usd">-621000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTAtNS0xLTEtMA_e4e67dac-bdda-4ee5-a63f-7f56fd8a3307"
      unitRef="usd">1163000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTAtNy0xLTEtMA_51da9010-74a1-45d8-af13-b3d55177c2a7"
      unitRef="usd">-67000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTEtMS0xLTEtMA_635e0ad8-202d-4250-9273-8c078af4ef24"
      unitRef="usd">-75000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTEtMy0xLTEtMA_b6a645b6-d96a-49a1-af8a-417d0b639f85"
      unitRef="usd">35000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTEtNS0xLTEtMA_b3b7c46b-9741-4955-a71c-4132c3c9dc7b"
      unitRef="usd">36000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTEtNy0xLTEtMA_d8850f7a-4d06-4d6f-bdc3-972c8c3cdc43"
      unitRef="usd">95000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTItMS0xLTEtMA_273405d5-64fd-43c8-9e57-4f81fe1a86f1"
      unitRef="usd">715000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTItMy0xLTEtMA_32a056ec-d7db-475c-93d9-7f4a27ad38d7"
      unitRef="usd">-656000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTItNS0xLTEtMA_36e27215-30c6-4af5-9bd4-149c6bef0ffe"
      unitRef="usd">1127000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xNi9mcmFnOmQyYjFkZTU3MzUwMTQ1ZTViMTkyOWNkY2VjZDNiN2Y3L3RhYmxlOmZlZDg2NDJhMzQxOTQ2MGI4ZGEwMjRkOTA5YzJmNjQ2L3RhYmxlcmFuZ2U6ZmVkODY0MmEzNDE5NDYwYjhkYTAyNGQ5MDljMmY2NDZfMTItNy0xLTEtMA_cf30678e-a44f-4b79-bfeb-353a7c24dbed"
      unitRef="usd">-162000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMy0xLTEtMS0w_9bfa4f06-1e15-4b60-903a-ddea6e17ddf7"
      unitRef="usd">3091000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMy0zLTEtMS0w_8ac6dcf0-f266-4389-bdac-88aed8033751"
      unitRef="usd">4015000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNC0xLTEtMS0w_f1c15020-1194-427b-acf9-d97b65fa8890"
      unitRef="usd">19285000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNC0zLTEtMS0w_aa1282b2-f484-4ec9-b4cc-333f8e4b9ea5"
      unitRef="usd">19950000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNS0xLTEtMS0w_64852765-888b-48ca-8420-9cd77cdcb6aa"
      unitRef="usd">18435000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNS0zLTEtMS0w_724c3c5a-9a68-4723-b933-63304829133c"
      unitRef="usd">16734000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNi0xLTEtMS0w_a3852de1-c7fa-48f0-a858-540d6364046a"
      unitRef="usd">833000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNi0zLTEtMS0w_4e3f9c04-80aa-4e11-a57e-25e46dae740c"
      unitRef="usd">906000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNy0xLTEtMS0w_625c2ace-3d18-40f5-9df2-e89c05b56f92"
      unitRef="usd">701000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNy0zLTEtMS0w_ded48bfc-eb0d-435c-b73f-e35e4004a18e"
      unitRef="usd">617000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfOC0xLTEtMS0w_f4804016-7733-4f11-a70a-2e3533635056"
      unitRef="usd">42345000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfOC0zLTEtMS0w_593c33ee-9ddc-4bc8-a76a-0b1f6f9a045a"
      unitRef="usd">42222000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfOS0xLTEtMS0w_dbbc369b-f887-481e-a623-0ff977a1aeec"
      unitRef="usd">2471000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfOS0zLTEtMS0w_147f18e6-fa7a-4e24-8a0b-07143f858fb7"
      unitRef="usd">2365000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTAtMS0xLTEtMA_930d087f-d35f-4669-9480-96dd7cac8ed0"
      unitRef="usd">1895000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTAtMy0xLTEtMA_400eddd5-5af5-49bf-b468-9d8729bdce16"
      unitRef="usd">1886000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTEtMS0xLTEtMA_15345445-b257-4cfd-8d95-8adba0ae8d76"
      unitRef="usd">9414000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTEtMy0xLTEtMA_afce8ae9-87ab-4dea-a029-b7c486873f2e"
      unitRef="usd">9360000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTItMS0xLTEtMA_97010a8f-9b36-453c-8df8-69547681f59b"
      unitRef="usd">3030000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTItMy0xLTEtMA_d728c73e-5105-40dd-a3f0-cb4ee91a9954"
      unitRef="usd">3156000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTQtMS0xLTEtMA_7a368309-8c42-4dec-8f42-25f40db24a37"
      unitRef="usd">2403000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTQtMy0xLTEtMA_a2701b85-dbdd-4b5f-987a-0e16b5e174f3"
      unitRef="usd">2258000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTUtMS0xLTEtMA_ddba9fde-c409-4c9a-8972-1bf32e532420"
      unitRef="usd">61558000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTUtMy0xLTEtMA_b51fd6fe-cf2d-4436-bc28-c63ebd53d691"
      unitRef="usd">61247000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTktMS0xLTEtMA_d59ac918-4cb6-4b5f-83ee-a22d53fc336d"
      unitRef="usd">36255000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMTktMy0xLTEtMA_bbdcc4f0-f0ee-4633-a041-15bdf5258e25"
      unitRef="usd">37195000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjEtMS0xLTEtMA_46115275-1a8c-4b17-afdf-811b1ea9512c"
      unitRef="usd">1760000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjEtMy0xLTEtMA_4752fd8e-7c14-4be6-b13f-e8c2b553e754"
      unitRef="usd">1052000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjItMS0xLTEtMA_fae474c1-a9fd-4c2f-871e-14f025e79224"
      unitRef="usd">367000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjItMy0xLTEtMA_f66b18d8-52fb-45f8-a5eb-3122d1e22752"
      unitRef="usd">354000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjMtMS0xLTEtMA_451305ba-ccee-464a-93da-e1d93caeb64a"
      unitRef="usd">537000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjMtMy0xLTEtMA_1d6ab8d8-b161-4669-87aa-08738b2a5a91"
      unitRef="usd">683000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjQtMS0xLTEtMA_11cbc3e9-2916-4d0f-9bc1-d85c8f2b3f38"
      unitRef="usd">3805000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjQtMy0xLTEtMA_2fe464bf-7ddb-42a6-a57e-4cc1084f8e04"
      unitRef="usd">3340000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjUtMS0xLTEtMA_a4a6b34d-1113-49ce-9a76-03570d37e6db"
      unitRef="usd">42724000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjUtMy0xLTEtMA_e23338e4-5740-43a5-b587-6cdc7864a16f"
      unitRef="usd">42624000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjYtMS0xLTEtMA_ea97f76e-093b-4574-ba56-336b5968776f"
      unitRef="usd">5848000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjYtMy0xLTEtMA_678d3f51-f32b-4e4f-9fb8-eef91b17bc04"
      unitRef="usd">6335000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjctMS0xLTEtMA_eedc6502-7023-4dc8-b694-4491f197661f"
      unitRef="usd">2293000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjctMy0xLTEtMA_272d9a3b-c245-4ea7-a2c6-31ba3c4cb48f"
      unitRef="usd">2255000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjgtMS0xLTEtMA_bbd4149d-5e77-4793-b601-a06246f7ff1f"
      unitRef="usd">1669000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjgtMy0xLTEtMA_20b2b9e7-e790-4b06-aee4-332c042a7562"
      unitRef="usd">1660000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjktMS0xLTEtMA_c6bc4cf6-6a2b-4adf-9546-45ea887768df"
      unitRef="usd">1669000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMjktMy0xLTEtMA_a1743f14-0186-472b-bb63-bead5c2924bf"
      unitRef="usd">1662000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzAtMS0xLTEtMA_fbf21d65-6d0e-4acf-915e-92e68590a052"
      unitRef="usd">1265000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzAtMy0xLTEtMA_e58258d0-17c4-46ed-907f-ab1a444aa9ce"
      unitRef="usd">1402000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzIx_453e728b-f497-424b-9db3-8b447362141a"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzIx_9c42c2b9-986f-40bc-b2a8-8c93c3a686e5"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzM1_98360614-0648-495c-8021-279688de8a7a"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzM1_bd849231-789f-447c-bb70-6ea20047a7df"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzU3_267f70e1-1675-419e-a2b1-c077e58688ae"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzU3_8c61678c-2ef9-41fc-b647-99e17ec3bb71"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzU3_bf7859a9-2014-4450-9822-90133dbf5bb4"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjUxODEzNjRjNjJlZDQyOWNhODM3Zjc0Y2Y2NGE5ZDY1XzU3_d8534ab2-28bb-4ecc-9b53-4456ef499038"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMS0xLTEtMA_8f4a93f3-0209-4045-a073-f5ae2a339e03"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzItMy0xLTEtMA_1a2ccc3b-ebaf-4971-88b9-9d18a9360d99"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlODlhOTIyNTM4YTQ3N2JiMTQxMWUyOThhOTNhNjM1XzE4_9905d288-f028-412f-bb2a-b9e58ad5d748"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlODlhOTIyNTM4YTQ3N2JiMTQxMWUyOThhOTNhNjM1XzE4_b2f402fc-aa14-4369-bf9b-21708809f0fa"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlODlhOTIyNTM4YTQ3N2JiMTQxMWUyOThhOTNhNjM1XzMy_7c3f0147-8bd8-4941-81af-b14d9c8c7a20"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlODlhOTIyNTM4YTQ3N2JiMTQxMWUyOThhOTNhNjM1XzMy_da510c24-f2e2-4425-b35b-698ff2518edf"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlODlhOTIyNTM4YTQ3N2JiMTQxMWUyOThhOTNhNjM1Xzcx_e6990d54-dc19-46da-afd6-0447313eeb89"
      unitRef="shares">273000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmVlODlhOTIyNTM4YTQ3N2JiMTQxMWUyOThhOTNhNjM1XzEwNDQ1MzYwNDYzOTc4_9b1f1861-0745-4b4f-b33b-613889601e19"
      unitRef="shares">272000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMS0xLTEtMA_c9a717ab-4569-4577-a728-ebae96338823"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzMtMy0xLTEtMA_442f599b-e865-4163-9ccc-388baf8786cf"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzQtMS0xLTEtMA_63e21425-99df-4504-bddd-2bce7b462d87"
      unitRef="usd">6780000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzQtMy0xLTEtMA_3af32827-bbbc-4698-8aac-550c762da02f"
      unitRef="usd">6663000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzUtMS0xLTEtMA_14811877-db17-4c4a-b736-c07c135b0d73"
      unitRef="usd">13890000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzUtMy0xLTEtMA_3d2194d7-0b7d-4e63-a647-283d1972025d"
      unitRef="usd">13022000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzYtMS0xLTEtMA_0287b86c-1903-4882-88f1-8fd5267ba7d0"
      unitRef="usd">-1597000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzYtMy0xLTEtMA_d58fdbca-9992-410c-913b-6087e1a8428b"
      unitRef="usd">-1703000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjZhMjE0ODNlYTRlZTQ1ODI4NjRmMzc2OGUyNjZlZjZkXzMw_2a3e96a1-179d-4db8-8a3a-1a3d77d2ca6f"
      unitRef="shares">112000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjZhMjE0ODNlYTRlZTQ1ODI4NjRmMzc2OGUyNjZlZjZkXzY1OTcwNjk3NjY3NDE_72d0b150-290a-45d1-a4f3-94d25e386f0f"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzgtMS0xLTEtMA_2b813fd4-e7b8-41f9-bc45-8c87df651074"
      unitRef="usd">13185000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzgtMy0xLTEtMA_41c7dc33-45d1-4a78-b382-bd3cb60bdb10"
      unitRef="usd">12892000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzktMS0xLTEtMA_ac8fd171-b01b-4723-be68-67ee5b9bcf87"
      unitRef="usd">5890000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfMzktMy0xLTEtMA_f6290b75-140f-4154-a3fe-05eab8e098f3"
      unitRef="usd">5092000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNDAtMS0xLTEtMA_3304b4d2-30fb-4036-8a6b-c840a744dab3"
      unitRef="usd">200000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNDAtMy0xLTEtMA_cf4c7d8c-daca-492b-bdc7-e3b70edab3e1"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNDEtMS0xLTEtMA_202dc0ab-0d82-4f47-9b8d-6a9d67170d60"
      unitRef="usd">6090000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNDEtMy0xLTEtMA_923d6915-b92c-48b8-b938-308d05417b1e"
      unitRef="usd">5309000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNDItMS0xLTEtMA_30358e24-7e11-48fc-a932-6882564a9688"
      unitRef="usd">61558000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8xOS9mcmFnOjk4Nzg1YTVhYzc3ZTRjNTE4ZmM1NTNlMzYyNTg0YjZiL3RhYmxlOmE1ZWY4MzNkMTFmYjRhYzE5Mzk0MDY4OWU3NWVmOTU4L3RhYmxlcmFuZ2U6YTVlZjgzM2QxMWZiNGFjMTkzOTQwNjg5ZTc1ZWY5NThfNDItMy0xLTEtMA_2f9aa81c-c411-47c1-b350-84eabf5ee682"
      unitRef="usd">61247000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="iabc3b5f8046b48bdbf4349b5c0383f8a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0xLTEtMS0w_d84692d5-f151-4dd3-8a86-3f3a3c710f30"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iabc3b5f8046b48bdbf4349b5c0383f8a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0zLTEtMS0w_9179c910-2dfb-4689-bb9f-e90d192ee4c0"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9dff60c859bc426a838f894b4001b9d9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy01LTEtMS0w_910e76f5-2911-4e86-819d-40c835524d2a"
      unitRef="usd">6711000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56da4268cdee4c4a9b797e2a40feb4ae_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy03LTEtMS0w_945d757e-d28a-46c9-a066-a0fa10c34ef0"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85c629cca8f64e44b872aac957b63d76_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy05LTEtMS0w_64503273-cf2b-4817-ba9f-0c7442d6cf26"
      unitRef="usd">13384000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib14ebdd9a67d42c6bff9fab1cd0291e3_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0xMS0xLTEtMA_42fc5e50-5cad-42e7-9399-6dccf45cfcf2"
      unitRef="usd">-1735000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i81a912f5f9a04d1ca5e7cb90f142a641_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0xMy0xLTEtMA_b78e2c33-20d7-42fa-8908-0c5a87e53309"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81a912f5f9a04d1ca5e7cb90f142a641_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0xNS0xLTEtMA_1f9a473c-6a0a-4ff1-87b3-cecfcd043707"
      unitRef="usd">-12916000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i86b3fd731c6a451da95296357c34854c_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0xNy0xLTEtMA_a3439cd6-d0ae-47b0-8994-fac5ba756c0c"
      unitRef="usd">207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i624020a8d4c24a6faaadd5ffc919e8d5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMy0xOS0xLTEtMA_2d651e1d-0e49-4d3a-832c-9100df1f4e1e"
      unitRef="usd">5653000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i86e7603b06d743728a36650859d04420_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfNi0xLTEtMS0w_6427ee6c-c58e-412c-bdf1-c8dd61793a35"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iff67f3d353954a34b18bf9eacb22eb74_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfNi01LTEtMS0w_dd465cf5-b64e-4a4f-a31b-17d4e6822dca"
      unitRef="usd">18000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i3307f8c1c01d4ecd976da193c588305c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfNi0xNS0xLTEtMA_ea37b13a-b435-435b-90f4-17bab0b6295e"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfNi0xOS0xLTEtMA_33a35287-0b49-49d4-8d1e-45cd8b0b82f6"
      unitRef="usd">18000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iff67f3d353954a34b18bf9eacb22eb74_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfNy01LTEtMS0w_0d7de6fa-dde0-4f28-805e-4e08574360cb"
      unitRef="usd">36000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfNy0xOS0xLTEtMA_e789a960-1d99-4068-8098-526b20ef7b88"
      unitRef="usd">36000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfOC0xNy0xLTEtMA_c6b1f56b-7654-4535-966f-ac9133752c45"
      unitRef="usd">50000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfOC0xOS0xLTEtMA_3593d8ce-9f16-453f-9c01-1762e0f612e4"
      unitRef="usd">50000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1dd3918b313740288772fde625402248_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfOS0xMS0xLTEtMA_107683de-a3aa-4609-8f6a-ed2f6ee77c29"
      unitRef="usd">138000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfOS0xOS0xLTEtMA_f9cf8eb4-3f00-4c9d-9dc2-27737e8c188b"
      unitRef="usd">138000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i3419ea2dc9594c8db2d6ab1f18fb857a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTAtOS0xLTEtMA_13d2641b-e543-47d5-a726-f6e188fecffa"
      unitRef="usd">577000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTAtMTctMS0xLTA_64c88783-7c2a-4616-81e5-d68f6e834957"
      unitRef="usd">40000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTAtMTktMS0xLTA_a8f6caf2-3f43-48a4-81fe-86ff78569994"
      unitRef="usd">617000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i3307f8c1c01d4ecd976da193c588305c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTEtMTMtMS0xLTA_ed9cdaa3-edf7-4735-8960-4b9f54b8a9cc"
      unitRef="shares">2000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i3307f8c1c01d4ecd976da193c588305c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTEtMTUtMS0xLTA_0004b995-a53d-4cca-98fc-c799dd341d03"
      unitRef="usd">269000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTEtMTktMS0xLTA_1aca15a1-c722-4fa0-8426-c3397b1898b8"
      unitRef="usd">269000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ2NDAyYzhkNDMyMzQ0Y2I4Y2ZkNTE3NjI2MDUzYTFhXzE2NDkyNjc0NDE3MjE_1fdabf4e-ced7-4825-afab-1ad5690fa35b"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3419ea2dc9594c8db2d6ab1f18fb857a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTMtOS0xLTEtMA_01331206-1dc0-4d1c-ada7-2af80539c2fc"
      unitRef="usd">69000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTMtMTktMS0xLTA_d519012d-ddd7-4898-a6b8-41fddc61d353"
      unitRef="usd">69000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="iff67f3d353954a34b18bf9eacb22eb74_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTQtNS0xLTEtMA_d9573e55-639d-4ce1-afec-6246e84cb0ba"
      unitRef="usd">-15000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i3419ea2dc9594c8db2d6ab1f18fb857a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTQtOS0xLTEtMA_b365dbca-9d65-48b2-84bf-e4cfd930b4c7"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTQtMTctMS0xLTA_d279a15c-bb1b-42d6-97f7-f94abf254083"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTQtMTktMS0xLTA_2708e8d0-bdd9-4828-913a-cdec86241e9f"
      unitRef="usd">-16000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="ia6d260abae684b3ea39deb99f2accdd9_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMS0xLTEtMA_369a5285-61e7-438b-b28d-68382e865946"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6d260abae684b3ea39deb99f2accdd9_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMy0xLTEtMA_a3d59343-af17-46aa-a9c4-99fd4a42cc53"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9648da59dbf240cc901798b3fb380aac_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtNS0xLTEtMA_c00df390-6a95-4579-ac8a-8a8a1a91132f"
      unitRef="usd">6780000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a499ada4b6a4143af9f09f3d2d3773d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtNy0xLTEtMA_355764f9-c2e5-494a-82cf-5bb92b34a9ff"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8b83385881344e4aaa0f55d53948d509_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtOS0xLTEtMA_15b351b3-1fb0-471e-8418-664017c745dc"
      unitRef="usd">13890000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id56ecd8e059f4e6696b7b1cc7c7988e4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMTEtMS0xLTA_30a449c8-218e-4ed5-82d6-a9ecbbd11acd"
      unitRef="usd">-1597000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ife081627cfce4fe3accedd30e135266f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMTMtMS0xLTA_385b7d4f-3fde-42a2-a1c9-3a0874541d62"
      unitRef="shares">112000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife081627cfce4fe3accedd30e135266f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMTUtMS0xLTA_15a076b1-f814-446f-be6e-8c0b5fab185f"
      unitRef="usd">-13185000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idadfecb50b694b9bad1fd34884a1ae60_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMTctMS0xLTA_edf15039-2de1-4954-9949-161291b27497"
      unitRef="usd">200000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjYwNzQ4N2U1YTcxYTQxY2I4ZGIyYmM5ZWIwM2VlYjRmL3RhYmxlcmFuZ2U6NjA3NDg3ZTVhNzFhNDFjYjhkYjJiYzllYjAzZWViNGZfMTUtMTktMS0xLTA_7495f418-24a4-4e4e-8e7b-1ababf27fd37"
      unitRef="usd">6090000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i750ef09c38ef490d90ed96590f8d7966_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0xLTEtMS0zMjQ_10140fea-3a46-4553-9d1e-8b6b63b10b54"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i750ef09c38ef490d90ed96590f8d7966_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0zLTEtMS0zMjQ_191f155b-e8a9-4b3a-b9bd-1824709b03ea"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b44c64ad2334280876102b25c03fa42_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy01LTEtMS0zMjQ_247a346c-089d-41f3-9b5a-b33af370001f"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie29e4f7dbe464f82b90c57337a3111f3_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy03LTEtMS0zMjQ_ff4adedf-4392-404e-8e86-3e88fbe44b71"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8a50be3402444652b3cf2b02bc8f0cc8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy05LTEtMS0zMjQ_1a597fb3-b45c-48a0-ad37-5b44e6940941"
      unitRef="usd">13022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c61eeba8b38459f985453da0e8c781d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0xMS0xLTEtMzI0_0333b6ab-542d-40cd-bff5-f6a1994272c1"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ie8e660e321e04b6ea0ec390e4691fed2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0xMy0xLTEtMzI0_67112051-ace1-42cb-8aa1-30385eff2586"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie8e660e321e04b6ea0ec390e4691fed2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0xNS0xLTEtMzI0_02e26c6a-66ee-434e-958c-e6e8ce2f31ff"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iebba672c55ee4c2a87f45e310c89afba_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0xNy0xLTEtMzI0_be84fe67-1e66-4a43-9449-b135b81c5fec"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMy0xOS0xLTEtMzI0_bc5a1703-449c-4d3b-ae21-fc983f80e267"
      unitRef="usd">5309000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if984c282fc6a4300aa9745b9ad1fd08a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNC05LTEtMS00NTc_a91b4461-15b1-44d3-85f4-3312d9604cda"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1cda9b3c50e4403fa7bbac61edca84dd_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNC0xOS0xLTEtNDU3_acb6b60e-b15e-4651-89a8-9dd3e3529207"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i07103e6d5410451f92642b65d23b443c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0xLTEtMS00NTc_55ed693d-7f3d-412e-aa5e-f1329098e78d"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i07103e6d5410451f92642b65d23b443c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0zLTEtMS00NTc_ab29c988-bf08-4374-96c8-7990d57306fd"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if90923f0cdf346f99356c5f1b103aa11_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS01LTEtMS00NTc_0bb41c72-a40e-4828-9919-31c7f9592088"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaac2ef7159664221a50c14397114988b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS03LTEtMS00NTc_f9dc5bd1-c79e-4210-b9ec-07be7c5dfde9"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib75098dd74134d5a900a9f389f1d593c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS05LTEtMS00NTc_efe371ce-25d3-47ee-a148-5fa153eb77d9"
      unitRef="usd">13009000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8628eafe53c44bb99de6a01f4fe1ec09_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0xMS0xLTEtNDU3_b8972016-4b7b-42d2-8e02-a4943b92d627"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i3ef50364db694bba8732ee06158ca2c4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0xMy0xLTEtNDU3_de91dcb1-2bb5-4e9c-b222-6ccd70fb0cde"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ef50364db694bba8732ee06158ca2c4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0xNS0xLTEtNDU3_e8d34857-5cd7-4dac-8708-5e63643fc69c"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie29be4b914d54b66b7225683b6f4fcab_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0xNy0xLTEtNDU3_e5eb6852-16d0-426b-af4d-cb77f912bdda"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f826e5b14454ea8a2ada91a6bda9f6f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNS0xOS0xLTEtNDU3_5a6e0c9f-4430-46b2-9ea8-a0b0c9064065"
      unitRef="usd">5296000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i5d91f70852e349d78d41746fc9b3a841_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNi0xLTEtMS00NTc_7ade01c3-e343-4894-b4c7-0000bc091ede"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i3845b80d46e4483e96a588f5092ba0ba_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNi01LTEtMS00NTc_12a6e9db-49a4-480f-b200-c8b1846cb8d9"
      unitRef="usd">39000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i151045664f014db396ec4d1388abafec_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNi0xNS0xLTEtNDU3_90e947e0-6eec-48b7-8301-e57ef173f728"
      unitRef="usd">-24000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNi0xOS0xLTEtNDU3_c1652b50-6ce8-44be-98ce-153d39eaf9b4"
      unitRef="usd">15000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3845b80d46e4483e96a588f5092ba0ba_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNy01LTEtMS00NTc_50f6a913-f845-42a1-95b2-ea93607fdbfc"
      unitRef="usd">59000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfNy0xOS0xLTEtNDU3_8ab3e39a-1fe3-4e68-bc87-9125bf48145b"
      unitRef="usd">59000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfOC0xNy0xLTEtNDU3_f9514aef-1e22-410a-a7ec-97f436be49e3"
      unitRef="usd">93000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfOC0xOS0xLTEtNDU3_dd3d200f-1aba-4f74-9b89-6554323f8258"
      unitRef="usd">93000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic98282253ac24d17bb300a34d9842800_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfOS0xMS0xLTEtNDU3_5ad389a3-9282-4a33-88cc-201e0e27f103"
      unitRef="usd">106000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfOS0xOS0xLTEtNDU3_a537872e-7aa8-4420-b45d-98b135da737e"
      unitRef="usd">106000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i837e1a2cf1964b3c874339affc1c8eac_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTAtOS0xLTEtNDU3_fac7698a-19a6-4023-b4b3-9727817e2c78"
      unitRef="usd">1021000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTAtMTctMS0xLTQ1Nw_1d5a870e-d057-4927-a5fd-eb725a1289e2"
      unitRef="usd">79000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTAtMTktMS0xLTQ1Nw_7f67026b-3f3e-463c-be47-4a0456e8937b"
      unitRef="usd">1100000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i3845b80d46e4483e96a588f5092ba0ba_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTEtNS0xLTEtNDU3_d633ab39-2d71-47ad-a16d-a2d52a81d541"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTEtMTktMS0xLTQ1Nw_d6f557ba-afb4-4348-9f22-6f686909a255"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i151045664f014db396ec4d1388abafec_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTItMTMtMS0xLTQ1Nw_6dc1d7cd-d1d8-4601-900e-b747c3269a73"
      unitRef="shares">2000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i151045664f014db396ec4d1388abafec_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTItMTUtMS0xLTQ1Nw_acb52f94-2b59-4f1a-852e-1e20fe88ce7d"
      unitRef="usd">269000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTItMTktMS0xLTQ1Nw_72576826-6d69-4e8f-8834-8d56e4b8b214"
      unitRef="usd">269000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTMtMC0xLTEtNDc4L3RleHRyZWdpb246OGNkOTMzZjhmOTUwNGYwNmI0YzJmYmM4YjUwNThiZjVfMTY0OTI2NzQ0MTcyMQ_dc2cd7b1-c7d3-4f54-a94e-cf11bb8c9d76"
      unitRef="usdPerShare">0.83</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i837e1a2cf1964b3c874339affc1c8eac_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTMtOS0xLTEtNDU3_c12a9f37-3469-4fa5-aed5-5c760d57ea38"
      unitRef="usd">136000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTMtMTktMS0xLTQ1Nw_636faa14-c344-44aa-81e2-5aa776fecd9a"
      unitRef="usd">136000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i3845b80d46e4483e96a588f5092ba0ba_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTQtNS0xLTEtNDU3_b5f3f0e8-f664-43ba-9b57-ed6d3e21161a"
      unitRef="usd">-16000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i837e1a2cf1964b3c874339affc1c8eac_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTQtOS0xLTEtNDU3_ef66b330-950d-4ff0-bfe5-5fad800f4d69"
      unitRef="usd">4000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTQtMTctMS0xLTQ1Nw_e0488d42-a322-40f9-a5b0-3656fa74668d"
      unitRef="usd">3000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTQtMTktMS0xLTQ1Nw_26af89f5-ab28-43c8-8639-26f34de89938"
      unitRef="usd">-9000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="ia6d260abae684b3ea39deb99f2accdd9_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMS0xLTEtMzM0_2599a2ef-e287-4a8b-92d8-ac42dd18bf81"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6d260abae684b3ea39deb99f2accdd9_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMy0xLTEtMzM0_13760973-3968-47a4-a21d-f593ef1ef38c"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9648da59dbf240cc901798b3fb380aac_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtNS0xLTEtMzM0_21c32d6a-0121-48c9-94ff-5a6957063f7e"
      unitRef="usd">6780000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a499ada4b6a4143af9f09f3d2d3773d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtNy0xLTEtMzM0_2a76cd48-dd1d-4069-b5cc-e265f5a78872"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8b83385881344e4aaa0f55d53948d509_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtOS0xLTEtMzM0_7e3b974d-7e1d-4a43-976f-1ec87804450d"
      unitRef="usd">13890000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id56ecd8e059f4e6696b7b1cc7c7988e4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMTEtMS0xLTMzNA_9750229d-18d9-449f-882f-d51cdabaf0c0"
      unitRef="usd">-1597000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ife081627cfce4fe3accedd30e135266f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMTMtMS0xLTMzNA_897df49b-b1e6-48ae-87d9-6eb43b9f696a"
      unitRef="shares">112000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife081627cfce4fe3accedd30e135266f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMTUtMS0xLTMzNA_c61f3c2b-a6e7-40aa-baa1-3b1c4d1e085f"
      unitRef="usd">-13185000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idadfecb50b694b9bad1fd34884a1ae60_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMTctMS0xLTMzNA_ca61d33f-6f2f-40eb-8c29-320e76a84449"
      unitRef="usd">200000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjIxY2ZmNWZjMTk2YjQwNTNhMzYxYzA1MmM3ODE2YmM0L3RhYmxlcmFuZ2U6MjFjZmY1ZmMxOTZiNDA1M2EzNjFjMDUyYzc4MTZiYzRfMTUtMTktMS0xLTMzNA_e37e1d93-2cc5-4f93-8a49-8a13f6307252"
      unitRef="usd">6090000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i7ab0556aa9f340e3ac3f07efb1786652_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0xLTEtMS0xMjUw_27070284-25b3-4125-ab4d-e0210ef9adc4"
      unitRef="shares">271000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ab0556aa9f340e3ac3f07efb1786652_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0zLTEtMS0xMjUw_4807c4fb-9955-45c4-8566-14d231ee811b"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd49ad70765946169fa5a2c37504d223_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy01LTEtMS0xMjUw_8eb10c3f-8ba2-4dfb-91ec-7fc0bc9af0dc"
      unitRef="usd">6483000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id27e19e091c34eb9b9768fcff47f09e6_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy03LTEtMS0xMjUw_bbc76e52-cecc-4f20-ae7e-b0ac274036fb"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f0ea496105b47b2be2796a2ab03ad9b_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy05LTEtMS0xMjUw_98d32d9e-a747-4216-9cb6-b6bebdf40bbc"
      unitRef="usd">12770000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i527d69e72eba46ae8d65ce3a0001cecc_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0xMS0xLTEtMTI1MA_547da7f6-c93e-4320-8d11-2a976a7a96f0"
      unitRef="usd">-1778000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i055c7fe4fa114e6fa2ee03924ec916e5_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0xMy0xLTEtMTI1MA_030cf7df-db76-418a-8656-73b38c9992b4"
      unitRef="shares">86000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i055c7fe4fa114e6fa2ee03924ec916e5_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0xNS0xLTEtMTI1MA_845f1be9-6562-42a0-8ad7-6db66301e721"
      unitRef="usd">-9603000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0e512234a3947858289f71240af0e24_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0xNy0xLTEtMTI1MA_c33985db-83a3-4c01-81fb-ae175db288fc"
      unitRef="usd">194000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56a82c257d8b45a3beba6b2dfcf0cceb_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMy0xOS0xLTEtMTI1MA_e31c0865-7180-4fe1-97ee-eca4d3921796"
      unitRef="usd">8068000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i9c459fbda98f4d89b895296afc039b3e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfNi0xLTEtMS0xMjk5_ec0f942c-0034-4c48-9d0e-26ce669ec465"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4e227831a81048e1a8c4e713692e6037_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfNi01LTEtMS0xMjk5_c6f30264-97d5-414e-bc98-1d8e630b1f41"
      unitRef="usd">56000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i5d9f213396824bbc864a45e30a5b1379_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfNi0xNS0xLTEtMTI5OQ_31816b3a-a674-40fb-8a4a-e154405c4d7b"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfNi0xOS0xLTEtMTI5OQ_733e072f-2ec8-4439-9b72-b845ee3b01d5"
      unitRef="usd">56000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4e227831a81048e1a8c4e713692e6037_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfNy01LTEtMS0xMjk5_dc2a4494-86b1-4aaa-bf4e-2a90ad3c919f"
      unitRef="usd">34000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfNy0xOS0xLTEtMTI5OQ_6e650043-22af-4b77-9773-5a6a5f9ed306"
      unitRef="usd">34000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfOC0xNy0xLTEtMTI5OQ_20b3860e-9d53-4d82-91e7-c874338fa998"
      unitRef="usd">37000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfOC0xOS0xLTEtMTI5OQ_e644d2a0-6aa2-4d28-a8e2-6fd8bcc28b4b"
      unitRef="usd">37000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i14715badbe50426696183870464fb77d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfOS0xMS0xLTEtMTI5OQ_a1ffddad-f531-4a98-8fa4-6a159fe824af"
      unitRef="usd">74000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfOS0xOS0xLTEtMTI5OQ_79a8ad9d-1983-4431-8a58-f44f732de650"
      unitRef="usd">74000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i5ccc82d868704bdeabe6b0ed81650efa_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTAtOS0xLTEtMTI5OQ_545402d4-6c89-4897-a8cb-8d88a97ec2fb"
      unitRef="usd">-730000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTAtMTctMS0xLTEyOTk_b2fb7e4b-3225-4a64-9f56-dcbae434def1"
      unitRef="usd">42000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTAtMTktMS0xLTEyOTk_af570123-1921-4ba0-88af-d61f5baf88ba"
      unitRef="usd">-688000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i5d9f213396824bbc864a45e30a5b1379_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTEtMTMtMS0xLTEyOTk_a40bbebe-6f5e-4123-876f-a0213acb86de"
      unitRef="shares">6000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i5d9f213396824bbc864a45e30a5b1379_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTEtMTUtMS0xLTEyOTk_f5e7028e-784e-4e7d-8fa3-2bdb4a5566c3"
      unitRef="usd">750000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTEtMTktMS0xLTEyOTk_0bd2b340-20a8-41f4-907b-25eb650b23de"
      unitRef="usd">750000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTMtMC0xLTEtMTIzNy90ZXh0cmVnaW9uOjNhNDJlYzAxNTVjYzQ1ZDY5ZmY5OGJlOTdiZGU2Y2VhXzI3NDg3NzkwNjk0OTY_85e29b41-fab7-4a45-bd99-b61a9bfc7877"
      unitRef="usdPerShare">0.41</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i5ccc82d868704bdeabe6b0ed81650efa_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTMtOS0xLTEtMTI5OQ_513ac044-7a2d-4727-86a6-431ea76c4d4d"
      unitRef="usd">75000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTMtMTktMS0xLTEyOTk_934d16bc-fd89-416a-8d60-1cb858c5edbe"
      unitRef="usd">75000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i4e227831a81048e1a8c4e713692e6037_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTQtNS0xLTEtMTI5OQ_54fb6d2b-5be4-44d5-9cfe-5cab0f29781c"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="iebfb081bd626464390ff45f5fef68f5e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTQtNy0xLTEtMTI5OQ_840d4132-99a7-4d39-90eb-f0080f2301a5"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTQtMTctMS0xLTEyOTk_27d45959-8d54-4423-bb8c-cf935719cedf"
      unitRef="usd">-11000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTQtMTktMS0xLTEyOTk_5a30e36c-efa4-4de9-9a0d-5c16830dc7e6"
      unitRef="usd">-10000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="ida674b76527d474486ce8b22743056d8_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMS0xLTEtMTI5OQ_92353648-0058-42dd-ac3d-a1dd59fd389a"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida674b76527d474486ce8b22743056d8_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMy0xLTEtMTI5OQ_7cb67c23-53ee-4b09-8806-cfdced128208"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i066d88a46b864f71bd116fd264f47155_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtNS0xLTEtMTI5OQ_8599978c-7a58-4e7e-94b0-42562ce2841f"
      unitRef="usd">6573000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b95a05a13af42d5b440fef8def022b9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtNy0xLTEtMTI5OQ_785f9acb-5db1-4b11-b151-654c0e59be2b"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1ef9e0529026452082cff03d5ad3ef31_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtOS0xLTEtMTI5OQ_a9a60a9e-e6ab-47e2-8faf-0bfdd3149f8a"
      unitRef="usd">11965000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1d225eb50904ac7afd16a3e52e96014_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMTEtMS0xLTEyOTk_445e9681-fba2-434e-a0ba-2ec0469fa931"
      unitRef="usd">-1704000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="id047fe71417d4ba0a432ed05ef05fedc_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMTMtMS0xLTEyOTk_29d46a33-0367-4b99-9d9a-6dbf242cb495"
      unitRef="shares">92000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id047fe71417d4ba0a432ed05ef05fedc_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMTUtMS0xLTEyOTk_2cfccead-c6f5-4964-8b81-8f0ffa630dd6"
      unitRef="usd">-10353000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2ca1a2d209b4ea4a677b11a4d562bff_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMTctMS0xLTEyOTk_3263dccc-0d83-4611-a358-3d64b898a07e"
      unitRef="usd">210000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia0bd0811c0224eb6a8188a2281171287_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOmM2OTdlNjJhYmU1MjQ5NDM5NWM2NWJjNjIxMTRiMzFhL3RhYmxlcmFuZ2U6YzY5N2U2MmFiZTUyNDk0Mzk1YzY1YmM2MjExNGIzMWFfMTUtMTktMS0xLTEyOTk_dc9aa1c0-e5e1-40fb-ba9c-adbdd60e4f64"
      unitRef="usd">6692000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i1038eaf9e8794cbcbded983f8ccfcb9a_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0xLTEtMS0w_b84be021-ea69-48b2-b471-d63546b0e436"
      unitRef="shares">271000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1038eaf9e8794cbcbded983f8ccfcb9a_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0zLTEtMS0w_ff954600-994c-481d-9dfa-bec848ffa750"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i74dbf3756e304d92aeaccdcd0a323a87_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy01LTEtMS0w_2908c1cf-47e5-4388-b266-ff9b63c91d71"
      unitRef="usd">6435000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i519675db2894462f940aec3609198a9f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy03LTEtMS0w_fb5df18f-dd14-4d8e-aed9-9d2c6840ff92"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8a280e4073e4978b428ac6b0c0dd2be_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy05LTEtMS0w_1bb65311-512f-46d3-a6b1-f7cc31b16252"
      unitRef="usd">12409000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0532330a51214e249b3b9e2fbc5ebee3_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0xMS0xLTEtMA_87a43d2b-86c4-4ee8-aaec-7d1285304156"
      unitRef="usd">-1849000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i0a26b872a65c49fbab22d3dd61751d4c_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0xMy0xLTEtMA_571925f6-ab9c-420a-bbb9-ebdb492d5124"
      unitRef="shares">81000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0a26b872a65c49fbab22d3dd61751d4c_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0xNS0xLTEtMA_705ee5e8-58eb-491f-ba00-7061428ec7ea"
      unitRef="usd">-8902000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7004546d044b4049a10a34e53e7b21d2_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0xNy0xLTEtMA_cb63204c-a7b3-47e8-9a5b-fe901d0506ba"
      unitRef="usd">193000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i793953b750ac4456be2099940de03f04_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMy0xOS0xLTEtMA_de1cc1c4-2500-43cc-8dbb-f4735d31420c"
      unitRef="usd">8287000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie193bb9fa6704fa3acc5751bc7472c22_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNC05LTEtMS0w_5521c3a1-a6df-4c7f-9bf8-49adac7f47fa"
      unitRef="usd">11000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9726c90f483c47acb129d2e23e982038_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNC0xOS0xLTEtMA_4dfc03b1-b669-4765-8026-d54031ed6291"
      unitRef="usd">11000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i153fe9ad0eb8417e837f3785055c6ed3_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0xLTEtMS0w_4a623797-3284-4a9a-9941-8ada1e23ba4b"
      unitRef="shares">271000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i153fe9ad0eb8417e837f3785055c6ed3_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0zLTEtMS0w_d1c5af13-7011-4e05-a4f0-32d55f976a83"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ba7615df4f54c9394bdceec616f160b_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS01LTEtMS0w_1ed89ba3-9bae-434a-b999-c1226972053d"
      unitRef="usd">6435000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f906acdf8544001a98097ca5fefee5f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS03LTEtMS0w_d4352301-374d-4460-8673-fbdbeb39bee1"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7f4bc7c87de41ec95337b9a9c2a5980_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS05LTEtMS0w_b535de27-e882-40c6-8fe9-43100aa43ec9"
      unitRef="usd">12420000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iffa749c811f44f839ea4c4218238ca96_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0xMS0xLTEtMA_512aac95-be40-4101-979f-47a2ad6b1f6f"
      unitRef="usd">-1849000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i1414642232a64093b59196114d7bbe81_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0xMy0xLTEtMA_8cea5553-cb75-4f08-a9f8-f9e5a9f215e1"
      unitRef="shares">81000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1414642232a64093b59196114d7bbe81_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0xNS0xLTEtMA_801fb3e9-1a26-46f8-b9a0-73c7c1d4aaa7"
      unitRef="usd">-8902000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia8097b9305824e04b33569a91abcc550_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0xNy0xLTEtMA_fbc174f6-3be7-435a-a122-193670b76380"
      unitRef="usd">193000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb9ee476d3394ecc80affa02786a5506_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNS0xOS0xLTEtMA_728e3e36-1c69-44cf-a994-38b117bae5d4"
      unitRef="usd">8298000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i27e2aad7746c41ebb5c5c95a5334fdd4_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNi0xLTEtMS0w_63ab6845-be59-4713-8db3-19e9b3cc89d3"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iee4f408f0d454849b9073de0b78b77a9_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNi01LTEtMS0w_f3a9761f-36bc-438e-99da-ed5991b44d1a"
      unitRef="usd">78000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i95551ce68b8e47f0bba655aea0ee5f0c_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNi0xNS0xLTEtMA_10fbf620-d722-4d3e-8118-63391716f459"
      unitRef="usd">-17000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNi0xOS0xLTEtMA_ac7212a8-6c8c-4d6d-b582-1f2e8927611e"
      unitRef="usd">61000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iee4f408f0d454849b9073de0b78b77a9_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNy01LTEtMS0w_a597d0d0-55ee-4414-bb24-3f998c887872"
      unitRef="usd">60000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfNy0xOS0xLTEtMA_de0b4cb0-3e29-4b62-962a-51e0db7d6729"
      unitRef="usd">60000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfOC0xNy0xLTEtMA_8d5f2fe4-c1a9-49b4-ac70-06f9ba44ece6"
      unitRef="usd">76000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfOC0xOS0xLTEtMA_e467b240-8c58-4aa3-9920-a397caf20eb4"
      unitRef="usd">76000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia3093e8b5aa4420189b9a3f12efb6235_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfOS0xMS0xLTEtMA_d643ebb9-fcbd-40fc-bd5a-10d77b7fb5c0"
      unitRef="usd">145000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfOS0xOS0xLTEtMA_e61ca33d-d34e-4bf8-a706-fdebaf70d14f"
      unitRef="usd">145000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i6278551f7fc3480497a143f010615c9c_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTAtOS0xLTEtMA_1ac04e6f-73eb-4f06-9cdf-4b6a3f1649df"
      unitRef="usd">-307000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTAtMTctMS0xLTA_3fbd7dbd-e82b-4daf-9df0-3975be117326"
      unitRef="usd">85000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTAtMTktMS0xLTA_24d2f928-0c8e-4270-a299-86c1fee1224b"
      unitRef="usd">-222000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i95551ce68b8e47f0bba655aea0ee5f0c_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTEtMTMtMS0xLTA_5f2306f9-fa22-45da-8d3f-3f7c22a9db38"
      unitRef="shares">11000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i95551ce68b8e47f0bba655aea0ee5f0c_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTEtMTUtMS0xLTA_8970d5a4-1600-4d86-8df7-8d8953e07e03"
      unitRef="usd">1434000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTEtMTktMS0xLTA_513330bf-1b0a-43ca-ae05-2ceadcbd2203"
      unitRef="usd">1434000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjJkODJkODg5YzE1NzRmYWM4MWY5NTVkNjVjYTU3Y2QyXzI3NDg3NzkwNjk0OTY_0a9a1c82-3386-4f25-b4a3-21ab33263e0d"
      unitRef="usdPerShare">0.80</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i6278551f7fc3480497a143f010615c9c_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTMtOS0xLTEtMA_6495d8c9-b46c-4a98-be9d-a9f05c0a34d2"
      unitRef="usd">148000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTMtMTktMS0xLTA_33e33768-9abd-4fcd-9ba7-e6daca9be3ab"
      unitRef="usd">148000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="iee4f408f0d454849b9073de0b78b77a9_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTQtNS0xLTEtMA_2320c9e3-17af-4c4d-8511-5308d7c29a3d"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ic8770d32fa2448e1a5a96bbcbabee231_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTQtNy0xLTEtMA_12ff929f-50d7-47ad-bb7f-ac886516a207"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTQtMTctMS0xLTA_f3ff36eb-c7f6-4015-966f-8f3becde9781"
      unitRef="usd">-8000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTQtMTktMS0xLTA_688df46f-ab35-492a-8976-3f12d86bd9e6"
      unitRef="usd">-8000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="ida674b76527d474486ce8b22743056d8_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMS0xLTEtMA_9d4a8a94-2d4e-4054-86b1-683498467e16"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida674b76527d474486ce8b22743056d8_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMy0xLTEtMA_3e69bae7-a36d-42b0-bb6b-5fb113abdd8d"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i066d88a46b864f71bd116fd264f47155_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtNS0xLTEtMA_89f37d5f-2e9a-40de-98fe-67552cb0d142"
      unitRef="usd">6573000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b95a05a13af42d5b440fef8def022b9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtNy0xLTEtMA_723e0ab3-96f2-4910-aa98-4ccad5019786"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1ef9e0529026452082cff03d5ad3ef31_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtOS0xLTEtMA_c3a720a2-e015-484a-a667-bfd6499bd6d5"
      unitRef="usd">11965000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1d225eb50904ac7afd16a3e52e96014_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMTEtMS0xLTA_10b1c847-e48f-4252-af55-0047fd2c8ade"
      unitRef="usd">-1704000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="id047fe71417d4ba0a432ed05ef05fedc_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMTMtMS0xLTA_877fe59b-fa44-41c3-b2cc-f99e499ff77c"
      unitRef="shares">92000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id047fe71417d4ba0a432ed05ef05fedc_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMTUtMS0xLTA_2553509a-ddab-432e-9e5a-bf92c8889b50"
      unitRef="usd">-10353000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2ca1a2d209b4ea4a677b11a4d562bff_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMTctMS0xLTA_41dffe8d-ce56-452b-8167-bce688149e30"
      unitRef="usd">210000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia0bd0811c0224eb6a8188a2281171287_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yMi9mcmFnOmEzNzlkODUzYTc2MjQ3MGRhOWNmZjEwYTA1MTg3NGM4L3RhYmxlOjA3NTM4YTI3NmM2ZjRjOTdhYWY2N2RmNzFmOTM4ZjhjL3RhYmxlcmFuZ2U6MDc1MzhhMjc2YzZmNGM5N2FhZjY3ZGY3MWY5MzhmOGNfMTUtMTktMS0xLTA_37786e50-dd89-4aa2-9a51-690055b672a3"
      unitRef="usd">6692000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMy0xLTEtMS0w_83302c50-db8f-4bd9-ad7f-81ce716fea1c"
      unitRef="usd">1121000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMy0zLTEtMS0w_e4a6b3af-7469-4e26-8dbb-05995138fe84"
      unitRef="usd">-200000000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNS0xLTEtMS0w_b15ae3fd-cb81-4d48-be1f-8f73e7824564"
      unitRef="usd">154000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNS0zLTEtMS0w_b4655c6d-f466-4ced-b1ac-0ba55492f37c"
      unitRef="usd">160000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNi0xLTEtMS0w_5ad89680-2833-4d06-a252-0ce15b07a6a3"
      unitRef="usd">285000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNi0zLTEtMS0w_7a2f50ab-c26e-403a-ade2-abcaa291407d"
      unitRef="usd">303000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AssetImpairmentCharges
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNy0xLTEtMS0w_6e2e1cc9-83f1-44e3-84bc-133a5c565172"
      unitRef="usd">104000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNy0zLTEtMS0w_b07df4a1-90a3-4f78-a7e2-d06a95ecb23d"
      unitRef="usd">12000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfOC0xLTEtMS0w_35457731-0fe0-49c9-83ee-40412b812be0"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfOC0zLTEtMS0w_9c9306be-e3da-4035-9f9d-07aaf7c103cd"
      unitRef="usd">-1450000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfOS0xLTEtMS0w_e298db0e-a13b-4196-b803-1734ad00c4f5"
      unitRef="usd">35000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfOS0zLTEtMS0w_b07d2245-0f1e-4841-939f-15633f7fd63a"
      unitRef="usd">380000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTAtMS0xLTEtMA_3f3c62bc-eebe-4a41-9843-732d95dd3f47"
      unitRef="usd">-104000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTAtMy0xLTEtMA_677aeb6f-8104-4eb4-bbfc-c06c349ad1a2"
      unitRef="usd">-48000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:OperatingLeaseExpense
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTEtMS0xLTEtMA_03126d1d-c0fb-48cc-958a-6c876ef7f01a"
      unitRef="usd">172000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTEtMy0xLTEtMA_65b7cd27-fa4d-47b6-8d53-28b4b8386a25"
      unitRef="usd">180000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTItMS0xLTEtMA_a3207a33-e91c-409d-83b6-4c086b277fd2"
      unitRef="usd">-1000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTItMy0xLTEtMA_cfc8718c-67bc-4f01-8647-938f68452532"
      unitRef="usd">1000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTMtMS0xLTEtMA_9339c9a6-18a9-466f-bb00-964a94470704"
      unitRef="usd">-17000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTMtMy0xLTEtMA_b8a3d9a6-09f1-4450-9690-583497119038"
      unitRef="usd">-145000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTUtMS0xLTEtMA_b95947d9-8a4a-4de9-90c7-820c4d250c08"
      unitRef="usd">-981000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTUtMy0xLTEtMA_bcc54610-60bb-4320-b10f-d9c15da870cd"
      unitRef="usd">866000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTYtMS0xLTEtMA_5c59d58b-61f1-4371-90a3-e0c509e55af7"
      unitRef="usd">1396000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTYtMy0xLTEtMA_11e174da-e723-4409-be59-7d7e68d06eea"
      unitRef="usd">-331000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTctMS0xLTEtMA_024c1335-be7e-4975-b185-99fc775c6478"
      unitRef="usd">-1305000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTctMy0xLTEtMA_e5496676-2b03-4ff1-9dcf-d25fb1f6029f"
      unitRef="usd">-1203000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <mck:IncreaseDecreaseinOperatingLeaseLiabilities
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTgtMS0xLTEtMA_470ecd24-5fdc-41ab-890f-24b433044f56"
      unitRef="usd">-185000000</mck:IncreaseDecreaseinOperatingLeaseLiabilities>
    <mck:IncreaseDecreaseinOperatingLeaseLiabilities
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTgtMy0xLTEtMA_2cf5bbed-01f6-47e8-b4ee-f300f57bceb5"
      unitRef="usd">-189000000</mck:IncreaseDecreaseinOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTktMS0xLTEtMA_78e734cf-40b2-4d3b-a31f-bccd6d5b948f"
      unitRef="usd">-58000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMTktMy0xLTEtMA_30e5340c-a15b-4c63-8802-b0e70b820294"
      unitRef="usd">70000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjAtMS0xLTEtMA_a1bc3d6f-96c4-447a-9ef3-d5b7eda75145"
      unitRef="usd">-207000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjAtMy0xLTEtMA_c976c273-9072-4186-9f93-5ed5cea9f012"
      unitRef="usd">-77000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjEtMS0xLTEtMA_08536a1d-8cc1-4da2-bb8e-86b431d4ccb1"
      unitRef="usd">-41000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjEtMy0xLTEtMA_610955e1-899f-4c2b-b4a7-737c2353264c"
      unitRef="usd">-159000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjQtMS0xLTEtMA_4c4931f9-9b6b-4bea-86fb-6406bb4d4c24"
      unitRef="usd">174000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjQtMy0xLTEtMA_58195e62-1aa4-4688-8671-7e591498ba23"
      unitRef="usd">126000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjUtMS0xLTEtMA_620180a8-d6af-414e-b0a6-1d5e58568b1f"
      unitRef="usd">91000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjUtMy0xLTEtMA_2d05afa5-af43-4725-b9cc-45955e0cd6e4"
      unitRef="usd">58000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjYtMS0xLTEtMA_717336c6-4f6c-4393-bd2f-14265da07224"
      unitRef="usd">8000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjYtMy0xLTEtMA_686570d8-9a6e-4e5e-9845-2af3dd000167"
      unitRef="usd">95000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjctMS0xLTEtMA_a1f572db-845c-4218-82ad-929f000acaf3"
      unitRef="usd">9000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjctMy0xLTEtMA_9bdc5c09-d85f-4cc3-b25c-48c1b326dad8"
      unitRef="usd">3000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjgtMS0xLTEtMA_86feaa7c-7004-41df-a016-51bd1f8d774e"
      unitRef="usd">14000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjgtMy0xLTEtMA_f48590e3-347f-43d5-a85e-25afd1f5f33e"
      unitRef="usd">9000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjktMS0xLTEtMA_c25c9b14-c274-4588-b79b-accf8ccaff8a"
      unitRef="usd">-278000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMjktMy0xLTEtMA_91037395-6153-4000-85b4-16edd0cb5e7c"
      unitRef="usd">-285000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzItMS0xLTEtMA_d7461c1e-4e71-4454-861d-7b524e6f5d21"
      unitRef="usd">5303000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzItMy0xLTEtMA_07fd7a53-1fe3-4cb2-bf5c-6ecd17ff20b3"
      unitRef="usd">8670000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzMtMS0xLTEtMA_90a7c3ef-960d-4b55-9595-d234e83562ed"
      unitRef="usd">5303000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzMtMy0xLTEtMA_bbd53135-5c6e-4f61-81ff-d6daf61fcbb0"
      unitRef="usd">8122000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzUtMS0xLTEtMA_b8ae7c25-1d65-4dca-b63b-0de86fe2b376"
      unitRef="usd">5000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzUtMy0xLTEtMA_54017a61-a8af-4ade-b1a8-9f49a97fbf91"
      unitRef="usd">5000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzctMS0xLTEtMA_7f8b416a-49d3-46b3-aaf6-8b9147dbc2d2"
      unitRef="usd">39000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzctMy0xLTEtMA_d1218993-705b-4e70-b329-2b9f837190bc"
      unitRef="usd">78000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzgtMS0xLTEtMA_6f3336bc-8c14-44e2-a483-69a00bc34f9b"
      unitRef="usd">272000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzgtMy0xLTEtMA_365dd549-fc6b-4e3b-9b93-01be05c34095"
      unitRef="usd">1452000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzktMS0xLTEtMA_04b44549-d284-4690-87fd-c45612162dfa"
      unitRef="usd">140000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfMzktMy0xLTEtMA_a4e607be-ed48-49a0-a121-311c5caac3c9"
      unitRef="usd">148000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDAtMS0xLTEtMA_3fa72840-121d-4390-bc59-90bdf4686e71"
      unitRef="usd">-23000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDAtMy0xLTEtMA_45b31d6d-db07-4fdb-8a9c-0282607b196b"
      unitRef="usd">-224000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDEtMS0xLTEtMA_6f379bbc-b052-4143-9a9b-8e0eeb84325d"
      unitRef="usd">-401000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDEtMy0xLTEtMA_f919bb0f-5886-42c2-9625-11e3cd94d260"
      unitRef="usd">-1203000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDItMS0xLTEtMA_f9071808-ca66-4675-8f9c-5daef418e446"
      unitRef="usd">-63000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDItMy0xLTEtMA_8ec3a2ca-0c11-4847-8b4f-6daa71c9b59a"
      unitRef="usd">22000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDMtMS0xLTEtMA_5937cdf8-22ad-44e6-b601-88a17290fbaa"
      unitRef="usd">-783000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDMtMy0xLTEtMA_c272b4f4-6eb9-4215-a541-5fe685806643"
      unitRef="usd">-1625000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDQtMS0xLTEtMA_6f674f02-8654-4209-8a3c-737137612403"
      unitRef="usd">4023000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i793953b750ac4456be2099940de03f04_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDQtMy0xLTEtMA_12d897d0-d894-4724-91b7-ae59a373f4f8"
      unitRef="usd">2981000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDUtMS0xLTEtMA_29a54411-1fbd-4acb-a5be-7b84f80e57e4"
      unitRef="usd">3240000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia0bd0811c0224eb6a8188a2281171287_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDUtMy0xLTEtMA_803b75cb-cfb3-43ab-b484-e18c06587a90"
      unitRef="usd">1356000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDYtMS0xLTEtMA_eaac7f0e-76da-4c26-91c5-b344e6a70301"
      unitRef="usd">149000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="ia0bd0811c0224eb6a8188a2281171287_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDYtMy0xLTEtMA_cf7c4edf-ab1b-4770-adce-904a84834e01"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDgtMS0xLTEtMA_93df0196-a7d7-4d4d-acd6-0616b23df3a1"
      unitRef="usd">3091000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia0bd0811c0224eb6a8188a2281171287_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8yNS9mcmFnOjBiZWQyOTdlZWE2ODQ5N2VhMzA4NTIwMDEwNzgwYzgyL3RhYmxlOjU5YzZjMWMwMTQ4YTQ5MWViMzIyMzkyNzlhMTI1YTNkL3RhYmxlcmFuZ2U6NTljNmMxYzAxNDhhNDkxZWIzMjIzOTI3OWExMjVhM2RfNDgtMy0xLTEtMA_3a03346f-6171-496d-a793-71137f4cac58"
      unitRef="usd">1356000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1NzM_fac7ff9e-1398-43b7-8985-974231d361fd">Significant Accounting Policies&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: McKesson Corporation (&#x201c;McKesson,&#x201d; or the &#x201c;Company,&#x201d;) is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. Commencing in the second quarter of 2021, the Company reports its financial results in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#x201c;RxTS&#x201d;). The Company&#x2019;s equity method investment in Change Healthcare LLC (&#x201c;Change Healthcare JV&#x201d;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented. All prior segment information has been recast to reflect the Company&#x2019;s new segment structure and current period presentation.  Refer to Financial Note 15, &#x201c;Segments of Business,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S.&#x201d;) of America (&#x201c;GAAP&#x201d;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The severity, magnitude, and duration, as well as the economic consequences of the coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, the Company&#x2019;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. The Company continues to evaluate the legislation for future impacts to its consolidated financial statements, however it did not cause a material impact to the Company&#x2019;s financial results for the three and six months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three and six months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 previously filed with the SEC on May 22, 2020 (&#x201c;2020 Annual Report&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company prospectively adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Retirement Benefits - Defined Benefit Plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#x2019;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company adopted ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to remove, modify and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#x2019;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company adopted ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2016-13&#x201d;), which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $13 million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for Credit Losses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the adoption of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1OTA_ef5deb27-a7a7-4410-a2df-e6fb8d4e63c9"&gt;ASU 2016-13&lt;/span&gt; in the first quarter of 2021, the Company began using the Current Expected Credit Losses ("CECL") methodology to determine an allowance for credit losses related to financial assets measured at amortized cost. The Company considers historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $219 million was included in Receivables, net on the Condensed Consolidated Balance Sheet as of September 30, 2020. Changes in the allowance were not material for the three and six months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In December 2019, ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The Company is currently evaluating the impact of this amended guidance on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTY0OTI2NzQ1MjM3NQ_177ff9d1-723a-4311-9b63-1ec03f851e22"
      unitRef="numberofsegments">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1OTg_3abbee8e-8b69-4fb5-a158-b12fa94a91bc">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S.&#x201d;) of America (&#x201c;GAAP&#x201d;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The severity, magnitude, and duration, as well as the economic consequences of the coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, the Company&#x2019;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. The Company continues to evaluate the legislation for future impacts to its consolidated financial statements, however it did not cause a material impact to the Company&#x2019;s financial results for the three and six months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1ODY_744f9ec9-e94f-4e2e-94c5-7389c443cc21">The results of operations for the three and six months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 previously filed with the SEC on May 22, 2020 (&#x201c;2020 Annual Report&#x201d;).</us-gaap:UseOfEstimates>
    <us-gaap:FiscalPeriod
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1NzY_cfe264b5-daaa-4c67-a614-2e02a48075f1">The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.</us-gaap:FiscalPeriod>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1ODc_5a972ec5-6ee4-4d74-9564-ffa808d97cf3">Certain prior year amounts have been reclassified to conform to the current year presentation.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1OTM_7214732a-00c8-4dd1-85a8-16db52224ba4">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company prospectively adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Retirement Benefits - Defined Benefit Plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#x2019;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company adopted ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to remove, modify and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#x2019;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company adopted ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2016-13&#x201d;), which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $13 million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for Credit Losses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the adoption of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1OTA_ef5deb27-a7a7-4410-a2df-e6fb8d4e63c9"&gt;ASU 2016-13&lt;/span&gt; in the first quarter of 2021, the Company began using the Current Expected Credit Losses ("CECL") methodology to determine an allowance for credit losses related to financial assets measured at amortized cost. The Company considers historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $219 million was included in Receivables, net on the Condensed Consolidated Balance Sheet as of September 30, 2020. Changes in the allowance were not material for the three and six months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In December 2019, ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The Company is currently evaluating the impact of this amended guidance on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i72068016134b43bfacb6383f8d1e74f7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTY0OTI2NzQ1MzExNA_4e5a634a-d555-40c2-8332-247ad7156182"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfOTU3OA_f49773cf-89b1-4e1e-9f0f-c8b9fd6ecdea"
      unitRef="usd">219000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMzk3Nw_a874b39a-f276-40d8-bdb1-4112cb666a33">Investment in Change Healthcare Joint Venture&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Until the separation of its interest in the Change Healthcare JV on March 10, 2020, the Company accounted for its interest in the joint venture using the equity method of accounting with a one-month reporting lag, with disclosure made for any intervening events of the joint venture in the lag period that could materially affect its condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective April 1, 2019, the Change Healthcare JV adopted the amended revenue recognition guidance. In the first quarter of 2020, the Company recorded its proportionate share of the joint venture&#x2019;s adoption impact of the amended revenue recognition guidance of approximately $80 million, net of tax, to the Company&#x2019;s opening retained earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 27, 2019, common stock and certain other securities of Change Healthcare Inc. (&#x201c;Change&#x201d;) began trading on the NASDAQ (&#x201c;IPO&#x201d;). Change was a holding company and did not own any material assets or have any operations other than its interest in the Change Healthcare JV.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 1, 2019, upon the completion of its IPO, Change received net cash proceeds of approximately $888 million. Change contributed the proceeds of $609 million from its offering of common stock to the Change Healthcare&#160;JV in exchange for additional membership interests of the Change Healthcare JV (&#x201c;LLC Units&#x201d;) at the equivalent of its offering price of $13 per share. The proceeds of $279 million from the concurrent offering of other securities were used by Change to acquire certain securities of the Change Healthcare JV that substantially mirrored the terms of other securities included in the offering by Change. As a result, McKesson&#x2019;s equity interest in the Change Healthcare JV was diluted from approximately 70% to approximately 58.5% while Change owned approximately 41.5% of the outstanding LLC Units. Accordingly, in the second quarter of 2020, the Company recognized a pre-tax dilution loss of $246 million primarily representing the difference between its proportionate share of the IPO proceeds and the dilution effect on the investment&#x2019;s carrying value. These items were included in Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#x2019;s Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2019. The Company&#x2019;s proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2020, the Company recorded a pre-tax other-than-temporary&#160;impairment (&#x201c;OTTI&#x201d;) charge of $1.2 billion to its investment in the Change Healthcare JV, representing the difference between the carrying value of the Company&#x2019;s investment and the fair value derived from the corresponding closing price of Change&#x2019;s common stock at September 30, 2019. This charge was included in Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#x2019;s Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded its proportionate share of loss from its investment in Change Healthcare JV of $51 million and $47 million, respectively, for the three and six months ended September 30, 2019. The Company&#x2019;s proportionate share of income or loss from this investment included integration expenses incurred by Change Healthcare JV and basis differences between the joint venture and McKesson, including amortization of fair value adjustments primarily representing incremental intangible assets. These amounts were included within Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#x2019;s Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV which eliminated the Company&#x2019;s investment in the joint venture. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While a party to the joint venture, the Company had various ancillary agreements related to the Change Healthcare JV, including transition services agreements (&#x201c;TSA&#x201d;), a transaction and advisory fee agreement (&#x201c;Advisory Agreement&#x201d;), a tax receivable agreement (&#x201c;TRA&#x201d;), and certain other agreements. Revenues recognized and expenses incurred under these agreements with the Change Healthcare JV were not material during the three and six months ended September 30, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the agreement executed in 2019 between the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson. McKesson exercised its right under the agreement and allocated certain depreciation and amortization deductions to Change for the tax year ended March 31, 2019, and estimated certain depreciation and amortization deductions for the tax year ended March 31, 2020. These allocated depreciation and amortization deductions may change as certain events occur, including the filing of the Change Healthcare JV tax return for the tax year ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After McKesson&#x2019;s separation of its interest in the Change Healthcare JV, the aforementioned TRA agreement requires the Change Healthcare JV to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the depreciation or amortization allocated to Change by McKesson. The receipt of any payments from the Change Healthcare JV under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings. This creates uncertainty over the amount, timing, and probability of the gain recognized. As such, the Company accounts for the TRA as a gain contingency, with no receivable recognized as of September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020 in conjunction with the separation transaction, the Company recorded a reversal of the deferred tax liability related to its investment. Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed. Any such change is not expected to have a material impact on the Company&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4506d920ace04fa991e79fe64d985216_I20190401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfNzA1_6f2e308f-e569-40a5-baa9-b99633c55d96"
      unitRef="usd">80000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="ic83c30e7937b464a894f08434c22f5e9_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0NjI3Nw_6be0b42d-ac05-40e4-b30c-75a05b13d69f"
      unitRef="usd">888000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i8f8e385f66604149983dba6c977a6283_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTA0NDUzNjA0ODMyOTc_302df439-38eb-4b7c-9cf3-77c16d8148ed"
      unitRef="usd">609000000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ifafa59fc61fa4be8b5cec6e15a260447_I20190701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMjc0ODc3OTA4MjU2Nw_869f390e-80e2-4b93-b824-6f0e61011a96"
      unitRef="usdPerShare">13</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="ic83c30e7937b464a894f08434c22f5e9_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTA0NDUzNjA0ODMzMjA_96e91657-90fc-457e-b806-a3cedb13eccc"
      unitRef="usd">279000000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i0ceed8f44d4e4223932f42e65df7847c_I20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0NzA0Nw_b66e3677-f4f3-45a4-b9b6-abdc2776171d"
      unitRef="number">0.70</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="id0a54c8ec69a4c91a3f3e8c1893a07aa_I20190701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0NzA2Nw_42f839d9-b97b-4eec-ba19-f4c45aab4311"
      unitRef="number">0.585</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="idf37a667c0ec40628d54cc1c80d639b0_I20190701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMjc0ODc3OTA4Mjc5Mw_b4c4030e-756a-4d1b-8ab1-d97c2db3a270"
      unitRef="number">0.415</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i4ed1ecc0893943d88156c671256bec07_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0NzI1OA_e6673afd-782e-44c9-a0e2-6b5db38176f5"
      unitRef="usd">-246000000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i9cbe8bd08e2043a691eb83cc4d84f2ec_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0NzI1OA_fa2e65bd-67b8-49c9-9df1-c6a43b6f647a"
      unitRef="usd">-246000000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i3bceb76fc90f4fc4a14733d6ed803565_D20190401-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTA0NDUzNjA0NzQwNDc_c8edc0fe-f588-48ad-ac0d-bce58ac3d90e"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i5abddbabf5c94c0fa20a7d1605f5465f_D20190701-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTA0NDUzNjA0NzQwNDc_dcd1812b-6158-496f-bdfc-8f1e323a3137"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5abddbabf5c94c0fa20a7d1605f5465f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0ODU4MA_477e685e-53b8-4c0e-b514-bed4765ae71c"
      unitRef="usd">-51000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3bceb76fc90f4fc4a14733d6ed803565_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMTY0OTI2NzQ0ODU4Nw_b30254c2-e9ea-4d26-acf3-d374ac9cb870"
      unitRef="usd">-47000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <mck:TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized
      contextRef="id816b0893be348beafb61bf8e5f30f0b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zNC9mcmFnOmU2YTAyMDAyZWEzMzRlZjE5ZTc3NWMyMTRiMzg1Njc3L3RleHRyZWdpb246ZTZhMDIwMDJlYTMzNGVmMTllNzc1YzIxNGIzODU2NzdfMjk3MA_c77a7e78-8de3-430b-93a8-b8c6492422e0"
      unitRef="number">0.85</mck:TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTUzOTMxNjI3OTQ1OTI_9daa5144-d60e-4acd-838a-0ce62fbac761">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are reclassified into &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less cost to sell is reported as an adjustment to the carrying value of the disposal group. Assets and liabilities that have met the classification of held for sale were $833 million and $537 million, respectively, at September 30, 2020 and $906 million and $683 million, respectively, at March 31, 2020. These amounts primarily consist of the majority of the Company&#x2019;s German pharmaceutical wholesale business described below.&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;German Pharmaceutical Wholesale Joint Venture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 12, 2019, the Company announced that it had entered into an agreement (the &#x201c;Contribution Agreement&#x201d;) with Walgreens Boots Alliance intending to contribute the majority of its German pharmaceutical wholesale business to create a joint venture in which McKesson will have a noncontrolling interest. This business is within the Company&#x2019;s International segment. The agreement was subject to regulatory approvals, which were received in the second quarter of 2021, and the contribution was completed on November 1, 2020, as noted below. The transaction does not meet the criteria to be reported as a discontinued operation as it does not constitute a significant strategic business shift. For the three and six months ended September 30, 2020, the Company recorded a charge of $10&#160;million to remeasure the held for sale assets and liabilities to fair value less costs to sell. The Company&#x2019;s measurement of the fair value of the disposal group was based on the total consideration received by the Company as outlined in the Contribution Agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The total assets and liabilities of the German pharmaceutical wholesale joint venture that have met the classification of held for sale on the Company&#x2019;s Condensed Consolidated Balance Sheets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of business held for sale to fair value less costs to sell&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes the effect of approximately $11 million unfavorable and $3 million favorable cumulative foreign currency translation adjustments as of September 30, 2020 and March 31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2020, the Company completed the contribution of the disposal group to the joint venture. The Company accounted for this transaction as a sale of the German pharmaceutical wholesale business and a subsequent purchase of a 30% interest in the newly formed joint venture in the third quarter of 2021. As a result of finalization of working capital amounts contributed and other adjustments, the Company may record additional gains or losses in future periods. These adjustments are not expected to have a material impact on the Company&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ia2bab316f14f4a24b71fb9d74d18cdf3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTAxMQ_ecb84a67-af7e-457e-ab39-1eb608ae5a5b"
      unitRef="usd">833000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ia2bab316f14f4a24b71fb9d74d18cdf3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTAxOA_21d8bd61-330a-4ff7-917f-ac8efbf2eb8f"
      unitRef="usd">537000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTA0Ng_4e3f9c04-80aa-4e11-a57e-25e46dae740c"
      unitRef="usd">906000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTA1Mw_1d6ab8d8-b161-4669-87aa-08738b2a5a91"
      unitRef="usd">683000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="ia19a8a6ef0bd48e1be49afd2d6d8a75d_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTA5OTUxMTYzMjk3NQ_013402e1-6e3b-4eb4-bd8c-e8727996bb42"
      unitRef="usd">10000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i5b52e33cd5364b31ad0004abbc59b28d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTA5OTUxMTYzMjk3NQ_81d8ec25-5112-4832-9fc8-24468254300f"
      unitRef="usd">10000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMjczMg_ed169262-9677-4b2b-8329-3e1c3ce3a9cf">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The total assets and liabilities of the German pharmaceutical wholesale joint venture that have met the classification of held for sale on the Company&#x2019;s Condensed Consolidated Balance Sheets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of business held for sale to fair value less costs to sell&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes the effect of approximately $11 million unfavorable and $3 million favorable cumulative foreign currency translation adjustments as of September 30, 2020 and March 31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i5a597186da7942b78a164787ea1dea53_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMy0xLTEtMS0w_f2c487eb-fc0c-43d5-8ffa-76278c49b8c1"
      unitRef="usd">519000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="iaf5d0799400b4399a996c8da70230763_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMy0zLTEtMS0w_55345600-296e-4cbb-ad4d-7b72fe6b8a42"
      unitRef="usd">548000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i5a597186da7942b78a164787ea1dea53_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfNC0xLTEtMS0w_cc94f532-f651-431d-8394-0ade477cbfc4"
      unitRef="usd">463000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="iaf5d0799400b4399a996c8da70230763_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfNC0zLTEtMS0w_1be26f77-4c52-43ad-9f46-476178bab267"
      unitRef="usd">478000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent
      contextRef="i5a597186da7942b78a164787ea1dea53_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfNi0xLTEtMS0w_b5afd656-6176-4585-805a-727304edc68c"
      unitRef="usd">95000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent
      contextRef="iaf5d0799400b4399a996c8da70230763_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfNi0zLTEtMS0w_efe2396c-a260-467b-8ec7-8d5531161c83"
      unitRef="usd">88000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="i5a597186da7942b78a164787ea1dea53_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfNy0xLTEtMS0w_b219617c-7bb5-4292-bd21-b9518bb24aed"
      unitRef="usd">296000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="iaf5d0799400b4399a996c8da70230763_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfNy0zLTEtMS0w_33dd10bb-be0e-4749-8094-e85447cebb68"
      unitRef="usd">272000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i5a597186da7942b78a164787ea1dea53_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfOC0xLTEtMS0w_c123a616-ffea-498e-b93d-d412c2ce7c41"
      unitRef="usd">781000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iaf5d0799400b4399a996c8da70230763_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfOC0zLTEtMS0w_d40d0000-8f6f-42e5-ba93-8587e29c47a5"
      unitRef="usd">842000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="i5a597186da7942b78a164787ea1dea53_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTItMS0xLTEtMA_952ba418-a324-4f00-a3b3-4f4fd6cc4c2a"
      unitRef="usd">292000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="iaf5d0799400b4399a996c8da70230763_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTItMy0xLTEtMA_d6475ef0-bcd0-4044-a1fa-447dd36eabeb"
      unitRef="usd">450000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="i5a597186da7942b78a164787ea1dea53_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTMtMS0xLTEtMA_81a1dd8e-1455-49e6-9f75-63d8aab02658"
      unitRef="usd">38000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="iaf5d0799400b4399a996c8da70230763_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTMtMy0xLTEtMA_50718e74-0ab2-45be-a823-fef6dc3771d8"
      unitRef="usd">40000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent
      contextRef="i5a597186da7942b78a164787ea1dea53_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTQtMS0xLTEtMA_2f22b330-d63b-447d-8398-a51f19cdfaaa"
      unitRef="usd">176000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent
      contextRef="iaf5d0799400b4399a996c8da70230763_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTQtMy0xLTEtMA_b8a12f8d-6ad6-4208-83e4-3e6ce442817f"
      unitRef="usd">166000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i5a597186da7942b78a164787ea1dea53_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTUtMS0xLTEtMA_630de06c-3c84-4ed4-ba2a-d12e9641f7b8"
      unitRef="usd">506000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iaf5d0799400b4399a996c8da70230763_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RhYmxlOmNjY2M3ZDZhN2ZjNjQwMTZhYjE1Y2Y5ZTkxNWMyZDcxL3RhYmxlcmFuZ2U6Y2NjYzdkNmE3ZmM2NDAxNmFiMTVjZjllOTE1YzJkNzFfMTUtMy0xLTEtMA_7e9d4379-83ba-4ff8-bf73-43735a2b5a81"
      unitRef="usd">656000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
      contextRef="ia19a8a6ef0bd48e1be49afd2d6d8a75d_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMjYxNw_0ac4a0f4-1e3d-4928-8329-1fc6f39700b4"
      unitRef="usd">-11000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
      contextRef="i49c0062ceda84079a8aac41c1f01e410_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMjYzNg_5435fd67-23cf-4089-af5b-2e04b4c7f3a7"
      unitRef="usd">3000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i805f21e7f7e04fbeb97134f767b3e1a8_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80My9mcmFnOmMxMGQxODdjNmViYTQyMDY5MDA2NDdlZjA5MzQ1MmM5L3RleHRyZWdpb246YzEwZDE4N2M2ZWJhNDIwNjkwMDY0N2VmMDkzNDUyYzlfMTU5NDI5MTg2MDc5NTk_0591fd12-90a2-4510-ac2a-5e333302711c"
      unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDQ5Mw_1a563de8-989e-49f9-a490-522165dc9ca2">Restructuring, Impairment, and Related Charges&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded restructuring, impairment, and related charges of $60 million and $116 million during the three and six months ended September 30, 2020, respectively, and $45 million and $68 million during the three and six months ended September 30, 2019, respectively. These charges are included under the caption, &#x201c;Restructuring, impairment, and related charges&#x201d; in Operating expenses in the Condensed Consolidated Statements of Operations. In addition, charges related to restructuring initiatives are included under the caption &#x201c;Cost of sales&#x201d; in its Condensed Consolidated Statements of Operations and were not material for the three and six months ended September 30, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Initiatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. The Company expects to record total charges of approximately $90 million to $125 million, of which $90 million of charges were recorded to date. Charges recorded in the three and six months ended September 30, 2020 and 2019 were not material. The estimated remaining charges primarily consist of lease and other exit-related costs, and employee-related expenses. The Company anticipates that the relocation will be complete by January 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company expects to incur total charges of approximately $300&#160;million to $320&#160;million for these programs, of which $271&#160;million of charges were recorded to date. Charges recorded in the three and six months ended September 30, 2020 and 2019 were not material and primarily represented employee severance, accelerated depreciation expense, and project consulting fees. The Company anticipates these additional programs will be substantially completed in 2022. The estimated remaining charges primarily consist of facility and other exit costs and employee-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#x201c;U.K.&#x201d;), which is included in the Company&#x2019;s International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. The Company expects to incur total charges of approximately $100&#160;million to $120&#160;million. The Company recorded charges of $27 million and $41 million, respectively, in the three and six months ended September 30, 2020, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. The initiative is expected to be substantially complete by the end of 2021 and estimated remaining charges primarily consist of accelerated amortization and impairments of long-lived assets, facility and other exit costs, and employee-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three and six months ended September 30, 2020 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three and six months ended September 30, 2019 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the six months ended September 30, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March 31, 2020, the total reserve balance was $157 million, of which $118 million was recorded in Other accrued liabilities and $39 million was recorded in Other non-current liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of September 30, 2020, the total reserve balance was $155 million, of which $128 million was recorded in Other accrued liabilities and $27 million was recorded in Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfMjc0ODc3OTA3OTQwMQ_0d72b820-8f49-4f71-90ad-16448597adcf"
      unitRef="usd">60000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNTQ5NzU1ODE0MzY1OA_200b1e15-3cf2-4363-bc17-473ce3534d67"
      unitRef="usd">116000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfOTA_921de08f-4c5c-4c55-b64e-40648a8e48c3"
      unitRef="usd">45000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNTQ5NzU1ODE0MzY5MA_26ee0be1-e0c4-41e7-9207-3601efab1b8f"
      unitRef="usd">68000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i2c678c2a6d6247e8b531105d084453a3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfODAz_92c55573-d626-4d71-8e75-58da867b7e83"
      unitRef="usd">90000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i7c9ccbb6fda842ceb43fb552e0daf01e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfODA5_535c70ba-f4ea-4ea6-ae48-c21c6df0b87a"
      unitRef="usd">125000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="id6656f9779e14248b3ab954ea86b6abd_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfODIy_c3390acc-f00b-4188-8366-767f233411a1"
      unitRef="usd">90000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="icdd739be481242018906607a0e292bcd_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfMTA0NDUzNjA0NzUxOTE_0561c1e9-bf11-4dae-8147-9864195f6f7c"
      unitRef="usd">300000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i0412307b393b4b31809303ea6964eadd_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfMTcxNw_354d9030-e721-4aef-b64d-7e4b0a98ea85"
      unitRef="usd">320000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="id4809ccdb789473eb416b9fdf1aea69a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfMTc0OQ_1cb3f37f-5685-4ac7-a81f-0d317fb47c38"
      unitRef="usd">271000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i1dcc43c72e854787a25695f0ff26f3e3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfMTA0NDUzNjA0NzQ5MTc_cfe5f5a2-04c2-4c20-987b-83afd40e43b0"
      unitRef="usd">100000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i31f383b4585b4d15840458661a81ecf3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfMTA0NDUzNjA0NzQ5NDk_03493320-85ef-4880-ba98-507eae10b62f"
      unitRef="usd">120000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringCharges
      contextRef="i46a8b56ffa35493ba482183ab526d9bd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNTQ5NzU1ODE0NDI0OA_b465380d-a557-44ee-b7f4-badbbd2d518e"
      unitRef="usd">27000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4d1520f234a14153a52538db1d0fbc55_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNTQ5NzU1ODE0NDI1Ng_b5152f2e-44ad-4658-ad0c-21201122114f"
      unitRef="usd">41000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDQ5OA_30f159ca-3be2-477a-bcc4-bf8a08d35afd">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three and six months ended September 30, 2020 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three and six months ended September 30, 2019 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="ia003613bb8bc483286b8644efc98f668_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMi0xLTEtMS0w_c48aa07b-c101-4279-b3eb-479d3802afb9"
      unitRef="usd">6000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMi0zLTEtMS0w_a12308b0-5e66-4712-bd6b-3a7a88d1e1df"
      unitRef="usd">3000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMi01LTEtMS0w_5203308a-a9b5-4482-9ff3-8f8b9e3c0ec0"
      unitRef="usd">3000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMi03LTEtMS0w_327d4541-8b74-4930-aa28-560bf9689256"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i27e5cc6dcf7146199a2f75c2b2ffa8af_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMi05LTEtMS0w_7054c587-ac7f-41f6-b735-dc1c1608f0ed"
      unitRef="usd">4000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMi0xMS0xLTEtMA_69aae1ba-c58c-434f-85ae-4e6208d91d0f"
      unitRef="usd">16000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ia003613bb8bc483286b8644efc98f668_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMy0xLTEtMS0w_81d370e6-e6b9-4994-9285-75929ee5bc70"
      unitRef="usd">4000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMy0zLTEtMS0w_8f51b42f-748a-4c21-8034-dd8c7e7e67b7"
      unitRef="usd">5000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMy01LTEtMS0w_7aa533a7-6048-4c3b-ab05-154c76bcef52"
      unitRef="usd">-1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMy03LTEtMS0w_b454e3d9-1dee-4465-91a2-6a8f5ec1cc15"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i27e5cc6dcf7146199a2f75c2b2ffa8af_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMy05LTEtMS0w_85f001e2-84d6-408c-a135-10d2edcb0e43"
      unitRef="usd">7000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfMy0xMS0xLTEtMA_9153282c-1f28-4134-8685-c2b4759097f2"
      unitRef="usd">15000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ia003613bb8bc483286b8644efc98f668_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNC0xLTEtMS0w_374bdc63-7f2c-4c84-96d1-7c0faed87bc9"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNC0zLTEtMS0w_2f8d3a5c-4687-4375-bb85-8b5ea8423cf8"
      unitRef="usd">27000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNC01LTEtMS0w_62194266-2964-42b9-a517-f017d9754ea0"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNC03LTEtMS0w_37032628-4a1e-4da7-a365-7bac4b5b0a44"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i27e5cc6dcf7146199a2f75c2b2ffa8af_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNC05LTEtMS0w_8b0a9d59-33ab-4978-ad5a-5116352a270b"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNC0xMS0xLTEtMA_cc83740a-ee70-4331-bf13-655a76a8057a"
      unitRef="usd">29000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="ia003613bb8bc483286b8644efc98f668_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNS0xLTEtMS0w_ee100235-cfbe-4399-ba6e-5a59787773f8"
      unitRef="usd">10000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNS0zLTEtMS0w_8b69dd96-46b9-4cfe-aaf5-89b8360f1574"
      unitRef="usd">35000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNS01LTEtMS0w_be35db55-dad1-46f9-9844-c094c7301094"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNS03LTEtMS0w_25fb5cbb-ff69-41fb-bbf3-1232eae309da"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i27e5cc6dcf7146199a2f75c2b2ffa8af_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNS05LTEtMS0w_9d69a1a8-5553-4fcc-a183-beebccca7619"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFiOWI4NTQ2ZWZiYzQ0ZWNhMDhjYWNjNzBhZDM3NzFiL3RhYmxlcmFuZ2U6YWI5Yjg1NDZlZmJjNDRlY2EwOGNhY2M3MGFkMzc3MWJfNS0xMS0xLTEtMA_90c6e759-5ea6-468c-a026-5cfa5523151a"
      unitRef="usd">60000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMi0xLTEtMS01MjQ_8d011329-be1a-4649-a1e7-7088a8372a74"
      unitRef="usd">7000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMi0zLTEtMS01MjQ_d0c4df8f-68c7-4316-a35d-4812fe9b587f"
      unitRef="usd">20000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMi01LTEtMS01MjQ_cd17f038-a9b7-407f-9e1e-1c4be8a37486"
      unitRef="usd">3000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMi03LTEtMS01MjQ_e6808e53-14e4-4e83-bdef-fbe2760c238e"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMi05LTEtMS01MjQ_c4b1e117-c3eb-49d2-af8d-18ecefdd1c8e"
      unitRef="usd">24000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMi0xMS0xLTEtNTI0_70519829-f9d2-42ba-a3a3-a45e6b7d9cae"
      unitRef="usd">54000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMy0xLTEtMS01MjQ_10d65bf0-b613-46b1-a958-0f2a44befbf2"
      unitRef="usd">5000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMy0zLTEtMS01MjQ_107c87ba-2e17-4c3b-91df-937d25beab96"
      unitRef="usd">7000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMy01LTEtMS01MjQ_eef0ddd3-50dc-4d78-a359-959680d07f26"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMy03LTEtMS01MjQ_637c4d96-feb9-48b1-a086-58fcc0dab373"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMy05LTEtMS01MjQ_a62dfb10-5e87-4ea7-93e2-ad0eb8c63687"
      unitRef="usd">14000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfMy0xMS0xLTEtNTI0_58fdd0ee-4cae-49fe-9bd2-34c9bf047552"
      unitRef="usd">28000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNC0xLTEtMS01MjQ_ed69fec0-3c52-4ba8-8b44-2d930c09bfc0"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNC0zLTEtMS01MjQ_c2baae96-0f11-407b-8657-0631011103b9"
      unitRef="usd">31000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNC01LTEtMS01MjQ_5119589d-7388-43fa-871d-15206c4d8387"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNC03LTEtMS01MjQ_7bfde05d-e21f-416c-b265-3f8e8b22df55"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNC05LTEtMS01MjQ_ab7184b4-a494-4cc3-a5ef-4e910cdbb100"
      unitRef="usd">2000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNC0xMS0xLTEtNTI0_490c2e24-35bf-48db-842f-16e08ed8e229"
      unitRef="usd">34000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNS0xLTEtMS01MjQ_27ba6a74-1990-4549-bd17-98adcbb306f7"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNS0zLTEtMS01MjQ_e8e1e041-5b9a-49da-b38a-a42205c1c02b"
      unitRef="usd">58000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNS01LTEtMS01MjQ_4874b972-1bf8-4694-92b4-6198eb8f9992"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNS03LTEtMS01MjQ_285e300b-c04f-4cab-910c-42e265ae3809"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNS05LTEtMS01MjQ_806dbf43-5b2d-4b2d-adb2-20735f6e1021"
      unitRef="usd">40000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmFmMzdiY2JhZTY3YjQ5MzQ5MGUxNGM1NzZjMDQ2NjFjL3RhYmxlcmFuZ2U6YWYzN2JjYmFlNjdiNDkzNDkwZTE0YzU3NmMwNDY2MWNfNS0xMS0xLTEtNTI0_299d1369-69c2-4deb-89ce-70956bf56d08"
      unitRef="usd">116000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMi0xLTEtMS0w_c7015ecc-728f-4fc3-a422-c42e4fc91d12"
      unitRef="usd">3000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMi0zLTEtMS0w_e7dcbe89-3f71-4f57-9f42-284dc015c640"
      unitRef="usd">5000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMi01LTEtMS0w_97510517-371f-4bc4-b52f-b6f70b10b38e"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMi03LTEtMS0w_0bfe1be5-f9d8-4c76-b771-5a90459a059b"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i1ee29e972613498aa1e93fe830d2eb8e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMi05LTEtMS0w_43121071-7ee4-40c7-8405-8bcf6c97795e"
      unitRef="usd">10000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMi0xMS0xLTEtMA_43f180a6-49ed-4fd6-a5c6-70cf1da6bf6f"
      unitRef="usd">19000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMy0xLTEtMS0w_0eb111c6-36f7-4cf8-92fc-d774e329e4eb"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMy0zLTEtMS0w_f23e63bb-f442-4886-9c3b-bcda0f71c4fb"
      unitRef="usd">4000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMy01LTEtMS0w_a03b39f1-abe3-48fa-a0a2-1756a8cb23c1"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMy03LTEtMS0w_f5580771-3d2b-4e3b-90ac-7d0c31259bd4"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i1ee29e972613498aa1e93fe830d2eb8e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMy05LTEtMS0w_267afee4-067e-4c94-8f80-38cb5d618c91"
      unitRef="usd">13000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfMy0xMS0xLTEtMA_d77a4d0e-c3e4-47f6-b071-654d898ae655"
      unitRef="usd">19000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNC0xLTEtMS0w_54b9b97d-d033-40ae-b1d4-26c852331684"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNC0zLTEtMS0w_c1a15da6-9d0c-4f4c-a07a-6ff4c3310140"
      unitRef="usd">3000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNC01LTEtMS0w_74da5156-63dd-48c9-97d9-1d192085455a"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNC03LTEtMS0w_bce69249-077c-42b0-9d79-225277e11977"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i1ee29e972613498aa1e93fe830d2eb8e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNC05LTEtMS0w_7b041725-e656-47b7-b190-a1c9c8d6bf6d"
      unitRef="usd">4000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNC0xMS0xLTEtMA_dde74934-ea77-434a-9371-3043557c3e95"
      unitRef="usd">7000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNS0xLTEtMS0w_8e3d3086-039b-462c-9161-481b5e6bdc39"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNS0zLTEtMS0w_9c734139-97cf-498b-884c-86139b1f7be2"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNS01LTEtMS0w_97112a41-2852-4007-9fbb-7cd0ac9085c2"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNS03LTEtMS0w_af4926dc-a215-4e9e-8523-8d76d936fa9f"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i1ee29e972613498aa1e93fe830d2eb8e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNS05LTEtMS0w_d11c8c93-6341-445c-9ee5-55d065c5cc90"
      unitRef="usd">27000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjExZDc5NWY2NDcxNzQ2NTliNzYxMmYzMmUyNTdjMjBhL3RhYmxlcmFuZ2U6MTFkNzk1ZjY0NzE3NDY1OWI3NjEyZjMyZTI1N2MyMGFfNS0xMS0xLTEtMA_982f3b77-f348-4639-935b-f968f1916af9"
      unitRef="usd">45000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMi0xLTEtMS03MTk_3d74336c-7961-47ff-9785-7dc83a53c540"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMi0zLTEtMS03MTk_7969f0cf-e7f3-4178-b44a-ae41d3382fb7"
      unitRef="usd">4000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMi01LTEtMS03MTk_f3c1d1ed-ba4d-4a0f-a9f7-f3e616138768"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMi03LTEtMS03MTk_c8610dc8-67e2-4304-906b-64ca52c4831d"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="if7c1d98305344009a39b536f04f12c9e_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMi05LTEtMS03MTk_ec09f684-f026-47bb-a9dc-e8fdd6655424"
      unitRef="usd">16000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMi0xMS0xLTEtNzE5_84055e1c-40e6-47cb-a489-70747a300f83"
      unitRef="usd">23000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMy0xLTEtMS03MTk_780661b2-9ff3-4aa9-96de-40e86d89ec18"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMy0zLTEtMS03MTk_5668ea56-1317-4aab-aa0f-c0e30a4736d9"
      unitRef="usd">6000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMy01LTEtMS03MTk_0133b27d-85c5-4cd4-97f2-bc5d778d38f4"
      unitRef="usd">4000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMy03LTEtMS03MTk_acfd7f2f-293c-40d4-81f5-f010e9d0dfc8"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="if7c1d98305344009a39b536f04f12c9e_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMy05LTEtMS03MTk_a74de242-2720-41d0-b9a8-32f8722bf592"
      unitRef="usd">23000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfMy0xMS0xLTEtNzE5_e9e68c60-97c0-4920-ad8a-45e7bbe354d4"
      unitRef="usd">33000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNC0xLTEtMS03MTk_5ae30753-9aad-4065-b763-db78d7a1dc47"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNC0zLTEtMS03MTk_ba1cf835-584e-4d3f-8974-5c9598af6f84"
      unitRef="usd">6000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNC01LTEtMS03MTk_aa0f13d9-f6d4-41c4-a5fd-cfaa589425f4"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNC03LTEtMS03MTk_fbc2f788-72e4-4a73-b348-2fdd9dafe757"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="if7c1d98305344009a39b536f04f12c9e_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNC05LTEtMS03MTk_490daa22-d3ce-4d1f-a8c4-22affad84a8c"
      unitRef="usd">5000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNC0xMS0xLTEtNzE5_ad583198-2256-4b46-94b8-6dac61364158"
      unitRef="usd">12000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNS0xLTEtMS03MTk_d0a25b70-09e9-42b4-85ca-0d36db847b74"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNS0zLTEtMS03MTk_e5a6e0a9-131b-45f0-8f8a-8e67104dc54a"
      unitRef="usd">16000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNS01LTEtMS03MTk_e69162ce-cfd7-4156-b3b4-75b48ba96020"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNS03LTEtMS03MTk_1d69a0c3-0866-45b2-84a9-c4bb01e61fee"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if7c1d98305344009a39b536f04f12c9e_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNS05LTEtMS03MTk_3e39f95b-3542-4f21-a89f-a360479cbe01"
      unitRef="usd">44000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOmIzNWY1YzI2NjE2OTQ3MDlhNTAxOTRmZDBjNmU0Y2UxL3RhYmxlcmFuZ2U6YjM1ZjVjMjY2MTY5NDcwOWE1MDE5NGZkMGM2ZTRjZTFfNS0xMS0xLTEtNzE5_f7782e5e-4d25-4377-8111-f9f2437249cf"
      unitRef="usd">68000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDUwMg_687967c9-6abf-470c-8d75-386a78edcb87">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the six months ended September 30, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March 31, 2020, the total reserve balance was $157 million, of which $118 million was recorded in Other accrued liabilities and $39 million was recorded in Other non-current liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of September 30, 2020, the total reserve balance was $155 million, of which $128 million was recorded in Other accrued liabilities and $27 million was recorded in Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="iedb569793bdf49caa63b344631feb0d0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMS0xLTEtMS0w_9931bd46-9c2b-4ef3-a6da-7d827c27fa3f"
      unitRef="usd">29000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iceed4414407b4b86847ad2d2815f97dd_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMS0zLTEtMS0w_e8f672de-581c-4ac9-9b05-d6d3b9c1c303"
      unitRef="usd">66000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id8f59e8d12d84c3893cbe9b46385b3ed_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMS01LTEtMS0w_f06a275a-3318-44f9-9520-7f96e47a8856"
      unitRef="usd">22000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3e76a24704794920bda6de2102ffebac_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMS03LTEtMS0w_23193d80-7671-448e-8d44-f2c9e5ed3041"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib73487326569472394f59d7b9300567d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMS05LTEtMS0w_77c7e320-c6eb-41ff-b77b-6bef49ecbca9"
      unitRef="usd">39000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMS0xMS0xLTEtMA_6ad2a628-45e5-4c3c-ab1a-1088e7e59f04"
      unitRef="usd">157000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMi0xLTEtMS0w_4bb8fa69-401e-43c6-85d0-2b2914a81de2"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMi0zLTEtMS0w_2fce430f-8f7f-4457-8ea4-fd4139ca396b"
      unitRef="usd">58000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMi01LTEtMS0w_01e9e5ee-913f-445a-a4c9-62e2157e060a"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMi03LTEtMS0w_94c5b2f6-56e8-45a0-bc83-13bb0e6b9661"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMi05LTEtMS0w_ca234516-df8e-4793-b5c4-fc63e73afe99"
      unitRef="usd">40000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMi0xMS0xLTEtMA_669b31d4-01ef-416d-908d-fc7ca65f6bf3"
      unitRef="usd">116000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMy0xLTEtMS0w_634d7fc0-012b-4908-89a9-4bbd9d788d0f"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMy0zLTEtMS0w_81a4ba3f-53cf-4520-b9a9-4448a281f52f"
      unitRef="usd">31000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMy01LTEtMS0w_1e5cc8d6-50a4-47ca-9ae2-66029395a518"
      unitRef="usd">1000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMy03LTEtMS0w_85120123-0b1c-4ea9-91a7-2a5e5434e72b"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMy05LTEtMS0w_05b56468-b863-4957-8be7-df1eacd4d835"
      unitRef="usd">2000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfMy0xMS0xLTEtMA_b39be95c-20c0-409d-9b06-0bcdc01d64d5"
      unitRef="usd">34000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring
      contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNC0xLTEtMS0w_3d0cf406-3c13-4c6a-aba3-6887e4d9df81"
      unitRef="usd">15000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNC0zLTEtMS0w_79b9f30f-8c69-488c-be43-f916afe6e079"
      unitRef="usd">16000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNC01LTEtMS0w_4326cddf-43a0-4b1e-97f0-5a0f81a839b2"
      unitRef="usd">11000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNC03LTEtMS0w_25995da9-18a9-4465-8f76-bb2a0aa23909"
      unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNC05LTEtMS0w_6d957bc3-0465-444d-a0b9-383d88697f5d"
      unitRef="usd">34000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNC0xMS0xLTEtMA_1794d94b-04fb-4ca3-b44c-fb16c0fecc0d"
      unitRef="usd">77000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNS0xLTEtMS0w_34a4b09b-23e6-4116-95d5-8f4ac5813587"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNS0zLTEtMS0w_6ad0ba8d-f2e1-42d7-b973-b4262f57a28e"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNS01LTEtMS0w_cc85c24b-d123-4f11-b555-05333487edae"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNS03LTEtMS0w_aca74522-3949-473c-88c3-d277815c9008"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNS05LTEtMS0w_d565745d-358f-450e-b9b7-762ac4426ba0"
      unitRef="usd">-5000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNS0xMS0xLTEtMA_f2fd6039-dee6-4805-b4e5-f09cd445f96d"
      unitRef="usd">-7000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i0838a6f327724e01a3d66fd6fc84b706_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNi0xLTEtMS0w_861fa199-bf14-4a8e-97aa-40b5712574b8"
      unitRef="usd">26000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="idd88456c2f48402184d07594c1ba6eeb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNi0zLTEtMS0w_426744cf-f671-4cf5-b171-29aa8aa4e6dd"
      unitRef="usd">76000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i68ff9ffbf98d4a1781d19ab625704e99_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNi01LTEtMS0w_646310b3-fc40-4675-a5dc-64e00f6360b4"
      unitRef="usd">15000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i11292865b78d4742933b20217600c04b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNi03LTEtMS0w_d554661e-aa0d-487b-ad01-5a9ff1353a8f"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i017eaec1fb0f4fcaa8bf8c05655a17ab_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNi05LTEtMS0w_37385666-145e-4137-a93d-5db4221ff38a"
      unitRef="usd">38000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RhYmxlOjQzYTYxY2YzZTEwMzRkMDFhNGI0ZDAxODJiMzQyNmYyL3RhYmxlcmFuZ2U6NDNhNjFjZjNlMTAzNGQwMWE0YjRkMDE4MmIzNDI2ZjJfNi0xMS0xLTEtMA_091cc3ea-bb8e-430f-9d15-274036cbfc59"
      unitRef="usd">155000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDMxMQ_c6fef802-9d24-4cbf-a64a-dc32a9a90b61"
      unitRef="usd">157000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4343021266684e09aac01da8724fc70e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDMyNA_a6a1e3e5-f350-4537-9a55-48080496e444"
      unitRef="usd">118000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i1671d32a17be409fba3f84f83e2794f7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDM1MA_366c3770-289b-4369-b9bd-12cecc8f358b"
      unitRef="usd">39000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDQyNQ_5fea4acb-0deb-4179-b02e-be5dabbe3115"
      unitRef="usd">155000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia54b0b6c830541ae8639a2eaa798e845_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDQzOA_b21d174a-0840-4398-8755-74b8f619bf72"
      unitRef="usd">128000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0c961f18f05e48699a6932152d3b4bf5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV80OS9mcmFnOjFkN2JhYTViMjUxODQ3OGFhZTdlNzM0YTcxMWQ5YWJmL3RleHRyZWdpb246MWQ3YmFhNWIyNTE4NDc4YWFlN2U3MzRhNzExZDlhYmZfNDQ2NA_c36368bd-6c70-4608-9cb9-293739c53276"
      unitRef="usd">27000000</us-gaap:RestructuringReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTMxOA_f417ff03-2623-4909-994e-4b4e0d401ccc">Income Taxes &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September 30, 2020 and 2019, the Company recorded income tax expense of $28 million and an income tax benefit of $294 million, respectively, related to continuing operations. During the six months ended September 30, 2020 and 2019, the Company recorded income tax expense of $178 million and an income tax benefit of $158 million, respectively, related to continuing operations. The Company&#x2019;s reported income tax rates were expense of 4.3% and benefit of 30.3% for the three months ended September 30, 2020 and 2019, respectively and expense of 13.7% and benefit of 45.0% for the six months ended September 30, 2020 and 2019, respectively. Fluctuations in the Company&#x2019;s reported income tax rates are primarily due to changes within the mix of earnings between various taxing jurisdictions and discrete items recognized in the quarters, primarily due to the impact of an intercompany sale of intellectual property during the three months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2021, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gain was eliminated upon consolidation. The acquiring entity of the intellectual property is entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#x201c;Intra-Entity Transfers of Assets Other Than Inventory,&#x201d; a discrete tax benefit of $105 million, which reduced the Company&#x2019;s reported income tax rates by 16.0 percentage points and 8.1 percentage points for the three and six months ended September 30, 2020, respectively, was recognized with a corresponding increase to a deferred tax asset for the temporary difference arising from the buyer&#x2019;s excess tax basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2020, the Company had $1 billion of unrecognized tax benefits, of which $882 million would reduce income tax expense and the effective tax rate if recognized. During the next twelve months, it is reasonably possible that the Company&#x2019;s unrecognized tax benefits may decrease by as much as $105 million due to settlements of tax examinations and statute of limitations expirations in the U.S. federal and state jurisdictions and in foreign jurisdictions. However, this amount may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#x201c;IRS&#x201d;) is currently examining the Company&#x2019;s U.S. corporation income tax returns for 2016 through 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfOTU_d20c0ef2-9b7e-4c68-8fa1-ce81302ce244"
      unitRef="usd">28000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTAy_01f96ad8-7843-4f41-a5c9-6fe4925e53e5"
      unitRef="usd">-294000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTY0OTI2NzQ0MzI2Nw_44e1622c-21cc-483b-acba-77c93761cff1"
      unitRef="usd">178000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTY0OTI2NzQ0MzI4Mg_e238f5f8-f02d-42b8-bbc0-88322bcab497"
      unitRef="usd">-158000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMjA3_440dca60-3e3a-4bca-a2e8-b056c174d3eb"
      unitRef="number">0.043</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMjE0_4a2302df-937c-40d1-bed5-5c9d3d6a67cb"
      unitRef="number">-0.303</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTY0OTI2NzQ0MzMwNg_ab5297b5-c51e-4e7f-8f78-f9ae3b061ecd"
      unitRef="number">0.137</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTY0OTI2NzQ0MzMxMw_3499cc8c-1fb6-464b-be29-de455979daa6"
      unitRef="number">-0.450</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTA0NDUzNjA0NjkxMDI_dbcd8891-a4f7-487e-af80-7e12cd2c6391"
      unitRef="usd">105000000</us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory>
    <mck:IncomeTaxExpenseBenefitDiscreteItems
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTA0NDUzNjA0NjkxMDI_e34a311d-e2ff-488c-833c-632adcb9630a"
      unitRef="usd">-105000000</mck:IncomeTaxExpenseBenefitDiscreteItems>
    <mck:EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTA0NDUzNjA0NzE1NzA_5391c2bf-b798-4485-88e8-725280252537"
      unitRef="number">-0.160</mck:EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory>
    <mck:EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTA0NDUzNjA0NzE5MjE_11afea85-88c8-4b34-9beb-2a3842d7750d"
      unitRef="number">-0.081</mck:EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfNDQx_66152659-03c4-4142-b6db-faba9daffaf0"
      unitRef="usd">1000000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfNDgz_d2f0dcb3-77a7-4255-8e6b-796aabda4e51"
      unitRef="usd">882000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81Mi9mcmFnOjBhNTgzZDcwNTljZjQ0Mzc5N2M4YWEwZDk4MmE0NTI1L3RleHRyZWdpb246MGE1ODNkNzA1OWNmNDQzNzk3YzhhYTBkOTgyYTQ1MjVfMTA0NDUzNjA0Njg3OTc_94e6aa27-c32e-482d-a53a-97320a2cd4b8"
      unitRef="usd">105000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0MjA0NTQ_4fdf18b7-41af-4266-a603-d72f8b91fc59">Redeemable Noncontrolling Interests and Noncontrolling Interests&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s redeemable noncontrolling interests primarily relate to its consolidated subsidiary, McKesson Europe AG (&#x201c;McKesson Europe&#x201d;). Under the December 2014 domination and profit and loss transfer agreement (the &#x201c;Domination Agreement&#x201d;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#x20ac;0.83 per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $10 million and $21 million during the three and six months ended September 30, 2020, respectively, and $11 million and $22 million during the three and six months ended September 30, 2019, respectively. All amounts were recorded in Net income attributable to noncontrolling interests in the Company&#x2019;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in Other accrued liabilities in the Company&#x2019;s Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#x201c;Put Right&#x201d;) their noncontrolling shares at &#x20ac;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#x201c;Put Amount&#x201d;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During the six months ended September 30, 2020, the Company paid $49 million to purchase 1.8&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $49 million, and the associated effect of the increase in the Company&#x2019;s ownership interest on its equity of $3 million was recorded as a net increase to McKesson&#x2019;s stockholders paid-in capital during 2021. During the three months ended September 30, 2020 and the three and six months ended September 30, 2019, there were no material exercises of the Put Right. The balance of the associated liability for Redeemable noncontrolling interests is reported as the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The Redeemable noncontrolling interest is also adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. At September 30, 2020 and March 31, 2020, the carrying value of redeemable noncontrolling interests of $1.3&#160;billion and $1.4&#160;billion, respectively, exceeded the maximum redemption value of $1.2 billion. At September 30, 2020 and March 31, 2020, the Company owned approximately 78% and 77%, respectively, of McKesson Europe&#x2019;s outstanding common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity interests in the Company&#x2019;s consolidated entities primarily related to ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and McKesson Europe, which were $200 million and $217 million at September 30, 2020 and March 31, 2020, respectively, in the Company&#x2019;s Condensed Consolidated Balance Sheets. The Company allocated a total of $40 million and $79 million of net income to noncontrolling interests during the three and six months ended September 30, 2020, respectively, and $42 million and $85 million during the three and six months ended September 30, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0MjA0NTY_8fba3330-e3b6-4e13-958f-54ff81d6d5d4">Redeemable Noncontrolling Interests and Noncontrolling Interests&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s redeemable noncontrolling interests primarily relate to its consolidated subsidiary, McKesson Europe AG (&#x201c;McKesson Europe&#x201d;). Under the December 2014 domination and profit and loss transfer agreement (the &#x201c;Domination Agreement&#x201d;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#x20ac;0.83 per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $10 million and $21 million during the three and six months ended September 30, 2020, respectively, and $11 million and $22 million during the three and six months ended September 30, 2019, respectively. All amounts were recorded in Net income attributable to noncontrolling interests in the Company&#x2019;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in Other accrued liabilities in the Company&#x2019;s Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#x201c;Put Right&#x201d;) their noncontrolling shares at &#x20ac;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#x201c;Put Amount&#x201d;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During the six months ended September 30, 2020, the Company paid $49 million to purchase 1.8&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $49 million, and the associated effect of the increase in the Company&#x2019;s ownership interest on its equity of $3 million was recorded as a net increase to McKesson&#x2019;s stockholders paid-in capital during 2021. During the three months ended September 30, 2020 and the three and six months ended September 30, 2019, there were no material exercises of the Put Right. The balance of the associated liability for Redeemable noncontrolling interests is reported as the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The Redeemable noncontrolling interest is also adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. At September 30, 2020 and March 31, 2020, the carrying value of redeemable noncontrolling interests of $1.3&#160;billion and $1.4&#160;billion, respectively, exceeded the maximum redemption value of $1.2 billion. At September 30, 2020 and March 31, 2020, the Company owned approximately 78% and 77%, respectively, of McKesson Europe&#x2019;s outstanding common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity interests in the Company&#x2019;s consolidated entities primarily related to ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and McKesson Europe, which were $200 million and $217 million at September 30, 2020 and March 31, 2020, respectively, in the Company&#x2019;s Condensed Consolidated Balance Sheets. The Company allocated a total of $40 million and $79 million of net income to noncontrolling interests during the three and six months ended September 30, 2020, respectively, and $42 million and $85 million during the three and six months ended September 30, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="idb66d47f37f94937b69269c1af59b8b9_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfNDEw_885a4b43-247c-417a-9509-7d2dbce8c3e8"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i47b5375d9880408783a5c35d0bf9a5a6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfNTQ5_c725a514-e4f4-4653-a7de-c694e6fa1893"
      unitRef="usd">10000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ia9749be689974b10b3717c1f4f66b1b7_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0NDc1Nw_af2178bd-27dc-44e2-97f1-8f945aefc728"
      unitRef="usd">21000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="id809ea9c3d4348ba9c6347b08f2823f8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0NDg0OA_073b3171-61e1-4c09-b041-8d4cc4d9cc5d"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i13b7d11348f2478dbc84c872d3eeacea_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0NDg1NQ_d7c7f8ef-7ef8-4cdd-b274-3701b8f00167"
      unitRef="usd">22000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfOTcz_30e9493b-aa70-44f9-a645-fab72e7fc0ad"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:PutRightValueInterestRateSpread
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTAzNg_3836ec8a-e7c1-45cc-ad5a-236b6cb3b25d"
      unitRef="number">0.05</mck:PutRightValueInterestRateSpread>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="ia9749be689974b10b3717c1f4f66b1b7_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTQwMQ_00960618-c86e-4da5-b659-0627c8faa29f"
      unitRef="usd">49000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="ia9749be689974b10b3717c1f4f66b1b7_D20200401-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTQ0Mw_269d74d3-8020-4c10-b2be-24ba48ccf475"
      unitRef="shares">1800000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjc0ODc3OTA3MzIzNw_d962c1c2-ad2c-4ccc-a45b-297a9e6b6b33"
      unitRef="usd">49000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i3845b80d46e4483e96a588f5092ba0ba_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0NDk0OA_d633ab39-2d71-47ad-a16d-a2d52a81d541"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i7f53e387d5a04f1fb44fa3972fa2143a_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTA0NDUzNjA0NjgyOTY_43607cb1-21bb-4c7c-a794-e2016ad294fc"
      unitRef="usd">1300000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i2f1078720e5143e4b52c84e6e385b68b_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTA0NDUzNjA0NjgzMDQ_97f88761-f1b4-49b6-aa62-68145d209706"
      unitRef="usd">1400000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue
      contextRef="i2f1078720e5143e4b52c84e6e385b68b_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjI0OQ_2998be1b-8d90-4d3a-aa51-4fb985ccbc62"
      unitRef="usd">1200000000</mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue>
    <mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue
      contextRef="i7f53e387d5a04f1fb44fa3972fa2143a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjI0OQ_87f659f6-9c8d-4156-844c-c77569562c15"
      unitRef="usd">1200000000</mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i7f53e387d5a04f1fb44fa3972fa2143a_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjI5OQ_80ca9e99-78e9-4386-8097-a41401ef23cb"
      unitRef="number">0.78</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i2f1078720e5143e4b52c84e6e385b68b_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjMwNg_f2b85e90-1459-4538-a0e1-dac69a0c63c9"
      unitRef="number">0.77</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterest
      contextRef="ifa11ecf1c6d5459db583272a482d2382_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjYwMA_757b9525-f5ab-418d-9387-6aee89961266"
      unitRef="usd">200000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ifbdd4b3c559743d6869a9f70f2186ede_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjYwNw_a409e6f0-3a4d-42e6-93e9-c39a4825f1f2"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0d27cf1f90fc45b3ae73b669b099480f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjc2NQ_01ac027d-63a6-4845-8e9e-7889ccfba782"
      unitRef="usd">40000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9ca04e14279740e28d9b9ddcb4dba385_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0NTA3Ng_67a542a5-5d34-4cfa-8e4c-b83babaecf03"
      unitRef="usd">79000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i17d9381377c24a9ab35373e9e45ff3c0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMjc3Mg_a07b019a-4e7e-4191-bd41-1e18f5ac1fc7"
      unitRef="usd">42000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i52c6f40d2729407c94ff1c3df7df4ff2_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0NTExNw_03719d91-2b6f-4c6c-91fe-34048216060d"
      unitRef="usd">85000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RleHRyZWdpb246YjBmOGUwMGQ4NDA1NDY0OTgwMjkzMDEwNThhYmI2NzNfMTY0OTI2NzQ0MjA0NTU_f067f7e3-8865-43ae-b6e8-e4452d8ce6e6">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <us-gaap:MinorityInterest
      contextRef="i86b3fd731c6a451da95296357c34854c_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfMS0yLTEtMS0w_d9198d7b-1314-4ee6-8edc-e334f513ac16"
      unitRef="usd">207000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i818f8654b0e24954be9c97bd24ef37ab_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfMS00LTEtMS0w_f803685e-8dfe-4a79-881d-0c621dd5fb5f"
      unitRef="usd">1414000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfMi0yLTEtMS0w_b01faaac-7f75-4944-ada3-e55e7e3b4610"
      unitRef="usd">40000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i389a8e5295ce4baf8bf99cd380e382ca_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfMi00LTEtMS0w_f6b5f3be-4c9a-42a4-82b2-b200de899e06"
      unitRef="usd">10000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfMy0yLTEtMS0w_812ba09e-a5ef-442f-bf69-8d8f7e95cbf1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i389a8e5295ce4baf8bf99cd380e382ca_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfMy00LTEtMS0w_35db4a41-9aaf-4819-a265-494a747c73e6"
      unitRef="usd">-151000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i389a8e5295ce4baf8bf99cd380e382ca_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfNC00LTEtMS0w_9603ae09-89c8-4417-a090-83b9bee00749"
      unitRef="usd">10000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfNS0yLTEtMS0w_73dc1b0a-b7e3-42a7-b36d-ea5590b58588"
      unitRef="usd">50000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i389a8e5295ce4baf8bf99cd380e382ca_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfNS00LTEtMS0w_c6c2fe8a-2d0e-402c-8559-bfcc19ba47ea"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i34d530fbb37c459cbc38523080582cdd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfOC0yLTEtMS0w_696f28e8-d7c3-4b7c-8d63-07d2ff592a42"
      unitRef="usd">3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i389a8e5295ce4baf8bf99cd380e382ca_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfOC00LTEtMS0w_761ae72f-e1e9-42f5-b921-3b3a18488ec9"
      unitRef="usd">2000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="idadfecb50b694b9bad1fd34884a1ae60_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfOS0yLTEtMS0w_1dfcf816-95a0-4511-b005-6e322443336f"
      unitRef="usd">200000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i4bc860b936064f418b265dc92fb1e420_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOmFjNjhhMTk2N2ZmYTQ5OWU4YzMxZDk2ZDc3ZGNjNzMwL3RhYmxlcmFuZ2U6YWM2OGExOTY3ZmZhNDk5ZThjMzFkOTZkNzdkY2M3MzBfOS00LTEtMS0w_a88ea3c3-371a-4fce-a0c6-401624ee5785"
      unitRef="usd">1265000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:MinorityInterest
      contextRef="iebba672c55ee4c2a87f45e310c89afba_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfMS0yLTEtMS0xMDgz_00239356-c257-48a4-95e9-156e15a3d59b"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ic9d9fefc80324149bd26fbe32cfb7e78_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfMS00LTEtMS0xMDgz_24e5bc8b-2e7e-4619-b973-111ce98becc1"
      unitRef="usd">1402000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfMi0yLTEtMS0xMDgz_1cdec38c-4631-4f1c-8d43-0dad1c3b282d"
      unitRef="usd">79000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfMi00LTEtMS0xMDgz_f7ef1468-d03b-46b6-b4c9-ab86d25b1de2"
      unitRef="usd">21000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfMy0yLTEtMS0xMDgz_25e0eda9-01e1-4b9b-83a0-7ba9d884c9d1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfMy00LTEtMS0xMDgz_7a093734-7cc5-4492-aece-5717b0ccffb4"
      unitRef="usd">-90000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfNC00LTEtMS0xMDgz_b4ae47e8-8b12-473e-9991-6557aa5c76c4"
      unitRef="usd">21000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfNS0yLTEtMS0xMDgz_70dac57a-ade8-43ae-8b2e-7d014aa191c9"
      unitRef="usd">93000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfNS00LTEtMS0xMDgz_2ce6f0b3-6d6a-450a-a7bd-229cac31787b"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfNy00LTEtMS0xMDgz_d962c1c2-ad2c-4ccc-a45b-297a9e6b6b33"
      unitRef="usd">49000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i5122b7932dfa4f90bb097811e46e2ae2_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfOC0yLTEtMS0xMDgz_60cbf9aa-597a-46b7-95b1-de9b6b8a801e"
      unitRef="usd">-3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="ieff4240cc3e74cb89e8992d4d0560762_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfOC00LTEtMS0xMDgz_1f34df92-ba0c-4bf4-aa29-72c41ca6ed03"
      unitRef="usd">2000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="idadfecb50b694b9bad1fd34884a1ae60_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfOS0yLTEtMS0xMDgz_ff9c0404-eae4-43b3-841b-7ee8e8b7bfd7"
      unitRef="usd">200000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i4bc860b936064f418b265dc92fb1e420_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjZkYjU5NGJmMzRmODQzODU5YjQ1ZDExMDRhMWE4ODY0L3RhYmxlcmFuZ2U6NmRiNTk0YmYzNGY4NDM4NTliNDVkMTEwNGExYTg4NjRfOS00LTEtMS0xMDgz_1a2c5bd1-f8c3-49c9-9184-5d44184c4dc0"
      unitRef="usd">1265000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:MinorityInterest
      contextRef="ie0e512234a3947858289f71240af0e24_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfMS0yLTEtMS0w_3096a858-8e65-4473-8885-a8da1543fe08"
      unitRef="usd">194000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ib35aa222c90b4f96af5dce4124e6fa37_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfMS00LTEtMS0w_7126ecba-e4bc-4897-b100-2ede3530d01a"
      unitRef="usd">1399000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfMi0yLTEtMS0w_feba7cf1-6bce-4df9-b6a8-12bdccb78062"
      unitRef="usd">42000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="iefc14ef243d44219b893fb6a33e8dec3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfMi00LTEtMS0w_54c0188a-71f5-4d6f-b50c-7b41a59429bd"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfMy0yLTEtMS0w_681669b9-8b3d-4a30-af35-2932d40bb7dd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="iefc14ef243d44219b893fb6a33e8dec3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfMy00LTEtMS0w_a549c02c-9a56-4aba-b1ca-6da6df1559bd"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="iefc14ef243d44219b893fb6a33e8dec3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNC00LTEtMS0w_90186a5c-48d1-45c2-a8fb-f1247d7dcf6e"
      unitRef="usd">11000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNS0yLTEtMS0w_0712d2d7-0d22-4ff5-bf51-004f6a96ec51"
      unitRef="usd">37000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iefc14ef243d44219b893fb6a33e8dec3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNS00LTEtMS0w_9f65c55e-0e58-4183-a09e-c245fb611a49"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="if5cc1cf56c11440c9fc5ea74d544cb2d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNi0yLTEtMS0w_735fc926-93c9-4e0b-9a80-350e32cd6c52"
      unitRef="usd">11000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="iefc14ef243d44219b893fb6a33e8dec3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNi00LTEtMS0w_3074f765-ebfc-47dc-86cb-e4eee8e58624"
      unitRef="usd">3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="ie2ca1a2d209b4ea4a677b11a4d562bff_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNy0yLTEtMS0w_cb8e8aff-a567-423b-a247-fb48ad9a58e0"
      unitRef="usd">210000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ic21c3596993443348892ffc6b8dca3b1_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjMyOWVkOWMwZGZhMTQ1NWI5ZDY5OWI0ZThmODI2YzM3L3RhYmxlcmFuZ2U6MzI5ZWQ5YzBkZmExNDU1YjlkNjk5YjRlOGY4MjZjMzdfNy00LTEtMS0w_9090a776-39c2-4aca-9be2-86241c3c3c14"
      unitRef="usd">1384000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:MinorityInterest
      contextRef="i7004546d044b4049a10a34e53e7b21d2_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfMS0yLTEtMS0yMjY2_676aaaf0-706d-498f-8af7-be5d5e1faaf7"
      unitRef="usd">193000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i453234fb946045ff8438628a7160ef19_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfMS00LTEtMS0yMjY2_7a18b260-050a-441f-b905-90213d0a18e6"
      unitRef="usd">1393000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfMi0yLTEtMS0yMjY5_d4b7132f-1a3a-4478-8a41-1723a66bb8e7"
      unitRef="usd">85000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i7a29c719f1364338a8ee516a3a09bc49_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfMi00LTEtMS0yMjY5_ae8de1ef-a3bd-4d53-b1d3-a4c07ba75246"
      unitRef="usd">22000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfMy0yLTEtMS0yMjY5_e29aced7-bcb5-4b29-af0a-91c3bf865846"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7a29c719f1364338a8ee516a3a09bc49_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfMy00LTEtMS0yMjY5_248a025a-5048-4b9e-af9a-922a68c1f432"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i7a29c719f1364338a8ee516a3a09bc49_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNC00LTEtMS0yMjc1_ba3619bc-0510-4c06-b509-7cac2e5fd8d0"
      unitRef="usd">22000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNS0yLTEtMS0yMjc1_f8ca69b2-033b-4511-8c93-c3b1ef2db21b"
      unitRef="usd">76000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i7a29c719f1364338a8ee516a3a09bc49_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNS00LTEtMS0yMjc1_faf55a99-9e3f-4132-83ce-9b2e21916c60"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i7e5891d6e8684d74a9e16e4bef18411b_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNi0yLTEtMS0yMjc1_8bbcca57-54d2-47b5-b41b-cd4fb01db75c"
      unitRef="usd">8000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i7a29c719f1364338a8ee516a3a09bc49_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNi00LTEtMS0yMjc1_4ddf1316-76b4-49fe-b001-45788e267984"
      unitRef="usd">3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="ie2ca1a2d209b4ea4a677b11a4d562bff_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNy0yLTEtMS0yMjc1_c16346b9-9166-41cf-8da5-e998cd7e0117"
      unitRef="usd">210000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ic21c3596993443348892ffc6b8dca3b1_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV81OC9mcmFnOmIwZjhlMDBkODQwNTQ2NDk4MDI5MzAxMDU4YWJiNjczL3RhYmxlOjlkMzUyZTY2YTEwMTQwYzY4ZjI1ODVhMTU1YjYzZjYwL3RhYmxlcmFuZ2U6OWQzNTJlNjZhMTAxNDBjNjhmMjU4NWExNTViNjNmNjBfNy00LTEtMS0yMjc1_947e19c7-15af-40a4-a7f7-646fa7c6154b"
      unitRef="usd">1384000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RleHRyZWdpb246Mzg3NzQ4MTQ2YjI0NDVlZGI0MjcxNTI1MTI0OGE0MzhfOTM3_e3809f59-24dd-4d8c-8a96-679bf6f9ff6f">Earnings Per Common Share&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings per common share is similar to that of basic earnings per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Diluted loss per common share for the three and six months ended September 30, 2019 was calculated by excluding potentially dilutive securities from the denominator of the share computation due to their anti-dilutive effects.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.967%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt; Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately 2 million of potentially dilutive securities for the three months and six months ended September 30, 2020 were excluded from the computations of diluted net earnings per common share as they were anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RleHRyZWdpb246Mzg3NzQ4MTQ2YjI0NDVlZGI0MjcxNTI1MTI0OGE0MzhfOTQ3_64026ff6-6e24-4fb6-b634-58f5e56d5192">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.967%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt; Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMi0xLTEtMS0w_be846081-eb95-4750-82ce-a7b89cb9d90a"
      unitRef="usd">627000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMi0zLTEtMS0w_241dd1f6-a874-4cf1-8f5e-8637dd6c13f0"
      unitRef="usd">-676000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMi01LTEtMS0w_4b646649-0466-42e2-bbfa-0a94f0154d62"
      unitRef="usd">1122000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMi03LTEtMS0w_a5694a91-84b9-400e-a5ba-e318bc781d34"
      unitRef="usd">-193000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMy0xLTEtMS0w_c867085e-0ca0-48c5-bf9c-23de805e299b"
      unitRef="usd">50000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMy0zLTEtMS0w_b6a4d599-b277-4732-b4ed-f3a83a2d608a"
      unitRef="usd">53000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMy01LTEtMS0w_2fa899b8-2f70-4288-9295-f7fcd2532b55"
      unitRef="usd">100000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMy03LTEtMS0w_5b66d056-4d37-4994-9b99-f535d944a9de"
      unitRef="usd">107000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNC0xLTEtMS0w_83466db5-94c1-4b85-9e02-7ca95604484b"
      unitRef="usd">577000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNC0zLTEtMS0w_73ea95f2-8215-4bf2-a62c-8797d476ba9b"
      unitRef="usd">-729000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNC01LTEtMS0w_9b2e08b8-9f02-412e-90ff-0fdcf925850e"
      unitRef="usd">1022000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNC03LTEtMS0w_790e3554-fe0f-4959-b7c4-7473bb1ac161"
      unitRef="usd">-300000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNS0xLTEtMS0w_947d2b3d-24e4-4183-b5d7-5c084a950575"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNS0zLTEtMS0w_48d20f61-73d4-4b46-9db4-888dd87687ee"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNS01LTEtMS0w_05374361-955d-4697-86f4-684b26801cc9"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNS03LTEtMS0w_ab13d97c-f5f0-43b6-adf9-8fed833f828f"
      unitRef="usd">-7000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNi0xLTEtMS0w_fbfcc0d3-d6ce-4f28-aa11-98caf756a560"
      unitRef="usd">577000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNi0zLTEtMS0w_8708f1a1-e322-400a-8d87-bed23eeb015d"
      unitRef="usd">-730000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNi01LTEtMS0w_eea9ba66-796b-43e7-86d4-f040a5eb6d70"
      unitRef="usd">1021000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfNi03LTEtMS0w_95354153-09c2-449a-8ed1-14d704756a2c"
      unitRef="usd">-307000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfOS0xLTEtMS0w_7ddc15ec-1709-471a-95c3-6923eb75d586"
      unitRef="shares">162000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfOS0zLTEtMS0w_1e795560-ff49-475e-a809-58ccf70ac28e"
      unitRef="shares">183000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfOS01LTEtMS0w_f0c620ee-6b4f-4939-bc07-a57fed89f91e"
      unitRef="shares">162000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfOS03LTEtMS0w_17363c6b-da6d-4685-91e6-c3fa6885828b"
      unitRef="shares">185000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTEtMS0xLTEtMA_46529b49-736e-44f2-931b-1c6376561b91"
      unitRef="shares">1000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTEtMy0xLTEtMA_853f485f-3af5-4592-99ce-f96294785872"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTEtNS0xLTEtMA_5559a341-ef93-41e2-99a5-435447c0246e"
      unitRef="shares">1000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTEtNy0xLTEtMA_49840fbc-662f-45b6-91c6-8371a24c0900"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTItMS0xLTEtMA_a84d3109-a6ca-494e-be37-f5d20251ff09"
      unitRef="shares">163000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTItMy0xLTEtMA_4251ab11-b8d8-4833-a55d-257fedb00a67"
      unitRef="shares">183000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTItNS0xLTEtMA_98ee0da2-f56c-448d-a6e8-cc88333c27ae"
      unitRef="shares">163000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTItNy0xLTEtMA_91411393-97a3-4407-a783-a1294125dbf2"
      unitRef="shares">185000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTYtMS0xLTEtMA_1b42c000-c593-4b7c-81c0-9e4f99983ce2"
      unitRef="usdPerShare">3.54</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTYtMy0xLTEtMA_02bce3d3-2d27-412f-b63e-cbca4357fbc4"
      unitRef="usdPerShare">-3.99</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTYtNS0xLTEtMA_fd918d79-c677-4f63-aadb-0cd8b07536fe"
      unitRef="usdPerShare">6.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTYtNy0xLTEtMA_9c8da92e-39d9-41a5-abc9-bce74b896ae8"
      unitRef="usdPerShare">-1.62</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTctMS0xLTEtMA_87684a09-4f90-4379-ae59-5b51440b392d"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTctMy0xLTEtMA_55df852f-9e87-475e-b6c9-8429ee9cec79"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTctNS0xLTEtMA_0a719ae8-dac4-41a8-887d-08fd48760b65"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTctNy0xLTEtMA_bf108e3f-a247-4780-a624-66539b16ffd4"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTgtMS0xLTEtMA_0204ab69-db0d-4719-b7a5-8bbed38a26be"
      unitRef="usdPerShare">3.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTgtMy0xLTEtMA_23cf101a-bffe-41c3-b956-439357113bba"
      unitRef="usdPerShare">-3.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTgtNS0xLTEtMA_6dc0cf3b-b6ce-4ce6-9875-0eec68439a4a"
      unitRef="usdPerShare">6.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMTgtNy0xLTEtMA_c2b4c8f5-fc1e-4042-b802-ebed61515bf1"
      unitRef="usdPerShare">-1.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjAtMS0xLTEtMA_78f4e3c9-7fed-4406-ba24-bd3e54f7906e"
      unitRef="usdPerShare">3.56</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjAtMy0xLTEtMA_eef86ded-cf18-459c-a8a4-125bb9c31b7c"
      unitRef="usdPerShare">-3.99</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjAtNS0xLTEtMA_111b0250-535a-4562-bf72-249c718f3980"
      unitRef="usdPerShare">6.31</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjAtNy0xLTEtMA_6b824e0e-db84-474d-b221-3094d195ecbd"
      unitRef="usdPerShare">-1.62</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjEtMS0xLTEtMA_b75c1d8e-5ac6-4bb4-b5b5-21e5e96f7502"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjEtMy0xLTEtMA_fe10e8fb-2448-42c4-834c-3f9d729c5c36"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjEtNS0xLTEtMA_897f0275-2434-45ee-a2d0-0a22e7133034"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjEtNy0xLTEtMA_463a67b6-7df4-4d91-b77d-99ac980e7f50"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjItMS0xLTEtMA_9cde2117-8bb9-4ce5-82a4-738d554b624d"
      unitRef="usdPerShare">3.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjItMy0xLTEtMA_1e65ebd9-6e12-476c-a468-5454af71bd8c"
      unitRef="usdPerShare">-3.99</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjItNS0xLTEtMA_e4584724-3428-4599-9fa6-84b6172571d9"
      unitRef="usdPerShare">6.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RhYmxlOjMzMjhiZDcxYTdkOTRlNTY5MjE5ZTAzNDc0ZmYwODYyL3RhYmxlcmFuZ2U6MzMyOGJkNzFhN2Q5NGU1NjkyMTllMDM0NzRmZjA4NjJfMjItNy0xLTEtMA_fc96d374-e314-49aa-8ae6-c3ce98b08298"
      unitRef="usdPerShare">-1.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RleHRyZWdpb246Mzg3NzQ4MTQ2YjI0NDVlZGI0MjcxNTI1MTI0OGE0MzhfMjE5OTAyMzI1NjYyOQ_5a10adad-dfa0-45d5-9abc-5ee04382c304"
      unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82NC9mcmFnOjM4Nzc0ODE0NmIyNDQ1ZWRiNDI3MTUyNTEyNDhhNDM4L3RleHRyZWdpb246Mzg3NzQ4MTQ2YjI0NDVlZGI0MjcxNTI1MTI0OGE0MzhfMjE5OTAyMzI1NjYyOQ_642492f6-1985-4171-a7e1-3d7751f55e45"
      unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTUzOTMxNjI4MDU0NTc_625f505c-e65d-4fa6-93c5-e5c4d253e2c2">Goodwill and Intangible Assets, Net &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a goodwill impairment charge of $69 million (pre-tax and after-tax) in the three and six months ended September 30, 2020 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. This impairment charge is included under the caption, &#x201c;Goodwill impairment charges&#x201d; in the Condensed Consolidated Statements of Operations. At September 30, 2020, the reporting units in Europe had no remaining balance of goodwill and the remaining balance of goodwill in the International segment relates to one of its reporting units in Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 12, &#x201c;Fair Value Measurements,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting, transfers and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Amortization expense of intangible assets was $106 million and $212 million during the three and six months ended September 30, 2020, respectively, and $118 million and $230 million during the three and six months ended September 30, 2019, respectively. Estimated amortization expense of these assets is as follows: $196 million, $367 million, $265 million, $248 million, and $245 million for the remainder of 2021 and each of the succeeding years through 2025 and $1.7 billion thereafter. All intangible assets were subject to amortization as of September 30, 2020 and March 31, 2020.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTUzOTMxNjI4MDU0NjQ_95f1a299-f360-4a6c-9603-c86ef724affd"
      unitRef="numberofsegments">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:GoodwillImpairmentLossNetOfTax
      contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTA0NDUzNjA0NzU3NDQ_be8d3794-b639-4dfd-979c-9a30950d977e"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLossNetOfTax>
    <us-gaap:GoodwillImpairmentLossNetOfTax
      contextRef="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTA0NDUzNjA0NzU3NDQ_c5f4c8d0-342b-4ef5-b664-ae5a63c025a1"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLossNetOfTax>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTA0NDUzNjA0NzU3NDQ_df074750-f2bf-49ae-93bc-bfa5d69949ab"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTA0NDUzNjA0NzU3NDQ_fe4dd822-a80c-4451-8306-bff3269f30e2"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i54063222c8ab42b3ae44fd8854c2bf05_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTUzOTMxNjI4MDI2NzI_b28c5881-3bc7-4ee0-b6d7-c3684360d03b"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTUzOTMxNjI4MDI2NzY_45ad47ca-c5a9-4deb-9834-ced94fde9e22">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting, transfers and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i9ba538365d5e441a82217d66cdb7223c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMS0xLTEtMS0w_7cedb6e9-74fa-4869-9533-0c2e2e5bcca7"
      unitRef="usd">3924000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8f3890eafd704e1a9986d7f4b86e0128_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMS0zLTEtMS0w_9c70c4a7-6716-4153-b88b-2e6d6bbcbea0"
      unitRef="usd">1443000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ief750a41c974485c93c0149cb17947dc_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMS01LTEtMS0w_240fb602-d91f-4bc0-aee0-fec38f3b5478"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4ecbc2cba03648fcb37d779597f1e7e6_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMS03LTEtMS0w_ae30634b-e1d5-4412-8e06-1f636e5aecd0"
      unitRef="usd">1540000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMS05LTEtMS0w_3cb78f65-9b1a-4df9-851f-bb0fa73ecf59"
      unitRef="usd">9360000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i2ef7bc345256444fb9b45e1218e9f993_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMi0xLTEtMS0w_a1ed0e8d-fa2c-4453-8fb8-c547a22dedcf"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMi0zLTEtMS0w_b1bbfd70-1e78-4b44-bb94-99d85c0888ab"
      unitRef="usd">1000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="idf45d6fc4e38421a8db5b7f7cafe2475_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMi01LTEtMS0w_e60dad51-74dd-4e26-8b48-8de065382a18"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4f8c08fbc7af4c1a9f49870c08e48b80_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMi03LTEtMS0w_1f8adba5-e011-4238-8721-6714daa0ff52"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMi05LTEtMS0w_b5109578-cce1-45d1-a904-03690c382f2a"
      unitRef="usd">1000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i2ef7bc345256444fb9b45e1218e9f993_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMy0xLTEtMS0w_dce257de-f899-4b03-aa27-add52b2e9923"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMy0zLTEtMS0w_891b3a7d-7914-4fb2-8457-2dd083e0b0aa"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="idf45d6fc4e38421a8db5b7f7cafe2475_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMy01LTEtMS0w_9aa019a1-9895-43e8-a556-20be75bd3712"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i4f8c08fbc7af4c1a9f49870c08e48b80_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMy03LTEtMS0w_af9c7acb-4610-4beb-b69b-d505165d27d3"
      unitRef="usd">2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfMy05LTEtMS0w_d4353eb4-2d37-48c7-baaa-357eead2b517"
      unitRef="usd">2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2ef7bc345256444fb9b45e1218e9f993_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS0xLTEtMS0w_e9e79687-ebe1-47ea-a0bc-f7ed5a4e401d"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLossNetOfTax
      contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS0zLTEtMS0w_be8d3794-b639-4dfd-979c-9a30950d977e"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLossNetOfTax>
    <us-gaap:GoodwillImpairmentLossNetOfTax
      contextRef="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS0zLTEtMS0w_c5f4c8d0-342b-4ef5-b664-ae5a63c025a1"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLossNetOfTax>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS0zLTEtMS0w_df074750-f2bf-49ae-93bc-bfa5d69949ab"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS0zLTEtMS0w_fe4dd822-a80c-4451-8306-bff3269f30e2"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="idf45d6fc4e38421a8db5b7f7cafe2475_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS01LTEtMS0w_7b2a6b84-35c3-4082-9dfc-7fde60a7212c"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4f8c08fbc7af4c1a9f49870c08e48b80_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS03LTEtMS0w_d9a6fd87-512c-4b35-ab8d-8ab1ccf7c4ab"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNS05LTEtMS0w_a83a2469-1d9d-4427-9e62-3b6e5e3cbbd4"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i2ef7bc345256444fb9b45e1218e9f993_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNi0xLTEtMS0w_99113eb0-eb46-41aa-829e-79ff01d8bea4"
      unitRef="usd">39000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNi0zLTEtMS0w_eb91ae0f-25c0-484a-9ad4-cd18e3e9657d"
      unitRef="usd">81000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="idf45d6fc4e38421a8db5b7f7cafe2475_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNi01LTEtMS0w_ee6cfc4d-6bff-4c8a-8300-f76322967158"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4f8c08fbc7af4c1a9f49870c08e48b80_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNi03LTEtMS0w_6a882ad0-cf8a-4da1-8ff3-86d7d43b79a0"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNi05LTEtMS0w_2776488c-73a6-4048-beee-d692d4180980"
      unitRef="usd">120000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ic320828dd03442ee9aaea62c9ff4f7ec_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNy0xLTEtMS0w_bbfc2ed1-dc9c-473a-bf34-83c038135f2d"
      unitRef="usd">3963000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iff6a7243fae845218e8fb56aa25e2fab_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNy0zLTEtMS0w_d778862b-9878-445d-8458-d836e16dfb65"
      unitRef="usd">1456000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6cc04539515847199daba415d910a6b7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNy01LTEtMS0w_c22d5ef2-ca0d-466b-9109-2ce6b96ed770"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7567972184114435b6959d8ccf29fe0a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNy03LTEtMS0w_057d1066-9f4e-4453-b9fe-e00f3aa3572c"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOjI1MjBhZjQ3ODI5NTRlZjliMjU0YTZmZjY5ZWE3ODA0L3RhYmxlcmFuZ2U6MjUyMGFmNDc4Mjk1NGVmOWIyNTRhNmZmNjllYTc4MDRfNy05LTEtMS0w_26d8a125-c310-4f18-a60b-b2ebe9ac8c84"
      unitRef="usd">9414000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfNTAx_5dca61f5-9c1d-40e6-9faa-3ab879357f4f">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="if4db1b4b02324493a0d2914c618224a4_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi0xLTEtMS0w_7b5eb6e5-173a-410c-bb86-43685d159e4d">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7a9512d260804f718da6e350b1800535_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi0zLTEtMS0w_bd88f016-c914-452d-9312-2dc7de1586d2"
      unitRef="usd">3736000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7a9512d260804f718da6e350b1800535_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi01LTEtMS0w_4c28f6c8-e40f-4195-bfaf-e905cba55169"
      unitRef="usd">2127000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7a9512d260804f718da6e350b1800535_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi03LTEtMS0w_5cd1bdc4-e27e-4731-8217-d5ffe0e34e79"
      unitRef="usd">1609000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i784afe00169946859b02a103c522f100_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi05LTEtMS0w_6258fe2e-cd37-4b04-92b6-248ffcb647b9"
      unitRef="usd">3650000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i784afe00169946859b02a103c522f100_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi0xMS0xLTEtMA_e8615b8e-be3e-4100-bfed-6ea619f1b67c"
      unitRef="usd">1950000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i784afe00169946859b02a103c522f100_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMi0xMy0xLTEtMA_c68b70b0-3988-4ebd-86fb-d575116f665f"
      unitRef="usd">1700000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i2978b39e5aad4aa98f0c28c043489c2a_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy0xLTEtMS0w_ccd7c53f-c929-4d61-af3c-47529e6fed9c">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7ff32fde532b4686b339b43a1460c33e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy0zLTEtMS0w_3afeaf90-3bd4-4ac6-b373-2478e2278518"
      unitRef="usd">997000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7ff32fde532b4686b339b43a1460c33e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy01LTEtMS0w_1455046d-4c3c-438b-98f6-93a91e5d87c7"
      unitRef="usd">506000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7ff32fde532b4686b339b43a1460c33e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy03LTEtMS0w_49408639-1217-4149-b222-7d3a96f72b0f"
      unitRef="usd">491000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie295c63a512442a9a5a5f6037b32648e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy05LTEtMS0w_f8097212-1931-4dbc-8311-bd95c36cecb0"
      unitRef="usd">994000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie295c63a512442a9a5a5f6037b32648e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy0xMS0xLTEtMA_81a0e637-3b5f-4dda-b248-ff80c48fe931"
      unitRef="usd">480000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie295c63a512442a9a5a5f6037b32648e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfMy0xMy0xLTEtMA_7656c399-a7fd-4938-90e2-f2084e921b13"
      unitRef="usd">514000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i13d8fa5857224b039c9983f670be125b_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC0xLTEtMS0w_5e4e6edf-c269-4b9b-b119-a237069dbe62">P26Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ieb2673c258d340f29617801db8c6fb15_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC0zLTEtMS0w_0dbd6ce6-d3d3-4d7c-b4da-5f3679b1c7ea"
      unitRef="usd">502000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ieb2673c258d340f29617801db8c6fb15_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC01LTEtMS0w_3f7b51d2-1cd9-4cf3-8262-60c230f5ee2e"
      unitRef="usd">222000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ieb2673c258d340f29617801db8c6fb15_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC03LTEtMS0w_8a60ad0e-88ec-4420-8a2b-0a84eeae23e8"
      unitRef="usd">280000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i910303b53ca54b109dae4facc910bf03_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC05LTEtMS0w_e8626941-a5dd-4714-bb44-4c13ed982544"
      unitRef="usd">492000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i910303b53ca54b109dae4facc910bf03_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC0xMS0xLTEtMA_1703d34b-03ae-4a71-becf-4ddf0e9b10c7"
      unitRef="usd">232000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i910303b53ca54b109dae4facc910bf03_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNC0xMy0xLTEtMA_6329f318-2fea-4b59-b4d3-57c88e1cd22a"
      unitRef="usd">260000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i643229e9e25c45bea23409a01f621fd7_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS0xLTEtMS0w_3b636439-2aec-4307-8233-33d446768470">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i819bef3ae9cf456ab4d6f597308e2091_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS0zLTEtMS0w_26bdabb5-1a3b-4066-a66c-333c975bd199"
      unitRef="usd">894000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i819bef3ae9cf456ab4d6f597308e2091_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS01LTEtMS0w_2e281044-1d8b-4225-b07a-6a64b6df9ab2"
      unitRef="usd">314000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i819bef3ae9cf456ab4d6f597308e2091_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS03LTEtMS0w_26fb39ca-4d1a-469e-879f-8542d4197a62"
      unitRef="usd">580000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib1f31df78005498ca5d7cdfcef7b62ff_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS05LTEtMS0w_82bcb8c1-efc4-4059-a46b-27eb5a751f19"
      unitRef="usd">808000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib1f31df78005498ca5d7cdfcef7b62ff_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS0xMS0xLTEtMA_728c11cd-4f7c-4d48-8fee-43ce260b71fe"
      unitRef="usd">242000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib1f31df78005498ca5d7cdfcef7b62ff_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNS0xMy0xLTEtMA_bc6bb527-9cdf-4ff9-817a-e0bf81c6c26f"
      unitRef="usd">566000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i3ac1d82117e34d24b3c7ace14a5f0a9c_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi0xLTEtMS0w_33646e89-5a4b-4d23-9b64-118f0ae28da7">P5Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i923fbba79f824ad3b6ee7bbdbb9b6d22_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi0zLTEtMS0w_fbdf1dc8-2c3c-4959-bff3-6fb620e2a2d6"
      unitRef="usd">147000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i923fbba79f824ad3b6ee7bbdbb9b6d22_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi01LTEtMS0w_62752598-a12f-4734-864c-cdc917324468"
      unitRef="usd">113000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i923fbba79f824ad3b6ee7bbdbb9b6d22_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi03LTEtMS0w_26aa4d60-38d4-4319-9251-18ca94ca309a"
      unitRef="usd">34000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie1112ba0650748618ecb2605c5c0d6e4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi05LTEtMS0w_a996fec9-0368-4ac8-bae0-59db45ade1f4"
      unitRef="usd">175000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie1112ba0650748618ecb2605c5c0d6e4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi0xMS0xLTEtMA_0ae69328-6275-4846-937a-60d209dd624a"
      unitRef="usd">111000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie1112ba0650748618ecb2605c5c0d6e4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNi0xMy0xLTEtMA_5c3bda80-c51a-46c1-90f6-39cab63eeeb7"
      unitRef="usd">64000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i2a05e5e085724cafb5736c6c660887d5_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy0xLTEtMS0w_a6861a3b-7e46-43eb-917b-e9652da59249">P5Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib26d4d498b2241b28165e3a6aa3585cc_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy0zLTEtMS0w_e0de8029-8758-41f2-bec0-044e48af07ad"
      unitRef="usd">253000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib26d4d498b2241b28165e3a6aa3585cc_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy01LTEtMS0w_55957c62-9a99-42fe-9268-a7b74825cfed"
      unitRef="usd">217000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib26d4d498b2241b28165e3a6aa3585cc_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy03LTEtMS0w_0e8cb65c-1106-4af0-92d0-97db50dbafa5"
      unitRef="usd">36000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i87e3ce919cec41759ba7b04549cc3dd9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy05LTEtMS0w_7b611525-1a37-4455-8b6d-137587c3c3fc"
      unitRef="usd">273000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i87e3ce919cec41759ba7b04549cc3dd9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy0xMS0xLTEtMA_f7521bea-40fc-47d4-8ba0-89df3e440e18"
      unitRef="usd">221000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i87e3ce919cec41759ba7b04549cc3dd9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfNy0xMy0xLTEtMA_545ad8e9-f10c-4f6e-ac26-471d41466bbb"
      unitRef="usd">52000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfOC0zLTEtMS0w_287094bd-d49f-497b-9020-bf957aae98d7"
      unitRef="usd">6529000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfOC01LTEtMS0w_4e69b703-16af-4f1c-a3b7-8f560d124fc2"
      unitRef="usd">3499000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfOC03LTEtMS0w_62b5164a-0a31-4b36-be85-7c0313b44489"
      unitRef="usd">3030000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfOC05LTEtMS0w_17a4df9b-5ccb-44ab-9b73-2d697b026409"
      unitRef="usd">6392000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfOC0xMS0xLTEtMA_fa68975b-add7-454e-9681-9b0cd0b89f6f"
      unitRef="usd">3236000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RhYmxlOmM4ZDYzYmVhZjhlZTRkYTNiNmVjOGY4MjA2MDg0YTgyL3RhYmxlcmFuZ2U6YzhkNjNiZWFmOGVlNGRhM2I2ZWM4ZjgyMDYwODRhODJfOC0xMy0xLTEtMA_3cacf974-d03c-48c3-a77b-20c1889fad18"
      unitRef="usd">3156000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTgw_de5a31a5-0607-40ca-9ade-92be5f0d16a3"
      unitRef="usd">106000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTA5OTUxMTYyODI5NQ_ec2a35f7-e41e-47a0-a5bb-81a8fcf0b231"
      unitRef="usd">212000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTg3_e74fc921-3479-4db7-8c3f-721a219c99ac"
      unitRef="usd">118000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMTA5OTUxMTYyODM5Mg_b1195dc0-0c39-421c-b50a-baf334c41327"
      unitRef="usd">230000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMzAx_cdde25d5-d22b-4d40-9b64-d593155504cf"
      unitRef="usd">196000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMzA1_d6735344-c327-4f5b-9b33-cf3bdeb47647"
      unitRef="usd">367000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMzA5_ec09f891-0029-4661-a21f-503f96834d07"
      unitRef="usd">265000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMzEz_4ae2b891-340c-4e18-9ee8-d0a7c8e181e9"
      unitRef="usd">248000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMzIx_04425f4a-76e3-4a8a-8b42-ada9e1c36c95"
      unitRef="usd">245000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV82Ny9mcmFnOmRmOTQxNmQ5ODhjMDRmYWQ4ZDEzM2EwNjM0ZTAyZTNlL3RleHRyZWdpb246ZGY5NDE2ZDk4OGMwNGZhZDhkMTMzYTA2MzRlMDJlM2VfMzk2_74543ae8-be87-482a-9e27-8e98a849a0ce"
      unitRef="usd">1700000000</mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTUzOTMxNjI3OTI1Mjc_23b8ce56-efd0-4676-9949-4ae1ab43cd41">Debt and Financing Activities&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65% Notes due November 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due March 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63% Euro Notes due August 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $7.6 billion and $7.4 billion at September 30, 2020 and March 31, 2020, respectively, of which $1.8 billion and $1.1 billion, respectively, was included under the caption &#x201c;Current portion of long-term debt&#x201d; within the Company&#x2019;s Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2020, the Company entered into a syndicated $4 billion five-year senior unsecured credit facility (the &#x201c;2020 Credit Facility&#x201d;), which has a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling and Euro. The 2020 Credit Facility matures in September 2024 and had no&#160;borrowings during the three and six months ended September 30, 2020 and no amounts outstanding as of September 30, 2020 and March 31, 2020. The remaining terms and conditions of the 2020 Credit Facility are substantially similar to those previously in place under the&#160;$3.5 billion five-year senior unsecured revolving credit facility (the &#x201c;Global Facility&#x201d;), which was scheduled to mature in October 2020. The Global Facility was terminated in connection with the execution of the 2020 Credit Facility in September 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility contains a financial covenant which obligates the Company to maintain a debt to capital ratio of no greater than 65% and other customary investment grade covenants. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At September 30, 2020, the Company was in compliance with all covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains bilateral credit facilities primarily denominated in Euro with a committed amount of $9 million and an uncommitted amount of $176 million as of September 30, 2020. Borrowings and repayments were not material during the three and six months ended September 30, 2020 and 2019, and amounts outstanding under these credit lines were not material as of September 30, 2020 and March 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. During the six months ended September 30, 2020 and 2019, the Company borrowed $5.3 billion and $8.7 billion, respectively, and repaid $5.3 billion and $8.1 billion, respectively, under the program. At September 30, 2020 and March 31, 2020, there were no commercial paper notes outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjgwNQ_e1012f4a-5ab3-4b4e-83ba-b7dbe93c52c6">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65% Notes due November 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due March 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63% Euro Notes due August 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8153b95460de463caaddc69ee4d76393_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMi0wLTEtMS0wL3RleHRyZWdpb246OTU5MWYxMWVkZTBkNDA1YTkyMDUxNWI2MTM4MzBkYjNfMTA5OTUxMTYyNzgxOA_3e821a2d-a237-4b99-9f2c-21e4d177c714"
      unitRef="number">0.0365</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i8153b95460de463caaddc69ee4d76393_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMi0xLTEtMS0w_145027f1-e326-466b-b482-16336b4453b3"
      unitRef="usd">700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie7ff3def80794627a2f81c1fa3fa88b7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMi0zLTEtMS0w_8b8925ba-008f-4566-90d6-29c9713be906"
      unitRef="usd">700000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i12cf340a696a46ccbc81980bb0ca828e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMy0wLTEtMS0wL3RleHRyZWdpb246M2EyMmFkMjUxODU5NGVkZTgxYTAzOTg2NjJiOWVmYjBfMTA5OTUxMTYyNzgxNA_84f2f517-6293-41ab-84ef-be0dcf77c625"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i12cf340a696a46ccbc81980bb0ca828e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMy0xLTEtMS0w_4e76264b-d1d2-445c-9ffa-11d1e2f134c6"
      unitRef="usd">323000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iaee8abcfafb84ff798eb09d3d083a04f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMy0zLTEtMS0w_dcdf1f92-c7a1-4325-979a-bfe7d4f7a34f"
      unitRef="usd">323000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1e6d0550b478436495bc0fe4be6cba3d_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNC0wLTEtMS0wL3RleHRyZWdpb246OTk5M2YxNTgwOTY0NDkxM2E1NTM4ODc0MWE5YmFlODVfMTA5OTUxMTYyNzgxOA_d61fcf4b-c6aa-40c0-b7f2-018f8eed1f10"
      unitRef="number">0.0270</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1e6d0550b478436495bc0fe4be6cba3d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNC0xLTEtMS0w_ea991afc-ced4-4e8a-85ac-57daee0bd196"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i15cc3c8cf89346e69d4e74ca74186f27_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNC0zLTEtMS0w_719f65ea-0a0c-4d71-8288-15e25448e3ba"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3c56f40d6044473b6be9ef97877702e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNS0wLTEtMS0wL3RleHRyZWdpb246M2YzZjY0N2Q1NTk1NDliYTk4NjIxNGZlY2YyMmI1ZTFfMTA5OTUxMTYyNzgxNQ_a8e0f845-07f3-4a20-800f-b6cd1f4ec0a8"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia3c56f40d6044473b6be9ef97877702e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNS0xLTEtMS0w_317b7b0c-e7ab-4047-bcaf-a0317a6c5c63"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i30b436690be1400f81e8c682814e47b5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNS0zLTEtMS0w_e7acae58-f5eb-4fe1-a599-f88873911f08"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6a7a25e2db1543149b28b05daeacffbe_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNi0wLTEtMS0wL3RleHRyZWdpb246YWY3OTkxM2U3ODdmNGZlZTk0NDgyZWI1YWMzNWUzNDFfMTA5OTUxMTYyNzgxNQ_9d53eae3-ac16-4b46-a63a-80cb0fb8e1c3"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6a7a25e2db1543149b28b05daeacffbe_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNi0xLTEtMS0w_e79bb33f-5082-4271-83a7-c0b132829b90"
      unitRef="usd">1100000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia52812d9b87043cbb33eb38e018afe29_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNi0zLTEtMS0w_42628f5f-2272-40c9-99b6-d31cb98b6ba1"
      unitRef="usd">1100000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i21479c35ac7947908fe229498bfad314_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNy0wLTEtMS0wL3RleHRyZWdpb246YTVhYmNjZDNlYTc0NGM1ZTg3Y2YyZmFlMjJkZTNmMjNfMTA5OTUxMTYyNzgxOQ_216d52ad-52a7-492d-9430-8fbd13fafcaa"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i21479c35ac7947908fe229498bfad314_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNy0xLTEtMS0w_553a5a24-1877-40a5-9bd8-6e8c7acaa99f"
      unitRef="usd">167000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i804e09f7332d4333b3d930fc39208c0b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfNy0zLTEtMS0w_e3f947a0-3e8a-4971-a767-7a0a8f39d8f7"
      unitRef="usd">167000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i367acbb5aa6f41a89563cba34fc5e16a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfOC0wLTEtMS0wL3RleHRyZWdpb246NDUwZjFiOTM5M2JmNDIxOWFmYjViMjczOGYzNjczNTRfMTA5OTUxMTYyNzgxOA_03b46e0f-239d-4667-86ee-e9c99a168ec6"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i367acbb5aa6f41a89563cba34fc5e16a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfOC0xLTEtMS0w_75945532-aaaa-4cae-9524-9129949cdbc6"
      unitRef="usd">600000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ied4ba394ed964ed29284c6a42d50859e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfOC0zLTEtMS0w_08231a5b-6b71-4990-bc58-7ecc0d961ba0"
      unitRef="usd">600000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1db34deedcb444fcafd3824ea72a77fa_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfOS0wLTEtMS0wL3RleHRyZWdpb246YmY2OWNjNDE0YjkzNDNhNTg3OTdmYzNlZDhhMTM3MDNfMTA5OTUxMTYyNzgxMw_ef293fac-9767-4b77-b6ef-0c3d3530e7a5"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1db34deedcb444fcafd3824ea72a77fa_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfOS0xLTEtMS0w_ef27e97e-dd31-4b62-aaec-b9c49150cf7e"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i986b499c7ecf4099ac52aa32adaf7eef_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfOS0zLTEtMS0w_160942ca-2409-4e2d-8995-34f8542ed006"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i840a57d92c2e46fca0b999599fd6e33b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjFmZDA1MDNmYTZmYTQ5YWY5MzdmYzgxOTY2OWYzYjRjXzEwOTk1MTE2Mjc4MTQ_778f7795-0db5-46b2-9a56-00b4dd58c112"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i840a57d92c2e46fca0b999599fd6e33b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTAtMS0xLTEtMA_5628f3db-fad5-4cd0-b50d-b2020faaacde"
      unitRef="usd">282000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i512dab20822e47d0a0cc52e0e34781dc_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTAtMy0xLTEtMA_93be6e8d-b0be-4b55-b0dc-7ef1fe4902a0"
      unitRef="usd">282000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idf662601f4324e058290f105eaa0b95f_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjc1Yzg4ZGNiNDgxMTRmMTg4OTBhZjQxZjczZDgyZTdkXzEwOTk1MTE2Mjc4MTU_e8270114-bd60-494a-ac72-2b6032276bec"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="idf662601f4324e058290f105eaa0b95f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTEtMS0xLTEtMA_9306fb1d-4677-4ecc-98a0-e55615c37a08"
      unitRef="usd">411000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie46a2a101c1946dfad26f454b2205e3a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTEtMy0xLTEtMA_6a1d6506-e64c-4f52-97e0-56bc5948e6ba"
      unitRef="usd">411000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i767d2070f41b43f08cadfcfde4ee0193_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOmMyNjY0OWQ1NzJiYjQ3ZTY5Mjc1Y2Y3OGVkMDllNDk3XzEwOTk1MTE2Mjc4MjE_089058b0-25b4-49e4-8fde-242d63fe0d91"
      unitRef="number">0.0063</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i767d2070f41b43f08cadfcfde4ee0193_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTMtMS0xLTEtMA_3eed8a36-82e3-4c23-935b-92b667bbfea3"
      unitRef="usd">703000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0094db52755c430db5bb53ecf3675114_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTMtMy0xLTEtMA_ac548b13-322f-417d-91a8-54b34ff61b93"
      unitRef="usd">662000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib3f4f9c5449c42758be9a4044c781b77_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjdjZmZiYjVkZDVkZjQ0MjNhNjFhMmUzNjA4ZDAwMzIxXzEwOTk1MTE2Mjc4MjM_31dfe312-fe05-427a-bc83-967694743dbe"
      unitRef="number">0.0150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib3f4f9c5449c42758be9a4044c781b77_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTQtMS0xLTEtMA_57c66f79-eaed-41ef-8b72-18c310b83077"
      unitRef="usd">700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i70c5081e1fcc46fbbaab261e039a3f10_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTQtMy0xLTEtMA_71b77635-7074-456e-bee0-efffcc32c297"
      unitRef="usd">659000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4cd299e885c34f10b74ee273e0f81d20_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZDJiMjZkZmYyNTQzYTM5ZWIwYWEwMmQxZDIzNTVkXzEwOTk1MTE2Mjc4MjI_558ac67f-e921-49e3-9771-5cbf86466a7d"
      unitRef="number">0.0163</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i4cd299e885c34f10b74ee273e0f81d20_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTUtMS0xLTEtMA_e6055b7a-2b59-4ede-ae48-eaa336f7f95c"
      unitRef="usd">586000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3028d3a5bee645aaa6efb97a0e849ab2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTUtMy0xLTEtMA_bdc815bc-1eab-40c5-8ee7-5cbd5a761ff7"
      unitRef="usd">552000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7950cda1af7346a88986fcba915ab374_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ZDFhOThiMDE0MTQxYWQ4YmQ2YTg4ZTM0ZmZjZTFmXzEwOTk1MTE2Mjc4Mjc_93df89c4-8621-456e-9f80-7cb567462a90"
      unitRef="number">0.0313</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i7950cda1af7346a88986fcba915ab374_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTYtMS0xLTEtMA_6807f3c8-1550-4c32-a746-829057838caa"
      unitRef="usd">597000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic3948c23924c4bb09533ac72ede98ae9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTYtMy0xLTEtMA_028ca27b-e074-47c4-9d61-8755783b2868"
      unitRef="usd">557000000</us-gaap:LongTermDebt>
    <us-gaap:FinanceLeaseLiability
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTgtMS0xLTEtMA_d1491cc7-d5ec-411c-92ed-47871b792a70"
      unitRef="usd">239000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTgtMy0xLTEtMA_d9bf056b-a1d0-4e8a-af1a-001dc89a42c6"
      unitRef="usd">174000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTktMS0xLTEtMA_0560648d-8f3f-45b5-aa34-726a91ac9a9b"
      unitRef="usd">7608000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMTktMy0xLTEtMA_0dd35b58-5914-4113-b564-1dd00c3cb133"
      unitRef="usd">7387000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMjAtMS0xLTEtMA_ade36811-91ef-45d9-a981-fd65013fe186"
      unitRef="usd">1760000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMjAtMy0xLTEtMA_e54541fb-2782-42ce-81cb-8c5fc7b78a6d"
      unitRef="usd">1052000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMjEtMS0xLTEtMA_5e79e7de-2a2a-474b-9053-db2e6aad5698"
      unitRef="usd">5848000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RhYmxlOmQwZWM3NzhkNjIxMTQ5ZGM4NTViMzZhMWVlYzhhNmIxL3RhYmxlcmFuZ2U6ZDBlYzc3OGQ2MjExNDlkYzg1NWIzNmExZWVjOGE2YjFfMjEtMy0xLTEtMA_fd6e3abe-a715-4c8f-996e-98a3e5d271d7"
      unitRef="usd">6335000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMzcz_4b7b2f9b-cfdf-4ba3-a5c7-9cb15b325efc"
      unitRef="usd">7600000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTcwNDI0MzAyMzM0OTQ_645e83fb-0d19-4c22-ae02-6db2e8ff263d"
      unitRef="usd">7400000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfNDE2_7c137e16-6b3c-46ba-8054-391a7ff2d200"
      unitRef="usd">1800000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTcwNDI0MzAyMzM1MTI_0d820768-007e-4e54-b080-486070f0c267"
      unitRef="usd">1100000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i39366f5479b542dfafca236d0d404772_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfNjEz_5eac2512-acb2-4544-862a-9a666ccfebeb"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i154e895b81404074985fd505c76d4a57_D20190701-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTUzOTMxNjI3OTI1MTc_7984d209-0c27-4a20-9e8f-0a3f17ab97e4">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i82f9efd5a22a44eba025d8456a2a8394_I20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfNjk5_520051c4-0438-4e07-b6b8-5c31f28af579"
      unitRef="usd">3600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i2fc86cfb0d1743db9420435fcbe782c0_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfODUw_8d5fd813-7983-4722-b607-7fe726fd7ac3"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ie51ec41d88fc4fcbbb4e98a2489344d4_D20200401-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfODUw_c5862ca1-f35c-4379-8071-9f31b14adbb8"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i747404c509964f31988b62072dd13f33_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfODk4_e5d841a9-fd5d-40e5-bb43-f81ba13bde16"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="icfac515039344132aade2b5793055812_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfODk4_f9836b7d-80e3-4ed4-b87a-a04de81ff37d"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6bd3593ba0404917bb09d01792baf9d6_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTA2Ng_11296bbe-288b-4115-b75b-3908b54c2565"
      unitRef="usd">3500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i44874b5446184867b047a21535e841fb_D20190901-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTUzOTMxNjI3OTI1MjY_97f1d936-cef7-434e-809b-bcf3685a6ca0">P5Y</us-gaap:DebtInstrumentTerm>
    <mck:DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio
      contextRef="icfac515039344132aade2b5793055812_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMTcyMg_75d185b7-6eec-4214-ad28-76043da52654"
      unitRef="number">0.65</mck:DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio>
    <us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases
      contextRef="ic59633479ac94c10987acde294155741_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjE0Ng_b4fdcebe-5e1b-410b-928f-7fce83eef4e4"
      unitRef="usd">9000000</us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="ic59633479ac94c10987acde294155741_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjE3OA_eb9f5c26-7da7-41ad-9559-3db61e239d8e"
      unitRef="usd">176000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id887e8ba801a4f9f9555dc352f23f1de_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjU1Nw_dc65a3d1-528a-4bd7-a1ac-38e518cdd8d1"
      unitRef="usd">4000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="i6b5dfa0efbd542b0bd5acb63dc7fb114_D20200401-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjY1OA_6cd84f84-822d-42de-a202-5253deab4def"
      unitRef="usd">5300000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="i5752cf5996be43f88c48f5343cf12504_D20190401-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjY2NQ_9335f144-1c6f-4017-8cf0-31835a7edf24"
      unitRef="usd">8700000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i6b5dfa0efbd542b0bd5acb63dc7fb114_D20200401-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjY5NA_8a7da7ce-d184-484a-a969-b5c83d5d0255"
      unitRef="usd">5300000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i5752cf5996be43f88c48f5343cf12504_D20190401-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjcwMQ_9e74a707-1e9b-4de7-8083-85ed7807bee6"
      unitRef="usd">8100000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:LongTermCommercialPaperCurrent
      contextRef="i629e2b60a9a340a78d36af765192f461_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjc2Mw_a55199a1-3b9a-4562-8191-fd619d574425"
      unitRef="usd">0</us-gaap:LongTermCommercialPaperCurrent>
    <us-gaap:LongTermCommercialPaperCurrent
      contextRef="id887e8ba801a4f9f9555dc352f23f1de_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83MC9mcmFnOjY2OGJmODQxY2UzZjQ0OTFhMGYwMmQ4YTI3MTE5ZmU2L3RleHRyZWdpb246NjY4YmY4NDFjZTNmNDQ5MWEwZjAyZDhhMjcxMTlmZTZfMjc2Mw_d595f2ca-48e2-4506-8918-a9aef48ee4b4"
      unitRef="usd">0</us-gaap:LongTermCommercialPaperCurrent>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0MTkwODM_7c06f26c-9b16-4166-a691-0fb15408d2f0">Pension Benefits&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net periodic expense for defined benefit pension plans was $7 million and $14 million for the three and six months ended September 30, 2020, respectively, and $111 million and $135 million for the three and six months ended September 30, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash contributions to these plans were $4 million and $11 million for the three and six months ended September 30, 2020, respectively, and $7 million and $13 million for the three and six months ended September 30, 2019, respectively. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#x2019; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 23, 2018, the Company&#x2019;s Board of Directors approved the termination of its frozen U.S. defined benefit pension plan (&#x201c;Plan&#x201d;). During the first quarter of 2020, the Company offered the option of receiving a lump sum payment to certain participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately 1,300 participants elected to receive the settlement, and lump sum payments of approximately $49 million were made from Plan assets to these participants in June 2019. The benefit obligation settled approximated payments to Plan participants and a pre-tax settlement charge of $17 million was recorded during the first quarter of 2020. During the second quarter of 2020, the Company transferred the remainder of the Plan&#x2019;s pension obligation to a third-party insurance provider by purchasing annuity contracts for approximately $280 million which was fully funded directly by Plan assets. The third-party insurance provider assumed the obligation to pay future benefits and provide administrative services on November 1, 2019. As a result, the remaining previously recorded unrecognized losses in accumulated other comprehensive loss for the Plan were recognized as expense and a pre-tax settlement charge of approximately $105 million was recorded in Other income (expense), net in the Company&#x2019;s Condensed Consolidated Statements of Operations during the second quarter of 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ibc317023efda478c82c32736a1b73ada_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfNzU_805aeae3-40a6-48db-a74d-10a362919c62"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i0473786d65074893b89caa770decaf2f_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0Mjk1Nw_57814b09-ca1b-4fe9-b1a9-5b8eeddd0dc3"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie58a935d3b8640fcb9895478c6828da4_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfODI_9ac9e30d-dd0c-40bf-9927-d5766ee81b3a"
      unitRef="usd">111000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ifafe5ac3b39e4334b35a9018a18479ae_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0Mjk3Ng_85f51e76-5d2d-4e94-932c-3d97a610e722"
      unitRef="usd">135000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ibc317023efda478c82c32736a1b73ada_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTcz_b4d77fa2-689d-40bc-ad42-79286e81d657"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i0473786d65074893b89caa770decaf2f_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0MzExMQ_1b2b2a80-b4c7-4d60-9815-ba20e10dbc98"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ie58a935d3b8640fcb9895478c6828da4_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTgw_a80a6434-4fa6-4a56-9d46-4b640db81bb7"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ifafe5ac3b39e4334b35a9018a18479ae_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0MzE0OA_34c12b5b-bb72-4dfd-8d30-1652742f040c"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanFundedPercentage
      contextRef="i49ee6f642eb4455483bb1c23124fdf11_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfNDE1_266ab1b2-f283-45e6-8a86-801aca821b94"
      unitRef="number">0.10</us-gaap:DefinedBenefitPlanFundedPercentage>
    <mck:DefinedBenefitPlanSettlementPlanParticipants
      contextRef="ic18da827aa754e04a2fad2bf8a72cc18_D20190601-20190630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfOTY5_2f93c2a7-88a3-48a0-9ea0-e5dab5b9b12c"
      unitRef="participant">1300</mck:DefinedBenefitPlanSettlementPlanParticipants>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="ic18da827aa754e04a2fad2bf8a72cc18_D20190601-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTA1OQ_85a02e3f-1eb1-4dbc-b3ed-188f3da24bc9"
      unitRef="usd">49000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i27674bc44ccc4dcc843eb0366732e666_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTIyNg_45e3c3bd-f16c-4e73-91ee-b9e429deeb49"
      unitRef="usd">-17000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <mck:DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract
      contextRef="i8259a0225045474dace4f33866146c8b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0MzQ1NQ_91108f62-6d6d-4ef1-b45a-3ca8e8bb7f12"
      unitRef="usd">280000000</mck:DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ic5be699bdd1a4617bcd28de6f863eaab_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83Ni9mcmFnOmI5MmNhMWI0MzNhYzQ3NmNhMjVlNmYxOWVmOGVlMWU5L3RleHRyZWdpb246YjkyY2ExYjQzM2FjNDc2Y2EyNWU2ZjE5ZWY4ZWUxZTlfMTY0OTI2NzQ0MzkxOA_bc48ee2e-5688-4ec6-a148-c251b93e5c6a"
      unitRef="usd">-105000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfOTY5NA_4468bb06-1439-43bf-a1c4-a54c06414234">Hedging Activities &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#x2019;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:2.25pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Exchange Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#x2019;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Derivative Instruments Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2020 and March 31, 2020, the Company had &#x20ac;1.7 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#x2019;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments within Accumulated other comprehensive loss in the Condensed Consolidated Statements of Stockholders&#x2019; Equity where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from net investment hedges recorded within Other comprehensive income were losses of $83 million and $117 million during the three and six months ended September 30, 2020, respectively, and gains of $91 million and $67 million during the three and six months ended September 30, 2019, respectively. There was no ineffectiveness in non-derivative net investment hedges during the three and six months ended September 30, 2020. Ineffectiveness on the Company&#x2019;s non-derivative net investment hedges during the three and six months ended September 30, 2019 resulted in gains of $20 million and $30&#160;million, respectively, which were recorded in earnings in Other income (expense), net in the Condensed Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2020 and March 31, 2020, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $1.5 billion Canadian dollars. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#x2019;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in Accumulated other comprehensive loss in the Condensed Consolidated Statements of Stockholders&#x2019; Equity where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#x2019;s net investment hedges for the three and six months ended September 30, 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2020, the Company terminated cross-currency swaps with a total gross notional amount of &#xa3;932 million British pound sterling due to ineffectiveness in its British pound sterling hedging program that arose due to 2019 impairments of goodwill and certain long-lived assets in the U.K. businesses. Proceeds from the termination of these swaps totaled $84 million and resulted in a settlement gain of $34 million for the six months ended September 30, 2019. This gain was recorded in earnings in Other income (expense), net, net in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from the Company&#x2019;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $12 million and $63 million during the three and six months ended September 30, 2020, respectively, and gains of $20 million and $9 million during the three and six months ended September 30, 2019, respectively. There was no ineffectiveness in the Company&#x2019;s cross-currency swap hedges for the three and six months ended September 30, 2020 and 2019. These cross-currency swaps will mature between November 2020 and November 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#xa3;450 million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#xa3;450 million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings for the three and six months September 30, 2020 and 2019 were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At September 30, 2020 and March 31, 2020, the Company had cross-currency swaps with total gross notional amounts of approximately $2.6 billion and $2.9 billion, respectively, which are designated as cash flow hedges. These swaps will mature between February 2021 and January 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $500&#160;million and &#x20ac;600&#160;million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500&#160;million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#x201c;EURIBOR&#x201d;) for the &#x20ac;600&#160;million swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Gains or losses from cash flow hedges recorded in Other comprehensive income were losses of $23 million and $28 million during the three and six months ended September 30, 2020, respectively, and were gains of $17 million and $35 million during the three and six months ended September 30, 2019, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in Operating expenses in the Condensed Consolidated Statements of Operations were not material in the three and six months ended September 30, 2020 and 2019. There was no ineffectiveness in the Company&#x2019;s cash flow hedges for the three and six months ended September 30, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Not Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At September 30, 2020 and March 31, 2020, the total gross notional amounts of these contracts were $44 million and $29 million, respectively. These contracts will predominantly mature through December 2020 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in Operating expenses. Changes in the fair values were not material in the three and six months ended September 30, 2020 and 2019. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended September 30, 2019, the Company also entered into a number of forward contracts to offset a portion of the earnings impacts from the ineffectiveness of the net investment hedges discussed above. These contracts matured in September 2019 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly in earnings. During the three and six months ended September 30, 2019, losses of $20 million and $39 million, respectively, were recorded in earnings within Other income (expense), net in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.481%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Refer to Financial Note 12, "Fair Value Measurements," for more information on these recurring fair value measurements.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:LongTermDebt
      contextRef="idf0d0beda4f94c1c95f3735c727aaa99_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTUwMw_b28ef460-d179-402c-9270-f4e5d5fb3b11"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iefe68917b64346948a4da9e249ab34f7_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTUwMw_f3d39168-88fd-4ac5-b471-b30e546ad3ca"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i28545f9d3bda45efaa5277b002e22e7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMjUyOA_8764417e-89bf-4c2a-9b7b-cee5ae445ecb"
      unitRef="usd">-83000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i11351bf2991743d7af90b551540fc919_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1MTM4MQ_72802e29-e007-4dbb-980c-133ea7d1bb46"
      unitRef="usd">-117000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib49781b522ea4f76b1513c0e998abcab_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMjUzNQ_5ce177cf-8b18-45a0-a6b1-807d5faf126a"
      unitRef="usd">91000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="if8234a3e5eda4043b4d3fa3510856378_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1MTQyNA_3e6016e9-093e-4183-96f5-df8709014d17"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMjcxMQ_d1829ce0-688d-4fc8-a60b-de4f2e51a63d"
      unitRef="usd">20000000</mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax>
    <mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1MTU4OQ_b7e94815-19f8-4976-b007-e694da3d1ca9"
      unitRef="usd">30000000</mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4ddc0b315b6f44b0ae7eb4080f845509_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMzA5MQ_9d84d765-8f0d-4f75-827f-847b4265a063"
      unitRef="cad">1500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if390d59ed27b4bc8a9ae736d392c53fb_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMzA5MQ_a6f49455-6559-4c44-a69d-3f433304c0c9"
      unitRef="cad">1500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iecdece7bccac464e91de8f41f5c11988_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNDQ5Ng_c75c6403-9aa8-4cdc-9d41-a6dc022eb9de"
      unitRef="gbp">932000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="ic8acb42c198243e4a41c9b1198ebd29b_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNDc0NQ_54838fe1-bd71-4b3c-b04e-b6a92c9c2665"
      unitRef="usd">84000000</us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ic8acb42c198243e4a41c9b1198ebd29b_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNDc4NQ_0efbf3c1-4cec-4d92-831e-ff41eaca17c0"
      unitRef="usd">34000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i845cf95a4c8a421fafec2976a240ff82_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNTA2MA_0ce2d3c3-dc3c-43e4-ad52-90ec2878aff4"
      unitRef="usd">-12000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i8df2eff3ed674556a1b6d76ac1e2fc2b_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1MTgyNQ_8b2b098f-fa67-4ff2-bec6-48f548b76d19"
      unitRef="usd">-63000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="ib993ed38bcaa44e992d425b235b667ba_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNTA2Nw_c5c17e67-e157-4cc2-84ac-b87284cb00f1"
      unitRef="usd">20000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="icdb08454a4384d82896df1a6d61f11f9_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1MTg3MA_4b967f25-633f-4f5f-aee6-88497c24fc5f"
      unitRef="usd">9000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:LongTermDebt
      contextRef="i88ca01400a5e4f17a31f7e6a13628bec_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNTQ0Mg_c7996fa5-a77d-4250-b80b-72736e37c5bd"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i88ca01400a5e4f17a31f7e6a13628bec_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNTc5NA_c7996fa5-a77d-4250-b80b-72736e37c5bd"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i31bf530a67154f4089f298f4daebb618_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNzA2MA_d965f8e7-794a-4790-a114-731710a0c78a"
      unitRef="usd">2600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iccbce5482ad640f5b90191abd057ac63_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfNzA2Nw_b0a77bce-d550-46e1-9cf2-e5d10953cd17"
      unitRef="usd">2900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8ad1ff26ff3e4d089de290e9695a1cb1_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfODE0OQ_761c5bcd-3ef5-4892-8897-64c646fd48cc"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8ad1ff26ff3e4d089de290e9695a1cb1_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfODE1Ng_3bf77314-ee71-4c37-8820-3a84fdcd800a"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8ad1ff26ff3e4d089de290e9695a1cb1_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfODM4NQ_c548fefc-2ede-4807-880f-74087d17599c"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8ad1ff26ff3e4d089de290e9695a1cb1_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfODYxMA_50aa6cf0-b191-48d1-a68c-25e23dc0dcca"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i2c1475ccb75f4635a9bf4d405fc5d8f5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1NTYxNQ_be733719-b173-4d93-875a-55c1528c1840"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i123bf8d69a8548fda1b8942d92d2fc33_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1NTYyMw_72351da2-6435-4a59-ac10-77e22b8ee6b9"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i85cd2589de304d938cfd483404ca1653_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1NTY2MA_5ed14946-3549-4ea8-9c8b-b167fe105b29"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ia124b703fd9c4666841454b448394b00_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1NTY2OA_b602502d-1c39-4fe6-813e-4124c9067255"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia9356380a99d4079b931630ff762728b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfOTAzOA_4d3a9a62-aeff-4950-a8cf-b84dc9e57c55"
      unitRef="usd">44000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i258110de1c154e9480bae6db28d0f729_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfOTA0NQ_096c2a83-9211-412e-acb3-0990eb565e26"
      unitRef="usd">29000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i3a7c1b74f86c479b816159c6d3ae04b0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1NDEwMg_2d6e6362-9d2c-42e4-bcab-a9c98cf0045a"
      unitRef="usd">-20000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i1b5ddc35c76e45c7a9c189c497c848b8_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfMTY0OTI2NzQ1NDExMA_1a6627eb-5d54-4cd6-8cc1-acd94ed96c6f"
      unitRef="usd">-39000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RleHRyZWdpb246MjIxMGZlNmZlNzUwNGYwN2FlZDdhMzM5ZjQ2NmFkN2NfOTY5Nw_c1b745a9-e410-4414-9624-54bbb63b217a">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.481%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6bc3ab577dc7480fae3d98e14277684f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNS0yLTEtMS0w_faa9498b-10cf-4fb6-a395-bc9eb8bb0c99"
      unitRef="usd">20000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i21e4948d75de4a3baf98851aa5242f47_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNS00LTEtMS0w_6aa409b1-eca0-4094-aa03-c4b664ce894f"
      unitRef="usd">12000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i9949b55995c54523b05daddb017a3ac4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNS01LTEtMS0w_65c5e4aa-fc38-4829-b15f-02d1fa310d68"
      unitRef="usd">925000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i206a9aeb7e4a4008803c87c65282730e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNS03LTEtMS0w_898bc9b7-736c-44ac-8f19-a10265ce408a"
      unitRef="usd">112000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic03b5f5fc26d47c3be37eff2f0e07604_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNS05LTEtMS0w_4d77bd4d-546b-4b24-93b0-d18a7c0d7a96"
      unitRef="usd">19000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="iba46bb814a6e4d07bedaae798f4c086c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNS0xMC0xLTEtMA_90f25b10-2d5e-4bf8-b9b1-1104facfdfc6"
      unitRef="usd">1279000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib2e52268a81f4aa28240eea26becc2ba_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNi0yLTEtMS0w_864901f7-96b0-4fc6-a0ad-c661e2fbaaa2"
      unitRef="usd">81000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i8f31411e76594912ad9c4c6fdc037070_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNi00LTEtMS0w_51b5eb41-4195-46b8-ba37-4a68a0121fc8"
      unitRef="usd">42000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i69864efaf345415db2c3cc9adba8a027_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNi01LTEtMS0w_629034fd-8096-49be-b269-f6bd177caaf9"
      unitRef="usd">3313000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4a67d47d26e744bea5b1a64745a103ef_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNi03LTEtMS0w_34121dc1-ebb1-4824-af4f-9195eac9a4e3"
      unitRef="usd">182000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie09c8165d0db4a47be02c5ba356b27a9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNi05LTEtMS0w_e3c2cf4a-78dd-4761-83a5-0f55ea554dfa"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i15eb6e4eb94b4f57885a65039289f579_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNi0xMC0xLTEtMA_ba75ddb6-936c-493c-8cb8-4c2dc7dde5e2"
      unitRef="usd">3313000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifb450020edcc4eafb4f6204bd56f1294_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNy0yLTEtMS0w_dbac0e1d-d6bc-472d-b112-10093f0f86d7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ifb450020edcc4eafb4f6204bd56f1294_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNy00LTEtMS0w_2e3a81bd-a4e6-48b3-ad13-2b219c16672d"
      unitRef="usd">11000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ifb450020edcc4eafb4f6204bd56f1294_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNy01LTEtMS0w_ffe18b38-3038-4c2f-9a0f-7ee72603fc8e"
      unitRef="usd">1203000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i48d17d2683c04f8e978bbfeeda49522e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNy03LTEtMS0w_7efffaca-ccb7-4488-829d-62571a401fb0"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i48d17d2683c04f8e978bbfeeda49522e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNy05LTEtMS0w_02e3147a-7622-4c57-8503-b4ebf1f70686"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i48d17d2683c04f8e978bbfeeda49522e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfNy0xMC0xLTEtMA_986e8522-c763-4142-a44a-e1a53796d9a0"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6c01ee54c64b4e738869a1a426b32be8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfOS0yLTEtMS0w_f0447782-613e-446d-bbeb-2eb24ee3d8e4"
      unitRef="usd">101000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6c01ee54c64b4e738869a1a426b32be8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfOS00LTEtMS0w_fccdf26d-12d1-4f59-aff0-998d2685ae5d"
      unitRef="usd">65000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1b838d45789a4813a7f70a4900210195_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfOS03LTEtMS0w_f0f2b3bc-9dd5-4f96-91c8-2ae627de3412"
      unitRef="usd">294000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1b838d45789a4813a7f70a4900210195_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfOS05LTEtMS0w_bd55f9ca-d93a-406e-86c9-69d2dd52a631"
      unitRef="usd">19000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6eaf2c336e1d400ba5e9a2c97cfb4467_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTEtMi0xLTEtMA_586de3bf-c055-471f-a5b6-a391ea8cfb5d"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6eaf2c336e1d400ba5e9a2c97cfb4467_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTEtNC0xLTEtMA_b2de3326-80e3-4b92-a383-64e1bb2c23c1"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i6eaf2c336e1d400ba5e9a2c97cfb4467_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTEtNS0xLTEtMA_171d049d-4990-4923-99ad-efcc90a47f78"
      unitRef="usd">32000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0e77147ea2824ec685fc498f61706e2b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTEtNy0xLTEtMA_89f36b59-6d1e-406a-9031-146759fd2aff"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i0e77147ea2824ec685fc498f61706e2b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTEtOS0xLTEtMA_b3226f3d-2062-4781-8076-d1c43e7111dc"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i0e77147ea2824ec685fc498f61706e2b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTEtMTAtMS0xLTA_ed08ff0b-e9af-49a4-8b54-b718fa0bef0d"
      unitRef="usd">24000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i851951555ad24db390460dd6eda13a71_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTItMi0xLTEtMA_b5a02998-7903-4118-8af7-44818d3622a6"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i851951555ad24db390460dd6eda13a71_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTItNC0xLTEtMA_8f89881b-0f3c-4166-9f3d-12bb393fa658"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i851951555ad24db390460dd6eda13a71_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTItNS0xLTEtMA_78c1f559-f36b-49bc-a8a3-f9a6cae3635f"
      unitRef="usd">13000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="idbba6884ea2d430c82bef1bffa38851e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTItNy0xLTEtMA_d664d233-a564-41d6-9131-357697a0993d"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="idbba6884ea2d430c82bef1bffa38851e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTItOS0xLTEtMA_a7deef44-06db-4480-8577-caae2d45137f"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="idbba6884ea2d430c82bef1bffa38851e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTItMTAtMS0xLTA_1625fed0-b3e0-4e89-8a0c-d558f5bd0c40"
      unitRef="usd">5000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i54c29ac67c524830b5346ac601e7912c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTMtMi0xLTEtMA_2dce22e1-bcb5-4b2d-b33f-5da92006a270"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i54c29ac67c524830b5346ac601e7912c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTMtNC0xLTEtMA_62c12e84-726b-4714-a3a2-9f4c1de173a3"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1469f9d2f2f144f6ac3ea35586bb7cf0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTMtNy0xLTEtMA_86379de6-f27a-4e13-8eda-b3c05c1b651f"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1469f9d2f2f144f6ac3ea35586bb7cf0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV83OS9mcmFnOjIyMTBmZTZmZTc1MDRmMDdhZWQ3YTMzOWY0NjZhZDdjL3RhYmxlOjRhNDBjZDZiNDJlMDQ0ZDhhODZkODhmN2Q5NmRiMGE4L3RhYmxlcmFuZ2U6NGE0MGNkNmI0MmUwNDRkOGE4NmQ4OGY3ZDk2ZGIwYThfMTMtOS0xLTEtMA_6215e6c1-8bee-4196-afd4-dd41ff5c428e"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfNDY4NA_c04d4351-99f5-4e96-ab3d-1b46b844416e">Fair Value Measurements&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2020 and March 31, 2020, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is carried at amortized cost. The carrying amounts and estimated fair values of these liabilities were $7.6 billion and $8.4 billion at September 30, 2020, respectively, and $7.4 billion and $7.8 billion at March 31, 2020, respectively. The estimated fair value of the Company&#x2019;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents at September 30, 2020 and March 31, 2020 included investments in money market funds of $129 million and $2.0 billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level&#160;1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of the Company&#x2019;s foreign currency forward contracts were determined using observable inputs from available market information. Fair values of the Company&#x2019;s cross-currency swaps were determined using quoted foreign currency exchange rates and other observable inputs from available market information. Fair values of the Company&#x2019;s interest rate swaps were determined using observable inputs from available market information. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 11, &#x201c;Hedging Activities,&#x201d; for fair value and other information on the Company&#x2019;s foreign currency derivatives including forward foreign currency contracts and cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry. These investments, with a carrying value of $235&#160;million and $170&#160;million, respectively, at September 30, 2020 and March 31, 2020, and primarily consisting of investments without readily determinable fair values, are included within Other non-current assets in the Condensed Consolidated Balance Sheets. In the second quarter of 2021, three of the companies in which McKesson holds investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition. Net gains related to the Company&#x2019;s investments in equity securities, primarily representing unrealized gains on the publicly traded securities discussed above, were $49 million and $59 million for the three and six months ended September 30, 2020, respectively. These gains were recorded under the caption, &#x201c;Other income (expense), net,&#x201d; in the Condensed Consolidated Income Statements. There were no other material changes in the carrying value of these investments during the three or six months ended September 30, 2020. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets measured at fair value on a nonrecurring basis as of September 30, 2020 included long-lived assets in the U.K. as discussed in more detail in Financial Note 4, &#x201c;Restructuring, Impairment, and Related Charges,&#x201d; and goodwill of the Company&#x2019;s Europe Retail Pharmacy reporting unit within the International segment. Refer to Financial Note 8, &#x201c;Goodwill and Intangible Assets, Net,&#x201d; for more information. At March 31, 2020, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#x2019;s European and Rexall Health businesses within the International segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aforementioned investments in equity securities includes the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no liabilities measured at fair value on a nonrecurring basis at September 30, 2020 and March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash, included within Prepaid expenses and other on the Company&#x2019;s Condensed Consolidated Balance Sheet as of September 30, 2020, primarily consists of funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. The amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within Other accrued liabilities on the Company&#x2019;s Condensed Consolidated Balance Sheet as of September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a discounted cash flow (&#x201c;DCF&#x201d;) model to determine the fair value of the reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.&lt;/span&gt;&lt;/div&gt;The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i7b890927812447aa911816632e628829_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfNjIw_4c23af64-83bb-4c7c-8dcc-ea5115615e29"
      unitRef="usd">7600000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i7b890927812447aa911816632e628829_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfNjI3_da39d183-ce6e-40f4-b4da-9411fddaca48"
      unitRef="usd">8400000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="i5badf059a14f4d8ab6f9ce6affac29bc_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfNjU1_29107fcb-576a-4ef0-8909-71b102af845d"
      unitRef="usd">7400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i5badf059a14f4d8ab6f9ce6affac29bc_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfNjYy_96cf336e-4210-4043-a822-e5de7d6b8ab1"
      unitRef="usd">7800000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9fa8c90408ea4e3dae6e394bf3fa943b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTE2OA_00f40321-7340-4f90-b36b-bf698fe02ec2"
      unitRef="usd">129000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9b844b3b721f4a0d922cde7ae32b2875_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTE3NQ_a619ebc9-3de4-4740-bd03-f709e2b5c2c0"
      unitRef="usd">2000000000.0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTA0NDUzNjA0NzU3OTc_6eaa5719-0f0c-45f3-9ab9-b360fa1fc416"
      unitRef="usd">235000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i66de38bda2a744608a06a9b06ebf6645_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTA0NDUzNjA0NzU4MTI_01b266ca-bbd2-49c2-aa17-5829190624bd"
      unitRef="usd">170000000</us-gaap:EquitySecuritiesFvNi>
    <mck:EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTUzOTMxNjI4MDIyMDE_02755aed-bd59-48a7-85e8-24c382c03b80"
      unitRef="company">3</mck:EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTIwOTQ2Mjc5MTYzNDQ_b7c62f1c-7960-49fa-ac76-616864e7533b"
      unitRef="usd">49000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMTIwOTQ2Mjc5MTYzNTI_76ea4425-9dff-411a-93ea-af97639950b8"
      unitRef="usd">59000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0f5ac3d5d5f4479592e96e5bf4ee0a01_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMjc1MA_2d49d8f9-ac15-4693-8ab6-b8aacb96abe4"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1cb4731f3b53414bac5ded8a850e5f3b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84NS9mcmFnOjljZmE1ZjM5ZGQyZjRlZWY5ZThkMTU2NjhmNGIzNmY3L3RleHRyZWdpb246OWNmYTVmMzlkZDJmNGVlZjllOGQxNTY2OGY0YjM2ZjdfMjc1MA_8b4ea66f-d23f-4038-bec4-d40ca99ec793"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4MjkyNDQ_b24796f2-e9ac-4ef3-8a79-547b36994f23">Commitments and Contingent Liabilities &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mck10k3312020.htm#sFDC7F65C03045D74BF3631026AD9426B" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 21 to the Company&#x2019;s 2020 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 13 to the Company&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&#x2019;&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;s 10-Q filing for the quarterly period ended June 30, 2020&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, it is not reasonably possible for the Company to determine that a loss is probable for a claim, or to reasonably estimate the amount of loss or a range of loss, because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to be resolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the loss probability has changed and whether it can make a reasonable estimate of the possible loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability in the amount of its estimate for the ultimate loss. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;I. Litigation and Claims Involving Distribution of Controlled Substances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, hospitals, Indian tribes, pension funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico, and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), state and federal controlled substances laws, and other statutes. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#x201c;MDL&#x201d;) in the United States District Court for the Northern District of Ohio captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;In re: National Prescription Opiate Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, Case No. 17-md-2804. At present, there are approximately 2,800 cases under the jurisdiction of the MDL court. In the suits filed against the Company by Cuyahoga County, Ohio in October 2017 and Summit County, Ohio in December 2017, the parties reached an agreement in principle on October 21, 2019 to settle all claims against the Company. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;County of Cuyahoga v. Purdue Pharma L.P., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, Case No. 1:17-op-45004-DAP (N.D. Ohio); &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;County of Summit, Ohio et al. v. Purdue Pharma L.P., et. al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, Case No. 1:18-op-45090-DAP (N.D. Ohio). The Company does not admit liability and expressly denies wrongdoing. As a result, the Company recorded a pre-tax charge of $82&#160;million related to two Ohio counties within operating expenses for the second quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three cases involving McKesson that were previously part of the federal MDL have been remanded to other federal courts for discovery and trial. On January 14, 2020, the Judicial Panel on Multidistrict Litigation finalized its Conditional Remand Order, ordering that the cases against the three largest distributors brought by Cabell County, West Virginia and the City of Huntington, West Virginia be remanded to the U.S. District Court for the Southern District of West Virginia. A trial has been scheduled for January 4, 2021. On February 5, 2020, the case brought by the City and County of San Francisco was remanded to the U.S. District Court for the Northern District of California; trial has been set for June 28, 2021. Also on February 5, 2020, the case brought by the Cherokee Nation was remanded to the U.S. District Court for the Eastern District of Oklahoma.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also named in approximately 400 similar state court cases pending in 36 states plus Puerto Rico, along with 3 cases in Canada. These include actions filed by 26 state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state cases. For example, trial was previously set to begin in March 2020 in the Supreme Court of New York, Suffolk County for a case brought by the New York attorney general and two New York county governments, but the trial was postponed in light of the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to be involved in discussions with the objective of achieving broad resolution of opioid-related claims brought by governmental entities. For example, in October 2020, a group of state attorneys general proposed a framework for the potential settlement of opioid claims of governmental entities, including political subdivisions, and compensation for the private attorneys representing these governmental entities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the framework proposed by the attorneys general, the three largest U.S. pharmaceutical distributors could be expected to pay an aggregate amount of up to $21.0 billion over 18 years, with up to approximately $8.0 billion over 18 years expected from the Company. The proposed framework would also require the three distributors, including the Company, to adopt changes to anti-diversion programs. If the negotiating parties agree on the terms for a broad resolution, those potential terms would need to be agreed to by numerous other state and local governments before an agreement could be accepted by the Company and finalized. Under the framework, before the distributors determine whether to enter into any final settlement, they would assess the sufficiency of the scope of settlement, based in part on the number and identities of the states, political subdivisions, and governmental entities that would participate in any such settlement. If states, political subdivisions or other governmental entities did not agree to a settlement under the framework, there would be a corresponding reduction in the amount due from the Company to account for this.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discussions with attorneys general and other parties continue. To be viable, a broad settlement arrangement would require participation of numerous parties and the resolution of many complex issues. Because of the many uncertainties associated with any potential settlement arrangements, and the uncertainty of the scope of potential participation by plaintiffs, the Company has not reached a point where settlement is probable, and as such has not recognized any liability related to any potential settlement framework as of September 30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company continues to be involved in discussions regarding a potential global settlement framework, the Company also continues to prepare for trial in these matters. The Company believes that it has valid defenses to the claims pending against it and intends to vigorously defend against all such claims. Because of the novelty of the claims asserted and the complexity of litigation, the Company has determined that liability is not probable, and is not able to reasonably estimate a loss or range of loss. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#x2019;s financial position, cash flows or liquidity, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Company was served with a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint filed by two relators alleging violations of the federal False Claims Act based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Kelley&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 19-cv-2233. On August 18, 2020, the court entered an order granting the Company&#x2019;s motion to dismiss and giving the relators permission to file an amended complaint. On September 8, 2020, pursuant to the court&#x2019;s order, the relators filed a Second Amended Complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;II. Other Litigation and Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#x201c;TCPA&#x201d;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$500&#160;to&#160;$1,500&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On July 16, 2015, plaintiffs filed a motion for class certification. On August 22, 2016, the court denied plaintiffs&#x2019; motion. On July 17, 2018, the United States Court of Appeals for the Ninth Circuit Court affirmed in part and reversed in part the district court&#x2019;s denial of class certification and remanded the case to the district court for further proceedings. On August 13, 2019, the court granted plaintiffs&#x2019; renewed motion for class certification. After class notice and the opt-out period, 9,490 fax numbers remain in the class, representing 48,769 faxes received. On March 5, 2020, McKesson moved to decertify the class and moved for summary judgment on plaintiffs&#x2019; claim for treble damages. Plaintiffs&#x2019; moved for summary judgment on the same day. Due to the COVID-19 pandemic, the trial date for this case was taken off calendar to be re-scheduled during 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 5, 2018, the Company&#x2019;s subsidiary, RxC Acquisition Company (d/b/a RxCrossroads), was served with a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint filed in July 2017 in the United States District Court for the Southern District of Illinois by a relator against RxC Acquisition Company, among others, alleging that UCB, Inc. provided illegal &#x201c;kickbacks&#x201d; to providers, including nurse educator services and reimbursement assistance services provided through RxC Acquisition Company, in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. CIMZNHCA, LLC v. UCB, Inc., et al.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 17-cv-00765. The complaint sought treble damages, civil penalties, and further relief. The United States and the states named in the complaint declined to intervene in the suit. On December 17, 2018, the United States filed a motion to dismiss the complaint in its entirety; this motion was denied on April 15, 2019. On June 7, 2019, the court denied the United States&#x2019; motion for reconsideration. On July 8, 2019, the United States appealed to the United States Court of Appeals for the Seventh Circuit seeking interlocutory review of the denial of its motion for reconsideration of the denial of the motion to dismiss the complaint. On September 3, 2019, the United States District Court for the Southern District of Illinois stayed the district court proceedings pending the appeal. On August 17, 2020, the Seventh Circuit reversed the district court&#x2019;s decision on the United States&#x2019; motion to dismiss and remanded the case with instructions that the district court enter judgment for the defendants on the relator&#x2019;s claims under the False Claims Act. The relator sought a re-hearing &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;en banc&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; at the Seventh Circuit, which was denied.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The relator did not pursue any further appeals and the relator&#x2019;s False Claims Act case was dismissed, with judgment entered in favor of the defendants on September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a defendant in an amended complaint filed on June 15, 2018 in a case pending in the United States District Court for the Southern District of Illinois alleging that the Company&#x2019;s subsidiary, McKesson Medical-Surgical Inc., among others, violated the Sherman Act by restraining trade in the sale of safety and conventional syringes and safety IV catheters. M&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;arion Diagnostic Center, LLC v. Becton, Dickinson, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 18:1059. The action is filed on behalf of a purported class of purchasers, and seeks treble damages and further relief, all in unspecified amounts. On July 20, 2018, the defendants filed a motion to dismiss. On November 30, 2018, the district court granted the motion to dismiss, and dismissed the complaint with prejudice. On December 27, 2018, plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit. On March 5, 2020, the United States Court of Appeals for the Seventh Circuit vacated the district court&#x2019;s order, and ruled that dismissal was appropriate on alternative grounds. The case was remanded to the district court to allow the plaintiffs an opportunity to amend their complaint. Plaintiffs filed an amended complaint on August 21, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 21, 2019, Jean E. Henry, a purported Company shareholder, filed a shareholder derivative complaint in the Superior Court of San Francisco, California against certain current and former officers and directors of the Company, and the Company as a nominal defendant, alleging violations of fiduciary duties and waste of corporate assets with respect to an alleged conspiracy to fix the prices of generic drugs, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Henry v. Tyler, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CGC-19-576119. On May 23, 2019, the Company removed the case to the United States District Court for the Northern District of California, Case No. 19-cv-02869. On August 26, 2019, the plaintiff filed an amended complaint, removing all claims except for an alleged breach of fiduciary duty by the named current and former officers and directors of the Company. On January 21, 2020, the United States District Court for the Northern District of California granted the defendants&#x2019; motion to dismiss the complaint, and on July 1, 2020, the court granted the defendant&#x2019;s motion to dismiss the plaintiff&#x2019;s amended complaint with prejudice. The plaintiff did not file an appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;III.&#160;Government Subpoenas and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 21, 2020, McKesson received correspondence from the U.S. Attorney&#x2019;s Office for the Western District of Tennessee alleging reporting and documentation deficiencies in violation of the Controlled Substances Act at the Company&#x2019;s former and no longer operational RxPak facility and at its Distribution Center in Memphis, Tennessee, and seeking civil penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:103%"&gt;IV.  State Opioid Statutes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legislative, regulatory or industry measures to address the misuse of prescription opioid medications could affect the Company&#x2019;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#x201c;OSA&#x201d;) which required the creation of an aggregate $100&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#x2019;s decision on procedural grounds. The Company has accrued a $50&#160;million pre-tax charge ($37&#160;million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized as Operating expenses in the accompanying condensed consolidated statement of operations and as Other accrued liabilities in the condensed consolidated balance sheets as of September 30, 2020. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTc1MjY_430c7721-b3eb-4f13-9b98-b873ba473a88">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mck10k3312020.htm#sFDC7F65C03045D74BF3631026AD9426B" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 21 to the Company&#x2019;s 2020 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 13 to the Company&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&#x2019;&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;s 10-Q filing for the quarterly period ended June 30, 2020&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, it is not reasonably possible for the Company to determine that a loss is probable for a claim, or to reasonably estimate the amount of loss or a range of loss, because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to be resolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the loss probability has changed and whether it can make a reasonable estimate of the possible loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability in the amount of its estimate for the ultimate loss. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i7ed3f74dc0ae44f8baf2c9b085580e45_I20200930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMzYxNQ_378466cf-3637-499b-9b97-c3d1f1bc1daa"
      unitRef="case">2800</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="ib06af04e28ba4e4ea6652465ca257cfe_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4NjY0NzQ_3fe14323-a0b2-4231-9aa7-c6a54d241ce8"
      unitRef="usd">82000000</us-gaap:PaymentsForLegalSettlements>
    <mck:LossContingencyNumberofCounties
      contextRef="i7ed3f74dc0ae44f8baf2c9b085580e45_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4NjY0OTE_e35a969c-2864-4fb9-896a-b53423b3ddd5"
      unitRef="county">2</mck:LossContingencyNumberofCounties>
    <mck:LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts
      contextRef="ibd6d24f4b8e64a778fb5af40d017aedc_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMzY2NQ_43e8247d-2775-42c6-b7f2-ddb437f22a2c"
      unitRef="case">3</mck:LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts>
    <mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges
      contextRef="ieaaee7621692492e90da6fe2f00a5923_I20200114"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMzk1MA_fe8fe097-01a8-4d6f-9db5-895057fca196"
      unitRef="company">3</mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i3e08cb2f184f4ac491a30c4f2f86b5cd_I20200930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNDU3Ng_a3deee45-4a6a-4a10-b12d-3db70f8837ec"
      unitRef="case">400</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofStates
      contextRef="i3e08cb2f184f4ac491a30c4f2f86b5cd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNDYxNg_cd7504d0-1887-4fc0-b5be-51fe6235b9a9"
      unitRef="state">36</mck:LossContingencyNumberofStates>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ia89ab571675d4fe1be458deb9d1756b6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTY0OTI2NzQ1OTQ0NQ_15353e7a-3332-44d6-a3f5-454c580e7154"
      unitRef="case">3</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofStateAttorneyGenerals
      contextRef="i3e08cb2f184f4ac491a30c4f2f86b5cd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNDY3NQ_1433aadd-d526-45fe-81fa-d2b11989301d"
      unitRef="state_attorney">26</mck:LossContingencyNumberofStateAttorneyGenerals>
    <mck:NumberOfCountyGovernments
      contextRef="ifef9ed0f951845c09b3a887cc0f7469f_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNTE0OA_7efee5d4-dd4a-45c4-8d63-29dedfdd5e86"
      unitRef="county">2</mck:NumberOfCountyGovernments>
    <mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges
      contextRef="i2b88d5a3d4ab496188c56155a2880f90_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNTgwMQ_4772394a-6a94-4d83-8d49-b47bac827ad5"
      unitRef="company">3</mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i56fa48494eef42e2a81d8b80e6683829_D20201001-20201031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTA5OTUxMTYzMTg2NzU_ee148ccb-4571-4e1b-bfc5-68f32ff65e39"
      unitRef="usd">21000000000.0</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="i56fa48494eef42e2a81d8b80e6683829_D20201001-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNTg4OQ_67a3ae3d-2f62-4264-a5f4-d6f1d1429de7">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ic4a0fa8d9f0a41d0a8385cb9c0f43e82_D20201001-20201031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTA5OTUxMTYzMTg3MDQ_4278e7e9-5142-4c6c-9153-a2b27f09d1e8"
      unitRef="usd">8000000000.0</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="ic4a0fa8d9f0a41d0a8385cb9c0f43e82_D20201001-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfNTkyNg_169575c0-12a1-4511-aac8-5ab2670ab61d">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <mck:LossContingencyNumberofRelatorsAllegingViolations
      contextRef="ife3f7c8428454d1a83b2d27fbb7084b5_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4MjkyNDE_c8840004-1e68-4d22-aaa7-af40abf4de51"
      unitRef="relator">2</mck:LossContingencyNumberofRelatorsAllegingViolations>
    <mck:LossContingencyDamagesSoughtPerViolationValue
      contextRef="ic933332211124a748e5866fc45b2d46c_D20130517-20130517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTA2ODk_d54e5f62-60f5-4d5d-99d1-18f52ff24046"
      unitRef="usd">500</mck:LossContingencyDamagesSoughtPerViolationValue>
    <mck:LossContingencyDamagesSoughtPerViolationValue
      contextRef="i1c69b4d259c846329b91b3b6969f1004_D20130517-20130517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTA2OTU_0a19737f-511c-4e23-a886-c7675c6845bb"
      unitRef="usd">1500</mck:LossContingencyDamagesSoughtPerViolationValue>
    <mck:LossContingencyClassActionNumberofFaxesRemainingintheClass
      contextRef="iace4f3d9ad444347aa132bbc7bb400f2_I20190813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTE1NjM_e163e8f4-4dc7-437a-a20d-ae1af8b178f5"
      unitRef="fax_number">9490</mck:LossContingencyClassActionNumberofFaxesRemainingintheClass>
    <mck:LossContingencyClassActionNumberofFaxesReceived
      contextRef="iace4f3d9ad444347aa132bbc7bb400f2_I20190813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTE2MTI_cb8b62a0-61fe-4334-a8de-4a4a7c11967a"
      unitRef="fax">48769</mck:LossContingencyClassActionNumberofFaxesReceived>
    <mck:OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids
      contextRef="ia241be660d814c9dbfbab339569e8b37_I20180430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4MjkyNzI_7050a148-59e6-439b-886a-6d5b7cd200fa"
      unitRef="usd">100000000</mck:OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4MjkyNDY_4976839c-74ce-4d60-a8db-d3bb6e862810"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <mck:LossContingencyAccrualAfterTax
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV84OC9mcmFnOjUwZTBjYTRlMWU0MzRkYWRhOWNiMTZhNjQxYTBmMzE1L3RleHRyZWdpb246NTBlMGNhNGUxZTQzNGRhZGE5Y2IxNmE2NDFhMGYzMTVfMTUzOTMxNjI4MjkyNTk_cecb74f5-f5f2-4d44-a74b-213ab483d9ac"
      unitRef="usd">37000000</mck:LossContingencyAccrualAfterTax>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0MjE5ODU_8d335b6e-42f8-4bda-aa36-344202304fdd">Stockholders' Equity &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of the Company&#x2019;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 29, 2020, the Company raised its quarterly dividend from $0.41 to $0.42 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#x201c;ASR&#x201d;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#x2019;s stock price, corporate and regulatory requirements, restrictions under the Company&#x2019;s debt obligations, and other market and economic conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June 30, 2020, there were no share repurchases made under previously authorized share repurchase programs. During the three months ended September 30, 2020, the Company repurchased 1.8&#160;million of the Company&#x2019;s shares for $269 million through open market transactions at an average price per share of $151.23, of which $21&#160;million was accrued within &#x201c;Other accrued liabilities&#x201d; on the Company&#x2019;s Condensed Consolidated Balance Sheets for share repurchases that were executed in late September and settled in early October. The total authorization outstanding for repurchases of the Company&#x2019;s common stock was $1.3 billion at September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments arising during period, net of income tax expense of nil, nil, nil, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on net investment hedges arising during period, net of income tax (expense) benefit of $25, $(29), $47, and $(20) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $4, $(4), $4, and $(10)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil,  nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in retirement-related benefit plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial gain and prior service cost arising during the period, net of income tax benefit of nil, $2, nil, and $1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense of $1, nil, $1, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other, net of income tax expense of nil, nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24.75pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, $27, nil, and $32 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;During the three and six months ended September 30, 2020, the net foreign currency translation adjustments were primarily due to the strengthening of the Canadian dollar and Euro against the U.S. dollar from April 1, 2020 to September 30, 2020. During the three and six months ended September 30, 2019, the net foreign currency translation adjustments were primarily due to the weakening of the Euro and British pound sterling against the U.S. dollar from April 1, 2019 to September 30, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and six months ended September 30, 2020 includes net foreign currency translation adjustments of $119 million and $61 million, respectively, and the three and six months ended September 30, 2019 includes net foreign currency translation adjustments of $19 million and $13 million, respectively, attributable to redeemable noncontrolling interests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and six months ended September 30, 2020 includes foreign currency losses of $83 million and $117 million, respectively, on the net investment hedges from the &#x20ac;1.7 billion&#160;Euro-denominated notes and &#xa3;450 million&#160;British pound sterling-denominated notes, losses of $12 million and $63 million, respectively, on the net investment hedges from cross-currency swaps, and losses on net investment hedges of $1 million attributable to redeemable noncontrolling interests. The three and six months ended September 30, 2019 include foreign currency gains of $91 million and $67 million, respectively, on the net investment hedges from the &#x20ac;1.95 billion Euro-denominated notes and&#160;&#xa3;450 million British pound sterling-denominated notes and gains of $20 million and $9 million, respectively, on the net investment hedges from cross-currency swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and six months ended September 30, 2020 include net actuarial losses of $5 million and $2 million, respectively, and the three and six months ended September 30, 2019 include net actuarial gains of $1 million, which are attributable to redeemable noncontrolling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Pre-tax amount was reclassified into Cost of sales and Operating expenses in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into Income tax benefit (expense) in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and six months ended September 30, 2019 primarily reflects a reclassification of a pension settlement charge from Accumulated other comprehensive loss to Other income (expense), net in the Condensed Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss) by component for the three and six months ended September 30, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss) by component for the three and six months ended September 30, 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <mck:CommonStockVotingRightsNumberofVotesPerCommonShare
      contextRef="i0ab19df7575e4779a1875a5d7ee85303_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfNzk_fd229708-a651-481c-b722-472f4670d60e"
      unitRef="vote">1</mck:CommonStockVotingRightsNumberofVotesPerCommonShare>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib24b30ad412f4321bcaff6b945c5ab8a_D20200728-20200728"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMzAy_b8abf6c2-125a-4472-8b3d-a5b25d555118"
      unitRef="usdPerShare">0.41</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ifc731429591343fb9685ce4e3d37b71c_D20200729-20200729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMzA4_d6f48072-34cb-4bd8-9466-1858623c2aa0"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i094f2986d473404cb6ffd79049564a6b_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTUzOTMxNjI3OTY0MDM_1bda6627-3851-4dbb-a16c-e8b36338dac0"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i360a0a25e36a496585c2f2d80ef31321_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTA0NDUzNjA0NzQxOTQ_a6743475-c044-486e-be14-c42460d8fb4e"
      unitRef="shares">1800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i360a0a25e36a496585c2f2d80ef31321_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTA0NDUzNjA0NzQyMTQ_e855fae6-113f-487a-ad96-c6a6f3bc6cc7"
      unitRef="usd">269000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTA0NDUzNjA0NzQyMTk_b342ee6c-d424-4e93-b718-e180948340cd"
      unitRef="usdPerShare">151.23</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i5e72211ec5474ca28d33b7a18d5879c3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTA0NDUzNjA0NzY5MDY_5d6d52a7-b3d4-4795-82e7-63d17d4117cf"
      unitRef="usd">21000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i1009c601f4d148e38fd22bf9694cd964_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTM1MA_f74b496a-950e-4fe4-81a0-ab8dd3897641"
      unitRef="usd">1300000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMzg1NA_5cbdf780-2b45-4e68-aa03-a2de7681497f">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments arising during period, net of income tax expense of nil, nil, nil, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on net investment hedges arising during period, net of income tax (expense) benefit of $25, $(29), $47, and $(20) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $4, $(4), $4, and $(10)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil,  nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in retirement-related benefit plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial gain and prior service cost arising during the period, net of income tax benefit of nil, $2, nil, and $1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense of $1, nil, $1, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other, net of income tax expense of nil, nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24.75pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, $27, nil, and $32 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;During the three and six months ended September 30, 2020, the net foreign currency translation adjustments were primarily due to the strengthening of the Canadian dollar and Euro against the U.S. dollar from April 1, 2020 to September 30, 2020. During the three and six months ended September 30, 2019, the net foreign currency translation adjustments were primarily due to the weakening of the Euro and British pound sterling against the U.S. dollar from April 1, 2019 to September 30, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and six months ended September 30, 2020 includes net foreign currency translation adjustments of $119 million and $61 million, respectively, and the three and six months ended September 30, 2019 includes net foreign currency translation adjustments of $19 million and $13 million, respectively, attributable to redeemable noncontrolling interests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and six months ended September 30, 2020 includes foreign currency losses of $83 million and $117 million, respectively, on the net investment hedges from the &#x20ac;1.7 billion&#160;Euro-denominated notes and &#xa3;450 million&#160;British pound sterling-denominated notes, losses of $12 million and $63 million, respectively, on the net investment hedges from cross-currency swaps, and losses on net investment hedges of $1 million attributable to redeemable noncontrolling interests. The three and six months ended September 30, 2019 include foreign currency gains of $91 million and $67 million, respectively, on the net investment hedges from the &#x20ac;1.95 billion Euro-denominated notes and&#160;&#xa3;450 million British pound sterling-denominated notes and gains of $20 million and $9 million, respectively, on the net investment hedges from cross-currency swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and six months ended September 30, 2020 include net actuarial losses of $5 million and $2 million, respectively, and the three and six months ended September 30, 2019 include net actuarial gains of $1 million, which are attributable to redeemable noncontrolling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Pre-tax amount was reclassified into Cost of sales and Operating expenses in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into Income tax benefit (expense) in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and six months ended September 30, 2019 primarily reflects a reclassification of a pension settlement charge from Accumulated other comprehensive loss to Other income (expense), net in the Condensed Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy0wLTEtMS0wL3RleHRyZWdpb246OGE4ZDM3ZjgxZWY2NDYzZTkxMmY3Y2Q0NDIzMTI1Y2FfOTg_4bb60240-73c0-4ed2-be9b-e6519c7c715b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy0wLTEtMS0wL3RleHRyZWdpb246OGE4ZDM3ZjgxZWY2NDYzZTkxMmY3Y2Q0NDIzMTI1Y2FfMTA1_f068b934-139e-4f09-a1a3-76181f80ddf0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy0wLTEtMS0wL3RleHRyZWdpb246OGE4ZDM3ZjgxZWY2NDYzZTkxMmY3Y2Q0NDIzMTI1Y2FfMjc0ODc3OTA2OTU2Ng_defbe7ad-50cb-4e05-ab0e-2a603d320c51"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy0wLTEtMS0wL3RleHRyZWdpb246OGE4ZDM3ZjgxZWY2NDYzZTkxMmY3Y2Q0NDIzMTI1Y2FfMjc0ODc3OTA2OTU3Ng_d6c3a818-f2ad-4565-9aec-a94e01d9fff7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy0xLTEtMS0w_350359ab-8a53-4449-b247-cad5637a800f"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy0zLTEtMS0w_08a30231-652b-446b-8b95-fb7d69dd9d61"
      unitRef="usd">-114000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy01LTEtMS0w_d7356042-141b-49fe-84af-db7d279ed9ca"
      unitRef="usd">207000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMy03LTEtMS0w_89954f07-0bce-4eec-b4ae-ecd2a8ddf921"
      unitRef="usd">-44000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC0wLTEtMS0wL3RleHRyZWdpb246NDhlMWQ3ZjdhNzI3NDcxYTgwMmRjMWQ0ZWNlODRhNWVfNjg_985adacc-7054-4b6e-8ae1-8e42e6d4a1d4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC0wLTEtMS0wL3RleHRyZWdpb246NDhlMWQ3ZjdhNzI3NDcxYTgwMmRjMWQ0ZWNlODRhNWVfNzU_4c548d8d-8233-400f-b758-2f9cc207c8fb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC0wLTEtMS0wL3RleHRyZWdpb246NDhlMWQ3ZjdhNzI3NDcxYTgwMmRjMWQ0ZWNlODRhNWVfMjc0ODc3OTA2OTUyMg_833f37ff-6fcb-49d1-9692-75d0de1b1d01"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC0wLTEtMS0wL3RleHRyZWdpb246NDhlMWQ3ZjdhNzI3NDcxYTgwMmRjMWQ0ZWNlODRhNWVfMjc0ODc3OTA2OTU0Mg_1cc6ca69-59ab-4d6b-be44-565b0bdaf531"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC0xLTEtMS0w_164e06ea-e471-42d8-9dc9-e35f61fb03e7"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC0zLTEtMS0w_5d6fe8ec-b024-4894-8647-b09baf2249a4"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC01LTEtMS0w_36a7984a-4def-4cf7-9360-e5f7ecca0463"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNC03LTEtMS0w_ef5dbd28-e0ec-47a9-964a-00e36de2864d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNS0xLTEtMS0w_efd59982-e6d4-447d-af9b-22fbff6e0605"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNS0zLTEtMS0w_bc630bff-8047-4e20-8a1c-f677a2744513"
      unitRef="usd">-114000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNS01LTEtMS0w_83d37f47-21a3-4b24-8e4f-2bad0c82932f"
      unitRef="usd">207000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNS03LTEtMS0w_0c575038-ce23-4b11-b552-9bb14827138d"
      unitRef="usd">-44000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy0wLTEtMS0wL3RleHRyZWdpb246ZTA1OWU5OThjYWM3NGQ3YjhmNDNlMWQzNzc4Yjk3MjVfMTAw_96f5c01c-eab5-4871-992c-0fdf25ec9b0f"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy0wLTEtMS0wL3RleHRyZWdpb246ZTA1OWU5OThjYWM3NGQ3YjhmNDNlMWQzNzc4Yjk3MjVfMTA3_68831fe8-32db-418b-a1aa-ddcfe26e3e97"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy0wLTEtMS0wL3RleHRyZWdpb246ZTA1OWU5OThjYWM3NGQ3YjhmNDNlMWQzNzc4Yjk3MjVfMjc0ODc3OTA2OTU5OA_d3f318bc-c8f1-4517-937f-0c044b8faf21"
      unitRef="usd">47000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy0wLTEtMS0wL3RleHRyZWdpb246ZTA1OWU5OThjYWM3NGQ3YjhmNDNlMWQzNzc4Yjk3MjVfMjc0ODc3OTA2OTYwOA_b508fb63-6d5d-436a-8f08-45c7f5b00ba3"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy0xLTEtMS0w_52ea8c7a-4d1f-4e3e-97e6-1b2f7abfce81"
      unitRef="usd">-70000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy0zLTEtMS0w_f63429a7-5fcd-4fa4-80b6-7df679858d59"
      unitRef="usd">82000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy01LTEtMS0w_5bbd6c46-51b4-4d6e-bc41-1e18f815e717"
      unitRef="usd">-133000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfNy03LTEtMS0w_6289f0e1-75dc-412f-b791-260745d37f33"
      unitRef="usd">56000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC0wLTEtMS0wL3RleHRyZWdpb246MGIwOTQ2ODE3MWFlNGI3MzhiZDhkMWVmZWFmNmM2M2FfNjg_6b384e5d-d2cb-4a2a-ae87-8a38a6d1488e"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC0wLTEtMS0wL3RleHRyZWdpb246MGIwOTQ2ODE3MWFlNGI3MzhiZDhkMWVmZWFmNmM2M2FfNzU_c7355715-ec21-4292-970f-eb0fb9c38949"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC0wLTEtMS0wL3RleHRyZWdpb246MGIwOTQ2ODE3MWFlNGI3MzhiZDhkMWVmZWFmNmM2M2FfMjc0ODc3OTA2OTUyNA_3110d249-d061-44cc-b245-80a77417ab4f"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC0wLTEtMS0wL3RleHRyZWdpb246MGIwOTQ2ODE3MWFlNGI3MzhiZDhkMWVmZWFmNmM2M2FfMjc0ODc3OTA2OTUzNA_7aa1e55a-9363-44f0-8a84-2f77103cb9f6"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC0xLTEtMS0w_bff89b89-eb66-433b-9d41-8a87a8b9ce9f"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC0zLTEtMS0w_b8196c1e-39bc-4ce6-9e97-62983f3c6f90"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC01LTEtMS0w_50208069-d6eb-4b7b-94d1-9b0a160e5f6a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOC03LTEtMS0w_e4d35d20-f1e4-487d-b5ac-02bb1505bbdf"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOS0xLTEtMS0w_d042fc15-de99-423d-a6df-99bf4aa00220"
      unitRef="usd">-70000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOS0zLTEtMS0w_e2b2b02c-2223-41e0-85e0-91e4a50cbc58"
      unitRef="usd">82000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOS01LTEtMS0w_feef3f42-9289-4025-91b8-43bf15fe8bb7"
      unitRef="usd">-133000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfOS03LTEtMS0w_b934f94d-03a0-4fed-8783-b9987d753ddc"
      unitRef="usd">56000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjM5YTBmNGJmZDlkMDQxYTA4OTZkMWVlYzE2ZmMyNGQyXzEwMw_44394b2d-5fb8-4b24-9f6b-f112b7aa5c4b"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjM5YTBmNGJmZDlkMDQxYTA4OTZkMWVlYzE2ZmMyNGQyXzExMA_5afcb4f0-53a4-42a2-b173-9369ddec5def"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjM5YTBmNGJmZDlkMDQxYTA4OTZkMWVlYzE2ZmMyNGQyXzE2NDkyNjc0NDE3ODc_acfdfc3d-59ba-40d0-aa93-572e0c3ac3ef"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjM5YTBmNGJmZDlkMDQxYTA4OTZkMWVlYzE2ZmMyNGQyXzE2NDkyNjc0NDE3OTc_6d9b560f-8a69-4c74-8bcd-8fde62bb7785"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtMS0xLTEtMA_164d3497-23b1-4b35-a807-687aa7b610f0"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtMy0xLTEtMA_96e500f2-d3d0-4870-a2fd-bf8b6d56d8b1"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtNS0xLTEtMA_eb92376c-c569-4a47-9336-bd4c1a230562"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTEtNy0xLTEtMA_31ad2b57-ff4f-4049-b367-cdd726a236c1"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjA3YmRkMjZhZDRiZDRmMDVhMTc2ZjU0ZTA3NWQ0YmUxXzY4_d2edec0b-4cda-46fa-8e89-ff79eb1ec4eb"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjA3YmRkMjZhZDRiZDRmMDVhMTc2ZjU0ZTA3NWQ0YmUxXzc1_f1c6376e-7192-4e53-8f9f-79226888694c"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjA3YmRkMjZhZDRiZDRmMDVhMTc2ZjU0ZTA3NWQ0YmUxXzE2NDkyNjc0NDE3NDk_ae330c2a-5383-4347-9cb3-d1179472a323"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjA3YmRkMjZhZDRiZDRmMDVhMTc2ZjU0ZTA3NWQ0YmUxXzE2NDkyNjc0NDE3NjM_290d2e02-b858-4246-9448-d18bd426a824"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItMS0xLTEtMA_3a8853c4-fdc1-4808-b002-27f45bd80463"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItMy0xLTEtMA_3235fa55-b11c-4a2a-a761-f630cb0d8ab6"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItNS0xLTEtMA_edb9f7b0-67c5-4b52-9700-7951e08801a3"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTItNy0xLTEtMA_f3bcd4b1-0805-447a-9eb4-6e0ab1862541"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTMtMS0xLTEtMA_3b4000f3-8a2b-4599-892d-33d34322fc32"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTMtMy0xLTEtMA_277d6d16-a4f5-44aa-a215-3f451c3cb093"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTMtNS0xLTEtMA_f5b201de-27a6-43ca-b7e9-1fe8148f5c3d"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTMtNy0xLTEtMA_e4231525-84e8-435a-b444-637b289260e1"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjAyNzZkZTkxZTRmNzQxNTM4MjRkZTBjNTI5ZWQzYjQzXzEwMw_7e560865-8837-4620-9f12-c4a70c868546"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjAyNzZkZTkxZTRmNzQxNTM4MjRkZTBjNTI5ZWQzYjQzXzExMA_c9f98030-425e-4474-97c5-7410d669db47"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjAyNzZkZTkxZTRmNzQxNTM4MjRkZTBjNTI5ZWQzYjQzXzE2NDkyNjc0NDE4MDk_1e8bd678-f44c-445e-aa99-dbca5d08d4d8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjAyNzZkZTkxZTRmNzQxNTM4MjRkZTBjNTI5ZWQzYjQzXzE2NDkyNjc0NDE4MTk_f0dfcfe9-0bbe-4796-9524-b041e5817850"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iade843f75deb448186e6e38895fb48b7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtMS0xLTEtMA_fc9f1774-7262-4d7a-825d-58d87170e7a6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i15202989514f4acf8e987ae99a0216ba_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtMy0xLTEtMA_d794be5a-5672-4843-8f56-df5206167fbd"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3646d4cbd2ad43c3b6da83e852552ca4_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtNS0xLTEtMA_47756b02-7ecc-4dd9-aac3-4d98b507bd37"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1cfff32ee6a14e168c5922d492015d9b_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTUtNy0xLTEtMA_d7c27f16-f53d-41a7-a5af-89e02faa26fc"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODIwNDgxNGNlMTRhOTJhMWNhMWI0YjQ1YjQ4ZTAxXzExMg_02353ca5-1c76-47e0-a843-6491176c7e4a"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODIwNDgxNGNlMTRhOTJhMWNhMWI0YjQ1YjQ4ZTAxXzExOQ_a9da9214-fbbd-4956-a351-dff9a4739d1b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODIwNDgxNGNlMTRhOTJhMWNhMWI0YjQ1YjQ4ZTAxXzE2NDkyNjc0NDE4MDA_5df7d99e-d8e4-42e4-9764-c56ee7c197f9"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODIwNDgxNGNlMTRhOTJhMWNhMWI0YjQ1YjQ4ZTAxXzE2NDkyNjc0NDE4MTA_7b4a92a7-eebf-4d30-9a50-7bac2ebe0a42"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4dfcb285fb6b4a5c8cbbe9bd79f0a497_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtMS0xLTEtMA_5740fc68-91cf-40eb-9d3b-d8e43ea29c58"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i93126ac576fd4ee59dbe2a22e4b7078f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtMy0xLTEtMA_0d285c7e-8993-4b99-86af-618887bb72dc"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i24e52575e1654c46a8f81e254c90ab96_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtNS0xLTEtMA_2dd14e2a-295a-492e-99f4-ab662ef64361"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i94c06ecc9cc7491180bd8fb5bd26438d_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTYtNy0xLTEtMA_17d5c675-2970-4193-af63-dc9dd7d42135"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjRmMGJkM2E4YzJhYTRiYzRhOTc4NDVlMWM3YTg3NGEzXzg2_fb146b74-dd36-4022-84fc-14eeb22cf252"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjRmMGJkM2E4YzJhYTRiYzRhOTc4NDVlMWM3YTg3NGEzXzkz_44f45569-45d2-41ab-a65c-1b64f597b6b4"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjRmMGJkM2E4YzJhYTRiYzRhOTc4NDVlMWM3YTg3NGEzXzE2NDkyNjc0NDE3NzA_30cfa976-8fe0-4c9d-a681-6e583770f243"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjRmMGJkM2E4YzJhYTRiYzRhOTc4NDVlMWM3YTg3NGEzXzE2NDkyNjc0NDE3ODA_d05aea18-fa29-4e8e-a53d-92dd51911e5d"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i081813b992464ea9ad8920cab184e999_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctMS0xLTEtMA_2dcc3b78-b3e3-44d5-9cc4-b05289bf2815"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2801f5e86df94d55bd75e10e15bf4d5b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctMy0xLTEtMA_34e23ad2-eb48-46a5-b94d-e944af34c827"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0d3a810191074649bfd35939eee1cfc4_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctNS0xLTEtMA_b98729bf-5885-44e5-b76c-be7628f4e1ab"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1b41db262baa42ac85b207a7a3c6851b_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTctNy0xLTEtMA_6c7374a5-aaa0-4f6a-a4dc-c17badfcf78b"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ie7ed596faccb4197854f21d92b8137b6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjhlODM0N2QyYTVhNjQxZTdhODhmZDZkYTBlZGIwMDZlXzY4_c8e1b37e-9a88-451c-8d00-1d80e45fed69"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i364845bbc169420e8195d9305f9f4c1a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjhlODM0N2QyYTVhNjQxZTdhODhmZDZkYTBlZGIwMDZlXzc1_56abb99b-0855-4e53-b109-0059d39ef330"
      unitRef="usd">27000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i9bd48cde79e84ac4a46f6744e674f4ab_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjhlODM0N2QyYTVhNjQxZTdhODhmZDZkYTBlZGIwMDZlXzE2NDkyNjc0NDE3NTY_26bdcce7-02b6-4d0c-9d2a-e1186aaa0b06"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i8de456c9de55433dac6af26e743f73cd_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjhlODM0N2QyYTVhNjQxZTdhODhmZDZkYTBlZGIwMDZlXzE2NDkyNjc0NDE3NjY_ba686e32-f38c-4d49-92f2-b3add74ab19e"
      unitRef="usd">32000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie7ed596faccb4197854f21d92b8137b6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtMS0xLTEtMA_feae9850-6928-4159-a275-1a66f28b8f45"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i364845bbc169420e8195d9305f9f4c1a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtMy0xLTEtMA_4f082bcf-f9e9-4a84-81ff-d839c848d081"
      unitRef="usd">-78000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9bd48cde79e84ac4a46f6744e674f4ab_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtNS0xLTEtMA_870b17d6-c216-44d7-8f3d-bd1af26d93d6"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8de456c9de55433dac6af26e743f73cd_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTgtNy0xLTEtMA_59bf94e4-97f2-424e-afa1-47b82a4c3971"
      unitRef="usd">-90000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie7ed596faccb4197854f21d92b8137b6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTktMS0xLTEtMA_78195e8d-12c4-441f-b756-9324beb51ac1"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i364845bbc169420e8195d9305f9f4c1a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTktMy0xLTEtMA_8850c9b0-b875-4fb9-9722-bc1240094751"
      unitRef="usd">75000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9bd48cde79e84ac4a46f6744e674f4ab_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTktNS0xLTEtMA_e31ad071-6102-4677-9eda-0db671539527"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8de456c9de55433dac6af26e743f73cd_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMTktNy0xLTEtMA_30a3f033-cfa2-4066-b548-0a69c008a2b3"
      unitRef="usd">96000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMjEtMS0xLTEtMA_770f7a80-c83d-4471-b970-d0f04f68d9f5"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMjEtMy0xLTEtMA_8d6922ed-ba40-4262-91c8-29446b888a58"
      unitRef="usd">56000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMjEtNS0xLTEtMA_e5134b6a-e6a4-40f5-b65d-b5aad8619c68"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjkzYjM5ZTljOGUwOTRkMmZiMGQ1YWE2ZmY2MmZjMTE3L3RhYmxlcmFuZ2U6OTNiMzllOWM4ZTA5NGQyZmIwZDVhYTZmZjYyZmMxMTdfMjEtNy0xLTEtMA_60b34af4-d131-4bbe-906e-7b785bc737fa"
      unitRef="usd">133000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest
      contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjI2MA_77c69acb-3568-41ab-aa93-21a90112912f"
      unitRef="usd">-119000000</mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest>
    <mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest
      contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NTg0MQ_273322e0-9f03-4aa4-93c3-3459e0be934e"
      unitRef="usd">-61000000</mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest>
    <mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest
      contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjM0MA_bb1bab95-8f97-4a96-8281-15bfe99c5827"
      unitRef="usd">-19000000</mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest>
    <mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest
      contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NTk1NA_a254a7ed-39a8-46c8-980b-a64641f47df1"
      unitRef="usd">-13000000</mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i28545f9d3bda45efaa5277b002e22e7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjQ1NA_8764417e-89bf-4c2a-9b7b-cee5ae445ecb"
      unitRef="usd">-83000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i11351bf2991743d7af90b551540fc919_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NjA0OA_72802e29-e007-4dbb-980c-133ea7d1bb46"
      unitRef="usd">-117000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:LongTermDebt
      contextRef="idf0d0beda4f94c1c95f3735c727aaa99_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjQ5NQ_b28ef460-d179-402c-9270-f4e5d5fb3b11"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iefe68917b64346948a4da9e249ab34f7_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjQ5NQ_f3d39168-88fd-4ac5-b471-b30e546ad3ca"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i71ac51620ddf48c0a43eb177d2b8787c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjUyNQ_59376cd6-6cc9-4be3-8141-2f51d6a9d636"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i845cf95a4c8a421fafec2976a240ff82_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjU4Mw_0ce2d3c3-dc3c-43e4-ad52-90ec2878aff4"
      unitRef="usd">-12000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i8df2eff3ed674556a1b6d76ac1e2fc2b_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NjA4Ng_8b2b098f-fa67-4ff2-bec6-48f548b76d19"
      unitRef="usd">-63000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTA0NDUzNjA0NzczMjY_4ee391cc-d0da-4bf9-939f-79db68deda32"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTA0NDUzNjA0NzczMjY_cce21275-4660-456d-b597-5377558c48a0"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib49781b522ea4f76b1513c0e998abcab_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjcwMA_5ce177cf-8b18-45a0-a6b1-807d5faf126a"
      unitRef="usd">91000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="if8234a3e5eda4043b4d3fa3510856378_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NjE2Ng_3e6016e9-093e-4183-96f5-df8709014d17"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:LongTermDebt
      contextRef="i8566f25837414d39ba7f2dfa91ef0a42_I20190930"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjc0MQ_8647347d-3bcf-40f2-b05b-ed15a689a82b"
      unitRef="eur">1950000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i88ca01400a5e4f17a31f7e6a13628bec_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjc3MQ_1e5d6f94-4134-4a0d-8a95-9a298c3de7db"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="ib993ed38bcaa44e992d425b235b667ba_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjgyOQ_c5c17e67-e157-4cc2-84ac-b87284cb00f1"
      unitRef="usd">20000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="icdb08454a4384d82896df1a6d61f11f9_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NjE4NQ_4b967f25-633f-4f5f-aee6-88497c24fc5f"
      unitRef="usd">9000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjk1MA_2c0706a7-1267-4ee6-aa59-c1a249914d38"
      unitRef="usd">-5000000</mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax>
    <mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0NjMxMg_3eb0c108-9b37-4af3-8afc-cb24c884eaa0"
      unitRef="usd">-2000000</mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax>
    <mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjk1Nw_1eaa7f53-e6af-4c6f-a2f9-ea6bb4c33dae"
      unitRef="usd">1000000</mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax>
    <mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMjk1Nw_415b1eac-7541-4b37-a1c7-c7b0176e1bf8"
      unitRef="usd">1000000</mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RleHRyZWdpb246ZTY1MjRmMmU5NGEyNDNkNmIxZGNkYTA1N2I4Yjc0NWZfMTY0OTI2NzQ0MjE5ODM_cc1bfb65-a0ec-4d87-9f18-c403a51ba7a7">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss) by component for the three and six months ended September 30, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss) by component for the three and six months ended September 30, 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i08d04048582a441a9829e7d02b02b64f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMi0xLTEtMS0w_c8c477bd-5f5a-4dbc-b67b-5da030637ff3"
      unitRef="usd">-1742000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iafe0cb7d5ecb4f14bdcf107625ab76a4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMi0zLTEtMS0w_53ed527c-f3e7-4773-baea-1cef6602c61f"
      unitRef="usd">75000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic3642cd678a64ba1b231726d09a37604_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMi01LTEtMS0w_ec9ed395-f706-4716-825f-80f88760c372"
      unitRef="usd">44000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id4cc9f5f8d11498da1ed9306dc8d7f7f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMi03LTEtMS0w_9c3f6ea8-91dd-47bb-ae13-af671b8308e0"
      unitRef="usd">-112000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib14ebdd9a67d42c6bff9fab1cd0291e3_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMi05LTEtMS0w_b9531010-63ed-4410-977c-6833e5e9dce0"
      unitRef="usd">-1735000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMy0xLTEtMS0w_33e08c6c-6e1d-4e36-885f-733f9f38f32f"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMy0zLTEtMS0w_0d63dd08-871b-44e1-9862-30ee1bda4f31"
      unitRef="usd">-70000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMy01LTEtMS0w_ab7197b8-eace-4551-baf4-f79872d91e02"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie2530e99848e4b36ba92e924f579d9df_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMy03LTEtMS0w_665f69d3-a2ef-42c8-a7b4-6f1db66406f5"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfMy05LTEtMS0w_3ab3bd88-04ce-4af4-99c9-793c6380eb23"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNC0xLTEtMS0w_887a8444-5035-4719-8cd7-86e16a512424"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNC0zLTEtMS0w_18f23f1d-3a94-4e6e-b070-ec43f6ef6d4a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNC01LTEtMS0w_cc59b1e6-3e15-4801-94d7-babe370f33cc"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie2530e99848e4b36ba92e924f579d9df_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNC03LTEtMS0w_1b5fa0b4-a9cc-41fd-8f33-954c483acb18"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNC05LTEtMS0w_cbb4eb6a-aaa7-458a-adb9-ae641dc5e775"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNS0xLTEtMS0w_06c62631-af5d-4b17-bee6-5e46eb4b02c2"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNS0zLTEtMS0w_d99f7e18-0a91-4dcd-a7eb-d8b320532ec5"
      unitRef="usd">-70000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNS01LTEtMS0w_bf0a899c-ef2b-48d1-813d-a6dd0a33eb2e"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie2530e99848e4b36ba92e924f579d9df_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNS03LTEtMS0w_5a7d9727-fd9c-4396-b21f-51d882108f29"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNS05LTEtMS0w_957cbac4-ff1b-4288-80b2-26d459749cc3"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNi0xLTEtMS0w_829cd636-c2fe-492d-bc64-2d6140c1064a"
      unitRef="usd">-119000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNi0zLTEtMS0w_5b46123a-2d55-4e15-9c68-ee6536b5d3f4"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNi01LTEtMS0w_19cde402-5e02-4274-9ef2-0d5beb2d4acc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie2530e99848e4b36ba92e924f579d9df_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNi03LTEtMS0w_93c27987-02cb-4c59-9dd2-2540bb8159b3"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNi05LTEtMS0w_fb4c69d6-91c0-4722-b64b-e892640fcc73"
      unitRef="usd">-125000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic3801a94ee254dec8814967fb501debd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNy0xLTEtMS0w_415262ec-af5a-4cfc-bc5d-e4de4842448d"
      unitRef="usd">230000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7adc6962b85b4a53989b178fd04df4f3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNy0zLTEtMS0w_615745c1-8710-458e-96d3-59ac1cdee763"
      unitRef="usd">-69000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4f87b4e7ce0844a981112ac8cdd03eb5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNy01LTEtMS0w_03765481-f5b7-4142-9ac2-4793abf31541"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie2530e99848e4b36ba92e924f579d9df_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNy03LTEtMS0w_8ea1fd73-29d8-4575-a3de-643a54fd8694"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfNy05LTEtMS0w_b5f5f347-480d-48e6-9020-75f78ec3ca5b"
      unitRef="usd">138000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i785fd2b4e9024f8ea22b4baf93fe610a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfOC0xLTEtMS0w_f65b53f2-3c5c-4e4b-b4bb-4f3337a98b4e"
      unitRef="usd">-1512000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c6aa5965ffb4e8b8ddd05a70b872808_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfOC0zLTEtMS0w_4f4546f4-0a8a-4f19-94f3-494c6b80af9e"
      unitRef="usd">6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if6a19d8b0fe745be9ff1c9a795dfd0bb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfOC01LTEtMS0w_7520cffb-e115-4d27-a931-cd3b1daca214"
      unitRef="usd">25000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64d90c4a197c4d62b7688640c6c181c2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfOC03LTEtMS0w_53e87fdc-33b3-4950-83f2-918b5f899f92"
      unitRef="usd">-116000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id56ecd8e059f4e6696b7b1cc7c7988e4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjA5OGM5ZjA0YjUyNzQ0ODU4OGI3MzY4ZjFlMjY4MjA1L3RhYmxlcmFuZ2U6MDk4YzlmMDRiNTI3NDQ4NTg4YjczNjhmMWUyNjgyMDVfOC05LTEtMS0w_75cc56f4-0bbd-4ec9-aff5-e2ded235ea64"
      unitRef="usd">-1597000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i584b4e2274074d37aba8cd24589cb580_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMi0xLTEtMS0xODQ2_65e9d95f-21b9-4e2e-935b-6da29f641f84"
      unitRef="usd">-1780000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i666e4b283dc645e7900ef3d3a1d91aac_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMi0zLTEtMS0xODQ2_0e7a571f-9d8c-4cfb-bdd3-81f125a33022"
      unitRef="usd">138000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i560a87a2893946699ede55eeca7bfd22_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMi01LTEtMS0xODQ2_a8046207-2c93-418f-9ec4-2244ad1f4256"
      unitRef="usd">49000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4ea0dc529a904ec9a931482f59d28dd8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMi03LTEtMS0xODQ2_f2160d10-35d2-4a25-8cf9-7bc56de520f8"
      unitRef="usd">-110000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c61eeba8b38459f985453da0e8c781d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMi05LTEtMS0xODQ2_65679ff3-7f9e-49e9-bf31-170c4051d40e"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMy0xLTEtMS0xODU3_8649bf30-2226-40d8-9b79-aa8f36930b17"
      unitRef="usd">207000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMy0zLTEtMS0xODU3_eebef5e5-3fe5-46bd-889f-a4bbed79e5a4"
      unitRef="usd">-133000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMy01LTEtMS0xODU3_3f6937c1-0c27-4be3-8a85-5a2bd363e4c7"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia0604a8575de4a9396ed7d28ed0294c7_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMy03LTEtMS0xODU3_789e24b4-66f2-4104-9aad-742e7b4145fc"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfMy05LTEtMS0xODU3_9a85f9c6-a21c-46fd-babe-3a7473e62e67"
      unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNC0xLTEtMS0xODQ2_f4c57f15-1d0b-444c-a9c7-28aff7537d34"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNC0zLTEtMS0xODQ2_58a3a392-176e-49e5-ad47-4d9cc64a9a6e"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNC01LTEtMS0xODQ2_c14da902-9810-49db-b8ee-4494a7aad297"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia0604a8575de4a9396ed7d28ed0294c7_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNC03LTEtMS0xODQ2_cb6f3eee-8952-4236-b441-2315c1e9720c"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNC05LTEtMS0xODQ2_022b69f7-c618-489b-a81f-dfd501ab7a89"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNS0xLTEtMS0xODQ2_140bd34d-7d82-44a4-9548-0f07299141b7"
      unitRef="usd">207000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNS0zLTEtMS0xODQ2_264143cc-371d-477c-bf2a-545c265b2497"
      unitRef="usd">-133000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNS01LTEtMS0xODQ2_5713cf4d-6084-4137-a89c-7b201d47a07d"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia0604a8575de4a9396ed7d28ed0294c7_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNS03LTEtMS0xODQ2_83ec7fa8-723a-471d-82ca-b6af53350543"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNS05LTEtMS0xODQ2_d30273c6-8733-4f5d-8ace-6e42810b053f"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNi0xLTEtMS0xODQ2_7f1293d5-48c4-4d1e-bc86-e77959a4aa99"
      unitRef="usd">-61000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNi0zLTEtMS0xODQ2_0637410d-4a04-4260-9bd5-34594ce6d56f"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNi01LTEtMS0xODQ2_5ad9e91f-3517-4ace-b28a-6c100527dc43"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ia0604a8575de4a9396ed7d28ed0294c7_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNi03LTEtMS0xODQ2_d05daf01-29d9-422c-8bb1-048059d6575c"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNi05LTEtMS0xODQ2_5aa9bf02-2924-457c-b70a-bcd0e33a85cd"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4207da73513f4ab7bbcd5f8728aef662_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNy0xLTEtMS0xODQ2_abac7c49-19f1-4fa2-b9e4-376497f8f7fa"
      unitRef="usd">268000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie03e547b25a54cde8ba60937df16c382_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNy0zLTEtMS0xODQ2_ddd4a147-7a4e-42c0-bfb6-3b73ce676ee4"
      unitRef="usd">-132000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ica5a9e84d23b42428c0595e6f0d8132e_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNy01LTEtMS0xODQ2_3a3c2dd0-df86-42d7-b50b-86e0265f106a"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia0604a8575de4a9396ed7d28ed0294c7_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNy03LTEtMS0xODQ2_e592cad6-53d0-484c-8d65-d5ec4cfbba0b"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfNy05LTEtMS0xODQ2_a8198364-262a-4f96-8496-0c7d491da6e6"
      unitRef="usd">106000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i785fd2b4e9024f8ea22b4baf93fe610a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfOC0xLTEtMS0xODQ2_d04c3b87-0a40-48ea-bb4b-3f42a346e2c3"
      unitRef="usd">-1512000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c6aa5965ffb4e8b8ddd05a70b872808_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfOC0zLTEtMS0xODQ2_ba95b1d3-6f51-4743-8355-cb4665fa4e19"
      unitRef="usd">6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if6a19d8b0fe745be9ff1c9a795dfd0bb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfOC01LTEtMS0xODQ2_40e4acdb-fd8e-45e4-93d2-b6e3202bf506"
      unitRef="usd">25000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64d90c4a197c4d62b7688640c6c181c2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfOC03LTEtMS0xODQ2_d296670b-5bbb-47bf-8917-c39cc05727cd"
      unitRef="usd">-116000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id56ecd8e059f4e6696b7b1cc7c7988e4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOmQ5MDZiNDFmNTEyZDQ1MDM5M2I0NjY3MThmZmFmYWUwL3RhYmxlcmFuZ2U6ZDkwNmI0MWY1MTJkNDUwMzkzYjQ2NjcxOGZmYWZhZTBfOC05LTEtMS0xODQ2_2ab69630-1655-46b6-8f8f-a7145c6bf701"
      unitRef="usd">-1597000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i152a0a34c50a4f5b95780eafe02e0ea9_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMi0xLTEtMS0w_7ff6a93a-33d2-404f-bbe4-f05406d1e2cd"
      unitRef="usd">-1564000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3de1a24b580146c49c37a4942dd6c16c_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMi0zLTEtMS0w_db8f76ed-f55f-4bd7-9bec-6f2969825d30"
      unitRef="usd">27000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id36e3e6db92b4ddd84ae2a9af1d43fd3_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMi01LTEtMS0w_ba530e5c-4806-4156-8218-cae609cb8793"
      unitRef="usd">-25000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4bdc606394464f49b8531ade9f76854b_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMi03LTEtMS0w_04353e3f-f292-42fe-a8e5-5b6dc89ea7fe"
      unitRef="usd">-216000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i527d69e72eba46ae8d65ce3a0001cecc_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMi05LTEtMS0w_0dac3002-cb0f-4d5a-9a87-62036a137e4e"
      unitRef="usd">-1778000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMy0xLTEtMS0w_99e677d1-2a12-4079-a7bc-f753e65c84a7"
      unitRef="usd">-114000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMy0zLTEtMS0w_0e0629d1-ef00-44e6-84e3-9ca278519c3d"
      unitRef="usd">82000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMy01LTEtMS0w_8fc28eb4-930b-4110-a074-cfbc2017b7db"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4a725751bc8343cdbc4cd04f87ce1ad6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMy03LTEtMS0w_8fe63962-db48-4a68-a7d2-21b99262a7f0"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfMy05LTEtMS0w_6dcfc84f-680c-4d8e-a714-1e8a6181cc88"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNC0xLTEtMS0w_31393217-9765-4a12-a9b9-6c797efe3ea6"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNC0zLTEtMS0w_4337f5ca-94d4-42e7-af67-d5dacf9a5333"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNC01LTEtMS0w_073a84dd-13f9-455f-904c-b46e2747b679"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4a725751bc8343cdbc4cd04f87ce1ad6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNC03LTEtMS0w_4c7e3750-102b-4e52-94ff-5a17db78b16f"
      unitRef="usd">-79000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNC05LTEtMS0w_7349f8fe-c29c-4866-b833-b630416884a9"
      unitRef="usd">-79000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNS0xLTEtMS0w_24abcfaa-2a27-434f-9bb7-a3d00e8c15c3"
      unitRef="usd">-114000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNS0zLTEtMS0w_328d438f-28e4-45cb-bd91-c0718cb73d59"
      unitRef="usd">82000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNS01LTEtMS0w_760c9f96-3e99-4999-8e37-7dc446a1e3dc"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4a725751bc8343cdbc4cd04f87ce1ad6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNS03LTEtMS0w_e3afeceb-55ff-472c-bf5b-ae0b5dc08632"
      unitRef="usd">75000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNS05LTEtMS0w_3bd6fc97-2344-48fa-a018-ed3ae35aa7d9"
      unitRef="usd">56000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNi0xLTEtMS0w_00742fcb-5178-445a-aacd-ac6e2357c2ec"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNi0zLTEtMS0w_c4ddfe3d-1c2c-4855-8a0e-4d2f17571210"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNi01LTEtMS0w_aefac24b-080a-4ffd-b134-c39f27e2ac43"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i4a725751bc8343cdbc4cd04f87ce1ad6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNi03LTEtMS0w_463144ec-e760-4988-8d52-4f21fc6a4302"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNi05LTEtMS0w_7f09240b-e979-4c5b-84b0-e99214d6b9a6"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1af87d288bf042caacbb0ca56e430bab_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNy0xLTEtMS0w_1383af74-6fdc-451e-92f7-e5cbc6a5d1e4"
      unitRef="usd">-95000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9452554038444fb391b19a1d6b9dea81_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNy0zLTEtMS0w_13280d11-a0dc-43c3-80bb-f5435d28bb82"
      unitRef="usd">82000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i89beb5496a6049e1863bf7dc292b04e2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNy01LTEtMS0w_fe663b9c-3d64-4b12-828d-ee1d2e59c01b"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4a725751bc8343cdbc4cd04f87ce1ad6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNy03LTEtMS0w_e7007f66-49a9-4594-90fe-585e195876fd"
      unitRef="usd">74000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfNy05LTEtMS0w_e853feab-6445-4d8e-aeb4-59fa49642f90"
      unitRef="usd">74000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i14767a5727ac4417a8c16be22209e0bf_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfOC0xLTEtMS0w_431aa850-1233-4b32-9d6c-fb8417efea96"
      unitRef="usd">-1659000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib0aa1d9903934d4bb44c6053ee11ca01_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfOC0zLTEtMS0w_a596bf48-1c6b-48d5-be4e-bd75e8bb979d"
      unitRef="usd">109000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5f028c579ca84ba1a3fdffbd5ad2731a_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfOC01LTEtMS0w_11258a7e-1a9f-4aba-8f35-19e400fe4d78"
      unitRef="usd">-12000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4471500f1af84287bc5e2719e750de11_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfOC03LTEtMS0w_f9959b95-a9c5-4870-bcb0-fbe241691fea"
      unitRef="usd">-142000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1d225eb50904ac7afd16a3e52e96014_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjc2NjhkN2QwMWIyMTQyNDI5NGNlZGJiMDkxYWQwMTgzL3RhYmxlcmFuZ2U6NzY2OGQ3ZDAxYjIxNDI0Mjk0Y2VkYmIwOTFhZDAxODNfOC05LTEtMS0w_d7bcca02-40da-491b-9976-4236c00e8e49"
      unitRef="usd">-1704000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64bc67d401ba41cd98cdc8120660d0ca_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMi0xLTEtMS0xODg1_7b565862-4a38-4b37-ae84-9b1fc4ea0e86"
      unitRef="usd">-1628000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f4759dae41f41e98b79f41976fa69ca_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMi0zLTEtMS0xODg1_2d2debd4-ba33-4984-8055-4fcc2890f510"
      unitRef="usd">53000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8e7e3d6a2fc24aba8fe36b60b9a70d8e_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMi01LTEtMS0xODg1_551e294f-3177-4ca2-89f4-994a6abcc5e2"
      unitRef="usd">-37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i10878ad786c14616809f16456682cb91_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMi03LTEtMS0xODg1_2b800e20-0d7d-4b82-b999-c2c7ccf9abca"
      unitRef="usd">-237000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0532330a51214e249b3b9e2fbc5ebee3_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMi05LTEtMS0xODg1_0025e7a6-00e9-4eba-82ac-437f96453f30"
      unitRef="usd">-1849000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMy0xLTEtMS0xODg5_0a85291e-cab8-46ea-85ea-e72db12e6976"
      unitRef="usd">-44000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMy0zLTEtMS0xODg5_c1b71818-3dca-492b-9f8f-28dc66fde603"
      unitRef="usd">56000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMy01LTEtMS0xODg5_edd0e3a8-8429-4bf8-a392-05f2f9eded02"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i47b46bdea51b4a518badab77507f0e56_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMy03LTEtMS0xODg5_c61802e5-5c0f-444d-af64-646f26dfe206"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfMy05LTEtMS0xODg5_e018cab1-b9b6-4386-9cda-f91c23cb430a"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNC0xLTEtMS0xODg5_dff5eb0c-de01-4d89-8c80-618a37554f28"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNC0zLTEtMS0xODg5_f66810e4-52f6-4ee0-b483-c5b93f156a85"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNC01LTEtMS0xODg5_c090f8c7-4784-4fca-b2d2-ec5cb1b56713"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i47b46bdea51b4a518badab77507f0e56_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNC03LTEtMS0xODg5_546ce3eb-f8e6-4ba5-9873-9f649e149643"
      unitRef="usd">-92000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNC05LTEtMS0xODg5_f9f63e4a-5614-46f2-b040-cb95c95be07e"
      unitRef="usd">-92000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNS0xLTEtMS0xODg5_862c168a-2677-4677-8f25-a301fbde3bfd"
      unitRef="usd">-44000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNS0zLTEtMS0xODg5_e77b4ef7-54c6-47fb-85bc-92d0543ce043"
      unitRef="usd">56000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNS01LTEtMS0xODg5_8b0226f0-bb8c-4dc8-96ef-56707f0edfc9"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i47b46bdea51b4a518badab77507f0e56_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNS03LTEtMS0xODg5_d0a0d8f6-8761-46e2-8055-f216c7f5ce47"
      unitRef="usd">96000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNS05LTEtMS0xODg5_f5d39b5d-1062-4150-bbf3-fba8164bfacd"
      unitRef="usd">133000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNi0xLTEtMS0xODkz_9b67639f-6938-4b30-8cdb-f47c2f851ed2"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNi0zLTEtMS0xODkz_d37bc01b-fe80-472a-be37-05e079cd4792"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNi01LTEtMS0xODkz_7bffc449-f786-4af8-baea-2be3a9b31566"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i47b46bdea51b4a518badab77507f0e56_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNi03LTEtMS0xODkz_a9748e58-6c9a-4734-88cc-4ba2c13479fa"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNi05LTEtMS0xODkz_f5a4ed70-c9c6-4c55-84c1-a1148d3c507d"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i117e252ad25d491e9797bbc74a687bb0_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNy0xLTEtMS0xODkz_c8d53613-7dce-4a9c-b7c6-127e31e9d578"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9402da87a7c5406081c7233223d81d2a_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNy0zLTEtMS0xODkz_436368ff-1b9f-49c3-93dc-28327fd85baf"
      unitRef="usd">56000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic928736b0c3140feb56d85d7dfc83761_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNy01LTEtMS0xODkz_ac8de551-1960-4531-9dd1-d5b9fa18e4d5"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i47b46bdea51b4a518badab77507f0e56_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNy03LTEtMS0xODkz_71fc91fe-2d48-4fcb-8384-e04739c849e8"
      unitRef="usd">95000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfNy05LTEtMS0xODkz_b932dbb3-a284-4579-b841-4b000efcd11a"
      unitRef="usd">145000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i14767a5727ac4417a8c16be22209e0bf_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfOC0xLTEtMS0xODkz_58daa8bb-b886-4a26-9acd-1ce20ead16b8"
      unitRef="usd">-1659000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib0aa1d9903934d4bb44c6053ee11ca01_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfOC0zLTEtMS0xODkz_f619eaaa-cb17-4c91-9579-2a04c14990a4"
      unitRef="usd">109000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5f028c579ca84ba1a3fdffbd5ad2731a_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfOC01LTEtMS0xODkz_35352f9c-a2e4-453b-8200-ddcd2554851e"
      unitRef="usd">-12000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4471500f1af84287bc5e2719e750de11_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfOC03LTEtMS0xODkz_7a57c84a-71ba-4d96-a1c5-33423168c5ff"
      unitRef="usd">-142000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1d225eb50904ac7afd16a3e52e96014_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85NC9mcmFnOmU2NTI0ZjJlOTRhMjQzZDZiMWRjZGEwNTdiOGI3NDVmL3RhYmxlOjZjOWMyNGEyNDJmYzRiZmViMWZkNjg2MWY1YjI4MjcxL3RhYmxlcmFuZ2U6NmM5YzI0YTI0MmZjNGJmZWIxZmQ2ODYxZjViMjgyNzFfOC05LTEtMS0xODkz_c079d110-628e-4822-84a7-8ba754fcb759"
      unitRef="usd">-1704000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTU5NDI5MTg2NjEyNjY_70b160de-9c70-4585-ba4a-3acf61050c60">Segments of Business&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commencing in the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. Other, for retrospective periods presented, consists of the Company&#x2019;s equity method investment in Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020. All prior segment information has been recast to reflect the Company&#x2019;s new segment structure and current period presentation. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The International segment includes the Company&#x2019;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#x2019;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 13 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#x2019;s Canada operations deliver vital medicines, supplies, and information technology services throughout Canada and includes Rexall Health retail pharmacies. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 275,000 national brand medical-surgical products as well as McKesson&#x2019;s own line of products through a network of distribution centers within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RxTS segment brings together existing businesses, including CoverMyMeds, RelayHealth, RxCrossroads, and High Volume Solutions, to serve the Company&#x2019;s biopharma and life sciences partners and patients, connecting pharmacies, providers, payers, and biopharma. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and High Volume Solutions were previously included in Other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other, for retrospective periods presented consists of the Company&#x2019;s investment in the Change Healthcare JV, which was split-off from the Company in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(970)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 6% of the International segment&#x2019;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and approximately 40% of the RxTS segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#x2019;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#x2019;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for the three and six months ended September 30, 2020 includes $52 million and $104 million, respectively, and for the three and six months ended September 30, 2019 includes $33 million and $48 million, respectively, of pre-tax credits related to the last-in, first-out (&#x201c;LIFO&#x201d;) method of accounting for inventories. The three and six months ended September 30, 2020 also includes a charge of $50 million recorded in connection with the Company&#x2019;s estimated liability under the State of New York&#x2019;s Opioid Stewardship Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss for the three and six months ended September 30, 2020 includes restructuring, impairment, and related charges of $35&#160;million and $58&#160;million, respectively, primarily associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 4, &#x201c;Restructuring, Impairment, and Related Charges,&#x201d; and a goodwill impairment charge of $69 million (pre-tax and after-tax) related to one of the Company&#x2019;s reporting units in Europe, as discussed in more detail in Financial Note 8, &#x201c;Goodwill and Intangible Assets, Net.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Operating loss for Other for the three and six months ended September 30, 2019 includes a pre-tax impairment charge of $1.2 billion and a pre-tax dilution loss of $246 million associated with the Company&#x2019;s investment in Change Healthcare JV. Operating loss for Other also includes the Company&#x2019;s proportionate share of loss from Change Healthcare JV of $51 million and $47 million for the three and six months ended September 30, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net for the six months ended September 30, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program. Corporate expenses, net, for the three and six months ended September 30, 2020 include net gains of $49 million and $59 million, respectively, associated with certain of the Company&#x2019;s equity investments and, for the three and six months ended September 30, 2019, include settlement charges of $105 million and $122 million, respectively, from the termination of the Company&#x2019;s defined benefit pension plan and a settlement charge of $82 million related to opioid claims. The three and six months ended September 30, 2020 includes $41 million and $84 million, respectively, and the three and six months ended September 30, 2019 includes $36 million and $72 million, respectively, of pre-tax charges opioid-related costs, primarily litigation expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTY0OTI2NzQ2NTA3MQ_95f1a299-f360-4a6c-9603-c86ef724affd"
      unitRef="numberofsegments">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="ifd8554d6b3ce4907859a8adc5bfd5199_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTY0OTI2NzQ2NTAzOQ_3c4bf9ce-49fc-4c53-b4cc-0161b6d2d077"
      unitRef="country">13</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <mck:NumberOfNationalBrandMedicalSurgicalProducts
      contextRef="i6cc04539515847199daba415d910a6b7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTY0OTI2NzQ0NjIyMjc_3a2576f0-726d-409e-9084-b9bbe0a81968"
      unitRef="numberofproducts">275000</mck:NumberOfNationalBrandMedicalSurgicalProducts>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfNDMyNQ_34ba05cf-c275-4ab4-ab0e-d00b7570e4b1">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(970)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 6% of the International segment&#x2019;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and approximately 40% of the RxTS segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#x2019;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#x2019;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for the three and six months ended September 30, 2020 includes $52 million and $104 million, respectively, and for the three and six months ended September 30, 2019 includes $33 million and $48 million, respectively, of pre-tax credits related to the last-in, first-out (&#x201c;LIFO&#x201d;) method of accounting for inventories. The three and six months ended September 30, 2020 also includes a charge of $50 million recorded in connection with the Company&#x2019;s estimated liability under the State of New York&#x2019;s Opioid Stewardship Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss for the three and six months ended September 30, 2020 includes restructuring, impairment, and related charges of $35&#160;million and $58&#160;million, respectively, primarily associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 4, &#x201c;Restructuring, Impairment, and Related Charges,&#x201d; and a goodwill impairment charge of $69 million (pre-tax and after-tax) related to one of the Company&#x2019;s reporting units in Europe, as discussed in more detail in Financial Note 8, &#x201c;Goodwill and Intangible Assets, Net.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Operating loss for Other for the three and six months ended September 30, 2019 includes a pre-tax impairment charge of $1.2 billion and a pre-tax dilution loss of $246 million associated with the Company&#x2019;s investment in Change Healthcare JV. Operating loss for Other also includes the Company&#x2019;s proportionate share of loss from Change Healthcare JV of $51 million and $47 million for the three and six months ended September 30, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net for the six months ended September 30, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program. Corporate expenses, net, for the three and six months ended September 30, 2020 include net gains of $49 million and $59 million, respectively, associated with certain of the Company&#x2019;s equity investments and, for the three and six months ended September 30, 2019, include settlement charges of $105 million and $122 million, respectively, from the termination of the Company&#x2019;s defined benefit pension plan and a settlement charge of $82 million related to opioid claims. The three and six months ended September 30, 2020 includes $41 million and $84 million, respectively, and the three and six months ended September 30, 2019 includes $36 million and $72 million, respectively, of pre-tax charges opioid-related costs, primarily litigation expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia003613bb8bc483286b8644efc98f668_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMy0xLTEtMS0w_aee63850-d66b-4d8d-b32b-b9c0ae257ec0"
      unitRef="usd">48067000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMy0zLTEtMS0w_e292439b-3590-4dcf-8c8e-292c90fd3710"
      unitRef="usd">45613000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMy01LTEtMS0w_23419cc2-d3ef-4e1a-8fb9-8cf75cae755a"
      unitRef="usd">92737000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMy03LTEtMS0w_aaa1486f-8c7f-44e5-b574-2975d94514b4"
      unitRef="usd">89402000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNC0xLTEtMS0w_4686e091-783d-47b1-ab84-b1698e238440"
      unitRef="usd">9540000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNC0zLTEtMS0w_c24d05ca-c760-4d66-881e-c76b9b43d851"
      unitRef="usd">9321000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNC01LTEtMS0w_599a384a-a1b8-4584-a95e-78b58674296d"
      unitRef="usd">18092000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNC03LTEtMS0w_28c56ceb-9cfb-46ff-8423-6914088e2e74"
      unitRef="usd">18728000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNS0xLTEtMS0w_aed51f48-24c3-410b-881e-210125066bd4"
      unitRef="usd">2533000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNS0zLTEtMS0w_81c9270f-df72-4a7b-aea6-b23d4245768c"
      unitRef="usd">2056000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNS01LTEtMS0w_491a957f-4af1-4903-9b1a-1e56e196ab2e"
      unitRef="usd">4334000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNS03LTEtMS0w_56071ea5-a51e-4427-9773-4d22320b6080"
      unitRef="usd">3959000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNi0xLTEtMS00NzA2_0c3dc3c3-8637-4455-9294-0fdf0266bb82"
      unitRef="usd">668000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNi0zLTEtMS00NzE3_8d5c0dfc-9e45-4b4b-b14b-8d7905ec92c9"
      unitRef="usd">626000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNi01LTEtMS00NzI0_3886c3a6-3504-40d9-922f-3bd406eb8c46"
      unitRef="usd">1324000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNi03LTEtMS00NzI4_e70eddaa-37f3-4b72-8c55-4a52b3649119"
      unitRef="usd">1255000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNy0xLTEtMS0w_e5c80e51-380d-4d9c-831e-704e17fa28c0"
      unitRef="usd">60808000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNy0zLTEtMS0w_6ad16e3c-acb9-411e-bb1c-088a691eba35"
      unitRef="usd">57616000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNy01LTEtMS0w_7f0e1707-421e-42f4-9a78-996a121470fe"
      unitRef="usd">116487000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfNy03LTEtMS0w_44a693b1-d89e-49db-be65-89f05fd9b116"
      unitRef="usd">113344000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia003613bb8bc483286b8644efc98f668_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTAtMS0xLTEtMA_fd3adfbe-d736-45c6-b294-4ed0d64b2db5"
      unitRef="usd">623000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iffab50301b0d405aa96967d9b196c8f8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTAtMy0xLTEtMA_fa9c09db-f47f-43fc-8185-7d7fa7d80753"
      unitRef="usd">641000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTAtNS0xLTEtMA_f11eeb4e-3c0d-4390-83db-70ea1e3769ef"
      unitRef="usd">1236000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTAtNy0xLTEtMA_f1f8c5da-f617-41ef-bf6b-5c9dddfd18a8"
      unitRef="usd">1217000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTEtMS0xLTEtMA_85e7ab0d-524c-4978-914e-d8940a782173"
      unitRef="usd">-45000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i44b63fac239941feb9f53b4e422d47c0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTEtMy0xLTEtMA_0e271c99-ee5a-4469-9a90-850bd7c57fe5"
      unitRef="usd">30000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTEtNS0xLTEtMA_d0d3bd3d-692e-4999-9a5e-e69407e1f080"
      unitRef="usd">-42000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTEtNy0xLTEtMA_88cccb7f-6d2a-4e7d-8996-5d56f722f304"
      unitRef="usd">61000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3f9dac273eea4949af6e030e735bbd35_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTItMS0xLTEtMA_df1e1349-9a2e-445c-8242-4da85205050a"
      unitRef="usd">187000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieef6982ed6044819ac8b2fe2065d492d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTItMy0xLTEtMA_e7f95505-2aa8-46cc-8a72-648c9347bd92"
      unitRef="usd">129000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTItNS0xLTEtMA_8499e4e8-674b-4105-b335-af6db04b0554"
      unitRef="usd">276000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTItNy0xLTEtMA_056b911a-0f6f-42c1-b0e6-9d558664db5d"
      unitRef="usd">254000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia6d90f79b6a34d9391e4d79551c5e745_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtMS0xLTEtNDczNQ_976fd668-c172-44b3-8e66-624260e2450b"
      unitRef="usd">88000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie9cca56cae0a42b996b8797bc3f43973_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtMy0xLTEtNDc0MA_dc14eb7f-88fb-46b2-b98a-911feebb20ee"
      unitRef="usd">98000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtNS0xLTEtNDc0NQ_46d9d40b-dd14-45f4-9ee9-6b2754d44db6"
      unitRef="usd">156000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtNy0xLTEtNDc1MA_15be923d-c267-438a-ac18-01b6c2878259"
      unitRef="usd">198000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i27e5cc6dcf7146199a2f75c2b2ffa8af_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTMtMS0xLTEtMA_d8abe5ea-52f7-47cc-aee0-a83ffc7ab9ef"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1ee29e972613498aa1e93fe830d2eb8e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTMtMy0xLTEtMA_6b62639d-1f53-415f-be5d-804e3f927a84"
      unitRef="usd">-1454000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9b4e56db69bd49f69ad0871d5d6fef5c_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTMtNS0xLTEtMA_c0c4a096-7fe8-4f09-8108-58a320a71786"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if7c1d98305344009a39b536f04f12c9e_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTMtNy0xLTEtMA_cca8893d-0c50-43f7-969a-b850c7a0ff36"
      unitRef="usd">-1450000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id3e327dccb0243cd8c395cc18f592326_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtMS0xLTEtMA_c03d8616-9a3d-4217-a746-3d382c0da5d4"
      unitRef="usd">853000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5842c602b5a9464db55d6b8a5ea2fef9_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtMy0xLTEtMA_a285b6fb-1f13-4067-bee1-5f891e5b5836"
      unitRef="usd">-556000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i02e816dd3ea9489cb878840d51f8df47_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtNS0xLTEtMA_7f770858-bb3b-42dd-9f48-f94400a2d017"
      unitRef="usd">1626000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9fed2bcc3c3b42febd8b01ce2735ad1d_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTQtNy0xLTEtMA_3742b4ad-da06-4f88-a7ca-d7a9838222a7"
      unitRef="usd">280000000</us-gaap:OperatingIncomeLoss>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTUtMS0xLTEtMA_89276e97-2693-494c-8ce7-6aea9993750b"
      unitRef="usd">148000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTUtMy0xLTEtMA_2208a5c4-94cf-4cd9-bd22-37eee6afa98c"
      unitRef="usd">350000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTUtNS0xLTEtMA_b48e87f4-e83e-47df-b5f8-f76dafe338c2"
      unitRef="usd">216000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTUtNy0xLTEtMA_813d619d-192b-4e70-a22f-5b283376d9bd"
      unitRef="usd">511000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:InterestAndDebtExpense
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTYtMS0xLTEtMA_95f4b909-3a71-4cdb-8d60-b3371e0e3a97"
      unitRef="usd">50000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTYtMy0xLTEtMA_1447ca6a-c847-4560-b96c-9e04ef0d6efa"
      unitRef="usd">64000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTYtNS0xLTEtMA_18cbb5f7-9137-4c13-bc7d-e43237dabf38"
      unitRef="usd">110000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTYtNy0xLTEtMA_6afd0e5d-2a22-4cf2-ad51-1fecc927807a"
      unitRef="usd">120000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTctMS0xLTEtMA_7c4efaae-b6b3-47df-8617-8d973244842a"
      unitRef="usd">655000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTctMy0xLTEtMA_884b14d3-6b0e-4ff5-a422-e03c02143704"
      unitRef="usd">-970000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTctNS0xLTEtMA_85a91115-6e0d-4954-9689-a125ee9a1c1d"
      unitRef="usd">1300000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9765dc40a0ea4fc39a68d023b1c7a59f_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RhYmxlOmNjMzYzODc0MzYxNDQ1NWVhYTM4OGJlOTdiMDVmZGZlL3RhYmxlcmFuZ2U6Y2MzNjM4NzQzNjE0NDU1ZWFhMzg4YmU5N2IwNWZkZmVfMTctNy0xLTEtMA_6ad3cb15-141a-424e-b820-3f4b2fbdc33a"
      unitRef="usd">-351000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ic95ceb09da3b4741a7d930eb78106ebb_D20200401-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjE0Nw_6f665427-731a-433e-b288-dd0ecccae2e7"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ibf0041d4c22f468389361a96fe954abc_D20190401-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjE0Nw_c1f72037-fa84-4de6-8f0f-ff2818ec2543"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjI0Nw_118e1247-d6dd-4864-ac26-c283054151e9"
      unitRef="number">0.06</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ic8914a4b8b1747c1b36590f26dbdcd71_D20190401-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjI0Nw_f228f5ff-71e9-4a8a-bc75-b206a83ba0f0"
      unitRef="number">0.06</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i8c96526fad904fdfa869e7d3f90af557_D20200401-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjM0MQ_545867bf-a09c-43dd-9a2e-bc0ad2287d7f"
      unitRef="number">0.02</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i3998c97252bb4f9fa438a0da8258f4a9_D20190401-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjM0MQ_992b8a2d-5a5e-4a0d-8b4a-9e5b48fd9fab"
      unitRef="number">0.02</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ib875ce3800a84805974094ef7390c47b_D20200401-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2MTk_1f7a2a0c-5234-4e21-a72b-5c5bf75e7fe8"
      unitRef="number">0.40</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ic4a1916f666b47f998d48f2271a18e1f_D20190401-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2MTk_84100eee-8fe2-45e4-92e1-b96431353dd7"
      unitRef="number">0.40</mck:RevenueDerivedFromServicesPercentage>
    <us-gaap:NumberOfReportableSegments
      contextRef="ida57532d2ac84b80a31ba148be33330e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTUzOTMxNjI4NDczNzQ_45f01839-762e-4d3a-b260-49b00197f94f"
      unitRef="numberofsegments">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i9ea2351304814e458dca8d34103c7273_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA0ODk1MzY_b96de969-3f25-4f7c-af30-94ead4ba68bc"
      unitRef="usd">-52000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i2ef7bc345256444fb9b45e1218e9f993_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2Mzc_9227dcf7-581c-4211-8e48-0d07151b392e"
      unitRef="usd">-104000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i76b51bde9d3d4cb0addfd0460eab9c05_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjczMQ_638bac24-4a83-478e-9a5f-30eb62629c17"
      unitRef="usd">-33000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i647a92415ea7432f9ea523b7b0536a18_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2NjE_cc23d5aa-a195-4b15-a8cf-8cbc35e8bad4"
      unitRef="usd">-48000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="ib06af04e28ba4e4ea6652465ca257cfe_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA5OTUxMTYzNDAwMzA_af0a0b42-bdd5-47ed-b135-e18be60340eb"
      unitRef="usd">50000000</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="i0e287f0b27c448b49c58667e8198eae1_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA5OTUxMTYzNDAwMzA_c7daac0a-0b5e-4716-8ed5-0a012c3273e4"
      unitRef="usd">50000000</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:RestructuringCharges
      contextRef="ie326a32f01b840c9895beb85d1906ee3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MjI5ODE_8b69dd96-46b9-4cfe-aaf5-89b8360f1574"
      unitRef="usd">35000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5f261a46293d4fd982faa133f2983858_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MjI5ODk_e8e1e041-5b9a-49da-b38a-a42205c1c02b"
      unitRef="usd">58000000</us-gaap:RestructuringCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjc0ODc3OTExNTIyOA_10b8508d-766c-4200-9988-c903d0daf4ad"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjc0ODc3OTExNTIyOA_1a925f5a-efb1-4850-807d-6ca731f2e51a"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLossNetOfTax
      contextRef="i887433c7fe2e4824b07987a40c9ae27b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjc0ODc3OTExNTIyOA_2ffc934f-f0f5-4efd-970a-95a46aec0f64"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLossNetOfTax>
    <us-gaap:GoodwillImpairmentLossNetOfTax
      contextRef="i660c5557487b4523bf470784c38e3aac_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjc0ODc3OTExNTIyOA_7a3b2e94-d15b-466c-91f8-8fc5ec8228ed"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLossNetOfTax>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i3bceb76fc90f4fc4a14733d6ed803565_D20190401-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU3MzM_c8edc0fe-f588-48ad-ac0d-bce58ac3d90e"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i5abddbabf5c94c0fa20a7d1605f5465f_D20190701-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU3MzM_dcd1812b-6158-496f-bdfc-8f1e323a3137"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i4ed1ecc0893943d88156c671256bec07_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2Nzk_e6673afd-782e-44c9-a0e2-6b5db38176f5"
      unitRef="usd">-246000000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i9cbe8bd08e2043a691eb83cc4d84f2ec_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2Nzk_fa2e65bd-67b8-49c9-9df1-c6a43b6f647a"
      unitRef="usd">-246000000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5abddbabf5c94c0fa20a7d1605f5465f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU2OTY_477e685e-53b8-4c0e-b514-bed4765ae71c"
      unitRef="usd">-51000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3bceb76fc90f4fc4a14733d6ed803565_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU3MDk_b30254c2-e9ea-4d26-acf3-d374ac9cb870"
      unitRef="usd">-47000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i0e287f0b27c448b49c58667e8198eae1_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMjg4OA_4d9d86ce-b631-466f-b682-b89922fe24f8"
      unitRef="usd">-131000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTI2NDQzODM3Nzc4NzQ_b7c62f1c-7960-49fa-ac76-616864e7533b"
      unitRef="usd">49000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTI2NDQzODM3Nzc5MjQ_76ea4425-9dff-411a-93ea-af97639950b8"
      unitRef="usd">59000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i8259a0225045474dace4f33866146c8b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU3NTY_05652386-5db0-45d6-878a-b24b6353c441"
      unitRef="usd">-105000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="if891f7281b7d419086880575baba6e9d_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU4OTI_b9fb6a10-b1a3-4621-aba9-df2a1a6d13e4"
      unitRef="usd">-122000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="icf4e3d6784d447beb68308a48fff9d3c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU5MDk_57941e73-5506-4ccf-b171-2b1ce1dd6f83"
      unitRef="usd">-82000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ie18fac8f12304381ba36b0b283d93b84_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDU5MDk_8616fd00-8547-4cac-82f7-4926324ff859"
      unitRef="usd">-82000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:LitigationSettlementExpense
      contextRef="ib06af04e28ba4e4ea6652465ca257cfe_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDc4ODU_ed4d9791-de69-4a34-b4e9-d7b202b21f02"
      unitRef="usd">41000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i0e287f0b27c448b49c58667e8198eae1_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDc5MTE_c2447ad6-e9c0-4ca9-9497-6e3926a91bb7"
      unitRef="usd">84000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="icf4e3d6784d447beb68308a48fff9d3c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDc4OTg_5f60722b-bfd3-4239-bdd0-fc2ed49e8635"
      unitRef="usd">36000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="ie18fac8f12304381ba36b0b283d93b84_D20190401-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV85Ny9mcmFnOjVkYzNjMGZmZTNkMjQ1NTU5OTgzMjU4NTQwMTBlN2VjL3RleHRyZWdpb246NWRjM2MwZmZlM2QyNDU1NTk5ODMyNTg1NDAxMGU3ZWNfMTA0NDUzNjA1MDc5MjQ_9fc84208-ed0c-4e3f-bf42-43048109a45a"
      unitRef="usd">72000000</us-gaap:LitigationSettlementExpense>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354632243336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-13252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">McKESSON CORPORATION<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3207296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555 State Hwy 161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irving<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">446-4800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">160,564,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A0625NotesDue2021Member', window );">0.625% notes Due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Notes due 2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK21A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member', window );">1.500% Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.500% Notes due 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member', window );">1.625% Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Notes due 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member', window );">3.125% Notes Due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A0625NotesDue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A0625NotesDue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354629278008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 60,808<span></span>
</td>
<td class="nump">$ 57,616<span></span>
</td>
<td class="nump">$ 116,487<span></span>
</td>
<td class="nump">$ 113,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(57,808)<span></span>
</td>
<td class="num">(54,749)<span></span>
</td>
<td class="num">(110,787)<span></span>
</td>
<td class="num">(107,690)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">2,867<span></span>
</td>
<td class="nump">5,700<span></span>
</td>
<td class="nump">5,654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Operating expenses</a></td>
<td class="num">(2,237)<span></span>
</td>
<td class="num">(2,196)<span></span>
</td>
<td class="num">(4,203)<span></span>
</td>
<td class="num">(4,326)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="num">(69)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RestructuringImpairmentandOtherRelatedCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(116)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(2,366)<span></span>
</td>
<td class="num">(2,241)<span></span>
</td>
<td class="num">(4,388)<span></span>
</td>
<td class="num">(4,394)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">634<span></span>
</td>
<td class="nump">626<span></span>
</td>
<td class="nump">1,312<span></span>
</td>
<td class="nump">1,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">71<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,454)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,450)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest expense</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(120)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="nump">655<span></span>
</td>
<td class="num">(970)<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="num">(351)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(28)<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">627<span></span>
</td>
<td class="num">(676)<span></span>
</td>
<td class="nump">1,122<span></span>
</td>
<td class="num">(193)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">627<span></span>
</td>
<td class="num">(677)<span></span>
</td>
<td class="nump">1,121<span></span>
</td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="nump">$ 577<span></span>
</td>
<td class="num">$ (730)<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
<td class="num">$ (307)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 3.54<span></span>
</td>
<td class="num">$ (3.99)<span></span>
</td>
<td class="nump">$ 6.26<span></span>
</td>
<td class="num">$ (1.62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">3.54<span></span>
</td>
<td class="num">(3.99)<span></span>
</td>
<td class="nump">6.26<span></span>
</td>
<td class="num">(1.65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">3.56<span></span>
</td>
<td class="num">(3.99)<span></span>
</td>
<td class="nump">6.31<span></span>
</td>
<td class="num">(1.62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 3.56<span></span>
</td>
<td class="num">$ (3.99)<span></span>
</td>
<td class="nump">$ 6.30<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RestructuringImpairmentandOtherRelatedCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Impairment and Other Related Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RestructuringImpairmentandOtherRelatedCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354624629576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 627<span></span>
</td>
<td class="num">$ (677)<span></span>
</td>
<td class="nump">$ 1,121<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">41<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gains (losses) on cash flow hedges</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Changes in retirement-related benefit plans</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">640<span></span>
</td>
<td class="num">(621)<span></span>
</td>
<td class="nump">1,163<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">75<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss) attributable to McKesson Corporation</a></td>
<td class="nump">$ 715<span></span>
</td>
<td class="num">$ (656)<span></span>
</td>
<td class="nump">$ 1,127<span></span>
</td>
<td class="num">$ (162)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354630122408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,091<span></span>
</td>
<td class="nump">$ 4,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">19,285<span></span>
</td>
<td class="nump">19,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">18,435<span></span>
</td>
<td class="nump">16,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">833<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">701<span></span>
</td>
<td class="nump">617<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">42,345<span></span>
</td>
<td class="nump">42,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">2,471<span></span>
</td>
<td class="nump">2,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,895<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,414<span></span>
</td>
<td class="nump">9,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">3,030<span></span>
</td>
<td class="nump">3,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">2,403<span></span>
</td>
<td class="nump">2,258<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">61,558<span></span>
</td>
<td class="nump">61,247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">36,255<span></span>
</td>
<td class="nump">37,195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,760<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">367<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">537<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">3,805<span></span>
</td>
<td class="nump">3,340<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">42,724<span></span>
</td>
<td class="nump">42,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">5,848<span></span>
</td>
<td class="nump">6,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">2,293<span></span>
</td>
<td class="nump">2,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,669<span></span>
</td>
<td class="nump">1,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,669<span></span>
</td>
<td class="nump">1,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value, 800 shares authorized and 273 and 272 shares issued at September 30, 2020 and March 31, 2020, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">6,780<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">13,890<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,597)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury shares, at cost, 112 and 110 shares at September 30, 2020 and March 31, 2020, respectively</a></td>
<td class="num">(13,185)<span></span>
</td>
<td class="num">(12,892)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total McKesson Corporation stockholders&#8217; equity</a></td>
<td class="nump">5,890<span></span>
</td>
<td class="nump">5,092<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">6,090<span></span>
</td>
<td class="nump">5,309<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests, and equity</a></td>
<td class="nump">$ 61,558<span></span>
</td>
<td class="nump">$ 61,247<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354630815768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">273,000,000<span></span>
</td>
<td class="nump">272,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">112,000,000<span></span>
</td>
<td class="nump">110,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354621203000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Other Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
<th class="th"><div>Opening retained earnings adjustment: adoption of new accounting standard</div></th>
<th class="th">
<div>Opening retained earnings adjustment: adoption of new accounting standard </div>
<div>Retained Earnings</div>
</th>
<th class="th"><div>Adjusted balance, April 1</div></th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Additional Paid-in Capital</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Other Capital</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Retained Earnings</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Accumulated Other Comprehensive Loss</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Treasury</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Noncontrolling Interests</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2019</a></td>
<td class="nump">$ 8,287<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 6,435<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 12,409<span></span>
</td>
<td class="num">$ (1,849)<span></span>
</td>
<td class="num">$ (8,902)<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 8,298<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 6,435<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 12,420<span></span>
</td>
<td class="num">$ (1,849)<span></span>
</td>
<td class="num">$ (8,902)<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="num">(222)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(1,434)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,434)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(148)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(148)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2019</a></td>
<td class="nump">6,692<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6,573<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">11,965<span></span>
</td>
<td class="num">(1,704)<span></span>
</td>
<td class="num">$ (10,353)<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(86)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2019</a></td>
<td class="nump">8,068<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6,483<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">12,770<span></span>
</td>
<td class="num">(1,778)<span></span>
</td>
<td class="num">$ (9,603)<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(37)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="num">(688)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(730)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2019</a></td>
<td class="nump">$ 6,692<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6,573<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">11,965<span></span>
</td>
<td class="num">(1,704)<span></span>
</td>
<td class="num">$ (10,353)<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Mar. 31, 2020</a></td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 5,296<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,009<span></span>
</td>
<td class="num">$ (1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(93)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(136)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Sep. 30, 2020</a></td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">$ 6,090<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,780<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,890<span></span>
</td>
<td class="num">(1,597)<span></span>
</td>
<td class="num">$ (13,185)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2020</a></td>
<td class="nump">5,653<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,711<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,384<span></span>
</td>
<td class="num">(1,735)<span></span>
</td>
<td class="num">$ (12,916)<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Sep. 30, 2020</a></td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">$ 6,090<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,780<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,890<span></span>
</td>
<td class="num">$ (1,597)<span></span>
</td>
<td class="num">$ (13,185)<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354631232456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 29, 2020</div></th>
<th class="th"><div>Jul. 28, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.83<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354722989960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,121<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill and other asset impairment charges</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(380)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Credits associated with last-in, first-out inventory method</a></td>
<td class="num">(104)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Loss (gain) from sales of businesses and investments</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in assets and liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="nump">981<span></span>
</td>
<td class="num">(866)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(1,396)<span></span>
</td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Drafts and accounts payable</a></td>
<td class="num">(1,305)<span></span>
</td>
<td class="num">(1,203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncreaseDecreaseinOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(185)<span></span>
</td>
<td class="num">(189)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Taxes</a></td>
<td class="num">(58)<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(159)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments for property, plant, and equipment</a></td>
<td class="num">(174)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireSoftware', window );">Capitalized software expenditures</a></td>
<td class="num">(91)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates', window );">Proceeds from sales of businesses and investments, net</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(278)<span></span>
</td>
<td class="num">(285)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">5,303<span></span>
</td>
<td class="nump">8,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of short-term borrowings</a></td>
<td class="num">(5,303)<span></span>
</td>
<td class="num">(8,122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract', window );"><strong>Common stock transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Issuances</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchases, including shares surrendered for tax withholding</a></td>
<td class="num">(272)<span></span>
</td>
<td class="num">(1,452)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(140)<span></span>
</td>
<td class="num">(148)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(224)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(401)<span></span>
</td>
<td class="num">(1,203)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="num">(63)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(783)<span></span>
</td>
<td class="num">(1,625)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">4,023<span></span>
</td>
<td class="nump">2,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of period</a></td>
<td class="nump">3,240<span></span>
</td>
<td class="nump">1,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Less: Restricted cash at end of period included in Prepaid expenses and other</a></td>
<td class="num">(149)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 3,091<span></span>
</td>
<td class="nump">$ 1,356<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncreaseDecreaseinOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncreaseDecreaseinOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627445480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. Commencing in the second quarter of 2021, the Company reports its financial results in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#8220;RxTS&#8221;). The Company&#8217;s equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented. All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation.  Refer to Financial Note 15, &#8220;Segments of Business,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The severity, magnitude, and duration, as well as the economic consequences of the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, the Company&#8217;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. The Company continues to evaluate the legislation for future impacts to its consolidated financial statements, however it did not cause a material impact to the Company&#8217;s financial results for the three and six months ended September 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and six months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 previously filed with the SEC on May 22, 2020 (&#8220;2020 Annual Report&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company prospectively adopted Accounting Standards Update (&#8220;ASU&#8221;) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Retirement Benefits - Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to remove, modify and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2016-13&#8221;), which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $13 million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1OTA_ef5deb27-a7a7-4410-a2df-e6fb8d4e63c9">ASU 2016-13</span> in the first quarter of 2021, the Company began using the Current Expected Credit Losses ("CECL") methodology to determine an allowance for credit losses related to financial assets measured at amortized cost. The Company considers historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $219 million was included in Receivables, net on the Condensed Consolidated Balance Sheet as of September 30, 2020. Changes in the allowance were not material for the three and six months ended September 30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2019, ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The Company is currently evaluating the impact of this amended guidance on its condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354625776008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Change Healthcare Joint Venture<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investment in Change Healthcare Joint Venture</a></td>
<td class="text">Investment in Change Healthcare Joint Venture<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the separation of its interest in the Change Healthcare JV on March 10, 2020, the Company accounted for its interest in the joint venture using the equity method of accounting with a one-month reporting lag, with disclosure made for any intervening events of the joint venture in the lag period that could materially affect its condensed consolidated financial statements. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective April 1, 2019, the Change Healthcare JV adopted the amended revenue recognition guidance. In the first quarter of 2020, the Company recorded its proportionate share of the joint venture&#8217;s adoption impact of the amended revenue recognition guidance of approximately $80 million, net of tax, to the Company&#8217;s opening retained earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2019, common stock and certain other securities of Change Healthcare Inc. (&#8220;Change&#8221;) began trading on the NASDAQ (&#8220;IPO&#8221;). Change was a holding company and did not own any material assets or have any operations other than its interest in the Change Healthcare JV.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2019, upon the completion of its IPO, Change received net cash proceeds of approximately $888 million. Change contributed the proceeds of $609 million from its offering of common stock to the Change Healthcare&#160;JV in exchange for additional membership interests of the Change Healthcare JV (&#8220;LLC Units&#8221;) at the equivalent of its offering price of $13 per share. The proceeds of $279 million from the concurrent offering of other securities were used by Change to acquire certain securities of the Change Healthcare JV that substantially mirrored the terms of other securities included in the offering by Change. As a result, McKesson&#8217;s equity interest in the Change Healthcare JV was diluted from approximately 70% to approximately 58.5% while Change owned approximately 41.5% of the outstanding LLC Units. Accordingly, in the second quarter of 2020, the Company recognized a pre-tax dilution loss of $246 million primarily representing the difference between its proportionate share of the IPO proceeds and the dilution effect on the investment&#8217;s carrying value. These items were included in Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#8217;s Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2019. The Company&#8217;s proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company recorded a pre-tax other-than-temporary&#160;impairment (&#8220;OTTI&#8221;) charge of $1.2 billion to its investment in the Change Healthcare JV, representing the difference between the carrying value of the Company&#8217;s investment and the fair value derived from the corresponding closing price of Change&#8217;s common stock at September 30, 2019. This charge was included in Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#8217;s Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded its proportionate share of loss from its investment in Change Healthcare JV of $51 million and $47 million, respectively, for the three and six months ended September 30, 2019. The Company&#8217;s proportionate share of income or loss from this investment included integration expenses incurred by Change Healthcare JV and basis differences between the joint venture and McKesson, including amortization of fair value adjustments primarily representing incremental intangible assets. These amounts were included within Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#8217;s Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV which eliminated the Company&#8217;s investment in the joint venture. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While a party to the joint venture, the Company had various ancillary agreements related to the Change Healthcare JV, including transition services agreements (&#8220;TSA&#8221;), a transaction and advisory fee agreement (&#8220;Advisory Agreement&#8221;), a tax receivable agreement (&#8220;TRA&#8221;), and certain other agreements. Revenues recognized and expenses incurred under these agreements with the Change Healthcare JV were not material during the three and six months ended September 30, 2020 and 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement executed in 2019 between the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson. McKesson exercised its right under the agreement and allocated certain depreciation and amortization deductions to Change for the tax year ended March 31, 2019, and estimated certain depreciation and amortization deductions for the tax year ended March 31, 2020. These allocated depreciation and amortization deductions may change as certain events occur, including the filing of the Change Healthcare JV tax return for the tax year ended March 31, 2020.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After McKesson&#8217;s separation of its interest in the Change Healthcare JV, the aforementioned TRA agreement requires the Change Healthcare JV to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the depreciation or amortization allocated to Change by McKesson. The receipt of any payments from the Change Healthcare JV under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings. This creates uncertainty over the amount, timing, and probability of the gain recognized. As such, the Company accounts for the TRA as a gain contingency, with no receivable recognized as of September 30, 2020.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020 in conjunction with the separation transaction, the Company recorded a reversal of the deferred tax liability related to its investment. Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed. Any such change is not expected to have a material impact on the Company&#8217;s condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627262856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Held for Sale</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span>Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less cost to sell is reported as an adjustment to the carrying value of the disposal group. Assets and liabilities that have met the classification of held for sale were $833 million and $537 million, respectively, at September 30, 2020 and $906 million and $683 million, respectively, at March 31, 2020. These amounts primarily consist of the majority of the Company&#8217;s German pharmaceutical wholesale business described below.<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">German Pharmaceutical Wholesale Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2019, the Company announced that it had entered into an agreement (the &#8220;Contribution Agreement&#8221;) with Walgreens Boots Alliance intending to contribute the majority of its German pharmaceutical wholesale business to create a joint venture in which McKesson will have a noncontrolling interest. This business is within the Company&#8217;s International segment. The agreement was subject to regulatory approvals, which were received in the second quarter of 2021, and the contribution was completed on November 1, 2020, as noted below. The transaction does not meet the criteria to be reported as a discontinued operation as it does not constitute a significant strategic business shift. For the three and six months ended September 30, 2020, the Company recorded a charge of $10&#160;million to remeasure the held for sale assets and liabilities to fair value less costs to sell. The Company&#8217;s measurement of the fair value of the disposal group was based on the total consideration received by the Company as outlined in the Contribution Agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The total assets and liabilities of the German pharmaceutical wholesale joint venture that have met the classification of held for sale on the Company&#8217;s Condensed Consolidated Balance Sheets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of business held for sale to fair value less costs to sell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes the effect of approximately $11 million unfavorable and $3 million favorable cumulative foreign currency translation adjustments as of September 30, 2020 and March 31, 2020, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020, the Company completed the contribution of the disposal group to the joint venture. The Company accounted for this transaction as a sale of the German pharmaceutical wholesale business and a subsequent purchase of a 30% interest in the newly formed joint venture in the third quarter of 2021. As a result of finalization of working capital amounts contributed and other adjustments, the Company may record additional gains or losses in future periods. These adjustments are not expected to have a material impact on the Company&#8217;s condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627484888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment and Related Charges<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring, Impairment and Related Charges</a></td>
<td class="text">Restructuring, Impairment, and Related Charges<div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges of $60 million and $116 million during the three and six months ended September 30, 2020, respectively, and $45 million and $68 million during the three and six months ended September 30, 2019, respectively. These charges are included under the caption, &#8220;Restructuring, impairment, and related charges&#8221; in Operating expenses in the Condensed Consolidated Statements of Operations. In addition, charges related to restructuring initiatives are included under the caption &#8220;Cost of sales&#8221; in its Condensed Consolidated Statements of Operations and were not material for the three and six months ended September 30, 2020 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. The Company expects to record total charges of approximately $90 million to $125 million, of which $90 million of charges were recorded to date. Charges recorded in the three and six months ended September 30, 2020 and 2019 were not material. The estimated remaining charges primarily consist of lease and other exit-related costs, and employee-related expenses. The Company anticipates that the relocation will be complete by January 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company expects to incur total charges of approximately $300&#160;million to $320&#160;million for these programs, of which $271&#160;million of charges were recorded to date. Charges recorded in the three and six months ended September 30, 2020 and 2019 were not material and primarily represented employee severance, accelerated depreciation expense, and project consulting fees. The Company anticipates these additional programs will be substantially completed in 2022. The estimated remaining charges primarily consist of facility and other exit costs and employee-related costs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which is included in the Company&#8217;s International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. The Company expects to incur total charges of approximately $100&#160;million to $120&#160;million. The Company recorded charges of $27 million and $41 million, respectively, in the three and six months ended September 30, 2020, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. The initiative is expected to be substantially complete by the end of 2021 and estimated remaining charges primarily consist of accelerated amortization and impairments of long-lived assets, facility and other exit costs, and employee-related costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and six months ended September 30, 2020 consisted of the following: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of project consulting fees.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of project consulting fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and six months ended September 30, 2019 consisted of the following: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the six months ended September 30, 2020: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2020, the total reserve balance was $157 million, of which $118 million was recorded in Other accrued liabilities and $39 million was recorded in Other non-current liabilities. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of September 30, 2020, the total reserve balance was $155 million, of which $128 million was recorded in Other accrued liabilities and $27 million was recorded in Other non-current liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627560088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020 and 2019, the Company recorded income tax expense of $28 million and an income tax benefit of $294 million, respectively, related to continuing operations. During the six months ended September 30, 2020 and 2019, the Company recorded income tax expense of $178 million and an income tax benefit of $158 million, respectively, related to continuing operations. The Company&#8217;s reported income tax rates were expense of 4.3% and benefit of 30.3% for the three months ended September 30, 2020 and 2019, respectively and expense of 13.7% and benefit of 45.0% for the six months ended September 30, 2020 and 2019, respectively. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to changes within the mix of earnings between various taxing jurisdictions and discrete items recognized in the quarters, primarily due to the impact of an intercompany sale of intellectual property during the three months ended September 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gain was eliminated upon consolidation. The acquiring entity of the intellectual property is entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#8220;Intra-Entity Transfers of Assets Other Than Inventory,&#8221; a discrete tax benefit of $105 million, which reduced the Company&#8217;s reported income tax rates by 16.0 percentage points and 8.1 percentage points for the three and six months ended September 30, 2020, respectively, was recognized with a corresponding increase to a deferred tax asset for the temporary difference arising from the buyer&#8217;s excess tax basis. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2020, the Company had $1 billion of unrecognized tax benefits, of which $882 million would reduce income tax expense and the effective tax rate if recognized. During the next twelve months, it is reasonably possible that the Company&#8217;s unrecognized tax benefits may decrease by as much as $105 million due to settlements of tax examinations and statute of limitations expirations in the U.S. federal and state jurisdictions and in foreign jurisdictions. However, this amount may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2016 through 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354626066984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text">Redeemable Noncontrolling Interests and Noncontrolling Interests<div style="margin-bottom:6pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable noncontrolling interests primarily relate to its consolidated subsidiary, McKesson Europe AG (&#8220;McKesson Europe&#8221;). Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;0.83 per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $10 million and $21 million during the three and six months ended September 30, 2020, respectively, and $11 million and $22 million during the three and six months ended September 30, 2019, respectively. All amounts were recorded in Net income attributable to noncontrolling interests in the Company&#8217;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in Other accrued liabilities in the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During the six months ended September 30, 2020, the Company paid $49 million to purchase 1.8&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $49 million, and the associated effect of the increase in the Company&#8217;s ownership interest on its equity of $3 million was recorded as a net increase to McKesson&#8217;s stockholders paid-in capital during 2021. During the three months ended September 30, 2020 and the three and six months ended September 30, 2019, there were no material exercises of the Put Right. The balance of the associated liability for Redeemable noncontrolling interests is reported as the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The Redeemable noncontrolling interest is also adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. At September 30, 2020 and March 31, 2020, the carrying value of redeemable noncontrolling interests of $1.3&#160;billion and $1.4&#160;billion, respectively, exceeded the maximum redemption value of $1.2 billion. At September 30, 2020 and March 31, 2020, the Company owned approximately 78% and 77%, respectively, of McKesson Europe&#8217;s outstanding common shares.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and McKesson Europe, which were $200 million and $217 million at September 30, 2020 and March 31, 2020, respectively, in the Company&#8217;s Condensed Consolidated Balance Sheets. The Company allocated a total of $40 million and $79 million of net income to noncontrolling interests during the three and six months ended September 30, 2020, respectively, and $42 million and $85 million during the three and six months ended September 30, 2019, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2020 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2019 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.031%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627560088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Common Share</a></td>
<td class="text">Earnings Per Common Share<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings per common share is similar to that of basic earnings per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Diluted loss per common share for the three and six months ended September 30, 2019 was calculated by excluding potentially dilutive securities from the denominator of the share computation due to their anti-dilutive effects.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:52.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.967%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.65)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.65)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"> Certain computations may reflect rounding adjustments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately 2 million of potentially dilutive securities for the three months and six months ended September 30, 2020 were excluded from the computations of diluted net earnings per common share as they were anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627359640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, Net</a></td>
<td class="text">Goodwill and Intangible Assets, Net <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a goodwill impairment charge of $69 million (pre-tax and after-tax) in the three and six months ended September 30, 2020 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. This impairment charge is included under the caption, &#8220;Goodwill impairment charges&#8221; in the Condensed Consolidated Statements of Operations. At September 30, 2020, the reporting units in Europe had no remaining balance of goodwill and the remaining balance of goodwill in the International segment relates to one of its reporting units in Canada.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 12, &#8220;Fair Value Measurements,&#8221; for more information.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.942%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March&#160;31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,456&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,414&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,127)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,950)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,529&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,499)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,236)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Amortization expense of intangible assets was $106 million and $212 million during the three and six months ended September 30, 2020, respectively, and $118 million and $230 million during the three and six months ended September 30, 2019, respectively. Estimated amortization expense of these assets is as follows: $196 million, $367 million, $265 million, $248 million, and $245 million for the remainder of 2021 and each of the succeeding years through 2025 and $1.7 billion thereafter. All intangible assets were subject to amortization as of September 30, 2020 and March 31, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627560088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt and Financing Activities</a></td>
<td class="text">Debt and Financing Activities<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65% Notes due November 30, 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due March 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,848&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $7.6 billion and $7.4 billion at September 30, 2020 and March 31, 2020, respectively, of which $1.8 billion and $1.1 billion, respectively, was included under the caption &#8220;Current portion of long-term debt&#8221; within the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company entered into a syndicated $4 billion five-year senior unsecured credit facility (the &#8220;2020 Credit Facility&#8221;), which has a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling and Euro. The 2020 Credit Facility matures in September 2024 and had no&#160;borrowings during the three and six months ended September 30, 2020 and no amounts outstanding as of September 30, 2020 and March 31, 2020. The remaining terms and conditions of the 2020 Credit Facility are substantially similar to those previously in place under the&#160;$3.5 billion five-year senior unsecured revolving credit facility (the &#8220;Global Facility&#8221;), which was scheduled to mature in October 2020. The Global Facility was terminated in connection with the execution of the 2020 Credit Facility in September 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility contains a financial covenant which obligates the Company to maintain a debt to capital ratio of no greater than 65% and other customary investment grade covenants. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At September 30, 2020, the Company was in compliance with all covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euro with a committed amount of $9 million and an uncommitted amount of $176 million as of September 30, 2020. Borrowings and repayments were not material during the three and six months ended September 30, 2020 and 2019, and amounts outstanding under these credit lines were not material as of September 30, 2020 and March 31, 2020. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. During the six months ended September 30, 2020 and 2019, the Company borrowed $5.3 billion and $8.7 billion, respectively, and repaid $5.3 billion and $8.1 billion, respectively, under the program. At September 30, 2020 and March 31, 2020, there were no commercial paper notes outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627585544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Benefits</a></td>
<td class="text">Pension Benefits<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic expense for defined benefit pension plans was $7 million and $14 million for the three and six months ended September 30, 2020, respectively, and $111 million and $135 million for the three and six months ended September 30, 2019, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash contributions to these plans were $4 million and $11 million for the three and six months ended September 30, 2020, respectively, and $7 million and $13 million for the three and six months ended September 30, 2019, respectively. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2018, the Company&#8217;s Board of Directors approved the termination of its frozen U.S. defined benefit pension plan (&#8220;Plan&#8221;). During the first quarter of 2020, the Company offered the option of receiving a lump sum payment to certain participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately 1,300 participants elected to receive the settlement, and lump sum payments of approximately $49 million were made from Plan assets to these participants in June 2019. The benefit obligation settled approximated payments to Plan participants and a pre-tax settlement charge of $17 million was recorded during the first quarter of 2020. During the second quarter of 2020, the Company transferred the remainder of the Plan&#8217;s pension obligation to a third-party insurance provider by purchasing annuity contracts for approximately $280 million which was fully funded directly by Plan assets. The third-party insurance provider assumed the obligation to pay future benefits and provide administrative services on November 1, 2019. As a result, the remaining previously recorded unrecognized losses in accumulated other comprehensive loss for the Plan were recognized as expense and a pre-tax settlement charge of approximately $105 million was recorded in Other income (expense), net in the Company&#8217;s Condensed Consolidated Statements of Operations during the second quarter of 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354752422296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Hedging Activities</a></td>
<td class="text">Hedging Activities <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. </span></div><div style="margin-bottom:6pt;padding-left:2.25pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and March 31, 2020, the Company had &#8364;1.7 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments within Accumulated other comprehensive loss in the Condensed Consolidated Statements of Stockholders&#8217; Equity where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from net investment hedges recorded within Other comprehensive income were losses of $83 million and $117 million during the three and six months ended September 30, 2020, respectively, and gains of $91 million and $67 million during the three and six months ended September 30, 2019, respectively. There was no ineffectiveness in non-derivative net investment hedges during the three and six months ended September 30, 2020. Ineffectiveness on the Company&#8217;s non-derivative net investment hedges during the three and six months ended September 30, 2019 resulted in gains of $20 million and $30&#160;million, respectively, which were recorded in earnings in Other income (expense), net in the Condensed Consolidated Statements of Operations. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and March 31, 2020, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $1.5 billion Canadian dollars. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in Accumulated other comprehensive loss in the Condensed Consolidated Statements of Stockholders&#8217; Equity where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#8217;s net investment hedges for the three and six months ended September 30, 2020 and 2019. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, the Company terminated cross-currency swaps with a total gross notional amount of &#163;932 million British pound sterling due to ineffectiveness in its British pound sterling hedging program that arose due to 2019 impairments of goodwill and certain long-lived assets in the U.K. businesses. Proceeds from the termination of these swaps totaled $84 million and resulted in a settlement gain of $34 million for the six months ended September 30, 2019. This gain was recorded in earnings in Other income (expense), net, net in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from the Company&#8217;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $12 million and $63 million during the three and six months ended September 30, 2020, respectively, and gains of $20 million and $9 million during the three and six months ended September 30, 2019, respectively. There was no ineffectiveness in the Company&#8217;s cross-currency swap hedges for the three and six months ended September 30, 2020 and 2019. These cross-currency swaps will mature between November 2020 and November 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#163;450 million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#163;450 million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings for the three and six months September 30, 2020 and 2019 were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At September 30, 2020 and March 31, 2020, the Company had cross-currency swaps with total gross notional amounts of approximately $2.6 billion and $2.9 billion, respectively, which are designated as cash flow hedges. These swaps will mature between February 2021 and January 2024. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $500&#160;million and &#8364;600&#160;million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500&#160;million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#8220;EURIBOR&#8221;) for the &#8364;600&#160;million swaps. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Gains or losses from cash flow hedges recorded in Other comprehensive income were losses of $23 million and $28 million during the three and six months ended September 30, 2020, respectively, and were gains of $17 million and $35 million during the three and six months ended September 30, 2019, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in Operating expenses in the Condensed Consolidated Statements of Operations were not material in the three and six months ended September 30, 2020 and 2019. There was no ineffectiveness in the Company&#8217;s cash flow hedges for the three and six months ended September 30, 2020 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At September 30, 2020 and March 31, 2020, the total gross notional amounts of these contracts were $44 million and $29 million, respectively. These contracts will predominantly mature through December 2020 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in Operating expenses. Changes in the fair values were not material in the three and six months ended September 30, 2020 and 2019. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2019, the Company also entered into a number of forward contracts to offset a portion of the earnings impacts from the ineffectiveness of the net investment hedges discussed above. These contracts matured in September 2019 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly in earnings. During the three and six months ended September 30, 2019, losses of $20 million and $39 million, respectively, were recorded in earnings within Other income (expense), net in the Condensed Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.672%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.817%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.206%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div>Refer to Financial Note 12, "Fair Value Measurements," for more information on these recurring fair value measurements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627314424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and March 31, 2020, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is carried at amortized cost. The carrying amounts and estimated fair values of these liabilities were $7.6 billion and $8.4 billion at September 30, 2020, respectively, and $7.4 billion and $7.8 billion at March 31, 2020, respectively. The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at September 30, 2020 and March 31, 2020 included investments in money market funds of $129 million and $2.0 billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level&#160;1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s foreign currency forward contracts were determined using observable inputs from available market information. Fair values of the Company&#8217;s cross-currency swaps were determined using quoted foreign currency exchange rates and other observable inputs from available market information. Fair values of the Company&#8217;s interest rate swaps were determined using observable inputs from available market information. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 11, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s foreign currency derivatives including forward foreign currency contracts and cross-currency swaps.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry. These investments, with a carrying value of $235&#160;million and $170&#160;million, respectively, at September 30, 2020 and March 31, 2020, and primarily consisting of investments without readily determinable fair values, are included within Other non-current assets in the Condensed Consolidated Balance Sheets. In the second quarter of 2021, three of the companies in which McKesson holds investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition. Net gains related to the Company&#8217;s investments in equity securities, primarily representing unrealized gains on the publicly traded securities discussed above, were $49 million and $59 million for the three and six months ended September 30, 2020, respectively. These gains were recorded under the caption, &#8220;Other income (expense), net,&#8221; in the Condensed Consolidated Income Statements. There were no other material changes in the carrying value of these investments during the three or six months ended September 30, 2020. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets measured at fair value on a nonrecurring basis as of September 30, 2020 included long-lived assets in the U.K. as discussed in more detail in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and goodwill of the Company&#8217;s Europe Retail Pharmacy reporting unit within the International segment. Refer to Financial Note 8, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information. At March 31, 2020, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s European and Rexall Health businesses within the International segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities includes the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no liabilities measured at fair value on a nonrecurring basis at September 30, 2020 and March 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, included within Prepaid expenses and other on the Company&#8217;s Condensed Consolidated Balance Sheet as of September 30, 2020, primarily consists of funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. The amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within Other accrued liabilities on the Company&#8217;s Condensed Consolidated Balance Sheet as of September 30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a discounted cash flow (&#8220;DCF&#8221;) model to determine the fair value of the reporting unit. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div>The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627597752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingent Liabilities</a></td>
<td class="text">Commitments and Contingent Liabilities <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mck10k3312020.htm#sFDC7F65C03045D74BF3631026AD9426B" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 21 to the Company&#8217;s 2020 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 13 to the Company</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8217;</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">s 10-Q filing for the quarterly period ended June 30, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, it is not reasonably possible for the Company to determine that a loss is probable for a claim, or to reasonably estimate the amount of loss or a range of loss, because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to be resolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the loss probability has changed and whether it can make a reasonable estimate of the possible loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability in the amount of its estimate for the ultimate loss. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, hospitals, Indian tribes, pension funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico, and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#8220;MDL&#8221;) in the United States District Court for the Northern District of Ohio captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: National Prescription Opiate Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Case No. 17-md-2804. At present, there are approximately 2,800 cases under the jurisdiction of the MDL court. In the suits filed against the Company by Cuyahoga County, Ohio in October 2017 and Summit County, Ohio in December 2017, the parties reached an agreement in principle on October 21, 2019 to settle all claims against the Company. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">County of Cuyahoga v. Purdue Pharma L.P., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Case No. 1:17-op-45004-DAP (N.D. Ohio); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">County of Summit, Ohio et al. v. Purdue Pharma L.P., et. al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Case No. 1:18-op-45090-DAP (N.D. Ohio). The Company does not admit liability and expressly denies wrongdoing. As a result, the Company recorded a pre-tax charge of $82&#160;million related to two Ohio counties within operating expenses for the second quarter of 2020.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three cases involving McKesson that were previously part of the federal MDL have been remanded to other federal courts for discovery and trial. On January 14, 2020, the Judicial Panel on Multidistrict Litigation finalized its Conditional Remand Order, ordering that the cases against the three largest distributors brought by Cabell County, West Virginia and the City of Huntington, West Virginia be remanded to the U.S. District Court for the Southern District of West Virginia. A trial has been scheduled for January 4, 2021. On February 5, 2020, the case brought by the City and County of San Francisco was remanded to the U.S. District Court for the Northern District of California; trial has been set for June 28, 2021. Also on February 5, 2020, the case brought by the Cherokee Nation was remanded to the U.S. District Court for the Eastern District of Oklahoma.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also named in approximately 400 similar state court cases pending in 36 states plus Puerto Rico, along with 3 cases in Canada. These include actions filed by 26 state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state cases. For example, trial was previously set to begin in March 2020 in the Supreme Court of New York, Suffolk County for a case brought by the New York attorney general and two New York county governments, but the trial was postponed in light of the COVID-19 pandemic.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to be involved in discussions with the objective of achieving broad resolution of opioid-related claims brought by governmental entities. For example, in October 2020, a group of state attorneys general proposed a framework for the potential settlement of opioid claims of governmental entities, including political subdivisions, and compensation for the private attorneys representing these governmental entities. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the framework proposed by the attorneys general, the three largest U.S. pharmaceutical distributors could be expected to pay an aggregate amount of up to $21.0 billion over 18 years, with up to approximately $8.0 billion over 18 years expected from the Company. The proposed framework would also require the three distributors, including the Company, to adopt changes to anti-diversion programs. If the negotiating parties agree on the terms for a broad resolution, those potential terms would need to be agreed to by numerous other state and local governments before an agreement could be accepted by the Company and finalized. Under the framework, before the distributors determine whether to enter into any final settlement, they would assess the sufficiency of the scope of settlement, based in part on the number and identities of the states, political subdivisions, and governmental entities that would participate in any such settlement. If states, political subdivisions or other governmental entities did not agree to a settlement under the framework, there would be a corresponding reduction in the amount due from the Company to account for this.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussions with attorneys general and other parties continue. To be viable, a broad settlement arrangement would require participation of numerous parties and the resolution of many complex issues. Because of the many uncertainties associated with any potential settlement arrangements, and the uncertainty of the scope of potential participation by plaintiffs, the Company has not reached a point where settlement is probable, and as such has not recognized any liability related to any potential settlement framework as of September 30, 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company continues to be involved in discussions regarding a potential global settlement framework, the Company also continues to prepare for trial in these matters. The Company believes that it has valid defenses to the claims pending against it and intends to vigorously defend against all such claims. Because of the novelty of the claims asserted and the complexity of litigation, the Company has determined that liability is not probable, and is not able to reasonably estimate a loss or range of loss. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed by two relators alleging violations of the federal False Claims Act based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-2233. On August 18, 2020, the court entered an order granting the Company&#8217;s motion to dismiss and giving the relators permission to file an amended complaint. On September 8, 2020, pursuant to the court&#8217;s order, the relators filed a Second Amended Complaint.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#8220;TCPA&#8221;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$500&#160;to&#160;$1,500&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On July 16, 2015, plaintiffs filed a motion for class certification. On August 22, 2016, the court denied plaintiffs&#8217; motion. On July 17, 2018, the United States Court of Appeals for the Ninth Circuit Court affirmed in part and reversed in part the district court&#8217;s denial of class certification and remanded the case to the district court for further proceedings. On August 13, 2019, the court granted plaintiffs&#8217; renewed motion for class certification. After class notice and the opt-out period, 9,490 fax numbers remain in the class, representing 48,769 faxes received. On March 5, 2020, McKesson moved to decertify the class and moved for summary judgment on plaintiffs&#8217; claim for treble damages. Plaintiffs&#8217; moved for summary judgment on the same day. Due to the COVID-19 pandemic, the trial date for this case was taken off calendar to be re-scheduled during 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 5, 2018, the Company&#8217;s subsidiary, RxC Acquisition Company (d/b/a RxCrossroads), was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in July 2017 in the United States District Court for the Southern District of Illinois by a relator against RxC Acquisition Company, among others, alleging that UCB, Inc. provided illegal &#8220;kickbacks&#8221; to providers, including nurse educator services and reimbursement assistance services provided through RxC Acquisition Company, in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. CIMZNHCA, LLC v. UCB, Inc., et al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 17-cv-00765. The complaint sought treble damages, civil penalties, and further relief. The United States and the states named in the complaint declined to intervene in the suit. On December 17, 2018, the United States filed a motion to dismiss the complaint in its entirety; this motion was denied on April 15, 2019. On June 7, 2019, the court denied the United States&#8217; motion for reconsideration. On July 8, 2019, the United States appealed to the United States Court of Appeals for the Seventh Circuit seeking interlocutory review of the denial of its motion for reconsideration of the denial of the motion to dismiss the complaint. On September 3, 2019, the United States District Court for the Southern District of Illinois stayed the district court proceedings pending the appeal. On August 17, 2020, the Seventh Circuit reversed the district court&#8217;s decision on the United States&#8217; motion to dismiss and remanded the case with instructions that the district court enter judgment for the defendants on the relator&#8217;s claims under the False Claims Act. The relator sought a re-hearing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">en banc</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at the Seventh Circuit, which was denied.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The relator did not pursue any further appeals and the relator&#8217;s False Claims Act case was dismissed, with judgment entered in favor of the defendants on September 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant in an amended complaint filed on June 15, 2018 in a case pending in the United States District Court for the Southern District of Illinois alleging that the Company&#8217;s subsidiary, McKesson Medical-Surgical Inc., among others, violated the Sherman Act by restraining trade in the sale of safety and conventional syringes and safety IV catheters. M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">arion Diagnostic Center, LLC v. Becton, Dickinson, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 18:1059. The action is filed on behalf of a purported class of purchasers, and seeks treble damages and further relief, all in unspecified amounts. On July 20, 2018, the defendants filed a motion to dismiss. On November 30, 2018, the district court granted the motion to dismiss, and dismissed the complaint with prejudice. On December 27, 2018, plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit. On March 5, 2020, the United States Court of Appeals for the Seventh Circuit vacated the district court&#8217;s order, and ruled that dismissal was appropriate on alternative grounds. The case was remanded to the district court to allow the plaintiffs an opportunity to amend their complaint. Plaintiffs filed an amended complaint on August 21, 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2019, Jean E. Henry, a purported Company shareholder, filed a shareholder derivative complaint in the Superior Court of San Francisco, California against certain current and former officers and directors of the Company, and the Company as a nominal defendant, alleging violations of fiduciary duties and waste of corporate assets with respect to an alleged conspiracy to fix the prices of generic drugs, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Henry v. Tyler, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CGC-19-576119. On May 23, 2019, the Company removed the case to the United States District Court for the Northern District of California, Case No. 19-cv-02869. On August 26, 2019, the plaintiff filed an amended complaint, removing all claims except for an alleged breach of fiduciary duty by the named current and former officers and directors of the Company. On January 21, 2020, the United States District Court for the Northern District of California granted the defendants&#8217; motion to dismiss the complaint, and on July 1, 2020, the court granted the defendant&#8217;s motion to dismiss the plaintiff&#8217;s amended complaint with prejudice. The plaintiff did not file an appeal.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2020, McKesson received correspondence from the U.S. Attorney&#8217;s Office for the Western District of Tennessee alleging reporting and documentation deficiencies in violation of the Controlled Substances Act at the Company&#8217;s former and no longer operational RxPak facility and at its Distribution Center in Memphis, Tennessee, and seeking civil penalties.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:103%">IV.  State Opioid Statutes</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory or industry measures to address the misuse of prescription opioid medications could affect the Company&#8217;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#8220;OSA&#8221;) which required the creation of an aggregate $100&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Company has accrued a $50&#160;million pre-tax charge ($37&#160;million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized as Operating expenses in the accompanying condensed consolidated statement of operations and as Other accrued liabilities in the condensed consolidated balance sheets as of September 30, 2020. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354628021928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2020, the Company raised its quarterly dividend from $0.41 to $0.42 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2020, there were no share repurchases made under previously authorized share repurchase programs. During the three months ended September 30, 2020, the Company repurchased 1.8&#160;million of the Company&#8217;s shares for $269 million through open market transactions at an average price per share of $151.23, of which $21&#160;million was accrued within &#8220;Other accrued liabilities&#8221; on the Company&#8217;s Condensed Consolidated Balance Sheets for share repurchases that were executed in late September and settled in early October. The total authorization outstanding for repurchases of the Company&#8217;s common stock was $1.3 billion at September 30, 2020.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Comprehensive Income (Loss)</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.261%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments arising during period, net of income tax expense of nil, nil, nil, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on net investment hedges arising during period, net of income tax (expense) benefit of $25, $(29), $47, and $(20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $4, $(4), $4, and $(10)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil,  nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain and prior service cost arising during the period, net of income tax benefit of nil, $2, nil, and $1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense of $1, nil, $1, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other, net of income tax expense of nil, nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, $27, nil, and $32 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the three and six months ended September 30, 2020, the net foreign currency translation adjustments were primarily due to the strengthening of the Canadian dollar and Euro against the U.S. dollar from April 1, 2020 to September 30, 2020. During the three and six months ended September 30, 2019, the net foreign currency translation adjustments were primarily due to the weakening of the Euro and British pound sterling against the U.S. dollar from April 1, 2019 to September 30, 2019. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and six months ended September 30, 2020 includes net foreign currency translation adjustments of $119 million and $61 million, respectively, and the three and six months ended September 30, 2019 includes net foreign currency translation adjustments of $19 million and $13 million, respectively, attributable to redeemable noncontrolling interests. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and six months ended September 30, 2020 includes foreign currency losses of $83 million and $117 million, respectively, on the net investment hedges from the &#8364;1.7 billion&#160;Euro-denominated notes and &#163;450 million&#160;British pound sterling-denominated notes, losses of $12 million and $63 million, respectively, on the net investment hedges from cross-currency swaps, and losses on net investment hedges of $1 million attributable to redeemable noncontrolling interests. The three and six months ended September 30, 2019 include foreign currency gains of $91 million and $67 million, respectively, on the net investment hedges from the &#8364;1.95 billion Euro-denominated notes and&#160;&#163;450 million British pound sterling-denominated notes and gains of $20 million and $9 million, respectively, on the net investment hedges from cross-currency swaps. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and six months ended September 30, 2020 include net actuarial losses of $5 million and $2 million, respectively, and the three and six months ended September 30, 2019 include net actuarial gains of $1 million, which are attributable to redeemable noncontrolling interests.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Pre-tax amount was reclassified into Cost of sales and Operating expenses in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into Income tax benefit (expense) in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and six months ended September 30, 2019 primarily reflects a reclassification of a pension settlement charge from Accumulated other comprehensive loss to Other income (expense), net in the Condensed Consolidated Statement of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss) </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three and six months ended September 30, 2020 are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,742)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,735)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,597)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,597)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three and six months ended September 30, 2019 are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,778)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2019</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,659)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,628)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2019</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,659)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354625754712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments of Business</a></td>
<td class="text">Segments of Business<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing in the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. Other, for retrospective periods presented, consists of the Company&#8217;s equity method investment in Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020. All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 13 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology services throughout Canada and includes Rexall Health retail pharmacies. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 275,000 national brand medical-surgical products as well as McKesson&#8217;s own line of products through a network of distribution centers within the United States.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment brings together existing businesses, including CoverMyMeds, RelayHealth, RxCrossroads, and High Volume Solutions, to serve the Company&#8217;s biopharma and life sciences partners and patients, connecting pharmacies, providers, payers, and biopharma. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and High Volume Solutions were previously included in Other.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, for retrospective periods presented consists of the Company&#8217;s investment in the Change Healthcare JV, which was split-off from the Company in the fourth quarter of 2020.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.260%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,808&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,344&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,454)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,450)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(511)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(970)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 6% of the International segment&#8217;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#8217;s total revenues, and approximately 40% of the RxTS segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#8217;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three and six months ended September 30, 2020 includes $52 million and $104 million, respectively, and for the three and six months ended September 30, 2019 includes $33 million and $48 million, respectively, of pre-tax credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories. The three and six months ended September 30, 2020 also includes a charge of $50 million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s Opioid Stewardship Act.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for the three and six months ended September 30, 2020 includes restructuring, impairment, and related charges of $35&#160;million and $58&#160;million, respectively, primarily associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and a goodwill impairment charge of $69 million (pre-tax and after-tax) related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 8, &#8220;Goodwill and Intangible Assets, Net.&#8221;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for the three and six months ended September 30, 2019 includes a pre-tax impairment charge of $1.2 billion and a pre-tax dilution loss of $246 million associated with the Company&#8217;s investment in Change Healthcare JV. Operating loss for Other also includes the Company&#8217;s proportionate share of loss from Change Healthcare JV of $51 million and $47 million for the three and six months ended September 30, 2019, respectively.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the six months ended September 30, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program. Corporate expenses, net, for the three and six months ended September 30, 2020 include net gains of $49 million and $59 million, respectively, associated with certain of the Company&#8217;s equity investments and, for the three and six months ended September 30, 2019, include settlement charges of $105 million and $122 million, respectively, from the termination of the Company&#8217;s defined benefit pension plan and a settlement charge of $82 million related to opioid claims. The three and six months ended September 30, 2020 includes $41 million and $84 million, respectively, and the three and six months ended September 30, 2019 includes $36 million and $72 million, respectively, of pre-tax charges opioid-related costs, primarily litigation expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354626011256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The severity, magnitude, and duration, as well as the economic consequences of the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, the Company&#8217;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. The Company continues to evaluate the legislation for future impacts to its consolidated financial statements, however it did not cause a material impact to the Company&#8217;s financial results for the three and six months ended September 30, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The results of operations for the three and six months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 previously filed with the SEC on May 22, 2020 (&#8220;2020 Annual Report&#8221;).<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Period</a></td>
<td class="text">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text">Certain prior year amounts have been reclassified to conform to the current year presentation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company prospectively adopted Accounting Standards Update (&#8220;ASU&#8221;) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Retirement Benefits - Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to remove, modify and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2016-13&#8221;), which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $13 million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVjZmEwZTViNzY2OTQwNmM4ODZmOGUyZGNkODdiODQ1L3NlYzplY2ZhMGU1Yjc2Njk0MDZjODg2ZjhlMmRjZDg3Yjg0NV8zMS9mcmFnOjAwMjBmNTYwMzEyMzRiMThiZmFkMDJiNGY0NDJkMDQ2L3RleHRyZWdpb246MDAyMGY1NjAzMTIzNGIxOGJmYWQwMmI0ZjQ0MmQwNDZfMTA1OTA_ef5deb27-a7a7-4410-a2df-e6fb8d4e63c9">ASU 2016-13</span> in the first quarter of 2021, the Company began using the Current Expected Credit Losses ("CECL") methodology to determine an allowance for credit losses related to financial assets measured at amortized cost. The Company considers historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $219 million was included in Receivables, net on the Condensed Consolidated Balance Sheet as of September 30, 2020. Changes in the allowance were not material for the three and six months ended September 30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2019, ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The Company is currently evaluating the impact of this amended guidance on its condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mck10k3312020.htm#sFDC7F65C03045D74BF3631026AD9426B" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 21 to the Company&#8217;s 2020 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 13 to the Company</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8217;</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">s 10-Q filing for the quarterly period ended June 30, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, it is not reasonably possible for the Company to determine that a loss is probable for a claim, or to reasonably estimate the amount of loss or a range of loss, because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to be resolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the loss probability has changed and whether it can make a reasonable estimate of the possible loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability in the amount of its estimate for the ultimate loss. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354625724328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Assets and Liabilities Held for Sale</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The total assets and liabilities of the German pharmaceutical wholesale joint venture that have met the classification of held for sale on the Company&#8217;s Condensed Consolidated Balance Sheets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of business held for sale to fair value less costs to sell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes the effect of approximately $11 million unfavorable and $3 million favorable cumulative foreign currency translation adjustments as of September 30, 2020 and March 31, 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354625832424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment and Related Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring, Impairment and Related Costs</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and six months ended September 30, 2020 consisted of the following: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of project consulting fees.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of project consulting fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and six months ended September 30, 2019 consisted of the following: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring and Asset Impairment Charges</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the six months ended September 30, 2020: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2020, the total reserve balance was $157 million, of which $118 million was recorded in Other accrued liabilities and $39 million was recorded in Other non-current liabilities. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of September 30, 2020, the total reserve balance was $155 million, of which $128 million was recorded in Other accrued liabilities and $27 million was recorded in Other non-current liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627460232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2020 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and six months ended September 30, 2019 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.031%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354628069736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of computations for basic and diluted earnings per common share</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:52.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.967%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.65)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.65)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"> Certain computations may reflect rounding adjustments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354625788728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of changes in the carrying amount of goodwill</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.942%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March&#160;31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,456&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,414&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of information regarding intangible assets</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,127)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,950)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,529&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,499)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,236)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627419672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65% Notes due November 30, 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due March 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,848&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354625736968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of information regarding the fair value of derivatives on a gross basis</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.672%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.817%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.206%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627267960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of information regarding other comprehensive income (loss) including noncontrolling and redeemable noncontrolling interests, net of tax, by component</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.261%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments arising during period, net of income tax expense of nil, nil, nil, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on net investment hedges arising during period, net of income tax (expense) benefit of $25, $(29), $47, and $(20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $4, $(4), $4, and $(10)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil,  nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain and prior service cost arising during the period, net of income tax benefit of nil, $2, nil, and $1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense of $1, nil, $1, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other, net of income tax expense of nil, nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, $27, nil, and $32 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the three and six months ended September 30, 2020, the net foreign currency translation adjustments were primarily due to the strengthening of the Canadian dollar and Euro against the U.S. dollar from April 1, 2020 to September 30, 2020. During the three and six months ended September 30, 2019, the net foreign currency translation adjustments were primarily due to the weakening of the Euro and British pound sterling against the U.S. dollar from April 1, 2019 to September 30, 2019. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and six months ended September 30, 2020 includes net foreign currency translation adjustments of $119 million and $61 million, respectively, and the three and six months ended September 30, 2019 includes net foreign currency translation adjustments of $19 million and $13 million, respectively, attributable to redeemable noncontrolling interests. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and six months ended September 30, 2020 includes foreign currency losses of $83 million and $117 million, respectively, on the net investment hedges from the &#8364;1.7 billion&#160;Euro-denominated notes and &#163;450 million&#160;British pound sterling-denominated notes, losses of $12 million and $63 million, respectively, on the net investment hedges from cross-currency swaps, and losses on net investment hedges of $1 million attributable to redeemable noncontrolling interests. The three and six months ended September 30, 2019 include foreign currency gains of $91 million and $67 million, respectively, on the net investment hedges from the &#8364;1.95 billion Euro-denominated notes and&#160;&#163;450 million British pound sterling-denominated notes and gains of $20 million and $9 million, respectively, on the net investment hedges from cross-currency swaps. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and six months ended September 30, 2020 include net actuarial losses of $5 million and $2 million, respectively, and the three and six months ended September 30, 2019 include net actuarial gains of $1 million, which are attributable to redeemable noncontrolling interests.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Pre-tax amount was reclassified into Cost of sales and Operating expenses in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into Income tax benefit (expense) in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and six months ended September 30, 2019 primarily reflects a reclassification of a pension settlement charge from Accumulated other comprehensive loss to Other income (expense), net in the Condensed Consolidated Statement of Operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three and six months ended September 30, 2020 are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,742)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,735)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,597)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,597)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three and six months ended September 30, 2019 are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,778)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2019</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,659)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,628)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2019</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,659)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354627961032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.260%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,808&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,344&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,454)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,450)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(511)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(970)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 6% of the International segment&#8217;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#8217;s total revenues, and approximately 40% of the RxTS segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#8217;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three and six months ended September 30, 2020 includes $52 million and $104 million, respectively, and for the three and six months ended September 30, 2019 includes $33 million and $48 million, respectively, of pre-tax credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories. The three and six months ended September 30, 2020 also includes a charge of $50 million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s Opioid Stewardship Act.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for the three and six months ended September 30, 2020 includes restructuring, impairment, and related charges of $35&#160;million and $58&#160;million, respectively, primarily associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and a goodwill impairment charge of $69 million (pre-tax and after-tax) related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 8, &#8220;Goodwill and Intangible Assets, Net.&#8221;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for the three and six months ended September 30, 2019 includes a pre-tax impairment charge of $1.2 billion and a pre-tax dilution loss of $246 million associated with the Company&#8217;s investment in Change Healthcare JV. Operating loss for Other also includes the Company&#8217;s proportionate share of loss from Change Healthcare JV of $51 million and $47 million for the three and six months ended September 30, 2019, respectively.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the six months ended September 30, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program. Corporate expenses, net, for the three and six months ended September 30, 2020 include net gains of $49 million and $59 million, respectively, associated with certain of the Company&#8217;s equity investments and, for the three and six months ended September 30, 2019, include settlement charges of $105 million and $122 million, respectively, from the termination of the Company&#8217;s defined benefit pension plan and a settlement charge of $82 million related to opioid claims. The three and six months ended September 30, 2020 includes $41 million and $84 million, respectively, and the three and six months ended September 30, 2019 includes $36 million and $72 million, respectively, of pre-tax charges opioid-related costs, primarily litigation expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354632269720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>numberOfSegments</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | numberOfSegments</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative-effect adjustment to beginning retained earnings</a></td>
<td class="nump">$ 6,090<span></span>
</td>
<td class="nump">$ 5,653<span></span>
</td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 6,692<span></span>
</td>
<td class="nump">$ 8,068<span></span>
</td>
<td class="nump">$ 8,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses</a></td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative-effect adjustment to beginning retained earnings</a></td>
<td class="nump">$ 13,890<span></span>
</td>
<td class="nump">$ 13,384<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
<td class="nump">$ 11,965<span></span>
</td>
<td class="nump">$ 12,770<span></span>
</td>
<td class="nump">12,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustment: adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative-effect adjustment to beginning retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustment: adoption of new accounting standard | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative-effect adjustment to beginning retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">ASU 2016-13 | Opening retained earnings adjustment: adoption of new accounting standard | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative-effect adjustment to beginning retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354629604264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Change Healthcare Joint Venture (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative-effect adjustment to beginning retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,090<span></span>
</td>
<td class="nump">$ 6,692<span></span>
</td>
<td class="nump">$ 6,090<span></span>
</td>
<td class="nump">$ 6,692<span></span>
</td>
<td class="nump">$ 5,653<span></span>
</td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 8,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Proportionate loss from investment in Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,454<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member', window );">Change Healthcare, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from Issuance Initial Public Offering</a></td>
<td class="nump">$ 888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from concurrent offering of other securities</a></td>
<td class="nump">$ 279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member', window );">Change Healthcare, Inc. | IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price (in usd per share)</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember', window );">Tax Receivable Agreement (&#8220;TRA&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized', window );">Percentage of net cash tax savings realized or deemed realized under TRA (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Pre-tax dilution loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare JV | Change Healthcare, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Contributions made in exchange for additional membership interests</a></td>
<td class="nump">$ 609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (percent)</a></td>
<td class="nump">41.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare JV | Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (percent)</a></td>
<td class="nump">58.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Proportionate loss from investment in Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative-effect adjustment to beginning retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,890<span></span>
</td>
<td class="nump">$ 11,965<span></span>
</td>
<td class="nump">$ 13,890<span></span>
</td>
<td class="nump">$ 11,965<span></span>
</td>
<td class="nump">$ 13,384<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
<td class="nump">$ 12,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustment: adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative-effect adjustment to beginning retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustment: adoption of new accounting standard | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative-effect adjustment to beginning retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustment: adoption of new accounting standard | ASU 2014-09 | Retained Earnings | Change Healthcare JV | Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative-effect adjustment to beginning retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=121548190&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354630375336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">$ 833<span></span>
</td>
<td class="nump">$ 833<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">537<span></span>
</td>
<td class="nump">537<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Joint Venture | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">833<span></span>
</td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">537<span></span>
</td>
<td class="nump">537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | German Pharmaceutical Wholesale Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses', window );">Favorable (unfavorable) cumulative foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=121548190&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354631154680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Held for Sale - Assets and Liabilities Held for Sale (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total assets held for sale</a></td>
<td class="nump">$ 833<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total liabilities held for sale</a></td>
<td class="nump">537<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total assets held for sale</a></td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total liabilities held for sale</a></td>
<td class="nump">537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net and other current assets</a></td>
<td class="nump">519<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent', window );">Long-term assets</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of business held for sale to fair value less costs to sell</a></td>
<td class="num">(296)<span></span>
</td>
<td class="num">(272)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total assets held for sale</a></td>
<td class="nump">781<span></span>
</td>
<td class="nump">842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent', window );">Long-term liabilities</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total liabilities held for sale</a></td>
<td class="nump">$ 506<span></span>
</td>
<td class="nump">$ 656<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354630176200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment and Related Charges - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Net restructuring, impairment and related charges recognized</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 116<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring liabilities</a></td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember', window );">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Pre-tax charges recorded to-date</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember', window );">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember', window );">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember', window );">Operating Model and Cost Optimization Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Pre-tax charges recorded to-date</a></td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember', window );">Operating Model and Cost Optimization Programs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember', window );">Operating Model and Cost Optimization Programs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember', window );">Strategic Growth Initiative Plan | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Net restructuring, impairment and related charges recognized</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember', window );">Strategic Growth Initiative Plan | Minimum | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember', window );">Strategic Growth Initiative Plan | Maximum | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354630194952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment and Related Charges - Summary of Restructuring Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges, Including Accelerated Depreciation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetImpairmentChargesIncludingAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354628810920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment and Related Charges - Summary of Restructuring Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354723084280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit) related to continuing operations</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="num">$ (294)<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
<td class="num">$ (158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Reported income tax rates (percent)</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="num">(30.30%)<span></span>
</td>
<td class="nump">13.70%<span></span>
</td>
<td class="num">(45.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncomeTaxExpenseBenefitDiscreteItems', window );">Discrete tax benefit recognized due to temporary difference arising from buyer's excess tax basis</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory', window );">Deferred tax asset for the temporary difference arising from buyer's excess tax basis</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory', window );">Effect of discrete tax benefit on reported income tax rates (percent)</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would reduce income tax expense and the effective tax rate</a></td>
<td class="nump">882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Possible decrease in unrecognized tax benefits during the next twelve months</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Intra-entity Transfer, Assets Other Than Inventory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncomeTaxExpenseBenefitDiscreteItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit) Discrete Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncomeTaxExpenseBenefitDiscreteItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from intra-entity transfer of asset within consolidated group. Excludes intra-entity transfer of inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354716751192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePrice', window );">Put right redemption price per share (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PutRightValueInterestRateSpread', window );">Put right value, interest rate spread (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Decrease in carrying value of non-controlling interest</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="nump">$ 37,000,000<span></span>
</td>
<td class="nump">$ 93,000,000<span></span>
</td>
<td class="nump">$ 76,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Associated increase in Company's ownership interest on its equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying value of redeemable noncontrolling interests</a></td>
<td class="nump">1,265,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,265,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,402,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">53,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">107,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Decrease in carrying value of non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Decrease in noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying value of redeemable noncontrolling interests</a></td>
<td class="nump">1,265,000,000<span></span>
</td>
<td class="nump">1,384,000,000<span></span>
</td>
<td class="nump">1,265,000,000<span></span>
</td>
<td class="nump">1,384,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,414,000,000<span></span>
</td>
<td class="nump">1,402,000,000<span></span>
</td>
<td class="nump">$ 1,399,000,000<span></span>
</td>
<td class="nump">$ 1,393,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Associated increase in Company's ownership interest on its equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember', window );">Mckesson Europe Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests', window );">Annual recurring dividend (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember', window );">Mckesson Europe Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments for purchase shares of Mckesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased', window );">Shares purchased (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying value of redeemable noncontrolling interests</a></td>
<td class="nump">1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue', window );">Maximum redemption value of redeemable noncontrolling interest</a></td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage (as a percent)</a></td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember', window );">Vantage and ClarusOne Sourcing Services LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="nump">$ 42,000,000<span></span>
</td>
<td class="nump">$ 79,000,000<span></span>
</td>
<td class="nump">$ 85,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Recurring Compensation Per Share to Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PutRightValueInterestRateSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Put Right Value, Interest Rate Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PutRightValueInterestRateSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interests, Maximum Redemption Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354628809576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive loss</a></td>
<td class="num">(125)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive loss</a></td>
<td class="num">(125)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ending balance</a></td>
<td class="nump">1,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive loss</a></td>
<td class="num">(151)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Beginning balance</a></td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">1,399<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
<td class="nump">1,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive loss</a></td>
<td class="num">(151)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercises of Put Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ending balance</a></td>
<td class="nump">$ 1,265<span></span>
</td>
<td class="nump">$ 1,384<span></span>
</td>
<td class="nump">$ 1,265<span></span>
</td>
<td class="nump">$ 1,384<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase (Decrease) Due to Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestIncreaseDecreaseDuetoOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationofTemporaryEquitytoLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationofTemporaryEquitytoLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354632281608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share - Schedule of Computation for Basic and Diluted Earnings per Common Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">$ 627<span></span>
</td>
<td class="num">$ (676)<span></span>
</td>
<td class="nump">$ 1,122<span></span>
</td>
<td class="num">$ (193)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations attributable to McKesson</a></td>
<td class="nump">577<span></span>
</td>
<td class="num">(729)<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="nump">$ 577<span></span>
</td>
<td class="num">$ (730)<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
<td class="num">$ (307)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Restricted stock units (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 3.54<span></span>
</td>
<td class="num">$ (3.99)<span></span>
</td>
<td class="nump">$ 6.26<span></span>
</td>
<td class="num">$ (1.62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">3.54<span></span>
</td>
<td class="num">(3.99)<span></span>
</td>
<td class="nump">6.26<span></span>
</td>
<td class="num">(1.65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">3.56<span></span>
</td>
<td class="num">(3.99)<span></span>
</td>
<td class="nump">6.31<span></span>
</td>
<td class="num">(1.62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 3.56<span></span>
</td>
<td class="num">$ (3.99)<span></span>
</td>
<td class="nump">$ 6.30<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities (shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354629326872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="num">$ (69)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">9,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">3,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">1,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 1,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354629203496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 6,529<span></span>
</td>
<td class="nump">$ 6,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(3,499)<span></span>
</td>
<td class="num">(3,236)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 3,030<span></span>
</td>
<td class="nump">3,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 3,736<span></span>
</td>
<td class="nump">3,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,127)<span></span>
</td>
<td class="num">(1,950)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,609<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Service agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 997<span></span>
</td>
<td class="nump">994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(506)<span></span>
</td>
<td class="num">(480)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 491<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember', window );">Pharmacy licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">26 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 502<span></span>
</td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(222)<span></span>
</td>
<td class="num">(232)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="nump">260<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 894<span></span>
</td>
<td class="nump">808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(314)<span></span>
</td>
<td class="num">(242)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 580<span></span>
</td>
<td class="nump">566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(113)<span></span>
</td>
<td class="num">(111)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(217)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354629103944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>numberOfSegments</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | numberOfSegments</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 69,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 69,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,360,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible assets</a></td>
<td class="nump">106,000,000<span></span>
</td>
<td class="nump">$ 118,000,000<span></span>
</td>
<td class="nump">212,000,000<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Estimated annual amortization expense, remainder of 2021</a></td>
<td class="nump">196,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization expense, 2022</a></td>
<td class="nump">367,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">367,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization expense, 2023</a></td>
<td class="nump">265,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization expense, 2024</a></td>
<td class="nump">248,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization expense, 2025</a></td>
<td class="nump">245,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Estimated annual amortization expense, thereafter</a></td>
<td class="nump">1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">69,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLossNetOfTax', window );">After-tax goodwill impairment</a></td>
<td class="nump">69,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,456,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,456,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,443,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember', window );">Retail Pharmacy Reporting Unit | International | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of loss recognized that results from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354636209960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Lease and other obligations</a></td>
<td class="nump">$ 239<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="nump">7,608<span></span>
</td>
<td class="nump">7,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: Current portion</a></td>
<td class="nump">1,760<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">$ 5,848<span></span>
</td>
<td class="nump">6,335<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A365NotesDueNovember302020Member', window );">3.65% Notes due November 30, 2020 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member', window );">4.75% Notes due March 1, 2021 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 323<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member', window );">2.70% Notes due December 15, 2022 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member', window );">3.80% Notes due March 15, 2024 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member', window );">7.65% Debentures due March 1, 2027 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member', window );">3.95% Notes due February 16, 2028 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member', window );">6.00% Notes due March 1, 2041 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 282<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member', window );">4.88% Notes due March 15, 2044 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 411<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member', window );">0.63% Euro Notes due August 17, 2021 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 703<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member', window );">1.50% Euro Notes due November 17, 2025 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member', window );">1.63% Euro Notes due October 30, 2026 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member', window );">3.13% Sterling Notes due February 17, 2029 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 597<span></span>
</td>
<td class="nump">$ 557<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A365NotesDueNovember302020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A365NotesDueNovember302020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354628060008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Long-Term Debt Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">$ 7,608<span></span>
</td>
<td class="nump">$ 7,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 1,760<span></span>
</td>
<td class="nump">$ 1,052<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354629728888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Revolving Credit Facilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Global Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Syndicated senior unsecured revolving credit facility term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases', window );">Committed balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Uncommitted balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Facility | The 2020 Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Syndicated senior unsecured revolving credit facility term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amounts outstanding under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio', window );">Debt to capital covenant ratio (no greater than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Facility | Canadian Dollar, British Pound Sterling, and Euros Sublimit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Terms, Maximum Debt To Capital Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354629966360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Commercial Paper (Details) - Commercial Paper - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Outstanding notes (up to)</a></td>
<td class="nump">$ 4,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Proceeds from issuance of commercial paper</a></td>
<td class="nump">5,300,000,000<span></span>
</td>
<td class="nump">$ 8,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Repayments of commercial paper</a></td>
<td class="nump">5,300,000,000<span></span>
</td>
<td class="nump">$ 8,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermCommercialPaperCurrent', window );">Commercial paper</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermCommercialPaperCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the current portion of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermCommercialPaperCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354726375880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Narrative (Details) - Pension Plan<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>participant</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Cash contributions to the plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedPercentage', window );">Percentage threshold of greater of projected benefit obligation or market value of assets (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanSettlementPlanParticipants', window );">Number of participants elected to receive settlement | participant</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Lump sum payments under settlement</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Pre-tax settlement expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract', window );">Annuity contracts purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States | Other income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Pre-tax settlement expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Payment For Annuity Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanSettlementPlanParticipants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Settlement, Plan Participants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanSettlementPlanParticipants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of plan assets to benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354717118424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Narrative (Details)<br> &#163; in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="3"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Apr. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>GBP (&#163;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax', window );">Gains on non-derivative net investment hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) from cash flow hedges recorded within other comprehensive income</a></td>
<td class="num">$ (19,000,000)<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="num">$ (24,000,000)<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) from net investment hedges recorded within other comprehensive income</a></td>
<td class="num">(83,000,000)<span></span>
</td>
<td class="nump">91,000,000<span></span>
</td>
<td class="num">(117,000,000)<span></span>
</td>
<td class="nump">67,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember', window );">Forward contracts to hedge Euro against British Pound cash flows | Derivatives not Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="nump">44,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gain (loss) on financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Derivatives used in net investment hedge, gains (loss) gross</a></td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="num">(63,000,000)<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | November 2018 cross currency swaps | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities', window );">Proceeds from termination of derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gain (loss) on financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) from cash flow hedges recorded within other comprehensive income</a></td>
<td class="num">(23,000,000)<span></span>
</td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="num">(28,000,000)<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency swap | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward starting interest rate swaps | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">&#8364; 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember', window );">British Pound Sterling Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_November2018CrossCurrencySwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_November2018CrossCurrencySwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354629393128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Derivative Instruments Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Prepaid expenses and other/Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">925<span></span>
</td>
<td class="nump">1,279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Non-current Asset / Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">3,313<span></span>
</td>
<td class="nump">3,313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Forward starting interest rate swaps | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">1,203<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting | Foreign Exchange Contract | Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting | Foreign Exchange Contract | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">U.S. Dollar, notional amount, liability</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_NoncurrentAssetLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_NoncurrentAssetLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354749791496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>company</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">$ 235,000,000<span></span>
</td>
<td class="nump">$ 235,000,000<span></span>
</td>
<td class="nump">$ 170,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies', window );">Number of companies in which equity securities were converted into public common stock | company</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized gain (loss) on equity investments</a></td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="nump">59,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Fair value, inputs, level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying amount of liabilities</a></td>
<td class="nump">7,600,000,000<span></span>
</td>
<td class="nump">7,600,000,000<span></span>
</td>
<td class="nump">7,400,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of liabilities</a></td>
<td class="nump">8,400,000,000<span></span>
</td>
<td class="nump">8,400,000,000<span></span>
</td>
<td class="nump">7,800,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Fair value, inputs, level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Investments in money market funds</a></td>
<td class="nump">129,000,000<span></span>
</td>
<td class="nump">129,000,000<span></span>
</td>
<td class="nump">2,000,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities measured at fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, Equity Security Investments Converted Into Public Common Stock, Number of Companies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354717049896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 17, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($) </div>
<div>company</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>state </div>
<div>case </div>
<div>state_attorney </div>
<div>county</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>county</div>
</th>
<th class="th">
<div>Jan. 14, 2020 </div>
<div>company</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>relator</div>
</th>
<th class="th">
<div>Aug. 13, 2019 </div>
<div>fax_number </div>
<div>fax</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids', window );">Aggregate annual surcharge on licensed manufacturers and distributors of opioids</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Pre-tax accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualAfterTax', window );">After-tax accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_InreNationalPrescriptionOpiateLitigationMember', window );">In re: National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Pre-tax charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofCounties', window );">Number of counties that filed claims | county</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelKelley19Cv2233Member', window );">United States ex rel. Kelley, 19-cv-2233</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofRelatorsAllegingViolations', window );">Number of relators alleging violations | relator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass', window );">Number of faxes remaining in the class | fax_number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyClassActionNumberofFaxesReceived', window );">Number of faxes received | fax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyDamagesSoughtPerViolationValue', window );">Statutory damages sought per violation</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyDamagesSoughtPerViolationValue', window );">Statutory damages sought per violation</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStates', window );">Number of states in which court cases are pending | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStateAttorneyGenerals', window );">Number of attorney generals that have filed claims | state_attorney</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfCountyGovernments', window );">Number of county government plaintiffs | county</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | In re: National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts', window );">Number of cases selected for possible remand to other federal courts | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | In re: National Prescription Opioid Litigation | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Period over which award would be payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | Three Largest U.S. Pharmaceutical Distributors | In re: National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges', window );">Number of largest pharmaceutical distributors to adopt anti-diversion programs under proposed framework | company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | Three Largest U.S. Pharmaceutical Distributors | In re: National Prescription Opioid Litigation | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges', window );">Number of largest pharmaceutical distributors to adopt anti-diversion programs under proposed framework | company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Period over which award would be payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClassActionNumberofFaxesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action, Number of Faxes Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClassActionNumberofFaxesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action, Number of Faxes Remaining in the Class</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClassActionNumberofFaxesRemainingintheClass</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyDamagesSoughtPerViolationValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Damages Sought Per Violation, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyDamagesSoughtPerViolationValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofCounties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Counties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofCounties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofRelatorsAllegingViolations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Relators Alleging Violations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofRelatorsAllegingViolations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStateAttorneyGenerals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of State Attorney Generals</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStateAttorneyGenerals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Award Payment Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementAgreementAwardPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfCountyGovernments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of County Governments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfCountyGovernments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_InreNationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_InreNationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelKelley19Cv2233Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesExRelKelley19Cv2233Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354629514424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 29, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 28, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare', window );">Number of votes per share of common stock permitted on proposals presented to stockholders (vote) | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.83<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price of shares repurchased (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember', window );">Open Market Share Repurchase Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Authorized amount available for future repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember', window );">Open Market Share Repurchase Transactions | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number of Votes Per Common Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockVotingRightsNumberofVotesPerCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354632975416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)<br> &#8364; in Millions, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>GBP (&#163;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Foreign currency translation adjustments, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax', window );">Reclassified to income statement, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Unrealized gains (loss) on cash flow hedges arising during period, tax</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect', window );">Net actuarial loss and prior service cost arising during the period, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax', window );">Amortization of actuarial (gain) loss and prior service costs, tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax', window );">Foreign currency translation adjustments and other, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax', window );">Net actuarial gain (losses) attributable to redeemable noncontrolling interest</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">111<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">111<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest', window );">Translation gain (loss) attributable to redeemable noncontrolling interest</a></td>
<td class="num">(119)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(70)<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(70)<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Unrealized gains (losses) on net investment hedges arising during period, tax</a></td>
<td class="nump">25<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassified to income statement, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) from net investment hedges recorded within other comprehensive income</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Unrealized gains (losses) on cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassified to income statement, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember', window );">Net actuarial gain and prior service cost arising during the period, net of income tax benefit of nil, $2, nil, and $1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember', window );">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember', window );">Foreign currency translation adjustments and other, net of income tax expense of nil, nil, nil, and nil</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Changes in retirement-related benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassified to income statement, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember', window );">British Pound Sterling Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Euro Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) from net investment hedges recorded within other comprehensive income</a></td>
<td class="num">(83)<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Derivatives used in net investment hedge, gains (loss) gross</a></td>
<td class="num">$ (12)<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="num">$ (63)<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income Translation Impact On Pension Plans, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30755-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30755-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354632924136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 5,653<span></span>
</td>
<td class="nump">$ 8,068<span></span>
</td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 8,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">13<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="num">(125)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">6,090<span></span>
</td>
<td class="nump">6,692<span></span>
</td>
<td class="nump">6,090<span></span>
</td>
<td class="nump">6,692<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,742)<span></span>
</td>
<td class="num">(1,564)<span></span>
</td>
<td class="num">(1,780)<span></span>
</td>
<td class="num">(1,628)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">111<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">111<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="num">(119)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">230<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,512)<span></span>
</td>
<td class="num">(1,659)<span></span>
</td>
<td class="num">(1,512)<span></span>
</td>
<td class="num">(1,659)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(70)<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(70)<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(69)<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Unrealized gains (losses) on cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">25<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember', window );">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(112)<span></span>
</td>
<td class="num">(216)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(237)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(116)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="num">(116)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,735)<span></span>
</td>
<td class="num">(1,778)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">(1,849)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (1,597)<span></span>
</td>
<td class="num">$ (1,704)<span></span>
</td>
<td class="num">$ (1,597)<span></span>
</td>
<td class="num">$ (1,704)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354632668536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business (Details)<br> numberOfProducts in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>numberOfSegments </div>
<div>country </div>
<div>numberOfProducts</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>country </div>
<div>numberOfProducts</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | numberOfSegments</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 60,808<span></span>
</td>
<td class="nump">$ 57,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,487<span></span>
</td>
<td class="nump">$ 113,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">634<span></span>
</td>
<td class="nump">626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,312<span></span>
</td>
<td class="nump">1,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate income (expenses), net</a></td>
<td class="num">(148)<span></span>
</td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(216)<span></span>
</td>
<td class="num">(511)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest expense</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(120)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="nump">655<span></span>
</td>
<td class="num">(970)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="num">(351)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Pre-tax credits related to LIFO accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Proportionate loss from investment in Change Healthcare</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Pre-tax dilution loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Joint Venture | Change Healthcare JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Proportionate loss from investment in Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Pre-tax settlement expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_InreNationalPrescriptionOpiateLitigationMember', window );">In re: National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate income (expenses), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Charge in connection with State of New York's Opioid Stewardship Act</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Opioid-related settlement charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Pre-tax litigation expense</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | numberOfSegments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">$ 853<span></span>
</td>
<td class="num">(556)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,626<span></span>
</td>
<td class="nump">280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,454)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Pre-tax credits related to LIFO accounting</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">48,067<span></span>
</td>
<td class="nump">45,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,737<span></span>
</td>
<td class="nump">89,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">623<span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,236<span></span>
</td>
<td class="nump">$ 1,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLossNetOfTax', window );">After-tax goodwill impairment</a></td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Strategic Growth Initiative Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which entity segment operates | country</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 9,540<span></span>
</td>
<td class="nump">9,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,092<span></span>
</td>
<td class="nump">18,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="num">(45)<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (42)<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfNationalBrandMedicalSurgicalProducts', window );">Number of national brand medical-surgical products offered (more than) | numberOfProducts</a></td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 2,533<span></span>
</td>
<td class="nump">2,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,334<span></span>
</td>
<td class="nump">3,959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">668<span></span>
</td>
<td class="nump">626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,324<span></span>
</td>
<td class="nump">1,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
<td class="nump">$ 198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CorporateOperatingExpenseandOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate Operating Expense and Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CorporateOperatingExpenseandOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfNationalBrandMedicalSurgicalProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of National Brand Medical-Surgical Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfNationalBrandMedicalSurgicalProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RevenueDerivedFromServicesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Derived From Services, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RevenueDerivedFromServicesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=121548190&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of loss recognized that results from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_InreNationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_InreNationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MVCPG*(RY5..,P5P^TII@B,/&'15-=Q01/;"FXW+'0PE38VR?NSI=!,3T>D9
ME%.F<T50S._(<LI:JLQ.5:U$5M,D1_4*OS\FJ4 ;=NUM=Q8!U4F;F'XPTDF;
MH+&QO(BCG51YR[C5,)1;&8<_MK'Z2424I;#">5G.=1F392;7$(PG*/ZRMX&6
MG:RB]%&03R)*U&H.@I?\*6/XZ2O\OLWPU.#[>MH$@?2IZ[EZE/9Z"CL\=25&
M*\:H78U=IDJ NE>O58\2=1$58E!%0+Y!% &!4-&Y8BC61;659-2NR6I9>Y2
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MEJ&NAD#CRY%W-[X6D@D&&NG*Z!!/(>JI*[2M"N#V-T5EP]K+U'QE0WVF,T5
M)M,#/(6H)YWI<.=L="VRQ_)0.H?,V*:J.OMJ[C8'W^?E<:]V_X)^F%#D_I1^
M"*MC[=9]=<I^%66/,?2?1"QA*&<0P$RSZN"ZNE!R4Y[,/DBEY+K\NA+10F0%
M 'Y?2JE>+XH!FG\?./L74$L#!!0    ( /M(8U&(/@&['00  # .   8
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MU2%NAI&Z9P'7!FI_RIA<3?1)7M[<^O\ 4$L#!!0    ( /M(8U%VM7-C.0L
M %9$   8    >&PO=V]R:W-H965T<R]S:&5E=#8N>&ULO5QK;]LX%OTK0C#
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M]]ZD,Q/X:4D-7>SP1&>I74G([J'''0V2Z;HJD;H<'M#T2I1Q^JH%<0^^V3E
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M-C;KDW6W_G/S3MQ1.6>E(AQF2'FM+G8?N>Z]:T&+RO[Z4Z&QD=AICL\52&.
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M=?)P%N/),B"#!'_>>W(#GT(/"5JYJ6?/U7/M+:^_'!WVF*U+T$5=8 CJ-4*
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M+_1-BAZ"2!.*,:0N"IE2I5%,@GL2JX+"";;F7QS+!N C */,$=C386U.OB(
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MG\QM"<-A),BQ0"PUEG"')P3A[JA9.&B3@^7TS@#.04/YR<@; I3TTQ@LOE)
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M,9+47%.,%5'K7/FU4O4?<3K*N8,>\4X0$_6KT-\B&>AVO&@SA.C;#6D'XIN
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MJ5_S[6#75ZAQ[UM@I3!!TQ=/$@N[PV?!]FG[4746OB5VR\,76;#B4H.42[7
MULGHY'@0.EGZX<V*ORS.C?>FXC\+)9%*6H#W"V-\^D$*VD_-Y[\#4$L#!!0
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MB)[60(TJL&ZQ";',:'P(3']''(3?G".BO6;D;*'5&A?M+:/? E;[/][L0ZC
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MLXQG\=:'IWT'*TA6/ZHT7I8:PRT:C]@7"$HL^YC%(EX_WX?UC0MA[<)E^*3
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MO\%WWVO4^",%TCRJ L%R-4["L'=\W *E2^E#VT/NE8@#+Z$I:O)51Z4%W(P
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M LI(-(P?B]L)BS48KTO!^[WE/9;6"&YJM!;*T&?1])+$%I8*X,_(P&>)7X4
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M 5'WPQJ//FF8 /MKC5XY3%C!^(P\^QM02P,$%     @ ^TAC4;E. 7[4!P
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M/&_*,1^G;#9+6!Q-QS\9MW5NS*>^OK/I&<Q[8G_.G.ZP8L:F"QS3!"#&L'X
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ML)(,09(:-]"["([WM[54]I6>0QD<^$O=OPJ[5Y0MPQ X=TWEFV420W4ERS-
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M:01IVV4W&!W^^..!XV=O!]M::V0K4N&V1!<T%E+=4KF^OP<>PZ#@83/%Y7C
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M_ MG3+<LQ%2^4IWZ_EO;;@M+HS$;?>"M\ML@SC1T*'>=Q;<&[W7?7[>KE>G
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M+.[EY&?LQ5X4P=/N1.&MT'MD%Y;@HQ6"6GNA3]?A45!N,U%M&,,N-LN#<2E
MCP08U56[QY58AWVO3=HKAWVOWD&AWOYX>+RC_#']:VO*_\K/?I$&N;T;;#C:
MJ,/]9J@-GC;VJNB4GM;I/LG3N%G,+4WNQW$WI]=Y#E^C5M3]C&VO/SJESLS7
M<;!!L.5?U,L?])[F7H,1\1^6_,-%@L[@.?SK#Y!U40[]7V7=/UDPJ"7=8%Q8
MQL"_;>*73909Z%#9S7 X>E(P\.^/1B&WY\F:0]_@?FHH&([I_W[&ZNNCKN@/
MOE:FK?7PU[WS9G 4>@=#07/<KYCOT?\=0:#4YZ _YMC>\==%_=2KZJA.[W=.
MM'\REZKGUTH'X8C@[M.K@69WZ'VJ. :M46_\-)^B-[&P9,3XGN@%S^%.XY#^
MCW"G]=+C ;_K^$KNU-WO3N'3W*D;5-SW1=#K/Y,_[?NN]+SV>>Y"88=.'R'3
M)Q_ R7^I6]VMOG.^\)_WKH?[CZ1A83,R[51-,;73'O9/A/$?'OL+IY?\L>]$
M.Z<7?#I7,E:&!N#Y5&M77M "U=??;_X+4$L#!!0    ( /M(8U'B3,91KPP
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M>X[*0[S1.N?C0323^AP=.L&F$<;M>+#X)"B1PBMG)EJC&?HC1&@-%3SN;I=
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M4V0C.,!&+ ! _0Z&Z!$I66;\,2&EG$+<J+C*=5N9-A=*W/?,,">Q4K)ZN7<
MJT\@WN@Z7I,0)W1- JJ)M.ZY/]F[W,+@ZVH,JLP\3WE*@6@%M0M[, ';]F4N
MS1(Y4>\'P]^A';XX&*A<DNP)401&PK#L*IF24FL#BRW?)B8YF5SN.7B7_B(Y
M3Z*+B!GD'$$>KIP5WU.RL8I=XX@@J5,+'FZI9KEEO ?AU'#=@GP:<>N-%Q76
M9=0E3EJH/A3H.3*AS5*'96SK\G(Q(N&&1C2I]N?.4'R9.L+@D"_(5669G$TK
M2G?L$>26I6F=J'_0E=32O$N@*HR;@VNTZ)&EC\KT9-HS C<38OU#9<F@(--M
MF3U!2"8[>5NV(2%S%%XIO>3K/<VXZUA<K]WER"4[$5]SUH)3OV7UF/"X%WL
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M>,^N^NOE/_'^DJ9SN6W(6XX;4@VI #Q0_<77+XS<N\MF+0U=76ZZHW\%5%:
MOF\D41\6UL#X]['\"5!+ P04    " #[2&-1+-0@6'@#  !O"   &0   'AL
M+W=O<FMS:&5E=',O<VAE970S,2YX;6RM5MMNVS@0_96!MB@:(+4DRDF3K&W
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MHBB3E,93'SL['W>Q[Y=%:??+TA![.H(5Y3ZON*)W.9U%?LL^KT#>*?UWS%Y
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MZ</96MKWK.Q BYEYMVDHM!93<SEA-&$2)\#]D1"Z&. &Y<MN%W\ 4$L#!!0
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MC+D64._7C,G#@S907O5,_@502P,$%     @ ^TAC49AN"+DH!@  PAX  !D
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M2Q38<9TU]S2RN32RL<QV<!=V<.NC=?V$;R$W@FY-'G@+SM[^DJ^_$-IO<FO
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M^A<]C*>NQMYJ8556CFE397'H*V\38#'H0@"?SY2RRT6AH/GS8?0?4$L#!!0
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ML?T=\KVWB'C$ZTE_&$__3!6DX[YT%RI2E85492$%GC^ =R[#")!? ?D%4#
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MIOM8/O+#KZP:4*#BA3S.BK_@4-F.!R#<9Y(GE7.>01*EY7_ZHRK$D4,>Q^Z
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M!;TA%D%5LW9U8^3&#9-+:7 T=9=K_#X!90WP>2ZE>;FQ!,T7S^Q?4$L#!!0
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M>;[,L,27YYRM ==XQ4__R),NIU=I0A.]/I:2JZ]4T<G+SR0D:L7=101\9$G
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M8ZH^\>=?:>W0I.#;\%26O^BYQOH#M#E*Q;/:&%:0L;SZ)R^U$!T#X+$;X-H
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M970T-2YX;6RMF5%SXC80Q[^*AKF'NYE<C"0#<88P$R!M[R&=3&C:ATX?%%N
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M$/H50M^*<+I8;--M0J2:#@6/R_B_HN[:0.XC^;7\5]@+FRC;K! .VF$&%<S
M"C/GR G3&!@SA%WL-@ &!D ,_0Y\PPK?T(IO5L@(Y4IVDV+^Q#K>"$L%C:K
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MH&O3 O!^S;EZ'>@%JAN]R?]02P,$%     @ ^TAC43@V/'(&!@  AB0  !D
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MG_3!JX-9A3F_S.*_HHW<74R""=CPN["(Y=?LX3=>'1 MZZVS.-=_P4,UUIN
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M;,",W>QD4Z\MEI06(4-N@HEA+!DEN1+#1C)F<NTIKOOEDFE@2LZ97(F=7%&
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M=?-<,@UBV3E#+;-#+9V?+J"T#:*G"RBSQD,BY1,Z*J-N57- S._4+$_=UTV
M.#ST<G@AL[U^;F2529DE>G/'PPT7Y0#U^5VF/%*]*!]%J1\]6OX/4$L#!!0
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M( "U;\Y]8&3E[_=*&MLM?KBU[QDJEV#7UU*:0^!:IGLAL]]02P,$%     @
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M-,!(_$')7AX](^W*DO-O>O Y'CJ>9D12$BFM L//CDQ(FFI-P..?0JE3VM3
MX^>#]KEQ'IQ98DDF//V3QBH9.G<.BLD*;U/UQ/>?2.%03^N+>"K--]H7LIZ#
MHJU4/"O P""C+/_%WXM ' % 3S,@* !!6T"G '3: KH%H-L6T"L O=> [AE
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M<#4P6ZNJ\E]U2!:N("XDF?+JFFOS8J*R 69^*<T-J#MV@>8-'OT'4$L#!!0
M   ( /M(8U$0JYT&'P0  *4.   9    >&PO=V]R:W-H965T<R]S:&5E=#4R
M+GAM;+U7VV[C-A#]%4+8 EF@&]U\B0/;0&S'Z1:;K;%&VH>B#[0TMMA(I$I2
M<0+TXSN49/DFJ0Y:[(M-4G,.9X8SG.%P*^2SB@ T>4UBKD96I'5Z:]LJB""A
MZEJDP/'+6LB$:IS*C:U2"33,04EL>X[3LQ/*N#4>YFL+.1Z*3,>,PT(2E24)
ME6\3B,5V9+G6;N$;VT3:+-CC84HWL 3]E"XDSNR*)60)<,4$)Q+6(^O.O7UP
MNP:02_S*8*L.QL28LA+BV4P^AR/+,1I!#($V%!3_7F *<6R84(^_2E*KVM,
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MA,8&/Q]&^(X$:03P^UH(O9N8#:J7Z?@?4$L#!!0    ( /M(8U$4C=1>I@8
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M7@7LXP:O=R - -^OA-"'@5F@NC#._P-02P,$%     @ ^TAC4<:&7H#$!@
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M$?XK&#73)C-V)( 72:[M&5MD'&>24T^<M ^=/M B)+$A"1T2LI,SY\=W>9%
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MK*N/*\[F/"\%ZO>%$/+I2]G![K]$7/P/4$L#!!0    ( /M(8U%O,\W%K@H
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M31U$IP5/FVW]?$%-_*8&/3A0)UN7<3O.I7U)0;Z=@M[3>;$3OGC89LMR2_S
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M+O]<T5#$6"$@?E\PQO<?B@X.#YRO_P]02P,$%     @ ^TAC4267@-J  @
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MIE/PG<01R:V>1Q6!-G2_'1TE"5U_H"3F#+O-'UQP.D%E'E@*21YU-=,J"VW
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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M_8-QY045Q5J3YJ-[4YYFS3NM72W$S)4]R@=%R].6MM-VO*__ E!+ P04
M" #[2&-1F!M:GOL!  #+(P  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QSS=I+;J- %(7AK5@L(.7[(DDKSJ@GF4;9 '+*#\4VB**59/=M.0/GH![T
M)*HS0@7B\H\^$/#PG _=M.]/9;<?RN+C>#B55;.;IN%72F6]R\>NW/1#/IV/
M;/KQV$WGY;A-0[=^Z[8YZ7+9IO'[C.;QX?O,Q<OGD/]G8K_9[-?Y=[_^<\RG
MZ1^#TWL_OI5=SE.S>.G&;9Y63?HX7'>7=-G(S7ERLWAZ737CTZLTJ7:00I#6
M#S((LOI!#D%>/R@@*.H'M1#4U@^ZA:#;^D%W$'17/^@>@N[K!\D295P2),VP
M)M!:D&LA\%H0;"$06Y!L(3!;$&TA4%N0;2%P6Q!N(9!;D&XAL%L0;R'06U%O
M)=!;46\ET%MG#]L$>BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'HKZJT$>BOJ
MK01Z&^IM!'H;ZFT$>AOJ;01ZV^QE"8'>AGH;@=Z&>AN!WH9Z&X'>AGH;@=Z&
M>AN!WH9Z&X'>CGH[@=Z.>CN!WHYZ.X'>CGH[@=X^>]E-H+>CWDZ@MZ/>3J"W
MH]Y.H+>CWDZ@MZ/>3J!WH-Y!H'>@WD&@=Z#>0:!WH-Y!H'>@WD&@=\P^5A+H
M':AW$.@=J'<0Z!VH=Q#H':AW$.C=HM[M3^I=IL]#+M>>KS5>_R>IGL[GYNOE
M+\NOG7B_:"\X)_AWY_$O4$L#!!0    ( /M(8U%TTL9BW@$  %HC   3
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M[ U02P$"% ,4    " #[2&-1!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /M(8U'N#!].[P   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( /M(8U&97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ ^TAC45=)RD0M!@  H!\  !@
M         ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( /M(8U%"GX%V!P<  $H@   8              " @7$.  !X;"]W;W)K
M<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #[2&-1B#X!NQT$   P#@
M&               @(&N%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!
M A0#%     @ ^TAC4:%'#I*<!@  F!L  !@              ("! 1H  'AL
M+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( /M(8U'-4K_>ZP(
M ,4)   8              " @=,@  !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6Q02P$"% ,4    " #[2&-1=K5S8SD+  !61   &               @('T
M(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ ^TAC40YK
M*:F- @  # <  !@              ("!8R\  'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;%!+ 0(4 Q0    ( /M(8U$3,J=<PP<  %8@   8
M  " @28R  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " #[
M2&-131D_-<T/  #6+   &               @($?.@  >&PO=V]R:W-H965T
M<R]S:&5E=#DN>&UL4$L! A0#%     @ ^TAC4<,B# *G"0  =AX  !D
M         ("!(DH  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M    " #[2&-1\695I6T&   F#P  &0              @($ 5   >&PO=V]R
M:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( /M(8U%G?,MRM0D  "LG
M   9              " @:1:  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL
M4$L! A0#%     @ ^TAC4>@DBUT0!@  $Q   !D              ("!D&0
M 'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " #[2&-1 P+Y
MO=4'  !B&P  &0              @('7:@  >&PO=V]R:W-H965T<R]S:&5E
M=#$T+GAM;%!+ 0(4 Q0    ( /M(8U&S%A>@_00  !L-   9
M  " @>-R  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @
M^TAC47:06.HL!@  4@X  !D              ("!%W@  'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6Q02P$"% ,4    " #[2&-1N4X!?M0'  "%%   &0
M            @(%Z?@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4
M Q0    ( /M(8U&2AKHR6@4  'X-   9              " @86&  !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ ^TAC41?2'-(4#0
MQS0  !D              ("!%HP  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6Q02P$"% ,4    " #[2&-15N!FUS$*  #1'P  &0              @(%A
MF0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( /M(8U&U
M/N31RQH  /5,   9              " @<FC  !X;"]W;W)K<VAE971S+W-H
M965T,C$N>&UL4$L! A0#%     @ ^TAC4>QD]9KP"P  "2X  !D
M     ("!R[X  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /M(8U&Y1,('>P,  $@,   9              "
M@=#S  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ ^TAC
M46Q>RE#) P  (0D  !D              ("!@O<  'AL+W=O<FMS:&5E=',O
M<VAE970R."YX;6Q02P$"% ,4    " #[2&-1S? I5%$$  "N"0  &0
M        @(&"^P  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0
M   ( /M(8U%'6]:KQP,  (D(   9              " @0H  0!X;"]W;W)K
M<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ ^TAC42S4(%AX P  ;P@
M !D              ("!" 0! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q0
M2P$"% ,4    " #[2&-1UAW*[-P(  #X)@  &0              @(&W!P$
M>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( /M(8U&UOA$Z
M, @  "87   9              " @<H0 0!X;"]W;W)K<VAE971S+W-H965T
M,S,N>&UL4$L! A0#%     @ ^TAC40OBKMA.!   ]A$  !D
M ("!,1D! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " #[
M2&-1F&X(N2@&  #"'@  &0              @(&V'0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( /M(8U&BT:N<# 0  (@0   9
M          " @14D 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#
M%     @ ^TAC43 [N?K& P  A@X  !D              ("!6"@! 'AL+W=O
M<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " #[2&-12Y^#&I,$  #&
M%@  &0              @(%5+ $ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM
M;%!+ 0(4 Q0    ( /M(8U$O W:[R04  )L@   9              " @1\Q
M 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ ^TAC4=%S
MU9@<!@  8B(  !D              ("!'S<! 'AL+W=O<FMS:&5E=',O<VAE
M970T,"YX;6Q02P$"% ,4    " #[2&-1- %?Y=(#  #]#   &0
M    @(%R/0$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (
M /M(8U%AS-O=2P8   $@   9              " @7M! 0!X;"]W;W)K<VAE
M971S+W-H965T-#(N>&UL4$L! A0#%     @ ^TAC47Y4U;'Z!0  )R(  !D
M             ("!_4<! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"
M% ,4    " #[2&-1<'?M8C4%   T%@  &0              @($N3@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( /M(8U&4/S0T& 4
M +H9   9              " @9I3 0!X;"]W;W)K<VAE971S+W-H965T-#4N
M>&UL4$L! A0#%     @ ^TAC46=3?<11!0  "1L  !D              ("!
MZ5@! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " #[2&-1
M?LR##ZH$  #=$P  &0              @(%Q7@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0W+GAM;%!+ 0(4 Q0    ( /M(8U$X-CQR!@8  (8D   9
M      " @5)C 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%
M  @ ^TAC48"!TM$[ @  +04  !D              ("!CVD! 'AL+W=O<FMS
M:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " #[2&-1P[Z&MQ<$   5$0
M&0              @($!; $ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+
M 0(4 Q0    ( /M(8U$=*2P"M (  (\'   9              " @4]P 0!X
M;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ ^TAC41"KG08?
M!   I0X  !D              ("!.G,! 'AL+W=O<FMS:&5E=',O<VAE970U
M,BYX;6Q02P$"% ,4    " #[2&-1%(W47J8&  "Q(0  &0
M@(&0=P$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( /M(
M8U'[NQ'_Z 0  +\;   9              " @6U^ 0!X;"]W;W)K<VAE971S
M+W-H965T-30N>&UL4$L! A0#%     @ ^TAC42]*C,K+ P  / X  !D
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M=#4Y+GAM;%!+ 0(4 Q0    ( /M(8U%O,\W%K@H  .P\   9
M  " @;VD 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @
M^TAC4267@-J  @  6 X   T              ( !HJ\! 'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " #[2&-1EXJ[',     3 @  "P              @ %-
ML@$ 7W)E;',O+G)E;'-02P$"% ,4    " #[2&-1?K*'K+T$   2*   #P
M            @ $VLP$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ^TAC
M49@;6I[[ 0  RR,  !H              ( !(+@! 'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ ^TAC4732QF+> 0  6B,  !,
M         ( !4[H! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $0 1 "3
)$@  8KP!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>420</ContextCount>
  <ElementCount>393</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>111</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>21</UnitCount>
  <MyReports>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Investment in Change Healthcare Joint Venture</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture</Role>
      <ShortName>Investment in Change Healthcare Joint Venture</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSale</Role>
      <ShortName>Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - Restructuring, Impairment and Related Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</Role>
      <ShortName>Restructuring, Impairment and Related Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2117106 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2121107 - Disclosure - Earnings Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsPerCommonShare</Role>
      <ShortName>Earnings Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2124108 - Disclosure - Goodwill and Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2129109 - Disclosure - Debt and Financing Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivities</Role>
      <ShortName>Debt and Financing Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2135110 - Disclosure - Pension Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefits</Role>
      <ShortName>Pension Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2137111 - Disclosure - Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivities</Role>
      <ShortName>Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2141112 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2143113 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2145114 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2150115 - Disclosure - Segments of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusiness</Role>
      <ShortName>Segments of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleTables</Role>
      <ShortName>Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HeldforSale</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Restructuring, Impairment and Related Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables</Role>
      <ShortName>Restructuring, Impairment and Related Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - Earnings Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsPerCommonShareTables</Role>
      <ShortName>Earnings Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsPerCommonShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2325305 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2330306 - Disclosure - Debt and Financing Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesTables</Role>
      <ShortName>Debt and Financing Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/DebtandFinancingActivities</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2338307 - Disclosure - Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesTables</Role>
      <ShortName>Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HedgingActivities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2346308 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquity</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2351309 - Disclosure - Segments of Business (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessTables</Role>
      <ShortName>Segments of Business (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SegmentsofBusiness</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Investment in Change Healthcare Joint Venture (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails</Role>
      <ShortName>Investment in Change Healthcare Joint Venture (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Held for Sale - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleNarrativeDetails</Role>
      <ShortName>Held for Sale - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails</Role>
      <ShortName>Held for Sale - Assets and Liabilities Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Restructuring, Impairment and Related Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails</Role>
      <ShortName>Restructuring, Impairment and Related Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Restructuring, Impairment and Related Charges - Summary of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails</Role>
      <ShortName>Restructuring, Impairment and Related Charges - Summary of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Restructuring, Impairment and Related Charges - Summary of Restructuring Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails</Role>
      <ShortName>Restructuring, Impairment and Related Charges - Summary of Restructuring Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/IncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Earnings Per Common Share - Schedule of Computation for Basic and Diluted Earnings per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails</Role>
      <ShortName>Earnings Per Common Share - Schedule of Computation for Basic and Diluted Earnings per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2426412 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2427413 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2428414 - Disclosure - Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2431415 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails</Role>
      <ShortName>Debt and Financing Activities - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2432416 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails</Role>
      <ShortName>Debt and Financing Activities - Long-Term Debt Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2433417 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails</Role>
      <ShortName>Debt and Financing Activities - Revolving Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails</Role>
      <ShortName>Debt and Financing Activities - Commercial Paper (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2436419 - Disclosure - Pension Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsNarrativeDetails</Role>
      <ShortName>Pension Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2439420 - Disclosure - Hedging Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesNarrativeDetails</Role>
      <ShortName>Hedging Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2440421 - Disclosure - Hedging Activities - Derivative Instruments Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails</Role>
      <ShortName>Hedging Activities - Derivative Instruments Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2442422 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FairValueMeasurements</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2444423 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails</Role>
      <ShortName>Commitments and Contingent Liabilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2447424 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2448425 - Disclosure - Stockholders' Equity - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2449426 - Disclosure - Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mck-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2452427 - Disclosure - Segments of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessDetails</Role>
      <ShortName>Segments of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SegmentsofBusinessTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mck-20200930.htm">mck-20200930.htm</File>
    <File>mck-20200930.xsd</File>
    <File>mck-20200930_cal.xml</File>
    <File>mck-20200930_def.xml</File>
    <File>mck-20200930_lab.xml</File>
    <File>mck-20200930_pre.xml</File>
    <File>mckexhibit1019302020.htm</File>
    <File>mckexhibit3119302020.htm</File>
    <File>mckexhibit3129302020.htm</File>
    <File>mckexhibit329302020.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mck-20200930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>78
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mck-20200930.htm": {
   "axisCustom": 0,
   "axisStandard": 35,
   "contextCount": 420,
   "dts": {
    "calculationLink": {
     "local": [
      "mck-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mck-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "mck-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mck-20200930_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mck-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mck-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 596,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 1,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 6
   },
   "keyCustom": 47,
   "keyStandard": 346,
   "memberCustom": 52,
   "memberStandard": 56,
   "nsprefix": "mck",
   "nsuri": "http://mckesson123.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://mckesson123.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Investment in Change Healthcare Joint Venture",
     "role": "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture",
     "shortName": "Investment in Change Healthcare Joint Venture",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Held for Sale",
     "role": "http://mckesson123.com/role/HeldforSale",
     "shortName": "Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - Restructuring, Impairment and Related Charges",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges",
     "shortName": "Restructuring, Impairment and Related Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Income Taxes",
     "role": "http://mckesson123.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117106 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121107 - Disclosure - Earnings Per Common Share",
     "role": "http://mckesson123.com/role/EarningsPerCommonShare",
     "shortName": "Earnings Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124108 - Disclosure - Goodwill and Intangible Assets, Net",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129109 - Disclosure - Debt and Financing Activities",
     "role": "http://mckesson123.com/role/DebtandFinancingActivities",
     "shortName": "Debt and Financing Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135110 - Disclosure - Pension Benefits",
     "role": "http://mckesson123.com/role/PensionBenefits",
     "shortName": "Pension Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137111 - Disclosure - Hedging Activities",
     "role": "http://mckesson123.com/role/HedgingActivities",
     "shortName": "Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141112 - Disclosure - Fair Value Measurements",
     "role": "http://mckesson123.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143113 - Disclosure - Commitments and Contingent Liabilities",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145114 - Disclosure - Stockholders' Equity",
     "role": "http://mckesson123.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150115 - Disclosure - Segments of Business",
     "role": "http://mckesson123.com/role/SegmentsofBusiness",
     "shortName": "Segments of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - Held for Sale (Tables)",
     "role": "http://mckesson123.com/role/HeldforSaleTables",
     "shortName": "Held for Sale (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Restructuring, Impairment and Related Charges (Tables)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables",
     "shortName": "Restructuring, Impairment and Related Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - Earnings Per Common Share (Tables)",
     "role": "http://mckesson123.com/role/EarningsPerCommonShareTables",
     "shortName": "Earnings Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325305 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330306 - Disclosure - Debt and Financing Activities (Tables)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesTables",
     "shortName": "Debt and Financing Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338307 - Disclosure - Hedging Activities (Tables)",
     "role": "http://mckesson123.com/role/HedgingActivitiesTables",
     "shortName": "Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2346308 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://mckesson123.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2351309 - Disclosure - Segments of Business (Tables)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessTables",
     "shortName": "Segments of Business (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "numberofsegments",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Investment in Change Healthcare Joint Venture (Details)",
     "role": "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
     "shortName": "Investment in Change Healthcare Joint Venture (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ic83c30e7937b464a894f08434c22f5e9_D20190701-20190701",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Held for Sale - Narrative (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
     "shortName": "Held for Sale - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i805f21e7f7e04fbeb97134f767b3e1a8_I20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
     "shortName": "Held for Sale - Assets and Liabilities Held for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i5a597186da7942b78a164787ea1dea53_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Restructuring, Impairment and Related Charges - Narrative (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
     "shortName": "Restructuring, Impairment and Related Charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Restructuring, Impairment and Related Charges - Summary of Restructuring Charges (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
     "shortName": "Restructuring, Impairment and Related Charges - Summary of Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i66de38bda2a744608a06a9b06ebf6645_I20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i66de38bda2a744608a06a9b06ebf6645_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Restructuring, Impairment and Related Charges - Summary of Restructuring Activity (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
     "shortName": "Restructuring, Impairment and Related Charges - Summary of Restructuring Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserveSettledWithoutCash2",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Income Taxes (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i66de38bda2a744608a06a9b06ebf6645_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i86b3fd731c6a451da95296357c34854c_I20200630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Earnings Per Common Share - Schedule of Computation for Basic and Diluted Earnings per Common Share (Details)",
     "role": "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails",
     "shortName": "Earnings Per Common Share - Schedule of Computation for Basic and Diluted Earnings per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i66de38bda2a744608a06a9b06ebf6645_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426412 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427413 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "numberofsegments",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428414 - Disclosure - Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431415 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
     "shortName": "Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
     "shortName": "Debt and Financing Activities - Long-Term Debt Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i6bd3593ba0404917bb09d01792baf9d6_I20190930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433417 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
     "shortName": "Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i44874b5446184867b047a21535e841fb_D20190901-20190930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "id887e8ba801a4f9f9555dc352f23f1de_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
     "shortName": "Debt and Financing Activities - Commercial Paper (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "id887e8ba801a4f9f9555dc352f23f1de_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ibc317023efda478c82c32736a1b73ada_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436419 - Disclosure - Pension Benefits - Narrative (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
     "shortName": "Pension Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ibc317023efda478c82c32736a1b73ada_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439420 - Disclosure - Hedging Activities - Narrative (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
     "shortName": "Hedging Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i9fa846afa17345aea4ac3fe417f8d349_D20190701-20190930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i6c01ee54c64b4e738869a1a426b32be8_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440421 - Disclosure - Hedging Activities - Derivative Instruments Fair Value (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
     "shortName": "Hedging Activities - Derivative Instruments Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i6c01ee54c64b4e738869a1a426b32be8_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442422 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i66de38bda2a744608a06a9b06ebf6645_I20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ia241be660d814c9dbfbab339569e8b37_I20180430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444423 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
     "shortName": "Commitments and Contingent Liabilities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ia241be660d814c9dbfbab339569e8b37_I20180430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i0ab19df7575e4779a1875a5d7ee85303_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447424 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockAcquiredAverageCostPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448425 - Disclosure - Stockholders' Equity - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails",
     "shortName": "Stockholders' Equity - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i624020a8d4c24a6faaadd5ffc919e8d5_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449426 - Disclosure - Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
     "shortName": "Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i08d04048582a441a9829e7d02b02b64f_I20200630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i1038eaf9e8794cbcbded983f8ccfcb9a_I20190331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "i1038eaf9e8794cbcbded983f8ccfcb9a_I20190331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "numberofsegments",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452427 - Disclosure - Segments of Business (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessDetails",
     "shortName": "Segments of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ie2c22a00d4074fbba7d5e267c66a5b2c_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:CorporateOperatingExpenseandOtherIncomeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ifc731429591343fb9685ce4e3d37b71c_D20200729-20200729",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Significant Accounting Policies",
     "role": "http://mckesson123.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20200930.htm",
      "contextRef": "ib79541f19f8e4f34a3e3ae3234644f14_D20200401-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 111,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mck_A0625NotesDue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "0.625% notes Due 2021",
        "label": "0.625% notes Due 2021 [Member]",
        "terseLabel": "0.625% notes Due 2021"
       }
      }
     },
     "localname": "A0625NotesDue2021Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A063EuroNotesDueAugust172021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "0.63% Euro Notes Due August 17, 2021",
        "label": "0.63% Euro Notes Due August 17, 2021 [Member]",
        "terseLabel": "0.63% Euro Notes due August 17, 2021"
       }
      }
     },
     "localname": "A063EuroNotesDueAugust172021Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1500NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.500% Notes Due 2025",
        "label": "1.500% Notes Due 2025 [Member]",
        "terseLabel": "1.500% Notes Due 2025"
       }
      }
     },
     "localname": "A1500NotesDue2025Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A150EuroNotesDueNovember172025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.50% Euro Notes Due November 17, 2025",
        "label": "1.50% Euro Notes Due November 17, 2025 [Member]",
        "terseLabel": "1.50% Euro Notes due November 17, 2025"
       }
      }
     },
     "localname": "A150EuroNotesDueNovember172025Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1625NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.625% Notes Due 2026",
        "label": "1.625% Notes Due 2026 [Member]",
        "terseLabel": "1.625% Notes Due 2026"
       }
      }
     },
     "localname": "A1625NotesDue2026Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A163EuroNotesDueOctober302026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.63% Euro Notes Due October 30, 2026",
        "label": "1.63% Euro Notes Due October 30, 2026 [Member]",
        "terseLabel": "1.63% Euro Notes due October 30, 2026"
       }
      }
     },
     "localname": "A163EuroNotesDueOctober302026Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A270NotesDueDecember152022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.70% Notes Due December 15, 2022",
        "label": "2.70% Notes Due December 15, 2022 [Member]",
        "terseLabel": "2.70% Notes due December 15, 2022"
       }
      }
     },
     "localname": "A270NotesDueDecember152022Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A285NotesDueMarch152023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.85% Notes Due March 15, 2023",
        "label": "2.85% Notes Due March 15, 2023 [Member]",
        "terseLabel": "2.85% Notes due March 15, 2023"
       }
      }
     },
     "localname": "A285NotesDueMarch152023Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A3125NotesDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.125% Notes Due 2029",
        "label": "3.125% Notes Due 2029 [Member]",
        "terseLabel": "3.125% Notes Due 2029"
       }
      }
     },
     "localname": "A3125NotesDue2029Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A313SterlingNotesDueFebruary172029Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.13% Sterling Notes Due February 17, 2029",
        "label": "3.13% Sterling Notes Due February 17, 2029 [Member]",
        "terseLabel": "3.13% Sterling Notes due February 17, 2029"
       }
      }
     },
     "localname": "A313SterlingNotesDueFebruary172029Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A365NotesDueNovember302020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.65% Notes Due November 30, 2020",
        "label": "3.65% Notes Due November 30, 2020 [Member]",
        "terseLabel": "3.65% Notes due November 30, 2020"
       }
      }
     },
     "localname": "A365NotesDueNovember302020Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A380NotesDueMarch152024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.80% Notes Due March 15, 2024",
        "label": "3.80% Notes Due March 15, 2024 [Member]",
        "terseLabel": "3.80% Notes due March 15, 2024"
       }
      }
     },
     "localname": "A380NotesDueMarch152024Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A395NotesDueFebruary162028Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.95% Notes Due February 16, 2028",
        "label": "3.95% Notes Due February 16, 2028 [Member]",
        "terseLabel": "3.95% Notes due February 16, 2028"
       }
      }
     },
     "localname": "A395NotesDueFebruary162028Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMarch12021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.75% Notes Due March 1, 2021",
        "label": "4.75% Notes Due March 1, 2021 [Member]",
        "terseLabel": "4.75% Notes due March 1, 2021"
       }
      }
     },
     "localname": "A475NotesDueMarch12021Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMay302029Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.75% Notes Due May 30, 2029",
        "label": "4.75% Notes Due May 30, 2029 [Member]",
        "terseLabel": "4.75% Notes due May 30, 2029"
       }
      }
     },
     "localname": "A475NotesDueMay302029Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A488NotesDueMarch152044Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.88% Notes Due March 15, 2044",
        "label": "4.88% Notes Due March 15, 2044 [Member]",
        "terseLabel": "4.88% Notes due March 15, 2044"
       }
      }
     },
     "localname": "A488NotesDueMarch152044Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A600NotesDueMarch12041Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "6.00% Notes Due March 1, 2041",
        "label": "6.00% Notes Due March 1, 2041 [Member]",
        "terseLabel": "6.00% Notes due March 1, 2041"
       }
      }
     },
     "localname": "A600NotesDueMarch12041Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A765DebenturesDueMarch12027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "7.65% Debentures Due March 1, 2027",
        "label": "7.65% Debentures Due March 1, 2027 [Member]",
        "terseLabel": "7.65% Debentures due March 1, 2027"
       }
      }
     },
     "localname": "A765DebenturesDueMarch12027Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]",
        "label": "Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Net actuarial gain and prior service cost arising during the period, net of income tax benefit of nil, $2, nil, and $1"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "label": "Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments and other, net of income tax expense of nil, nil, nil, and nil"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "label": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "terseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe",
        "verboseLabel": "Associated increase in Company's ownership interest on its equity"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "label": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "terseLabel": "Annual recurring dividend (in euro per share)"
       }
      }
     },
     "localname": "AnnualRecurringCompensationPerSharetoNoncontrollingInterests",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_AssetImpairmentChargesIncludingAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset Impairment Charges, Including Accelerated Depreciation",
        "label": "Asset Impairment Charges, Including Accelerated Depreciation",
        "terseLabel": "Asset impairments and accelerated depreciation"
       }
      }
     },
     "localname": "AssetImpairmentChargesIncludingAcceleratedDepreciation",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_BritishPoundSterlingDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "British Pound Sterling Denominated Notes [Member]",
        "label": "British Pound Sterling Denominated Notes [Member]",
        "terseLabel": "British Pound Sterling Denominated Notes"
       }
      }
     },
     "localname": "BritishPoundSterlingDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ChangeHealthcareInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change Healthcare, Inc. [Member]",
        "label": "Change Healthcare, Inc. [Member]",
        "terseLabel": "Change Healthcare, Inc."
       }
      }
     },
     "localname": "ChangeHealthcareInc.Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ChangeHealthcareLLCChangeHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change Healthcare, LLC (\u201cChange Healthcare\u201d) [Member]",
        "label": "Change Healthcare, LLC (\u201cChange Healthcare\u201d) [Member]",
        "terseLabel": "Change Healthcare JV"
       }
      }
     },
     "localname": "ChangeHealthcareLLCChangeHealthcareMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CommonStockVotingRightsNumberofVotesPerCommonShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "label": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "terseLabel": "Number of votes per share of common stock permitted on proposals presented to stockholders (vote)"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberofVotesPerCommonShare",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_CorporateOperatingExpenseandOtherIncomeNet": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/SegmentsofBusinessDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate Operating Expense and Other Income, Net",
        "label": "Corporate Operating Expense and Other Income, Net",
        "negatedTerseLabel": "Corporate income (expenses), net"
       }
      }
     },
     "localname": "CorporateOperatingExpenseandOtherIncomeNet",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CurrentAssetLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Current Asset / Liability [Member]",
        "label": "Current Asset / Liability [Member]",
        "terseLabel": "Prepaid expenses and other/Other accrued liabilities"
       }
      }
     },
     "localname": "CurrentAssetLiabilityMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant Terms, Maximum Debt To Capital Ratio",
        "label": "Debt Instrument, Covenant Terms, Maximum Debt To Capital Ratio",
        "terseLabel": "Debt to capital covenant ratio (no greater than)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantTermsMaximumDebtToCapitalRatio",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Payment For Annuity Contract",
        "label": "Defined Benefit Plan, Plan Assets, Payment For Annuity Contract",
        "terseLabel": "Annuity contracts purchased"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanSettlementPlanParticipants": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined Benefit Plan, Settlement, Plan Participants",
        "label": "Defined Benefit Plan, Settlement, Plan Participants",
        "terseLabel": "Number of participants elected to receive settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementPlanParticipants",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "label": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current",
        "label": "Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current",
        "terseLabel": "Long-term assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current",
        "terseLabel": "Long-term liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "negatedTerseLabel": "Remeasurement of assets of business held for sale to fair value less costs to sell"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainonWritedown1",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Intra-entity Transfer, Assets Other Than Inventory",
        "label": "Effective Income Tax Rate Reconciliation, Intra-entity Transfer, Assets Other Than Inventory",
        "negatedTerseLabel": "Effect of discrete tax benefit on reported income tax rates (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIntraEntityTransferAssetsOtherThanInventory",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities, Equity Security Investments Converted Into Public Common Stock, Number of Companies",
        "label": "Equity Securities, Equity Security Investments Converted Into Public Common Stock, Number of Companies",
        "terseLabel": "Number of companies in which equity securities were converted into public common stock"
       }
      }
     },
     "localname": "EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_EuroDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Euro Denominated Notes [Member]",
        "label": "Euro Denominated Notes [Member]",
        "terseLabel": "Euro Denominated Notes"
       }
      }
     },
     "localname": "EuroDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "terseLabel": "Estimated annual amortization expense, thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]",
        "label": "Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]",
        "terseLabel": "Forward contracts to hedge Euro against British Pound cash flows"
       }
      }
     },
     "localname": "ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GermanPharmaceuticalWholesaleJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "German Wholesale Joint Venture [Member]",
        "label": "German Pharmaceutical Wholesale Joint Venture [Member]",
        "terseLabel": "German Pharmaceutical Wholesale Joint Venture"
       }
      }
     },
     "localname": "GermanPharmaceuticalWholesaleJointVentureMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GermanWholesaleBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "German Wholesale Business [Member]",
        "label": "German Wholesale Business [Member]",
        "terseLabel": "German Wholesale Business"
       }
      }
     },
     "localname": "GermanWholesaleBusinessMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_IncomeTaxExpenseBenefitDiscreteItems": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Tax Expense (Benefit) Discrete Items",
        "label": "Income Tax Expense (Benefit) Discrete Items",
        "negatedTerseLabel": "Discrete tax benefit recognized due to temporary difference arising from buyer's excess tax basis"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitDiscreteItems",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncreaseDecreaseinOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase (Decrease) in Operating Lease Liabilities",
        "label": "Increase (Decrease) in Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseinOperatingLeaseLiabilities",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_InreNationalPrescriptionOpiateLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In re: National Prescription Opiate Litigation [Member]",
        "label": "In re: National Prescription Opiate Litigation [Member]",
        "terseLabel": "In re: National Prescription Opioid Litigation"
       }
      }
     },
     "localname": "InreNationalPrescriptionOpiateLitigationMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InternationalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "International Segment [Member]",
        "label": "International Segment [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalSegmentMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LossContingencyAccrualAfterTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency Accrual, After Tax",
        "label": "Loss Contingency Accrual, After Tax",
        "terseLabel": "After-tax accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAfterTax",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyClassActionNumberofFaxesReceived": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Class Action, Number of Faxes Received",
        "label": "Loss Contingency, Class Action, Number of Faxes Received",
        "terseLabel": "Number of faxes received"
       }
      }
     },
     "localname": "LossContingencyClassActionNumberofFaxesReceived",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyClassActionNumberofFaxesRemainingintheClass": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Class Action, Number of Faxes Remaining in the Class",
        "label": "Loss Contingency, Class Action, Number of Faxes Remaining in the Class",
        "terseLabel": "Number of faxes remaining in the class"
       }
      }
     },
     "localname": "LossContingencyClassActionNumberofFaxesRemainingintheClass",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyDamagesSoughtPerViolationValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Damages Sought Per Violation, Value",
        "label": "Loss Contingency, Damages Sought Per Violation, Value",
        "terseLabel": "Statutory damages sought per violation"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtPerViolationValue",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts",
        "label": "Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts",
        "terseLabel": "Number of cases selected for possible remand to other federal courts"
       }
      }
     },
     "localname": "LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofCounties": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Counties",
        "label": "Loss Contingency, Number of Counties",
        "terseLabel": "Number of counties that filed claims"
       }
      }
     },
     "localname": "LossContingencyNumberofCounties",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofRelatorsAllegingViolations": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Relators Alleging Violations",
        "label": "Loss Contingency, Number of Relators Alleging Violations",
        "terseLabel": "Number of relators alleging violations"
       }
      }
     },
     "localname": "LossContingencyNumberofRelatorsAllegingViolations",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStateAttorneyGenerals": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of State Attorney Generals",
        "label": "Loss Contingency, Number of State Attorney Generals",
        "terseLabel": "Number of attorney generals that have filed claims"
       }
      }
     },
     "localname": "LossContingencyNumberofStateAttorneyGenerals",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStates": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of States",
        "label": "Loss Contingency, Number of States",
        "terseLabel": "Number of states in which court cases are pending"
       }
      }
     },
     "localname": "LossContingencyNumberofStates",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencySettlementAgreementAwardPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "label": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "terseLabel": "Period over which award would be payable under proposed framework"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementAwardPaymentPeriod",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes",
        "label": "Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes",
        "terseLabel": "Number of largest pharmaceutical distributors to adopt anti-diversion programs under proposed framework"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_MckessonEuropeSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Mckesson Europe Subsidiary [Member]",
        "label": "Mckesson Europe Subsidiary [Member]",
        "terseLabel": "Mckesson Europe Subsidiary"
       }
      }
     },
     "localname": "MckessonEuropeSubsidiaryMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MedicalSurgicalSolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical-Surgical Solutions Segment [Member]",
        "label": "Medical-Surgical Solutions Segment [Member]",
        "terseLabel": "Medical-Surgical Solutions"
       }
      }
     },
     "localname": "MedicalSurgicalSolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "label": "Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "terseLabel": "Gains on non-derivative net investment hedge"
       }
      }
     },
     "localname": "NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestDecreaseForExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "label": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "negatedLabel": "Decrease in noncontrolling interest",
        "negatedTerseLabel": "Exercises of Put Right"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseForExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestIncreaseDecreaseDuetoOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "label": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "terseLabel": "Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDecreaseDuetoOther",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price",
        "label": "Noncontrolling Interests, Put Right, Exercise Price",
        "terseLabel": "Put right redemption price per share (in euros per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePrice",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NoncurrentAssetLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non-current Asset / Liability [Member]",
        "label": "Non-current Asset / Liability [Member]",
        "terseLabel": "Non-current Asset / Liability"
       }
      }
     },
     "localname": "NoncurrentAssetLiabilityMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_November2018CrossCurrencySwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "November 2018 Cross Currency Swaps [Member]",
        "label": "November 2018 Cross Currency Swaps [Member]",
        "terseLabel": "November 2018 cross currency swaps"
       }
      }
     },
     "localname": "November2018CrossCurrencySwapsMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NumberOfCountyGovernments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of County Governments",
        "label": "Number of County Governments",
        "terseLabel": "Number of county government plaintiffs"
       }
      }
     },
     "localname": "NumberOfCountyGovernments",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberOfNationalBrandMedicalSurgicalProducts": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of National Brand Medical-Surgical Products",
        "label": "Number of National Brand Medical-Surgical Products",
        "terseLabel": "Number of national brand medical-surgical products offered (more than)"
       }
      }
     },
     "localname": "NumberOfNationalBrandMedicalSurgicalProducts",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_OpenMarketShareRepurchaseTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Open Market Share Repurchase Transactions [Member]",
        "label": "Open Market Share Repurchase Transactions [Member]",
        "terseLabel": "Open Market Share Repurchase Transactions"
       }
      }
     },
     "localname": "OpenMarketShareRepurchaseTransactionsMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OperatingModelAndCostOptimizationProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Model and Cost Optimization Programs",
        "label": "Operating Model and Cost Optimization Programs [Member]",
        "terseLabel": "Operating Model and Cost Optimization Programs"
       }
      }
     },
     "localname": "OperatingModelAndCostOptimizationProgramsMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids",
        "label": "Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids",
        "terseLabel": "Aggregate annual surcharge on licensed manufacturers and distributors of opioids"
       }
      }
     },
     "localname": "OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax",
        "label": "Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax",
        "terseLabel": "Net actuarial gain (losses) attributable to redeemable noncontrolling interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest",
        "label": "Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest",
        "terseLabel": "Translation gain (loss) attributable to redeemable noncontrolling interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Comprehensive Income Translation Impact On Pension Plans, Tax",
        "label": "Other Comprehensive Income Translation Impact On Pension Plans, Tax",
        "terseLabel": "Foreign currency translation adjustments and other, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_PharmacyLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmacy licenses [Member]",
        "label": "Pharmacy Licenses [Member]",
        "terseLabel": "Pharmacy licenses"
       }
      }
     },
     "localname": "PharmacyLicensesMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrescriptionTechnologySolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Prescription Technology Solutions Segment",
        "label": "Prescription Technology Solutions Segment [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "PrescriptionTechnologySolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PutRightValueInterestRateSpread": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Put Right Value, Interest Rate Spread",
        "label": "Put Right Value, Interest Rate Spread",
        "terseLabel": "Put right value, interest rate spread (as a percent)"
       }
      }
     },
     "localname": "PutRightValueInterestRateSpread",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_ReclassificationofTemporaryEquitytoLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Liability",
        "label": "Reclassification of Temporary Equity to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "ReclassificationofTemporaryEquitytoLiability",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RedeemableNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Member]",
        "label": "Redeemable Noncontrolling Interest [Member]",
        "terseLabel": "Redeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests, Maximum Redemption Value",
        "label": "Redeemable Noncontrolling Interests, Maximum Redemption Value",
        "terseLabel": "Maximum redemption value of redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestsMaximumRedemptionValue",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "label": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "terseLabel": "Shares purchased (shares)"
       }
      }
     },
     "localname": "RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_RestructuringImpairmentandOtherRelatedCharges": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring, Impairment and Other Related Charges",
        "label": "Restructuring, Impairment and Other Related Charges",
        "negatedTerseLabel": "Restructuring, impairment, and related charges"
       }
      }
     },
     "localname": "RestructuringImpairmentandOtherRelatedCharges",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RetailPharmacyReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Retail Pharmacy Reporting Unit [Member]",
        "label": "Retail Pharmacy Reporting Unit [Member]",
        "terseLabel": "Retail Pharmacy Reporting Unit"
       }
      }
     },
     "localname": "RetailPharmacyReportingUnitMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RevenueDerivedFromServicesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue Derived From Services, Percentage",
        "label": "Revenue Derived From Services, Percentage",
        "terseLabel": "Revenue derived from services, percentage (less than)"
       }
      }
     },
     "localname": "RevenueDerivedFromServicesPercentage",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "terseLabel": "Canadian Dollar, British Pound Sterling, and Euros Sublimit"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "terseLabel": "The 2020 Credit Facility"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Unsecured Revolving Credit Facility (Global Facility) [Member]",
        "label": "Senior Unsecured Revolving Credit Facility (Global Facility) [Member]",
        "terseLabel": "Global Facility"
       }
      }
     },
     "localname": "SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StrategicGrowthInitiativePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Strategic Growth Initiative Plan [Member]",
        "label": "Strategic Growth Initiative Plan [Member]",
        "terseLabel": "Strategic Growth Initiative Plan"
       }
      }
     },
     "localname": "StrategicGrowthInitiativePlanMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Strategic Growth Initiative Plan Relocation of Corporate Headquarters [Member]",
        "label": "Strategic Growth Initiative Plan - Relocation of Corporate Headquarters [Member]",
        "terseLabel": "Strategic Growth Initiative Plan - Relocation of Corporate Headquarters"
       }
      }
     },
     "localname": "StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized",
        "label": "Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized",
        "terseLabel": "Percentage of net cash tax savings realized or deemed realized under TRA (percent)"
       }
      }
     },
     "localname": "TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_TaxReceivableAgreementTRAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax Receivable Agreement (\u201cTRA\u201d) [Member]",
        "label": "Tax Receivable Agreement (\u201cTRA\u201d) [Member]",
        "terseLabel": "Tax Receivable Agreement (\u201cTRA\u201d)"
       }
      }
     },
     "localname": "TaxReceivableAgreementTRAMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreeLargestU.S.PharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "label": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "terseLabel": "Three Largest U.S. Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeLargestU.S.PharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]",
        "label": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]",
        "terseLabel": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al"
       }
      }
     },
     "localname": "TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_USPharmaceuticalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "U.S. Pharmaceutical Segment [Member]",
        "label": "U.S. Pharmaceutical Segment [Member]",
        "terseLabel": "U.S. Pharmaceutical"
       }
      }
     },
     "localname": "USPharmaceuticalSegmentMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesExRelKelley19Cv2233Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "United States ex rel. Kelley, 19-cv-2233",
        "label": "United States ex rel. Kelley, 19-cv-2233 [Member]",
        "terseLabel": "United States ex rel. Kelley, 19-cv-2233"
       }
      }
     },
     "localname": "UnitedStatesExRelKelley19Cv2233Member",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_VantageandClarusOneSourcingServicesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "label": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "terseLabel": "Vantage and ClarusOne Sourcing Services LLC"
       }
      }
     },
     "localname": "VantageandClarusOneSourcingServicesLLCMember",
     "nsuri": "http://mckesson123.com/20200930",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r190",
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r210",
      "r214"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r190",
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r210",
      "r214"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r142",
      "r150",
      "r236",
      "r423",
      "r424",
      "r425",
      "r443",
      "r444"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Adjusted balance, April 1"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r142",
      "r150",
      "r236",
      "r423",
      "r424",
      "r425",
      "r443",
      "r444"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Opening retained earnings adjustment: adoption of new accounting standard"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r142",
      "r150",
      "r236",
      "r423",
      "r424",
      "r425",
      "r443",
      "r444"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r142",
      "r150",
      "r236",
      "r423",
      "r424",
      "r425",
      "r443",
      "r444"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r409",
      "r414",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r560",
      "r624",
      "r626"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r409",
      "r414",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r560",
      "r624",
      "r626"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r350",
      "r409",
      "r414",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r560",
      "r624",
      "r626"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r350",
      "r409",
      "r414",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r560",
      "r624",
      "r626"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r218",
      "r219",
      "r322",
      "r323",
      "r625",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r218",
      "r219",
      "r322",
      "r323",
      "r625",
      "r640",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "ASU 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "ASU 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r146",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r443",
      "r444",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r75",
      "r81",
      "r83",
      "r472"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Changes in retirement-related benefit plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": {
     "auth_ref": [
      "r74",
      "r81",
      "r83",
      "r472"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]",
        "terseLabel": "Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r69",
      "r81",
      "r83",
      "r472"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r81",
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized gains (losses) on cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r81",
      "r83"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]",
        "verboseLabel": "Unrealized Gains on Net Investment Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r39",
      "r78",
      "r80",
      "r81",
      "r603",
      "r634",
      "r638"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r536"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r77",
      "r81",
      "r83",
      "r139",
      "r140",
      "r141",
      "r472",
      "r629",
      "r630"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Total Accumulated Other Comprehensive Income (Loss)",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r37",
      "r426"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r423",
      "r424",
      "r425"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r126",
      "r257"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r146",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r441",
      "r442",
      "r443",
      "r444",
      "r563",
      "r564",
      "r565",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r416",
      "r417",
      "r427",
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r185",
      "r203",
      "r204",
      "r205",
      "r206",
      "r208"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r43",
      "r223",
      "r239"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r126",
      "r252",
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive securities (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r126",
      "r262"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Goodwill and other asset impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r133",
      "r198",
      "r205",
      "r212",
      "r230",
      "r465",
      "r475",
      "r524",
      "r581",
      "r601"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r25",
      "r26",
      "r64",
      "r133",
      "r230",
      "r465",
      "r475",
      "r524"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r17",
      "r21",
      "r263",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale",
        "totalLabel": "Total assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r492",
      "r496"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r126",
      "r272",
      "r278",
      "r284"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Exit and other-related costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r23",
      "r47",
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents at end of period"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Investments in money market funds"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r122",
      "r128",
      "r129"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r122",
      "r528"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r131",
      "r133",
      "r158",
      "r162",
      "r163",
      "r165",
      "r167",
      "r175",
      "r176",
      "r177",
      "r230",
      "r524"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r287",
      "r288",
      "r289",
      "r298"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingent Liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r301",
      "r641",
      "r642"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r139",
      "r140"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value, 800 shares authorized and 273 and 272 shares issued at September 30, 2020 and March 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r86",
      "r88",
      "r89",
      "r99",
      "r596",
      "r617"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss) attributable to McKesson Corporation"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r86",
      "r88",
      "r98",
      "r463",
      "r464",
      "r479",
      "r595",
      "r616"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive (income) loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r86",
      "r88",
      "r97",
      "r462",
      "r479",
      "r594",
      "r615"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "auth_ref": [
      "r473",
      "r480"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]",
        "terseLabel": "Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r467"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project.",
        "label": "Corporate Joint Venture [Member]",
        "terseLabel": "Joint Venture"
       }
      }
     },
     "localname": "CorporateJointVentureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r214",
      "r216"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r106",
      "r561"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Cross currency swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r586",
      "r609"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt and Financing Activities"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r582",
      "r583",
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair values of liabilities"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on debt instrument (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r55",
      "r135",
      "r312",
      "r313",
      "r314",
      "r315",
      "r539",
      "r540",
      "r541",
      "r599"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Syndicated senior unsecured revolving credit facility term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r435"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Possible decrease in unrecognized tax benefits during the next twelve months"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r430",
      "r431"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from intra-entity transfer of asset within consolidated group. Excludes intra-entity transfer of inventory.",
        "label": "Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory",
        "terseLabel": "Deferred tax asset for the temporary difference arising from buyer's excess tax basis"
       }
      }
     },
     "localname": "DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r343",
      "r351",
      "r353",
      "r397",
      "r399",
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Cash contributions to the plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of plan assets to benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Funded Percentage",
        "terseLabel": "Percentage threshold of greater of projected benefit obligation or market value of assets (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r362",
      "r389",
      "r399",
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "terseLabel": "Net periodic pension expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r328",
      "r369",
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedTerseLabel": "Pre-tax settlement expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "terseLabel": "Lump sum payments under settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r126",
      "r264"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r484",
      "r485",
      "r487"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "U.S. Dollar notional amount, asset"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r65",
      "r66",
      "r494",
      "r559"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Fair value of derivative, asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r65",
      "r66",
      "r494",
      "r559"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Fair value of derivative, liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r493",
      "r495",
      "r499",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative, by Nature [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r490",
      "r493",
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r498",
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Gain (loss) on financial instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r484",
      "r485",
      "r487"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "U.S. Dollar, notional amount, liability"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r485",
      "r487"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional values of financial instruments"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r483",
      "r486",
      "r487",
      "r490",
      "r491",
      "r497",
      "r499",
      "r506",
      "r507",
      "r509"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated for hedge accounting"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r17",
      "r261",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Held-for-sale"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Receivables, net and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses": {
     "auth_ref": [
      "r533"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity.",
        "label": "Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)",
        "terseLabel": "Favorable (unfavorable) cumulative foreign currency translation adjustment"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r263",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r22",
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r405",
      "r410"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r404",
      "r408",
      "r413"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson Corporation"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r100",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r156",
      "r158",
      "r165",
      "r166",
      "r167",
      "r171",
      "r172",
      "r597",
      "r618"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r100",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r158",
      "r165",
      "r166",
      "r167",
      "r171",
      "r172",
      "r597",
      "r618"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r168",
      "r169",
      "r170",
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r528"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Reported income tax rates (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r144",
      "r153",
      "r155",
      "r174",
      "r236",
      "r311",
      "r316",
      "r423",
      "r424",
      "r425",
      "r443",
      "r444",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r536",
      "r629",
      "r630",
      "r631"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Impairment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership interest (percent)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Investment in Change Healthcare Joint Venture"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r225",
      "r620"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized gain (loss) on equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r511",
      "r512",
      "r513",
      "r519"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r511",
      "r523"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of information regarding the fair value of derivatives on a gross basis"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r399",
      "r512",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r511",
      "r512",
      "r515",
      "r516",
      "r520"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r351",
      "r353",
      "r358",
      "r399",
      "r512",
      "r550"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair value, inputs, level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r351",
      "r353",
      "r358",
      "r399",
      "r512",
      "r551"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair value, inputs, level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r399",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r511",
      "r512",
      "r515",
      "r516",
      "r517",
      "r520"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r518",
      "r520"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r492",
      "r497",
      "r508"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r543",
      "r545"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Lease and other obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization expense, 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Estimated annual amortization expense, remainder of 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r253",
      "r254",
      "r256",
      "r259",
      "r562",
      "r566"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r256",
      "r566"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r253",
      "r255"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r256",
      "r562"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Period"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r351",
      "r503"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "verboseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedTerseLabel": "Loss (gain) from sales of businesses and investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee": {
     "auth_ref": [
      "r101",
      "r102",
      "r126",
      "r589",
      "r619"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee",
        "negatedTerseLabel": "Pre-tax dilution loss"
       }
      }
     },
     "localname": "GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Opioid-related settlement charges"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r241",
      "r243",
      "r580"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation adjustments, net"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r126",
      "r242",
      "r245",
      "r250"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill impairment charges",
        "terseLabel": "Goodwill impairment charge"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLossNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of loss recognized that results from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss, Net of Tax",
        "terseLabel": "After-tax goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r247",
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Acquisition accounting, transfers and other adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r103",
      "r133",
      "r198",
      "r204",
      "r208",
      "r211",
      "r214",
      "r230",
      "r524"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r490",
      "r505"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r104",
      "r127",
      "r148",
      "r149",
      "r150",
      "r151",
      "r164",
      "r167",
      "r461"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income (loss) from continuing operations attributable to McKesson"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r92",
      "r198",
      "r204",
      "r208",
      "r211",
      "r214",
      "r579",
      "r590",
      "r598",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SegmentsofBusinessDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r133",
      "r143",
      "r198",
      "r204",
      "r208",
      "r211",
      "r214",
      "r230",
      "r462",
      "r524"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income (loss) from continuing operations",
        "totalLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r91",
      "r100",
      "r143",
      "r148",
      "r149",
      "r150",
      "r151",
      "r158",
      "r165",
      "r166",
      "r587",
      "r591",
      "r597",
      "r611"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in dollars per share)",
        "verboseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r91",
      "r100",
      "r143",
      "r148",
      "r149",
      "r150",
      "r151",
      "r158",
      "r165",
      "r166",
      "r167",
      "r597",
      "r611",
      "r614",
      "r618"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in dollars per share)",
        "verboseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r18",
      "r21",
      "r449",
      "r612"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Loss from discontinued operations, net of tax",
        "verboseLabel": "Loss from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r94",
      "r100",
      "r162",
      "r165",
      "r166",
      "r597",
      "r612",
      "r614",
      "r618"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in dollars per share)",
        "verboseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r162",
      "r165",
      "r166",
      "r481"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in dollars per share)",
        "verboseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r93",
      "r126",
      "r195",
      "r227",
      "r588",
      "r610"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity earnings and charges from investment in Change Healthcare Joint Venture",
        "negatedTerseLabel": "Proportionate loss from investment in Change Healthcare",
        "terseLabel": "Equity earnings and charges from investment in Change Healthcare Joint Venture"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r405",
      "r410"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r2",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r16",
      "r19",
      "r20",
      "r21",
      "r269",
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r434",
      "r438",
      "r439",
      "r445",
      "r447",
      "r450",
      "r451",
      "r452"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r134",
      "r154",
      "r155",
      "r196",
      "r432",
      "r446",
      "r448",
      "r622"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)",
        "terseLabel": "Income tax expense (benefit) related to continuing operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "terseLabel": "Taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Assets [Abstract]",
        "terseLabel": "Changes in assets and liabilities, net of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r167"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Restricted stock units (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestAndDebtExpense": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://mckesson123.com/role/SegmentsofBusinessDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.",
        "label": "Interest and Debt Expense",
        "negatedLabel": "Interest expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestAndDebtExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Forward starting interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r61",
      "r62",
      "r63",
      "r240"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory, LIFO Reserve, Period Charge",
        "negatedLabel": "Pre-tax credits related to LIFO accounting",
        "terseLabel": "Credits associated with last-in, first-out inventory method"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r24",
      "r60"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r42",
      "r133",
      "r230",
      "r524",
      "r585",
      "r606"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable noncontrolling interests, and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r53",
      "r133",
      "r230",
      "r466",
      "r475",
      "r476",
      "r524"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities measured at fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r17",
      "r21",
      "r263",
      "r267"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale",
        "totalLabel": "Total liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r32",
      "r583",
      "r600"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Amounts outstanding under facility"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.",
        "label": "Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases",
        "terseLabel": "Committed balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Uncommitted balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "netLabel": "Outstanding notes (up to)",
        "terseLabel": "Syndicated senior unsecured revolving credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r50",
      "r135"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Award payable under proposed framework"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Pre-tax litigation expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loan",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermCommercialPaperCurrent": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the current portion of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Long-term Commercial Paper, Current",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "LongTermCommercialPaperCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r32",
      "r305",
      "r583",
      "r602"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt outstanding",
        "verboseLabel": "Carrying amount of liabilities"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/FairValueMeasurementsDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Less: Current portion",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r55",
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r290",
      "r291",
      "r292",
      "r294",
      "r295",
      "r296",
      "r297",
      "r299",
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Pre-tax accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Charge in connection with State of New York's Opioid Stewardship Act"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Complaints filed against the entity"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r59",
      "r133",
      "r230",
      "r524",
      "r584",
      "r605"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Payments to noncontrolling interests",
        "negatedTerseLabel": "Payments to noncontrolling interests",
        "terseLabel": "Decrease in carrying value of non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Ownership percentage (as a percent)"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r59",
      "r105",
      "r460",
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "MovementInMinorityInterestRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r122",
      "r124",
      "r127"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r21",
      "r84",
      "r87",
      "r95",
      "r127",
      "r133",
      "r143",
      "r148",
      "r149",
      "r150",
      "r151",
      "r154",
      "r155",
      "r164",
      "r198",
      "r204",
      "r208",
      "r211",
      "r214",
      "r230",
      "r524",
      "r592",
      "r613"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to McKesson Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r84",
      "r87",
      "r154",
      "r155",
      "r469",
      "r478"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net income attributable to noncontrolling interests",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "verboseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r150",
      "r171",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r441",
      "r442",
      "r443",
      "r444",
      "r563",
      "r564",
      "r565",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r316",
      "r459"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated for hedge accounting",
        "verboseLabel": "Derivatives not Designated for Hedge Accounting"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which entity segment operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "negatedTerseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r198",
      "r204",
      "r208",
      "r211",
      "r214"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SegmentsofBusinessDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating profit (loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment operating profit (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r214"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAdditionalCapitalMember": {
     "auth_ref": [
      "r108",
      "r304"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents a category to capture additional Paid-in Capital other than attributable to capital contributed by shareholders in excess of the par or stated value of the common or preferred stock issued by an entity. Certain entities report two components of additional Paid-in Capital consisting of (i) capital in excess of par or stated value and (ii) other additional capital. This member is only to be used if the entity distinguishes between additional Paid-in Capital and other additional capital in its financial statements. If using this element, the preparer would be expected to elevate the Other Additional Capital [Member] to the same level as the Additional Paid-in Capital [Member].",
        "label": "Other Additional Capital [Member]",
        "terseLabel": "Other Capital"
       }
      }
     },
     "localname": "OtherAdditionalCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r68",
      "r79",
      "r525",
      "r527",
      "r535"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax",
        "terseLabel": "Foreign currency translation adjustments, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Amortization of actuarial (gain) loss and prior service costs, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r81",
      "r90",
      "r529",
      "r531",
      "r536"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "verboseLabel": "Unrealized gains (losses) on net investment hedges arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r70",
      "r78"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Gains (losses) from cash flow hedges recorded within other comprehensive income",
        "verboseLabel": "Unrealized gains (losses) on cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Unrealized gains (loss) on cash flow hedges arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax": {
     "auth_ref": [
      "r79",
      "r527",
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax",
        "terseLabel": "Reclassified to income statement, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "verboseLabel": "Gain (loss) from net investment hedges recorded within other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r85",
      "r88",
      "r90",
      "r96",
      "r311",
      "r529",
      "r534",
      "r536",
      "r593",
      "r614"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r85",
      "r88",
      "r462",
      "r463",
      "r471"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Less: amounts attributable to noncontrolling and redeemable noncontrolling interests",
        "verboseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r85",
      "r88",
      "r462",
      "r463",
      "r471"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Other comprehensive income (loss) attributable to McKesson"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r76",
      "r78"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Changes in retirement-related benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect": {
     "auth_ref": [
      "r79",
      "r462"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax",
        "terseLabel": "Net actuarial loss and prior service cost arising during the period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other noncurrent assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "verboseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Pre-tax charges"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r110",
      "r113",
      "r137"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Share repurchases, including shares surrendered for tax withholding"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "terseLabel": "Payments for purchase shares of Mckesson Europe"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r120",
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash, cash equivalents, and restricted cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.",
        "label": "Payments to Acquire Interest in Joint Venture",
        "terseLabel": "Contributions made in exchange for additional membership interests"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Payments for property, plant, and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireSoftware": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Acquire Software",
        "negatedLabel": "Capitalized software expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireSoftware",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r350",
      "r352",
      "r358",
      "r376",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r399",
      "r401",
      "r402",
      "r403",
      "r415"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r325",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r375",
      "r377",
      "r380",
      "r384",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r403",
      "r404",
      "r410",
      "r411",
      "r412",
      "r413"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r25",
      "r45",
      "r46"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.",
        "label": "Proceeds from Derivative Instrument, Investing Activities",
        "terseLabel": "Proceeds from termination of derivative instruments"
       }
      }
     },
     "localname": "ProceedsFromDerivativeInstrumentInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).",
        "label": "Proceeds from Divestiture of Businesses and Interests in Affiliates",
        "terseLabel": "Proceeds from sales of businesses and investments, net"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from Issuance Initial Public Offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommercialPaper": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from borrowing by issuing commercial paper.",
        "label": "Proceeds from Issuance of Commercial Paper",
        "terseLabel": "Proceeds from issuance of commercial paper"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r114",
      "r418"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised [Abstract]",
        "terseLabel": "Common stock transactions:"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r115",
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings under facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "terseLabel": "Proceeds from concurrent offering of other securities"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r116",
      "r119",
      "r137"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r21",
      "r84",
      "r87",
      "r121",
      "r133",
      "r143",
      "r154",
      "r155",
      "r198",
      "r204",
      "r208",
      "r211",
      "r214",
      "r230",
      "r462",
      "r468",
      "r470",
      "r478",
      "r479",
      "r524",
      "r598"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r28",
      "r29",
      "r265",
      "r608"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r36",
      "r44",
      "r607",
      "r639"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r81",
      "r83",
      "r90",
      "r529",
      "r533",
      "r536"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedLabel": "Reclassified to income statement, net of income tax expense",
        "negatedTerseLabel": "Amounts reclassified to earnings and other"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r79",
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Reclassified to income statement, tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r310"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Redeemable noncontrolling interests",
        "verboseLabel": "Carrying value of redeemable noncontrolling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r377",
      "r546",
      "r547"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r377",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r377",
      "r546",
      "r548",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper.",
        "label": "Repayments of Commercial Paper",
        "terseLabel": "Repayments of commercial paper"
       }
      }
     },
     "localname": "RepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedLabel": "Repayments of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r249",
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r23",
      "r27",
      "r129"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "negatedTerseLabel": "Less: Restricted cash at end of period included in Prepaid expenses and other"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring, Impairment and Related Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r273",
      "r275",
      "r282",
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Pre-tax charges recorded to-date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r273",
      "r275",
      "r282",
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected total pre-tax charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r126",
      "r272",
      "r278",
      "r284"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring, impairment, and related charges",
        "totalLabel": "Total",
        "verboseLabel": "Net restructuring, impairment and related charges recognized"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r274",
      "r280"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Restructuring liabilities"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r272",
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Non-cash charges"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r274",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r38",
      "r316",
      "r426",
      "r604",
      "r633",
      "r638"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r144",
      "r153",
      "r155",
      "r236",
      "r423",
      "r424",
      "r425",
      "r443",
      "r444",
      "r629",
      "r631"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r377",
      "r380",
      "r385",
      "r386",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r404",
      "r408",
      "r413"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r377",
      "r380",
      "r385",
      "r386",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r404",
      "r408",
      "r413"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r375",
      "r377",
      "r380",
      "r384",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r375",
      "r377",
      "r380",
      "r384",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r189",
      "r190",
      "r203",
      "r209",
      "r210",
      "r217",
      "r218",
      "r221",
      "r321",
      "r322",
      "r561"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Segment revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Offering price (in usd per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r81",
      "r534",
      "r536"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of information regarding other comprehensive income (loss) including noncontrolling and redeemable noncontrolling interests, net of tax, by component"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r383",
      "r384",
      "r387",
      "r388",
      "r399"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r2",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r16",
      "r19",
      "r20",
      "r21",
      "r269",
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Assets and Liabilities Held for Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of computations for basic and diluted earnings per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r21",
      "r133",
      "r229",
      "r230",
      "r524"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r253",
      "r255"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of information regarding intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r248",
      "r251"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r248",
      "r251"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of changes in the carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r276",
      "r277",
      "r281"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r276",
      "r277",
      "r281"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring, Impairment and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r274",
      "r283"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Asset Impairment Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r198",
      "r201",
      "r207",
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r198",
      "r201",
      "r207",
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r185",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r221",
      "r623"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r185",
      "r187",
      "r188",
      "r198",
      "r202",
      "r208",
      "r212",
      "r213",
      "r214",
      "r215",
      "r217",
      "r220",
      "r221",
      "r222"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segments of Business"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information, Profit (Loss) [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Service agreements"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r126",
      "r272",
      "r278",
      "r284"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance and employee-related costs, net"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Beginning balance (shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r8",
      "r185",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r203",
      "r204",
      "r205",
      "r206",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r221",
      "r248",
      "r268",
      "r275",
      "r285",
      "r623"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r33",
      "r34",
      "r35",
      "r131",
      "r133",
      "r158",
      "r162",
      "r163",
      "r165",
      "r167",
      "r175",
      "r176",
      "r177",
      "r230",
      "r311",
      "r524"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r58",
      "r139",
      "r140",
      "r141",
      "r144",
      "r153",
      "r155",
      "r174",
      "r236",
      "r311",
      "r316",
      "r423",
      "r424",
      "r425",
      "r443",
      "r444",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r536",
      "r629",
      "r630",
      "r631"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r174",
      "r561"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r34",
      "r35",
      "r311",
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of shares under employee plans (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r34",
      "r35",
      "r311",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of shares under employee plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Authorized amount available for future repurchases"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r34",
      "r35",
      "r311",
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r34",
      "r35",
      "r311",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r35",
      "r40",
      "r41",
      "r133",
      "r224",
      "r230",
      "r524"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total McKesson Corporation stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "McKesson Corporation stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r133",
      "r139",
      "r140",
      "r141",
      "r144",
      "r153",
      "r230",
      "r236",
      "r316",
      "r423",
      "r424",
      "r425",
      "r443",
      "r444",
      "r459",
      "r460",
      "r477",
      "r524",
      "r529",
      "r530",
      "r536",
      "r630",
      "r631"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity",
        "verboseLabel": "Cumulative-effect adjustment to beginning retained earnings"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r132",
      "r316",
      "r320"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r537",
      "r549"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r537",
      "r549"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r537",
      "r549"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and trade names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax": {
     "auth_ref": [
      "r526",
      "r531"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "verboseLabel": "Derivatives used in net investment hedge, gains (loss) gross"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price of shares repurchased (in usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r57",
      "r318"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r57",
      "r318"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Ending balance (shares)",
        "negatedPeriodStartLabel": "Beginning balance (shares)",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r35",
      "r311",
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Common stock repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r57",
      "r318",
      "r319"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury shares, at cost, 112 and 110 shares at September 30, 2020 and March 31, 2020, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r311",
      "r316",
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "terseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r146",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r441",
      "r442",
      "r443",
      "r444",
      "r563",
      "r564",
      "r565",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r429",
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "verboseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r437"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "verboseLabel": "Unrecognized tax benefits that would reduce income tax expense and the effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r157",
      "r167"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average common shares outstanding",
        "verboseLabel": "Weighted-average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r156",
      "r167"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsPerCommonShareScheduleofComputationforBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 21
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.T)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868742-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117546-209714"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=121548190&loc=d3e32787-111569"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL82887624-210437"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2599-110228"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4815-112606"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=d3e5291-111683"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30755-110894"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(g))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r652": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r653": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r654": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r655": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r656": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r657": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e526-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>79
<FILENAME>0000927653-20-000093-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927653-20-000093-xbrl.zip
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M#&XRT.Q)?>\()G74G$\JHA"AHA,R.23O$WMK;?63@6D_ZGM'*"$W1Z0>C .
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MC$3]A,G_78D9"4Z]SR7XWBK;<FF, Q;)@<3A.:O3#:MO6/UG6?V!BFB7K.9
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M /^LS'CU:K@\O*B*D@2?0B%$ P83>@[9AV):&,R!XT@J"3S\9:&K]>'L>!_
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M)+1C*/YXW8FP(XM0:HPN&EO!-UU@ CHRU9J@W&U#J".V"(#XFPP33###M*O
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M'LI(,(D22F6C54H )Z;]X"S1EYRJ] 67XXGI]PK._L/8D(++-;0@5A1\1<R
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M8G:*SW'C0+NGX_;6U\__2'E]LM)MRNNMX^>7.C]\_KI?Z_VY&MM,,KK4/&\
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MTE!I^V'0?-^^\ZIIJL>-OQ\ S\V@N43JPH%+.Z"NRQ92:'8WA0JQ[TF5IA+
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M>4=J7K!W*3> %A0"ELQ8/%CC<VI#<03(?82Z?O;DT2&OCCCKR:9C^V$">Y3
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M;KN;>_.JUR^&Q[[XSR7,BI&3743?V[O9:^HI_*^Y=!(1KWCL]/FYUWW?O8D
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M=;_XHMMGCSGJNK/T=EK.M?WR2>^8#T=TF$7W#J*[/<DQ]D)0ZARPB#) &4%
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MF@XG/[$<YGA ,_M3I?N>83R,99]*I_YB<^>JWW^^EKOK=P2C5&[L-8N=T@'
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M1I\7>5UZMC<%^'Z_,XG=S !/:J]=^\I;C[8RAN<9MLH8GA6&)]$I(QR2 DK
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MZ;"(B)=2*VH%=JEO_XK(.CXC_KE#%!GQ#T;\)"8A"<9*00="H#A:]48!K4T
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M[MGU@&# 31_)[YSM.U]4HX=F;ZC;16\V-11+6AY6^0*+G!+V '6R.UU8$5Q
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M!'"DF2<2N[COT<]@/_;57ZCZJ%P;6=U0PBV)DYDP*D08$XM*66=MM&D!YH@
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MXT](.&@XB=XBJZV3'U%XF\60 ;B %389@/,%X)1_;H@1EG(#E$AC3Q6+_KE
M-@*08$NL<E:8", ?4]HR !?:F<X ?%8 3C2@DY+!('1JQI$Z<O  C+,DXA%;
M&1$8]YG4UM5\-> +/XS_P36NVW_[P2""<K/7/^WURU8T#TSY&3WH-1)WQO7.
MTO4O;S7/Z9O9 ZHVU5<T^2&S^+U8?.=*(D-T12%S#' :'*#$2J \$X &B8)'
M6O* :NL"S:JQTNRPLAC#2S-KOGC6K'Q&2>;/^_+GQ HF4<DQ[BUP(G5N$<P"
M19P"(E"-A79$NG1R=$-IU4,GHF;JS-3Y4JAS\=)T,I?>DTNG0GJ$>RPP8H#
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MZ.J/ZFSWY/VWW:WMB\9)7._)W^W#K7?GNQ\;Q[M;=7)X8N$!/L"-U]OL<.L
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M3BH7T1NZE[GH;#%=?T(+B5@W A8R< :B:@IO?5.K$24F$T0QA>I/$%-<=Z0
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M(VEM/#8KLKY:"EK&<^&4S8&>919QG2MD?.Z0S@,6%FO&'8W%(M0Z!V<V2MI
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MZE<NAN[8'[^PR(:UH =)#+$+"PBAN"1M[):;(,Y>G1SDC.46C@-$E,X1S[*
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M<<(],CB6]W/""R4R94C8V,KOP/?W1-U[SUM)[Y\E-$IZ4R6M!2X[+'30 NG
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M56Y!T1-]G**FTC:N7(ES'K&?XH>K>LY5!=>XG1;"^XK+P;]U+[[0'[5^'0R
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M(WL:0$,6LC:')LSQE9&K?QDIZK98UC^Y8-.+LR@+LV<6I,<<#C!X,YRK('*
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M!H;N+YO_WAS8M__Q;H"!C>[80MZ8'5"\EX/:6D.ALQN_]^W_N1_P0/X+G3R
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M(YX7VN51]"<M>/'WJQ>RH"\-L#Z,]/07"%:T JN24IV6K<BVB%5XK5U*H\9
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M=WWYMS1S?,6_*[-^39KK0U3<,(ZB50IQQBTR++O!,6="*,^B$1M;:HTX>-F
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ML.9_M#M3J%-ARP+84O\P8?QF ?O$ 4J8)R ,>&F1=98AJ;6*/)B0=,X1%H]
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M-6$85$R:+0YWR2F91("2)TC!]==U45(PR6HN+;Q=,2YL(3"S%#-BZ,"XR:1
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M<+C#ER?M9O,*M2];V4L5O\-O8(Y]1]6 0/;]OV.WV\[[:7L%2>6J/,4.AP;
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MI%M(^'!7JS68[-7_N"7^9DJ:+?I^SN>G;S0;Q1DP#V:Z=^#,&Y2/)ZCN>I?
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MF(K>^T7O64D",>*H,46T\D# YD0\I:5\KC8F<:6MJ=5;%G<#4JW>LG Y_K4
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M1EUTD<3L*$KL*(EU/A"9$@5A>! 4?F!<73HA[A@&J!/B(2>$ @Z69T68-9(
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MQ)I2+AMD+"5=#(E&J,14S%[)YAQ)J2JC5D:MC/J@P;X0*$AA)9,&-+,V.N^
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M1%-9]DNA-.>-MKC69\A+K83(_XJ=>S X3*-R5"<S<-<-/O?V1A.)GUUORF:
M7CX:O=3;BVD/^<TT"^*<294WI:SV1HQ7"'60/KM!F>.MWNF,:+EF2K1Z0_P-
MV;'?W_\V?'FV=M3%!Q\C3&$3IKI"7MH3^. -($[1.P(A=D#??1VFER>__'92
M<JRWUSQ&\Z%+ L>_?>O%@^VR9BS3T;HQCF>/[S^^O-Q<.L<<HVM<+%/.K[Q,
ME]F5UWYT6[O,S=57?W37'W\C8W+F;35XU\?35FOTHVGK_?2KIK>[:YT##S,'
M[+7N^I-LG-O639SI.F.NI=TOUVN3!#]VG8<*N%:FP<,\UN790C]/$OK!L%V9
M[LCDX^R-MAN$[99@E_3$8YC)]N0AFQN^[!W@EX7K[*Q>*PIE@!IIKX7?UT<I
M-;RPS_8R1\H-K(W%'OB/S1\IDG_[P:\KJ]@R]SDUO[]+NPX-C;W/HRN[^]CF
MXT9M-B^,3LQK?OUE,V$?SJS?K@374^S_-X/]X;#IQ5=N,#B:ZN[#O:OW&]<>
MO;I'5T,XW#WL.YS4%V=N[=";=V@G'=QA@C[++JNHKJA>\ Z]+JIO6P'DMCVU
M6.5!7AT.<8302!@5:$=YN-W[>O6QF_?8+_.<03>+ZESJ\,X0/?/@*1<<P I'
M([<,@F*&<W"7.[RG(CC8IO R'@Z.4%J>]X3_P/]]*EJG^6$D5=GC](:/@CS8
MCJVUS>/-W;^WR[VWNN^^;'8[O0ZV>>/-)K1W5GE[[3/=['X^.A_DV3S>_M+9
MZ?2V/OZ!S_%WO_/FW7:;K_.MCWC/G<]'[;7-;QMK[[8WUOXL9SI_GRH**%,I
M2D18R9,'1@/QWB@"0AD9F;0)8MD$=2$.<M_HN'84^J:0>VI1YAL__Y.)(FMG
M)>.1*VHH9,U,="H)23TSE$HA9Q!%_@$+-?+O:427YT<\4T7EHS&9,D5"<TRH
MY)%8P3CA,>B8F#0J\K)+1XL[YY3?8E&>Q[;J2H.5!F=2#O)A>7#*:)O68Y49
M;\:,D]QP"-QD%0Q)0#-*,BM+]?U,DJ4R>"<E4[;DAC.N[U _LI)B)<7'1HJ/
MAA,[Z:#RW\WX;Y+)+4-D/@8@B>M4]F\S8CC3),J<$TT"DK8EDUO1616MK"18
M2?!)DJ !AY!!*\M:4$9:3[EC5 3)><:[C4E0"%8-Y 6AP4GZM>+2E$.32&@.
M _84B.5>$0XFY^ 5:&^+@:SDK H451JL-/AH:/!&!O*#\F UD&<3LVB?'".[
M^BD9Q:0WB?@D4HE:4#214R0J.<5L9E[I9K.?O80;JXE<:?'ITN*C8<5J(M^"
M 8].&3 HXS7UE AK#('D(S$J>S22M61,9:5D+@RHZ:-1A[>M;?EH\DS>I\$_
MO9!:[O,@I>; F5M%T7_^V(\LC81;;;RP23H7P3EK,@W<! H"C W<U322A22D
MZ9J+(40=I,@D6%Z."%>,N"Q*]47);5*HS6P19'0F:23/^Z"XFZSPY0C?'),4
MW.,*K[P0UH-P#!0-0J2KG>#5R7.?N)ED00A48"Y;7,9]! (N*.*%%H2#-HES
M;20S2RO67HSTU?,<%QNF-_)/W#].JQ-B)LB=1.D92$E!10*AK'/"E.J861$K
MG&5)1J.#7EJ1]&+V4CT$?6%!NUB8K2;RC?$YB2*#!6J4L(25V#$PL,1SSHF.
M"%"5-?<4#62P=SX_K8)T<4&:N)5!"2<9!^#..NED5E1H+[@"DZYV<54!?)\P
MG40YLZ&EM"(GS J&AJ,/Q C&B(\X<D*%%#PM GA6):8J3!=1 ,\!IU4 S\;E
M,Q6%,\S1I(1&XU5FQ&YTN,2"(1E!'<#DA)#&)=;<)0978?NL5]<J@6^!T$F4
M2"NI@K"6.)W14K7"$$L3)YE3 \ERYIE (W5F!1P?) QT^?%JBQL&^FO;#79=
M.&KU>R'M#=.==AH_G2@0$]%D)XW4G(.GP@9KC<A*4Y\8E[Y&@1:1<#JOIJ)
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M<;#9(D<:CAY13H-D*>)@R-H&7I=7NTG_/XUWPUZW8KAM#H^&_4&#J'K0P6U
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M<Q\L4!MNDW RN$6N1J,,#A:A_)I_GBS_^-SO[J?QSZC6NG1_%D2;?2D5TG'
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MKH#YT>T-2J$[-;M*@VS6#)LC4JXSNT;VUF7_^8R4FO6UWVQ%E3'3L7.]4:#
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M?9I/>A86;4K;$&S'U.TP,D^S96CZR4^[[)=@J77\?V,J? V:?'!IDX6:'F%
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M-6B8&#"8X129PA+$",5(&P,:1AC./&'8A30&EGP%0'LB,'D+E'!BQ)68&4L
M",\8&:5=T8M9*JP3#O!#$P/XHT>!<J.%=F!2"H98M!HI+0Q*4#*$6NJ]Y\^>
M#S_?1"ZIC/MJ4VL0@2IM#7[,"(ZB]A#F E'?@D6RP(O[2I3L464*EK'.K1?
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M+9TV2$??3J5N=T06:] 15H&.H!MTA#582X..T* C/ YTA*^B'<R@(PB6R%<
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MVRY,9EC2O([<,0):[W)8(B>[,+9B\\U*K(/+#E@=(EL=?&-RE;6]69G$U82
M03DC-T]#*8>*C\UO0O)MQ*3YG7&7)O9N4-FXU6TGUE!:/FICCB$S:C#9NKB
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MOAR!'VP=2<M 6H,K%8*-B'E:(&UX@23X'2384!A&YDOKQU@2*[YE5,Y/@6'
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MK-'K_/)^;^O]]L[!C>67_\[(UU(M:JV -H7CWBFP4*7!!?B'#$B41ZR)+,T
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M!>>^;8\S#RQVH'I]=V'F2K!S>Z?E+92:FC[B!Y'B^:2U)C/N1%)$VHA63V)
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M?#="RP];K^%H"(<!^BU!-UL%D N6)[IR8*Z<T4=4#.VV@[/:PF$NC[(T&L6
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M^/LM'<__[/O+DT^?59;5EX->!P:H1Q8VQDD;'D\OQ5%[4#H/<):A/_BNWMS
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M2!3H(=E 601NA/*)I1J^<(_A"PAP820/TB>2/-5$9FM1?8^>).-+-A/.N4>
M<[NLE#8_'-YW%-=P9^5N+D?@LU[_J(<X@!9\/8+N  :;K2X,US',05];YJ:Z
M:)=0'G[$HH?QTY.SM7-&I;^/UI#OIB989L2L>S"LQ#H7L;Z9R>3GN-'@#.':
MH;GD9"0V@B':HQ;LG##-80@F+\:$U5W1!X'9)10UKYB]"\Q.E"'.J?4J2H)H
MS43&Y$A(G!-A *!,I;-Q8UNLRAY*Q>RR,;N$4MP5LW> V2D/19 6K,F2@!5
MI$F9!)4MR48GGT$(&SD:,.PV;LF*V17&[!+J1U?,W@5FIS+_,9$T*S&#CH>2
M^8\2SWDF:,I8(1"X+J2-;<4NIOY;YUB%U0U1:$H P&!XZDQX9&D([L42/_5G
MGH[]TVYZ#F$XIIO*+G.QR]MIR]NI+ /R/!'>L*+%!V*3IB5/D6% 4:-S!MGE
M-DI\/3"YPA!=FN%=(;I<B$X4 ":EB5Y[$JTT1*J"3J<C<4 E9)HT9%]*)E:(
M/DR(+LW.KA!=*D2G[&IF8T!#VA#'!$(T,D%"-(F Q&DRR8<L2M4N5L7H \7H
MTNSJBM'E8G3J[)W/B9;#=AS-9\1HYL0GQ0C+$*/CQE)3TEKS%<'HHEOSXYB!
MT<.P!=>$#:RRG5V<1ZV?.KW!X.=6[O<.&\BUN\?8_%9OY'+J=0>M +G7AU9[
M=/W0?X4+J0%O.VA7!F(\AAJI2QJ<U2;[^_5JG 9GO<!5_NQLD;\\6^._-4M\
M=-U^6>"_?QWV/8Y[N^O[)SM#.!SL];JEE?U>I]/$>XW$1Q48<PF,..T:,1'-
M*^^!!!W$:+/$EJ*L-CDCN)16\F)WJ8OU!1<[\+D<G-W17LM-Q<R\-:<K$S]V
M)KYC[]45YV$J)Z\0)T^7P9*!R22(#A2(S%D1+U&=!RHBY4P*4\I@.;.$H)-*
MQY6.*QW/E2;U]H[*&Q]=JOR\.OP\7?%$><<84T0#343B>B!.6T<\XPK >199
M*D>@!+WU&8E*TY6F*TW?D[.Z:LVKS\K3KN\D8D!69I)Y(KD$$BRG1&09> XI
M"N%+J/820LCNEXZO<9JG]N"HXT]*#^'[#%ZOG+VR#FP=V/6ZL@YL'=CUNK(9
MV%^&/G3@]'0O_CB]X]#W/[2[IX)5H%(X_DL1I26GVUA^DJ*P/V%V5HO_>#P8
MMO/)Z$_M;H+N\ DI%RU;7777::N\T5;9SS_D\/5-WCX[4&9+\3(*K^ S=(_Q
M%<U&,S[W<SOB)U2D?0LGRW_XT(</?@BI%?R@/6CUX0BU4AS&5@<&@];P 'MQ
MI0K>/3X,T#]?J\*I"(&ZY$60!A4SDU#1AF LHQK"=45E=O9>3)_%&+?_.0[(
M9TA%^WX][L.?T(_83O]A$CU"^'KJT!WXYZN3=W^GH\"EWOO[U<==OOL%[^SL
M\K].BCZ\M_])O7R^>[*W_X'M/7_Z%=LCWOV]EW>+OOSE?2D,HB0WQ(BB!PN!
M>C"WEJ1$(<;H@8/YCL?KTFD,&>>()1DYSU);89W0S#N=P2GI0[S&F*K3./\T
M1I8-I\*0LOM#9 )-;*:9Y,PMLQ"YDF)C^Z(Q<^$/_[?5RPA=:+W9>KW5^O/
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ML#FPZGV3#3HMN\U[+58R\%[QZ-J^9=\K,"=@;MNV.>IT[;K=!.6ERVVK/AJ
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M5),F3H@%<,</I6X<<M33YA.EU6P"H>L*KH5#"/(F+[S):X5?R[;7JZV8-R5
M]!E>90;.C+#WEIL33^!],I9*Z44XET9K0J*63:0?KAW^@)(/+(10J7ZKIC8L
MEK9]_'BA]Y!7^*;V]/2Y#L:YBZ3@P)D4,-.T/8&%QYQ3FCQ#@\=7TROH5&D<
M2"!/9!"#@>5%\FK4S="B#>+/:<HE!5T_G:D5U#GLZJCIBY6C/$AUDW[]A1Q3
M9DT=#QX(1(Z]+6T'H2,##_B3:QXP9W&I[-14_JG(DD#&Y0>BOM'B(I5+U0+D
MC9)1B:?X/="A)_BV.$Z*2_-[YL8LD@62<'$$!JP^R&:((66-*35,J_Z ^[(?
M&S *!W@?*O*JYQK5%=R384 <6KTG[S4(U*0=I3X!C6068Y'P5Z#38O^W4.74
MXF_5R"7!I^>'48PYCF8B$QK[4RIP28N)H!BQ[[C!X^"6A"9@5_L/=(_Q%"-1
M?V.H"BV!)=Q-(Z%R#$P98HUO)+_?CL7B&"P;&\?Z\WUI6CW=F.9& ]O6RE/B
M_A#+9^SF(D9W,964*,M&?D6DDK CG <>$+HMN<*-\6=A>GLG7[]]_NJ\C?VM
M (G^'MVK<\6,W48/[R)''N_3]JFE_2/+IDPCF=UH_3:1^HOX1'(<@\!"&[10
MCCAC-&?' 4/O#.BHW,.0<2W1F&O&V/&EHTNJK??8=FK"Z]1A'G!ZEMV0%<1R
M^M.\@JMCVDI;E?XR)71)6$IU%_4/9/4F3TF5FA%I!0=. S<FI@>!I0!G%=O3
M@D)K\GA8;1C4QPR)/&,>2&^>OD3UYHW]Y!7][8;^,JKO?KT.H30*%LD(!SA'
MB4Z74C(0UW13-<*L"T!=BP$-82TC:57*?>WY7AW)6>(C$DU"D62(2L.MED9,
M;>@*R[<F50X[)H=HQN!K)$JSW!#JU2F&(E5?-'^$DB9^!I<]QV%6\13:0.*H
MI^/.OR@M+LGJJ,CJ9<EJN0FY5QK3G%XZ,>JAVI]T_:3IH68 NW9P?F7&>Y)V
M;Z2\'MH%HW2]K\#[,4,S(I,$GT<DC3U&O@TL3'F4*J?R 1"&X=^%_-L5NCX=
M7=%/<=C,G]AYF#!S_ATQ$]B[4CZRUN0%JDR?'H$,X6,L&'D4_@_XQ_<+'/T9
M^,R2:/T+;,3X#>@3C,B;M 9#0YE(VH!")@0!/9#U2DJ'I70(2"]?(_.>5>Q9
M&'3!%,[T-%U32+^EYUY^T@=.Y+N-\*@R&3?,9!PNSV2L<A*KG,0J)W%E3N+9
MQ?75[>75UX64OXW=>R7)6"Q5Q/3]=V[&Y!2_(?_DXYLC=KX^)KKS!'[JXL^%
MR/_&'[5'7]BITQDC!9<T!SVX)/%IRQA!+2_MK"8UC+]BQ\* SU:M=BIK[[FV
MD*\^7_B![[%[)X@I$XVSD(M:-!V#N_[M\EV]-=)C(S,XDI^EMQWDC0\:<?%A
M6(CKME$S=#E.T=<X[S],>T'N23_$_@%FP(6G9%FK*H9:N]B]>L<#:"\<8TNX
MX=A3,3"9=8#1!1]V /N'V_*]1&^5%R2FCSFFC+8F"GT2RC?"21Q9_H,,P843
M[F)7?L#JF<LP"A6@%=HP?I\XKHA1Z<75!62]LF,XE@OD5H/-&R%[V.AV* $,
MGP9( F/ T$9 #953-(^7F%S=7&B%H>*-;?SQ&'A0NFS4N6&+:A"RWCF8T%&X
M:4/_BJQW0];OE@(O23V@WFCDRA=A>F66*JL0QR<F/7%)"Q&D_4[R"=0N ]]5
MB04X-);F3BC.\>Y",PTT287?/0E-)'21&N H>8CQ.PMF:#W"YM1ZU[_?).MQ
M-A4TC.I1(#I9)>CNTSGMF$*%&A/OF4F),#+/UG1<%Z4C^8\P==2#M\D<9QDY
MA_L2#[$DRV?"[F6D7EY4.AK]CN.'*N-9&+#"?HT!SL#UI -*G>F77V[2=R2"
M%R+>"$0X';LBYI"A8\FN-CT \;XE-X$\%^A93/  *K2 *T_2&<GPKHG_D#RX
M6D'0:29^'&&RHTPWU^W\U"JA[#0(JQ]6[N.K6Y&+CF?XJB0 9@^\.HRLQC$'
M 5D^7KI9%];#8Z5#X6%4Z1W88:C?; SU>(*LGK-!SQ"IE?1_2-HAB00D3(U6
M0TI3;VNU^HW>PNLV;% B7];)?9E(YTG+;OUB)TS5#UL!6$D>.KSA@V_8_C+P
M'Z@_*+& /+^?=.IAYH5<L<C&YZ:'6R C0B[YCNJ'+OE(NL[9BBE=9+W^@\JA
M*Z1 KMKC8ETU+;BZR6GY#)5R4^%_"%@RIRK![MX/!:F0LGB"I,XH(8E<K ^9
M*V@QJ\\J_%\>+,OXM@L0S9)SMGXH1$6;G5+0##H%X-F/EQ^N#7B=Y4COP,:;
MKHGZ#^;"FKYMH]DF V38+W>>A%-W64FREZ6A6Q\4H90W1V>./G'N]MHIL_W1
M1DVG$<]R8JK"-R4S_E0BW08)?_"CPU(O%P;A):.D5+;A/O5,I9:3EIE)1!3#
M_4IHQ5?TFJ)7F<-#5G-"F[UF;H<\] @ D*;T@>LP4$+1J4L1*5%SB=D1N +>
MP/_YP;>4%4_=]6XBCI5BY$<X-R/C+%5?>WUSGA07I E6+JN78%A!%QZNQ2C/
ML\QN/(2:N",BYW([Y=:2\U.F>K0ZK2</=MC%W 9D')O.:2@? I9;GKS# 8H
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M9+E>>L8[;@H=20PX WT&E";JI2$=(F:2V*C[9[ XE"TF'(^ZU/BIK,=OGO^
M\\!3X66L?1'5*D+/^#T&0Z\&YI[C,1% _]T/7$OE^5RG^GI0F)F,3!TX9,KY
M^3D> ]344^^G'/0=S\386;:="W)OP$U/]Q<$+9]Y,:;\).%RLG%ECJ).$DQL
MSU:QM-H#!_SO7.<_HA:;:><A&X&(CB@H])*;QU8NOI>)]*=[=5!FUVTJRQ2
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M[$FV\8,??)-U"6GQAQ\;INN'Z*HFIXW6'/)X!')61$CJ+RA:05@ ;:P/4G7
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M877?KHM4,"?*>E^IVC=X)-*> D-"$@5#0?(X+(B?B/D!8KX4 4@T54VF78F
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MHJC0\.,HC)B'QWU*0]@B-WHX.L-J?T*_:&7T$[#KF36(3;?T%+7P&%%@6*'
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MF^Q<[@/V'IOHJ0< ^5/X@<6G>'@6&@R^#&,W(D9Y_=OENWIK5#,>)HXY,:S
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MPPS3]8DY!* >DG +^,R%C9$ IH?@MYY!3@K#)WF3VHO8(!SL%C:D#J'8P"R
M>R;=-<2+F3%4FSW\4RGJ<//QV'5"H</B3X40#06+"N/9S'7@9Z@U>[$-RP&+
M@*=(325:!LC=.Q:8$J'09<4JBF!1?18WX3I3O"/Q-7D X94)WF,+9 ZO.1?W
MSK_/N!?2Q@- @#L/* J4Y0D72.$!]Q"Z -[HO'[N+]@1I+'[7GWN8Z6U&Q/N
MXF92^P%M@G-+8(+ U^1-RF!)\^-$.\'?*85^V?L(^A,&[,Q% $LS#M[I @3O
M :7T10A^4.0>M#FUZ@@[O2Q!59)" 27F-CXFK<$7,A5X.XCZB)/4PITQSXMA
M]?0S F'@R;3ZAQA!?RL$A1T@:=>!':7@!KL PHB$P!$[!E[V77"Z:0J'Z2(0
M<HI(-,U.V2/H<; F*)*@68K72Q"1X",:!.G! Y1-^G> O1=R;T!AS'O41QRC
MF8LO!A$-)!W#_1'PF8%7$3BXB@ 0/(BWM'@I@L!Q[_#Y/7.%?DN<1Y]=L(AY
MW@7W". S8T%Q+!*HZEEJ=[83(GCQ+AM9A0M[D$M%[#F8\:+6IP(#:%F3#J*P
MQ1(417<M3>A$K]<FL[*O-]4,RF8K4Q6[<2V4.L#<]X))+H:6<GS.!Z;UG(-H
MF0(T-(T@SO@>>M'Q$Z2!B$[KZ]-*D1!NZ6-3R@G2 YINO@LH%KY9--7>_E,T
MW->Q* JKPL6X;!;R-^J/GT$#!SG]^,;QZ'CT4$XR;1)^:31%"$:F_\KUY=<-
M^FHN_"R^ZW0;[>'RKYN-UM+O5BT[: Q;PZU67?5=&_;:.^F]]AJ#P7;[6;4J
M[+7??H9[;0X');G7,NWU^7"@O]&J:\H,UJ8&C19^FI,U(D)F>\KO6I"0HL\+
MB81/0A2\SQ$%&Z1=%JC]V.5/RWKE-R![2W/A&]+%7E.D1FNUPR5I;.]0,PG(
M,)+>FW AKRTOH:Q P>^!XR(J>KLZ\2:E7\=T<ZW1+DBU7U(N)@SWBEHJ:JFH
M92MJV;99]E*L.+1\Y96R]WK!2[&S<<-'W7&EV.'W7EBP\M3M6KLSV/' ]'VT
M"EV_F9W-4:]PNS2XW1H5[8IU'+B]4;74T_&\#'52[9- @ -A0@5ALU!/7/'D
M8^?)W5J[6;2@N9PD6>D;IX?;G<)=.(\#MRM](]7MNO!DA9(!_T 8T)-TC1T-
MD=CW':P\\7]\WWIP7)&EY00B,W."6=O;S4@[Z+:DJ[LCEZ\'Z?$UCGV&44\'
M#*:G\9(7!-"V@5N<B[;E9+331O6*&1TZA"IFM'\ '08WVM$PW<U&C*52H.7S
M=?SQFZ0C;KH#[IYHXPL/HP K5;'HKY92+46M@BJ1F=<S15^(+:S%$K*/?K.:
M6'G8$.H6[:=706CO'+ZSI=>X@ME+456KM:7SLP+1BXFF806AO4.H(.,;M,H-
MLY>>U[M7 KM=4OZWLWE61QT,+';XO1/RFN2C3G_7(_D.R;E08?#Q8W"[6U3V
ME F#R^_%+*A);,F.JDE\SY;65O'*(^&5W5IG6-2V*A.OK##X!#!XU#UB##ZA
M8%A]5[&P Z'6E\WTRN;!Y0XF.5C?1,&;^LP#K-/$WD6![+"]5698T2L[' UZ
M=<BA,2R:J[$M\KQ,4N=&^]DW#F\Y@:["SPH_]P^24\//@@)GN\RJ"FE?&D[C
MV8GA\1H^.WA:B7R%LA6??5X]8,NX?H6?%7[NI4BNR&SO"E?W+/ZKN:4O/+>T
MFC^ZX?S1;C5_] #V4LT?K>:/[N$\F\\?/=R) A^*S$.J+9\ND,PYPRJ<I3^C
MR98SX?4'KIAV_,,?4P;[LPR<1['A-(R&\6'S24LKMI]]]]9' .XD;V'3[2_+
MUQ23K.8'^8GQ"_B[$'#)L4&#\R+#@7.&;PI,[TCQ!R*H3+77?!@I#V'W5 #6
M5BZ\=E];FB^_A>QUM;J-'M[%8B_++2=NZ,FJ3!:Q(8:][C7U;#%5XB:'WB3#
M7ER'C1T7)VLE(VVN;\X18V> HHX?AS@TQ@G-. QIC!3]Y)EO<G/5/P%O\^?;
M "Y(C+/[ZIE@K !YXG@B.6YR?]!_]1;'^: "\G.1X;(5B;T B6T^S$;1F#]S
M?,>J*Y+2ZR+)=5MS4P3[ZM^YXP"'<], !^V=3@-,ICZEZ!^(W;D3EIW:^L\5
M4AX*4A;D]CB5[HXY-)WL=:O32C%\&G&([W"\, YP#*F8/(ISZ@)N<L 1JT8+
MX,A%@&_@\<?P_S=L+N=N)]K+ PODS.R92SS5MN&'.!@QY&Y-3%ST/,'AQ&A"
M/$I*?@1\Y@>(?Z];@Y[>8\BCR!7#%^5HJA"$%Y_XKD5#40/GGIP'.(LM1XC!
M.Z/ I]FJ83P.(SQBB)?GX&!(&C?GWP5L>DC8?8X3Z$X+IS?68](\EJ61(Z72
M#-LI##=]0LL<](,K87?P8GH<T$4L9N ,W3GN;0)"3V&KCBLUY@??N)XXOB'&
M?@)O+)_$WLS/=WAX--RM4JRGO-)DUY#=PYI"2K>;6;&;S/Z=EZ XPC5@\+?@
MB.@X0*V2\$I.4I3?!]ACPC'E*/0P]$V'$(SP40U</B165.%2 5RB,;";#MO4
M7$Q.S00^-4,')$^)5)JPF1C^.(8;^50\0T&9C$@6(]3E0&\<+(I#7^7,]$_<
MHFC,30RH@W-%;]!O+O /EO_R_?9&S5 /&^7C8N46AROZ&!(+ZH^6C!??&"-9
MN%($(H9(Z,/O"'9"&DZ$HVPJYNWF3YN5XV4;QA<<92_Q_;!L?D,:_?JB+_5%
M'Y"];XRYZS\0B.TXH&G&%@<)XE8VUPL39+$>4$5UU[2C(+&ZM2!0J\Y9,._C
MP)]QN!_%[Z5DN%@0&&2H-8Q+4%C@;&+8>\ZB0?J0\'KX)5E08L"TW(Z5<O69
M;$9H*HGI C4E(/Z0N=IMIL3-A8^XA>(*_J*L 7KK303_,U73A*7 53*('-(4
M/U;#MY\V43C+D [3"YE!-("8AL'AL26\U@^.!X8S@N;*!X3KUHR\<]12[%40
MS!>)=1<""VL*6R1HF$G:DO>(EV!JU#'3J&/K5X<)$FDD)<GDA,:O>MC]%_(B
MH$[^P0^F1JM9_Y7P:>H3<L.?4R:<K+#!(L'!RNK?EJNN#D7%GLWN@9&-D1>F
MPE( *5@8=)8X"$ ->83'3)IS9M@N8ISD(%OQBO)/I,]'@!P]9\OX]X%%D\\7
M(DVN+R--*':(_Y][7@QX)AA C9 B"6'9<!W&/7-CKN;9?S+_!\(4^,0%\YC%
MI/L1\3,&=HS8QCDY-$D"!@$Q*;$"QKU8$*F5I/2AM]_EJ/01;*-A_.(_\'L>
MU R?-+S ";^!Q,X8>W8,C)2#\G</G'=&K*X&YIXYH=BPE.GT$EA(:.K"ZQG6
M4H9BP._ !HS\ ,-U*L(E@PE:Q I2HN&TW_@C?!Y\XQ&Z).+I3!"6ZTSA&O!\
M*O@'7%M=*+I-_^1$JB8+)T"2_@-LXF'BP&9-/W8MV"]L,N0 +F;;\%,19\Z
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MKY;2:,],S%SJ1UU%<#FG/QR"6RV+:[UNLR")K8#U<Y'8W"NWXHIE!E*GW:J
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M+KT'V["> .C/0U),UA&6B/'@ -%Y<$#D'V SA&24K/' ,D.:330#]#LY2WD
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MQM%FM!_,=H(PFG>#-8R%>RMN]))0I\BQQ^^8B&HFYC9L/HQG,]?AM%F3:T#
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M(7H#Z"OU;/J="^G*W&%H8OJ4Z92&"7'72+4NHAS2N8*V%\S\$I2]QB+$'UV
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MG'?52%SY/(]?4H2>X0N5H*I@M\43SJE6>#,.KO@&SF)/7:I#N,K 2/.=WJW
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MIFZ8VI1W3MAOF27/*)'CI3;7(]IQ7Z0_DY2D:U&F7+F.>A!0J:V;*,Z:ZXV
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M_)HXUYP)FPZ+[5ET>V"T-%JUP7,3Y.OA-"QPIO@#YOLT.\J?W+>;<"6-EN*
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MFOJLFCAQJX#K4^S=)V)5-^QN*<>)M(R8"-H9AS&D#&!%U*"EQE604$UXDZ,
MZU.NK@+>3#IDZOC5>=>E<?C^J7/CJ0MSQHSC_*L+=L?_=[XH];E2F>"&XSPA
MP+-RYH8(!BY0"C)01:5VU,<V"> FXO1IP:C.V'4&ZXX8L9/A_<I-3]Z,)E]_
M3?%S^L4-Q_.3P7E6LHEAY*;381XN.KP5V5 "2Y13VC!@4>$,Z,H..+<$N*3"
M*)=R=#M?>=85HD\KU%Z9W-3Z.^'OA_*-.;SYISY,IK,NS89=*L/NXHS(AQ$.
MR26#,2%J%YP$SA@*PXG#P4@D&.I22()X:YN4KC629\VL=N-.:OND]:Y(L?-4
M^<N#=P?O7QT>_WIX^*E:5\>;#VV5!G\ >J6D][NA\\/1<#9,T\72/!LX9CQ'
M#0"3SI9VJQ0<,1R2EKC^LI"5:7*&_2Z4;>? @Q FY^/9](/[7@*42P&E]]X)
M(0"=!P:B)(:L5@I0O"PT=]FT2>8OA],G#W%+-MR>;BKHO]IZ^&XR_OPI=:>E
M#/P2B$Z,4<8$X&#W(&(V8*G&.)5*IZ0C+K2)SI9@Z9-W59D%VVJ^&@60CMUY
MBDO$LRQ&7#TM1,$D"*T,.),3**ZR\QK]M&@;S0C+$?5IL[W^I%#!"O4KT-XE
M-TV7J+Y?8E(I><4$!V-TZ0"2+%C/ I0.3UH+80AO4O;],*PUS_X\)7I4M$>]
MM>.'B$?Y]7!Z-IFZT2_=Y/SL*A^ZM#+]$G0H76MC]. 5+G/"J]+GGI4CO.BM
MTZ2D=4VV&K?$O0K+Y--DV2XM6HV&Q[-)^/-D,D+%3Q?G)0>9&J&]54 TYR!2
M).!CV?+43D:3HM2VB:]^%\KVVWPI)U1NG#_Z7VYTG@:,&5P0G <;E"T56 (<
MR@7&EZY/H;2I:'1,[@Z6/GGI6_+@[M[==IJON8%^.AE?0T&BD\30@(/;.1#4
MX'@KI]&E4B))34S,3;IZW ;2)^>\LO&WTGD]SSS&89'=C3ZX87P[?N7.AC,W
M&D1GO-$2XP*/<RTN[A9,2!&2<EQ%HJ2R31;.>_#TR2NOS(,:%JA&AX]IYH;C
M%"_; 6+(<'YZ/J_3?IWR, QG V*$3,2BXR=U1%Q(6">#@)""=\43I+2)7_XX
MM#[YYI5)4MDN-0/[2QPKI="9==DYE)SRLJ&8LP*,+QD$=-^LD;:<=VH4[J^#
MLT_^=^WIIJ'%JM'J4X<AZ'GW_=KJZ$P*DA,D=5+SQA$15T=G@(C(G-#,T]"D
M*_M=**N00^UJXZHR.[94?(NXOYR6O"MD"+*TS)- :2E\9N5B(F,%6&2EQ_!4
M2Y):T.$Q8/4CS8T*OV@RV5O),"S6M!1N4/ A"5#>9Y]\V1ML4LI3!WZ?0KZJ
M3+P]W/9@[19#]#(W$\M=D5022-Z6&Z0TQJXI6F I&,V2XR$VJ1+>+(N_ATV=
M^@S:T@I--OD*2R^P4$*2#]J %Q'7(HEKD;$8V)9P5E+#K?!MINFE</H41;9E
MQ?;6J%L.=4W::WB,(CGSP(';>>.#D,&&G""1Y)S30K+8Q*>['U*?0LBF#*ED
ME8J)AYC2:5GEEJ]Q"Y$7.;-7KNN^EZXJIZ7& =50=JU=*(<=RE45QH$M=PN1
MK+5WTADOFVPA;PZY3^%E4Y;MR*K56/CZ(A]_U2SQ^@A)"(IXD45R$!B7"$H9
M*$MJZ63A,@G2!M5DT^<17&M&I$^73S7MT[J.X=J,:@7GAB@-N.(BEY6SX'PH
MMZT'HB/7QLFV;6?N0[8*<?1?@3AU;50O?3J=IMET(+AP6C,!&*R)LOVCP3)T
MX%F.666G9)9-=ML6KZ\CQ%69"/4$/4E>?$RT4A0>C$(?4P=FM< A&6@3G^X&
MBCXE$#:P\9V<[<8:KME"%X?0['NI0R\]?<N8/+NH1,>QXX/+T@&&F67:+?D'
MITH"DG"FF4J^30.*AT#U*0-0@0+5]%^]==) TJ"58@ID(!GC!62F)1JEE-:+
M%"P5;6H%+@'T*:JO8.F-]%K-JF^&8Y3PW?!+<;)F;OQYB,[[0JK"-,E9P'68
M ;5&@^#E.CAM V3.O?!<.[15"UL_#*M/47L%!E2T0=TLS@6&'TZ3C^6E)H*A
MZ'0+X1BX9"A0$9BW0@<1F_0.78JF3U%U!19LK_%&$<['HK^C_/MTP<F!L$8X
MPBSD9,L1-(4Q.V4!A60J<!$R1F7MHYM;J/H4$M<@0S4+5(Y=+IU2;KC..3'0
MFK(BG$<(BD+4W$C)5,2E:\=N_P9ED&YZ@KY5^:OX5U_<J-R$<C"[3$TM-L0E
MNME*"P[16QR"093\J(P0C#8B*Y:(;=,P>15T_8M\-F'(G5K)ZH:IF+@."0'A
M"ET6YZN#=B&AYQT(QFB>X(B4..I+RUN1L]3,$*]BDSJGI6CZ%PK5X,3VBJ]X
MG<47?/>D^U[<,R:<2-Z(<E6VP17:( M-N8(^$2H2\Q[)V,+TUT'T+R2J8?&-
MU5PQ"Y+.W/"RE?7E@?V;$B8GI/&, @L6&:A$ A.,0W-QYHF3&)XW2H8\BJU_
M<5(-6M0V2F4/:;-33D[S*'V"5'9>18@93%0"K'(*N>VRXTWB[,TA]R_ZJL&M
M'9FPX4&UC0K*-&/9^4PA<(78J31@=?0897(OJ<V*\";>?(ORP1I*'##.HF!>
M@BF''47B$EP,#K357""/@F%-)O7'"DS[=ARN.=L>KZ!<RU;5!MYOP_&DFRO@
M0BA''4O4!@Q&(@8CV:%+*J4&EI*EGCL;1),H\3:0/CG_/>#+5G;:;P.E#ZZL
M*R=I-L0W3F]BJM1.Z=8K=M)<Z2&QKEHMO:BIU>M7'!Q_.GKUOW\]>O?Z\./Q
MX?_Y_>VG_UM+L8^\91?W-SPFW#[4>\/<N]'US5?N1_$/B-W>"J\.CG]]\^[H
MCVH]V)8_?"=7DBP7I5)/MI)(<M.3#]WDRQ"?]O+[[].R![>X%KO4)H;9\,N\
M1&F@=,C&20DTRG).WT:P!-<DPR/-(E#O59,3-JM#W#K9X;[/;P+_-#D(N%AW
MZ=X:A 'UA"I.]>+>.E'R;\[A(DI\+H?'0DJQ29G_ZA#7=)O;'MIK1+,[B9$V
M!JR73;N-[WB29U]QHAP0=.!S# HRY09$9!%,.=#,@PPF"FLB:>(\WXNH5W=_
M[(L^&YFG'5M>GD^'XW*MZN*P\GR/:/&3. B!2J0M >9BR?G,"X%- ,NC%5%@
M$!B;Y,_6 =FK!KC[XE0M(]8L="RSW<6EUW/I9^==.LH_D.+,>1D^3M^.#W(>
MCH9NAIJACA05."#,IS*+!D",#IC13CMA*&5-?((M,/=I2V!7'-R1A:O/?&\F
MW77L\VV.9<JAT@9GC $<-AE$X!9<<@2H,(%PDJ7.3;*W:^)<<\?@+S7_M3!E
MO6Y@J(A;I1;SJUR'H5S7NBC%N/F-:Y_\D+KAI!S0*9TDTNNT^/LJSW?X+9RX
M\>?T$8?384;G<C;@-&I&;095#G<(4ZX,HX9#9H3JQ),,JDGPL%LQMS7*XBE'
M^?J3C\9;R3#01C)>FO]&1PBRRR'/;.(@> @Q1FY4FW;<#63IT[9(C\?/[?EH
MWZRJ-F?=,W^_&8[=.-R:4U%%H9R"U]'STF=/@&54 >'ENI#(7,Y->ENN#K%/
M>S9/B,R-.-":H\O6_:29H3(+8#1K$%EI'$.EUMM0R[EW5L8F,_.FV<7]EI@]
M?8YNRX'6'+VJ/[^&S_) &=<:E"LG]'7">5X4!U6C.^RD"L&;'7)T"<0^!;=/
MGZ/;<F ?''5"!BME!JLI135$ U8I"B24=O746-LOCFZ4K[JZ_U52SY)W$+3V
M()@WX"TUH&A,P3 G0YO36/V\I+<12QZZ?W<-_5=L67+6I3"<:V0@.&4Q^@22
MX+HA0N0H")4@+94T^*P";W(4]SJ(/CFO.^+ QC:H6VK\]O3,#;N27WIUXKK/
M*!1+-G,9/;B@52F%*P?#C48WERFE4K*B3=GB<CA]<AEWQ(P*=JG8ZOWR]L W
MD^[@M!3<_=>"LCZ3D(DBP'5@($AI':V3AY)\5"()S5R3#-R]B/KDN.V**56L
M4Z^[P\7MJD?C8W1!C_*U,Q4#GJ/B2I2TM\D@E/=@B+60HJ&!Z^B4;!*</H#I
M*>PEU&9,+1-5/ 9W.SZYTZ\+1=96I1 #!V)" B&S!,N]!)\CMS2(Z'*39E@K
MH>M5;^\=\:B^V>H?K'SW]LT11L>I^Y(6L?!B)1UHAK.?9>ABI>Q 6)K <1N
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MER=Y\G$A_9HP+,D5<"8:)K.OM3-38*'(Q$(" ]F(R#O%H]!XUY2#OEI5C*Z
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M%($+P)F1 -ER#]HW20@[HCYT+3]V)'781>)'J4*FA "AA&3!HK^LB@J^*%;
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MR S6$+#6$2/-)W<(K;40?).8^(V('H$2]"/MHU_H*Z.$J/4* VJRG86HW6:
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M$&O*P6_#68+1?R!,9T_B;#Z%-!_DDJ(S,3*E>>U"I&O37@,L!9Z4B]%*.';
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M"J1JXMYN0[DD4IPHZ ;.[;OII,ZCF+TB*=0USM8+OY(JEFQC[8%+7IW.KK!
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M >6-(S^>T!',2#!S2BQ'8P/] 3BQ$;;O:1_<^9%GN#SM34^3]D)N<##\"]S
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MCJR1O9S<4J Q0HJ.__?U*%W_-IZ38_#V"T[)DL^N?'%!%X0ZU<"21X"2 7?
MG(H.HB5W 9JTD>T&[X(9TZ->>FXFOD;X9K%JN/EE"N/\)^91@IL/M]-/]?=W
MTTF^3<3R$K$Z)!2BZEI49G6]R"4'DRL40@< +KNT%S_FF1=$BJ;B;G V<$ 0
M!)'"R\6 Y3B;3R'-KT#0AI?1L2S=HG>Z8#Y:S:!P0 HBE88VR23'H+P@-K77
M4H,H_SU^Q?$M?L>#1O&<@V:JHM#%(0/G%1/@A0P<O)=-\FHV@3PI8IRJMZU$
M]!.$WN#\>X6GYL._K.>B!.E_C^;7+V]G\\EGG/[V]^K<],5L1K$#YIK +*71
M1HO(P ?)-&A:NN*.%<LM"J5E-DTZ4SX"Z_!4.DW!N]G23#LM"KL6?M3B'5KG
M -V)(AI:;/">I23),5<&6(Q%,"FRP*B%A](F57P_IDO>:_I210-W9@>TJYA
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M!$DW:&YT5TSXIMYOW/=-T&(F_S,S*T6I,QX,^:;9,:,%AT"V3J4F/4?V(KH
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M$-X+G1SG788'=WI/[S_X.:OQ)"'VO -_3T%Z"3-<CE8*4*(KA0$G)T/S>DG
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M89-1M\(+WGL\R"XD>V%.CO!7M'\E^_\G6.3_E63_+=C_(]<$P,E 1UL\!CX
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M*)5O\U;0LMWWE!2+(&(1I$1Z$/F! XG/8ACCB$J7ALK]D*ON[O[)P7-8D-%
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M,*M^!96JD^1G-@!EW$S-?0)GSMEL8/M^]F:3EX81R:?G559U>I95+(.(N"B
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MA+'ZFW25"Q'$1LOZ7BE+&XJ[L^7*5WL"MUM=P<-:\5N92&EQIG\<WM-'4:.
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M>O_LS&L?Q"U9=]+NKESE/V)]Y.<+X2J6CY!R(86 C DLA.<[82BM4N$>E[5
M8H<Z"KVN[6+I+/9A:N8JCH34U&3=S9)6Z=E)M3UB"G\#-";*BK8G[K72H1VS
MNR</VM%7AA'%3:[\S4W^5"53JZ]Y7[(_-DDN^(J)**#<#Q285+F#1"TXXPA[
MT(NPCR.&9<BLTOSWR%H:433I  NM:2<O(P??)RFP2@UB K09>XP$W\3LT6I9
MIU)LTT)<@%;5\?C# (\Q^:-/W*S\86#W2_XP>>4\1^,F:QIL4T9<I_^>)6GY
M-_7A)A<K1ETO$BZ!)'"Y3L*FN,0+,?1"2D-)J8P#.L3I."%W>;R2UD7C*A?\
MGG !%*&(;ZS.:ZQG7,)YHC]6T^Y]Y0I6)0V38;7+3+O'SG\9$?2Y?)DR:QEH
M5\A,(5^I#1J]QW=M#(&:PLTY)?I57!Y#/(ZY/Z:OVV^37?JQ\S$K1?%V(WY1
M;]ZY@<(7-;L&@F O( CI_78"D?09C%G@PHB%@<-='(?8.)5_KZ2ET97_8^S\
M$ZC4!7PC0*4P<(,+H'4VWZ/IA_?TMM=HH$U,-UV\WN[A-6!SJQ\X\]VLT0"<
M:?NJ'\AQ]JR,,.G9I.I_?[9=*2,SNMM09B\,<P<_9.GMC<COWPI:7J;\BCPD
M)5E79QJ?Z#JYK;XVA?(&0R\D;@3CNC8*"2"50:1S?A'E"#*&?,_&&S03NS1V
MO<F4DF"M=(=*W#W@2GL[]\X0;C/O;GP0)V;;#UODM,K5G9]*6[!3=SR7S@Z=
M,3TZ0\FS.G1V:+STYRS?'EK,,D\>B;[3_B$A-%DGY9-BO6IA=7FOX\-6/'8\
MBI5;ARGW(4*N^BGT?2BI@ZAT/9>QT*Z,Y0F)2R.@7W_\^B-XFZW7)+\ ::,J
M()6N%V#=&F%;Q?(4[F9T-"J:$S/13E>P5?8"M.J"6M\QJU0:0C-N?<I30F>N
M3&F(P7Y-2M,7A_'.1_%G)P]BGJ7J1U;OU7_*ZU)+UVGWB21ER<-::9.*ZU+<
M%ZLX<EP6*<?(9:X'D>?%D"#/A<*+I1?Z5)" V/#2V1HMC;>40:";^_.92:JS
M0%,F+$F?/];8!7[3EH'*-,N\JN=WKAGYS=IE$Y/C++UES:&C(3PFQYZOU*P<
M/!J&+SEZO(8'IE3X='5]6=8[]?J"]DWVF>@;VA]%^4GJY$A9=?GQ3Y+SE1<A
M$H2N@$&$'8B<((8Q493M$S?V R0#XMLEK#:7O31>UJJ#KNYZV[W67GE#HDH6
MJ!.1_:9M (T1MIFM+;K&C&LG GQB5AT9:_OT#O:HC9KSP4+\O(D@[''9RPXQ
MH D[GJN(,W]:75VN0C\B#D42(JXX# DN(&8,01F+F!$11*'9A8)=DTMCI2N2
M$D[,6*8#3#]Y##-W8DZXNOQX^?;R_#&^;US/G>GFX7KH-K^\'+6=!F<9C/L&
MM&/LP"?#7(0ZBN+3IBQ*DNH"K*NZ0@5E4 B'0A12"F,_]B#G* P"SGG \>I!
MK3XS_K4D>6GF#NS)L?F^O90VW5?OC;A-4GTA"E"B/F#"LH+2<5@)8SYUJ/HZ
MT5BOAOT04A0P2&0<<TD)9K'3P/HN-:P1/ *HK:SI('U7:38ZGF9.T5D(34QS
M;4A91[OQ_)JCAH_IO>P+F=5'.6KC2T_D^(/G[LE?IT695R?)Q<>L?"N*Y#;5
M=R@OB[\*?EN5'MH^T":34?[/BB&*>!R%$#M"N2N,ZON/R(6!%-@7(@I(:+4W
M=K9&2_-VZD1*:YU(2>=@ETFJV",AJB]VZ@_=T!_::;8;_C-TQ7P' AU=]8D
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MF.ZU;.-WSHM&N;Y_($E>%43/%).+\I/4>](418&G>!4*&>N$GC2"V)$^%%Z
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M 9#96P/+']79 -Y]8W>J6:%OPFC7ICFXE4Y$0R;5,LOE1)&+P#"FZI\08R_
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MW-CU,9%08J;<%*%@)0*K7QV7NK%R4D+/L2&I >D$9B"B&RUC6,8 J\P B\L
M,/8U_^FN\[_&M?W^Z_EC7,/_(LHDKY+PZP"FKP]JW&;YL\)9;B00\:, !BX-
M=8),!\8">= 50JT@B%HI4*L$:"<E+F_-T"I<%^%K5#ZO5-EIW$V7%2.B.?D2
MXSP@!RPX#,$9=_%Q2NC,"Q%##/87):8O#LQ"EA0/64'6/^?9YN%JK>:^1":=
M[[\34\P0TZL3G8S,]S#$/HZ@S_W0);[C2\FMDI'URUL:Z[3J@DI?\%SA091S
M"G SPAD1QHGIYBP$[=.4F>$R:K:R$R+G35IF9O]>[C+#UX9Z-\WQ_Z]I4C9E
MKH00@70##F/,&421'T$:H1@Z#I$>PI&'S:[Z]\A8&I?L0E>TC@.+AQW"TM1'
M.0NAR;T2.W &>"%'S1_7[]@7,[.G<=3.?=_B^*,#TXDEJB7Q(7G4J5.?)RK[
M*,H5\04)D:!0AI%4BQ@_A$2H?QB5:BT38,>55LD*^\4M;?Q?OTQ*..#LXP3
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M.V'6O:9N8=6N:;O#[@O0M0[LNJ]U@4X%WTS;C^9QD:_5GS-%3L[>KU8!EE.
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M?E3A#;\;BXP)ZNB!%"_EO2G-7I97U4.?#SM4_GFW7F;B&=RKGQOPFWFM_FM
M%NH*X9 $Y2W#I-S5%:%C6NL\3D?&8\]U4NVM^.]MEJO?MH6QM^QARQA77[1-
MJ:U_(Q>$,,P3@:!*8VW8+B60\K#\9Q @$4N*A5^Y9)_IG5[+20LFEY(569V?
MMZK.G+:VP4U5X<!L3]D/MK0*WI0G5WN!D6>E[Z[\ *M5\Z1)GS5SI,BAUV$:
M>FS$MD?&6CRPEWSG!BC+$MQ>P]J?%#N -B@A^LP_+1EV0.:$"+N,T8T$S9[Z
MN%Y]VY@]LTR]+&ZWFX=U;L^4"QF'(H@UAS8/W'(>@C2.!-2)4"P.XI0&7E<2
M+7/-S9BK1 6%E?6F2O8N -N)6Z:#5S_UO%-HP]N-KP9"<61ZJ@'\5@%8"0KV
MD@['1 YP#$D\;=--RC,.>A_3BLLC/?I.E#E@RWJ2:OP77;?+G_W&"B5K?KO-
M<_.5*9\K%B3!E 4AATF,;8D0I2!5)(6I0)*')(C,>=*[#4XOD>;&25_W%E3)
M2V"[RC9%=RH:8-$<@R0F78JQHROVRH"&Y&IV.W+DO\N6V[)FYGNME2BML?*3
MD%LM0:TF.-1SX%X8@V ^>(^,?E)-WSMC$!3/]M089N1NE/UIO?I^K_)'6^3?
M-D&KJG-_LD4)O^QB*HJWV]S>1BT"% 8J00B&.*40J9! IE,%1:*IHHCSD"$?
M=O::?6Y$_,E8XG\#M7#@R5[!^+K[_-#'J62!P P**6Q9<\D@#S2R_XQ3J:AF
M*?8KGS4:_A,5SWJ)O:76I=$(FM5_!-+H-.9JN&UZHR$\\O[V:8=CV6ZE[-A4
MUJ?=2WW3?/>'VZXZH37DSN0GP*2;4"=LCO>;;H-T3:BU/6/$9FN;JMMKZW?K
M1Y:M%K$.(ML$'3)IM@X4QPDDE"'("6)(ZQB9'<8OE?;L/'/;+EZ(60:$@#\K
M23T3X2[AZD9( Z U^HV//U =<F9;81@V6_;\5!/GR;;J>YHAV_[QKI?+:Z&4
M+%,B/A;%EAG1OVAK^*I<9+9#S),M9\,2G":Q@)&0,41$Q)#$H8*)")! 6F+*
MO2),G&:=&ULT0E=)3%DM=GF[LA,</%G)?2^879; ]59Y8&#'OBMY@>G' TSW
M,H.[5DP[7!M[8#3L7;'+Q!-?$'M@<7HK[/-PW]S]NCO-5U4>+6SNE5[GCZ5U
M]-MS_4L;9E!&&2Q"Q%.%M;:EA;2Q:,(4DB .(,?('(L#%G#IY;3L*,?<..PP
MHUUG*[-B]@7+]BJ 7"VKBNAEB7RK8^DUV]?#+YI&3=7=<57T.JN3.,U#FP=E
M<W:E6EE?FOE;L5YFL@S!+3.(/?-TNWX!W/AR@F4=F4$/5[06$^R4  =:W-C2
M]\TGJB(&XX3E],1TG'H'?J*\4CV$3GA=KI?0;3@_GI8J6[RKRPQ6 4+O5_*=
M>=L7.*+6,HRABI(0(DUBR&/!H8Y5Q*A204R<TDHNSC W;FV$!)64P(@)K)QN
M?'<9R'8F&P2>D3G*&QEGSKFJ_9Y-BH9."B5^_;[^\7_,LP:"D-J_0/N7 P*Y
M/.XDU'!5K>:EO_Y!_X*_I\D-]O]5G_CZMN/#.K]=K;;9YMFFT9=E!G$H9(B$
MA@P1#A%C"%(<:4B#B&B&64*0=JWZVTF"N=%!+5Y9O\3*5X G,_2#O3-R+SS;
M;2W:&6,2A,=FE+.IL*5CJE+B9G>+:_0 S5HTFHR] .[E?T=?B(EJ (^U(%ZU
M@'N!V5(0N-NXDU4%[J7V86G@?@/Y&X[O5QLST%?UW18=9JO-9_,%6QB[4"2$
M8)B4S>83'D*F9 1I1#"+">,H=MI(+DTPMWVBDA'LA0162G>C\2R(UVW&OM",
M3/">J'@9C&VJ][ 7SPX[F;G8IM2AM=CZN3ZU]+Z9+::,?]E5GN8HE"%6&B*%
M!$0\)) B1"'A) U#;B#D7E'*%^:9VPM=5S#;R=FSJO<IKFZNK0'0&OD=[P)4
MQP)O%V$8OCC;Z52O4%CMHK[GBZ)=_GCONB1E70R;'YBK![4JLA]U?;6F^ AF
M*@QQ!'FB"40IUI KAJ$B"L4D3<,8I7X!5,YSSR]XZK!<Q;Z>R$YX8.L(="X=
M<F4A$H%9RG@"$X82B**(0Y)J; PP'05I2&*.O<AZE&68I&6/O:0 UY;B15G+
ML=;$C>A'07IDZK_]\O;CJ]17<4-HI"(J5R9_K4HI;IBTE$-Q'*#;7K+KE5N&
MQ'W*ZBQS6XBS#ON,D28H9@K&=N= J4"0)$Q"&0;FY!@+H=W:"#K/.#?*VD>&
M[J]IEV5HZ+(6/O,MCWP==3=R&A3+D4EIWPV\%/8&[,2M"A$/'5KKC,V0='1]
MTDEIR!F#8_IQ?[ ;[7S(5MG&C/O#]NO>F*])9G:IRA5V6]5V*CVJ[W\^V4"'
M_U0L_V"^B(LP# E)N#GI1J&$2"82$IH2F,I8*92&-$5>/26ZB3$W@GI?;++'
MTI9BJ]76F%?L0':@*N%O@/G*8C^:ZKA*;MPU/O8C$UJE "PU 'L5*H_\#;""
METF+A]K< *L(L)H,QW3]D!R2_CI*,BDG]D/KF"A[CN9_?^Q1)Z^L*_--Y3\R
MH=A*FI\TY?*, ;G<2AOI7"42'9X5-NOS5=CK4U.4"AR*1$.,4@Z1"!#D-C$K
M$7&0IH&,I$I<;Z)?69>Y\;@M7<+$9LMR&S;XW=;*M%& 3U9U4%2Z [$NS*?R
MK+"6E*Q2!FQ0X%,9G[ K2;-OW;$O&:W!*EO>@/\5W51_L8/_K]#]MO:UOWK7
M+][_!WVAQG8!>-=F+0$!-2+E=^.X8NL.&% C<^)CN-!0I$-/X-?^KKG'&/P/
M^LY-%*WP/^R[YQ4$,9/5;@FG>&T))PO,>&U%SX1XS$6DCK[ "XY&*]2=_8&1
M956Y(^^,%9*K35;5<KBHY!=]SWXN4H8BI!&%. P41-2<W[EF,0R1P#2DFC#-
MFAJ"]QZ.Q''$=2+4ES4'[Z>HS/5@*V 4QK #>TU@F4]RT!;DR>KDZ8L<:=4=
M/9BON(@3^3W/W&^]J93\I;QSO#F[21KS7-ON+\<505_LG=5'VEH>^+M-QUV0
M09VM(XDZK8MV7+Q/'+LC3S?\SG/H1ME/;+,B[36GL\P?UOG1KOO6?+;JAVSI
M*DK"D(:1A#CB 4288LAM6RH91;$. QT@O]YPKZ_2W-P;AUJ73:IVKHXWUM?Q
M"[!M22]X/ Q);GP;N[S^"@RP!\[OJS+7[?+E&=*J!]Y4"OYRT[:+5LGQ%LV;
MZ7;2:9=UJDUW(JUFLS]/NXH^6_G$DDU2?<">?Q>8*9H*LSE+; /I5$(A#>Q9
M4@I$<4Q2%GEUW^@@P]SVU3XYZIXQTUU6S&T/''D=1MZTQEF"L6L#'(+XBG4!
M2C'F7!/@$*>>]0!>##5(/LAO;&DKPWQ[4,H6N+N5LFQ.P9;OLD(8BWIKON>_
M/9M_/*T+MOQ[OMX^[3V,]C-5IVXE]XVZJ_=6Q:&,8IG"-!$"(ITPR!&*H>9"
MI9SA1)$^^25CR3TW=FXT )4*-P<W&8=:@+T:W:AYJJ^%&YW/<+%'W@)&6.>^
MV3ACHSYB=L]HHK]FMM#8ZW$E^VCTZ;OM9W\49O-L0AB+A51:,"T13'B*(0IP
M HDDPGQE-,<!%RB)J<^V\W+XN>T.1CIK,^[D\^/\(^C<J+D[(",SZ#$6-Z!N
M;S=JF[OS< Q);4<S3,I Y[4[)HH+G^J8G5@&/]85E7=9M4*$G%'%H-14VP(V
M*61QJB!+E#9'=Q:&<>J5 '=NEKF]W4VY=E8*ZYG'=A9&MU>\-SAC!Z?5-4L:
M?,;(3&[%8- ,M+,339MMUJ;K2699ZX<[OO-[%^,Z/_0]+B0-0IR& F***40X
MH9"D+(0$X1!%42HD\ZH4>G&FN;W[A[)YOOD7P71\^X> :&P&<$''_YV_IOF@
M[_W%R:9]]Z_I?/+^7WV@HS??]N;ZJIHR;'?Y^GO.'K\J6T;='"#V/=?VGS&S
M;U>;<$&C1"6),?(5,18",J8^I-(FFPJ"14A$H)B?4[^S*+-CD7WK159*"-@/
MEBW+F%>]SH'>;LRQS982KO7PK?_;?=$<_?J3+,78[OVR[=Q>0E"K8>^5:T4.
M>CP>?K#294 /?V\X!W7T=Y=F6G]_;]1.W/[]1^S:M[:I^&T8VS;DNG]@J_]X
M6"^7SU_^6BGY;<N+3&8L?Z[J/=@?YL5#]M1$"E=-^8HON@XH_:P.RGHS2D*%
MD82ITL9:2Q&&E&H!S?\CA95&B? ZI8TJ[=RX^B!"]ZN2RGP7+$M?2$NH ITN
M_=*WM^Z8WPDWGI_-2H^\%;S0\P983<'&2 PJ74&I+-AK>]/47=DIO%OEF[I!
M9E$VY*BTKM)AQJP?/\E"#=MY>$R!)^Y=/ 'VI]V/IYBT<Q?VX^BE7?Z 4FD4
MB@1#'BL"D8Q32!!-H4*<<9:D"5/AHNQYX;H779S+:R?9S3@FR1Q&/]:IO&^6
M92(<.TI[^UW\NUG3]0J\7>=/Z[R#OZ%M$5S)?Q!H1Z?NBR7&*MHU-&PDOKE0
M.6O0UNW7X!JX=?O%Z:9NW7Y-[S.MVZ\^TK4UF](JSPW_65/>+/&7O+PIE?]D
MRZVZ4WG9A'@1:9[@&(=0Q$1;BUA#'B .48"43DC(&/=R3;A-.S?3=B=UU8']
M!CRQ'/RP$I=MV*793%A>V!H$54MVSYI]CFOA1D;#(SPR+^W!_5:!:V0&-I2]
ME!J48MO>'E47]2$[M?D -6RK-J>9)^[5YH/&:;,VKZ<'Z"]K_J'R'^JK>?4^
MK/._6"X7@L:)P &!,4\,0Z6&L&A"$0RB1*,H)%&DO4(GKLPW-Y)ZV4:UEA?\
M:24&M<A]&L^> =R-D :$<60FZH5@OXZTEW$9K3/MF2E?KT/M9?U;.]6V/#9X
M8;X/Y5W#F:I6S5WR2GXPSWW;"MNWT@CW(2L$6]J:5\4N@"%06.@XL!6I(V$X
M*DP@TYS"F/)0JH3))/+JA3VRO'/CN-::<\7-BUISX'U3^>]W9K\MFV>PRU/H
M6C1_[*^'&Z/.:-%'9N0)UWO(LH-#KL)$]0D'$7DNA0R'Q-^CXN&@T_;ON/Y.
MY=D/(X;U'-@]T\8\?%S],/NGO:(3YA=EZ>8%292F,HVA0'$,$=,!I&%LR_0K
M%$1QDB9^J?\=9)C;/O.R<[@M?IVM=HG[<J<3R'9*>=Y9=5DGU_/_J.B/[@PX
M!'XO/]@K8%-+:A7 7H=Q.KA[ CA6/W=7,5ZMN[LG3FV]WGV'ZL:3G[>V8)CM
M)[]=;7(SWL?5?SQDXN%]V<"JRO"PV1A<T1A1;%B1,(A"8[,SAA&D*#$_#2.4
MQE[4Z#;MW-BPDMI2GVCDMK?\?UG)@:IZJ=6-V^L> ;YQ6([+X<: PX,\,NGM
M\7U[BF\E-?AR#5=OGO.#:4AJ<YQY4C;S0^.8P#R?[FC;54TRB_OUK?CO;9;;
ML"LS\N;9UJJPQN5[\],G^Y$%3Q4/D3'DB-;&D.,DAC0.$$S3V)AZ4O&(ATW)
M04>CSGERIQ?K90'!L:VY6O8R9/2IEONF+!:XJ<I JT9X3RO.?44<C;=A49[(
M9FO@W:Q!+3:XVZ%\MT?Y_564_8TU;\ &M='<9Y_6-/-&Y<0B\Q_!C]2*?/,R
M-.?C1CT6[]8V@G3!2219J"/(963,+D8YY$PKJ'5L3J>$"H6<;G+:)IF;D?5"
M3E *"OZL1'5T4K9"VLX_0P$U>@A+!XR<.<4%A!;V,(\?,(?YUS%KM(X_"3^X
M:-@P@=-GNW;EOF<_/TI[<F@*TE4&U,*\VN9D%<0P(C0R=HM2D-*00L&E""71
M"#'LUY[[PDQS>_MK*]]("UZ*"RIY?3MV7P*XG08&A6UD+NB,6(=NWE?0Z-W6
M^]+X$_?WOJ+F::/O:P]T.^?<YXH5V_RYC"4I TAJ&T3>L;S\]^]J\["6"T$(
M44(* VBLC)G (T@P85#&.$%<)D*EVL<[XSKQW,BC#*XI#K+@I-\QQAEPMT/,
M&#".3":-R$T(6BGE37.:D55,6A6)5LD^W G&%ZTASR_.<T]Z>O%%Y/CLXOU\
MARYD21!\7F]4\<X,9IY\"*, A77OG)2%7%*,#>"1S2*3#-) FB,,30(48QYA
MMRRR:Q/-C8:27X/@WT I+9#V3;'R@M!V7D0^;;;:L&UGH"$1&YEQ#L%Z=PQ6
MEX91;:AY=',:"+V)6BVUHCA0QR,'1-K:$;4]/EVO( <E7C3R<?E\-^ON[^NU
M_"M;+F]7)_$3^T)L^_3+6%"%F8ZAI!)#A(((L@B9LR'62:2Q-N="X6/C^4T_
M-XIMI"_=J6?BH3XK3P^VYVJX&8#C83PR*;?#"_;"@S]'24[M!MR0%J&G!)/:
MA=W0.;8..X[2C>QL=MW;LF[D=[42S[="Y%NVO-V\97G^;'Y86J.+,(Z4Y)1#
M&U!@SK$VU3.,)0QBRN-02Q4CKR)13K/.C=KN<@5MNU962>M'8VXXN['7X.B-
M3%I67G @,+B]@J W+7DA,B0;N4T\*0EY87',/7X/=XQL4G6XE#6__Z'D=S-N
M?0Q BB0L81ARGBB($H0@%3B".-4RUA)%C'CYRRY/-3=RL>G->U%!+:MGC-)E
M8-V(91BX1F:3\T@-V$76'8U!0XXNSS9MF-%5K4]"BZX_X>^_.NX'M=;WZM&6
M3\B?[<7^YGFS_I0QGBW-7Q>IBE@H>0 U2@A$) PA2U(,64 #:?\02>C1O]1W
M_@[Q1%,T)#UIJ;76(%=BFY?)@V+]:"/_J]]LUF!=MO4J;1LEP;+6K2UNN=^:
M7?>3#;X$4^5HGL*^$QQ4DEO =[*/!+"[2VTLH"=RL0T'N)?;K0MJ+6XXK^$F
M<\MU4?+03=?I^3YM=ZP!:X/TJ]&K:Y3][E0L0H6TBBF&@;:I1#:?B N-(&-2
M4A+$!.' OVG.E5GG9FS6[X1BN:V%6%6Z$P\LM\7QRK26;&]?9:NZ])FQM-AR
M\R!8KL#_76?F5_\TO]^V%+SHL4R218'280I3R05$5&-(-&90R314+$V(D,(O
M/'BXA9HT,GC^2Z6$691 2!C+(#5+A3@D908*B3 +!<>,T0[-X\=:KRDL+QN*
M:E,LURLS8]4UUV6MQE@=MX/?X"PVLHWUHC98A6W]HE12'QP0!\Q'\4)I^-Y+
MUR9^A<Y)CEB<[WOD^G#G/&.=;>P<"T54*#$WFSR2"*(PC2%+HQ J)J.8D0#Q
M6/L4*MP/[;6Q3U"7T/I&7E0C],[Y;3 +<)I&491"*KB]RR0*\CC@, T90BC@
M 4J]"@UWQ&PBS]LPF.$$)V;/2\W^9]T0/*;0?+DBR'08L"35%$=D\4/E?#TN
M:H=3_$_ S6V/ZH;%),[(%X4J]VT%[RH;X*1<Y86BTH,FB!]!-7#>=S/ZU.G<
M1UJ=R=(^_H1__/]]SNSJ?7M^Y.OE BNFJ*8"AC)(((I#6^Y68D@5I4(DD<+(
M*;KC9.2YT6 M'*BD<X_F?PE7^ZO<"X21WV1'_;UB\\_JVB,6_^5XD\7>GU7C
M,-;^_ >ZUE!\Z3&R%N*M$-O'[=(>W[Y8-_69HK-U 9L[E6=KN:N.3*6.$DH5
M)$@:*R;0&G)$*10R)4&$-4J09Y;QD.+-S]NPUTY)NU/5^WO1="B] :NJ#'/]
M"QL.H:H*0KZ%&P=<982D$(S&$+,PA4BD"236N\<#B@+K@F!2=O! O/)23^&H
MJ%J>V,2,E^O^PMU4W@R]XO*ZF8>3K]8KW2:5SHX#Q4"I&3A7.WW?O[%2[["(
M^I!50H<'?MB2H@/*-W']T>&1/2U6.L(<W7;^.G3@G2JR[U4ML]N?F3E5$VK^
M9X@]YN9HC;@6=C=G,(X"2I,@BK1?[.'Y:>9FCC=A+0=B@C^MH)[U0"^ ZL:I
M_:$:F1T[H.3-;^T@#,E4%V::E'/:M3UFCRN?[II\_W&EU_ECU0\G6ZDRKW^!
M&(Z9YAB&<<@@TCR YDO!(4VQ"$6H[3G=+_/^W#1SXX$ZB?Q 5/"G%;:J+>%(
M!E>0O7YH'P:OD<F@*U0=TNW;D.B=:W]V\(D3[=L4/,VR;_UT-V.@JDAFN&5_
M5[2K0<U3*36+8I@*)B"2)(34-J>-$J4PUDRC./2Q"%KFFAL=?'M1Q-!N?4^E
MS[.3"[X-8S<#82#D1B:&G90O7?6CU-QV0&1(DZ%MNDGM!@>]CXT'ET?\ X??
M9<73NF#+O^?K[=/N+L8F3I5I#5MSIJGF7:_>Y4QO"K:2YL!3^D'NV+.]HZD/
M-PN!F2$4QJ! MEV+X#%D 2(P8&D2"T&)1$ZU58<5:VZ45(E;>HI8+3!XJB1V
MCVP=<-7:F>OUUF)DDFN4 J56A]>0AXJ!G68WX&#A&NU K=[.<_0J*^@>N?PZ
M*SE17//$*^H5_#P\\"VAT0-.-EG@]/  '895CS!Z-S/=0Y!F_K)JP^U*?EJS
M5?%5"97]L/)\5IM%R+$(B&30O!L(HH022*FQ>U*$.1=Q3"2/? S[0:6;V[Z[
M%ZZHKN5V=S5 U&Y_5B:-^QT*AEU1MV/$JZW3[/;D1KV;NF2,7=-21;#7L;V(
MAO>)913PASSC#"O@I*>B4; ]/D>-,TE'M\V%^R)[N/M-Z76NCB^<"GO%&XF0
M<Q)H2%""(4H5MK7(.%2II%P&88B9\(N<[":(#W=,$V7YQRI7;)G]R]#$=Y89
M'B@=/:KX!:Q7)>L?Y!0\*&G30EB>%99C9-4E\JF^^]VT7/H.N9:.GJ/1UV=L
MI]+%:_?&O<1+-<")'C?#WK_W0W)09U0W2:;U4_5"Z\2%U6^TKB5[5M]MPZ]W
MBF_NS1!-2?HD9E02"HGBAD-50" GFD*F4X&L68V"Q*]&S[EIYF8%6RFA%1-8
M.<VK96;PK$I_!5<W/NN/ULA\U0VH#I5XVG 8MO3.V9DFKK73INUI<9W63W=C
M@[*&[-=]8>5WY:Y?!>941:5LNFPJ0@;3((D@(B*"U.;S2)*0B/- &'+H$!YY
M=>*9QCSN1:[ZA3T^&DNJL,KXT<5UX-V88Q@<IR&14E9P("RHI-T%&)8"#\<F
MSM@,22S7)YV48YPQ.*8;]P>[,4^5M_G-5I0I"\5\^/$Y6Z0!BI,HD) 2$D#$
M @6)C /((X)%1%*BL%<_PG.3S,T&.4A:M7G=JLI$+G8R^_'*65C=J*0O6".S
M1YVBO9?O!GSX)_S\<3B^: -@2(HX.\^DK-"FZ3$1M'[6/T;OD]FKEU7@3QE+
M2BD*4J4%C E*K/,F@,:N2& 4AQ&E.L0",]? O*.QY_:FE^(U#2]]PG'/X=;^
M3O=$8^S3A <07O%U%U3N$51W/.)DD7075#D,G[OTD?ZMU9OV>!_6>>FD^)"M
MV$J\;-<=T(0KH5(H4F6;V D.68)"R(,@25,M.$F=>EEUG']N+_<7_SPG7\3=
MMO$1<1R9%EXV1W]SV-;TESI1::? Z*W1/: ;JRVZBPBOUA+= Y^V=N@^PW0,
M,JC3"Y2\+>J,@WWG];K +0\297MRFM-&BJN6-N:PH2&+$ZP2KGGLEAW@,>?<
M^&O?E[X <B=^V5*XO!EJPO.\ZPJ[X.]XT3\LJF-?W^]!9,6NT/!>X!%J#GL
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M.H"<"7-:"B(*28HUQ%$J><"3B!+<5*&X=S=9O 5Q^CJ_K%!Q/\$+;?2HLSL
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M(-<HA@$F"=*I#C#S[(OK-O'<;"Q[!'JJQ31_617V'5$_[=\\:W8X0^]&-&,
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MC3\W3MB+!_XL!>P<2%S!Y_;V]P!E["M =SQZA :_T'J<8.!JBE<*_WVAW^6
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M6YO7<)-M3EV4/-Q>.CWOOT'</;#\D8GG3YE09BMK:J $B10$:0H#G#*(DHA
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M%!0826W. W6/O+J$9#N=#(3/R.QQ%IH.T6F7,'(/3QL JXGBT_R^3EZA:5=
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M!\W*.9QM<Q6*(:V9RY--:K]<U?G88KG^0,<:R+F2V>8#$[8;]O.[]2/+5HN
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M;\*>FBEF%7'GRSZS=7T)&VD.!E[#2BU@H08XZ%$&8MZ 6A70U.4&%!,!K#K
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M=9;G>8HH3KU:@CB//#5^KP4'=K)!+3JH9 >E\*"6WL_8=I\.-WMZ$) '9OM
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M*.6QU ED$>:0<)E"CA,*5:X()PJG6#E59G09;&J\=J'VC*<;I15>-YX*!=K
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MQ=6;4@_WI>6"HZ7=0/)UC5N&.HT>L%;*1AZ$+$U2,_L0.=( D=,A=4 ==5&
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MTW?9.I>\L=8T";FVD],-HHY2]OV=\'C)=X"?U_/9QP^X.*_7?UZQ(&M^4ZD
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M+6UD2D+00D%"5Q235@G79,;G3M0=GW&_?,B'>DHZ092Z&$5K+^6Z%$6&((2
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M$%_-TI^O:@:#=M8G"\S6-!8O#J*7#CCGK'AAC$YJAWWCX2>,I_7#M?5(0O!
MT77@D[Z_B,MIGH;%U_>AFL?U-(3U<I"\DBL<Z%3'1%M5:.=D#)PLN>A2#*FZ
M297(0Q2-?"GZ"2I$!M%%#Z"Z(;]FW]^4;_VR9*7!>D>,TK7L/IEZ*21+$%G)
M-DAK@FDS+^6[I(U<-S(,!NXC:UB%= "Q5V_?7!VYL,(#"TA&NU[VH8T$IT(
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MR,6(J1C(.2A0*=>AV(8\C'IMEQ<II-AF=N]^=#X5H[@/OAZ^BWIXU740_3S
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MH&Y '?5VY$XR,T$+$X'Y*B5?ZJ#<;"#)A R1!2F;%&G?HV+<K(/V1^5!4N[
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M<1'1=0VU$]$+%QB84A]W$D;P1GEPW")MI\"<;.(##D+]N"7R3:Z@SZ_53FO
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M<8[,[5RQM_/9E\^X^+86[]']>HY=J:V%.H#+MH;+VN04B^N$Z4!.L8O@C,N
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M!1#>%^8$DTXTGECRHBJG#U+](973A^BA TQM*<FL?4VC2 R$,Z;>W]>L$,Y
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MK=RL?GZJ(EM+]<V/=],)4Z5(Z\@]CZEV_E(<7"FLODX5E-HA;]-M;1LQG=0
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MRV3B+<]893O)HZHO:(D[,H^7I#QQ?OVB#TE)EBCID#S-TYI4);$E*R(N']
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MFD34YC+',PU07N]*Y2-&),4$,U,D2A$Y\.28KW(K_QA!TZ)J#&4_BY\#)-\
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M)D;!+Y!Z%%\O+OH_NZOKOK7J1X9DT#Z4B<]1VD2D!$F<\8Q$S!Z-X48[[@8
M8M"'3=L+- XVQI?JQ# Y0S7$Q>QKO^<"XN6\N^HNOC_"5^0TNC*?F2G93PJW
MY76>PH"!<Z&TDUK0 6C9YS.G;<L9!S359#PA=I:+U?D;)+Z[VNQ5Z]OW^QB,
M!1.4T)8 +U.\;7F2'%397BYE2DI"ID."5/R$.P$J?G4_.'V<A(E/H1/E.R.I
MH#D0;:Q-1H8"41*MK9_3ESBQD ,QP5')9';(53T839GJC*78)W%R@)0;2(<_
M?(6%+Z:TS?HV7E,C'[ZT("AC%9%,66(%).)]RH+F%'BLT\>TFYZ6<'.(HN\W
M(HT@]0; \Z9;H"/VJS)M\\=#%S0D#,H2T9SE\AY28<"6#%%EMZ)#=RQBE9ZA
M1RF:Y@2K!J!Q)#_Q2753>?H9NHN%_WI9,H#>*WN((5H*1.6^592+\@*;$9."
MPVA?"T_96$?5HU1,G%Z=,.@91Q%3HVDMB;LL; S-"<V<,((P[6)INM=H:+P\
M@97*N) L#'JD.0Q-CU$QW0DVDG:[L44](5YB=SU?+;Z?__W3N;*1,6"14.-]
MJ4.Z,F!D?<$O<E0LN!VO')=;="PA_M=%]^W/F]^X!LCFB_OXN/W4"<$PCNJZ
MH^0XL:?XZ7K1?=T.^Y#:.Y$S$,%9V=*3!0F>2J(9LY;):"@=\H1JD'.X^\'3
M!23C0N H@4X,A/>SU>RBE_D;OX3UJ%'G<S Y$T_Q])2T%*2ISP30+P*-5J@\
MY+IY$!P>?OS$Q;D3AAQ'BKXIX'S&_\?&@FR"G!GW1"1:Q)$R<:PL$5"EL1ZL
MIV%(I_$!\+DE8KK#Y5BE/HJ/ R4\^;WA G[=7'O=+5E_^#K#B.R6PVVA&C23
M@#Z7QK(D2^'AZ;G5A L6G47?/.PR8+]/;04LAVJX.XFX&ZBU?+Q915O&YWWZ
M6JH*B_?=9LU:,37M/9(L!*%]YL^\(E8%BV*T*=#,O(E57CD\2]FT#V=/W2TU
MKJ):1][&9IGE-*$[)^CERZ)9@#)1! /)<I67G.$)J@PB&$#;M*TT(Z-A'ZP=
MH)H&T(94PW(UBX6A;4:1O$_)2.*3I>4&5Q*K-1 =C&&.4LUCE3T)#TEI&$N'
M:+L;5?1MU'.0?ZY5#J4$P8@$ETF9?T= :4X96.EA1P+W(NLY8^GM83%G'R$V
MX#-^-(P22O:>U>;HA&*)A"20"Q.!N$@ER2)&;R,57%1YN;";G&E'+$P;!1VD
MDB:!M>U<\H):XPQ)W&NTK^!(B ;0ZV9@,87$LSH-M-H+<@Y3]K/X.4#R#2#H
MK,P9Z>;]R/,?IZ!O.V"34EX(2\#)B <VBLN"CNAOH^#:* NQ2N3\'&&M(>H0
M]7<5==$ MCY"/PWOS"]6W_M5Q#[V_8^OO]_]EXTIHKAL:;+,%.,!*(/3K4//
MGD$8S0S')*2.OQI*XK1S6DY_/%9176.@W-BL2L)3I=#["X-FQ;@@H33DYNR8
MBAA7RE"EE^PA*5,[M3I*?P);!VB@ 0S==#?]3S>;K_Z!HKU>;*\7@6:=A,3,
M!N6#5F<X*3D-T=%:9WQPF*U4[2Q[2%,[J#I$W8]UEATI^ZF[@6X<^GH<UB^P
MNNS2[::PA]\%^-5_60>NDJI2*O&$)\Z)5$")"\P1IIR2)@D7!VT1&M8P= 2A
M@X!G7_J9>5)U3MV:\@@?V^I>4B:(+$G4TA#I()- &4-<:>I >3]L<\NP9I4G
M29FP@^ED4.BJZ&7B2^GU3ON_@;]:7484]OOW;^Y_:^/M!6/ &8M$>5K2]QR)
MH\J0&"-DQ1P5]\.VG??1@S]P.DB-J=VNMJ@;B,\^HH06UQ$C@S)?$M/I=3<I
M==(QS)XS8XI(3S$Z",H39R5+@ANJ>*4[P!W4# *3>^E'XW@*:1%5VWX0D[(+
M5I' ).9"*3CD@"O"0^**2>LRJS*CXQ%ZIH[VC];T<]@Y0.P3GVF?5B5AN9C%
MGQ?=[ZO+=_/9:H8:^09W;L22R9B?!%_NP<KL9F>)99A10^2,1V^4#V+ :3;@
MHQH#R"'J[.K)M@%'\X1/?G^S-XT+[:)6FN1R;R'+X1RDHT0(IFB.1BE69?O1
M$.*&(8S^44ZWT?75  9_O2Z6\R&OF2HBVCX%/><YBQ2Y(>"\+0U!@K@R:%*Q
M'"FSFJLZY=+'26IB&M&(ZN^JZ*(A5+WI6SEFL'PW_^?E+%[^-%]A@K-^=0RE
MNFR<S(#^VI6=' [0&*GQQ(A@?-!&:E]EIMXP\IH8>50?;2/J:.+P:\O1MOGZ
M]<+/T[W!/F>++F%4LCS/ 3B7ODS[TH)(+<L^4@Q+J #&I/,8NZ8!<=@^G]G$
MG*3Q 555] TXLR<$ARSEV:JL;;D9LNHQX!0)2F. 246"C-B@)489U(.47DA?
M9TO)/E0V,7RIGFNKI[$&X/@1OL'\&F[I!R5H2DX24:B6V0#QQ@K"O&7<46\M
M%S40=Y^09J.S8W7^H%!QA +: 5#99?FF[-Y!%OXY6UV^N5ZNNB^P^.E?FX4]
MKY9+P/^DLCF0<R659*'<_G,B?;E[%=20K*D&)F3I6*J(L7UHG;KL<0PX=B.M
MFJ8: ./-!*+;#6@WH@L*A>.L)3%R3'J$\B2$S AGB4&0S/I<9U_CXS0UFQ.,
M[./&4DN;"#L/T4MA,+C0P3,B@[#$&2:)"EE07UX<F"%S?<9 UK3N:C0]/X^?
MO80^]>7TMOGHAH^?_O45YDO K*9?WKAFZU=8G4>;.94H)1NA<$4=<5I'HF4*
M/,4@9;I7P]A].SWX$YO-(D=R017EW\Y6[>VFPU?S]!;":L/=N89H!&A%<BSC
M9Y-(!$_Q3%RR23H>4F!5-L/O)J?9+''DPVX$9;2$K*W#W8:-L_DUBF]C2:7-
M%U"0FXVS&#'"\J=_H0Q1G;.Y7WSOL^_'UG)JFZ/0F)/[,J14HAOW,G%B,,8M
M<R&SK',#7I&GB6<"G!#C;<!BPG7$Y6#99%1O83'[!JF(XA,LOLTB+,]@$8OJ
M+]#P!23&9"!:.T4D1Q%;$(J R4PXPW7,0QK.AGQ6L_ [OB0\NJ@;R"5*4]X<
M?^3[^W=__? 1E;7X!F?]&N$WEWY1^/&<:I0,YMS];0F-Q"O :,1QP<!&[:%*
M+>XYPB9^]%N[X#NJ7HX]R\=O0ELSL3PW%"52AO12'=%:;&EC$( )FO#,I.@S
M=Y5>SSTD9N)W<K41=;3\&_!6/W==^GUV=?7NRU<_6Q1Y]7FX<=ZCITT$@$LB
MP0+Q5GL,<Y/@CDI-:95;]]WD3/QVI#:.1M!!LTC"]/M#+C5GKZV007,"H1>0
M0&[ 1Y)!6DDQ<]*J2J?0TV1-W'H]#;(.TDD#"-O]AJ:O]7R^]///\*44A# /
MN>'V/!O!N'&.J.0ID0K%Z)%X0L&%H!5:5JQR)[4_J5/W2=:&8F7E-0#/G_UL
M7LSKP_R3[QM.5UW\[=W\TW58SM(,6?NPV/5XY]Q%QIV1Z.<=!@L2.)!04G;J
MA1766!5CE5?"!]([#*@OM\/R%&ILM12XVTB7YQF9 YL2H8&%LOHPD8#?(=Y)
MH"R!QS"E?E'O$>J& ?+E-F&.KZ)VX%>X6A<:+V >OY<OW\W76?FY<IS%% WA
M8!VZ?ZF( RU(3#Q0Y:5WJ4HE^0F:AD'MY;5GCJV.!D[C'X<FE0= 'R%V%_/9
MOR%A +SU\F^OX7/W"5:KJWZ"TY*=NV#+UFA*C"B/CY0#@M^ TD:OF?#1AU1G
M@N>!! _#Y,MMU#R)(MOQB%M^-J-2/G>WP\!ON3M/)AGI?2">231&KA)QI6,B
M\TRS9SDX6Z4Y91!UPQ#Y\FXLZJFH'?CM8F5[V<VXYDE03K16R!$SCOB2GE%/
ME15&)4>KE'">H&D8U%[NI<58ZACM0/[O/S^0-'+ZVU_^M/F'\C_!+^$O?_I_
M4$L#!!0    ( /M(8U%QG&Q>$5\! &G1"@ 8    ;6-K97AH:6)I=#$P,3DS
M,#(P,C N:'1M[+UK4^-8EB[\_?T5.E5GNB'"27$GJ>JI"!+(:DYG0@:0-3.?
M)F1Y&ZM3EMRZ0+I__;MN^Z*;;6XI&YB(J4[ EK:VUE[79SWK;__GY.+X^G^^
MG'JC?!QY7[Y^^'1V[/WT[I=?_FOG^)=?3JY/O+]??_[D[6YL;GG7J1]G81XF
ML1_]\LOI^4_>3Z,\G_SZRR]W=W<;=SL;27KSR_7E+WBIW5^B),G4QB ?_/3[
MW_ W\%_E#W[___[V?]Z]\TZ2H!BK./>"5/FY&GA%%L8WWG\-5/;->_=./G6<
M3*9I>#/*O>W-[4WOOY+T6WCK\]_S,(_4[_HZ?_N%?_[;+W23O_63P?3WOPW"
M6R\<_.=/H;^WO[FUJ=3[H#_<'>[T#_M!?U>]/U!;AYN'[P\._W<+%OD+?)R_
MD^732/WG3^,P?C=2>/]?W^]L;.]-\M_NPD$^^G5K<_,_?BI]-%??\W=^%-[$
MO]*"X:_#!!Y/_APD49+^^O,F_=]O^)=W0W\<1M-?_WH=CE7FG:L[[S(9^_%?
M>QEL\KM,I>&0/YB%_U9P1[@Y_7C'"SJ ZT1AK/0"M[9Q2:??1V$_S+VMS8VM
MO_V"G]>/57NXB3\8P):_B]0P_W5G=W\#'^_9'V-[WF/L',!C7'R]OCH[.?5.
MSBY/CZ\O+KT36/?IOPKX[[&?C<I/YKXP/[V!=Y8G$[Z3\S@!"(E*.WB>]_ \
MGX-_G%Y=79Q[QQ>77RXNCZ[/X-_>W_KI[U?71]>GGT_/K[V+C][UZ>7G*^_H
M_ 0^=WYRAI^"'[]\@2-Y].'3J7=]P5^Z/+VZOCP[OCX]\:ZN+X[_X7T]/[N^
M\OZX/#K'W^F/57?Q"H[WY=57^!!^Y/KOIW"JMG;D$E\^'9VOU+[NP[Y^3%+O
M#U!*>>9]4+#"&'7(19 G?95ZV^][I#86>:J=]Y,N9!V?X6Q#+_#'W_VWDA+8
M?K^QLXO[<'9^?7EQ\O48!? A,O'/(LO#X91_%<8#$)%?=_9_P [OUI[Q$';X
M>J2\81)%R1V*!TCK.//\>. %23P@:Y9YV<B/(L^?3**IER?>I<KR- S0+EWE
M2?#-^QJ#4CVZ\]-!YMV@P*'%@@=+O1PN_B7R8[JBGRHO*_K_5$&.E\&_-=XN
M&9KO;7C7HS"#VX 5)(,(?[LVWSFVWX$/A7!?N.D KSU6*J>+I KT8DK?I0L?
M)P/E7<$*X%O>[N;A$:\LGL(G;XK(YZOA[](B@DV>I,FXB&[(",/U4D7/M>&=
MQ71Y=2N+PBN$,3Q$%F:PC&#J]55^IQ1^;*$'P!_U4_?LOO'6WR2W*H7-./8G
M80Y2]&]<#5TE3N"2N+"[,%/>0 WA_0Y@)8O>EJ\_\F\5W7.L?-(2&6S?,$GS
M$5]*7L:BTMZ5KE@B9;&SL4]*L]D8O0"UL?6#]KKI[I6]/M ;-5!!DM(1_I6.
M*7[OI]]),7E'-ZE2[ MWM>R??M_PCF9I3Z,\08/!V;\H\BP$=74""@RL=EK5
MJ7QV^ZB%X&-Q %_L3SV_[0YZ _#J^*7O*BAR_@Y>LG8WK9&.DW0BVXIZ(4?]
MP+IAG@:?\:@;WJD?C%H^04Z+=Y[D8:#D*5&W\C(4+CA50]#%\,ATYW[%KBRN
M<),;A<K3ZX,.]082+6FMB-H<XB;8I%E/H[<5357+AS(R?7Z4)?>V?R] 4VRO
MC*9HDI-NU06*U-$ (FWP*F"]>"KE)[@BNFM:%XQ\6'B1CY(TS,E)&RB4+;AD
MX^'.\"-WHV3<,\<\AY5[<(.<GL#/X<]A,.JQ3B*A;)'MNY"UT-@?*/9<XF*,
M(09\A3_!"L?'<Z\&?$<\7^2WM!Z!K #]0-_)-KS_"N%\IBJ;R-GQX[CPH\4\
M4?AX_?'+JK3GWLWJU<IAK7C)/7?!Y#'*:O 73W9P#WZ$/]4L?FM'Z\MR<K<.
M-U"#S3J\;#1.0.UW>V3)KM6,Z=C'B,#(9*N1)C<@89][@,8.3H+"*XK$8V"#
M$H@'!+\V2B+8 3@A1PW^0CZ"8PS&4$4JD). U_V0X$UT?%*^<%:],JV<3->#
MED]+L#<U6@G#-0]U0Y9$\-$P"U*%;[3]W.AMWMLXP%S<).%<ZZ^IPJCM5K4F
M'\&VY\GXUTW[%;\/=P6S7OO*$\O,X3R1V=I#^TAI)MI$4N57U\?>6O5=KC?E
M*_F_H]0F+6_4NWZJ_&_O_"%L]*]^=.=/LY^>.&W[.Z;/YN1/5TC+?5@:+;>]
MN;&Y/5O+G9=-:[>J[FL<J2PKY1_D>)NH@H]]PJ;V#TIC^.BV'R?C<9CG2FEO
MES^XAO_\R\_OM[<W?VOZ-/UIZ[?U9C]#JZ>AW*^B,^G/QETIKQ5$-QQHC^JC
M'Z;>9S_]IG+O3S\J:)&^=S5"-[ZBG/FB80RZ]?]NO=_LP9Y[:W?HKF!*:)CZ
M 5>$6$&F24$IJF*BE7&L?/0;T!D#18@?6J?L$LH%A5QYPLX)W:@'CLOC]YQW
M[PQ6,E%T_KSC$3ZR<7R,GJ^:!WG<Y]B[[2?:.P@;\1)9#BZ97A0(A+I)X*<>
MFITXD;P=/R])R@V$<9CE:Y4I<CJG=1L[*=*L\#FJ9B>R:</@@^)'J^^!@LOM
MX<-B.B!6=]'46.A&OP'^J<# P2Y.4HJ !\TW4<,A)C;AD\6DLM--,0">I:V#
MW\0]$%$S\K/J#BP6RM:.U__R\];^YF_U_W:E. _^8Z9VM\GU+F// ^O(/B);
MI17ML(A PF_A0JKFVM(E5CW)@37,G<Z2'._OF>0X"2E;.."*L1]APJN[M:.@
MF14INR+4TSK>;TT]@#8?&BG$0@6H?#7VR(*0+B[X4UH2(<8 H\I2V%>@_(=<
MNFF(G$"DL9JB4OB*%_@9Z/4@  .4PS7S,.++4\K$STBB>8>GJ(W)UG'.+\RR
M0CV=+NU0P'=71L"/L@SVS^^'49A/NY7LIJ"<G0ZLVX%$3M"-RD6)9BJ*P#5#
M&!$(7L^;1&IP \Z:3P^$/H2* W9/VLZ#I-1&(-.N8^)[_P)W(1R&\/E! H^8
MAX''@3-EVU),AH$@E^J'BHNE<-MK! ]Y9]J1^+IQ!=9A/(F2J<*,=RX%5O H
M [@XEE<+2D,>!2]"M^^MC.B#_W!E<S?>)5ZF8^5^KD*2R28M&U.5:8JG( .5
M#*\9!8W.@OJNT@##FX;O&<>5DA*9EE93BY_I[ Z4C];!EKUQ ?(EN1X%+$X.
MC V*FWV>Z1:AAS\Q26-X651SPSR8[_63Y!L^9SJEC'T?$W $$;*'+L4W.S!5
M(*?Z9IY!JP@(6Q1%M.7E-9NCB1\.;&" A;S(%,AP#V8]$JF&+$C#/J]3 RC.
MSC;VX2&BY.XEG//]E3GGUU2K&7I?_*E^A<T6H=NS?\HGP2>82DUR#EAR>FUU
MI9GUF[(5)=$FOXSRGK,U0*8FOI2S,=>MTELL,],AJI:[UR05U:%<S')TBAPN
MCZ;\A#Q5*H@9N%.7KUZGZ;H\4#,VSNM\;S9_NVJ20MFW-E36)$TP4A)PW9+N
M+2[X<_ /E:%)=P_3B0ZGCI/Q1,49_]:I;N./5 $Y.SLS1^_D^.@+_D*+5+<:
M32M<DRG%HC?I-3:R8L.'23J6T-*?P%N;I"$!5ZSU?[31YV_H!&>KLBOBU&K7
MD&Z:Y?JN-M<IRZ\4O&?A=SJMTS44J)X):5UM+*@)!C46;+_LZMS>[F3&U5?2
MUSM8&5_O"GZ3#;D4@D?51$]\)"_N8HB>1N'$^Z, #8#?Z=CK^TB5IR1K0AW=
MC1(V:V/!9R_P-*BMN+3A"98 \VXM;J,NLY3\PXI:F^TW$93'5MPLOBD<C]4
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M:=R+GI9/!,B &ID; B1T3+A@D9"*1".F$?NXD2J*:)V,7I%%T&"2^%TU9'
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MU/O2'-R]C7U]<$G+ULX/S];$C$O(=!9X (=ABI1"<8QS_'@Z^+!:ZJL@*%U
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M\@W6]"1P^#VGZ/MJW1N&D=0'I!R@S$P02R*"XR?Q_!<R8?8H(#V_=;BS0\X
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M 'B^\/Y239!6DJ^<TL$J$F<8I<G IMB+I\P$K%Z>&:XG?G[=MYU'%B@IF+A
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MP!),"9V%575!,JVA2-3FIDO"$2?$H:,CK9V5UNA2[OX(9W%5D_G5WQWS[QP
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M%9B& -1,!-H!FV3Q<RK-IZ3)XAM*SS0V[E5032B75:-4RD39$BOEU684$*Q
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MG0 GX@DU;<58Z5N(]!EAYX?DZ)6FDE?W84Z[9FUSG+Z>3&,':[\K"#O(!TT
M;FO.GA293FTV2@3)'%^(M],W!W)!I;)N>>/I;-$*%AADU[+*IC-16A^^IBPK
MJ%+$7%*&/)+IZMV6.CR$@MAQ.9?,P+YPJ%F>>@]X\I[6;],R%C0Q0^@KQX.0
MFKSP:AL>8PS)=Y6I0K>V'\]9NTX%&JF;B_84U(?&,)8@GC28T)FPV'#B49IQ
MTT&BFT2ZV<RUHEQ?KJP_:",>>@B>7%3OL?T5&2:-2.5$G^ =C:K1D:49E.ST
M0/,:YR$@A, J)HC>E<("%:ET@I1H$OV&2JCV!8YYI%@Z[[MN?@3/W!^8(15J
M7J=>I*U'>118@UUL/%T-,&9VR'A$]ZQ^7]M1S'TC+4^SYM!]5IB^0";,_%9<
MW= /P:OPTV^@0TN273?#\@W]\$RS9T<U:>W ECVKW =9"3(CP/>YZZWDKL1C
MJ#@"#8OB:70_VBG7RMT<3;?87O<>)0M?\9F;9&CF"#XM.+V'N1WT=7Y/!*^2
MEN\GM+!O:9=2VN7]2TB[K,8@X0=G"R10GI,PL+%33QIW1!',TSIS?(.GB]9-
M<+,8171=%;4O\@Y14I6X3?1U=2K4_&?%#E'7P:JQ%RR)YS_7[V]_T&6/ -+F
M",!D>TI.6^\%>6WW,K(_P#M[ZK&LG=$\8&+Z\]G5\>FG3T?GIQ=?[T_<L+(3
M[)>MTW\.1=LI:3]48]<:!6A'DW0\SUX?;#HC[DA8RRP8D#Y'.Z\):(=%2MF\
M)M1>.[H/YT@XF=13^:5)H%IJ T;/" [&7MI,WV5]J"]007YI3)76<32VFIP"
M2<26X)CE.2EE>@[DZT"$%6SYCQ[FW.'A6K8>_5F'BX;4D"%VWALALCXFJ4*>
MRV/DF<(T?K?G["R&8)RPAS>M2Q[*D@.]9':=RY"4D:2 A@4B4RP&!9L!U"W1
M9$EG]T*L-BXBT1^@).H%.I@A5 ?4N:!N?3B!\!!1$E#7DKZ.V^/$"$^Z4:1N
MX&.$;/"_EX82;'@?68=@N:57\T]F\EYS):$TXB"9T9/5JN'D2]:3%XX![1-3
M;4P-*CO1J_$^5AKY+>-/2/F+6&%>AH;:I=1?030MI9VGEK I:R[>VLBG#MJA
M'Z#*TX0!OA4%MZF 5D6[G.AMJ7EM&"R@<!%Y@# NX+O1V"_N(<8GS5E.*?W"
MQ3_G$5!, EINF+%21JF]2> ;;WF(4A[B\)7E(?9VGP[]L5H&<]EH'&89S#.G
MVP,'IPXAL,(?NK6.B-YS^U!$B6EFS!O0$2Z(U3AO.KJT:0[8C10;S!M)G!"H
MC?5Y0>;K/U'].F5R M!YGX-_P!6(W]2!1.SO[>WA%!W0T'^'M<,I];;VMWK>
M67I+[&_7ZCM8YH.]S9W#GDD+2;N>^Q1,==HT;::T]-I0&LEKR(>HNR*@N;U]
M%1/E<47A_Q4,#U:02D;NR"!]"3X!MV!;JJ_J&X $]1.0^A\HHC[/R6)A'Z*3
M(:-O\^NCJ\GSFD>R_*;$#D9DR(,"+!WOQ=V(R)$)ZB@H R: @$]DRD=^:!43
MAP#E*.Y2?S*QJU64)?#1_F1^.$!L_ TF$E-&8 9(9$#C)YB+@$P(_+0&_\B1
MTX J<3>.-37?"22EH+ $HC ?L2ZK2ZBH.I06R3X.+QRYOV667'(YX'S@]F%^
M!>&3D2%;Z'E9XF&?E:[FC=&VWM!TI"!2/CX]%6XP::(LE2A?11Y^#7$I%D"L
M6RI)\!Q:!QST,<GEUV!F!O97J;# XF)MJHQ6L@&AE;MB<$RJ[S,)@B+E%TC%
M2D*/VL$BU&&F3[,%,NDG-<S8\@5^1[0^23C!'\))"$\O:\F:SK,C9[107AI^
MPASHO_R\O_O;./A&)WH#')=7%,BMTOR0<I!S F^?4<;'!N#>L86B/H# Q3Y7
M(S/MG"N3#J4H@ZI^: S^56!V%+_NI\RP4@FQM -NS9K1U[V.(/^K)?"=311Y
M;%KP@FSN![#D0X@941BZ'N*0(('=C=@5ARM$2+]XY3,&-E"^P$3>BMM?!EK?
MD],R1!^,<A6:6+TR88U</;0P8&K2^@15I@2(,YU_R(I45ZB26G9214-BGI=S
M)A1(:+7);-1+) L/0X>PISH,??5/TBK-0/DOD!4<Y %?Z?;07*H;4-J1@' <
MEL8&"',Y?TT<;K4I)'"!H8+']"-0_[F,1>;T4!@3B47N?T=O4GBXY #TD+(Q
M3>"8TI_UT($DMJS[J2%"^OZ.DC#H?A,7DOYIQA2 ]H2:2?DA''OF=+<UJ0%<
MPP(NY99GN "+A*Y^Q0\,VYPSU@ZA[6/<FBC4U8&A(,1KUR8:$%)"V,Y4&UKW
MUXQV'Z&3<B4&WDT)625C['P:)BDE<$G9C534-H/3?<T<&Y0JJ5)&:7ZT"OVP
M;NXL2<[:UCKFE9%XN=0>3RJRE,_#AT/Q-(0,6-1Q!\4T;!<I_ECJIZ8T[[.$
M:A^(J[LV_6N*WSU3#B;*-,L0ZWS-STHS,RF4*/I,/YE79QF:A&QMR((6/HD<
M*,"1Q[(TK\X>ZE\2"9W0O3J(W.UU;Y!PZ8M&G'#\E IV#O>ZS,6!;7\@$&FE
MM&1V0K?0-NP<IVR1/8%V"3LJ8IWM;3I\93&OOS."9Q 6@^TC7:*(_%0R\ C4
M,;GW7@-OI\1FI%[<D>;P;9 ':HZ@:2?8+5'JD^RK_$Y).$AE&>^$JH;R6C3N
M@\$=D;JE]^=_)PU!,(=%C_Q"YX(Y%<;&"Q XBA6V=9W;=G--=V)*>!M963;O
M\\R]>,N$NYGP[<U5SH0OKX_V1<.-&H]4PB?^SCI'^I0UZ%SWT%&N!TF?L1<*
M38L_0.P8'N4TQ?HY5XMXNBO8P21MY(=N.9D]L8IAJET="F1Q) ^RC^7R-W?L
M)BI8NAE;V :*A!M1I,U6'RRSM'9AL_>X7Z'D,I B(A8FB^INFJ');N1[)?X/
MXTX%?C;B-G(](HNP3 W^3X.WT+)ATO:TW; J(E-5=NI1F[FLI!DDPZO;WGS/
M(LCX"N[?0$H'/KUC^IN(0*.[LS:C"-M7$#<.*X8;W;$B'R6IYG(KMXJ5_S9G
MNWBTE$U6-ZX0-?Z\^FB#TU/?VW5-I>*M[91?C!VBA:0!659HW'?9):*EN\/Z
MK(=4.: ;WK$?!3+B2[_I&GZ3[V><T?*<KU*7 ";;N9.?DMBZ8=)!Y\H'44O]
M#W(4\6]-&Z/\64CL=5EBK,=YH=*IK*9$ND!0"/"@1!D9V",ON?K&*O:9-A2$
MG^,J"'KX\3>\_ZK%3KK)0&2='$0#',91[8U:[;&Z!IU$]!MYW^O8R4:"E38G
MIH0GG>4SE9&=L##]#%SB<1["G:K-+.XH[Q&A0%&4:_QTBV</E]=07L/;NDU
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MJ=B/2;0+6$S 0)4FA,:,KYB%<E)+J?4>HTP17Y@460/@LT?Y1<T%R=PO^)L
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MRT+A"V$!P/*%_<L5Z9,C7R6%@Z-$C&&4)@V;8BN>(A,P>IDS/$_L_+IMNXP
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MJJ0RH+ZB6%V@]GU*048WW%TM$>Z\W+?OO#(;=FK[4^2X!M>,QZS ](7*Q8-
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M?<1/K?\-*SWBRPXA=45)>S,@L-Z\Y,VXSD,DQ1I'"9:-+;!R%)81=G^,#<[
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MA/@G#VZSDJ/X>FDSC=I#7FUB!7(,>K9!D:ZI\N% M8D98;R$.W -;+2>#_R
MW_>.@6,E5HZ#;MV*E/F7-;M+"Z\KPF7CQ7R(R0F,8"+JV*" ?05,85%@ %3
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MJ5#SQ]:*=3R'<_$1+*$$J1FK6\ZZN*'!3%5+T4)J]5]?^R8:?^<A:_AB'N:
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MQDY7680AAD0D1JWRLEG,]Z?W9>H18&]MQ3!D]0"^!O-<\F4$-9W943;]1/]
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M$J'Y1E73_?([I)(;\R)2S25U)"8&X%1U,?>2Y#E0O>CR=QUTCE-=V7U^OG,
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M=(42T2[, <HX$RLM_,A_\S>9I$UW:O4:M"S5@>^>)+*CR3Q)%NXUZ(KUBB:
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M],'7_%HIF"7S@M2YE7F^"G^^N8C8XSXO(_"PM]R.9H8A YRKPVWAIN45G4C
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M UK3$TH!A0@<M-R-)@=9/314Z&R7A199,E;Y"@KDBVU!47U.7XR=_,78G\!
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M/.0AAW+(9!C;@)-[#O$,"\"=:(0)U&Y$#T@&QLP%"_$KF;#08 "R* =H ()
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ML-"*Z7V:24H]N\3+_F[.=%%C+!V#=HX0#H%Y>4^''52=VTU)@>)M[-L+HUN
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M%MN8J>+S&ANA)FW'2D]ACRJZRG0TM'-8:MCF<3\V_6NXUNB 27YX (VHTA$
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M5WPFU5?!NA.C\)*:"9%>D?D8'Q%>=TRD'H99@;,K3@](*V[08;E9,T:_5.R
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M'P(Q(>QHH7Q(R6<1[Q6)J@<5^UV(!<55T78%Q=L'G8$Z1[\_ZEJ]70Q$C(3
M4,ZDSB[0ZM ,.&=&WCK3X>GWO 4Z1X!L;P'PORIB3#4J4X"(B@-A?T>H\5G.
M<EOV@)13-A K&\)^0M%1?Z'+!=(,,M,7$CN&/XS$OD^B"ND;3-M300 =+_
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M\&S#L*2*7 9+G6^)\T@W O@ 5HCQ*!;<)YN0T1<ZAG<#C:"B,]Q#<BVJ-1@
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M/$%4_@TE+V;>:3C]0+MIE7KL7*0D1O?I");^&F[4<I.="\XKE35UPF JPN@
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M1[AU%ND0 1#,L!&\'(BGHAV#;)"9@71,%Y[Z"6,>52U/8#&P,R)3AQWA0XP
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M9NS7"JTGH)H9E%8P@')%$)XL@Y0NA;L)@R@T;)HYNU34R(+/^C;.Y"&*_C$
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M*:4 #,.]QO!3G3X@_+\%,T:MC]3]\IFPX<86#QHEPF+9:M+=5 L" [%0)=0
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M9^_VMY[X]//EV;<_>A>W-^+[L]-OXA/Q^3^%[W=Q>WI^X9W_(5S 6W"(SB_
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MM7SP/_OI8";^=S\=C_[[_P=02P,$%     @ ^TAC4;?W'GY2"   J"D  !@
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MW6M4#UOMC8:MN>7U2XQ4F90GKTNMTJQ#D?].,[UCC=7T$R3NY\\#Z=L3@_O
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MRY=^S.M'>W\!4$L! A0#%     @ ^TAC4?N]*('%1@, IG<H !
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M,C R,# Y,S!?9S$N:G!G4$L! A0#%     @ ^TAC43L-_VXL(0$ ^\$+ !0
M             ( !?$$$ &UC:RTR,#(P,#DS,%]L86(N>&UL4$L! A0#%
M  @ ^TAC4>!E5>2$NP  2G$( !0              ( !VF(% &UC:RTR,#(P
M,#DS,%]P<F4N>&UL4$L! A0#%     @ ^TAC47&<;%X17P$ :=$* !@
M         ( !D!X& &UC:V5X:&EB:70Q,#$Y,S R,#(P+FAT;5!+ 0(4 Q0
M   ( /M(8U&W]QY^4@@  *@I   8              "  ==]!P!M8VME>&AI
M8FET,S$Q.3,P,C R,"YH=&U02P$"% ,4    " #[2&-14A=Q!68(  "@*0
M&               @ %?A@< ;6-K97AH:6)I=#,Q,CDS,#(P,C N:'1M4$L!
M A0#%     @ ^TAC4:J=UNXM!@  V20  !<              ( !^XX' &UC
K:V5X:&EB:70S,CDS,#(P,C N:'1M4$L%!@     +  L W (  %V5!P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
